EarningsCanvas

Loading your research…

Opening the latest published company and exchange records.

Management on record

Daily management commentary captured from CNBC-TV18 interviews — financial highlights, guidance, strategy and risk flags, per company.

200 interviews·200 linked to companies

Emmvee Photovoltaic Power Ltd.NSE: EMMVEE

D.V. Manjunatha; Pawan Kumar Jain; Emmvee senior management · Chairman and Managing Director; Chief Financial Officer; senior management

Q1 FY2027 results, per-watt economics, DCR mix, order conversion, capacity utilization, project funding and backward integration·Technology·16 Jul 2026·Official NSE Q1 FY2027 result, earnings release, investor presentation and company-hosted earnings-call audio

▾

Key highlights

→Revenue from operations was Rs 1,555.5 crore, up 51% year on year.
→EBITDA was Rs 548.1 crore, up 56%, with margin at 35.2% versus 34.1% a year ago and 32.8% in Q4 FY2026.
→PAT was Rs 380.3 crore, up 103%, with margin at 24.2%.
→Finance cost fell to Rs 11.1 crore from Rs 53.1 crore in Q1 FY2026, supporting reported PAT growth.
→Module production reached 970 MW, up 53%, and cell production reached 454 MW, up 26%.
→Effective cell utilization reached 83%, while module utilization was 45%.
→Order inflow was 1.484 GW and the order book reached 9.9 GW.
→The investor presentation showed the largest customer at 28% of Q1 revenue, the top five at 55% and the top ten at 73%.
→Repeat-customer rate increased to 57%.
→Management retained roughly Rs 2,400 crore of FY2027 EBITDA as its operating target.
→Management indicated unit EBITDA of about Rs 2.0-2.5 per watt for non-DCR modules, Rs 6.5 per watt for cells and Rs 8.5-9.0 per watt for integrated DCR modules.
→DCR represented more than half of the Q1 mix and contributed to the higher reported margin.
→Management expects more non-DCR module volume in coming quarters but advised using stable per-watt economics as the base case.
→The 6 GW integrated TOPCon project is estimated at about Rs 5,500 crore, including roughly Rs 4,600 crore of hard cost.
→Approximately Rs 3,300 crore of project debt has been tied up below 8%.
→Equipment representing roughly 60% of project hard cost has already been ordered.
→The module line remains targeted for December 2026 and the cell line for March 2027.
→Management said existing cell utilization can move toward roughly 85%-90% and module utilization toward about 65%.
→The G12R cell transition is partly complete and should increase effective production.
→Standalone cell sales were described as meaningful and the highest in company history, but the exact merchant-cell mix was not disclosed.
→Finished-goods inventory increased with higher production and some delayed customer pickup.
→Management expects the order book to absorb finished-goods inventory and is carrying extra raw material against geopolitical supply risk.
→Management said silver-import approvals remain procedural, with roughly three months of requirements applied for at a time and no current India pricing premium.
→Cell and C&I-market selling prices were described as dollar-linked, providing a partial offset to imported-input FX exposure.
→The proposed 9 GW ingot and wafer facility is planned in two phases, 5 GW in FY2029 and 4 GW in FY2030, subject to ALMM List III clarity and market conditions.

Financial highlights

Order book: Approximately 9.9 GW
Order inflow: 1.484 GW
Q1 FY2027 PAT: Rs 380.3 crore; up 103% year on year
Cell production: 454 MW; up 26% year on year
Cell unit EBITDA: About Rs 6.5 per watt
Cell utilization: 83%
Q1 FY2027 EBITDA: Rs 548.1 crore; up 56% year on year
6 GW project cost: Approximately Rs 5,500 crore, including about Rs 4,600 crore hard cost
6 GW project debt: Approximately Rs 3,300 crore tied up below 8%
Module production: 970 MW; up 53% year on year
Module utilization: 45%

Guidance

CALL-ONLY: management retained roughly Rs 2,400 crore of FY2027 EBITDA and indicated stable unit EBITDA of about Rs 2.0-2.5 per watt for non-DCR modules, Rs 6.5 per watt for cells and Rs 8.5-9.0 per watt for integrated DCR modules. The module line remains targeted for December 2026 and the cell line for March 2027. No quarterly revenue, cash-flow or leverage guide was provided.

Strategy & commentary

Increase utilization of the existing 10.3 GW module and 2.94 GW cell base, convert the 9.9 GW order book, commission the 6 GW integrated TOPCon expansion, use ALMM List II to grow DCR demand and later deepen integration into ingot and wafer manufacturing. Management emphasizes absolute EBITDA per watt, selective customer economics and supply-chain resilience rather than maximizing utilization at weak returns.

Risks / watch items

The principal risks are cash conversion, finished-goods and raw-material inventory, customer concentration, undisclosed order-book execution timing and margins, shifting DCR/non-DCR mix, silver and upstream input volatility, the debt-funded 6 GW commissioning schedule, peak leverage, ramp-up utilization and the conditional timing of the 9 GW ingot/wafer project.

SourcesOfficial NSE Q1 FY2027 result, earnings release, investor presentation and company-hosted earnings-call audio ↗Official Q1 FY2027 earnings release ↗Official Q1 FY2027 investor presentation ↗NSE-filed Q1 FY2027 call-recording intimation ↗Company-hosted official Q1 FY2027 call audio ↗

Infomedia Press LimitedNSE: INFOMEDIA

Infomedia Press Limited · Official company filing; no Q1 earnings call published

Q1 FY2027 discontinued operations, losses, negative net worth, going concern and parent support·Financial Services·14 Jul 2026·Official NSE-filed Q1 FY2027 unaudited financial results and limited-review report

▾

Key highlights

→The company has no operations; its previous operations were discontinued in prior years.
→No operating segment is reported because the business remains discontinued.
→Other income was Rs 0.0024 cr, down 52.9% QoQ and versus nil YoY.
→Finance cost was Rs 0.6480 cr, up 1.1% QoQ and down 12.1% YoY.
→Depreciation was Rs 0.0008 cr.
→The continuing-operation loss was Rs 0.6464 cr, 1.6% worse QoQ and 12.4% lower YoY.
→The discontinued-operation loss was Rs 0.2814 cr, 59.4% worse QoQ and 3.1% lower YoY.
→

Viji Finance LimitedNSE: VIJIFIN

Viji Finance Limited · Official company filings; no Q1 earnings call published

Q1 FY2027 income quality, lending disclosure, warrant dilution, capital actions and governance·NBFC·14 Jul 2026·Official NSE-filed Q1 FY2027 unaudited financial results, limited-review report and capital/governance filings

▾

Key highlights

→Interest income was Rs 0.89 cr, down 62.2% QoQ and up 57.1% YoY.
→The company reported no fee or commission income in Q1.
→Other income was Rs 1.19 cr versus nil QoQ and Rs 0.09 cr YoY.
→Other income supplied 57.2% of total income and 77.5% of PBT; these shares are analyst-derived from the filed table.
→Total income was Rs 2.07 cr, down 11.7% QoQ and up 214.9% YoY.
→Finance cost was Rs 0.18 cr, up 134.6% QoQ and down 0.6% YoY.
→Employee cost was Rs 0.05 cr, down 32.7% QoQ and 73.4% YoY.
→

Aditya Birla Money LimitedNSE: BIRLAMONEY

Aditya Birla Money Limited · Official company filing; no Q1 earnings call published

Q1 FY2027 broking conversion, wholesale-debt concentration, funding cost, leverage, fair-value earnings quality and missing asset-quality KPIs·Asset Management·14 Jul 2026·Official NSE- and BSE-filed Q1 FY2027 unaudited financial results and limited-review report

▾

Key highlights

→Revenue from operations was Rs 130.77 cr, up 0.8% QoQ and 16.0% YoY.
→Interest income was Rs 70.75 cr, flat QoQ and up 27.8% YoY.
→Fees and commission income was Rs 46.20 cr, down 2.9% QoQ and up 4.5% YoY.
→Net fair-value gains were Rs 13.83 cr, up 20.8% QoQ and 5.4% YoY.
→Other income fell to Rs 0.69 cr from Rs 3.83 cr QoQ.
→Finance cost was Rs 43.67 cr, up 8.5% QoQ and 38.2% YoY.
→Employee cost was Rs 31.74 cr, up 21.2% QoQ and 13.8% YoY.
→

Den Networks LimitedNSE: DEN

Den Networks Limited · Official company filings; no Q1 earnings call published

Q1 FY2027 subscription, placement revenue, content costs, cable and broadband profitability, cash, working capital and capital allocation·Media·14 Jul 2026·Official company-hosted Q1 FY2027 unaudited results and investor update, corroborated by NSE result and presentation announcements

▾

Key highlights

→Consolidated revenue from operations was Rs 242.77 cr, up 0.9% QoQ and 0.6% YoY.
→The investor update rounded total operating revenue to Rs 243 cr, up 1% QoQ and 1% YoY.
→Subscription revenue was Rs 91 cr, down 2% QoQ and 14% YoY.
→Placement and marketing revenue was Rs 134 cr, down 6% QoQ and up 3% YoY.
→Other operating income increased to Rs 16 cr from Rs 5 cr QoQ and Rs 4 cr YoY.
→Content cost was Rs 165 cr, up 7% QoQ and 10% YoY.
→Personnel cost was Rs 15 cr, down 4% QoQ and 24% YoY.

Anand Rathi Share and Stock Brokers LimitedNSE: ARSSBL

Anand Rathi Share and Stock Brokers Limited · Official company filings and prior management call; pre-call result note

Q1 FY2027 results, broking recovery, active clients, MTF funding, distribution, client-asset restoration, controls, insurance, leverage and NCD capacity·NBFC·14 Jul 2026·NSE-filed ARSSBL Q1 FY2027 results, investor presentation, revised earnings release and official call notice, with the official Q4 FY2026 transcript as management baseline

▾

Key highlights

→Consolidated revenue from operations was Rs 246.10 cr, up 22.4% YoY and down 3.7% QoQ.
→Company-reported EBITDA was Rs 97.30 cr, up 30.2% YoY and down 11.8% QoQ.
→EBITDA margin was 39.5%, up about 237 bps YoY and down about 362 bps QoQ.
→PAT before exceptional item was Rs 39.06 cr, up 71.2% YoY and down 6.0% QoQ.
→Reported PAT after exceptional item was Rs 23.35 cr, up 2.4% YoY and down 43.8% QoQ.
→The company recognized a Rs 21.00 cr exceptional expense for compensation and restoration of securities to two DP clients affected by fraudulent off-market transfers.

Manaksia Coated Metals & Industries LimitedNSE: MANAKCOAT

Manaksia Coated Metals & Industries Limited · Official company filings and prior management call; pre-call result note

Q1 FY2027 results, margin recovery, inventory build, coated-steel capacity, solar commissioning, export mix and warrant dilution·Industrials·14 Jul 2026·NSE-filed Manaksia Coated Metals & Industries Q1 FY2027 results and limited-review reports, official call notice and company-hosted Q4 FY2026 transcript baseline

▾

Key highlights

→Consolidated revenue from operations was Rs 262.14 cr, up 15.2% QoQ and 4.9% YoY.
→Consolidated total income was Rs 263.07 cr, up 15.0% QoQ and 3.6% YoY.
→Analyst-derived EBITDA was Rs 29.08 cr, up 86.0% QoQ and 1.6% YoY.
→Analyst-derived EBITDA margin was 11.09%, up about 422 bps QoQ but down about 36 bps YoY.
→Consolidated PBT was Rs 18.93 cr and PAT was Rs 14.10 cr.
→Consolidated PAT rose 162.5% QoQ but only 0.7% YoY.
→Finance cost fell 11.8% YoY to Rs 6.86 cr.

Jindal Saw Ltd.NSE: JINDALSAW

Jindal Saw Limited · Official company filing and financial-highlights presentation; pre-call result note

Q1 FY2027 results, MENA export disruption, domestic water pipes, API licence restoration, order book, debt and regional expansion·Steel·14 Jul 2026·NSE-filed Jindal Saw Q1 FY2027 results, limited-review report and financial-highlights presentation

▾

Key highlights

→Consolidated revenue from operations was Rs 4,452.31 cr, down 3.9% QoQ and up 9.0% YoY.
→Consolidated total income was Rs 4,475.98 cr, down 3.9% QoQ and up 9.1% YoY.
→Management-reported consolidated EBITDA was Rs 420.4 cr, down 16.6% QoQ and 38.9% YoY.
→Consolidated EBITDA margin fell to 9.4% from 10.8% in Q4 FY2026 and 16.8% in Q1 FY2026.
→Consolidated PAT was Rs 90.79 cr, down 26.5% QoQ and 78.1% YoY.
→Standalone total income was Rs 3,755.7 cr, EBITDA was Rs 341.0 cr and PAT was Rs 109.8 cr.
→Pipe production was 371,000 MT and pipe sales were 362,000 MT; sales rose 11.0% YoY but fell 6.5% QoQ.

SG Finserve LimitedNSE: SGFIN

SG Finserve Limited · Official company filing and investor presentation; pre-call result note

Q1 FY2027 results, supply-chain finance scale-up, factoring and TReDS commercialization, returns, funding, asset quality and strategic options·NBFC·14 Jul 2026·NSE-filed SG Finserve Q1 FY2027 board outcome, unaudited financial results, limited-review report, investor presentation and press release

▾

Key highlights

→Total income was Rs 136.13 cr, up 28.8% QoQ and 101.7% YoY.
→Net interest income was Rs 82.06 cr, up 31% QoQ and 92% YoY.
→PBT was Rs 71.60 cr, up 27% QoQ and 111% YoY.
→PAT was Rs 53.68 cr, up 27.0% QoQ and 118.9% YoY.
→The closing loan book reached Rs 4,552 cr, up 16% QoQ and 82% YoY.
→The average loan book reached Rs 3,954 cr, up 21% QoQ and 89% YoY.
→Gross disbursements exceeded Rs 7,300 cr during the quarter.
→

Dhampur Bio Organics LimitedNSE: DBOL

Dhampur Bio Organics Limited · Official company filing

Q1 FY2027 results, segment performance and completion of the Meerganj undertaking sale·FMCG·14 Jul 2026·NSE filing / Dhampur Bio Organics Q1 FY2027 board outcome, unaudited financial results and limited-review reports

▾

Key highlights

→Consolidated continuing revenue from operations was Rs 918.56 cr, up 22.4% YoY and 32.5% QoQ.
→The net-of-excise continuing revenue proxy was Rs 532.89 cr, up 19.4% YoY and 42.5% QoQ.
→Analyst-derived continuing EBITDA excluding other income was Rs 8.94 cr, up 2.8% YoY and down 88.8% QoQ.
→Analyst-derived EBITDA margin on the net-of-excise proxy was 1.68%, down about 27 bps YoY.
→Continuing PBT was a Rs 18.29 cr loss and continuing PAT was a Rs 13.75 cr loss.
→Reported total PAT was Rs 36.79 cr because discontinued operations contributed Rs 50.54 cr after tax.
→The Meerganj sugar and co-generation undertaking transferred on June 18 for Rs 305 cr, full consideration was received and a Rs 63.89 cr pre-tax gain was recognized.

ICICI Prudential Asset Management Company Ltd.NSE: ICICIAMC

Nimesh Shah; Naveen Agarwal; ICICI Prudential AMC senior management · Managing Director and Chief Executive Officer; Chief Financial Officer; senior business leadership

Q1 FY2027 results, TER and yields, AUM and market share, SIPs, employee cost, alternatives, product launches and investment-book income·Asset Management·13 Jul 2026·Official NSE Q1 FY2027 results and investor presentation plus company-hosted official analyst-call audio

▾

Key highlights

→Operating revenue was Rs 1,564.22 crore, up 17.6% year on year and 1.4% quarter on quarter.
→Company-reported operating profit before tax was Rs 1,099.85 crore, up 20.2% year on year.
→PBT was Rs 1,280.65 crore, up 20.6% year on year, and PAT was Rs 964.63 crore, up 23.1%.
→Total mutual-fund QAAUM was Rs 11.17 trillion, up 18.3% year on year and 1.1% sequentially, with 13.4% market share.
→Active mutual-fund QAAUM was Rs 9.25 trillion, up 15.1% year on year, with 13.5% market share.
→Equity-scheme QAAUM was Rs 6.31 trillion, up 19.8% year on year, with 14.0% market share.

Nuvoco Vistas Corporation Ltd.NSE: NUVOCO

Nuvoco Vistas Corporation Limited · Official company filings and investor presentation; management call pending

Q1 FY2027 volume, company EBITDA per ton, cement and RMX performance, capacity milestones, finance cost, leverage markers and July 14 call evidence gaps·Cement·13 Jul 2026·Official NSE Q1 FY2027 board outcome, unaudited results, investor presentation, limited-review reports, revised analyst-call notice, auditor-change disclosures, Q4 FY2026 transcript and Limla capacity filing

▾

Key highlights

→Nuvoco filed its Q1 FY2027 unaudited results with NSE on July 13, 2026 after the board meeting concluded at 7:45 PM IST.
→The registered Q1 analyst call is scheduled for July 14, 2026 at 4:00 PM IST.
→The official investor presentation was filed at 9:07 PM IST on July 13, 2026.
→Consolidated revenue from operations was Rs 3,128.71 cr, up 8.9% YoY and down 5.4% QoQ.
→Company-reported cement volume was 5.3 MMT, up 5% YoY and down about 12% QoQ using rounded deck figures.
→Company-reported EBITDA was Rs 572 cr, up 7% YoY and down about 3% QoQ; Nuvoco described it as its strongest first-quarter EBITDA performance.

Bajaj Consumer Care LimitedNSE: BAJAJCON

Bajaj Consumer Care management · Company result filing, investor presentation and earnings call

Q1 FY2027 reported growth and earnings call, ADHO volume, channel performance, margin durability, Aarohan, growth portfolio and commodity costs·FMCG·13 Jul 2026·Official NSE Q1 FY2027 board outcome, unaudited consolidated financial results, limited-review report, investor presentation and company-hosted official earnings-call audio

▾

Key highlights

→Bajaj Consumer Care filed its Q1 FY2027 unaudited results and investor presentation on July 13, 2026 and published the complete 37:58 official call audio on its investor page.
→Consolidated revenue from operations was Rs 341.57 cr, up 24.9% YoY and 4.6% QoQ.
→The presentation's net-sales measure was Rs 341.4 cr, up 28.3% YoY; this differs from reported revenue growth because the prior-year other-operating-revenue base is excluded.
→Company-defined EBITDA was Rs 84.4 cr, up 101.2% YoY and 9.0% QoQ, with margin at 24.7% versus 15.8% in Q1 FY2026 and 23.7% in Q4 FY2026.
→Gross profit was Rs 211.0 cr, up 39.7% YoY, while gross margin was 61.8%, up about 510 bps YoY and down about 190 bps QoQ.

GM Breweries LimitedNSE: GMBREW

GM Breweries Limited · Official company filing

Q1 FY2027 board outcome and unaudited financial results·FMCG·13 Jul 2026·NSE filing / GM Breweries Q1 FY2027 board outcome, unaudited financial results and limited-review reports

▾

Key highlights

→Gross revenue from operations was Rs 802.90 cr, up 25.8% YoY and down 1.1% QoQ.
→The net-of-excise revenue proxy was Rs 199.58 cr, up 22.5% YoY and down 1.4% QoQ.
→Analyst-derived EBITDA excluding other income was Rs 46.45 cr, up 50.3% YoY and down 11.4% QoQ.
→Analyst-derived EBITDA margin on the net-of-excise revenue proxy was 23.27%, up about 430 bps YoY and down about 263 bps QoQ.
→PBT and PAT were Rs 50.43 cr and Rs 37.74 cr, respectively, both up about 45.9% YoY.
→There was no exceptional item; the effective tax rate was stable at about 25.2%.
→The filing gives no volume, realization, market-share, working-capital or cash-flow bridge, and no Q1 call or presentation was located.

Krishana Phoschem LimitedNSE: KRISHANA

Krishana Phoschem Limited · Official company filing

Q1 FY2027 board outcome and unaudited financial results·Fertilizers·13 Jul 2026·NSE filing / Krishana Phoschem Q1 FY2027 board outcome, unaudited financial results and limited-review report

▾

Key highlights

→Revenue from operations was Rs 532.31 cr, up 34.6% YoY and down 29.5% QoQ.
→Analyst-derived EBITDA excluding other income was Rs 88.95 cr, up 35.7% YoY, with margin broadly stable at 16.71%.
→PBT was Rs 60.60 cr, up 18.2% YoY, while PBT margin fell 158 bps to 11.38% as finance cost and depreciation rose sharply.
→PAT was Rs 47.09 cr, up 54.0% YoY, but the effective tax rate fell to 22.3% from 40.3%, amplifying the headline growth rate.
→Analyst-derived gross margin fell about 465 bps YoY to 32.67% but recovered about 642 bps QoQ.
→Finance cost rose 120.0% YoY to Rs 20.80 cr and depreciation rose 79.4% to Rs 13.71 cr.
→The filing provides no manufactured-versus-traded revenue, volume, receivable, inventory, borrowing or cash-flow bridge; these remain call questions.

LTM Ltd.NSE: LTM

Venu Lambu; Vipul Chandra · Chief Executive Officer and Managing Director; Whole-time Director and Chief Financial Officer

Q1 FY2027 result and call, Q2 growth conversion, AI-adjusted pricing, margin expansion, Voicing.AI fair-value gain and Randstad integration·Information Technology·11 Jul 2026·NSE-filed LTM Q1 FY2027 results, investor presentation and official two-part earnings-call audio

▾

Key highlights

→Revenue from operations rose 18.0% YoY to Rs 11,608.0 cr, while USD revenue grew 0.1% QoQ and constant-currency revenue grew 0.3% QoQ.
→EBITDA margin expanded 30 bps QoQ to 17.8% and EBIT margin expanded 40 bps to 15.5%.
→Reported PAT rose 17.1% YoY to Rs 1,468.6 cr, but other income includes a Rs 197.8 cr fair-value gain on Voicing.AI instruments.
→Order inflow was US$1.68 bn and US$6.65 bn on a TTM basis.
→Active clients fell to 740 from 751, while the US$5 mn-plus through US$50 mn-plus client buckets expanded.
→Financial Services grew 3.2% QoQ CC but remained down 2.5% YoY CC; Production declined 5.7% QoQ CC.

Avenue Supermarts Ltd.NSE: DMART

Anshul Asawa and Vikram Dasu · Managing Director and CEO, Avenue Supermarts; Whole Time Director and CEO, Avenue E-Commerce

Q1 FY2027 results, mature-store growth, metro productivity, store rollout and DMart Ready rationalization·Retail·11 Jul 2026·Avenue Supermarts Q1 FY2027 official press release and investor presentation

▾

Key highlights

→Standalone revenue grew 15.1% YoY, EBITDA grew 16.3% and PAT grew 12.8%.
→Like-for-like growth for stores older than 24 months slowed to 5.5% from 7.1% a year ago.
→Management said older large-metro stores were flat, while non-metro stores continued to grow well.
→Only three stores were added in Q1 FY2027, taking the store count to 503 and retail area to 20.7 mn sq ft.
→DMart Ready discontinued seven marginal cities during the quarter and now operates in 11 cities, versus 24 a year ago.
→The board approved up to Rs 1,000 cr of private-placement non-convertible debentures.

Financial highlights

Avantel LimitedNSE: AVANTEL

Avantel Limited · Official company filing

Q1 FY2027 board outcome and unaudited financial results·11 Jul 2026·NSE filing / Avantel Q1 FY2027 board outcome and unaudited financial results

▾

Key highlights

→Consolidated revenue was Rs 70.42 cr, up 35.7% YoY and 10.3% QoQ.
→PBT was Rs 8.70 cr, up 64.1% YoY, and PAT was Rs 5.39 cr, up 67.2% YoY.
→Communications segment revenue grew 35.4% YoY to Rs 70.24 cr and segment result grew 63.0% to Rs 10.92 cr.
→Healthcare reported revenue of Rs 0.30 cr and a segment loss of Rs 2.22 cr, equal to 41.2% of consolidated PAT.
→Total liabilities rose to Rs 157.86 cr from Rs 71.70 cr at March 2026, while the filing did not include a cash-flow or working-capital bridge.

Financial highlights

PAT: Rs 5.39 cr; +67.2% YoY; +13.0% QoQ
PBT

Indian BankNSE: INDIANB

Indian Bank management and finance team · Management commentary in official result materials and earnings call

Q1 FY2027 results, balanced growth, deposits, NIM, asset quality, ECL transition, fee income and foreign-currency funding·Banking·10 Jul 2026·NSE-filed Indian Bank Q1 FY2027 results, press release, investor presentation and official earnings-call audio

▾

Key highlights

→Net profit increased 10.09% YoY and 5.48% QoQ to Rs 3,273 cr, with operating profit up 16.50% YoY to Rs 5,557 cr.
→Net interest income grew 16.92% YoY to Rs 7,435 cr and domestic NIM improved to 3.41%.
→Deposits and advances grew a balanced 13.47% and 13.89% YoY, while domestic CASA reached 39.73%.
→Asset quality improved to 1.86% GNPA and 0.15% NNPA; recoveries of Rs 1,885 cr exceeded fresh slippages of Rs 1,250 cr.
→Credit cost fell to 0.23%, slippage ratio to 0.77% and PCR including technical write-offs was 98.22%.
→Management retained all FY2027 guidance and said Q1 supports an upper-quartile outcome within the existing ranges.

Elecon Engineering Co. Ltd.NSE: ELECON

Prayasvin B. Patel · Chairman & Managing Director

Q1 FY2027 results release and investor presentation·Capital Goods·10 Jul 2026·NSE filing / Elecon Q1 FY2027 official press release, board outcome and investor presentation

▾

Key highlights

→Consolidated revenue was Rs 521 cr in Q1 FY2027, up 11.9% YoY on the adjusted Q1 FY2026 base.
→EBITDA was Rs 109 cr with a 21.0% margin, up 3.9% YoY on the adjusted base but down 160 bps on margin.
→PAT was Rs 70 cr with a 13.5% PAT margin, up 2.3% YoY on the adjusted base.
→Consolidated order intake was Rs 755 cr, up 23.0% YoY, and open order book was Rs 1,518 cr, up 36.8% YoY.
→Gear division revenue grew 16.3% YoY to Rs 416 cr, while MHE revenue declined 2.9% YoY to Rs 105 cr due to temporary project-execution softness.

Financial highlights

PAT: Rs 70 cr; +2.3% YoY on adjusted Q1 FY2026 base

Bank of MaharashtraNSE: MAHABANK

Bank of Maharashtra management and finance team · Management commentary in official result materials and earnings call

Q1 FY2027 results, profitable loan growth, deposits and funding, NIM, asset quality, ECL transition, capital and branch expansion·Banking·10 Jul 2026·NSE-filed Bank of Maharashtra Q1 FY2027 results, investor presentation and official earnings-call audio

▾

Key highlights

→Net profit increased 26.84% YoY to Rs 2,020 cr in Q1 FY2027, with operating profit up 21.29% YoY to Rs 3,117 cr.
→Net interest income grew 14.53% YoY to Rs 3,770 cr and domestic NIM stood at 3.85%.
→Total global business grew 19.10% YoY to Rs 6,50,457 cr, with gross global advances up 26.90% YoY to Rs 3,05,964 cr.
→Asset quality remained strong: gross NPA was 1.45%, net NPA was 0.13% and provision coverage ratio was 98.55%.
→Capital remained comfortable with CRAR at 18.64%, Tier I at 16.35% and CET1 at 15.56%.
→Management retained 15% NII growth, at least 3.75% NIM and 18% advance-growth guidance despite Q1 advances growing 26.90% YoY.

Tata Consultancy Services Ltd.NSE: TCS

K Krithivasan, Aarthi Subramanian, Samir Seksaria and Sudeep Kunnumal · Chief Executive Officer, Chief Operating Officer, Chief Financial Officer and Chief Human Resources Officer

Q1 FY2027 results and earnings-call Q&A·IT Services·9 Jul 2026·NSE filing / TCS Q1 FY2027 official press release / company-published earnings-call transcript / official call audio

▾

Key highlights

→TCS reported Q1 FY2027 revenue of Rs 72,275 cr, up 2.2% QoQ and 13.9% YoY in INR, with constant-currency revenue up 0.4% QoQ and 3.2% YoY.
→Operating margin was 24.0% and net margin was 19.2%, both excluding exceptional items.
→Net income was Rs 13,849 cr excluding exceptional items, up 8.5% YoY; net cash from operations was Rs 12,412 cr, equal to 93% of net income.
→Total contract value was US$9.5 bn, including an US$800 mn AI-led transformation deal with SKF and additional AI/ServiceNow/Fortune Global 50 deal wins.
→Annualized AI revenue reached US$2.6 bn in Q1 FY2027, up 13.6% QoQ; workforce was 593,798 and LTM IT Services attrition was 13.6%.
→Management expects demand to improve sometime in Q2 as clients address pent-up technology work, but it did not quantify the Q1 macro drag or the rate of recovery.

Brightcom Group Ltd.NSE: BCG

M. Suresh Kumar Reddy; Raghunath Allamsetty; Brad Cohen; Kallol Sen; M. Shreedhar Reddy; Gal Peleg; Brightcom Group Limited · Chairman and Managing Director / CEO; Executive Director; Chief Strategy Officer; Head of International Divisions; General Manager - Operations; General Manager - OMS; issuer filings

Q4 and FY2026 audited results, qualified audit opinion, foreign subsidiary verification and receivables cash-conversion quality, AdTech/OMS execution, Azerion infrastructure milestone, four-division structure, Brightcom Defence and NextGen initiatives, shareholder-call and governance reset disclosures·Communication Services·19 Jun 2026·NSE-filed Q4/FY2026 audited financial-results board outcome, FY2026 investor presentation, shareholder conference-call intimation, April monthly update, February-March monthly update, OMS operational milestone filing, governance clarification filing and NSE announcement slice

▾

Key highlights

→Brightcom Group filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on June 7, 2026.
→The board meeting approving the audited results was held on June 7, 2026 and ran from 3:30 PM to 6:45 PM.
→Brightcom filed an FY2026 investor presentation with NSE on June 19, 2026.
→Brightcom filed a shareholder conference-call intimation with NSE on June 8, 2026.

Jyothy Labs Ltd.NSE: JYOTHYLAB

M. R. Jyothy; Pawan Agarwal; Shreyas Trivedi · Chairperson and Managing Director; Chief Financial Officer; Head - Legal and Company Secretary

Q4 and FY2026 results, Pril and Fa license non-renewal, Exo liquid scale-up, FY2027 dishwash transition, input-cost inflation, margin pressure, volume growth, modern trade and quick-commerce growth, household-insecticides turnaround, dividend, ESG rating, Patiala warehouse fire and daily FMCG market-signal tracking·FMCG·18 Jun 2026·NSE-filed Jyothy Labs June 18, 2026 analyst/investor conference-call transcript on Pril and Fa brand-license transition, Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone financial-results and board-outcome filing, Q4 press release, May 9, 2026 Pril/Fa license non-renewal board outcome and press release, NSE ESG-rating filing, Patiala C&FA warehouse fire filing, company annual-report and AGM notice pages and BSE company-announcements mirror

▾

Key highlights

→Jyothy Labs filed the transcript of its June 18, 2026 analyst/investor conference call with NSE on June 22, 2026.
→The June 18, 2026 call was held to discuss the update on Pril and Fa brand licenses.
→Management participants on the June 18 call were M. R. Jyothy, Chairperson and Managing Director, and Pawan Agarwal, Chief Financial Officer.
→Jyothy Labs filed the Q4 and FY2026 earnings-call transcript with NSE on May 7, 2026.

Procter & Gamble Health Ltd.NSE: PGHL

Milind Thatte; Shashank Srowthy; Zeal Rupani · Managing Director; Director Executive and Chief Financial Officer; Company Secretary

Q4 and FY2026 results, VMS category growth, Livogen Iron Gummies, Neurobion Nerve Pain Relief Cream, Evion L5000, brand and HCP execution, e-pharmacy/e-commerce/quick-commerce channels, extra-urban pharmacy coverage, productivity savings, margins, exports, dividend, governance updates, property-sale disclosure and daily VMS/consumer-health market-signal tracking·Pharmaceuticals·18 Jun 2026·NSE-filed PGHL Q4/FY2026 analyst-meet transcript and recording filing, investor presentation, analyst-meet schedule, audited results and board-outcome filing, press release, AGM/record-date filing, independent-director reappointment filing, April 2026 immovable-property sale intimation, company investor page and BSE company page

▾

Key highlights

→PGHL held its virtual analysts and institutional investors connect on June 18, 2026 at 2:30 p.m. IST and concluded it at 3:48 p.m. IST.
→The transcript filing says the recording and transcript were made available on the company's investor page.
→The analyst-meet speakers were Milind Thatte, Managing Director, Shashank Srowthy, Director Executive and Chief Financial Officer, and Zeal Rupani, Company Secretary.
→The June 4, 2026 schedule filing said no unpublished price sensitive information would be shared during the analyst and institutional investor meeting.

Gillette India Ltd.NSE: GILLETTE

V. Kumar; Srividya Srinivasan · Managing Director; Executive Director and Chief Financial Officer

FY2026 and Q4 results, five-year growth record, integrated growth strategy, Grooming and Oral Care innovation, Guard 3in1, Venus, trimmers, Oral-B Sensitive, distribution and quick-commerce execution, productivity savings, margin expansion, West Asia commodity and resin inflation, dividend, fiscal-year comparability, CFO transition and daily FMCG/grooming/oral-care market-signal tracking·FMCG·16 Jun 2026·Gillette India official FY2026 analyst-meet transcript, analyst presentation, audited-results board outcome, FY2026 press release, dividend record-date filing and director/KMP change filing

▾

Key highlights

→Gillette India held an analyst and institutional-investor meet on June 16, 2026 at 3:30 p.m.
→The company posted the analyst-meet transcript and presentation on its official investor-relations website.
→The FY2026 audited results and board outcome were approved at the board meeting held on May 27, 2026.
→The FY2026 results covered the financial year ended March 31, 2026 after the company changed its financial year end from June 30 to March 31.
→The previous financial year, FY2025, was a nine-month period from July 1, 2024 to March 31, 2025, so the printed statutory FY2025 period is not directly comparable with FY2026.

Procter & Gamble Hygiene & Health Care Ltd.NSE: PGHH

V. Kumar; Srividya Srinivasan; Zeal Rupani · Managing Director; Incoming Chief Financial Officer; Moderator

FY2026 results, flat sales versus profit growth, fiscal-year-change comparability, feminine-care and healthcare category growth, Whisper Period Panties, Whisper Nights, Vicks portfolio, media and retail fragmentation, productivity savings, margin expansion, West Asia cost pressure, quick-commerce execution and daily FMCG market-signal tracking·FMCG·16 Jun 2026·P&G India official PGHH investor pages, FY2026 audited financial results, FY2026 press release, June 16 2026 analyst and investor meet transcript, analyst-meet presentation, analyst-meet intimation and newspaper publication

▾

Key highlights

→PGHH held its official investor and analyst call on June 16, 2026 from 1:30 p.m. to 2:49 p.m. IST.
→The speakers were V. Kumar, Managing Director, Srividya Srinivasan, incoming CFO effective July 1, and Zeal Rupani from the corporate secretarial team.
→Management said the call covered company performance, results, strategy, business outlook and pre-submitted investor questions.
→Management included the standard caveat that forward-looking statements are based on current plans and assumptions and may differ materially from actual results.
→

IFB Industries Ltd.NSE: IFBIND

Rajshankar Ray; Sagnik Sen; Prabir Chatterjee; Ritesh Agarwal; IFB Industries Limited · Managing Director and CEO; President and CEO, Home Appliances; Chief Financial Officer; Vice President, Investor Relations; issuer filings

Q4 and FY2026 performance, Home Appliances margin recovery, export growth, AC outsourcing, Fluff washing-machine ramp, Engineering margin normalization, Motors operating leverage, Steel losses, distribution expansion, e-waste provisioning, dividend, AGM and auditor transition·Consumer Durables·13 Jun 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, IFB-hosted Q4/FY2026 investor presentation, IFB investor-relations financial-results page, audited-results board-outcome filing, AGM/shareholder-meeting filings, auditor-transition filings and routine compliance filings

▾

Key highlights

→IFB Industries filed the Q4/FY2026 earnings-call transcript with NSE on June 15, 2026.
→The Q4/FY2026 earnings call was conducted on June 13, 2026.
→Ritesh Agarwal from Asian Markets Securities moderated the earnings call.
→Management participants included Rajshankar Ray, Sagnik Sen and Prabir Chatterjee.
→Rajshankar Ray represented IFB Industries as Managing Director and CEO.

Avanti Feeds Ltd.NSE: AVANTIFEED

Dr. A. Indra Kumar; C. Ramachandra Rao; A. Venkata Sanjeev; A. Nikhilesh; B. Santhi Latha; D. V. S. Satyanarayana; K. Srinivasa Reddy · Chairman and Managing Director; Joint Managing Director, Company Secretary, Compliance Officer and CFO; Executive Director; Executive Director, Avanti Frozen Foods Pvt. Ltd.; CFO, Avanti Feeds Ltd.; CFO, Avanti Frozen Foods Pvt. Ltd.; CFO, Avanti Pet Care Pvt. Ltd.

Q4 and FY2026 results, shrimp-feed raw-material inflation, feed price hikes, shrimp processing exports, value-added products, pet-care rollout, FY2027 feed and export outlook, U.S. tariff refund watch, dividend, Sealuxe investment and daily aquaculture market-signal tracking·FMCG·12 Jun 2026·Avanti Feeds official Q4/FY2026 investor-call transcript, audited-results and board-outcome filing, Q4 FY2026 investor presentation, conference-call intimation, audio-recording filing, June 2026 Sealuxe B.V. investment filing, company corporate-announcements page and BSE company-announcements hub

▾

Key highlights

→Avanti Feeds held its Q4 FY2026 investor audio conference call on June 12, 2026 at 4:00 p.m. IST.
→The company filed the conference-call intimation with BSE/NSE on June 9, 2026.
→The company filed the audio-recording availability outcome with BSE/NSE on June 12, 2026.
→The company published the Q4 FY2026 investor-call transcript on its official corporate-announcements page on June 16, 2026.

Aegis Logistics Ltd.NSE: AEGISLOG

Raj Chandaria; Murad Moledina; Board of Directors · Chairman and Managing Director; Chief Financial Officer; Board of Directors

Q4 and FY2026 results, active NSE successor coverage from AEGISCHEM to AEGISLOG, LPG and liquid logistics performance, port expansions, Aegis Vopak and Itochu ammonia-terminal partnership, capex pipeline, dividend and FY2027/FY2030 growth outlook·Oil Gas & Consumable Fuels·9 Jun 2026·NSE-filed Aegis Logistics Q4/FY2026 earnings-call transcript, investor presentation, audited results and board outcome, final-dividend outcome, corporate-guarantee filing and current NSE EQ list

▾

Key highlights

→The current NSE EQ list shows Aegis Logistics Limited under symbol AEGISLOG with ISIN INE208C01025.
→The legacy queue symbol AEGISCHEM is absent from the current NSE EQ list; launch coverage should therefore sit under AEGISLOG.
→Aegis Logistics filed the Q4/FY2026 investor presentation and audited results with NSE on May 29, 2026.
→Aegis Logistics filed the Q4/FY2026 earnings-call audio-link filing with NSE on June 9, 2026.
→Aegis Logistics filed the Q4/FY2026 earnings-call transcript with NSE on June 15, 2026.

Hinduja Global Solutions Ltd.NSE: HGS

Venkatesh Korla; Vynsley Fernandes; Mahesh Kumar Nutalapati; Rajiv Bhargava; Hinduja Global Solutions Limited · Global Chief Executive Officer; Whole-Time Director, HGS and CEO of NXTDIGITAL Media Business; Global Chief Financial Officer; Media Group Chief Financial Officer; issuer filings

Q4 and FY2026 results, integrated Intelligent Experience positioning, Realized AI and AgentX, new-logo wins, BPM and Digital Media mix, media loss reduction plan, Project GANGA, CelerityX, treasury surplus, dividend, GAAR/tax matters and FY2027 rebuild outlook·Industrials·5 Jun 2026·NSE-filed Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone/consolidated financial-results board outcome, dividend filing, Project GANGA launch press release, GenAI recognition press release, income-tax demand filing and NSE announcement slice

▾

Key highlights

→HGS filed its Q4/FY2026 earnings-call transcript with NSE on June 11, 2026.
→The Q4/FY2026 earnings call was held on June 5, 2026.
→Management participants included Venkatesh Korla, Global CEO; Vynsley Fernandes, Whole-Time Director, HGS and CEO of NXTDIGITAL Media Business; and Mahesh Kumar Nutalapati, Global CFO.
→HGS filed its Q4/FY2026 investor presentation with NSE on June 5, 2026.
→

Rajesh Exports Ltd.NSE: RAJESHEXPO

Rajesh Mehta; T. D. Joseph; Vikash Kumar Khetan; Rajesh Exports Limited; Securities and Exchange Board of India · Chairman; Communication-in-charge; Compliance Officer; issuer filings; regulator order

Q4 and FY2026 audited results, consolidated Valcambi-led revenue base, standalone gold-product performance, SEBI interim-order response, forensic-audit and disclosure-risk watch, Enforcement Directorate search update, promoter encumbrance disclosure, SDD compliance and daily market-signal tracking·Apparel & Footwear·5 Jun 2026·NSE-filed FY2026 standalone and consolidated audited financial-results board outcomes, SEBI interim order dated June 3, 2026, company clarifications on the SEBI interim order, company update on Enforcement Directorate search, SAST promoter disclosure, SDD certificate and NSE announcement slice

▾

Key highlights

→Rajesh Exports filed standalone audited financial results for the quarter and year ended March 31, 2026 with NSE on May 30, 2026.
→Rajesh Exports filed consolidated audited financial results for the quarter and year ended March 31, 2026 with NSE on May 31, 2026.
→The Board approved the standalone and consolidated audited financial results at its May 30, 2026 meeting.
→The consolidated-results filing stated that the board meeting started at 8:00 PM and ended at 10:50 PM on May 30, 2026.

Tata Teleservices (Maharashtra) Ltd.NSE: TTML

Harjit Singh; Amit Gupta; Shinu Mathai; Tata Teleservices (Maharashtra) Limited Board of Directors · Managing Director; Company Secretary and Compliance Officer; Chief Financial Officer; Board-approved exchange filings

FY2026 annual report and AGM management commentary, Smart Digital Solutions for SMEs, Q4/FY2026 audited results, AGR liability reset, debt and liquidity, Harjit Singh reappointment, TRAI QoS order, volume-spurt clarifications and daily telecom market-signal tracking·Telecom·5 Jun 2026·Company-hosted Tata Teleservices (Maharashtra) FY2025-2026 annual report and MD letter, NSE-hosted Q4/FY2026 audited financial-results filing, AGM notice and annual-report filing, AGM proceedings and voting-results filing, newspaper-results filing, June 2026 TRAI order filing, June 2026 volume-spurt clarifications and trading-window filing; official Q4 FY2026 earnings-call transcript not found

▾

Key highlights

→Tata Teleservices (Maharashtra) filed audited financial results for the quarter and year ended March 31, 2026 with NSE on April 23, 2026.
→The financial-results filing says the audit committee reviewed and the board approved the Q4/FY2026 results at its April 23, 2026 meeting.
→Price Waterhouse Chartered Accountants LLP issued the auditors' report on the FY2026 financial results.
→The company filed a declaration that the statutory auditors submitted an unmodified opinion for FY2026.

Wockhardt Ltd.NSE: WOCKPHARMA

Habil Khorakiwala; Huzaifa Khorakiwala; Murtaza Khorakiwala; Zahabiya Khorakiwala; Mahesh Patel; Sachin Bhagwat; Annapurna Das; William McNey; Dennis Deruelle; Leo Yasinski; Sandy Estrada · Founder Chairman; Executive Director; Managing Director; Director; Chief Scientific Mentor; Chief Scientific Officer; President - India Business and NCE Emerging Markets; Chief Commercial Officer - Novel Antibiotics Business; Chief Medical Officer - US Novel Antibiotics Business; Vice President - Market Access NCE Business; Senior National Director - Field Medical and Medical Science Liaison

Q4 and FY2026 results, return to positive PBT, ZAYNICH US FDA and DCGI approvals, US/India launch strategy, hospital formulary penetration, antimicrobial stewardship, biosimilar growth and capacity, QIP utilization, ICRA rating upgrade, senior-management designations and daily pharma/antimicrobial-resistance market-signal tracking·Pharmaceuticals·4 Jun 2026·Wockhardt Q4/FY2026 NSE-hosted audited-results filing, Q4 press release, June 2026 investor presentation, June 2026 investor-meet transcript, ZAYNICH US FDA approval release, ZAYNICH DCGI approval release, QIP monitoring report, credit-rating update and senior-management change filing

▾

Key highlights

→Wockhardt filed its Q4 and FY2026 audited standalone and consolidated results with NSE on May 4, 2026.
→The statutory auditor issued an unmodified opinion on the audited FY2026 standalone and consolidated financial results.
→Wockhardt filed a Q4 FY2026 press release on May 4, 2026 reporting positive FY2026 PBT of Rs 238 cr.

Bata India Ltd.NSE: BATAINDIA

Gunjan Shah; Amit Aggarwal; Nitin Bagaria · Managing Director and Chief Executive Officer; Director Finance and Chief Financial Officer; AVP - Company Secretary and Compliance Officer

Q4 and FY2026 results, volume-led recovery, zero-based merchandising, inventory reduction, franchise and SIS expansion, e-commerce, premium brands, value segment stabilization, exceptional items, cash flow, dividend, CEO transition and daily footwear retail market-signal tracking·Apparel & Footwear·3 Jun 2026·NSE-filed Bata India Q4/FY2026 earnings-call transcript, audited standalone and consolidated financial-results and board-outcome filing, Q4/FY2026 press-release filing, investor-presentation filing, earnings-call audio-link filing, post-earnings-call schedule filing, dividend and record-date filings, leadership-transition filing and company investor-relations pages

▾

Key highlights

→Bata India held its Q4 FY2026 earnings conference call on June 3, 2026, hosted by 360 ONE Capital.
→Bata India filed the Q4 FY2026 earnings-call transcript with NSE on June 8, 2026.
→The transcript identifies Gunjan Shah, Managing Director and Chief Executive Officer; Amit Aggarwal, Director Finance and Chief Financial Officer; and Nitin Bagaria, AVP - Company Secretary and Compliance Officer, as management participants.
→The Q4/FY2026 board meeting was held on May 27, 2026 and approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.

Steel Strips Wheels LimitedNSE: SSWL

Dheeraj Garg, Rahul Kumar, Pranav Jain and Aditya Dixit · Managing Director; Chief Financial Officer; Vice President, Finance; Executive Director, International Marketing and Operations

Q4 and FY2026 results, product mix, exports, labor availability, Bhuj expansion, utilization, leverage and FY2027 operating targets·Auto Ancillaries·2 Jun 2026·Steel Strips Wheels official Q4 and FY2026 earnings-call transcript published in the company investor archive

▾

Key highlights

→Q4 FY2026 standalone revenue from operations was Rs 1,474.6 cr, up 19.5% YoY, supported by domestic demand and growth in alloy, tractor and commercial-vehicle wheels.
→Q4 standalone EBITDA excluding other income was Rs 149.3 cr, up 11.0%, while EBITDA margin fell to 10.1% from 10.9%; standalone PAT was Rs 64.46 cr, up 4.5%, with PAT margin at 4.4% versus 5.0%.
→FY2026 standalone revenue reached a record Rs 5,182.8 cr, up 17.0%, and total wheel volume reached 199.52 lakh units, up 4%.
→FY2026 standalone EBITDA excluding other income was Rs 511.1 cr, up 5.0%, but margin compressed to 9.9% from 11.0%; PAT declined 3.7% to Rs 202.1 cr as depreciation rose to Rs 128.8 cr and exports weakened.
→Alloy wheels contributed Rs 1,865.8 cr, or about 36% of FY2026 revenue, with volume up 19% to 39.47 lakh units; steel wheels contributed Rs 3,248.4 cr, or about 63%.

ITI Ltd.NSE: ITI

Rajesh Rai; C.V. Ramana Babu; Y. Sathyan · Chairman and Managing Director; Director Finance and Chief Financial Officer; Company Secretary and Compliance Officer

Q4 and FY2026 results, corrected Q4 balancing figures, exceptional land-sale profit, debtor write-off, ASCON Phase IV execution, order-book and unbilled-revenue conversion, government support, asset monetization, public-shareholding compliance, working-capital borrowings, credit rating, CFO/governance changes and daily telecom-equipment/defence/PSU market-signal tracking·Technology·2 Jun 2026·ITI official company-hosted Q4/FY2026 audited-results corrigendum, audited financial-results filing, newspaper-publication filings, Q3 FY2026 financial-results filing, credit-rating filing, EMD filing and investor page

▾

Key highlights

→ITI filed a corrigendum on June 2, 2026 to the audited financial results for the quarter and year ended March 31, 2026.
→The corrigendum referenced the company's May 29, 2026 outcome filing for audited Q4 and FY2026 results.
→The board meeting for the FY2026 results commenced on May 28, 2026 at 1:54 PM and concluded on May 29, 2026 at 7:45 AM.
→The corrigendum said FY2026 standalone and consolidated annual results were correctly reported, while certain Q4 balancing figures had clerical or typographical errors.

UFLEX Ltd.NSE: UFLEX

Sumeet Kumar; Surajit Pal; Ashok Chaturvedi; Ritesh Chaudhry; UFlex Limited · Executive Vice President Finance, UFlex Group; Vice President and Head of Investor Relations; Chairman and Managing Director; Sr. Vice President - Secretarial and Company Secretary; issuer filings

Q4 and FY2026 results, packaging films recovery, packaging solutions growth, aseptic packaging ramp-up, Egypt and Mexico capacity commissioning, Noida recycling-unit commissioning, Dharwad BOPP capex, PET chips performance, margin normalization, debt and cost-of-funds posture, income-tax demand litigation, dividend and governance filings, market-signal false-positive cleanup and daily announcement tracking·Paper & Packaging·1 Jun 2026·NSE-filed Q4/FY2026 earnings-call transcript, earnings presentation, earnings release, audited standalone and consolidated financial-results board outcome, PET/mixed-plastics recycling-unit commissioning filing, earnings-call invite and audio-recording filings, investor-meet filings, promoter SAST disclosure, trading-window corrigendum and NSE announcement slice

▾

Key highlights

→UFlex filed its Q4/FY2026 earnings-call transcript with NSE on June 8, 2026.
→The Q4/FY2026 earnings conference call was conducted on June 1, 2026 at 4:00 PM IST.
→The call was hosted by Arihant Capital Markets Limited.
→Management participants on the call included Sumeet Kumar, Executive Vice President Finance, UFlex Group, and Surajit Pal, Vice President and Head of Investor Relations.

Indo Count Industries Ltd.NSE: ICIL

Mohit Jain; K. Muralidharan; Manish Bhatia; Anil Kumar Jain; Satnam Saini; Board of Directors · Executive Vice Chairman; Group Chief Financial Officer; Chief Financial Officer; Executive Chairman; Company Secretary and GM - Legal; Board of Directors

Q4 and FY2026 results, U.S. tariff impact, core bed-linen volume, utility bedding and U.S. brand scale-up, FY2027 revenue and EBITDA-margin guide, FY2028 revenue run-rate ambition, North Carolina facility ramp-up, Wamsutta and licensed-brand strategy, non-U.S. diversification, ESG score, capex, dividend, capacity-corrigendum and governance filings·Textiles·1 Jun 2026·NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, press release, audited standalone and consolidated financial-results board outcome, investor-call invite and audio filing, capacity-addition and capacity-timeline corrigendum filings, June investor-conference schedule, independent-director reappointment and takeover-regulation disclosure

▾

Key highlights

→Indo Count filed the Q4 and FY2026 investors conference-call transcript with NSE on June 8, 2026.
→The earnings call was held on June 1, 2026 at 11:30 a.m. IST.
→The call covered audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
→The call transcript says the audio recording uploaded to the stock exchange on June 1, 2026 prevails in case of discrepancy.

JM Financial Ltd.NSE: JMFINANCIL

Vishal Kampani; Nishit Shah; Chirag Negandhi; Manish Sheth; Amitabh Mohanty; Sonia Dasgupta · Vice Chairman and Managing Director; Managing Director and Group Chief Financial Officer; Managing Director; MD and CEO; CEO; Managing Director and Chief Executive Officer, Investment Banking

Q4 and FY2026 results, strategic pivot, corporate advisory and capital markets pipeline, private-markets recoveries and loan-book growth, wealth and asset-management productivity, affordable home loans, dividend, governance filings and daily finance-sector market-signal tracking·Asset Management·1 Jun 2026·NSE-filed JM Financial Q4/FY2026 earnings-call transcript, investor presentation, press release, audited financial-results and board-outcome filing, earnings-call audio-recording and call-intimation filings, dividend, record-date, AGM, senior-management and director-change filings, May 2026 ESOP grant filing, April 2026 senior-management cessation filing, April 2026 ESG-rating filing, company financial-results and press-release pages, NSE company page and BSE company page

▾

Key highlights

→JM Financial filed the Q4 FY2026 earnings-call transcript with NSE on June 4, 2026.
→The transcript says the Q4 FY2026 earnings conference call was held on June 1, 2026.
→The May 26, 2026 call-intimation filing scheduled the earnings conference call for June 1, 2026.
→The company filed the Q4 FY2026 audio-recording intimation with NSE on June 1, 2026.

Gujarat State Petronet Ltd.NSE: GSPL

Avantika Singh Aulakh; Sandeep Dave; Rajesh Sivadasan; Vikas Gangal; Devendra Agarwal · Managing Director, Gujarat Energy; Company Secretary, Gujarat Energy; Chief Financial Officer, Gujarat Energy; Senior Vice President - Commercial and Marketing, IT and ERP, Gujarat Energy; Executive Director, Regulatory Affairs - Gas Sourcing and Gas Dispatch Centre, Gujarat Energy

GSPL transition after the GSPC group scheme, GSPL merger into Gujarat Gas, GSPL Transmission demerger, final pre-merger GSPL Q3 FY2026 financials, Gujarat Energy Q4/FY2026 successor commentary, transmission business continuity, GTL listing timeline, PNGRB tariff reset, Morbi/CGD gas demand, LNG sourcing and daily market-signal tracking·Oil Gas & Consumable Fuels·1 Jun 2026·Gujarat State Petronet NSE-hosted Q3 FY2026 financial results, MCA scheme order and effective-date filing, plus Gujarat Energy / erstwhile Gujarat Gas NSE-hosted Q4/FY2026 earnings-call transcript, investor presentation, revised financial results, press release and allotment filing

▾

Key highlights

→GSPL did not have a normal standalone Q4 FY2026 management call after the scheme became effective; the official management trail is the successor Gujarat Energy Q4/FY2026 call plus GSPL's exchange filings on the scheme.
→Gujarat Energy filed the transcript of its Q4/FY2026 post-results earnings conference call with NSE on June 5, 2026.
→The Gujarat Energy post-results earnings conference call was held on June 1, 2026 at 4:00 p.m. IST.

NBCC (India) Ltd.NSE: NBCC

Dr K. P. Mahadevaswamy; Shri Anjeev Kumar Jain; M. B. Singhal; Balkishan Singla · Chairman and Managing Director; Director Finance; Executive Director Finance; Investor Relations

Q4 and FY2026 results, record standalone income, consolidated order book, business secured, redevelopment model, 7 GPRA monetisation, Amrapali Phase 2, Supertech project, Ghitorni land, Dubai real estate, overseas expansion, Green View remediation, audited-result emphasis matters and daily order-win/redevelopment/stalled-housing/urban-infra market-signal tracking·Construction·1 Jun 2026·NBCC official BSE investor-meet video-link filing with modified investor presentation, official FY2025-26 audited-results PDF, official press release and company investor pages

▾

Key highlights

→NBCC filed a June 4, 2026 BSE/NSE update with the video-recording link, investor participant list and modified investor presentation for the investor meet held on June 1 and June 2, 2026.
→The investor-meet filing said discussions did not involve disclosure of unpublished price-sensitive information.
→The investor-meet filing identified the company management representatives as Dr K. P. Mahadevaswamy, Shri Anjeev Kumar Jain, M. B. Singhal and Balkishan Singla.
→NBCC's official Presentation and Transcript page showed Q4 FY2025-26 investor-meet intimations and presentation materials, but it did not show a current Q4 FY2026 text transcript as of this note.

Gujarat Gas Ltd.NSE: GUJGASLTD

Avantika Singh Aulakh; Sandeep Dave; Rajesh Sivadasan; Vikas Gangal; Devendra Agarwal · Managing Director; Company Secretary; Chief Financial Officer; Senior Vice President - Commercial and Marketing, IT and ERP; Executive Director, Regulatory Affairs - Gas Sourcing and Gas Dispatch Centre

Q4 and FY2026 results, Gujarat Gas rename to Gujarat Energy, GSPC/GSPL/GSPC Energy merger, GSPL Transmission demerger, CGD, CNG, PNG, Morbi industrial gas recovery, gas trading, E&P, wind power, LNG sourcing, long-term contracts, tax-loss utilization, capex, dividend, digital transformation, compressed biogas, propane optionality, power-plant turnaround watch and daily market-signal tracking·Power·1 Jun 2026·Gujarat Energy / erstwhile Gujarat Gas Q4/FY2026 NSE-hosted earnings-call transcript, Q4/FY2026 investor presentation, revised audited financial results, Q4/FY2026 press release, name-change filing, scheme effective-date filing and allotment filing

▾

Key highlights

→Gujarat Energy filed the transcript of its Q4/FY2026 post-results earnings conference call with NSE on June 5, 2026.
→The post-results earnings conference call was held on June 1, 2026 at 4:00 p.m. IST.
→The company described itself as Gujarat Energy Limited, erstwhile Gujarat Gas Limited, after the post-scheme name change.
→Management participants included Avantika Singh Aulakh, Devendra Agarwal, Sandeep Dave, Rajesh Sivadasan and Vikas Gangal.

Ipca Laboratories Ltd.NSE: IPCALAB

A.K. Jain; Harish Kamath · Managing Director and Chief Financial Officer; Corporate Counsel and Company Secretary

Q4 and FY2026 results, domestic formulations growth, export branded/generic momentum, institutional business decline, API performance, Unichem recovery plan, FY2027 revenue and EBITDA guidance, raw-material and freight inflation, exceptional items, dividend and daily pharma market-signal watch items·Pharmaceuticals·1 Jun 2026·Ipca Laboratories Q4/FY2026 company-hosted earnings-call transcript, conference-call intimation, NSE audited financial-results filing, Q4/FY2026 press release and company financial-results pages

▾

Key highlights

→Ipca Laboratories filed the transcript of its Q4/FY2026 earnings call after the June 1, 2026 analyst and institutional-investor interaction.
→The call was scheduled for June 1, 2026 at 3:30 p.m. IST to discuss Q4 and FY2026 earnings and business updates.
→Management participants included A.K. Jain, Managing Director and Chief Financial Officer, and Harish Kamath, Corporate Counsel and Company Secretary.
→The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 29, 2026 meeting.
→The statutory auditors issued unmodified reports on the standalone and consolidated audited financial results.

Glenmark Pharmaceuticals Ltd.NSE: GLENMARK

Glenn Saldanha, Anurag Mantri and Utkarsh Gandhi · Chairman and Managing Director; Executive Director and Global Chief Financial Officer; Senior General Manager, Investor Relations

Q4 and FY2026 earnings, FY2027 guidance, AbbVie/ISB-2001 licensing income, RYALTRIS, U.S. respiratory launches, India growth, GLIPIQ semaglutide, oncology in-licensing, exceptional legal/GST/labour-code items, balance sheet, working capital, capital allocation and daily market-signal items·Pharmaceuticals·1 Jun 2026·Glenmark Pharmaceuticals Q4/FY2026 earnings-call transcript, press release, MDA, audited financial results, earnings-call recording and intimation, board-meeting intimation, quarterly-results page, newsroom 2026 and other-announcements 2026

▾

Key highlights

→Glenmark held its Q4 and FY2026 earnings conference call on June 1, 2026, after the board approved audited results on May 29, 2026.
→Management participants were Glenn Saldanha, Chairman and Managing Director, Anurag Mantri, Executive Director and Global CFO, and Utkarsh Gandhi, Senior General Manager, Investor Relations.
→The company framed FY2026 as a transition year in which the operating platform, balance sheet and innovation portfolio were repositioned ahead of FY2027.
→Utkarsh Gandhi said Glenmark had an Investor Day coming up in about a week, where the company would address more strategic and mid-to-long-term questions.

General Insurance Corporation of IndiaNSE: GICRE

Jayashri Balkrishna and Sanjay Mokashi · Executive Director; General Manager and Chief Underwriting Officer

Q4 and FY2026 earnings, underwriting improvement, combined-ratio trajectory, investment income, domestic and international reinsurance pricing, April 1 renewals, obligatory cession, fire, motor, health, agriculture, life and international portfolio mix, solvency, dividend, RBC and IFRS readiness, management transition and analyst-meeting signals·Insurance·1 Jun 2026·GIC Re Q4/FY2026 earnings-call transcript, investor presentation, audited financial results, press release, conference-call audio filing, analyst-meeting disclosure and CFO-transition filing

▾

Key highlights

→GIC Re reported Q4 FY2026 gross premium income of Rs 11,030.48 cr versus Rs 10,367.08 cr YoY and Rs 10,986.55 cr QoQ.
→Q4 FY2026 net premium was Rs 9,917.07 cr versus Rs 9,420.91 cr YoY and Rs 10,354.86 cr QoQ.
→Q4 FY2026 earned premium was Rs 9,785.06 cr versus Rs 8,680.15 cr YoY and Rs 9,580.28 cr QoQ.
→Q4 FY2026 incurred claims were Rs 7,902.16 cr versus Rs 7,134.24 cr YoY and Rs 8,425.04 cr QoQ.
→Q4 FY2026 incurred claims ratio improved to 80.8% from 82.2% YoY and 87.9% QoQ.

NMDC Ltd.NSE: NMDC

Amitava Mukherjee and Anurag Kapil · Chairman and Managing Director; Director - Finance

Q4 and FY2026 production, sales, revenue, EBITDA, PAT, 60 mt FY2027 target, 100 mt roadmap, Deposit 4 and Deposit 13 ramp-up, Tokisud and Rohne coal mines, Vizag blending yard, DR-grade pellets, rare earths, overseas acquisitions, capex and margin outlook·Steel·1 Jun 2026·NMDC Q4 and FY2026 earnings-call transcript, corporate investor presentation, audited financial results and investor pages

▾

Key highlights

→Management said FY2026 was encouraging, with iron ore production crossing 53 mt and sales revenue growing to about Rs 31,000 cr, putting NMDC on track for Maharatna eligibility.
→The Q4 investor presentation showed best-ever Q4 physical performance, with iron ore production of 162.72 lakh tonnes, up 22% YoY, and sales of 152.99 lakh tonnes, up 21% YoY.
→Q4 FY2026 revenue from operations was Rs 11,173 cr, up 61% YoY, EBITDA was Rs 3,072 cr, up 21% YoY, PBT was Rs 2,875 cr, up 22% YoY, and PAT was Rs 2,020 cr, up 35% YoY.
→FY2026 iron ore production was 531.58 lakh tonnes, up 21% YoY, and iron ore sales were 502.39 lakh tonnes, up 13% YoY.
→FY2026 revenue from operations was Rs 31,554 cr, up 33% YoY, PBT was Rs 10,155 cr, up 9%, and PAT was Rs 7,421 cr, up 11%.

MMTC Ltd.NSE: MMTC

Nitin Kumar Yadav; Jatinderjit Singh Mann; Ajay Kumar Misra; MMTC Limited Board of Directors · Chairman and Managing Director, additional charge; Director Marketing; Company Secretary; Board-approved exchange filings

Q4 and FY2026 audited results, qualified audit opinion, Anglo Coal provision gap, NINL divestment escrow income, going-concern uncertainty, PSU governance changes, CMD additional charge, volume-spurt clarifications, SAST promoter disclosure, IEPF and share-transfer compliance·Conglomerate·31 May 2026·NSE-hosted MMTC Q4/FY2026 audited financial-results and board-outcome filing, newspaper-results publication, audit-qualification impact filing, volume-spurt clarifications, Ministry/director-change filings, SAST disclosure, IEPF/re-lodgement filings, company investor pages and BSE company page; official Q4 FY2026 earnings-call transcript not found

▾

Key highlights

→MMTC filed its board-meeting outcome and audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on May 31, 2026.
→The results pack says the 490th board meeting was held on May 29, 2026, commenced at 12:00 hours and concluded at 11:00 p.m.
→The board approved audited standalone financial results, audited consolidated financial results and the auditors' reports for the quarter and year ended March 31, 2026.
→The newspaper-publication filing says extracts of the audited standalone and consolidated results were published in Financial Express and Jansatta on May 31, 2026.

Dhampur Bio Organics LimitedNSE: DBOL

Dhampur Bio Organics Limited · Management investor presentation

Q4 and FY2026 sugar, biofuel, spirits and power performance; working capital, debt and Meerganj asset sale·FMCG·30 May 2026·Official company Q4 FY2026 investor presentation, audited results and Meerganj business-transfer disclosure

▾

Key highlights

→Q4 FY2026 net revenue was Rs 552.44 crore, up 19% year on year.
→Q4 EBITDA was Rs 102.44 crore, up 3% year on year, with margin of 18.54% versus 21.45%.
→Q4 PAT was Rs 46 crore, up 16% year on year, with margin of 8.33%.
→FY2026 net revenue was Rs 2,082.01 crore, up 10.57% year on year.
→FY2026 EBITDA was Rs 162.01 crore, up 13% year on year, with margin of 7.78%.
→FY2026 PAT was Rs 24.97 crore versus Rs 12.09 crore in FY2025.
→Q4 sugar revenue was Rs 496.24 crore, up 11.98% year on year, and sugar EBIT was Rs 91.58 crore, up 10.05%.
→

Easy Trip Planners Ltd.NSE: EASEMYTRIP

Nishant Pitti; Vikash Goyal; Easy Trip Planners Limited · Founder and Chairman; Chief Strategy Officer; issuer filings

Q4 and FY2026 results, Vision 2030, hotel and holiday package momentum, Dubai growth, AI travel integration, non-air expansion, rights issue, preferential allotment, AB Finance transaction termination, governance watch and market-signal coverage·Hospitality·30 May 2026·NSE-filed Q4/FY2026 press release, Q4/FY2026 investor presentation, audited-results board-outcome filing, newspaper publication, rights-issue board approval, preferential-allotment and AB Finance transaction-termination filing, annual secretarial compliance report, SAST disclosure, technology and partnership press releases and NSE announcement slice

▾

Key highlights

→EaseMyTrip filed its Q4 FY2026 press release with NSE on May 31, 2026.
→The press release was dated May 30, 2026 and titled EaseMyTrip Unveils Vision 2030, Reports Robust Q4 FY26 Results.
→EaseMyTrip filed its Q4 and FY2026 investor presentation with NSE on May 31, 2026.
→The company filed audited financial results for the quarter and year ended March 31, 2026 with NSE on May 31, 2026.
→EaseMyTrip filed newspaper publication of audited Q4/FY2026 financial results with NSE on June 1, 2026.

RHI MAGNESITA INDIA LTD.NSE: RHIM

Parmod Sagar; Azim Syed; Sanjay Kumar; Sonu Chadha · Chairman, Managing Director and Chief Executive Officer; Whole-time Director and Chief Financial Officer / Chief Investor Relations Officer; Company Secretary; Non-Executive and Independent Director of RHI Magnesita India Refractories Limited

Q4 and FY2026 results, adjusted versus reported earnings quality, goodwill impairment, steel and ironmaking growth, cement pricing pressure, 4PRO contracts, robotics, price increases, coke-oven order book, quartzite mines, capex, dividend, related-party postal ballot and daily refractory market-signal tracking·Industrials·30 May 2026·NSE-filed RHI Magnesita India Q4/FY2026 earnings-call transcript, investor presentation, audited consolidated and standalone financial-results filing, Q4/FY2026 press release, earnings-call audio-link filing, dividend and board-outcome filing, investor-meet schedule filing, subsidiary merger filing, material-subsidiary director appointment filing, postal-ballot filings, RHI Magnesita India investor-relations pages, and BSE company page

▾

Key highlights

→RHI Magnesita India held its Q4 FY2026 earnings conference call on May 30, 2026 at 11:00 a.m. IST.
→The company filed the Q4 FY2026 earnings-call transcript with NSE on June 3, 2026.
→The company filed its Q4 FY2026 investor presentation with NSE on May 29, 2026.
→The company filed its Q4 FY2026 press release with NSE on May 29, 2026.

Linde India Ltd.NSE: LINDEINDIA

Milan Sadhukhan, Michael James Devine and Abhijit Banerjee · Managing Director; Non-Executive Chairman; former Managing Director

Q4 and FY2026 audited results, qualified audit opinion, related-party and business-allocation litigation, industrial gases demand, project engineering order book, ASU capex, specialty and electronics gases, renewable power sourcing, management transition, dividend and daily market-signal items·Chemicals·30 May 2026·Linde India Q4/FY2026 audited financial-results and board outcome, latest official AGM transcript and notice, FY2024-25 annual report, managing-director transition disclosure, interim CFO disclosure and investor financial/disclosure pages

▾

Key highlights

→Linde India's board approved audited standalone and consolidated financial results for Q4 and FY2026 on May 30, 2026.
→The FY2026 results pack was signed by Milan Sadhukhan as Managing Director; an official December 29, 2025 disclosure said Abhijit Banerjee resigned as Managing Director effective close of December 31, 2025 and Milan Sadhukhan was appointed Managing Director from January 1, 2026, subject to member approval.
→The board recommended a total FY2026 dividend of 120%, equal to Rs 12 per equity share of face value Rs 10, including a special dividend of 80%, or Rs 8 per share.
→The statutory auditors issued a qualified opinion on the standalone and consolidated annual financial results for FY2026.

ION Exchange (India) LimitedNSE: IONEXCHANG

Aankur Patni; Indraneel Dutt; Vasant Naik; Nikisha Solanki · Vice Chairman; Managing Director and CEO; Group Chief Financial Officer; Company Secretary

Q4 and FY2026 results, engineering order book, West Asia logistics impact, Roha resin ramp, MANN+HUMMEL membrane technology transfer, Oman DBOOT project, consumer products scale-up, FY2027 outlook, dividend, ESOP scheme and market-signal tracking·Environmental Services·29 May 2026·ION Exchange official NSE-filed Q4/FY2026 earnings-call transcript, earnings presentation, audited-results board outcome, audio-recording filing, earnings-call invite, MANN+HUMMEL technology-transfer filing, postal-ballot filings, dividend/record-date filing and auditor/cost-auditor disclosure

▾

Key highlights

→ION Exchange held its Q4 and FY2026 earnings conference call on May 29, 2026 and filed the transcript with NSE on June 5, 2026.
→The call was hosted by Valorem Advisors and management participants included Aankur Patni, Vice Chairman; Indraneel Dutt, Managing Director and CEO; Vasant Naik, Group CFO; and Nikisha Solanki, Company Secretary.
→The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 26, 2026.
→Deloitte Haskins & Sells LLP issued audit reports with unmodified opinions on the annual standalone and consolidated financial results.

AvenuesAI LimitedNSE: CCAVENUE

Vishal Mehta; Vishwas Patel; Sunil Bhagat; B. Ravi · Chairman and Managing Director; Managing Director and Chief Executive Officer; Chief Financial Officer; Independent Consultant - Corporate and Financial Strategy

Q4 and FY2026 results, INFIBEAM successor-symbol cleanup, AvenuesAI rebrand, CCAvenue payments, AI-native transaction infrastructure, Rediff ecosystem, embedded finance, OPL/Ratnaafin/Nueromind investments, Rediff business transfer, rights-issue monitoring, UAE license approval and daily market-signal tracking·Financial Services·29 May 2026·AvenuesAI Q4/FY2026 earnings-call transcript, investor presentation, audited-results board outcome, Rediff business-transfer filing, rights-issue deviation and monitoring-agency reports, UAE payment-license filing and NSE current equity list; NSE archive filenames still use the old INFIBEAM prefix while filings identify the live NSE symbol as CCAVENUE

▾

Key highlights

→The current NSE EQ list identifies the live symbol as CCAVENUE / AvenuesAI Limited with ISIN INE483S01020; the old launch queue symbol INFIBEAM is absent from the current NSE EQ list.
→Official filings describe AvenuesAI Limited as formerly Infibeam Avenues Limited.
→NSE archive filenames for FY2026 filings still carry the legacy INFIBEAM prefix, while the filings themselves show NSE symbol CCAVENUE.
→The company held its Q4 and FY2026 earnings conference call on May 29, 2026 after the board meeting.

TCI Express Ltd.NSE: TCIEXP

Chander Agarwal; Mukti Lal; Pabitra Panda; Priyanka; TCI Express Limited · Managing Director; Executive Director and Chief Financial Officer; Chief Business Officer; Company Secretary and Compliance Officer; issuer filings

Q4 and FY2026 results, express logistics demand recovery, multimodal growth, air/fuel and labour cost pressure, branch expansion, Nagpur sorting centre, capex revision, FY2027 revenue and volume guidance, debt-free balance sheet, CRISIL rating reaffirmation, ESOP and governance actions·Logistics·29 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone/consolidated financial-results board outcome, Q4/FY2026 press release, call invite/postponement/audio filings, CRISIL credit-rating filing, ESOP/remuneration/Executive Committee governance filings, promoter SAST disclosure and NSE announcement slice

▾

Key highlights

→TCI Express filed its Q4/FY2026 earnings-call transcript with NSE on June 4, 2026.
→The Q4/FY2026 earnings call was held on May 29, 2026.
→PhillipCapital hosted the call and Vikram Suryavanshi moderated it.
→Management participants on the call were Chander Agarwal, Managing Director; Mukti Lal, Executive Director and Chief Financial Officer; and Pabitra Panda, Chief Business Officer.
→

KNR Constructions Ltd.NSE: KNRCON

K. Narasimha Reddy; K. Jalandhar Reddy; Haritha Varanasi; KNR Constructions Limited · Founder Promoter and Managing Director; Promoter and Executive Director / CFO signatory; Company Secretary; issuer filings

Q4 and FY2026 results, standalone and consolidated revenue decline, EBITDA margin compression, order book, HAM/EPC project wins, Malkajgiri flyover LOA, Kaleswaram receivable and ECL risk, cash flow, debt, dividend, project execution and daily construction market-signal tracking·Construction·29 May 2026·NSE-filed Q4/FY2026 investor presentation, audited standalone and consolidated financial-results board outcome, earnings-call audio-recording filing, order-win filing, Regulation 30 intimations and promoter SAST disclosure; no official Q4 FY2026 transcript was found in the checked NSE Apr 1-Jun 27 source pack

▾

Key highlights

→KNR Constructions filed its Q4/FY2026 investor presentation with NSE on May 29, 2026.
→KNR Constructions filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on May 29, 2026 and again on June 15, 2026.
→The company filed an earnings-call audio-recording link with NSE on June 1, 2026.
→No official Q4 FY2026 earnings-call transcript was found in the checked NSE Apr 1-Jun 27 source pack.

Jamna Auto Industries Ltd.NSE: JAMNAAUTO

Randeep Singh Jauhar; P.S. Jauhar; Jamna Auto Industries Limited issuer filings · Chairman and Executive Director; Managing Director and CEO; issuer filings

Q4 and FY2026 results, record revenue and PBT, Lakshya RISE 5000, Adityapur and Indore capacity commissioning, export-customer expansion, aftermarket and allied-product expansion, suspension product launches, digital transformation, ESG targets, dividend, GST show-cause notice and ICRA rating upgrade·Auto Ancillaries·29 May 2026·Official company-hosted Q4 FY2026 investor presentation and audited results, NSE-filed Q4 board outcome, GST show-cause disclosure, ICRA credit-rating filing, postal-ballot notice and independent-director reappointment filing

▾

Key highlights

→Jamna Auto Industries filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 29, 2026.
→The May 29, 2026 board meeting approved the audited financial results and concluded at 13:10 IST.
→The Board recommended a final dividend of Rs 1.50 per equity share of face value Re 1.
→The board also approved revision in remuneration of Mr. S.P.S. Kohli, subject to member approval.
→The auditors issued unmodified opinions on the audited standalone financial results.

RattanIndia Enterprises Ltd.NSE: RTNINDIA

Anjali Rattan; Roy Kurian; RattanIndia Enterprises Limited issuer filings · Chairperson; President, Revolt Motors; issuer filings

Q4 and FY2026 audited results, Cocoblu e-commerce scale, Revolt EV motorcycle leadership, NeoBrands launch portfolio, NeoSky drone expansion, RattanIndia Power associate stake, Cocoblu internal transfer, trust-disclosure compliance and volume-spurt clarification·Retail·29 May 2026·Official NSE-filed audited Q4/FY2026 results, investor presentation, Revolt Motors press releases, Cocoblu transfer filing, SEBI trust-disclosure filing and exchange volume-spurt clarification

▾

Key highlights

→RattanIndia Enterprises filed audited standalone and consolidated results for Q4 and FY2026 with NSE on May 29, 2026.
→The board approved the audited results at its May 29, 2026 meeting.
→No official Q4 FY2026 earnings-call transcript was found in the checked NSE source pack.
→The May 29 investor presentation described RattanIndia Enterprises as building scalable businesses in sunrise sectors.
→The presentation said FY2026 total income was Rs 7,537 cr versus Rs 6,876 cr in FY2025, up 10%.
→

Gujarat Alkalies & Chemicals Ltd.NSE: GUJALKALI

Avantika Singh, IAS; Shailesh Damani; Gujarat Alkalies and Chemicals Limited · Managing Director; General Manager Finance and Chief Financial Officer; issuer filings

Q4 and FY2026 audited results, standalone profit recovery, consolidated JV drag, dividend, renewable-power mix, hydrogen peroxide capex, phosphoric acid and KOH expansion, biofuel/coal boilers, CleanMax group-captive renewable project, Project Ahvaan, digitization and FY2027 commissioning priorities·Chemicals·29 May 2026·Official NSE-filed audited Q4/FY2026 results and board-outcome filing, company-hosted Q4/FY2026 results pack, MD press-release commentary, dividend filing, high-purity hydrogen peroxide project filing, February 2026 capex board-outcome filing, CleanMax renewable-power project press note, CleanMax SPV equity-contribution filing and GACL financial-results page

▾

Key highlights

→Gujarat Alkalies and Chemicals filed audited standalone and consolidated results for Q4 and FY2026 with NSE on May 29, 2026.
→The May 29, 2026 board meeting approved audited financial results for the quarter and year ended March 31, 2026.
→The May 29, 2026 filing includes a press release with Managing Director Avantika Singh's operating commentary.
→No official Q4 FY2026 earnings-call transcript was found in the checked NSE and company source pack.

Happiest Minds Technologies Ltd.NSE: HAPPSTMNDS

Joseph Anantharaju; Venkatraman Narayanan; Sridhar Mantha; Anand Balakrishnan; Happiest Minds Technologies Limited · Co-Chairman and Chief Executive Officer; Managing Director; Chief Executive Officer - Gen AI Business Services; Chief Financial Officer; issuer filings

Q4 and FY2026 audited results, FY27 constant-currency guidance, AI-first services strategy, Enterprise AI Platform, Rel(AI)Build, GBS scale-up, PureSoftware integration and scheme, dividend, cash flow, leverage and operating risks·IT Services·29 May 2026·NSE-filed audited standalone and consolidated financial results, Q4/FY2026 investor presentation and press release, official earnings-call transcript, FY27 Plan and Enterprise AI Platform press releases, Rel(AI)Build press release, PureSoftware Scheme of Arrangement order, dividend record-date filing, shareholder communication, SAST disclosure and routine compliance filings

▾

Key highlights

→Happiest Minds filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on May 28, 2026.
→The May 28 board-outcome filing states that the Board approved audited standalone and consolidated financial results recommended by the Audit Committee.
→Deloitte Haskins & Sells issued audit reports with unmodified opinions on the annual standalone and consolidated financial results.
→The May 28 board meeting commenced at 8:45 p.m. and concluded at 9:30 p.m.

Praj Industries Ltd.NSE: PRAJIND

Ashish Gaikwad; Sachin Raole; Praj Industries Limited · Managing Director; Joint Managing Director and Chief Financial Officer; issuer filings

Q4 and FY2026 results, bioenergy policy tailwinds, ethanol and CBG pipeline, GenX modularization and data-center pivot, SAF engineering, order backlog, margin pressure, R&D investment, governance changes and FY2027 recovery markers·Construction·29 May 2026·NSE-filed Q4 and FY2026 earnings-call transcript, audited standalone and consolidated financial-results board outcome, press release, investor presentations, precision-fermentation lab press release, Joint Managing Director appointment filing and postal-ballot result filing

▾

Key highlights

→Praj filed audited standalone and consolidated Q4 and FY2026 financial results with NSE on May 28, 2026.
→The board meeting approving the audited results was held on May 28, 2026.
→The audited-results filing states that M S K A & Associates LLP issued audit reports with unmodified opinions on the standalone and consolidated FY2026 financial results.
→The May 28 press release announced Q4 FY2026 consolidated revenue of Rs 8,445.6 mn and PAT of Rs 116.1 mn.
→The May 28 press release announced FY2026 consolidated revenue of Rs 31,678.8 mn and PAT of Rs 238.5 mn.

Gujarat Pipavav Port Ltd.NSE: GPPL

Girish Aggarwal; Santosh Breed; Manish Agnihotri · Managing Director; Chief Financial Officer; Company Secretary and Compliance Officer

Q4 and FY2026 results, container/RoRo/dry-bulk/liquid cargo trends, Middle East disruption, SEIS and GMB one-off items, EBITDA and EBIT margins, final dividend, liquid-jetty capex, concession discussions, rail/customer arbitration, promoter shareholding, governance changes and daily port/logistics market-signal tracking·Logistics·29 May 2026·NSE-filed Gujarat Pipavav Port Q4/FY2026 investor presentation, audited standalone and consolidated financial-results and board-outcome filings, operational-data filing, dividend and record-date filings, BSE audited-results filing, company financial-results page listing the Q4 FY2026 recording and transcript, public transcript mirror, promoter non-encumbrance disclosures, chief-commercial-officer exit filing and nominee-director appointment filing

▾

Key highlights

→Gujarat Pipavav Port filed its Q4 and FY2026 investor presentation with NSE on May 28, 2026.
→The company filed audited standalone and consolidated financial results with NSE on May 28, 2026.
→The company filed the same audited financial-results PDF with BSE, where the PDF was available through BSE's corporate filing archive.
→The company filed operational data for the quarter and financial year ended March 31, 2026 with NSE on April 6, 2026.

Relaxo Footwears Ltd.NSE: RELAXO

Ramesh Kumar Dua; Gaurav Kumaar Dua; Ritesh Dua; Sushil Batra; Ankit Jain · Chairman and Managing Director; Co-Chief Executive Officer and Whole-time Director; Co-Chief Executive Officer; Executive Director; Company Secretary and Compliance Officer

Q4/FY2026 earnings commentary, GST-led demand recovery, general-trade channel recovery, price hikes, raw-material and wage inflation, EBO expansion, premiumization, e-commerce, Clean Max captive solar SPV investment, senior-management changes, dividend and daily footwear market-signal tracking·Apparel & Footwear·29 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, NSE-filed investor presentation, NSE-filed audited financial-results and board-outcome filing, NSE-filed press release, Clean Max renewable-energy SPV investment filing, senior-management-change filing, dividend/record-date filings, SAST disclosure, company investor pages and BSE company page

▾

Key highlights

→Relaxo Footwears held its Q4/FY2026 earnings conference call on May 29, 2026 after the board approved audited FY2026 results on May 28, 2026.
→The NSE transcript filing was submitted on June 3, 2026, and says the call discussed business strategy and outlook after results for the quarter and financial year ended March 31, 2026.
→The call was hosted by IIFL Capital Services, with Sameer Gupta as the moderator.
→Management participants on the call were Ramesh Kumar Dua, Chairman and Managing Director, Gaurav Kumaar Dua, Co-Chief Executive Officer and Whole-time Director, Ritesh Dua, Co-Chief Executive Officer, Sushil Batra, Executive Director, and Ankit Jain, Company Secretary and Compliance Officer.

Finolex Cables Ltd.NSE: FINCABLES

Mahesh Viswanathan · Deputy Chief Executive Officer and Chief Financial Officer; elevated to Chief Executive Officer effective June 1, 2026 per the May 28, 2026 Board outcome

Q4 and FY2026 results, electrical cables, communication cables, optical fiber and preform expansion, solar-cable capacity, EHV Sumitomo JV, exports, FMEG portfolio, capex, copper and fiber raw-material risks, inventory build, pricing pass-through, leadership changes, dividend and daily NSE/BSE market-signal tracking·Capital Goods·29 May 2026·Finolex Cables official Regulation 30 transcript/intimation to BSE and NSE, official Q4/FY2026 investor presentation, audited results filing, company investor pages, NSE company page and BSE company page

▾

Key highlights

→Finolex Cables held its Q4 and FY2026 earnings conference call on May 29, 2026 at 4.30 PM IST.
→The official transcript was filed as a Regulation 30 intimation dated June 3, 2026 addressed to BSE and NSE.
→The company posted the Q4/FY2026 transcript, investor presentation and audited results on its official investor pages.
→Management speaker on the call was Mahesh Viswanathan, Deputy CEO and CFO of Finolex Cables.
→The May 28, 2026 Board outcome approved audited standalone and consolidated results for the quarter and financial year ended March 31, 2026.

NATCO Pharma Ltd.NSE: NATCOPHARM

Rajeev Nannapaneni; Amit Parekh; Rajesh Chebiyam; Rajeev Menon · Vice Chairman and Chief Executive Officer; Chief Financial Officer; Executive Vice President, Crop Health Sciences; Investor Relations

Q4 and FY2026 results, Revlimid decline, FY2027 reset-year guidance, Adcock Ingram associate contribution, semaglutide India launch, Brazil and Canada growth, oncology pipeline, U.S. exclusivity pipeline, R&D intensity, M&A use of cash, crop-health demerger, NPPA demand notice, Eribulin approval, facility inspection status and daily pharma/generics market-signal tracking·Pharmaceuticals·29 May 2026·NATCO Pharma Q4/FY2026 earnings-call transcript filed with NSE/BSE, NSE-hosted audited-results and board-outcome filing, NSE-hosted investor presentation, conference-call intimation, Eribulin USFDA approval press release, NPPA demand-notice disclosure, newspaper-results publication, company investor-relations pages and BSE company-announcements hub

▾

Key highlights

→NATCO Pharma held its Q4 FY2026 earnings conference call on May 29, 2026 at 4:30 p.m. IST.
→The company filed the earnings-call transcript with NSE/BSE on June 4, 2026.
→Management participants were Rajeev Nannapaneni, Vice Chairman and CEO; Amit Parekh, CFO; Rajesh Chebiyam, Executive Vice President, Crop Health Sciences; and Rajeev Menon, Investor Relations.
→The May 29, 2026 board meeting approved audited standalone and consolidated financial results for Q4 and FY2026.

EIH Ltd.NSE: EIHOTEL

Vikram Oberoi; Vineet Kapur · Managing Director and Chief Executive Officer; Chief Financial Officer

Q4 and FY2026 results, hospitality demand, ARR and RevPAR, geopolitical and travel disruptions, owned and managed hotel pipeline, liquidity, renovations, premium positioning, Vision 2030 and daily hospitality market-signal tracking·Hospitality·29 May 2026·EIH Limited official Q4/FY2026 investor-call transcript, company/NSE investor presentation, company/NSE audited financial-results filing, company investor pages and BSE company-announcement hub

▾

Key highlights

→EIH Limited held its Q4 and FY2026 result webinar on May 29, 2026.
→Management participants were Vikram Oberoi, Managing Director and CEO, and Vineet Kapur, CFO.
→The transcript says the webinar covered the audited financial results for the year ended March 31, 2026, approved by the board on May 26, 2026.
→Management said FY2026 was challenging because of India-Pakistan tensions, Operation Sindoor, West Asia conflict, heavy rain and airline disruptions during peak winter months.
→Management said the industry fundamentals still look strong and EIH delivered the highest EBITDA performance in its history.

Elgi Equipments Ltd.NSE: ELGIEQUIP

Jairam Varadaraj; Rohit Gupte; Elgi Equipments Board of Directors · Managing Director; Company Secretary and Compliance Officer; Board of Directors

Q4 and FY2026 results, air compressors, automotive equipment, India demand, North America growth, Europe turnaround, tariffs, commodity inflation, Demand=Match, low-cost compressor response to Chinese competition, vacuum-entry strategy, inventory rationalisation, digital/process transformation, capex, dividends and daily capital-goods/compressor market-signal tracking·Capital Goods·29 May 2026·Elgi Equipments official Q4 FY2026 analyst/investor call transcript, Q4 FY2026 analyst presentation, May 27 2026 audited financial-results filing, board-outcome and dividend filing, NSE-hosted exchange filings, company filings addressed to NSE/BSE, analyst-conference page and stock-exchange-intimation page

▾

Key highlights

→Elgi Equipments held its Q4 and FY2026 analyst/investor call on May 29, 2026.
→The official transcript was filed on June 3, 2026 and identifies Jairam Varadaraj, Managing Director, as the management speaker.
→The source pack includes the company-hosted transcript, presentation and results filings, plus validator-reachable NSE exchange copies for the transcript, presentation, audited results, dividend, record date, press release, call intimation and call recording; the company filings are addressed to both NSE and BSE.
→

Grindwell Norton Ltd.NSE: GRINDWELL

Venugopal Shanbhag; Grindwell Norton Board of Directors · Managing Director; Board of Directors

Q4 and FY2026 results, Investor Meet 2026 financial indicators, Abrasives and Ceramics & Plastics growth, Digital Services, domestic/export mix, capex program, dividend, balance sheet, labour-code impact, regulatory disclosures and daily abrasives/ceramics/industrial-materials market-signal tracking·Industrials·29 May 2026·Grindwell Norton official Q4/FY2026 audited standalone and consolidated financial results, May 29 2026 Investor Meet 2026 presentation, Q4 FY2026 results page, shareholders-corner disclosures and corporate-announcements feed

▾

Key highlights

→Grindwell Norton approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at the board meeting held on May 8, 2026.
→The statutory auditor issued unmodified audit opinions on standalone and consolidated annual financial results for FY2026.
→The official reports page shows the Q4 FY2026 financial-results PDF and half-year related-party-transaction PDF under the 2025-26 January-March financial-results section.
→The company posted an Investor Meet 2026 presentation on May 29, 2026 and a separate Investor Meet 2026 video link on the corporate feed.
→

K.P.R. Mill Ltd.NSE: KPRMILL

K.P.R. Mill senior management; P. L. Murugappan; P. Kandaswamy · Senior management; Chief Financial Officer and investor contact; Company Secretary and Compliance Officer

Q4 and FY2026 results, textile and garment demand, yarn and fabric volume, sugar and ethanol, vertical integration, net cash balance sheet, dividend, investor meetings, cotton import duty exemption, textile export policy read-through and daily market-signal tracking·Textiles·29 May 2026·K.P.R. Mill Q4/FY2026 audited financial results, Q4/FY2026 investor presentation, company con-call/transcript page, May 2026 investor-meet intimations and PIB cotton-import-duty policy releases

▾

Key highlights

→K.P.R. Mill approved audited standalone and consolidated financial results for the year ended March 31, 2026 at its May 12, 2026 board meeting.
→The May 12, 2026 board meeting commenced at 11:30 a.m. and concluded at 1:35 p.m.
→The board recommended a 250% final dividend for FY2025-26, equal to Rs 2.50 per equity share of face value Re 1.
→Including interim payouts, the aggregate dividend for FY2025-26 is 500%.
→The statutory auditor issued an unmodified audit report on standalone and consolidated annual financial results.

Fertilisers and Chemicals Travancore Ltd.NSE: FACT

S. Sakthimani and Pradeep Kumar C · Chairman and Managing Director and Director (Finance); General Manager (Corporate Finance)

Q4 and FY2026 audited results, revenue scale-up, Q4 profit compression, FY2026 net loss, fertilizer segment performance, finance-cost and working-capital pressure, FRBL deconsolidation disclosure, subsidy accounting, labour-code cost, and major project execution·Fertilizers·29 May 2026·FACT audited Q4/FY2026 financial results, board-meeting intimation, official quarterly/audited-results pages and major-project disclosure; official earnings-call transcript not found

▾

Key highlights

→FACT's board approved audited results for the quarter and year ended March 31, 2026 at its May 29, 2026 meeting; the prior board intimation said the 536th Board Meeting would consider the audited Q4/FY2026 results on that date.
→FY2026 revenue from operations grew to Rs 5,723.76 cr from Rs 4,050.91 cr in FY2025, while Q4 FY2026 revenue from operations was Rs 1,483.85 cr versus Rs 1,053.28 cr in Q4 FY2025.
→Despite the revenue scale-up, FY2026 reported profit after tax moved to a loss of Rs 39.60 cr from profit of Rs 41.23 cr in FY2025, reflecting weak operating conversion, finance-cost drag and non-operating pressure.
→Q4 FY2026 PAT was Rs 3.16 cr, down sharply from Rs 70.72 cr in Q4 FY2025, although it improved from a Rs 67.90 cr loss in Q3 FY2026.

Cummins India Ltd.NSE: CUMMINSIND

Shveta Arya and Soma Ghosh · Managing Director; Chief Financial Officer

Q4 FY2026 and FY2026 sales growth, PowerGen data-center demand, CPCB IV+ localisation, distribution services, industrial demand pockets, exports and supply-chain caution·Capital Goods·29 May 2026·Company earnings conference call transcript

▾

Key highlights

→Management reported FY2026 sales of Rs 11,950 cr, up 18% YoY, with domestic sales up 19% to Rs 9,961 cr and exports up 12% to Rs 1,989 cr.
→Q4 FY2026 sales were Rs 2,963 cr, up 23% YoY, with domestic sales up 30% to Rs 2,513 cr while exports declined 6% YoY to Rs 450 cr.
→FY2026 PBT before exceptional items rose 24% YoY to Rs 3,104 cr, and Q4 FY2026 PBT before exceptional items rose 20% YoY to Rs 820 cr.
→Power Generation domestic sales were Rs 4,758 cr in FY2026, up 24% YoY, and Rs 1,294 cr in Q4 FY2026, up 48% YoY and 21% QoQ.
→Management said data centers contributed 30%-35% of FY2026 domestic Power Generation revenue and about 35% of Q4 domestic Power Generation revenue.
→Data-center inquiry velocity picked up materially after October 2025, led by both hyperscalers and, more strongly, colocation players.

Asian Paints Ltd.NSE: ASIANPAINT

Amit Syngle, R.J. Jeyamurugan, Parag Rane and Lakshya Sharma · MD and CEO; CFO and Company Secretary; AVP Finance; Investor Relations

Q4 FY2026 and FY2026 demand recovery, decorative volumes, premiumization, B2B, margin guidance, pricing and competition·Chemicals·29 May 2026·NSE exchange filing / Q4 FY2026 investor conference transcript

▾

Key highlights

→Management said Q4 FY2026 was a strong growth quarter, with India decorative volume growth back in double digits at 12.4% and value growth at 10.2%.
→Decorative plus industrial coatings grew 12.7% in volume and 11.0% in value in Q4, with management saying the company grew strongly above market growth rates.
→Demand improved across all three months, rural growth was ahead of urban growth, and B2B projects continued to make inroads in factories, hospitality, government and infrastructure.
→Premiumization improved mix through the PreLux portfolio, new products contributed about 17% of revenues, and the VAM-VAE backward integration project remained on track for first-phase commissioning in H1 FY2027.
→Gross margins improved sharply on raw-material deflation, sourcing and formulation efficiencies, with Q4 consolidated gross margin at 44.7% and standalone gross margin at 45.6%.

InterGlobe Aviation Ltd.NSE: INDIGO

Rahul Bhatia, Gaurav Negi and Richa Chhabra · Managing Director; Chief Financial Officer; Head of Investor Relations

Q4 FY2026 results, December disruption, Middle East airspace disruption, forex losses, fleet, liquidity, international expansion and Q1 FY2027 outlook·Aviation·29 May 2026·IndiGo Q4 FY2026 financial results conference call transcript

▾

Key highlights

→Management said FY2026 was one of the most demanding years for Indian aviation, with external disruptions, the December operational disruption and Middle East airspace issues affecting capacity, revenue and cost.
→IndiGo served more than 123 mn passengers in FY2026, its highest ever, despite capacity and demand being disrupted during the year.
→Reported FY2026 net loss was INR 23.9 bn, mainly due to foreign-exchange movement and exceptional items, but underlying net profit excluding forex and exceptional items was INR 75 bn.
→Q4 FY2026 reported net loss was INR 25.4 bn versus net profit of INR 30.7 bn in Q4 FY2025, affected by a high Maha Kumbh base, Middle East disruptions and INR 48.2 bn of forex losses.
→Management said operational discipline was restored after December, with IndiGo leading on-time performance across the last quarter.

Graphite India Ltd.NSE: GRAPHITE

K. K. Bangur; Sanjeev Marda · Chairman; Company Secretary

Q4 and FY2026 results, graphite-electrode volume growth and capacity utilization, EBITDA and net-profit pressure from treasury fair-value losses and inventory NRV write-downs, net-cash balance, dividend, first phase of electrode capacity expansion, SGAM diversification, GrafTech stake increase, EAF and CBAM demand drivers, West Asia logistics and energy-input risks, ESG score updates and daily NSE/BSE market-signal tracking·Capital Goods·28 May 2026·Graphite India official Q4 and FY2026 earnings presentation, audited standalone and consolidated FY2026 financial results, FY2026 AGM and dividend record-date filing, SGAM new-business filing, GrafTech investment filing, ESG rating filings, volume-clarification filing, corporate presentation and exchange-directed company filings

▾

Key highlights

→Graphite India released its Q4 and FY2026 earnings presentation on May 28, 2026, addressed to BSE and NSE under BSE scrip code 509488 and NSE symbol GRAPHITE.
→The official management source is the company's earnings presentation and Chairman's Message; no separate post-result call transcript was located in the official Graphite India investor page during this checkpoint.
→The Board approved audited standalone and consolidated results for the year ended March 31, 2026 at its May 28, 2026 meeting, which commenced at 12:15 p.m. and concluded at 1:50 p.m.
→

Sumitomo Chemical India Ltd.NSE: SUMICHEM

Chetan Shah; Sushil Marfatia; Suresh Ramachandran; Kunal Mittal; Anil Nawal; Deepika Trivedi · Managing Director; Executive Director; Deputy Managing Director; Senior Vice President - Planning and Coordination Office; Chief Financial Officer; Company Secretary and Compliance Officer

Q4 and FY2026 results, record profitability, domestic branded formulations, herbicides and biologicals, regulatory normalization, Africa exports, digital farmer engagement, pricing discipline, working capital, Dahej/Bhavnagar/Tarapur expansion, parent-company manufacturing-hub strategy, leadership transition, monsoon/fertilizer risk and daily agrochemical market-signal tracking·Fertilizers·28 May 2026·Sumitomo Chemical India official NSE-hosted Q4/FY2026 earnings-call transcript, investor presentation, integrated audited financial-results filing, board outcome, dividend and record-date filings, leadership-transition filings, credit-rating filing and company investor-relations page

▾

Key highlights

→Sumitomo Chemical India held its Q4/FY2026 earnings call on May 28, 2026 after the board approved audited results on May 26, 2026.
→The company filed the official earnings-call transcript with exchanges on June 4, 2026.
→Management participants included Chetan Shah, Managing Director; Sushil Marfatia, Executive Director; Dr. Suresh Ramachandran, Deputy Managing Director; Kunal Mittal, Senior Vice President - Planning and Coordination Office; Anil Nawal, Chief Financial Officer; and Deepika Trivedi, Company Secretary and Compliance Officer.

Bharat Dynamics Ltd.NSE: BDL

D. V. Srinivas Rao; N. Nagaraja; CRISIL Ratings · Director (Technical) and Chairman and Managing Director (Additional Charge); Company Secretary; credit rating agency

Q4 and FY2026 results, execution slowdown, orderbook and FY2027 order pipeline, Advanced Akash delivery readiness, additional manufacturing facilities, indigenous torpedo productionization, dividend, cash and working capital, CRISIL rating, senior-management change, governance/Audit Committee limitation, Labour Code liability and daily market-signal tracking·Defence·28 May 2026·Bharat Dynamics Q4/FY2026 audited financial results, official investor-meeting intimation, Advanced Akash update, additional manufacturing facilities update, CRISIL rating rationale, senior-management disclosure and torpedo media release

▾

Key highlights

→Bharat Dynamics' BDL management note is based on official audited results and stock-exchange/company disclosures because no complete official Q4 FY2026 earnings-call transcript was found in the source pack reviewed.
→The board approved audited financial results for the quarter and year ended March 31, 2026 at its meeting on May 28, 2026.
→The board recommended a final dividend of Rs 0.40 per share on face value of Rs 5, payable after shareholder approval at the AGM.
→BDL had already paid interim dividend of Rs 4.50 per share for FY2026 in February 2026, taking total FY2026 dividend proposed/paid to Rs 4.90 per share.

Alkem Laboratories Ltd.NSE: ALKEM

Sandeep Singh, Vikas Gupta, Nitin Agrawal and Purvi Shah · Managing Director; Chief Executive Officer; Chief Financial Officer; Head of Investor Relations

Q4 and FY2026 earnings, India formulations, GLP-1 launch, international business, margin quality, R&D, tax regime, capital allocation, MedTech, biosimilars, CDMO, regulatory observations, governance changes, investor meetings and daily market-signal items·Pharmaceuticals·28 May 2026·Alkem Laboratories Q4/FY2026 earnings-call transcript, results presentation, press release, audited results, board-outcome filing, exchange transcript filing, conference-call invite, investor-meeting disclosures, MedTech investor-meet materials and recent Regulation 30 filings

▾

Key highlights

→Alkem Laboratories held its Q4 and FY2026 earnings call on May 28, 2026, after board approval of audited standalone and consolidated results for the quarter and financial year ended March 31, 2026.
→The call was hosted by Motilal Oswal, moderated by Tushar Manudhane, and attended by Sandeep Singh, Managing Director, Dr. Vikas Gupta, Chief Executive Officer, Nitin Agrawal, Chief Financial Officer, and Purvi Shah, Head of Investor Relations.
→The company filed the signed earnings-call transcript with NSE on June 1, 2026.
→Management framed FY2026 as a landmark year because the company crossed Rs 3,000 cr of EBITDA for the first time.

Ashok Leyland Ltd.NSE: ASHOKLEY

Shenu Agarwal and K. M. Balaji · Managing Director and Chief Executive Officer; President - Finance and Chief Financial Officer

Q4 and FY2026 record CV volumes, revenue, EBITDA, PAT, cash surplus, GST-led replacement demand, MHCV and LCV market share, exports, defense, power solutions, aftermarket, Switch Mobility, battery-pack manufacturing, capex, material-cost pressure and FY2027 demand outlook·Capital Goods·28 May 2026·Ashok Leyland Q4 and FY2026 earnings-call transcript, Q4 press release, audited financial-results filing, transcript page and investor recording page

▾

Key highlights

→Management described FY2026 as the best annual performance in Ashok Leyland's history, with all-time-high CV volume, revenue, profit and cash surplus.
→Q4 FY2026 revenue was Rs 14,161 cr, up 19% YoY, EBITDA was Rs 2,066 cr, up 15.3% YoY, and EBITDA margin was 14.6%.
→FY2026 revenue was Rs 44,007 cr, up 13.6% YoY, and full-year EBITDA margin was 13.0%, putting the company into what management called the teen bracket.
→Q4 operating PBT before exceptional items was Rs 1,909 cr, up 14% YoY, and PAT excluding exceptional items was Rs 1,405 cr, up 13% YoY.
→FY2026 PBT before exceptional items was Rs 5,163 cr, up 22% YoY, while PAT excluding exceptional items was Rs 3,914 cr; reported FY2026 PAT was affected by a Rs 308 cr one-time charge linked to the new Labour Code.

Siemens Ltd.NSE: SIEMENS

Sunil Mathur, Wolfgang Wrumnig and Radhika Arora · Managing Director and CEO; Executive Director and CFO; Head of Investor Relations

Quarter ended March 2026 results, order backlog, private and public capex, railways, data centres, commodity and currency pressure, localization, low-voltage motors divestment and business mix·Capital Goods·28 May 2026·Siemens Limited India analyst and investor call transcript for the quarter ended March 31, 2026

▾

Key highlights

→Management said Siemens India does not yet see a slowdown in either private capex or public capex, despite West Asia uncertainty, rupee depreciation and commodity volatility.
→The March 2026 quarter was described as the final quarter of the changed financial year, after Siemens Limited shifted from an October-September cycle to an April-March cycle.
→Order backlog increased to Rs 450.3 bn, from Rs 412 bn twelve months earlier, giving future revenue visibility.
→Q6 new orders rose 33% YoY to Rs 67.3 bn, driven by double-digit growth in Smart Infrastructure and Mobility.
→Q6 revenue rose 14.6% YoY to Rs 46.2 bn, with all three businesses growing double-digit.
→

Astra Microwave Products LimitedNSE: ASTRAMICRO

S. G. Reddy; M. V. Reddy; Atim Kabra · Managing Director; Joint Managing Director; Director - Business Development and Strategy

Q4 and FY2026 results, order book, radar/EW/space/meteorology pipeline, FY2027 revenue guide, ARC joint venture, operating cash-flow improvement, demerger of space/meteorology/hydrology business, MD transition, preferential-warrant monitoring and defence-electronics market-signal tracking·Technology·27 May 2026·Astra Microwave official Q4/FY2026 earnings-call transcript, investor presentation, audited-results board outcome, press release, monitoring-agency report, demerger scheme approval, ARC order disclosure and management-transition filings

▾

Key highlights

→Astra Microwave filed the Q4 and FY2026 earnings-call transcript with NSE on June 1, 2026; the call was held on May 27, 2026.
→Management speakers on the call were S. G. Reddy, Managing Director; M. V. Reddy, Joint Managing Director; and Atim Kabra, Director - Business Development and Strategy.
→The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 26, 2026.
→The statutory auditors issued unmodified audit opinions on standalone and consolidated FY2026 financial statements.
→

Hikal Ltd.NSE: HIKAL

Sameer Hiremath; Kuldeep Jain; Manoj Mehrotra; Ravi Khadabadi; Anish Swadi; Jai Hiremath; Hikal Limited · Executive Vice Chairman and Managing Director; Chief Financial Officer; Head of Pharmaceuticals; President-Crop Protection and Specialty Chemicals; Senior President of Business Transformation and Head of Animal Health; Executive Chairman; issuer filings

Q4 and FY2026 results, pharma recovery after Bangalore FDA remediation headwinds, Panoli pilot plant and CDMO derisking, crop-protection volume rebound, animal-health CDMO pipeline, capex discipline, dividend, fraud/default disclosure and governance market-signal coverage·Pharmaceuticals·27 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, Q4/FY2026 earnings release, audited standalone/consolidated financial-results board outcome, earnings-call invite and recording filings, fraud/default employee disclosure, senior-management appointment and retirement disclosures, dividend filing, postal-ballot notice, promoter SAST disclosures and NSE announcement slice

▾

Key highlights

→Hikal filed its Q4/FY2026 earnings-call transcript with NSE on June 3, 2026.
→The Q4/FY2026 earnings call was held on May 27, 2026.
→Management participants on the call included Sameer Hiremath, Executive Vice Chairman and Managing Director; Kuldeep Jain, Chief Financial Officer; Manoj Mehrotra, Head of Pharmaceuticals; Ravi Khadabadi, new Crop Protection Head; and Anish Swadi, Senior President of Business Transformation and Head of Animal Health.

Polyplex Corporation Ltd.NSE: POLYPLEX

Polyplex Corporation Limited; issuer filings · issuer filings

Q4 and FY2026 results, U.S. line ramp-up, overcapacity and tariff pressure, D-PAC portfolio contribution, India/Turkey growth capex, TechNova Printrite acquisition, Polyplex Thailand tender-offer intention, Q1 FY2027 guidance, sustainability/recycling disclosures, dividend and governance updates·Chemicals·27 May 2026·NSE-filed Q4/FY2026 investor presentation, audited standalone and consolidated financial-results board outcome, TechNova Printrite acquisition-completion filing, Polyplex Thailand tender-offer intention filing, dividend filing, postal-ballot/director filings, senior-management appointment filing, trading-window filing and NSE announcement slice. No official Q4 FY2026 earnings-call transcript was found in the checked NSE April 1 to June 27, 2026 source pack.

▾

Key highlights

→Polyplex filed its Q4/FY2026 investor presentation with NSE on May 27, 2026.
→Polyplex filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on May 23, 2026.
→The board approved the audited standalone and consolidated financial results at its May 23, 2026 board meeting.
→The auditors issued unmodified opinions on the audited standalone and consolidated financial results for FY2026.

FDC Ltd.NSE: FDC

Varsharani Katre; Vishal Shah; Mohan A. Chandavarkar; FDC Limited · Company Secretary and Legal Head; Chief Financial Officer; Chairman and Managing Director; issuer filings

Q4 and FY2026 results, domestic formulations rebound, export formulations recovery, US business execution, API growth, EBITDA margin improvement, USFDA product approvals, Enerzal stock-seizure disclosure, postal-ballot director appointment and launch-readiness filing signals·Pharmaceuticals·27 May 2026·NSE-filed revised Q4 and FY2026 press release, audited standalone and consolidated financial-results board outcome, USFDA ANDA approval filing, Enerzal/FDA Maharashtra regulatory disclosure, postal-ballot director-appointment filings and large-corporate disclosure

▾

Key highlights

→FDC filed its Q4 and FY2026 results press release with NSE on May 27, 2026.
→FDC filed a revised press release with NSE on May 28, 2026 to correct a typographical error in the subject line.
→The May 28, 2026 revised filing said there was no change in the contents of the May 27, 2026 press release.
→FDC announced financial results for the fourth quarter and year ended March 31, 2026.
→FDC filed audited standalone and consolidated financial results with NSE on May 27, 2026.

Sudarshan Chemical Industries Ltd.NSE: SUDARSCHEM

Rajesh Rathi; Nilkanth Natu; Amey Athalye; Mandar Velankar; Board of Directors · Chairman and Managing Director; Chief Financial Officer; General Manager Finance; General Counsel and Company Secretary; Board of Directors

Q4 and FY2026 results, Heubach/Clariant acquired-group integration, One Sudarshan operating model, SAP/GCC/culture rollout, inventory and debt reduction, FY2027 acquired-group EBITDA target, RIECO turnaround, final dividend, auditor appointments, promoter warrant conversion, Frankfurt global head office, CRISIL rating, GST order and daily market-signal tracking·Chemicals·27 May 2026·Company/NSE-filed Q4 FY2026 earnings-call transcript, investor presentation, audited standalone and consolidated financial-results board outcome, analyst-call intimation, June 2026 press releases and investor-meet filings, warrant-conversion/allotment filing, CRISIL commercial-paper rating filing, and GST-order disclosure

▾

Key highlights

→Sudarshan filed the Q4 FY2026 analysts and institutional investors conference-call transcript with NSE on June 4, 2026.
→The transcript states that the conference call took place on Wednesday, May 27, 2026 after announcement of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
→Management participants on the call were Rajesh Rathi, Nilkanth Natu and Amey Athalye.
→

Varroc Engineering Ltd.NSE: VARROC

Tarang Jain; Arjun Jain; Dhruv Jain; K Mahendra Kumar; Bikash Dugar · Chairman and Managing Director; Whole-time Director and CEO, Business I; Whole-time Director and CEO, Business II; Group CFO; Head Investor Relations and Finance Controller Business II

Q4 and FY2026 results, highest-ever order intake, EV-linked growth, overseas revival, Romania and Thailand programs, capex, net debt, audit qualification, dividend, TOLYY digital-cockpit partnership and daily auto-ancillary market-signal tracking·Auto Ancillaries·27 May 2026·NSE-filed VARROC Q4/FY2026 earnings-call transcript, investor presentation, audited financial-results and board-outcome filing, Q4/FY2026 press release, earnings-call audio filing, June 2026 TOLYY strategic-cooperation filings, June 2026 investor presentation, Varroc investor pages and BSE company page

▾

Key highlights

→VARROC filed the transcript of its Q4 and FY2026 earnings conference call with NSE on June 2, 2026.
→The conference call was held on May 27, 2026 after the board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
→The call was led by Tarang Jain, Chairman and Managing Director; Arjun Jain, Whole-time Director and CEO, Business I; Dhruv Jain, Whole-time Director and CEO, Business II; K Mahendra Kumar, Group CFO; and Bikash Dugar, Head Investor Relations and Finance Controller Business II.
→

Finolex Industries Ltd.NSE: FINPIPE

Udipt Agarwal; Chandan Verma · Managing Director; Chief Financial Officer

Q4 and FY2026 results, revenue realization, EBITDA margin, flat Q4 volumes, FY2026 volume decline, PVC resin and VCM volatility, Middle East supply-chain risk, agri and non-agri demand, CPVC and fittings mix, capacity, capex, net cash, dividend, credit rating and daily market-signal tracking·Industrials·27 May 2026·NSE-filed Finolex Industries Q4/FY2026 earnings-call transcript, company-hosted transcript, investor presentation, audited-results and board-outcome filing, conference-call intimation, audio-recording filing, credit-rating filing, promoter takeover-regulation disclosures, shareholder newspaper-publication filing, company financials page and BSE company page

▾

Key highlights

→Finolex Industries filed the Q4 FY2026 conference-call intimation with NSE on May 20, 2026.
→The call intimation says the investor conference call was scheduled for Wednesday, May 27, 2026 at 4:00 p.m. IST to discuss Q4 FY2026 financial results.
→The call intimation listed Udipt Agarwal, Managing Director, and Chandan Verma, Chief Financial Officer, as the company representatives.
→The call was coordinated by ICICI Securities.
→Finolex Industries filed the Q4/FY2026 audited standalone and consolidated results and board-outcome pack with NSE on May 26, 2026.

E.I.D. Parry (India) Ltd.NSE: EIDPARRY

Muthiah Murugappan; Y. Venkateshwarlu; Suresh Kannan; Abdul Hakeem Ashiq; Biswa Mohan Rath · Whole-time Director and Chief Executive Officer; Chief Financial Officer; Whole-time Director, Parry Sugars Refinery India Private Limited; Chief Operating Officer, Sugar and Biofuel Division; Senior VP, Legal and Company Secretary

Q4 and FY2026 results, sugar and biofuel operations, distillery realizations, co-generation, consumer products recalibration, nutraceuticals, PSRIPL refinery closure, Coromandel/Farm Inputs contribution, ethanol blending, cane planting and recovery, capex allocation, promoter/holding-structure questions and daily NSE/BSE market-signal tracking·Fertilizers·27 May 2026·E.I.D. Parry official NSE-filed Q4/FY2026 earnings-call transcript, NSE/company Q4/FY2026 audited standalone and consolidated financial-results and board-outcome bundle, NSE/company investor presentation, conference-call invitation and audio-recording filing, company financials page, NSE company page, BSE company page and related exchange filings

▾

Key highlights

→E.I.D. Parry held its Q4 and FY2026 earnings conference call on May 27, 2026 at 11:00 IST, hosted by DAM Capital Advisors.
→The company filed the official conference-call transcript with NSE and BSE on June 2, 2026 under Regulation 30.
→Management participants on the transcript were Muthiah Murugappan, Whole-time Director and CEO; Y. Venkateshwarlu, CFO; Suresh Kannan, Whole-time Director of Parry Sugars Refinery India Private Limited; Abdul Hakeem Ashiq, COO of the Sugar and Biofuel Division; and Biswa Mohan Rath, Senior VP - Legal and Company Secretary.

Vinati Organics Ltd.NSE: VINATIORGA

Vinati Saraf Mutreja; Gulshan Sakhuja; Aditya Churiwala · Managing Director and Chief Executive Officer; Chief Financial Officer; AGM, Corporate Finance

Q4 and FY2026 results, FY2027 volume growth and margin outlook, ATBS expansion and utilization, VOPL process reengineering and revenue timing, antioxidants and butyl phenols roadmap, new downstream products, capex, raw-material/logistics normalization, China/ADD risk and daily NSE/BSE market-signal tracking·Chemicals·27 May 2026·Vinati Organics official NSE-filed Q4/FY2026 earnings-call transcript, audited standalone and consolidated financial results, board outcome and dividend filings, conference-call invitation and audio-recording filing, Veeral Organics investment filing, ATBS capacity-addition filing, NSE company page and BSE company page

▾

Key highlights

→Vinati Organics held its Q4 FY2026 earnings conference call on May 27, 2026 at 15:30 IST, hosted by Nuvama Institutional Equities.
→The company filed the official conference-call transcript with NSE on May 29, 2026 under Regulation 30.
→Management participants were Vinati Saraf Mutreja, Managing Director and CEO, Gulshan Sakhuja, CFO, and Aditya Churiwala, AGM, Corporate Finance.
→The Board meeting on May 12, 2026 approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.

Asahi India Glass Ltd.NSE: ASAHIINDIA

Gopal Ganatra; Asahi India Glass board and management · Executive Director, General Counsel and Company Secretary; Board and management

Q4 and FY2026 audited results, dividend, automotive and float-glass segment growth, QIP-funded balance-sheet reset, capex, subsidiary merger, Labour Code exceptional item, working-capital movement and daily auto/float-glass/building-material market-signal tracking·Auto Ancillaries·27 May 2026·NSE-hosted Asahi India Glass Q4/FY2026 board-outcome and audited financial-results filing, AIS company latest-results page and corporate-announcement page

▾

Key highlights

→Asahi India Glass filed its Q4/FY2026 board outcome and audited standalone/consolidated financial results with NSE and BSE on May 27, 2026.
→No official Q4 FY2026 earnings-call transcript or investor-presentation PDF was found in the company, NSE and BSE source trail reviewed; this note is built from the board outcome, audited results, dividend disclosure, segment tables and company investor pages.
→The board meeting started at 11:00 a.m. and concluded at 2:40 p.m. on May 27, 2026.
→The statutory auditors issued unmodified standalone and consolidated audit opinions for the quarter and year ended March 31, 2026.
→The board recommended a final dividend of Rs 2 per equity share of face value Re 1 for FY2026, subject to shareholder approval.

Indian Railway Catering And Tourism Corporation Ltd.NSE: IRCTC

Sanjay Kumar Jain; Sudhir Kumar; Rahul Himalian; Manoj Sharma; Suman Kalra · Chairman and Managing Director; Director (Finance) and Chief Financial Officer; Director (Tourism and Marketing); Director (Catering Services); Company Secretary and Compliance Officer

Q4 and FY2026 results, record revenue/PAT/EBITDA, segment growth, internet-ticketing KPIs, convenience fee, 30% EBITDA-margin aspiration, Rail Neer expansion, payment-aggregator application, catering economics, tourism growth, dividend, governance penalty and market-signal watch items·Hospitality·27 May 2026·IRCTC Q4/FY2026 NSE earnings-call transcript, BSE audited Q4/FY2026 standalone and consolidated results/board-outcome filing, NSE earnings-call intimation and revised intimation, and NSE governance penalty disclosure

▾

Key highlights

→IRCTC filed the transcript of its Q4 and FY2026 earnings conference call held on May 27, 2026 with NSE on May 29, 2026.
→IRCTC's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 26, 2026 board meeting.
→The audited results were reviewed and recommended by the Audit Committee before board approval.
→The statutory auditors issued audit reports with unmodified opinion on the audited standalone and consolidated results for Q4/FY2026.

NLC India Ltd.NSE: NLCINDIA

M. Prasanna Kumar; P. K. Acharya; H. Ashok Kumar; Suresh Chandra Suman; Samir Swain; Ashok Kumar Mali · Chairman and Managing Director; Director - Finance; Director - Power; Director - Mines; Director - Planning and Projects; Company Secretary

Q4 and FY2026 results, record consolidated revenue/PAT, Talabira and Pachwara coal production, Ghatampur ramp-up, FY2027 revenue bridge, renewable capacity additions, NIRL IPO plan, SECI storage-linked solar award, debt headroom, land/lignite risk and daily tracking items·Power·27 May 2026·NLC India Q4/FY2026 investor-meet transcript, official company-hosted audio and investor-info page, May 2026 corporate presentation, audited financial results, investor-meet intimation, company FY2026 performance press release and NSE-hosted audited-result filing

▾

Key highlights

→NLC India held its Q4/FY2026 investor meet on May 27, 2026 with CMD M. Prasanna Kumar and senior functional directors covering finance, power, mines, planning/projects and company secretarial matters.
→The company reported its highest-ever consolidated revenue from operations of Rs 17,489.53 cr in FY2026 versus Rs 15,282.96 cr in FY2025, a 14.44% increase.
→Consolidated PAT rose to Rs 3,769.46 cr in FY2026 versus Rs 2,713.61 cr in FY2025, up 38.91%, aided by rate-regulated account movements and tax benefits from renewables transfer and NTPL 80-IA reversals.
→Q4 FY2026 consolidated revenue from operations was Rs 5,042.46 cr versus Rs 4,443.05 cr in Q3 FY2026 and Rs 3,836.00 cr in Q4 FY2025.

Amara Raja Energy & Mobility Ltd.NSE: ARE&M

Harshavardhana Gourineni; Vikramadithya Gourineni; Y. Delli Babu; Jayadev Galla; Board of Directors · Executive Director - Automotive and Industrial; Executive Director - New Energy Business; Chief Financial Officer; Chairman and Managing Director; Board of Directors

Q4 and FY2026 results, active NSE successor coverage from AMARAJABAT to ARE&M, lead-acid growth, New Energy and lithium-pack ramp, telecom 1 GWh milestone, Giga Corridor execution, BESS facility, CQP, capex, margins, raw-material pressure, dividends and FY2027 outlook·Capital Goods·26 May 2026·NSE-filed ARE&M Q4/FY2026 earnings-call transcript, audited results and board outcome, investor presentation, press release, audio-link filing, 1 GWh exchange clarification, senior-management transition filing and current NSE EQ list

▾

Key highlights

→The current NSE EQ list shows Amara Raja Energy & Mobility Limited under symbol ARE&M with ISIN INE885A01032; AMARAJABAT is the stale legacy symbol for the launch universe.
→The NSE filings identify the company as Amara Raja Energy & Mobility Limited, formerly known as Amara Raja Batteries Limited.
→ARE&M filed audited Q4/FY2026 results, board outcome, investor presentation and results press release with NSE on May 25, 2026.
→ARE&M filed the audio-link intimation for its May 26, 2026 earnings call with NSE on May 26, 2026.

Chemplast Sanmar Ltd.NSE: CHEMPLASTS

S. Ganeshkumar; A. R. Balaji; Krishna Kumar Rangachari; N. Muralidharan; P. Srinivasan; Chemplast Sanmar Limited · Managing Director; Chief Financial Officer; Head of Custom Manufactured Chemicals Division; Executive Director Finance; Company Secretary and Compliance Officer; issuer filings

Q4 and FY2026 results, specialty chemicals performance, Paste PVC antidumping duty watch, custom manufactured chemicals pipeline, R32 refrigerant gas ramp-up, value-added chemicals pressure, suspension PVC / CCVL stress, exceptional impairment and onerous-contract provision, strategic-priorities committee, FY2027 operating posture, production-start market signals, governance changes and daily market-signal tracking·Chemicals·26 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, audited standalone and consolidated financial-results board outcome, earnings-call invite and audio-recording filings, R32 swing-plant commercial-production filing, CMCD MPB III Phase III commercial-production filing, spurt-in-volume clarification, director resignation and director appointment / strategic-priorities committee filings

▾

Key highlights

→Chemplast Sanmar filed its Q4/FY2026 earnings-call transcript with NSE on June 2, 2026.
→The Q4/FY2026 earnings call was held on May 26, 2026.
→Management participants included Managing Director S. Ganeshkumar, CFO A. R. Balaji, CMCD head Dr. Krishna Kumar Rangachari and Executive Director Finance N. Muralidharan.

Suprajit Engineering Ltd.NSE: SUPRAJIT

K. Ajith Kumar Rai; N.S. Mohan; Akhilesh Rai; Medappa Gowda J; Suprajit Engineering Limited · Founder and Chairman; Managing Director and Group Chief Executive Officer; Director and Chief Strategy Officer; Chief Financial Officer and Company Secretary; issuer filings

Q4 and FY2026 results, SCS turnaround, Controls restructuring, division renaming, FY2027 outlook, GCM contract wins, tariff recovery, capex, technology-center products, Phoenix Lighting recovery and Middle East commodity risks·Auto Ancillaries·26 May 2026·NSE-filed Q4 and FY2026 earnings-call transcript, audited standalone and consolidated financial-results board outcome, press release and investor presentation, business-update filing, earnings-call recording filing, conference-call schedule, dividend filing and chairman podcast filing

▾

Key highlights

→Suprajit filed audited standalone and consolidated Q4 and FY2026 financial results with NSE on May 25, 2026.
→The board meeting approving the audited results was held on May 25, 2026.
→S.R. Batliboi & Associates LLP issued the statutory audit reports on the annual standalone and consolidated results.
→The statutory auditors issued unmodified opinions on the audited standalone and consolidated FY2026 results.
→

Aditya Birla Fashion and Retail Ltd.NSE: ABFRL

Ashish Dikshit; Jagdish Bajaj; Sangeeta Tanwani; Rajeev Agrawal · Managing Director; Chief Financial Officer; Director and CEO - Pantaloons; Company Secretary and Compliance Officer

Q4 and FY2026 results, Pantaloons rebound, OWND scale-up, ethnic portfolio margin expansion, TCNS loss reduction, Tasva/Jaypore/designer-led growth, TMRW funding and profitability path, Galeries Lafayette launch, demerger comparability, cash-use plan, leverage, auditor reappointment and daily retail/apparel/capital-structure market-signal tracking·Apparel & Footwear·26 May 2026·NSE-filed ABFRL Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone/consolidated financial-results and board-outcome filing, Q4 press release, statutory-auditor reappointment filing, monitoring-agency report, CRISIL rating filing, subsidiary investment and TMRW-Bewakoof stake-increase filings, Pantaloons leadership-transition filing, BSE security identity page and company investor-relations pages

▾

Key highlights

→ABFRL filed the transcript of its Q4 and FY2026 earnings call with NSE on May 28, 2026.
→The Q4 FY2026 earnings call was held on May 26, 2026.
→Management participants on the call included Ashish Dikshit, Managing Director; Jagdish Bajaj, CFO; and Sangeeta Tanwani, Director and CEO - Pantaloons.
→ABFRL filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE and BSE on May 25, 2026.

Jubilant Ingrevia Ltd.NSE: JUBLINGREA

Shyam Bhartia; Deepak Jain; Varun Gupta; Pavleen Taneja · Chairman; CEO and Managing Director; Chief Financial Officer; Head - Investor Relations

Q4 and FY2026 results, Specialty Chemicals, Nutrition and Health Solutions, Chemical Intermediates, CDMO, Pinnacle Journey, Gajraula MPP, Bharuch CDMO commissioning, Remidex Pharma, semiconductor chemicals, Middle East disruption, net debt, working capital, dividend, ESOP grant, tax/GST matters, investor meetings and daily market-signal tracking·Chemicals·26 May 2026·NSE-filed JUBLINGREA Q4/FY2026 earnings-call transcript, audio-recording filing, investor presentation, press release, audited-results and board-outcome filing, dividend/record-date/cost-auditor filing, investor-conference filings, ESOP grant filing, tax/GST order filings, company investor pages and BSE company page

▾

Key highlights

→Jubilant Ingrevia filed the transcript for its Q4 and FY2026 earnings conference call with NSE on May 29, 2026.
→The earnings call was held on May 26, 2026 after the board approved audited standalone and consolidated results for the quarter and year ended March 31, 2026.
→The transcript lists Shyam Bhartia, Chairman; Deepak Jain, CEO and Managing Director; Varun Gupta, CFO; and Pavleen Taneja, Head - Investor Relations, as management attendees.
→External Q&A participants listed in the transcript included Siddharth Gadekar of Equirus, Abhijit Akella of Kotak, Harsh Shah of Rare Enterprises, Archit Joshi of Nuvama, Srishti Jain of Monarch and Nitesh Dhoot of Anand Rathi.

Amara Raja Energy & Mobility Ltd.NSE: ARE&M

Harshavardhana Gourineni; Vikramadithya Gourineni; Y Delli Babu · Executive Director - Automotive and Industrial; Executive Director - New Energy Business; Chief Financial Officer

Q4 and FY2026 results, lead-acid battery growth, domestic OEM and aftermarket demand, home energy, industrial and telecom batteries, lithium packs and chargers, ARACT investment, Divitipally giga corridor, BESS pivot, cell localization, margin trajectory, raw-material inflation, dividend and daily market-signal tracking·Capital Goods·26 May 2026·Amara Raja Energy & Mobility Q4/FY2026 earnings-call transcript filed with NSE/BSE, NSE-hosted conference-call intimation, NSE-hosted audited results and board outcome, NSE-hosted investor presentation and BSE company hub

▾

Key highlights

→Amara Raja Energy & Mobility held its Q4 FY2026 earnings conference call on May 26, 2026.
→The company filed the earnings-call transcript with NSE/BSE on June 2, 2026.
→The May 21, 2026 call intimation scheduled the Q4 FY2026 investor call for May 26, 2026 at 4:30 p.m. IST.
→The call was hosted by Anand Rathi Research.
→Management participants were Harshavardhana Gourineni, Executive Director - Automotive and Industrial; Vikramadithya Gourineni, Executive Director - New Energy Business; and Y Delli Babu, CFO.

Bayer Cropscience Ltd.NSE: BAYERCROP

Simon Wiebusch; Vinit Jindal; Bharati Shetty; Bayer CropScience Board of Directors · Vice Chairman, Managing Director and Chief Executive Officer; Executive Director and Chief Financial Officer; Company Secretary and Compliance Officer; Board of Directors

Q4 and FY2026 results, Agri Care performance, corn season softness, crop-protection momentum, Kharif disruption, channel discipline, receivables and inventory, cash generation, dividend, Labour Code monitoring and daily agri-input market-signal tracking·Fertilizers·26 May 2026·Bayer CropScience official May 26 2026 board outcome, audited FY2026 financial results, press release, dividend recommendation and notices-to-stock-exchange page

▾

Key highlights

→Bayer CropScience's board approved audited financial results for the financial year ended March 31, 2026 at its May 26, 2026 board meeting.
→The May 26, 2026 board meeting started at 3:30 p.m. IST and concluded at 4:30 p.m. IST.
→The statutory auditors issued an unmodified opinion on the FY2026 audited financial results.
→The company has one reportable business segment, Agri Care.
→The company does not have any subsidiary, joint venture or associate company and therefore does not prepare consolidated financial results under the stated SEBI listing-regulation requirement.

AstraZenca Pharma India Ltd.NSE: ASTRAZEN

Bhavana Agrawal; Praveen Rao Akkinepally; AstraZeneca Pharma India Board of Directors · Chief Financial Officer and Director; Managing Director; Board of Directors

Q4 and FY2026 audited results, 33% annual revenue growth, therapy-area mix, product approvals, dividend, balance sheet, working-capital intensity, Labour Code and manufacturing-site closure items, senior-management changes and daily pharma market-signal tracking·Pharmaceuticals·26 May 2026·AstraZeneca Pharma India official FY2025-26 board-outcome and audited-results filing, Q4 FY2026 press release, stock-exchange disclosures and product-approval filings; official Q4 FY2026 earnings-call transcript not found

▾

Key highlights

→AstraZeneca Pharma India's board approved audited financial results for the quarter and financial year ended March 31, 2026 on May 26, 2026.
→The May 26, 2026 board meeting commenced at 2:15 p.m. and concluded at 5:10 p.m. IST.
→The board recommended a dividend of Rs 36 per equity share of Rs 2 face value for FY2026, subject to shareholder approval.
→The company confirmed that the statutory auditors' report on the audited FY2026 financial results had an unmodified opinion.
→The board approved re-appointment of Shilpa Divekar Nirula as a Non-Executive Independent Director for a second five-year term from December 29, 2026, subject to shareholder approval.

Container Corporation of India Ltd.NSE: CONCOR

Sanjay Swarup; Vivek Gupta; Harish Chandra; Ajit Kumar Panda; Vijay Kumar Singh · Chairman and Managing Director; Director Finance and CFO; Principal Executive Director Finance and Company Secretary; Director Projects and Services; Director International Marketing and Operations

Q4 and FY2026 results, record TEU throughput, EXIM and domestic volume guidance, WDFC/JNPT connectivity, PSA Mumbai collaboration, tank-container scale-up, domestic empty-running pressure, rail coefficient, market share, capex, dividends, land license fee and daily logistics/rail market-signal tracking·Logistics·26 May 2026·CONCOR Q4/FY2026 NSE-hosted audited results and board-outcome filing, official post-result call audio filing, PSA Mumbai press release, AlphaStreet transcript mirror, Quartr event-summary cross-check and NSE corporate-announcement metadata

▾

Key highlights

→CONCOR filed audited standalone and consolidated Q4/FY2026 results after the board meeting held on May 25, 2026.
→The board meeting started at 15:30 and ended at 18:40 on May 25, 2026.
→The official NSE post-result call filing says the audio recording of the post-results conference call held on May 26, 2026 at 11:30 is available on CONCOR's website.
→AlphaStreet's transcript mirror identifies the Q4 FY2026 earnings call date as May 26, 2026 and the host as DAM Capital Advisors.

Gujarat Fluorochemicals Ltd.NSE: FLUOROCHEM

Dr. Bir Kapoor; Akhil Jindal; Manoj Agrawal; Kapil Malhotra; Rajiv Rao; Bhavin Desai · Chief Executive Officer and Deputy Managing Director; Group Chief Financial Officer; Chief Financial Officer; Business Unit Head - Fluoropolymers; Business Head - Battery Materials, GFCL EV Products; Company Secretary

Q4 and FY2026 results, fluoropolymers growth, R-32 refrigerant ramp, GFCL EV battery-materials commercialization, LiPF6 and LFP qualification, natural graphite anode active materials, FY2027 capex, working-capital cycle, commodity/logistics volatility, labour-code exceptional item, dividend, scheme of arrangement and daily chemicals/EV market-signal watch items·Chemicals·26 May 2026·Gujarat Fluorochemicals Q4/FY2026 company-hosted earnings-call transcript, NSE transcript filing, company Q4/FY2026 investor presentation, audited financial results and material-event filings

▾

Key highlights

→Gujarat Fluorochemicals filed its Q4/FY2026 conference-call transcript with NSE on June 1, 2026.
→The transcript covered the analyst and institutional-investor call held on May 26, 2026 at 6:00 p.m. IST.
→The company said the transcript was also available on its website, and the GFL transcript-call page links the FY2026 fourth-quarter transcript.
→Management participants included Dr. Bir Kapoor, Akhil Jindal, Manoj Agrawal, Kapil Malhotra and Rajiv Rao.

Narayana Hrudayalaya Ltd.NSE: NH

Viren Shetty; Dr. Emmanuel Rupert; Sandhya J; R. Venkatesh; Dr. Anesh Shetty; Nishant Singh; Vivek Agarwal; Sridhar S. · Vice-Chairman; Chief Executive Officer and Managing Director; Group Chief Financial Officer; Group Chief Operating Officer; MD, International Businesses; Vice President - Finance and Investor Relations; Deputy General Manager - Finance and Investor Relations; Group Company Secretary, Legal and Compliance Officer

Q4 and FY2026 results, India hospital margin expansion, Bangalore high-end procedures, robotic cardiac surgery, TAVI and oncology mix, integrated care, clinics and insurance losses, Practice Plus Group UK integration, Cayman hospital and insurance growth, capex pipeline, debt, dividend, possible debt-securities issuance, digital transformation and daily healthcare market-signal watch items·Healthcare·26 May 2026·Narayana Health Q4/FY2026 NSE earnings-call transcript, NSE investor presentation, audited financial-results/board-outcome filing, Q4/FY2026 press release and company stakeholder-relations pages

▾

Key highlights

→Narayana Hrudayalaya filed the Q4/FY2026 earnings-call transcript with NSE on June 2, 2026.
→The Q4/FY2026 earnings call was held on May 26, 2026 for the quarter and financial year ended March 31, 2026.
→The NSE filing said the earnings-call transcript was also available on the company's stakeholder-relations website.
→

AIA Engineering Ltd.NSE: AIAENG

Kunal D. Shah; Sanjay S. Majmudar; S. N. Jetheliya; Bhadresh Kantilal Shah · Executive Director, Corporate Affairs; Non-Executive and Non-Independent Director; Company Secretary; Chairman and Managing Director

Q4 and FY2026 results, mining conversion breakthrough, high chrome grinding media, mill liners and discharge systems, South America trials, order book, realizations, cash deployment, renewable power capex, US duties, Brazil scale-up, dividend and board actions·Capital Goods·26 May 2026·AIA Engineering Q4/FY2026 investor presentation, audited financial results and board outcome, and Q4 FY2026 earnings-call transcript page

▾

Key highlights

→AIA Engineering filed its Q4/FY2026 investor presentation and audited financial results with NSE and BSE on May 26, 2026.
→The board meeting on May 26, 2026 approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
→The statutory auditors B S R & Co. LLP issued unmodified audit opinions on the standalone and consolidated audited financial results.
→The board recommended a dividend of Rs 16 per equity share of face value Rs 2, equal to 800%, for FY2026, subject to shareholder approval.
→The company fixed September 5, 2026 as the record date for the dividend, which is payable on or before October 14, 2026 if approved at the AGM.

Rail Vikas Nigam Ltd.NSE: RVNL

Saleem Ahmad; Anupam Ban; Mritunjay Pratap Singh; Abhishek Kumar; Amit Tandon; Chandan Kumar Verma · Chairman and Managing Director; Director - Personnel; Director - Operations; Director - Finance; Director - Projects; Chief Financial Officer

Q4 and FY2026 results, Rs 99,262 cr order book, margin pressure, FY2027 15%-20% revenue-growth outlook, BharatNet, Rishikesh-Karnaprayag, Vande Bharat sleeper trainsets, Krishnapatnam receivable, MoR receivable, bidding/nomination mix, PMC expansion, execution dashboards, drones, order wins and daily market-signal watch items·Construction·26 May 2026·Rail Vikas Nigam Q4/FY2026 earnings-call transcript, official company-hosted audio/transcript, NSE transcript filing, audited financial results, official RVNL financial-results/disclosure feeds and NSE-hosted June 2026 LOA filing

▾

Key highlights

→RVNL held its Q4/FY2026 earnings call on May 26, 2026 with Saleem Ahmad, CMD; Anupam Ban, Director Personnel; Mritunjay Pratap Singh, Director Operations; Abhishek Kumar, Director Finance; Amit Tandon, Director Projects; and Chandan Kumar Verma, CFO.
→Management described FY2026 as a challenging year, but said RVNL remained focused on operational performance, timely execution, efficiency improvement and expansion into additional business opportunities.
→The company achieved a Department of Public Enterprises MoU rating of Very Good for FY2025, according to management commentary.
→

Hitachi Energy India Ltd.NSE: POWERINDIA

N Venu, Ajay Singh and Poovanna Ammatanda · Managing Director & CEO; Chief Financial Officer; General Counsel & Company Secretary

Q4 FY2026 execution, record order backlog, HVDC commissioning, Rs 4,000 cr capacity expansion, data-center opportunity, exports, BESS and grid investment demand·Capital Goods·26 May 2026·Company Q4 FY2026 analyst call transcript, investor presentation and result release

▾

Key highlights

→Management said FY2026 closed ahead of the previous year across key performance indicators, supported by execution, resilient demand, go-to-market focus and operational discipline.
→Q4 FY2026 orders were Rs 2,422.5 cr, up 10.6% YoY and down 2.2% QoQ, while FY2026 orders were Rs 18,456.5 cr, up 1.6% YoY on a high FY2025 base.
→Q4 FY2026 revenue was Rs 2,754.1 cr, up 46.2% YoY and 32.3% QoQ, and FY2026 revenue was Rs 8,147.7 cr, up 27.6% YoY.
→Q4 FY2026 operational EBITDA was about Rs 452 cr, up 92% YoY, with a 16.4% margin; FY2026 operational EBITDA was about Rs 1,253 cr with a 15.4% margin.
→Order backlog was Rs 29,555.3 cr as of March 31, 2026, up about 54% YoY, giving management strong revenue visibility.

Oil & Natural Gas Corporation Ltd.NSE: ONGC

ONGC management · Board of Directors and senior management

Q4 FY2026 results, production initiatives and group-company performance·Oil & Gas·26 May 2026·ONGC Q4 FY2026 results press release filed with NSE

▾

Key highlights

→ONGC reported a 53% YoY increase in Q4 consolidated net profit and highlighted sharply improved performance from HPCL, MRPL, OVL and OPaL.
→The board recommended a final dividend of Rs 1 per share, taking FY2026 total dividend to Rs 13.25 per share and a payout of Rs 16,669 cr.
→Management said BP's technical service provider work in the Mumbai High field showed early production revival, with oil production at 102% and gas production at 108% of target baseline.
→ONGC began monetizing gas production from the Daman Upside Development Project in Western Offshore, which management expects to increase gas production by nearly 9% of ONGC's current gas production.
→Management highlighted Rs 33,075 cr of Western Offshore projects under progress, Project DeepX for deepwater exploration, and three FY2026 hydrocarbon discoveries.

Financial highlights

VA Tech Wabag LimitedNSE: WABAG

Rajiv Mittal; Bhupesh Chowdary Nagineni; S. Varadarajan; Skandaprasad Seetharaman; Shailesh Kumar; Rohan Mittal · Chairman and Managing Director; Deputy Managing Director; Whole-time Director and Chief Growth Officer; Chief Financial Officer; Chief Executive Officer - India Cluster; Head - Strategy and Business Growth - GCC

Annual Investor Meet 2026, Q4 and FY2026 results, order backlog, GCC desalination and wastewater growth, India reuse/O&M strategy, Bio-CNG and ultra-pure-water adjacencies, payment-security discipline, FY2026 order wins, post-results Kuwait/Ajman/DJB orders, GST matters, leadership additions and market-signal tracking·Construction·25 May 2026·VA Tech Wabag official Annual Investor Meet 2026 and Q4/FY2026 results-call transcript, annual investor presentation, Q4 investor presentation, audited-results board outcome, press release, order-intimation filings, Bio-CNG filing, KMP and board filings, GST filings, WOS incorporation and strategic-investment disclosures

▾

Key highlights

→VA Tech Wabag filed the transcript of its Annual Investor Meet 2026 and Q4/FY2026 results conference call with NSE on June 1, 2026; the meeting and call were held on May 25, 2026.
→Management speakers included Rajiv Mittal, Chairman and Managing Director; Bhupesh Chowdary Nagineni, Deputy Managing Director; S. Varadarajan, Whole-time Director and Chief Growth Officer; Skandaprasad Seetharaman, CFO; Shailesh Kumar, CEO - India Cluster; and Rohan Mittal, Head - Strategy and Business Growth - GCC.
→The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 21, 2026.

HLE Glascoat Ltd.NSE: HLEGLAS

Himanshu Patel; Harsh Patel; Naveen Kandpal; Nilesh Ganjwala; HLE Glascoat Limited · Managing Director; Executive Director; Chief Financial Officer; Senior Advisor; issuer filings

Q4 and FY2026 results, order book and FY2027 visibility, Omeras acquisition integration and turnaround, Thaletec demand and global expansion, glass-lined equipment recovery, filtration/drying leadership, Kinam heat-transfer growth, working-capital and balance-sheet discipline, dividend, auditor re-appointments and senior-management update·Capital Goods·25 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, investor release, audited standalone/consolidated financial-results board outcome, earnings-call invite and recording filings, internal/cost auditor re-appointment filing, senior-management appointment filing, newspaper publication and NSE announcement slice

▾

Key highlights

→HLE Glascoat filed its Q4/FY2026 earnings-call transcript with NSE on June 1, 2026.
→The Q4/FY2026 earnings call was held on May 25, 2026.
→The call was moderated by Vidhi Vasa of MUFG Intime.
→Management participants on the call were Himanshu Patel, Managing Director; Harsh Patel, Executive Director; Naveen Kandpal, Chief Financial Officer; and Nilesh Ganjwala, Senior Advisor.
→

Indigo Paints Ltd.NSE: INDIGOPNTS

Hemant Jalan; Suresh Babu; Chetan Humane; Aishwarya Pratap Singh; Srihari Santhakumar; Indigo Paints Limited issuer filings · Managing Director; Chief Operating Officer; Chief Financial Officer; Chief Business Officer; GM Finance and Head of Investor Relations; issuer filings

Q4 and FY2026 results, demand recovery, raw-material shock, gross-margin resilience, product-category growth, Apple Chemie waterproofing/construction-chemicals scale-up, Jodhpur capacity commissioning, free-cash-flow inflection, FY2027 growth posture, dividend, ESOP grant and senior-management appointments·Chemicals·25 May 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, audited standalone and consolidated financial-results and board-outcome filing, conference-call invite, ESOP grant filing and dividend/board-governance disclosures

▾

Key highlights

→Indigo Paints filed its Q4/FY2026 earnings-call transcript with NSE on May 29, 2026.
→The Q4/FY2026 earnings call was held on May 25, 2026 at 11:00 IST.
→The earnings-call invite was filed with NSE on May 19, 2026.
→Management participants on the call were Hemant Jalan, Suresh Babu, Chetan Humane, Aishwarya Pratap Singh and Srihari Santhakumar.
→Hemant Jalan represented the company as Managing Director.

Gujarat State Fertilizers & Chemicals Ltd.NSE: GSFC

S. K. Bajpai; Nidhi Pillai; Dr. Rajender Kumar; Gujarat State Fertilizers & Chemicals Limited · Senior Vice President, Finance and Legal and Chief Financial Officer; Company Secretary and Vice President (Legal); Managing Director; issuer filings

Q4 and FY2026 results, fertilizer volume growth, subsidy and raw-material protection, Industrial Products turnaround, Sikka APS flexibility, Q1 FY2027 outlook, ESG rating and senior-management change·Fertilizers·25 May 2026·NSE-filed Q4 and FY2026 earnings-call transcript, media release and investor presentation, audited standalone and consolidated financial-results board outcome, call recording link, ESG rating intimation, senior-management change filings and shareholder/governance filings

▾

Key highlights

→GSFC filed audited standalone and consolidated Q4 and FY2026 financial results with NSE on May 22, 2026.
→The board meeting approving the audited results was held on May 22, 2026.
→The board meeting commenced at 12:00 noon and concluded at 1:15 p.m.
→CNK & Associates LLP issued statutory audit reports on the standalone and consolidated annual financial results.
→The statutory auditors issued an unmodified opinion on the audited standalone and consolidated FY2026 financial results.

NESCO Ltd.NSE: NESCO

Board of Directors; Shalini Kamath; Rajesh G. Upadhyay · Board of Directors; Company Secretary and Compliance Officer; Additional Director and Whole-time Director designated Executive Director - Commercial and Operations

Q4/FY2026 results, Realty, Bombay Exhibition Center, Foods, Indabrator, Wayside Amenities, dividend, AGM, board reconstitution and daily market-signal tracking·Conglomerate·25 May 2026·NSE-filed Q4/FY2026 audited standalone and consolidated financial-results and board-outcome filing, NSE-filed dividend record-date and director-change filings, NSE-filed newspaper publication filings, NSE-filed Wayside Amenities updates, SAST disclosure, company financials page, FY2024-25 annual report for durable business-segment context and BSE company page

▾

Key highlights

→NESCO's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its meeting on May 25, 2026.
→The auditors issued an unmodified opinion on the Q4/FY2026 financial results.
→No recent NSE-filed earnings-call transcript or investor presentation was found for NESCO in the current source set, so this note is filing-led rather than transcript-led.
→The audited consolidated results and board-outcome filing are used as the numeric source of truth for FY2026 and Q4 FY2026.

IRCON International Ltd.NSE: IRCON

Hari Mohan Gupta; Ragini Advani; Alin Roy Choudhury; Ram Kumar Goyal; Sachin Garg · Chairman and Managing Director; Director Finance; CFO and CGM Finance; GM Finance; DGM Finance and Investor Relations

Q4 and FY2026 results, order book, FY2027 revenue posture, competitive railway bidding, core EBITDA margins, cash, PPP/SPV investment, debt, international projects, JV profitability, West Asia risk, governance fine and SAST disclosure tracking·Construction·25 May 2026·NSE-hosted IRCON Q4/FY2026 analyst-call transcript, investor presentation, audited results and board outcome, press release, analyst-call intimation, audio-recording filing, governance fine board comments, SAST disclosure, NSE company page and BSE company page

▾

Key highlights

→IRCON held its Q4 and FY2026 post-results analyst conference call on May 25, 2026 at 3:30 p.m. IST.
→The May 26, 2026 transcript filing says the call discussed financial results for the quarter and financial year ended March 31, 2026.
→The transcript lists Hari Mohan Gupta, Chairman and Managing Director; Ragini Advani, Director Finance; Alin Roy Choudhury, CFO and CGM Finance; Ram Kumar Goyal, GM Finance; and Sachin Garg, DGM Finance and Investor Relations as management participants.
→The May 19, 2026 call-intimation filing scheduled the conference call for May 25, 2026 and listed the finance and investor-relations management team.

Poly Medicure Ltd.NSE: POLYMED

Himanshu Baid; Naresh Vijayvergiya; Rahul Gautam · Managing Director; Chief Financial Officer; President - Strategy and Corporate Development

Q4 and FY2026 results, FY2027 revenue and EBITDA-margin guidance, high-technology medical-device transition, PendraCare and Citieffe integration, Medyneo Brazil acquisition, renal and cardiology growth, US and Europe restart, raw-material and freight inflation, China dumping, working capital, capex, dividend and daily NSE/BSE market-signal tracking·Healthcare·25 May 2026·Poly Medicure official NSE-filed Q4/FY2026 conference-call transcript, investor presentation, audited standalone and consolidated financial results, company IR pages, NSE company page and BSE company page

▾

Key highlights

→Poly Medicure held its Q4 FY2026 earnings conference call on May 25, 2026 at 17:00 IST.
→The official transcript was filed with NSE and BSE on May 29, 2026 under Regulation 30.
→Management participants included Himanshu Baid, Managing Director, Naresh Vijayvergiya, Chief Financial Officer, and Rahul Gautam, President - Strategy and Corporate Development.
→The Board meeting on May 25, 2026 approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
→

Anupam Rasayan India Ltd.NSE: ANURAS

Anand Desai; Gopal Agrawal; Amit Khurana; Vishal Thakkar · Managing Director; Chief Executive Officer; Chief Financial Officer; Deputy Chief Financial Officer

Q4 and FY2026 results, highest-ever revenue and operating cash flow, portfolio diversification, agrochemicals, pharma, performance materials, personal care, Tanfac fluorination platform, Jayhawk acquisition, Bliss GVS Pharma acquisition, order book, capex, working capital, leverage, ETFA flow-chemistry commercialization and daily NSE/BSE market-signal tracking·Chemicals·25 May 2026·Official NSE-hosted Anupam Rasayan Q4/FY2026 earnings-call transcript, company Q4/FY2026 investor presentation, audited standalone and consolidated results, Board outcome, results press release, Bliss GVS Pharma acquisition press release and deck, ETFA commercialization release, company investor pages, NSE company page and BSE company page

▾

Key highlights

→Anupam Rasayan held its Q4 FY2026 earnings conference call on May 25, 2026.
→The official transcript was filed with BSE and NSE as a Regulation 30 intimation dated May 30, 2026.
→Management participants on the call were Anand Desai, Gopal Agrawal, Amit Khurana and Vishal Thakkar.
→The company posted the Q4/FY2026 investor presentation, audited standalone results, audited consolidated results, Board outcome and press releases on its investor pages.

Century Plyboards (India) Ltd.NSE: CENTURYPLY

Sanjay Agarwal; Keshav Bhajanka; Nikita Bansal; Arun Julasaria; Navarun Sen; Sumant Wattas; Vishu Goel · Managing Director and Chief Executive Officer; Executive Director; Executive Director; Chief Financial Officer; Chief Operating Officer, Plywood; Chief Executive Officer, MDF and Particle Board; Chief Executive Officer, Laminates

Q4 and FY2026 results, plywood capacity, Hoshiarpur and brownfield expansion, UP and Odisha project pipeline, MDF utilization and debottlenecking, laminates turnaround, particle-board ramp-up, Century Ports, CACL resin production, chemical and timber price inflation, price pass-through, debt and capex discipline, ESG rating and daily building-materials market-signal tracking·Basic Materials·25 May 2026·Century Plyboards (India) Q4/FY2026 earnings-call transcript filed with NSE/BSE, NSE-hosted audited-results and board-outcome filing, NSE-hosted investor presentation, conference-call intimation and audio-recording filing, Odisha project disclosure, Century Adhesives & Chemicals commercial-production disclosure, ESG-rating filing, dividend filing, company investor-relations pages and BSE company-announcements hub

▾

Key highlights

→Century Plyboards held its Q4 and FY2026 earnings conference call on May 25, 2026 at 3:30 p.m. IST.
→The company filed the conference-call transcript with NSE/BSE on May 27, 2026.
→Management participants were Sanjay Agarwal, MD and CEO; Keshav Bhajanka, Executive Director; Nikita Bansal, Executive Director; Arun Julasaria, CFO; Navarun Sen, COO, Plywood; Sumant Wattas, CEO, MDF and Particle Board; and Vishu Goel, CEO, Laminates.

J.K. Cement Ltd.NSE: JKCEMENT

Ajay Kumar Saraogi; Prashant Seth · Deputy Managing Director and Chief Financial Officer; President, Business Information and Investor Relations

Q4 and FY2026 results, grey cement volume ramp-up, white cement and wall putty outlook, paints breakeven plan, Panna/Buxar/Hamirpur/Muddapur capacity commissioning, Jaisalmer/Bikaner/Punjab expansion, Nathdwara wall putty plant, FY2027/FY2028 capex, cost inflation, price pass-through, green power and AFR cost savings, incentive accruals, Labour Code impact, debt metrics, limestone blocks, Mahan Coal Mine and daily market-signal watch items·Cement·25 May 2026·J.K. Cement Q4/FY2026 earnings-call transcript, board-meeting outcome and audited financial results, Q4/FY2026 investor presentation, transcript page, financial reports page, investor-presentation page, limestone-block LOI filings and Mahan Coal Mine mining-lease filing

▾

Key highlights

→J.K. Cement's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 23, 2026 meeting.
→The May 23, 2026 board meeting commenced at 12:42 p.m. IST and concluded at 2:15 p.m. IST.
→The board recommended a final dividend of Rs 20 per Rs 10 equity share, equal to 200%, subject to shareholder approval at the 32nd AGM.
→The board approved appointment of Dr. Sameer Sharma as an Additional Director and Non-Executive Independent Director for five years from May 23, 2026, subject to shareholder approval.

Sundaram Finance Ltd.NSE: SUNDARMFIN

Harsha Viji; Rajiv Lochan; M. Ramaswamy; P. N. Srikant · Executive Vice Chairman; Managing Director; Chief Financial Officer; Chief Compliance Officer and Company Secretary

FY2026 and Q4 FY2026 results, AUM and disbursement growth, asset quality, NII, stage 3 assets, NPA ratios, ROA, ROE, capital adequacy, dividend, group-company performance, GST 2.0, H2 demand recovery, geopolitical risk, market-share intent and institutional-investor meeting disclosures·NBFC·25 May 2026·Sundaram Finance FY2026 press release, audited financial-results filing, NSE-hosted FY2026 performance highlights, official investor financial-information page, corporate-announcement page and analyst/institutional-investor meeting disclosures

▾

Key highlights

→Sundaram Finance's FY2026 management note is based on official press-release, audited-result, performance-highlight and investor-meeting disclosures because no complete official Q4 FY2026 earnings-call transcript was found in the company source pack.
→The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 25, 2026.
→Harsha Viji, Executive Vice Chairman, said Q4 FY2026 saw continued improvement in the economic environment after GST 2.0 reforms in September 2025.
→Management said H1 FY2026 was muted by trade-tariff complications, while H2 FY2026 gathered momentum from monetary-policy transmission and fiscal-policy stimulus.

Fortis Healthcare Ltd.NSE: FORTIS

Dr. Ashutosh Raghuvanshi, Vivek Goyal, Anurag Kalra, Anand K and Akshay Tiwari · Managing Director and Chief Executive Officer, Fortis Healthcare; Chief Financial Officer, Fortis Healthcare; Head - Investor Relations, Fortis Healthcare; Managing Director and Chief Executive Officer, Agilus Diagnostics; Chief Financial Officer, Agilus Diagnostics

Q4 and FY2026 earnings, hospital revenue growth, EBITDA-margin expansion, occupancy and ARPOB, bed additions and acquisitions, Agilus Diagnostics margin recovery, international-patient growth, oncology reimbursement policy impact, capex, leverage, dividend and FY2028 hospital-margin ambition·Healthcare·25 May 2026·Fortis Healthcare Q4/FY2026 earnings-call transcript, investor presentation, press release, audited financial results and post-earnings audio filing with BSE

▾

Key highlights

→Fortis Healthcare reported FY2026 consolidated revenue of Rs 9,128 cr, up 17.3% YoY.
→FY2026 hospital revenue was Rs 7,773 cr, up 19.1% YoY, and remained about 85% of consolidated revenue.
→FY2026 diagnostics net revenue was Rs 1,355 cr, up 8.0% YoY.
→FY2026 consolidated operating EBITDA was Rs 2,085 cr, with margin expanding to 22.8% from 20.4% in FY2025.
→FY2026 hospital operating EBITDA margin improved to 22.2% from 20.5% in FY2025.

Suzlon Energy Ltd.NSE: SUZLON

J.P. Chalasani, Ajay Kapur and Rahul Jain · Group Executive Counsel; Group Chief Executive Officer; Group Chief Financial Officer

Q4 and FY2026 earnings, record deliveries, order book, WTG margin, OMS, SE Forge, EPC mix, DevCo pipeline, Andhra Pradesh FDRE opportunity, working capital, capex, deferred tax assets, DSM forecasting, Blue Sky export platform, Sunsure order and Suzlon 2.0 growth ambition·Capital Goods·25 May 2026·Suzlon Energy Q4/FY2026 earnings-call transcript, investor presentation, Q4 results press release, Sunsure order announcement and Suzlon 2.0 strategy update

▾

Key highlights

→Suzlon reported Q4 FY2026 consolidated net revenue of Rs 5,468 cr, up 45% YoY, with 830 MW of net deliveries, the company's highest India quarterly delivery number.
→Q4 FY2026 EBITDA was Rs 964 cr, up 39% YoY, with EBITDA margin of 17.6%.
→Q4 FY2026 PBT was Rs 833 cr, up 51% YoY, and reported PAT was Rs 1,114 cr.
→Q4 reported PAT benefited from a deferred-tax-asset related tax credit; management said roughly Rs 281 cr should be adjusted for the quarter.
→FY2026 net deliveries rose 58% YoY to 2,456 MW versus 1,550 MW in FY2025.
→

Oil India Ltd.NSE: OIL

Ranjit Rath, Trailukya Borgohain, Saloma Yomdo, Abhijit Majumder, Ankur Baruah, Bhaskar Jyoti Phukan, Sachidananda Maharana, Abhijit Das, A. K. Sahoo and Varatharajan S. · Chairman and Managing Director; Director - Operations; Director - Exploration and Development; Director - Finance; Director - Human Resources; Managing Director - Numaligarh Refinery; Director - Finance - Numaligarh Refinery; Chief Investor Relations Officer; Company Secretary; Antique Stock Broking moderator

FY2026 investor meet, Q4/FY2026 financials, oil and gas production, drilling and workovers, reserve replacement, offshore exploration, TotalEnergies partnership, Samudra Manthan, NRL expansion, pipeline capacity, Mozambique LNG, Russia dividends, Libya discovery, CGD, CBG, green hydrogen, capex, debt, dividends and energy-security policy tailwinds·Oil & Gas·25 May 2026·Oil India FY2026 investors and analysts meet transcript, investor presentation, audited Q4/FY2026 financial results, investor-services pages and financial-results page

▾

Key highlights

→Management positioned Oil India as an integrated Maharatna energy company moving beyond a pure upstream profile into upstream, pipelines, refining, petrochemicals, city gas, renewables, green hydrogen, CBG, bioethanol and critical minerals.
→FY2026 consolidated total income was Rs 38,981 cr, up 3% YoY, despite crude oil realization declining to about $69/bbl from about $78/bbl in FY2025.
→FY2026 consolidated EBITDA was Rs 13,498 cr, up 5% YoY, and consolidated PAT was Rs 7,551 cr, up 7% YoY.

HBL Engineering Ltd.NSE: HBLENGINE

Company management and Board of Directors · Management commentary in shareholder information note and Board of Directors filing-led disclosures

Q4 and FY2026 results interpretation, KAVACH order cycle, electronics-led FY2026 growth, margin variability, provisions, Labour Code and R&D costs, cash generation, dividend, preferential-issue monitoring and HBLPOWER to HBLENGINE symbol cleanup·Defence·24 May 2026·NSE-filed HBL Engineering shareholder information note, audited Q4/FY2026 financial-results and board-outcome filing, KAVACH order-intimation filings, statement-of-deviation filing, promoter SAST disclosure and current NSE equity list; NSE archive filenames still use the old HBLPOWER prefix while the current NSE symbol is HBLENGINE

▾

Key highlights

→The current NSE equity list identifies the live symbol as HBLENGINE / HBL Engineering Limited with ISIN INE292B01021; the launch queue symbol HBLPOWER is absent from the current NSE equity list.
→NSE archive filenames for the April-June 2026 filings still use the legacy HBLPOWER prefix, but the filings identify HBL Engineering Limited and the live NSE symbol has moved to HBLENGINE.
→HBL filed a shareholder information note on May 24, 2026 after publishing results on May 23, 2026 to explain the interpretation of the results.
→Management said Q4 FY2026 sales were better than Q4 FY2025 but profitability was lower.

Divi's Laboratories Ltd.NSE: DIVISLAB

Kiran S. Divi, Nilima Prasad Divi, Venkatesa Perumallu Pasumarthy and M. Satish Choudhury · Whole-time Director and CEO; Whole-time Director, Commercial; CFO; Company Secretary and Chief Investor Relations Officer

Q4 FY2026 results, generic APIs, custom synthesis, peptides, supply chain, Unit 3, technology platforms, capex and FY2027 outlook·Pharmaceuticals·23 May 2026·Divi's Laboratories Q4 FY2026 earnings conference call transcript

▾

Key highlights

→Management said Q4 FY2026 was marked by a complex global backdrop, but execution discipline, supply reliability and capacity planning helped maintain continuity across segments.
→Generic-business volumes stayed stable through the quarter and full year, although pricing remained competitive.
→Custom synthesis engagement remained strong, with an active project pipeline moving from development toward near-commercialization.
→The peptide business deepened capabilities in protected amino acids, solid-phase and liquid-phase synthesis, with several fragments validated during the quarter.
→Unit 3 is increasingly supporting backward integration and capacity optimization by transferring select activities from Unit 1 and Unit 2 and freeing GMP space.

NTPC Ltd.NSE: NTPC

Jaikumar Srinivasan, Shivam Srivastava, K. Shanmugha Sundaram, Ravindra Kumar and Anil Kumar Jadli · Director Finance; Director Fuel; Director Projects; Director Operations; Director HR

Q4 FY2026 results, power demand, fuel security and diversified capacity growth·Power·23 May 2026·NTPC Q4 FY2026 earnings conference call transcript filed with NSE

▾

Key highlights

→Management said West Asia developments reinforce energy security, fuel diversification and resilient domestic energy systems, but are not expected to have a material operational impact on NTPC.
→Coal stock at NTPC power stations was comfortable at nearly 18 days, while captive mines met nearly 18% of coal requirement.
→NTPC Group capacity stood at 89,108 MW at March 31, 2026 and crossed 90 GW after year end, with FY2026 capacity addition of 9,618 MW, the highest annual addition since inception.
→NTPC highlighted record Indian peak demand of 271 GW and record daily generation of 6,268 million units on May 21, 2026, supporting the need for reliable baseload alongside renewables.
→Management said NTPC is expanding across coal, renewables, storage, nuclear and domestic energy value chains while pursuing the 60 GW renewable target by 2032.

Financial highlights

Vaibhav Global Ltd.NSE: VAIBHAVGBL

Sunil Agrawal; Nitin Panwad; Vivek Jain; Vaibhav Global Limited · Managing Director; Group Chief Financial Officer; Head of Investor Relations; issuer filings

Q4 and FY2026 results, digital mix, in-house brands, lab-grown diamonds, Germany EBITDA breakeven, U.S. and U.K. demand, FY2027 revenue and margin guidance, free cash flow, MAT credit, Mindful Souls impairment, ESG score, dividend, ESOP grants and daily market-signal tracking·Apparel & Footwear·22 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, financial-results presentation, press release, audited financial-results board outcome, dividend record-date filing, ESOP grant and allotment filings, and promoter SAST disclosure

▾

Key highlights

→Vaibhav Global filed its Q4 and FY2026 earnings-call transcript with NSE on May 28, 2026.
→The Q4 and FY2026 earnings call was held on May 22, 2026.
→Management participants were Sunil Agrawal, Managing Director, Nitin Panwad, Group CFO, and Vivek Jain, Head of Investor Relations.
→Vaibhav Global filed its Q4/FY2026 financial-results presentation with NSE on May 22, 2026.
→Vaibhav Global filed its Q4/FY2026 press release with NSE on May 22, 2026.

Electronics Mart India LtdNSE: EMIL

Karan Bajaj; Premchand Devarakonda; Electronics Mart India Limited issuer filings · Chief Executive Officer and Promoter; Chief Financial Officer; issuer filings

Q4 and FY2026 results, same-store sales growth, cluster performance, store expansion, mature versus non-mature store economics, North cluster ramp-up, South cluster resilience, category demand, cash flow, IQ store transfer, Labour Code exceptional item, post-result store openings and retail-network optimization·Retail·22 May 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, results press release, audited standalone/consolidated financial-results board outcome, earnings-call recording filing, store-opening filings, store-closure filing and volume-spurt clarification

▾

Key highlights

→Electronics Mart India filed the Q4/FY2026 earnings-call transcript with NSE on May 27, 2026.
→The Q4/FY2026 earnings call was held on May 22, 2026 at 3:00 p.m. IST.
→Management participants included Karan Bajaj, Chief Executive Officer and Promoter, and Premchand Devarakonda, Chief Financial Officer.
→The company filed the Q4/FY2026 investor presentation with NSE on May 22, 2026.
→The company filed the Q4/FY2026 results press release with NSE on May 22, 2026.

Laxmi Organic Industries Ltd.NSE: LXCHEM

Dr. Rajan Venkatesh; Harshvardhan Goenka; Laxmi Organic Industries Limited issuer filings · Managing Director and Chief Executive Officer; Executive Director and Interim Chief Financial Officer; issuer filings

Q4 and FY2026 results, sequential recovery, feedstock and specialty-chemicals demand pressure, essentials and specialties mix, ethyl acetate commissioning at Lote, Dahej phase-2 chemical charging and FY2027 ramp, fluorination setup order book, supply-chain digitization, QIP and IPO proceeds monitoring, dividend, CFO transition and exchange volume-spurt clarification·Chemicals·22 May 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, audited standalone and corrected consolidated financial-results filings, ethyl-acetate commissioning disclosure, QIP and IPO monitoring agency reports, CFO transition filing and volume-spurt clarification

▾

Key highlights

→Laxmi Organic filed the transcript of its May 22, 2026 Q4 FY2026 earnings conference call with NSE on May 29, 2026.
→The earnings call was hosted by Strategic Growth Advisors and discussed performance for the quarter and year ended March 31, 2026.
→The transcript filing said no unpublished price-sensitive information was shared or discussed in the investor meeting.
→The call management team comprised Dr. Rajan Venkatesh, Managing Director and Chief Executive Officer, and Harshvardhan Goenka, Executive Director and Interim Chief Financial Officer.

TTK Prestige Ltd.NSE: TTKPRESTIG

Venkatesh Vijayaraghavan; Shankaran; Saranyan; Yash Jain · Managing Director and Chief Executive Officer; Advisor to the Board; Whole-Time Director and Chief Financial Officer; Ambit Capital moderator

Q4 and FY2026 results, domestic growth, channel and category performance, induction cooktop and induction-compatible cookware demand, pricing and gross-margin bridge, export and CSD pressure, Judge repositioning, business-excellence investments, Prestige Xclusive network, Horwood and Ultrafresh subsidiaries, dividend and record date, CIDO appointment, GreenCo certification and daily consumer-durables market-signal tracking·Consumer Durables·22 May 2026·NSE-filed TTK Prestige Q4/FY2026 earnings-call transcript, investor presentation, audited standalone and consolidated financial-results and board-outcome filings, directors-report extract, audio-link and analyst-call filings, BSE mirror announcements, company-hosted transcript PDF, dividend/record-date filing, CIDO appointment filing and GreenCo certification filing

▾

Key highlights

→TTK Prestige filed the Q4 FY2026 earnings-call transcript with NSE and BSE on May 28, 2026.
→The transcript states that the Q4 FY2026 earnings conference call was held on May 22, 2026.
→The company-hosted transcript URL was included inside the NSE transcript filing.
→Ambit Capital hosted the earnings conference call.

Shilpa Medicare Ltd.NSE: SHILPAMED

Keshav Bhutada; Alpesh Dalal; Monish Shah · Executive Director and CEO, Shilpa Pharma Lifesciences; Chief Financial Officer, Shilpa Medicare Limited; Head Strategy and Investor Relations, Shilpa Medicare Limited

Q4 and FY2026 results, complex API, specialty formulation, biologics, ADC, albumin and CDMO platforms, FY2027 and FY2028 launch markers, licensing income, regulatory updates, USFDA Unit VI Dabaspet Form 483, Gate2Brain CNS-delivery partnership, dividend, registered-office shift, captive renewable-power investment, formulation COO transition and daily pharma market-signal tracking·Pharmaceuticals·22 May 2026·NSE-filed SHILPAMED Q4/FY2026 conference-call transcript, call-recording filing, investor presentation, board-outcome and audited-results filing, USFDA Unit VI Dabaspet inspection update, Gate2Brain strategic-equity partnership press release, postal-ballot notice, senior-management filings, company investor pages and BSE company page

▾

Key highlights

→SHILPAMED held its Q4 FY2026 results conference call on May 22, 2026 at 16:00 hrs.
→The transcript filing dated May 26, 2026 says the conference call followed the company's May 14, 2026 intimation and that the transcript was enclosed for stock exchanges.
→The call speakers were Keshav Bhutada, Executive Director and CEO of Shilpa Pharma Lifesciences, Alpesh Dalal, CFO of Shilpa Medicare, and Monish Shah, Head Strategy and Investor Relations.
→

Whirlpool of India Ltd.NSE: WHIRLPOOL

Arvind Uppal; Narasimhan Eswar; Aditya Jain; Sweta Srivastava · Chairman; Managing Director; Chief Financial Officer; Company Secretary and Compliance Officer

Q4 and FY2026 results, revenue recovery, washer and air-conditioner share gains, refrigerator regulatory transition, e-waste and energy-cost pressure, P4G cost savings, premiumization, Elica performance, cash deployment, post-parent-control strategy, governance transition, dividend and daily consumer-durables market-signal tracking·Consumer Durables·22 May 2026·NSE-filed Whirlpool of India Q4/FY2026 analyst-call transcript, investor presentation, audited financial-results and board-outcome filings, Q4 press release, audio-recording filing, postal-ballot and governance filings, Legal Metrology compounding disclosure, SAST no-encumbrance disclosure and BSE company page

▾

Key highlights

→Whirlpool of India held its Q4 FY2026 analyst conference call on May 22, 2026.
→The company filed the Q4 FY2026 call transcript with NSE on May 29, 2026.
→The transcript identifies Arvind Uppal, Narasimhan Eswar, Aditya Jain and Sweta Srivastava as company participants.
→Axis Capital hosted the call, with Deepak Agarwal moderating.
→Whirlpool filed the Q4 FY2026 investor presentation with NSE on May 22, 2026.

Trident Ltd.NSE: TRIDENT

Deepak Nanda; Sushil Sharma; Trident Limited Board of Directors · Managing Director; Company Secretary and Head, Investor Relations; Board of Directors

Q4 and FY2026 results, margin recovery, US tariff and geopolitical pressure, cost optimisation, export mix, segment mix, net debt, dividend, NCD enabling resolution, Managing Director reappointment, CFO transition and export-award tracking·Textiles·22 May 2026·NSE-hosted Trident Q4/FY2026 press release, investor presentation, audited results and board outcome, dividend and record-date filings, CFO resignation filing, TEXPROCIL export-award press release, company investor pages, NSE company page and BSE company page

▾

Key highlights

→Trident filed its audited Q4 and FY2026 standalone and consolidated financial results with NSE on May 19, 2026.
→The board meeting on May 19, 2026 commenced at 11:00 a.m. IST and concluded at 3:55 p.m. IST.
→The board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
→The board declared the first interim dividend of Rs 0.50 per fully paid-up equity share of Rs 1 each for FY2027.
→The board fixed May 23, 2026 as the record date for the interim dividend.

Engineers India Ltd.NSE: ENGINERSIN

Sanjay Jindal; Suvendu Padhi; R.P. Batra; Vivek Midha; Amanpreet Singh Chopra; Neha Narula · Director (Finance); Company Secretary and Investor Relations; Executive Director (F&A); Chief General Manager (Marketing and Business Development); Senior General Manager (C&MD Office); Senior Manager (Company Secretariat)

Q4 and FY2026 results, record order book, FY2027 order-inflow outlook, consultancy and LSTK margins, Middle East slowdown, Africa and Saudi opportunity pipeline, domestic refinery projects, coal gasification and governance/audit watch items·Construction·22 May 2026·NSE-hosted Engineers India Q4/FY2026 post-earnings transcript filing, NSE investor presentation filing, NSE audited results and board-outcome filing, NSE call-intimation and audio-recording filings, NSE iXBRL filing, NSE company page and BSE company page

▾

Key highlights

→Engineers India held its Q4 FY2026 post-results earnings call on May 22, 2026 at 15:00 IST.
→The May 15, 2026 call-intimation filing listed the management speakers as Sanjay Jindal, Suvendu Padhi, R.P. Batra, Vivek Midha, Amanpreet Singh Chopra and Neha Narula.
→The May 27, 2026 transcript filing says the transcript of the earning call held on May 22, 2026 was enclosed and was also available on the company website.
→The May 23, 2026 audio-recording filing says the company virtually participated in the meeting with several funds and individual investors on May 22, 2026.

BASF India Ltd.NSE: BASF

Manohar Kamath; Alexander Gerding; Narendranath J. Baliga; Anil Chaudhary · Director - Legal, General Counsel (India) and Company Secretary; Managing Director; Chief Financial Officer and Whole-time Director; Whole-time Director and Head of Manufacturing

Q4 and FY2026 results, consolidated revenue and PBT before exceptional items, volume-price mix, working capital, cash flow, segment performance, Agricultural Solutions demerger, Coatings divestiture, Mangalore dispersions expansion, Celasto capacity expansion, capex, India strategic footprint, West Asia input-cost risk, local-for-local manufacturing, dividend, AGM, related-party monitoring and daily NSE/BSE market-signal tracking·Chemicals·22 May 2026·BASF India official analyst and fund-managers meeting transcript and presentation, audited standalone and consolidated FY2026 financial results, dividend and AGM filings, Mangalore dispersions expansion filing, MCD production-line closure filing, Coatings divestiture filing, BASF India investor page and exchange-directed company filings

▾

Key highlights

→BASF India held its analyst and fund-managers meeting on May 22, 2026 at 4:00 p.m. through audio-visual means.
→The official transcript identifies Manohar Kamath, Director - Legal, General Counsel (India) and Company Secretary; Alexander Gerding, Managing Director; Narendranath J. Baliga, Chief Financial Officer and Whole-time Director; and Anil Chaudhary, Whole-time Director and Head of Manufacturing as BASF participants.
→Management said it would discuss only matters in the public domain and, as a matter of policy, would not provide forecasts, future-business guidance or business-outlook comments.

Jubilant Pharmova Ltd.NSE: JUBLPHARMA

Priyavrat Bhartia; Arjun Shanker Bhartia; Harsher Singh; Chris Preti; Arun Kumar Sharma; Tushar Gupta; Anuj Mohnot; Pankaj Dhawan · Managing Director; Joint Managing Director; CEO - Jubilant Radiopharma; CEO - CDMO Sterile Injectables; Chief Financial Officer; Head Corporate Strategy; Head FP&A; Vice President and Head, Investor Relations

Q4 and FY2026 results, Vision 2030, Radiopharma, SPECT supply, Ruby-Fill, MIBG, PET radiopharmacy expansion, Allergy Immunotherapy, CDMO Sterile Injectables, Spokane Line 3 and Line 4, Montreal Line 5 and remediation, CRDMO, API transfer to Jubilant Biosys, Generics turnaround, proprietary novel drugs, capex, deleveraging, dividend, US tariffs, Biosecure Act and daily market-signal tracking·Pharmaceuticals·22 May 2026·Jubilant Pharmova official Q4/FY2026 earnings webinar transcript, press release, earnings presentation, standalone and consolidated results, FAQ, quarterly-results page and BSE company hub

▾

Key highlights

→Jubilant Pharmova held its Q4 and FY2026 earnings webinar on May 22, 2026.
→The company posted the Q4/FY2026 earnings webinar transcript, press release, results presentation, standalone results, consolidated results, FAQ and audio transcript on its official quarterly-results page.
→Management participants in the transcript were Priyavrat Bhartia, Arjun Shanker Bhartia, Harsher Singh, Chris Preti, Arun Kumar Sharma, Tushar Gupta, Anuj Mohnot and Pankaj Dhawan.

The Ramco Cements Ltd.NSE: RAMCOCEM

P.R. Venketrama Raja; K. Selvanayagam; The Ramco Cements Board of Directors · Managing Director; Secretary; Board of Directors

Q4 and FY2026 results, cement demand and pricing, Tamil Nadu mineral bearing land tax, fuel and logistics cost inflation, green-power mix, capex, Kolimigundala expansion, non-core asset monetisation, deleveraging, dividend and daily cement market-signal tracking·Cement·22 May 2026·The Ramco Cements official May 22 2026 board outcome and audited FY2026 standalone and consolidated financial results, FY2026 standalone-results press release, financials page and exchange-announcements page

▾

Key highlights

→The Ramco Cements' board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 22, 2026 meeting.
→The May 22, 2026 board meeting started at 5:09 p.m. IST and ended at 6:51 p.m. IST.
→The board recommended a dividend of Rs 2.50 per equity share of face value Re 1 each for FY2026, payable within 30 days of declaration at the ensuing AGM.
→The Annual General Meeting is scheduled for August 20, 2026 and is proposed to be conducted through video conferencing or other audio visual means.
→The CFO declared that the statutory auditors issued unmodified audit opinions on the standalone and consolidated annual financial results for FY2026.

3M India Ltd.NSE: 3MINDIA

Aseem Joshi; Ramesh Ramadurai; Nikhil Arora; Pratap Rudra Bhuvanagiri · Managing Director; former Managing Director; Chief Financial Officer; Company Secretary and Compliance Officer

Q4 and FY2026 results, segment growth, dividend, APA tax settlement, Labour Code impact, Ranjangaon expansion, local R&D, commercial excellence, local supply chain, Solventum agreement, automotive and electronics growth, board transition and daily industrial, healthcare, consumer and electronics market-signal tracking·Conglomerate·22 May 2026·3M India Q4/FY2026 audited results and board outcome, NSE filing, FY2026 dividend filing, May 2026 investor-meet presentation, March 2026 investor interaction transcript and official investor-relations page

▾

Key highlights

→3M India reported audited Q4 and FY2026 financial results through its May 22, 2026 board outcome.
→The board meeting commenced at 12:37 p.m. IST and concluded at 2:25 p.m. IST on May 22, 2026.
→B S R & Co. LLP issued an unmodified audit opinion on the annual audited financial results.
→No Q4 FY2026 earnings-call transcript was found on the official investor page during this note build; the latest official management-interaction transcript available was the March 12, 2026 investor meet, and the company also filed a May 27, 2026 investor-meet presentation after the results.

Welspun Corp Ltd.NSE: WELCORP

Vipul Mathur; Percy Birdy; Yashovardhan Agarwal; Goutam Chakraborty · Managing Director and CEO; Chief Financial Officer; Director, Sintex; Head - Investor Relations

Q4 and FY2026 results, clean PAT, order book, FY2027 revenue and EBITDA guidance, US and Saudi expansion, line pipes, ductile iron pipes, Sintex, WSSL, EPIC, net cash, free cash flow, capex, large order win, EPIC stake sale, WPC KSA update, ESG, dividend and daily market-signal tracking·Steel·22 May 2026·Welspun Corp Q4/FY2026 company-hosted earnings-call transcript dated May 22, 2026, NSE audited financial results, NSE press release/investor presentation packet, audio-recording intimation, order filing, EPIC stake-sale filing, WPC KSA update filing and financial-results page

▾

Key highlights

→Welspun Corp held its Q4 and FY2026 post-results earnings call on May 22, 2026.
→Management participants included Vipul Mathur, Percy Birdy, Yashovardhan Agarwal and Goutam Chakraborty.
→The board meeting approving Q4 and FY2026 audited standalone and consolidated financial results was held on May 21, 2026.
→The board meeting commenced at 11:30 a.m. and concluded at 3:45 p.m.
→The board recommended a final dividend of Rs 5 per equity share of face value Rs 5, equal to 100%, subject to shareholder approval.

Colgate Palmolive (India) Ltd.NSE: COLPAL

Prabha Narasimhan, Jacob Sebastian Madukkakuzy and the Colgate-Palmolive India Board of Directors · Managing Director and Chief Executive Officer; Whole-time Director and Chief Financial Officer; Board of Directors

Q4 and FY2026 results, domestic growth, premiumization, advertising investment, gross-margin resilience, GST inverted-duty impact, dividend, CFO reappointment, oral-care innovation, Bright Smiles Bright Futures scale, ESG recognition and daily market-signal watch items·FMCG·22 May 2026·Colgate-Palmolive India Q4/FY2026 press release, board-meeting outcome, audited financial-results filing, newsletter, analyst-call intimation, official financial-results page, stock-exchange notification page and leadership pages

▾

Key highlights

→Colgate-Palmolive India announced Q4 and FY2026 results on May 22, 2026, with the board approving audited financial results for the quarter and year ended March 31, 2026.
→The statutory auditors issued an unmodified opinion on the audited financial results.
→Q4 FY2026 net sales were Rs 1,582.8 cr in the company newsletter and Rs 1,583 cr in the press release, up 9% YoY from Rs 1,452 cr.
→Management said domestic business growth was 9.2% YoY in Q4 FY2026 and was broad-based across core and premium portfolios, with the mix balanced between pricing and volume.

Prestige Estates Projects Ltd.NSE: PRESTIGE

Irfan Razack, Zayd Noaman and Amit Mor · Chairman and Managing Director; Executive Director; Chief Financial Officer

Q4 and FY2026 earnings, record presales and collections, FY2027 launch pipeline, Golden Grove launch, business development, operating cash flow, debt, annuity portfolio, revenue recognition, margin trajectory, legal/tax caveats and daily market-signal items·Realty·22 May 2026·Prestige Estates Projects Q4/FY2026 earnings-call transcript, audited financial results, investor presentation, operational-performance update, concall invite and NSE transcript intimation

▾

Key highlights

→Prestige Estates Projects held its Q4/FY2026 earnings call on May 22, 2026 with Irfan Razack, Chairman and Managing Director; Zayd Noaman, Executive Director; and Amit Mor, Chief Financial Officer.
→The company said FY2026 was marked by strong operating momentum across residential, commercial, retail and hospitality.
→Management said Prestige crossed 200 mn sq ft of completed developments across more than 300 projects since inception.
→FY2026 sales were the company's highest ever at Rs 300,245 mn, or about Rs 30,024.5 cr, up 76% YoY.
→FY2026 sales volume was 22.28 mn sq ft, up 77% YoY, with 11,692 units sold.

Info Edge (India) Ltd.NSE: NAUKRI

Sanjeev Bikhchandani, Hitesh Oberoi and Ambarish Raghuvanshi · Founder and Vice Chairman; Co-Promoter and Managing Director; Interim Chief Financial Officer

Q4 and FY2026 earnings, recruitment growth, 99acres turnaround path, Jeevansathi and Aisle improvement, Shiksha traffic pressure, AI-led product strategy, investee portfolio moves, governance changes, labour-code accounting effects and daily company-move signals·Internet·22 May 2026·Info Edge Q4/FY2026 earnings-call transcript, earnings-call presentation, audited financial results, audited financial statements, press release, post-result audio/video disclosure, March-quarter company update, May JobSpeak filing, SIHL investment filing, NCLAT appeal filing, WTD/CBO-Naukri exit filing and June board-refresh filing

▾

Key highlights

→Info Edge reported Q4 FY2026 standalone billings of Rs 1,057 cr, up 7.4% YoY.
→Q4 FY2026 standalone revenue from operations was Rs 805 cr, up 17.2% YoY.
→Q4 FY2026 standalone operating profit was Rs 323 cr, up 39.4% YoY.
→Q4 FY2026 standalone operating margin was 40.1%, up 639 bps YoY.
→Q4 FY2026 cash generated from operations before taxes was Rs 621 cr, up about 16% YoY.

Aurobindo Pharma Ltd.NSE: AUROPHARMA

S. Subramanian, Swami Iyer, V. Muralidharan, Satakarni Makkapati, Yugandhar Puvvala, Ashish Anvekar and Varun Mali · Chief Financial Officer; CEO - Aurobindo Pharma USA; CEO - Europe Formulations Business; CEO - Aurobindo Biosimilars, Vaccines and Peptide Businesses and Director; CEO - Eugia Pharma Specialities; Acrotech Biopharma representative; Investor Relations and Corporate Communications

Q4 and FY2026 revenue, EBITDA margin, gRevlimid normalization, Europe EUR 1 billion milestone, US $2 billion aspiration, Lannett acquisition timing, biosimilars filings and commercialization, TheraNym biologics CMO phasing, Pen-G and 6-APA ramp-up, R&D, capex, net cash, raw-material inflation and FY2027 margin outlook·Pharmaceuticals·22 May 2026·Aurobindo Pharma Q4 and FY2026 earnings-call transcript, press release, earnings presentation, audited-results outcome and results-announcements page

▾

Key highlights

→Management said Aurobindo delivered its highest-ever quarterly and annual revenue and EBITDA in FY2026, supported by stable volumes, new launches, regulated-market momentum and pricing conditions.
→Q4 FY2026 revenue was Rs 8,853 cr, up 5.6% YoY, while EBITDA was Rs 1,801 cr with 20.3% margin and PAT was Rs 921 cr, up 2% YoY.
→FY2026 revenue was Rs 33,653 cr, up 6.1% YoY, and EBITDA was Rs 6,856 cr with 20.4% margin.
→Management highlighted that FY2026 ex-gRevlimid revenue growth was 9.5%, while Q4 ex-gRevlimid YoY growth was 15.3%, or 7% in USD terms.

Max Healthcare Institute Ltd.NSE: MAXHEALTH

Abhay Soi, Yogesh Sareen and Keshav Gupta · Chairman and Managing Director; Senior Director and Chief Financial Officer; Senior Director - Growth, M&A and Business Planning

Q4 and FY2026 performance, brownfield capacity ramp, Gurgaon commissioning, oncology revenue mix, ARPOB, ALOS, international patients, digital revenue, Max@Home, Max Lab, Kalinga Hospital acquisition, Lucknow greenfield investment, net debt, free cash flow and FY2027 priorities·Healthcare·22 May 2026·Max Healthcare Q4 and FY2026 earnings-call transcript, earnings update, press release, audited financial results, board-meeting outcome and acquisition update

▾

Key highlights

→Management said Max Healthcare delivered its 22nd consecutive quarter of YoY growth, with Q4 FY2026 Network gross revenue up 10% YoY and operating EBITDA up 8% YoY.
→Q4 FY2026 Network gross revenue was Rs 2,664 cr, up 10% YoY and 2% QoQ; excluding oncology, gross revenue grew 15% YoY and 5% QoQ.
→Q4 FY2026 Network operating EBITDA was Rs 682 cr, up 8% YoY and 5% QoQ, with operating EBITDA margin of 26.8%.
→Q4 FY2026 Network PAT was Rs 387 cr versus Rs 376 cr in Q4 FY2025 and Rs 344 cr in Q3 FY2026.
→Average occupancy stayed above 75% despite higher operational bed capacity, while occupied bed days grew 8% YoY and 4% QoQ.

GAIL (India) Ltd.NSE: GAIL

Deepak Gupta, Rakesh Kumar Jain, Sanjay Kumar, Rajeev Kumar Singhal and GAIL management · Chairman and Managing Director; Director Finance; Director Marketing; Director Business Development; company management

FY2026 performance, natural gas transmission, gas marketing, LNG sourcing, petrochemicals, LPG transmission, capex, pipeline projects, renewable energy, compressed biogas, LNG stations, tariff and geopolitical risk, FY2027 capital allocation and Strategy 2030·Power·22 May 2026·GAIL FY2025-26 investors and analysts meet presentation, transcript-link filing, audited financial results filing and project disclosures

▾

Key highlights

→GAIL's FY2026 standalone gross turnover was Rs 1,38,328 cr, up about 1% YoY, while standalone EBITDA moderated to Rs 13,119 cr from Rs 19,168 cr in FY2025.
→FY2026 standalone PBT was Rs 8,964 cr and PAT was Rs 6,968 cr versus Rs 14,825 cr and Rs 11,312 cr respectively in FY2025.
→FY2026 consolidated gross turnover was Rs 1,41,716 cr, consolidated EBITDA was Rs 14,524 cr, consolidated PBT was Rs 9,725 cr and consolidated PAT was Rs 7,582 cr.
→The board recommended a final dividend of Re 0.50 per share for FY2026, taking total FY2026 dividend per share to Rs 5.50 and dividend payout to 51.90%.
→Natural gas transmission volume was 122.18 MMSCMD in FY2026, with GAIL operating an 18,000-plus km pipeline network, about 65% market share and about 1,500 km under construction.

Torrent Pharmaceuticals Ltd.NSE: TORNTPHARM

Sudhir Menon, Aman Mehta and Sanjay Gupta · Executive Director Finance & CFO; Managing Director; Executive Director International Business

Q4 FY2026 results, JB Pharma consolidation, synergy phasing, leverage, India and Brazil growth, semaglutide, new launches, Germany biosimilars and US pipeline·Pharmaceuticals·22 May 2026·Company Q4 FY2026 earnings call transcript and financial results

▾

Key highlights

→Management said consolidated Q4 FY2026 revenue was Rs 4,197 cr, up 42%, after including JB Pharma financials and acquisition effects from January 21, 2026.
→Operating EBITDA was Rs 1,356 cr in Q4 FY2026, up 41%, with combined operating EBITDA margin at 32.3%.
→Excluding JB Pharma, Torrent's base business revenue grew 16% in Q4 and operating EBITDA also grew 16%, with base-business EBITDA margin at 32.7%.
→For FY2026, overall revenue grew 15%, operating EBITDA grew 16% and EBITDA margin was maintained at 32.7%.
→India revenue was Rs 2,215 cr in Q4 FY2026, up 43%; Torrent's base India business excluding JB grew 15% versus 10% IPM growth as per PharmaTrac.
→Management said Curatio grew 27% in FY2026, supported by OTC advertising and field-force expansion, and should continue strong traction in the coming year.

Eicher Motors Ltd.NSE: EICHERMOT

Siddhartha Lal, Vinod Aggarwal, B. Govindarajan, B. Srinivas and Vidhya Srinivasan · Executive Chairman; Vice Chairman EML and Chairman VECV; Managing Director EML and CEO Royal Enfield; Managing Director and CEO VECV; CFO

Q4 FY2026 and FY2026 record performance, Royal Enfield growth, VECV milestone year, capacity expansion, EV entry and Volvo finance JV·Automobiles·22 May 2026·Company exchange filing / Q4 FY2026 earnings call transcript

▾

Key highlights

→Management described FY2026 as a record-setting year, with Royal Enfield crossing 1.2 mn motorcycle sales, VECV crossing 1 lakh vehicles for the first time and combined EML plus VECV revenue crossing Rs 50,000 cr.
→Q4 FY2026 consolidated EML revenue was Rs 6,080 cr, EBITDA was Rs 1,514 cr and PAT was Rs 1,520 cr; FY2026 revenue was Rs 23,408 cr, EBITDA Rs 5,785 cr and PAT Rs 5,515 cr.
→Royal Enfield sold 1,227,977 motorcycles in FY2026, up 22% YoY, with domestic volumes of 1,107,343 units, up 23%, and international volumes of 120,634 units, up 20%.
→Management said premium motorcycle demand remains structurally healthy, April 2026 momentum was strong and inquiries/bookings were robust, while inventory tightness was described as temporary.
→Royal Enfield is expanding Cheyyar brownfield capacity with a Rs 958 cr project and has secured a 215.7-acre land parcel at Tada, Andhra Pradesh for a proposed greenfield expansion.

Hindalco Industries Ltd.NSE: HINDALCO

Satish Pai, Bharat Goenka, Steve Fisher, Dev Ahuja and Subir Sen · Managing Director; CFO Hindalco; President and CEO Novelis; CFO Novelis; Head Investor Relations

Q4 FY2026 and FY2026 record India business performance, Novelis recovery, capex, leverage, copper and aluminium outlook·Metals·22 May 2026·NSE exchange filing / Q4 FY2026 earnings call transcript

▾

Key highlights

→Management said Hindalco posted all-time high consolidated quarterly revenue and EBITDA, led by record India business performance and steady recovery at Novelis.
→Q4 consolidated revenue was Rs 78,133 cr, up 20%, while consolidated EBITDA was Rs 11,197 cr and PAT before exceptional items was Rs 5,796 cr, up 10%.
→Reported Q4 PAT was Rs 2,597 cr, down because of exceptional items including the Novelis Oswego plant fire, but management described the Oswego impact as timing-related and expected substantial recovery next fiscal year.
→India business segment EBITDA rose 17% YoY to Rs 6,610 cr in Q4, with record aluminium upstream EBITDA, all-time high aluminium downstream EBITDA and record copper quarterly EBITDA.
→Novelis' long-term $600-plus per tonne EBITDA guidance remains intact, supported by a $350 mn-$400 mn structural cost-reduction program by FY2028 exit and Bay Minette commissioning.

Sun Pharmaceutical Industries Ltd.NSE: SUNPHARMA

Dilip Shanghvi, Kirti Ganorkar, Aalok Shanghvi, Jayashree Satagopan and Richard Ascroft · Chairman; Managing Director; COO; CFO; CEO, North America

Q4 FY2026 earnings call and FY2027 outlook·Pharmaceuticals·22 May 2026·Sun Pharma Q4 FY2026 earnings call transcript

▾

Key highlights

→Q4 FY2026 sales were INR 145,598 mn, up 13.6% YoY, with gross margin of 80.8% and EBITDA margin of 27.1%.
→Global Innovative Medicines sales grew 20.1% in Q4 to US$354 mn and reached US$1.42 bn for FY2026, accounting for 22.2% of Sun sales in the quarter.
→India formulations sales grew 14.8% in Q4 to INR 48,359 mn, with Sun ranked number one in the Indian pharmaceutical market and gaining market share to 8.4%.
→US sales declined 1.1% in Q4 to US$459 mn as Innovative Medicines growth was offset by generic competition, but US Innovative Medicines crossed US$1 bn for FY2026.
→Management guided FY2027 consolidated top-line growth in the high single digits and R&D spend at 6%-7% of sales, while the Organon acquisition is expected to close in Q4 FY2027.

Financial highlights

Embassy Developments LimitedNSE: EMBDL

Aditya Virwani; Sachin Shah; Rajesh Kaimal · Promoter and Managing Director; Chief Executive Officer and Executive Director; Chief Financial Officer and Executive Director

Q4 and FY2026 results, IBREALEST successor-symbol cleanup, presales, collections, launch pipeline, completed-contract accounting, debt, legal-resolution filings, CARE monitoring, Lucknow MoU, Embassy Citadel construction partner, asset monetisation and daily real-estate market-signal tracking·Realty·21 May 2026·Embassy Developments Q4/FY2026 earnings-call transcript, investor update, audited-results board outcome, Q4 operational update, CARE monitoring-agency report, legal-resolution filings, project press releases, subsidiary-sale filings and NSE current equity list; the launch queue still carried stale IBREALEST while official filings identify the live NSE symbol as EMBDL

▾

Key highlights

→The current NSE EQ list identifies the live symbol as EMBDL / Embassy Developments Limited with ISIN INE069I01010; the old launch queue symbol IBREALEST is absent from the current NSE EQ list.
→Official company filings describe Embassy Developments Limited as formerly Equinox India Developments Limited and earlier Indiabulls Real Estate Limited.
→The company filed its Q4 and FY2026 earnings-call transcript with exchanges on May 29, 2026.
→The Q4 and FY2026 earnings call was held on May 21, 2026 at 11:00 a.m. IST.

LMW LimitedNSE: LMW

V. Senthil; Board of Directors · Chief Financial Officer; Board of Directors

Q4 and FY2026 results, active NSE successor coverage from LAXMIMACH to LMW, textile machinery order-book recovery, machine-tool and foundry growth, Advanced Technology Centre aerospace/composites ramp, export strategy, capex, USD 30 million LMW Holding investment and GST-order watch·Capital Goods·21 May 2026·NSE-filed LMW Q4/FY2026 analyst-meeting transcript, audited standalone/consolidated results and board outcome, audio-link filing, LMW Holding investment filings, GST-order disclosure and current NSE EQ list

▾

Key highlights

→The current NSE EQ list shows LMW Limited under symbol LMW with ISIN INE269B01029; LAXMIMACH is a stale legacy symbol for the launch universe.
→LMW filed audited standalone and consolidated Q4/FY2026 results and board outcomes with NSE on May 20, 2026.
→LMW filed the audio-link intimation for its May 21, 2026 analyst meeting with NSE on May 22, 2026.
→LMW filed the transcript of the May 21, 2026 analyst meeting with NSE on May 25, 2026.
→Management opened the call by saying FY2026 standalone revenue was Rs 3,082 crore versus Rs 2,909 crore in FY2025, up about 6%.

GMM Pfaudler Ltd.NSE: GMMPFAUDLR

Tarak Patel; Gregory Gelhaus; Alexander Poempner; Ankit Nayyar; Mittal Mehta; GMM Pfaudler Limited · Managing Director; Group Chief Executive Officer; Group Chief Financial Officer; Deputy Chief Financial Officer; Company Secretary and Compliance Officer; issuer filings

Q4 and FY2026 results, order intake and backlog, non-traditional market diversification, India performance, international restructuring, Germany/Waghausel severance, Poland low-cost hub, cash/debt cleanup, FY2027 profitability improvement posture, medium-term 15% EBITDA-margin aspiration, Group CEO and Deputy CFO appointments, dividend and daily market-signal tracking·Capital Goods·21 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, audited standalone and consolidated financial-results board outcome, Q4/FY2026 press release, earnings-call invite and recording filing, management-change filings, materiality-disclosure update, dividend filing and investor-meeting disclosure

▾

Key highlights

→GMM Pfaudler filed its Q4/FY2026 earnings-call transcript with NSE on May 28, 2026.
→The Q4/FY2026 earnings call was held on May 21, 2026 at 6:00 PM IST.
→Management participants included Managing Director Tarak Patel, Group CEO Gregory Gelhaus, Group CFO Alexander Poempner, Deputy CFO Ankit Nayyar and Company Secretary Mittal Mehta.
→GMM Pfaudler filed its Q4/FY2026 investor presentation with NSE on May 21, 2026.

Lux Industries Ltd.NSE: LUXIND

Lux Industries Limited issuer filings; Ashok Kumar Todi; Pradip Kumar Todi; Ajay Nagar; Board of Directors · Issuer filings; Chairman; Managing Director; Chief Financial Officer; Board of Directors

Q4 and FY2026 results, apparel and innerwear portfolio, brand investments, new products, omnichannel distribution, exports, Jagadishpur Hosiery Park facility, working-capital cycle, promoter dividend waiver, family-settlement demerger plan, WOS incorporations, auditor appointments, CIO resignation and exchange clarification replies·Apparel & Footwear·21 May 2026·Official NSE-filed Q4/FY2026 investor presentation, audited standalone/consolidated financial-results board outcome, dividend/auditor filings, family-settlement and wholly owned subsidiary filings, governance filings and exchange clarification replies; no Q4 FY2026 earnings-call transcript was found in the checked NSE Apr 1-Jun 27 2026 source slice

▾

Key highlights

→Lux Industries filed its Q4/FY2026 investor presentation with NSE on May 21, 2026.
→Lux Industries filed audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on May 21, 2026.
→The board meeting approving the audited results was held on May 21, 2026.
→The May 21, 2026 results board meeting commenced at 1:45 p.m. and concluded at 5:45 p.m.

Rashtriya Chemicals & Fertilizers Ltd.NSE: RCF

Nazhat J. Shaikh; J. B. Sharma; Board of Directors · Chairperson and Managing Director; Executive Director - Legal and Company Secretary; Board of Directors

Q4 and FY2026 results, final and interim dividend, fertilizer, industrial-chemicals and trading segment performance, subsidy receivables, gas-pooling exposure, Middle East gas-supply disruption, phosphoric-acid backward-integration capex, credit ratings, tax and CESTAT matters, CMD transition and daily fertilizer market-signal tracking·Fertilizers·21 May 2026·RCF NSE-filed Q4 and FY2026 audited standalone and consolidated financial-results and board-outcome filing, company financial-results page, dividend filing, February 2026 phosphoric-acid capacity-addition filing, Ind-Ra and ICRA credit-rating filings, March 2026 gas/tax/dispute disclosures, January 2026 CMD transition filing and BSE security identity page; recent official FY2026 earnings-call transcript or investor presentation not found

▾

Key highlights

→RCF's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 21, 2026 meeting.
→The May 21, 2026 board meeting commenced at 11:45 a.m. IST and concluded at 3:50 p.m. IST.
→The statutory auditors issued unmodified audit reports on the audited standalone and consolidated annual financial results.
→No recent official FY2026 earnings-call transcript or FY2026 investor presentation was found in the official exchange and company materials reviewed during this note build; this note is therefore filing-led rather than transcript-led.

JK Lakshmi Cement Ltd.NSE: JKLAKSHMI

Arun Kumar Shukla; Sudhir Bidkar · President and Director; Executive Director, Corporate Affairs and Chief Financial Officer

Q4 and FY2026 results, cement demand, pricing and fuel-cost outlook, sales volume, realization, EBITDA per tonne, capacity utilization, blended-cement mix, renewable power, TSR, Durg/East expansion, Northeast and Assam limestone strategy, NECEM acquisition, adjacent building-material pilots, dividend, director reappointment, captive-solar SPVs, GST orders and daily cement market-signal tracking·Cement·21 May 2026·NSE-filed JK Lakshmi Cement Q4/FY2026 earnings-call transcript, conference-call audio-link filing, audited standalone and consolidated financial-results and board-outcome filing, Q4/FY2026 press release, company operational and financial performance presentation, company investor-conference-call page, company financial-results page, company corporate-presentation page, director reappointment filing, captive-solar SPV acquisition filings, limestone-block filings and GST order disclosures

▾

Key highlights

→JK Lakshmi Cement filed its Q4 and FY2026 earnings-call transcript with NSE on May 22, 2026.
→The Q4 and FY2026 earnings call was held on May 21, 2026 at 4:00 P.M. IST.
→The company filed an audio-link intimation for the May 21, 2026 conference call with NSE on May 21, 2026.
→The company filed its conference-call invitation with NSE on May 13, 2026.

SKF India Ltd.NSE: SKFINDIA

Shailesh Sharma; Mayank Holani; Girish Kumar; Aashi Arora; Mayuri Kulkarni; Cilvina Pereira · Managing Director; Chief Financial Officer; Head - Strategy and Business Development / Head - Strategy and Special Projects; former Interim Chief Financial Officer; Company Secretary and Compliance Officer; Head - Marketing and Communication, Automotive Business

Q4 and FY2026 results, post-demerger standalone automotive-bearing profile, sales growth, PBT margin normalization, working capital, cash conversion, RACE strategy, EV and emission-norm order wins, customer awards, dividend, CFO transition, audit clarification and daily automotive bearing market-signal tracking·Capital Goods·21 May 2026·NSE-filed SKF India Q4/FY2026 earnings-call transcript, investor presentation, audited financial results and board outcome, Q4/FY2026 press release, earnings-call audio-link filing, NSE financial-results clarification reply, dividend and AGM record-date filing, CFO and senior-management change filings, prior automotive-business head cessation filing, SKF India investor-relations page, and BSE company page

▾

Key highlights

→SKF India held its Q4 FY2026 earnings call on May 21, 2026 at 11:00 a.m. IST.
→SKF India filed the Q4 FY2026 earnings-call transcript with NSE on May 26, 2026.
→The company filed the investor-presentation deck with NSE on May 21, 2026 before the earnings call.
→

Medplus Health Services Ltd.NSE: MEDPLUS

Sujit Kumar Mahato · Chief Financial Officer

Q4 and FY2026 results, pharmacy-store expansion, franchise model economics, private-label strategy, diagnostics, omni-channel, working capital, cash flow, governance changes, store-level regulatory filings and daily market-signal tracking·Pharmaceuticals·21 May 2026·NSE-filed MedPlus Health Services Q4/FY2026 earnings-call transcript, investor presentation, audited-results and board-outcome filing, call-intimation and audio-recording filings, investor-meet filing, governance filings, drug-license regulatory updates, promoter takeover-regulation disclosures and BSE company page

▾

Key highlights

→MedPlus Health Services filed its Q4 and FY2026 earnings-call intimation with NSE on May 11, 2026.
→The call intimation scheduled the Q4 and FY2026 earnings call for Thursday, May 21, 2026 at 16:00 IST.
→MedPlus filed its Q4/FY2026 audited-results and board-outcome pack with NSE on May 20, 2026.
→The results filing says the Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 20, 2026 meeting.
→The statutory auditors expressed an unqualified opinion on the audited financial results.

Fine Organic Industries Ltd.NSE: FINEORG

Mukesh Shah; Sonali Bhadani · Promoter, Chairman and Whole-Time Director; Chief Financial Officer

Q4 and FY2026 results, specialty-additives demand, raw-material and freight inflation, full-capacity operations, Patalganga ramp-up, JNPA SEZ project, U.S. manufacturing project, Oleofine Organics Malaysia acquisition, Thailand and UAE expansion, FY2027 flat-growth and margin commentary, dividend, labour-code provision, tax order, strategic hiring and daily market-signal tracking·Chemicals·21 May 2026·Fine Organic Industries official Q4 and FY2026 earnings-call transcript, investor release, investor presentation, audited standalone and consolidated financial results, board-meeting outcome, investor-call intimation, investor-conference intimation, U.S. and UAE subsidiary filings, U.S. land-acquisition filing, income-tax assessment-order disclosure, company investor pages and exchange-directed filings

▾

Key highlights

→Fine Organic Industries scheduled its Q4 and FY2026 earnings conference call for May 21, 2026 at 3:30 p.m. IST to discuss results for the quarter and financial year ended March 31, 2026.
→The official call participants listed in the investor-call intimation were Mukesh Shah, Chairman and Whole-Time Director, and Sonali Bhadani, Chief Financial Officer.
→The Board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 at its May 19, 2026 meeting.

Emami Ltd.NSE: EMAMILTD

Mohan Goenka; Vivek Dhir; Dhruv Aggarwal; Gul Raj Bhatia; Manish Gupta; Rajesh Sharma · Whole-time Director and Vice Chairman; Chief Executive Officer - International Business; Chief Growth Officer; President - Healthcare; President - Sales; President - Finance and Investor Relations

Q4 and FY2026 results, summer portfolio disruption, talc decline, domestic ex-summer growth, West Asia international disruption, channel mix, quick commerce, GT Marts, Axiom Ayurveda/AloFrut, IncNut/Vedix/SkinKraft, pricing, crude/input-cost pressure, dividends and daily FMCG market-signal tracking·FMCG·21 May 2026·Emami Q4/FY2026 conference-call transcript filed with NSE/BSE, NSE-hosted press-release and investor-presentation filing, NSE-hosted audited-results and board-outcome filing, NSE call-recording link filing, Axiom Ayurveda acquisition and guarantee filings, IncNut acquisition filings and BSE company-announcements hub

▾

Key highlights

→Emami held its Q4 FY2026 earnings conference call on May 21, 2026, hosted by IIFL Capital Services.
→The transcript was filed with BSE and NSE on May 25, 2026 after declaration of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
→Management participants on the call were Mohan Goenka, Whole-time Director and Vice Chairman; Vivek Dhir, CEO - International Business; Dhruv Aggarwal, Chief Growth Officer; Gul Raj Bhatia, President - Healthcare; Manish Gupta, President - Sales; and Rajesh Sharma, President - Finance and Investor Relations.

Sun TV Network Ltd.NSE: SUNTV

Mahesh Kumar Rajaraman; R. Ravi; Sun TV Network Board of Directors · Managing Director; Company Secretary and Compliance Officer; Board of Directors

Q4 and FY2026 results, broadcasting and subscription revenue, cricket-franchise economics, SunNXT and media portfolio, exceptional items, dividend, treasury/MTM impact, radio investee impairment and daily media market-signal tracking·Media·21 May 2026·Sun TV Network official May 21 2026 board outcome, audited Q4/FY2026 standalone and consolidated financial results, earnings release, financial-information page, board-meeting notice and interim-dividend disclosures

▾

Key highlights

→Sun TV Network's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 21, 2026 board meeting.
→The May 21, 2026 board meeting started at 2:30 p.m. IST and ended at 4:30 p.m. IST.
→The official financial-information page lists the FY2025-26 audited financial results for the quarter and year ended March 31, 2026, the March 2026 board-meeting notice, interim-dividend disclosures and earlier FY2026 quarterly results.
→The company described itself as one of India's largest television broadcasters, operating satellite television channels across Tamil, Telugu, Kannada, Malayalam, Bangla, Marathi and Hindi, FM radio stations across India, movie production, three cricket franchises and the SunNXT digital OTT platform.

IRB Infrastructure Developers Ltd.NSE: IRB

Virendra D. Mhaiskar; Anil Yadav; Tushar Kawedia · Chairman and Managing Director; management; finance leadership

Q4 and FY2026 results, toll-revenue growth, Ganga Expressway and TOT-18 tolling, BEST asset-rotation strategy, Private InvIT to Public InvIT transfers, order book, construction-revenue visibility, net-debt-zero path, dividend distribution, WPI/tariff reset, interest-rate locking and daily roads-infrastructure market-signal tracking·Infrastructure·21 May 2026·IRB Infrastructure Developers official Q4/FY2026 earnings-call transcript, Q4/FY2026 press release, investor presentation, audited-results board outcome, investor-relations archive and BSE-hosted transcript/results/project filings

▾

Key highlights

→IRB Infrastructure Developers held its Q4 FY2026 earnings conference call on May 21, 2026 after the May 20, 2026 board meeting and result release.
→The call discussed financial results for the quarter and year ended March 31, 2026, along with recent project and asset-rotation developments.
→Management participants included Virendra D. Mhaiskar, Amitabh Murarka, S.S. Rana, Anil Yadav, Tushar Kawedia, Poonam Nishal and Mehul Patel.
→The board approved consolidated and standalone audited financial results for Q4 and FY2026 on May 20, 2026.
→

Metro Brands Ltd.NSE: METROBRAND

Rafique Malik; Farah Malik Bhanji; Nissan Joseph; Kaushal Parekh; Mohit Dhanjal; Alisha Rafique Malik · Chairman; Managing Director; Chief Executive Officer; Chief Financial Officer; Chief Operating Officer; President - Sports Division, E-Commerce and CRM

Q4 and FY2026 results, festive and wedding-season demand, GST rate cut below Rs 2,500, store expansion, e-commerce and omni-channel growth, Clarks, MetroActiv, Foot Locker, FILA local manufacturing, BIS supply-chain disruption, warehouse expansion, working capital, credit rating and daily footwear/QSR-like retail market-signal tracking·Apparel & Footwear·21 May 2026·Metro Brands official Q4/FY2026 board-outcome results, investor presentation, press release, investor-call intimation/outcome, audio recording and CareEdge credit-rating filing

▾

Key highlights

→Metro Brands reported Q4 and FY2026 results on May 20, 2026 and held an earnings conference call on May 21, 2026 from 3:30 PM to 4:15 PM IST.
→The company confirmed the May 21, 2026 audio recording was uploaded on its website, but the official stock-exchange-disclosures page did not show a Q4 FY2026 transcript PDF at the time of review.
→The conference-call invite named Rafique Malik, Farah Malik Bhanji, Nissan Joseph, Kaushal Parekh, Mohit Dhanjal and Alisha Rafique Malik as management participants.
→Q4 FY2026 growth was driven by festive and wedding-season demand and supported by the reduction in GST rates for footwear below Rs 2,500.

Page Industries Ltd.NSE: PAGEIND

V. S. Ganesh; Deepanjan Bandyopadhyay; Karthik Yathindra; Murugesh C · Managing Director; Chief Financial Officer; Chief Executive Officer; Company Secretary

Q4 and FY2026 results, Jockey and Speedo demand, channel inventory normalization, volume-led growth, premiumization, ecommerce, distribution automation, input-cost inflation, Odisha subsidies, dividend, New Labour Codes and FY2027 margin outlook·Apparel & Footwear·21 May 2026·NSE audited Q4/FY2026 results, Page Industries Q4 FY2026 earnings-call transcript, company investor and Regulation 46 pages, and Quartr earnings summary cross-check

▾

Key highlights

→Page Industries' board approved audited financial results for the quarter and year ended March 31, 2026 at its May 21, 2026 meeting.
→The statutory auditor issued an unmodified opinion on the audited financial results.
→The board declared a fourth interim dividend of Rs 150 per equity share for FY2026.
→The record date for the fourth interim dividend is May 27, 2026 and payment is scheduled on or before June 19, 2026.
→The board meeting on May 21, 2026 commenced at 12:00 p.m. and concluded at 1:40 p.m.
→

FSN E-Commerce Ventures Ltd.NSE: NYKAA

Falguni Nayar, Anchit Nayar, Adwaita Nayar, Vishal Gupta, Abhijeet Dabas and P. Ganesh · Executive Chairperson, Managing Director and Chief Executive Officer; Executive Director and CEO - Beauty; Executive Director, Co-Founder and CEO of House of Nykaa Brands; CEO - Nykaa Distribution; Head of NykaaFashion.com; Chief Financial Officer

Q4 and FY2026 earnings, consolidated GMV and revenue growth, gross-margin expansion, EBITDA and PAT leverage, beauty omnichannel, Fashion acceleration, House of Nykaa owned brands, Superstore eB2B, store expansion, global beauty partnerships, AI personalization, Earth Rhythm acquisition and policy impact from the Labour Codes·Retail·21 May 2026·Nykaa Q4/FY2026 official analyst-call transcript reviewed on the company IR page, NSE investor presentation, NSE press release, board-outcome audited-results filing and quarterly revenue update

▾

Key highlights

→Nykaa delivered Q4 FY2026 GMV of Rs 5,241 cr, up 28% YoY, extending the company's mid-20s growth streak over the last 14 quarters.
→Q4 FY2026 revenue from operations was Rs 2,648 cr, up 28% YoY, which management described as the highest growth in the last 12 quarters.
→Q4 FY2026 gross profit was Rs 1,203 cr, up 32% YoY, with gross margin at 45.4% of net revenue.
→Q4 FY2026 EBITDA was Rs 223 cr, up 67% YoY, with EBITDA margin at 8.4% of net revenue versus 6.5% in Q4 FY2025.

Bosch Ltd.NSE: BOSCHLTD

Guruprasad Mudlapur, Sandeep N and Bosch Limited management · Managing Director; Joint Managing Director; company management

Q4 and FY2026 performance, mobility growth, Power Solutions, two-wheeler powersports, mobility aftermarket, consumer goods, FY2027 automotive production outlook, CAFE Phase 3, CV ADAS, GST-led demand, supply-chain resilience, power tools, exports, JV with Brakes India and Wheels India, dividend and PAT quality·Auto Ancillaries·21 May 2026·Bosch Limited Q4 and FY2026 revised investor presentation, audited financial results, press release, dividend filing and earnings-call recording intimation

▾

Key highlights

→Bosch reported Q4 FY2026 revenue from operations of Rs 5,566 cr, up 13.3% YoY, and FY2026 revenue from operations of Rs 20,035 cr, up 10.8% YoY.
→Q4 FY2026 EBITDA increased 20.8% YoY to Rs 782 cr, while FY2026 EBITDA increased 14.7% YoY to Rs 2,650 cr.
→Q4 FY2026 PAT increased 2.7% YoY to Rs 568 cr, while FY2026 PAT increased 37.6% YoY to Rs 2,770 cr.
→Management attributed Q4 revenue growth to Power Solutions growth of 27.4% and two-wheeler powersports growth of 63.4%.
→FY2026 revenue growth was driven by Power Solutions growth of 17.6%, Mobility Aftermarket growth of 3.7% and two-wheeler powersports growth of 69.1%.

Apollo Hospitals Enterprise Ltd.NSE: APOLLOHOSP

Suneeta Reddy, A. Krishnan, Madhu Sasidhar, Madhivanan Balakrishnan, Sriram Iyer, Sanjiv Gupta and Obul Reddy · Managing Director; Group CFO; President and CEO, Hospitals Division; CEO, Apollo HealthCo; CEO, AHLL; CFO, Apollo HealthCo; CFO, Pharmacy

Q4 and FY2026 performance, hospital growth, occupancy, case mix, Apollo HealthCo profitability, Apollo 24/7, AHLL, Cloudnine transaction, bed additions, demerger timing and FY2027 operating priorities·Healthcare·21 May 2026·Apollo Hospitals Q4 and FY2026 earnings conference call transcript, results release and earnings update

▾

Key highlights

→Apollo Hospitals reported Q4 FY2026 consolidated revenue of Rs 6,605 cr, up 18% YoY, consolidated EBITDA of Rs 1,011 cr, up 31% YoY, and consolidated PAT of Rs 529 cr, up 36% YoY.
→FY2026 consolidated revenue crossed Rs 25,000 cr for the first time at Rs 25,229 cr, up 16% YoY, with EBITDA of Rs 3,769 cr, up 25%, and PAT of Rs 1,942 cr, up 34%.
→Healthcare Services Q4 revenue was Rs 3,268 cr, up 16% YoY, supported by management's bridge of roughly 7% volume growth, 5% case-mix improvement and 4% price revisions.
→Management said CONGO specialties, covering cardiac, oncology, neurosciences, gastro and orthopedics, grew revenue 22% YoY in Q4 and remain the key acuity and mix lever.

ITC Ltd.NSE: ITC

ITC management · Corporate management and investor relations

Q4 FY2026 and FY2026 results across cigarettes, FMCG, agri and paperboards·FMCG·21 May 2026·ITC Q4 FY2026 result presentation

▾

Key highlights

→ITC reported resilient Q4 FY2026 performance despite supply-chain disruptions and logistical challenges from the West Asia conflict.
→Consolidated Q4 gross revenue grew 17.1% YoY, EBITDA grew 6.9% YoY, and PAT grew 6.1% YoY.
→FMCG Others delivered broad-based growth, with Q4 segment revenue up 15% YoY and segment PBIT up 51% YoY; EBITDA margin expanded 200 bps YoY to 11% excluding Sresta.
→Cigarettes faced an unprecedented tax increase from February 1, 2026, and management responded with staggered pricing, agile portfolio re-architecture and trademark-led market interventions.
→Paperboards, Paper and Packaging saw Q4 segment PBIT rise 21% YoY and 24% QoQ, helped by improved wood availability, MIP relief on virgin multi-layer paperboard and packaging growth.

Financial highlights

Viyash Scientific LimitedNSE: VIYASH

Dr. Haribabu B.; Rajaram; Ramakant S.; Abhishek Singhal; Board of Directors · Managing Director and Group CEO; Executive Director and CEO Animal Health; Chief Financial Officer; conference host; Board of Directors

Q4 and FY2026 results, active NSE successor coverage from SEQUENT to VIYASH, Sequent-Viyash integration, formulations, APIs, CDMO, animal health, synergy roadmap, deleveraging, BioForLife acquisition and rating actions·Healthcare·20 May 2026·NSE-filed Viyash Scientific Q4/FY2026 earnings-call transcript, audited financial-results and board-outcome filing, press release, investor presentation, Investor Day deck, BioForLife acquisition disclosure, acquisition press release, India Ratings filings and current NSE EQ list

▾

Key highlights

→The current NSE EQ list shows Viyash Scientific Limited under symbol VIYASH with ISIN INE807F01027; SEQUENT is a stale legacy symbol for the launch universe.
→Viyash's NSE filings describe the issuer as Viyash Scientific Limited, formerly known as Sequent Scientific Limited.
→Viyash filed audited financial results and board outcomes with NSE on May 19, 2026.
→Viyash filed its Q4/FY2026 press release and investor presentation with NSE on May 19, 2026.
→Viyash filed its Q4/FY2026 earnings-call transcript with NSE on May 22, 2026.

Sammaan Capital Ltd.NSE: SAMMAANCAP

Peter Abraam; H.E. Dalia Khorshid; Gagan Banga; Nikunj Jain; Board of Directors · Chief Strategy and Growth Officer, IHC; Chief Executive Officer, Avalora Holdings; Managing Director and Chief Executive Officer, Sammaan Capital; Investor Relations, MUFG; Board of Directors

Q4 and FY2026 results, active NSE successor coverage from IBULHSGFIN to SAMMAANCAP, IHC promoter transition, provisioning reset, opening AUM quality, FY2027-FY2030 growth targets, rating upgrades, AI and operating model, debt/fundraising authorization, Sammaan Finserve scheme and liability management·Financial Services·20 May 2026·NSE-filed Sammaan Capital Q4/FY2026 earnings-call transcript, revised earnings update, audited financial-results and board-outcome filing, press release, monitoring-agency report, IHC promoter-classification filing, scheme-of-arrangement filings, rating upgrade disclosures and current NSE EQ list

▾

Key highlights

→The current NSE EQ list shows Sammaan Capital Limited under symbol SAMMAANCAP with ISIN INE148I01020; IBULHSGFIN is a stale legacy symbol for the launch universe.
→Sammaan Capital's NSE filings describe the company as Sammaan Capital Limited, formerly known as Indiabulls Housing Finance Limited.
→Sammaan filed audited standalone and consolidated financial results and board outcomes with NSE on May 20, 2026.
→Sammaan filed a Q4/FY2026 earnings update with NSE on May 20, 2026 and a revised earnings update later the same day.

Teamlease Services Ltd.NSE: TEAMLEASE

Suparna Mitra; Ashok Reddy; Ramani Dathi; Neeti Sharma; Balasubramanian A.; TeamLease Services Limited · Managing Director and Chief Executive Officer; Executive Vice Chairman; Chief Financial Officer and Chief Operating Officer; CEO - Specialised Staffing; Senior Vice President - Enterprise; issuer filings

Q4 and FY2026 results, NBFC client insourcing impact, staffing and apprenticeship headcount recovery, specialised staffing and GCC growth, margin and PAPM improvement, FY2027 labour-code transition, buyback, cash allocation, EPFO/GST/NEEM litigation and legal-risk market signals·Industrials·20 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, Q4/FY2026 earnings press release, audited standalone/consolidated financial-results board outcome, buyback and record-date filings, postal-ballot notice, senior-management and independent-director filings, EPFO/GST/NEEM litigation disclosures, SAST disclosure and NSE announcement slice

▾

Key highlights

→TeamLease filed its Q4/FY2026 earnings-call transcript with NSE on May 22, 2026.
→The Q4/FY2026 earnings call was hosted on May 20, 2026 at 4:00 PM IST.
→HDFC Securities hosted the call, moderated by Arjun Savla.
→Management participants included Suparna Mitra, Managing Director and CEO; Ashok Reddy, Executive Vice Chairman; Ramani Dathi, CFO and COO; Neeti Sharma, CEO - Specialised Staffing; and Balasubramanian A., Senior Vice President - Enterprise.

Prince Pipes and Fittings Ltd.NSE: PRINCEPIPE

Parag Chheda; Nihar Chheda; Anand Gupta; Prince Pipes And Fittings Limited · Joint Managing Director; Vice President - Strategy; Chief Financial Officer; issuer filings

Q4 and FY2026 results, highest-ever quarterly volume, PVC/channel volatility, working-capital improvement, 11%-13% margin and 12%-15% volume-growth management markers, Aquel/Bathware expansion, Bhuj manufacturing-facility acquisition, DECILO launch, final dividend, governance and auditor changes, GST demand-order tracking and NSE market-signal cleanup·Industrials·20 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, earnings press release, audited standalone financial-results board outcome, earnings-call schedule and recording filings, Bhuj/Aquel bathware manufacturing-facility acquisition press release, GST demand-order filing, final-dividend filing, company-secretary appointment filing, auditor-appointment filing, investor-meet filings, trading-window filing and NSE announcement slice

▾

Key highlights

→Prince Pipes filed its Q4/FY2026 earnings-call transcript with NSE on May 26, 2026.
→The Q4/FY2026 earnings call was held on May 20, 2026 at 11:00 AM IST.
→Management participants on the call were Parag Chheda, Joint Managing Director; Nihar Chheda, Vice President - Strategy; and Anand Gupta, Chief Financial Officer.
→The call was moderated by Sumeet Khaitan of MUFG Intime.

Bajaj Electricals LtdNSE: BAJAJELEC

Shekhar Bajaj; Sanjay Sachdeva; Vishal Chadha; Rajesh Naik; Ashween Anand; Suketu Shah; Bajaj Electricals Limited · Chairman; Managing Director and CEO; COO - Consumer Products; COO - Lighting Solutions; Chief Financial Officer; Finance Controller / former interim CFO; issuer filings

Q4 and FY2026 results, Consumer Products reset, Lighting Solutions growth and margin, wires and cables category expansion, negative working capital, cash flow, Morphy Richards brand acquisition, exceptional items, CFO transition, dividend, CRISIL rating, GST orders and daily market-signal tracking·Consumer Durables·20 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone and consolidated financial-results board outcome, Cables category entry filing, CFO appointment filings and press release, CRISIL rating filing, dividend/AGM filings, ESOP filings and GST/tax-order disclosures

▾

Key highlights

→Bajaj Electricals filed its Q4 FY2026 earnings-call transcript with NSE on May 26, 2026.
→The Q4 FY2026 earnings call was held on May 20, 2026.
→Management participants included Chairman Shekhar Bajaj, Managing Director and CEO Sanjay Sachdeva, COO - Consumer Products Vishal Chadha, COO - Lighting Solutions Rajesh Naik, CFO Ashween Anand and Finance Controller Suketu Shah.
→Bajaj Electricals filed its Q4/FY2026 investor presentation with NSE on May 18, 2026.

Hemisphere Properties India Ltd.NSE: HEMIPROP

Hemisphere Properties India Limited issuer filings; D. Thara; Board of Directors; Lubna · Issuer filings; Chairperson and Managing Director; Board of Directors; Company Secretary and Compliance Officer

Q4 and FY2026 standalone results, Bopkhel Pune land e-auction, HyperVault AI Data Center material related-party transaction, postal-ballot approval process, investment-property carrying and fair values, stamp-duty and property-tax emphasis matters, board-composition non-compliance, Delhi stamp-duty notice and director changes·Realty·20 May 2026·Official NSE-filed audited standalone financial-results board outcome, Bopkhel Pune e-auction disclosure, postal-ballot notice for the HyperVault AI Data Center material related-party transaction, director-change filings and newspaper postal-ballot advertisement; no official Q4 FY2026 earnings-call transcript or investor presentation was found in the checked NSE Apr 1-Jun 27 2026 source pack

▾

Key highlights

→Hemisphere Properties filed its audited standalone financial results for the quarter and year ended March 31, 2026 with NSE on May 20, 2026.
→The board meeting approving the audited financial results was held on May 20, 2026.
→The May 20, 2026 board meeting commenced at 2:30 p.m. and concluded at 4:00 p.m.
→The results were reviewed by the Audit Committee and approved by the Board of Directors.

C.E. Info Systems Ltd.NSE: MAPMYINDIA

Rakesh Verma; Rohan Verma; Anuj Jain; Sapna Ahuja; Nikhil Kumar; C.E. Info Systems Limited issuer filings · Co-Founder, Chairman and Managing Director; Managing Director - Mappls DT Private Limited and Gtropy Systems Private Limited; Chief Financial Officer; Chief Operating Officer; President - Government Business, Mappls DT Private Limited; issuer filings

Q4 and FY2026 results, order-book visibility, FY2027 growth outlook, FY2028 revenue roadmap, government and IoT execution timing, Mappls App adoption, AI-led productivity, capital allocation, dividend and audited financials·IT Services·20 May 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, results press release, integrated audited financial-results board outcome, call-recording link filing and earnings-call schedule

▾

Key highlights

→C.E. Info Systems Limited filed the Q4 FY2026 earnings-call transcript with NSE on May 25, 2026.
→The Q4 FY2026 earnings call was held on May 20, 2026.
→The call was hosted by DAM Capital and moderated by Anmol Garg.
→Management participants included Rakesh Verma, Rohan Verma, Anuj Jain, Sapna Ahuja and Nikhil Kumar.
→The company filed its Q4 FY2026 results press release with NSE on May 19, 2026.

PNC Infratech Ltd.NSE: PNCINFRA

Yogesh Jain; T. R. Rao; Pankaj Agarwal; PNC Infratech Limited · Managing Director; Director (Infra); Vice President, Finance and Accounts; issuer filings

Q4 and FY2026 audited results, execution delays, order book, HAM equity needs, FY2027 and FY2028 revenue guidance, order-inflow pipeline, road-sector awarding, asset monetisation, fresh EPC/HAM wins, settlements, PCODs and balance-sheet position·Construction·20 May 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone and consolidated financial results and board outcome, press release, post-result order-win filings, settlement/arbitration filings, PCOD filings, SPV incorporation filings, ESG rating filing and CFO appointment filing

▾

Key highlights

→PNC Infratech filed its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 with NSE on May 19, 2026.
→The May 19 board meeting commenced at 12:30 p.m. and concluded at 3:55 p.m.
→The Board approved audited standalone and consolidated financial results for Q4 and FY2026.
→NSBP & Co. issued audit reports with unmodified opinions on the audited standalone and consolidated financial results.
→The Board recommended a final dividend of 30%, equal to Rs 0.60 per equity share of face value Rs 2, subject to shareholder approval.

Garware Technical Fibres Ltd.NSE: GARFIBRES

Vayu R. Garware; Sunil Agarwal; Shashank Gupta; Garware Technical Fibres Limited · Chairman and Managing Director; Company Secretary and Compliance Officer; Chief Financial Officer; issuer filings

Q4 and FY2026 results, H2 normalization, salmon aquaculture and U.S. order-flow recovery, Middle East logistics/raw-material disruption, geosynthetics growth, OTS/AMS acquisition, buyback completion, dividend, rating reaffirmation and governance updates·Textiles·20 May 2026·NSE-filed Q4 and FY2026 press release, audited standalone and consolidated financial-results board outcome, investor presentation, buyback approval and completion filings, ICRA rating reaffirmation, investor-meet schedule, governance filings and volume-spurt response

▾

Key highlights

→Garware Technical Fibres filed audited standalone and consolidated financial results with NSE on May 20, 2026.
→The board meeting approving the audited results was held on May 20, 2026.
→The board meeting started at 1:00 p.m. and concluded at 4:00 p.m.
→Mehta Chokshi & Shah LLP issued the statutory audit reports on the annual financial results.
→The statutory auditors expressed an unmodified opinion on the financial statements.

RITES Ltd.NSE: RITES

Rahul Mithal; Deepak Tripathi; Krishna Gopal Agarwal; Prem Singh Meena · Chairman and Managing Director; Director Technical; Director Finance and Chief Financial Officer; Director Projects

Q4 and FY2026 results, highest-ever order book, export revival, FY2027 order-book conversion, margin guardrails, consultancy versus turnkey mix, final dividend, international business development, RITES-Crisil MoU, NALCO order enhancement, governance filings, promoter no-encumbrance disclosure and daily market-signal tracking·Construction·20 May 2026·NSE-filed RITES Q4/FY2026 conference-call transcript, audio-recording filing, investor presentation, press release, audited standalone and consolidated financial-results/board-outcome filing, dividend outcome, call invitation, Philippines representative-office filing, RITES-Crisil MoU release, NALCO order update, MMG-Metro Management Group closure filing, volume-spurt clarification, SAST promoter disclosure and BSE company page

▾

Key highlights

→RITES filed the transcript of its Q4 and FY2026 post-results conference call with NSE and BSE on May 26, 2026.
→The conference call was held on May 20, 2026 at 11:00 IST to discuss audited financial results for the quarter and year ended March 31, 2026.
→The call participants from RITES were Rahul Mithal, Chairman and Managing Director; Dr. Deepak Tripathi, Director Technical; Krishna Gopal Agarwal, Director Finance and CFO; and Prem Singh Meena, Director Projects.

Eris Lifesciences Ltd.NSE: ERIS

Amit Bakshi; V. Krishnakumar; Sachin Shah; Kruti Raval; Eris Lifesciences Board of Directors · Chairman and Managing Director; Chief Operating Officer and Executive Director; Chief Financial Officer; Vice President - Investor Relations and M&A; Board of Directors

Q4 and FY2026 results, domestic branded formulations, insulin, derma, Sundae semaglutide launch, international business, EU GMP observations, delayed launches, Bhopal insulin manufacturing, working capital, net debt, capex, tax, ROCE and daily pharma market-signal tracking·Pharmaceuticals·20 May 2026·Eris Lifesciences official company Q4 and FY2026 earnings-call transcript, NSE transcript intimation, NSE/BSE audited consolidated financial results, NSE investor presentation, earnings-call recording intimation, HALMED inspection filing, Ind-Ra rating filings, postal-ballot filings and governance penalty disclosure

▾

Key highlights

→Eris Lifesciences held its Q4 and FY2026 analyst and investor conference call on May 20, 2026.
→The management participants were Amit Bakshi, V. Krishnakumar, Sachin Shah and Kruti Raval.
→The Q4 FY2026 results package includes the official call transcript, investor presentation, audited financial results, earnings-call intimation and board-meeting notice.
→The NSE transcript intimation filed on May 26, 2026 pointed investors to the company financials page; the direct official company-hosted transcript PDF is validator-reachable.

Jubilant Foodworks Ltd.NSE: JUBLFOOD

Shyam S. Bhartia; Hari S. Bhartia; Sameer Khetarpal; Suman Hegde; Apar · Chairman and Director; Co-Chairman and Director; Chief Executive Officer and Managing Director; Chief Financial Officer; Head of Investor Relations and M&A

Q4 and FY2026 results, Domino's India LFL moderation, Rs 99 affordability action, delivery order growth, dine-in/takeaway softness, LPG and labour inflation, margin levers, store expansion, Popeyes scale-up, Turkey cash generation, owned-app growth, AI and supply-chain execution, and daily QSR market-signal tracking·Restaurants·20 May 2026·Jubilant FoodWorks official Q4/FY2026 conference-call transcript, shareholder letter, earnings presentation and business update filed with BSE and NSE

▾

Key highlights

→Jubilant FoodWorks filed its Q4/FY2026 shareholder letter and earnings presentation on May 20, 2026 and the transcript of the May 20, 2026 analyst and investor call on May 27, 2026.
→The April 6, 2026 business update gave an early pre-result signal: Q4 FY2026 consolidated revenue from operations was provisionally Rs 25,058 mn, up 19.1% YoY, and standalone revenue was Rs 16,860 mn, up 6.2% YoY.
→The audited presentation reported Q4 FY2026 consolidated revenue from operations of Rs 24,995 mn, up 19.3% YoY, and FY2026 consolidated revenue of Rs 95,125 mn, up 17.4% YoY.
→Q4 FY2026 consolidated operating EBITDA was Rs 4,849 mn, up 23.7% YoY, with EBITDA margin expanding 69 bps YoY to 19.4%.

Honeywell Automation India Ltd.NSE: HONAUT

Honeywell Automation India Board of Directors; Indu Daryani · Board approval and company secretary filing; annual-report management discussion

Q4 and FY2026 audited results, dividend, single-segment automation and control systems performance, labour-code exceptional item, cash and working capital, CFO transition, annual-report strategy, order-book and daily automation market-signal tracking·Capital Goods·20 May 2026·Honeywell Automation India official Q4/FY2026 audited financial-results filing, FY2024-25 annual-report management discussion and Regulation 30 management-change disclosures

▾

Key highlights

→Honeywell Automation India's board approved audited standalone financial results for the financial year ended March 31, 2026 at its May 20, 2026 meeting.
→The May 20, 2026 board meeting started at 2:45 p.m. and concluded at 4:30 p.m.
→The statutory auditors issued an unmodified audit opinion on the FY2026 annual financial results.
→No official Q4 FY2026 earnings-call transcript was located on the company investor page or in the exchange-source checks for this pass, so this management note is filing-led rather than concall-led.
→The board recommended a final dividend of Rs 110 per equity share for FY2026, versus Rs 105 per share for FY2025, subject to shareholder approval.

Astral Ltd.NSE: ASTRAL

Sandeep Engineer; Kairav Engineer; Hiranand Savlani; Chintankumar Patel · Managing Director; Executive Director; Whole Time Director and CFO; Company Secretary

Q4 and FY2026 results, plumbing volume growth, CPVC resin backward integration, polymer-price and duty reset, new product launches, decentralised plants, bathware, paints, adhesives, UK/US Bond IT recovery, working capital, capex, dividend and FY2027 outlook·Industrials·20 May 2026·Astral Q4/FY2026 analyst-meet transcript, audited financial results and board outcome, Q4 FY2026 press release, and company investor presentation page

▾

Key highlights

→Astral's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 18, 2026 board meeting.
→The board meeting started at 2:45 p.m. and concluded at 3:40 p.m. on May 18, 2026.
→The statutory auditors issued unmodified audit reports on Astral's standalone and consolidated FY2026 financial results.
→The board recommended a final dividend of Rs 2.50 per equity share of face value Re 1 for FY2026, subject to shareholder approval.
→The final dividend is in addition to the Rs 1.50 per share interim dividend, taking FY2026 declared dividend to Rs 4.00 per share.

PI Industries Ltd.NSE: PIIND

Mayank Singhal; Sanjay Agarwal; Atul Gupta; Jagresh Rana; Ramesh Subramanian; Nishid Solanki · Vice Chairperson and Managing Director; Group Chief Financial Officer; CEO, CSM Agchem; Global CEO, PI AgSciences; Global CEO, PI Health Sciences; Investor relations moderator

Q4 and FY2026 results, agchem export downcycle, domestic agri demand, new molecule launches, Pioxaniliprole, biologicals, pharma CRDMO, electronic chemicals, order book, capex, working capital, net cash, dividend, New Labour Codes and FY2027 recovery setup·Fertilizers·20 May 2026·PI Industries Q4 FY2026 earnings-call transcript, audited financial results, NSE-hosted investor presentation and company investor pages

▾

Key highlights

→PI Industries held its Q4 FY2026 earnings conference call on May 20, 2026.
→The company filed the Q4 FY2026 investor presentation with NSE and BSE on May 19, 2026 for the May 20, 2026 analyst and investor call.
→The board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 at its May 19, 2026 meeting.
→The audited consolidated financial statements carried an unmodified audit opinion.
→The board recommended a final dividend of Rs 10 per equity share, subject to shareholder approval at the ensuing AGM.

Bharat Petroleum Corporation Ltd.NSE: BPCL

V.R.K. Gupta, Pankaj Kumar, Ashish Goyal, Anuya Vatsal Thakar and Balagirish J. · Director Finance; Executive Director Corporate Finance; CGM Corporate Treasury; DGM Finance; Senior Manager Finance

Q4 and FY2026 results, West Asia energy-market volatility, crude sourcing, refining throughput, GRM, marketing volumes, LPG compensation, gas growth, project capex, Bina petrochemicals, upstream impairment, debt and liquidity·Oil & Gas·20 May 2026·Bharat Petroleum Corporation Q4 and FY2026 earnings call transcript, audited financial results, investor handout and investor presentation

▾

Key highlights

→Management said BPCL delivered operational resilience during West Asia-led energy-market volatility while ensuring uninterrupted MS, HSD and LPG supply across India.
→Crude supply security was supported by flexible sourcing, with Russian crude procurement rising from 25% in Q3 to 31% in Q4 and 8 new crude grades diversified across 4 geographical regions during FY2026.
→Management said crude supplies had been secured through July 2026, though Q1 FY2027 would be challenging because the full impact of the war and supply disruption was not realized in Q4.
→FY2026 refinery throughput was 41.15 MMT at 116% utilization, the highest ever according to management, with distillate yield at 84.54%.

Grasim Industries Ltd.NSE: GRASIM

Himanshu Kapania, Hemant Kadel, Vadiraj Kulkarni, Jayant Dhobley, Sachin Sahay and Sandeep Komaravelly · Managing Director and Business Head, Birla Opus Paints; CFO; Business Head, Cellulosic Fibres; Business Head, Chemicals, Fashion Yarn and Insulators; CEO, Birla Opus; CEO, Birla Pivot

Q4 FY2026 results, Birla Opus scale-up, Birla Pivot, cellulosic fibres, chemicals, UltraTech, AB Capital and capital allocation·Cement·20 May 2026·Grasim Industries Q4 FY2026 earnings conference call transcript

▾

Key highlights

→Management described FY2026 as a landmark transformation year, with Grasim moving from legacy manufacturing leadership into consumer, digital, financial services and building-materials platforms.
→Consolidated FY2026 revenue was INR 1,75,431 cr, above USD 18 bn, while standalone revenue reached INR 41,039 cr.
→Birla Opus delivered 52% year-on-year like-for-like Q4 revenue growth, 100% FY2026 revenue growth versus FY2025, and expanded FY2026 revenue market share by about 370 bps.
→Management said Birla Opus crossed 50,000 dealers, 11,500 towns, 146 depots, nearly 37,000 active tinting machines and 1,200-plus exclusive franchise stores.
→The CFO said UltraTech crossed 200 MTPA grey-cement capacity in April 2026 and remains on track for 240-plus MTPA by March 2028.

Bharat Electronics Ltd.NSE: BEL

Manoj Jain, Damodar Bhattad S and S. Sreenivas · Chairman and Managing Director; Director Finance and CFO; Company Secretary

Q4 FY2026 results, defence electronics order book, new technology pipeline and FY2027 outlook·Defence·20 May 2026·Bharat Electronics Q4 FY2026 earnings conference call transcript

▾

Key highlights

→Management said BEL met all FY2026 guidance parameters, with revenue from operations up 16%, PBT up 14%, PAT up 14%, EBITDA margin at 30%, and EPS at INR 8.27.
→Order book stood at INR 73,882 cr as of April 1, 2026, while orders acquired during FY2026 were INR 30,045 cr.
→BEL is building new-technology capabilities across DRDO, start-up, academia and in-house channels, with proof-of-concepts already given to defence users in areas such as drones, QKD and quantum-safe communication.
→Management said INR 100-plus cr has been invested in compute infrastructure over the last two years, with another INR 100 cr to INR 200 cr in different stages of approval.
→For the P-75I submarine opportunity, management said more than 50% to 60% of the electronics content should come from BEL, subject to program finalization and foreign-partner scope.

Financial highlights

Gujarat Narmada Valley Fertilizers and Chemicals Ltd.NSE: GNFC

D. V. Parikh; Rajkumar Beniwal; Nitin Patel; P. K. Purohit; Rajesh Pillai; Tejash Shah; V. Biradar · Executive Director and Chief Financial Officer; Managing Director; Executive Director; Executive Director; Company Secretary and Compliance Officer; Marketing Industrial Products; Fertilizer Marketing

Q4 and FY2026 results, chemical realization improvement, lower input costs, fertilizer under-recovery, TDI, ammonium nitrate and technical grade urea drivers, capex pipeline, methanol and RLNG availability, Middle East force-majeure effects, dividend, auditor transition, senior-management changes, ESG ratings and daily chemicals/fertilizer market-signal tracking·Chemicals·19 May 2026·NSE-filed GNFC Q4/FY2026 earnings-call transcript, Q4/FY2026 investor presentation, audited standalone/consolidated financial-results and board-outcome filing, Q4 press release, earnings-call audio filing, board-meeting and trading-window filings, statutory-auditor appointment filing, dividend filings, postal-ballot and voting-result filings, senior-management change filings, force-majeure and gas-leakage filings, ESG-rating filings, BSE corporate-announcement mirror and BSE security identity page

▾

Key highlights

→GNFC filed the transcript of its Q4 FY2026 earnings conference call with NSE and BSE on May 23, 2026.
→The Q4 FY2026 earnings call was held on May 19, 2026 at 4:00 p.m. IST.
→The Q4 call was hosted by Anurag Services LLP on behalf of GNFC.

Zee Entertainment Enterprises Ltd.NSE: ZEEL

Punit Goenka; Mukund Galgali; Ankit Arora · Chief Executive Officer; Deputy Chief Executive Officer and Chief Financial Officer; Head Investor Relations

Q4 and FY2026 results, ZEE5 breakeven, linear-TV share gains, advertising softness, movie-rights amortisation reset, Phantom AVGC investment, Bullet micro-drama, Unite8 Sports, FIFA rights, Rs 2,300 crore capital-raise approval and daily media market-signal tracking·Media·19 May 2026·NSE-filed ZEEL Q4/FY2026 earnings-call transcript, earnings release, audited financial-results and board-outcome filing, earnings-call audio filing, Phantom Digital Effects investment filing, ZBullet investment filing, Unite8 Sports launch filing, FIFA rights filing, Jiostar litigation filing, SMP resignation filing, June 2026 capital-raise board outcome and BSE company page

▾

Key highlights

→ZEEL filed the transcript of its Q4 and FY2026 earnings conference call with NSE on May 26, 2026.
→The conference call was held on May 19, 2026 after the board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.
→The call was led by Punit Goenka, CEO; Mukund Galgali, Deputy CEO and CFO; and Ankit Arora, Head Investor Relations.
→The May 19, 2026 board outcome said the board approved audited standalone and consolidated financial results for Q4 and FY2026.

Hatsun Agro Product Ltd.NSE: HATSUN

R G Chandramogan; C Sathyan; Hatsun Agro Product Board of Directors · Chairman; Vice Chairman; Board of Directors

Q4 and FY2026 results, private-sector dairy growth, operating efficiency, debt reduction, Milk Mantra amalgamation, distribution expansion, procurement and packaging inflation, dividend, CRISIL upgrade and daily dairy/FMCG market-signal tracking·FMCG·19 May 2026·Hatsun Agro Product official May 19 2026 board outcome and audited FY2026 financial results, FY2026 results press release, March 16 2026 CNBC TV18 Chairman interview transcript, dividend filing, Milk Mantra amalgamation update, CRISIL rating intimation and investor-relations pages

▾

Key highlights

→Hatsun Agro Product's board meeting on May 19, 2026 approved audited financial results for the quarter and year ended March 31, 2026.
→Deloitte Haskins & Sells LLP issued an unmodified audit opinion on the FY2026 annual financial results and an unmodified review conclusion on the Q4 FY2026 results.
→The May 19 board meeting also noted related-party transactions for the half year ended March 31, 2026, approved FY2026 board-report materials and appointed M/s Ramachandran & Associates as cost auditors for FY2027.
→The board declared a first interim dividend of Rs 10 per equity share of face value Re 1 each, or 1000%, for FY2027.

Triveni Turbine Ltd.NSE: TRITURBINE

Nikhil Sawhney; S.N. Prasad; Sachin Parab; Manikantan Rajendran; Shreya Sharma; Triveni Turbine Board of Directors · Vice Chairman and Managing Director; Chief Executive Officer; Chief Operating Officer; Chief Marketing Officer; Head - Investor Relations and Value Creation; Board of Directors

Q4 and FY2026 audited results, record revenue, export and aftermarket order momentum, margin mix, receivables, FY2027 back-ended outlook, U.S. and geothermal enquiry conversion, NTPC energy-storage project and daily capital-goods market-signal tracking·Capital Goods·19 May 2026·Triveni Turbine official NSE-hosted May 18, 2026 board-outcome and audited-results filing, NSE-hosted May 19, 2026 Q4/FY2026 earnings-call transcript, and company-hosted Q4/FY2026 investor brief

▾

Key highlights

→Triveni Turbine's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 18, 2026.
→The May 18, 2026 board meeting commenced at 12:15 p.m. and concluded at 4:50 p.m.
→The statutory auditors issued audit reports with unmodified opinion on the audited financial results.
→The board recommended a final dividend of Rs 2.00 per equity share of face value Re 1 for FY2026, subject to shareholder approval, in addition to the Rs 2.25 interim dividend paid during Q4 FY2026.

Indraprastha Gas Ltd.NSE: IGL

Kamal Kishore Chatiwal; Mohit Bhatia; Sanjay Kumar; Manjeet Singh · Managing Director; Director - Commercial; Chief Financial Officer; Vice President - Finance

Q4 and FY2026 results, FY2027 capex and volume outlook, CNG and PNG growth, gas-sourcing mix, final dividend, DDA/license-fee and labour-code watchpoints, CFO and MD transition, and daily CGD market-signal tracking·Power·19 May 2026·Indraprastha Gas official audited-results filing, FY2025-26 investor presentation, earnings-call intimation and audio-recording filing

▾

Key highlights

→IGL's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 18, 2026.
→The board meeting commenced at 2:45 p.m. and concluded at 6:00 p.m. on May 18, 2026.
→The statutory auditors expressed unmodified opinions on the standalone and consolidated audited financial results.
→The board recommended a final dividend of Rs. 1.50 per share, or 75% of face value of Rs. 2 per share, for FY2026, subject to shareholder approval.
→A Q4 FY2026 results conference call was scheduled and held on May 19, 2026 at 3:00 p.m. IST.
→

Timken India Ltd.NSE: TIMKEN

Sanjay Koul; Sujit Kumar Pattanaik; Timken India Board of Directors · Chairman and Managing Director; Business Controller - India, Chief Financial Officer and Whole-time Director; Board of Directors

Q4 and FY2026 results, record quarterly standalone revenue, segment mix across rail, mobile, distribution, process and exports, Bharuch SRB/CRB ramp-up, Jamshedpur rail expansion, GGB acquisition and amalgamation, Sunstream renewable sourcing investment, price pass-through, dividend, civil-suit disclosure and daily rail/CV/industrial/export/capex market-signal tracking·Capital Goods·19 May 2026·Timken India official Q4/FY2026 earnings-call transcript, audited standalone and consolidated results, integrated filings, board outcome and post-result statutory disclosures

▾

Key highlights

→Timken India held its Q4 FY2026 earnings conference call on May 19, 2026 at 5:30 p.m. IST, hosted by Avendus Spark.
→The official call invite listed Sanjay Koul and Sujit Kumar Pattanaik as management representatives.
→The Q4 FY2026 conference-call transcript was uploaded on Timken India's statutory-compliances page.
→The Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 18, 2026.
→

Zydus Lifesciences Ltd.NSE: ZYDUSLIFE

Dr. Sharvil Patel, Ganesh Nayak, Tushar Shroff, Arvind Bothra and Alok Garg · Managing Director; Director; Chief Financial Officer; Head Investor Relations; MD Office

Q4 and FY2026 performance, India formulations, chronic portfolio, North America generics and specialty, Assertio acquisition, Sentynl, 505(b)(2), Saroglitazar, Semaglutide, biosimilars, Consumer Wellness, MedTech, FY2027 revenue and margin outlook, R&D, capex, net debt, buyback and acquisition integration·Pharmaceuticals·19 May 2026·Zydus Lifesciences Q4 and FY2026 post-results earnings call transcript, financial performance release, press release, investor presentation, earnings-call intimation and investor zone

▾

Key highlights

→Zydus reported Q4 FY2026 revenue from operations of Rs 75,870 mn, up 16.2% YoY and 10.5% QoQ.
→Q4 FY2026 EBITDA was Rs 25,544 mn, up 20.2% YoY, with EBITDA margin of 33.7%, up 110 bps YoY.
→Q4 FY2026 adjusted net profit was Rs 15,929 mn, up 14.6% YoY, adjusted for exceptional expenses including the Mirabegron litigation settlement.
→FY2026 revenue from operations was Rs 271,484 mn, up 16.8% YoY, while FY2026 EBITDA was Rs 84,751 mn, up 20.1%, with EBITDA margin of 31.2%.
→FY2026 adjusted net profit was Rs 54,564 mn, up 15.0% YoY, while reported net profit was Rs 50,400 mn, up 11.4% YoY.

Indian Oil Corporation Ltd.NSE: IOC

Anuj Jain, Nitin Kumar and Pramod Jain · Director Finance; Executive Director Corporate Finance and Treasury; Chief General Manager Treasury

Q4 FY2026 and FY2026 operational records, refining and marketing outlook, capex, LPG under-recovery, debt reduction and energy-transition projects·Oil & Gas·19 May 2026·Company earnings conference call transcript / NSE investor handout

▾

Key highlights

→Management described FY2026 as a landmark operational year, with highest-ever refining throughput, consolidated annual sales volumes, lubricants sales and petrochemical sales.
→FY2026 revenue from operations was Rs 8,86,224 cr versus Rs 8,45,513 cr in FY2025, while FY2026 PAT was Rs 36,802 cr versus Rs 12,962 cr in FY2025.
→Q4 FY2026 revenue from operations was Rs 2,32,855 cr versus Rs 2,17,725 cr in Q4 FY2025, with Q4 PAT of Rs 11,378 cr.
→IndianOil highlighted supply-chain resilience during US-Iran and Strait of Hormuz disruptions, including alternate crude and LPG sourcing, refinery-diet changes and domestic LPG production ramp-up.
→FY2026 refining throughput reached 75.5 MMT with 107.4% capacity utilisation; pipeline throughput reached 105.6 MMT; total sales volume reached 105.117 MMT.

UNO Minda Ltd.NSE: UNOMINDA

Sunil Bohra; Ankur Modi; Board of Directors · Group Chief Financial Officer; Investor Relations/management participant; Board of Directors

Q4 and FY2026 results, active NSE successor coverage from MINDAIND to UNOMINDA, segment growth, green mobility, 4W EV powertrain capex, order wins, capital allocation, FY2027 execution and commodity/labour pass-through risks·Automobile and Auto Components·18 May 2026·NSE-filed UNO Minda Q4/FY2026 earnings-call transcript, audited standalone/consolidated results and board outcome, investor presentation, results press release, 4W EV powertrain press release, capacity and acquisition disclosures, and current NSE EQ list

▾

Key highlights

→The current NSE EQ list shows UNO Minda Limited under symbol UNOMINDA with ISIN INE405E01023; MINDAIND is a stale legacy symbol for the launch universe.
→UNO Minda filed audited standalone and consolidated financial results and board outcomes with NSE on May 16, 2026.
→UNO Minda filed its Q4/FY2026 results press release and investor presentation with NSE on May 16, 2026.
→UNO Minda filed its Q4/FY2026 earnings-call transcript with NSE on May 22, 2026.
→Management said Q4 FY2026 delivered the company's highest-ever quarterly revenues and profitability.

Aarti Drugs Ltd.NSE: AARTIDRUGS

Adhish P. Patil; Harshit M. Savla; Harit P. Shah; Vishwa Savla; Aarti Drugs Limited · Chief Operating Officer and Chief Financial Officer; Joint Managing Director; Whole-Time Director; Managing Director - Pinnacle Life Science Private Limited; issuer filings

Q4 and FY2026 results, transition from investment phase to operating scale-up, Sayakha methylamines ramp-up, salicylic-acid restart path, formulation export growth, regulated-market mix, API price recovery, FY2027 EBITDA-margin target, brownfield/formulation capex, balance-sheet leverage and daily market-signal tracking·Pharmaceuticals·18 May 2026·NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, press release, audited standalone and consolidated financial-results board outcome, earnings-call invite, earnings-call recording filing and investor-meeting disclosures

▾

Key highlights

→Aarti Drugs filed its Q4/FY2026 earnings-call transcript with NSE on May 23, 2026.
→The Q4/FY2026 earnings call was held on May 18, 2026 at 11:00 AM IST.
→Management participants included Adhish P. Patil, Harshit M. Savla, Harit P. Shah and Vishwa Savla.
→Aarti Drugs filed its Q4/FY2026 investor presentation with NSE on May 16, 2026.
→Aarti Drugs filed its Q4/FY2026 press release with NSE on May 16, 2026.

Symphony Ltd.NSE: SYMPHONY

Achal Bakeri; Nrupesh Shah; Rajesh Mishra; Symphony Limited issuer filings · Chairman and Managing Director; Managing Director - Corporate Affairs; Chief Growth Officer; issuer filings

Q4 and FY2026 results, India air-cooler demand reset, Beyond India Summer Products contribution, Australia balance-sheet reset, Bonaire USA and IPR acquisition, treasury and capital allocation, GSK China loan repayment, US momentum, dividend, tax-order disclosures and management reappointment·Consumer Durables·18 May 2026·Official NSE-filed Q4/FY2026 earnings-call transcript, investor presentation, press release, audited-results and board-outcome filings, Australia/Bonaire reset filings, GST/VAT order disclosures and managing-director reappointment filing

▾

Key highlights

→Symphony filed the Q4/FY2026 earnings-call transcript with NSE on May 22, 2026.
→The earnings call was conducted on May 18, 2026.
→The call was moderated by Manan Goyal from ICICI Securities.
→Management participants included Achal Bakeri, Nrupesh Shah and Rajesh Mishra.
→Achal Bakeri participated as Chairman and Managing Director.
→

JK Paper Ltd.NSE: JKPAPER

Harsh Pati Singhania; Pradeep Joshi; K. R. Veerappan; JK Paper Limited · Chairman and Managing Director; Company Secretary and Compliance Officer; Chief Financial Officer; issuer filings

Q4 and FY2026 results, paper and packaging volume, margin pressure from wood cost and imports, rupee/Euro restatement loss, BCTMP backward integration, composite scheme, BPPL acquisition update, dividend and governance changes·Paper & Packaging·18 May 2026·NSE-filed Q4 and FY2026 press release, audited standalone and consolidated financial-results board outcome, acquisition update, dividend filing, director and senior-management filings, secretarial-auditor filings and shareholder-service filings

▾

Key highlights

→JK Paper filed audited standalone and consolidated Q4 and FY2026 financial results with NSE on May 18, 2026.
→The board meeting approving the audited results was held on May 18, 2026.
→The board meeting commenced at 2:15 p.m. and concluded at 5:45 p.m.
→Lodha & Co LLP issued the statutory audit reports on the annual standalone and consolidated financial results.
→The statutory auditors issued unmodified opinions on the audited standalone and consolidated FY2026 results.

Latent View Analytics Ltd.NSE: LATENTVIEW

Rajan Sethuraman; Rajan Bala Venkatesan; P. Srinivasan; Asha Gupta · Chief Executive Officer; Chief Financial Officer; Company Secretary and Compliance Officer; Investor Relations moderator

Q4 and FY2026 results, AI and agentic analytics traction, Databricks partnership, Healtheon AI SAFE investment, Decision Point integration and dispute, technology-client headwinds, BFSI and consumer growth, FY2027 growth and margin posture, client concentration, cash conversion, governance and ESG filings·Industrials·18 May 2026·NSE-filed Q4 FY2026 earnings-call transcript, investor presentation, press release, audited standalone and consolidated financial-results board outcome, earnings-call recording and invite filings, SAFE investment filing, internal-auditor and director filings, postal-ballot notice and ESG-rating disclosures

▾

Key highlights

→Latent View filed its Q4 FY2026 earnings-call transcript with NSE on May 25, 2026.
→The Q4 FY2026 earnings call was held on May 18, 2026.
→The Q4 FY2026 results, investor presentation and press release were available before the call.
→E&Y LLP Investor Relations moderated the earnings call.
→Asha Gupta represented E&Y LLP as investor-relations moderator on the call.

Sun Pharma Advanced Research Company Ltd.NSE: SPARC

Anil Raghavan; Dr. Mudgal Kothekar; Dr. Sandeep Inamdar; Jaydeep Issrani; Dilip S. Shanghvi; Kajal Damania; S R B C & Co LLP; Board of Directors · Chief Executive Officer; VP Clinical Development - Immunology; VP Clinical Development - Oncology; Head - Business Development, Corporate Communication and Investor Relations; Chairman; Company Secretary and Compliance Officer; Statutory Auditors; Board of Directors

Q4 and FY2026 audited results, Sezaby priority review voucher accounting and sale, reported-profit quality, PDP-716 Complete Response Letter, preferential-warrant funding, R&D portfolio reset, SCD-153 and SBO-154 milestones, cost reset, cash runway and governance filings·Pharmaceuticals·18 May 2026·Official SPARC-hosted audited Q4/FY2026 financial-results filing, company press releases, R&D Day transcript and presentation, plus NSE-filed PRV sale, PDP-716 CRL, preferential-warrant allotment, auditor certificate, senior-management resignation and routine compliance disclosures

▾

Key highlights

→SPARC's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 on May 18, 2026.
→The May 18, 2026 board meeting commenced at 5:30 p.m. IST and concluded at 7:00 p.m. IST.
→The audited-result filing was signed by Chairman Dilip S. Shanghvi.
→S R B C & Co LLP issued the statutory audit reports on the standalone and consolidated financial results.

Balaji Amines Ltd.NSE: BALAMINES

D Ram Reddy; Abhijeet Kothadiya; M. Anandam & Co.; Board of Directors · Managing Director; Company Secretary and Compliance Officer; Statutory Auditors; Board of Directors

Q4 and FY2026 results, margin recovery, amines and specialty-chemicals volume, DME commissioning, NMM and ACN project pipeline, Balaji Speciality Chemicals Rs 750 crore expansion, FY2027 volume and margin outlook, raw-material/geopolitical risks, dividend, AGM, BRSR, volume clarification and senior-management changes·Chemicals·18 May 2026·Company/NSE-filed Q4 FY2026 earnings-call transcript, investor presentation, press release, audited standalone and consolidated financial-results board outcome, analyst-call intimation and audio filing, DME commercial-production filing, AGM/annual-report and record-date filings, volume-clarification reply, internal-audit update, and senior-management resignation filings

▾

Key highlights

→Balaji Amines filed the Q4 FY2026 earnings-call transcript with NSE on May 23, 2026.
→The Q4 FY2026 earnings conference call was held on Monday, May 18, 2026.
→D Ram Reddy, Managing Director of Balaji Amines, represented management on the earnings call.
→Gagan Dixit of Elara Securities moderated the Q4 FY2026 earnings call.
→Management said the Q4 FY2026 financial results, press release and investor presentation had been uploaded on the stock exchanges and company website.

KRBL Ltd.NSE: KRBL

Anil Kumar Mittal; Anoop Kumar Gupta; Ayush Gupta; Ashish Jain · Chairman and Managing Director; Joint Managing Director; Head - India Business; Chief Financial Officer

Q4 and FY2026 earnings, domestic branded rice momentum, export disruption from Middle East logistics, inventory and net-cash position, rice industry outlook, product/category expansion, dividend, audit qualification and daily market-signal items·FMCG·18 May 2026·KRBL Q4/FY2026 earnings-call transcript, NSE transcript filing, investor presentation, audited financial results and board outcome, earnings-call audio filing, call intimation, financial-results newspaper publication, India Gate Poha launch filing, XBRL discrepancy clarification, KRBL-DMCC name-change filing, analyst and media interaction filings, and BSE company page

▾

Key highlights

→KRBL held its Q4 FY2026 earnings conference call on May 18, 2026 at 12:00 noon IST.
→The company filed the Q4 FY2026 earnings-call audio intimation with NSE on May 18, 2026 and filed the transcript with NSE on May 22, 2026.
→Management participants on the call were Anil Kumar Mittal, Anoop Kumar Gupta, Ayush Gupta and Ashish Jain.
→The board approved audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 on May 14, 2026.
→

Strides Pharma Science Ltd.NSE: STAR

Badree Komandur; Vikesh Kumar; Abhishek Singhal · Managing Director and Group CEO; Group CFO; Investor Relations consultant

Q4 and FY2026 results, US and ex-US growth mix, access-market pressure, controlled substances, nasal sprays, Sandoz Africa portfolio, margins, operating cash flow, net debt, dividend, board/KMP/SMP changes, auditor rotation, Arco/Pivot demerger, Bangalore USFDA inspection and daily market-signal tracking·Pharmaceuticals·18 May 2026·NSE-filed STAR Q4/FY2026 earnings-call transcript, audio-link filing, earnings presentation, press release, audited-results and board-outcome filing, board/KMP/SMP movement filings, auditor-rotation filing, Arco/Pivot demerger filings, Bangalore USFDA inspection filing, company quarterly-results and announcement pages and BSE company page

▾

Key highlights

→STAR held its Q4 and FY2026 earnings conference call on May 18, 2026 after the board approved audited results for the quarter and year ended March 31, 2026.
→The May 21, 2026 NSE filing enclosed the transcript of the Q4 and FY2026 earnings conference call.
→The May 18, 2026 NSE filing said the audio recording of the earnings call was available on the company's investor website.
→Management speakers on the call included Badree Komandur, Managing Director and Group CEO, and Vikesh Kumar, Group CFO.

Balrampur Chini Mills Ltd.NSE: BALRAMCHIN

Vivek Saraogi; Pramod Patwari · Chairman and Managing Director; Chief Financial Officer

Q4 and FY2026 results, sugar and ethanol cycle, cane costs, sugar inventory, distillery pricing, PLA project progress, capex funding, preferential allotment, lactogypsum by-product monetization, Bioyug market development and daily market-signal tracking·FMCG·18 May 2026·NSE-filed Balrampur Chini Mills Q4/FY2026 earnings-call transcript, Q4/FY2026 results presentation, audited-results and board-outcome filing, Q4 press release, sugar-season operational-data filing, PLA project and capital-raising call transcript, credit-rating filing, preferential-issue approval and allotment filings, EGM minutes, June 2026 corporate presentation, Bioyug PLA market-development filings and BSE company page

▾

Key highlights

→Balrampur Chini Mills filed its Q4 and FY2026 results presentation with NSE and BSE on May 15, 2026.
→Balrampur Chini Mills filed its Q4 and FY2026 audited-results and board-outcome pack with NSE and BSE on May 15, 2026.
→Balrampur Chini Mills filed its Q4 and FY2026 press release with NSE and BSE on May 15, 2026.
→Balrampur Chini Mills held its Q4 and FY2026 earnings conference call on May 18, 2026 and filed the transcript with NSE on May 22, 2026.
→

Financial highlights

FY2025 ROE: 8.172%
FY2025 ROCE: 11.66%
FY2026 standalone PAT: Rs 0.06 crore
NSE announcement slice: 12 filings, zero actionable market signals, zero daily briefs
FY2025 consolidated EPS: Rs 3.52 basic and diluted
FY2025 consolidated PAT: Rs 710.04 crore
FY2026 consolidated EPS: Rs 4.77 basic and diluted
FY2026 consolidated PAT: Rs 962.33 crore
FY2026 consolidated PBT: Rs 1,432.11 crore
FY2026 consolidated ROE: 9.19%
FY2026 consolidated ROCE: 13.53%
Q4 FY2026 consolidated EPS: Rs 1.03 basic and diluted
Q4 FY2026 consolidated PAT: Rs 207.83 crore
Q4 FY2026 consolidated PBT: Rs 339.33 crore
Q4 FY2026 standalone net loss: Rs 0.28 crore
FY2026 consolidated PAT growth: approximately 35.5% YoY
FY2026 consolidated taxes paid: Rs 481.21 crore
FY2026 consolidated tax expense: Rs 469.79 crore
FY2026 consolidated revenue growth: approximately 34.6% YoY
Auditor qualification - Vuchi shares: 1,40,70,000 equity shares allotted to Vuchi Media pending cancellation subject to legal process
Auditor qualification - Vuchi impairment: no provision made for Rs 16,886.81 lakh impairment despite cancelled Vuchi Media proposed acquisition
FY2026 Digital Marketing segment revenue: Rs 6,502.70 crore
FY2026 standalone revenue from operations: Rs 432.43 crore
Consolidated total assets at March 31 2026: Rs 11,989.48 crore
Consolidated total equity at March 31 2026: Rs 10,571.00 crore
Consolidated current loans at March 31 2026: Rs 2,285.90 crore
FY2025 consolidated revenue from operations: Rs 5,146.67 crore
FY2026 Software Development segment revenue: Rs 425.36 crore
FY2026 consolidated net financing cash flow: positive Rs 735.56 crore
FY2026 consolidated net investing cash flow: negative Rs 576.10 crore
FY2026 consolidated net operating cash flow: Rs 102.65 crore
FY2026 consolidated revenue from operations: Rs 6,928.06 crore
Q4 FY2026 Digital Marketing segment revenue: Rs 1,492.13 crore
Auditor qualification - foreign subsidiaries: foreign subsidiaries collectively accounted for approximately 86% of group revenue; auditor relied on CPA confirmations and did not perform extended verification
Q4 FY2026 standalone revenue from operations: Rs 106.31 crore
Q4 FY2026 Software Development segment result: loss of about Rs 0.13 crore
FY2026 consolidated total comprehensive income: Rs 1,881.75 crore
Q4 FY2026 Software Development segment revenue: Rs 104.51 crore
Q4 FY2026 consolidated revenue from operations: Rs 1,596.64 crore
Consolidated trade receivables at March 31 2026: Rs 5,185.73 crore
FY2026 trade-receivable working-capital absorption: Rs 1,289.65 crore increase in trade receivables
Consolidated other intangible assets at March 31 2026: Rs 1,135.70 crore
Consolidated capital work-in-progress at March 31 2026: Rs 284.94 crore
Consolidated cash and cash equivalents at March 31 2026: Rs 1,414.98 crore in balance sheet; Rs 1,415.51 crore in cash-flow statement
FY2026 foreign-currency fluctuation financing cash-flow line: positive Rs 748.22 crore
FY2026 Digital Marketing segment result before tax and interest: Rs 1,432.05 crore
Consolidated intangible assets under development at March 31 2026: Rs 291.16 crore
FY2026 Software Development segment result before tax and interest: Rs 0.08 crore
Q4 FY2026 Digital Marketing segment result before tax and interest: Rs 339.46 crore
FY2026 consolidated operating profit before working-capital changes: Rs 1,782.51 crore

Financial highlights

channel_partners: 10000
manufacturing_plants: 23
fy2026_pat_margin_pct: 11.3
nse_esg_rating_fy2025: 64
direct_reach_outlets_mn: 1.4
fy2025_gross_margin_pct: 50.2
fy2026_gross_margin_pct: 47
fy2026_net_profit_rs_cr: 333.19
fy2026_volume_growth_pct: 6
q4_fy2026_pat_margin_pct: 9.4
fy2026_revenue_growth_pct: 3.5
fy2026_total_income_rs_cr: 3011.85
nse_ytd_announcement_rows: 65
fy2026_dividend_paid_rs_cr: 128.53
q4_fy2025_gross_margin_pct: 49.2
q4_fy2026_gross_margin_pct: 45.2
q4_fy2026_net_profit_rs_cr: 67.52
final_dividend_per_share_rs: 3.5
fy2026_capex_purchase_rs_cr: 66.88
fy2026_others_revenue_rs_cr: 122.22
q4_fy2026_volume_growth_pct: 10.8
solar_installed_capacity_kw: 1226
q4_fy2026_revenue_growth_pct: 7.7
q4_fy2026_total_income_rs_cr: 733.2
dividend_record_date_yyyymmdd: 20260629
fy2025_operating_ebitda_rs_cr: 499.8
fy2026_operating_ebitda_rs_cr: 449.9
fy2026_profit_before_tax_rs_cr: 451.19
q4_fy2026_others_revenue_rs_cr: 26.83
fy2026_dishwashing_revenue_rs_cr: 959.31
fy2026_fabric_care_revenue_rs_cr: 1345.88
q4_fy2025_operating_ebitda_rs_cr: 112.1
q4_fy2026_operating_ebitda_rs_cr: 96.8
pan_india_availability_outlets_mn: 4
q4_fy2026_profit_before_tax_rs_cr: 95.51
fy2025_operating_ebitda_margin_pct: 17.6
fy2026_operating_ebitda_margin_pct: 15.3
fy2026_personal_care_revenue_rs_cr: 320.84
fy2026_dishwashing_value_growth_pct: -1.3
fy2026_fabric_care_value_growth_pct: 8.1
q4_fy2026_dishwashing_revenue_rs_cr: 225.43
q4_fy2026_fabric_care_revenue_rs_cr: 326.71
fy2025_revenue_from_operations_rs_cr: 2843.92
fy2026_dishwashing_volume_growth_pct: 6
fy2026_fabric_care_volume_growth_pct: 9.5
fy2026_revenue_from_operations_rs_cr: 2944.29
fy2025_operating_working_capital_days: 19
fy2026_operating_working_capital_days: 15
fy2026_personal_care_value_growth_pct: 5.2
q4_fy2025_operating_ebitda_margin_pct: 16.8
q4_fy2026_operating_ebitda_margin_pct: 13.5
q4_fy2026_personal_care_revenue_rs_cr: 67.72
fy2026_advertising_and_promotion_rs_cr: 227.5
fy2026_cash_flow_from_operations_rs_cr: 412.13
fy2026_personal_care_volume_growth_pct: 1.6
q4_fy2026_fabric_care_value_growth_pct: 14.4
q3_fy2026_revenue_from_operations_rs_cr: 739.61
q4_fy2025_revenue_from_operations_rs_cr: 665.96
q4_fy2026_dishwashing_volume_growth_pct: 5
q4_fy2026_fabric_care_volume_growth_pct: 17.8
q4_fy2026_revenue_from_operations_rs_cr: 717.41
q4_fy2026_personal_care_value_growth_pct: 20.1
q4_fy2026_advertising_and_promotion_rs_cr: 50.3
q4_fy2026_personal_care_volume_growth_pct: 20.8
fy2026_cash_and_cash_equivalents_end_rs_cr: 52.59
fy2026_household_insecticides_revenue_rs_cr: 196.04
pril_revenue_share_of_company_revenue_pct_low: 7
fy2026_household_insecticides_value_growth_pct: -1.3
pril_revenue_share_of_company_revenue_pct_high: 8
q4_fy2026_household_insecticides_revenue_rs_cr: 70.72
fy2025_household_insecticides_loss_rs_cr_approx: -25
fy2026_advertising_and_promotion_to_revenue_pct: 7.7
fy2026_household_insecticides_loss_rs_cr_approx: -5
q4_fy2026_household_insecticides_value_growth_pct: 3
q4_fy2026_advertising_and_promotion_to_revenue_pct: 7
pril_revenue_management_agreed_broad_range_rs_cr_low: 225
pril_revenue_management_agreed_broad_range_rs_cr_high: 240
fy2026_modern_trade_ecommerce_quick_commerce_growth_pct: 26
household_insecticides_liquid_vaporizer_mix_pct_current: 55
household_insecticides_liquid_vaporizer_mix_pct_prior_year: 50
fy2026_cash_balance_including_fixed_deposits_mutual_funds_and_bank_rs_cr: 997

Financial highlights

Exports: Finished goods exported to more than 10 countries
AGM date: August 26, 2026
Record date: August 19, 2026 for AGM and dividend payment if approved
FY2026 sales: About Rs 3,100 cr, up 8% versus comparable 12-month prior period according to management
Final dividend: Rs 60 per share recommended, subject to shareholder approval
Power oral care: Almost 1.5x during the year and doubled over the last three years per management
Manual oral care: High-single-digit growth per management
Guard 3in1 launch: About 1 million razors sold in launch month and more than 6 lakh store reach
Five-year PAT CAGR: 17% according to analyst presentation
FY2026 total income: Rs 3,127.42 cr
Domestic manufacture: Around 85% of products manufactured domestically
FY2026 total dividend: Rs 240 per share including interim dividend of Rs 180 per share and proposed final dividend of Rs 60 per share
Male grooming offtake: 8% in P6M and 12% in P12M, per management
Q4 FY2026 total income: Rs 796.98 cr
FY2026 Grooming revenue: Rs 2,543.18 cr
FY2026 profit after tax: Rs 654.31 cr in the audited statement; about Rs 650 cr per management, up 23% versus comparable 12-month prior period
Venus / female grooming: Double-digit salience to Grooming business and upwards of 20% growth per management
FY2026 Oral Care revenue: Rs 556.35 cr
FY2026 profit before tax: Rs 880.34 cr
Five-year net-sales CAGR: 10% according to analyst presentation
Gillette Guard franchise: 20 million new users over the last three years
FY2026 operating cash flow: Rs 606.64 cr
Five-year operating record: Absolute sales 1.5x and absolute profit doubled, according to management
Q4 FY2026 Grooming revenue: Rs 653.26 cr
Q4 FY2026 profit after tax: Rs 192.51 cr versus Rs 158.68 cr in Q4 FY2025, up about 21% YoY
FY2026 productivity savings: Rs 38 cr
Net profit margin expansion: Roughly 600 bps over five years, according to management
Q4 FY2026 Oral Care revenue: Rs 138.74 cr
Q4 FY2026 profit before tax: Rs 260.05 cr
FY2026 basic and diluted EPS: Rs 200.80
Male grooming category growth: Approximately 12% per management
FY2026 Grooming segment result: Rs 752.98 cr before finance cost and tax
FY2026 revenue from operations: Rs 3,099.53 cr in the audited statement
FY2026 Oral Care segment result: Rs 108.58 cr before finance cost and tax
Q4 FY2026 basic and diluted EPS: Rs 59.08
Q4 FY2026 Grooming segment result: Rs 229.97 cr before finance cost and tax
Q4 FY2026 revenue from operations: Rs 792.00 cr versus Rs 767.47 cr in Q4 FY2025, up about 3% YoY
Q4 FY2026 Oral Care segment result: Rs 28.56 cr before finance cost and tax

Financial highlights

FY2026 EPS: Basic and diluted EPS of Rs 263.86
FY2026 PAT: Rs 856.50 cr versus Rs 636.59 cr in the nine-month FY2025 period
FY2026 PBT: Rs 1,166.63 cr versus Rs 862.16 cr in the nine-month FY2025 period
Q4 FY2026 EPS: Basic and diluted EPS of Rs 47.17
Q4 FY2026 PAT: Rs 153.13 cr versus Rs 156.10 cr in Q4 FY2025
Q4 FY2026 PBT: Rs 218.11 cr versus Rs 212.66 cr in Q4 FY2025
FY2026 other income: Rs 42.47 cr
FY2026 total income: Rs 4,332.89 cr
FY2026 total expenses: Rs 3,166.26 cr
Q4 FY2026 other income: Rs 12.47 cr
Q4 FY2026 total income: Rs 953.79 cr
FY2026 dividend proposal: Rs 60 final dividend; Rs 255 total dividend including Rs 195 interim and one-time special dividend, subject to shareholder approval
Q4 FY2026 total expenses: Rs 735.68 cr
FY2026 capex cash outflow: Rs 49.54 cr for property, plant, equipment and capital work-in-progress
FY2026 productivity savings: Rs 86 cr
West Asia input-cost marker: Management said crude and resin prices increased by 30%-50%
FY2026 PAT per press release: Rs 857 cr, up 19% versus comparable twelve-month FY2025 period
Inventories at March 31 2026: Rs 217.93 cr versus Rs 221.40 cr at March 31 2025
Long-term company performance: Analyst presentation showed 6% net-sales CAGR, 8% PAT CAGR and 3x ROE increase over the past 10 years
Structural margin improvement: Management said structural margins improved by 1 point in FY2026
Total assets at March 31 2026: Rs 1,803.54 cr versus Rs 1,754.73 cr at March 31 2025
Total equity at March 31 2026: Rs 753.47 cr versus Rs 736.99 cr at March 31 2025
FY2026 dividend paid cash flow: Rs 843.97 cr
FY2026 revenue from operations: Rs 4,290.42 cr versus Rs 3,374.42 cr in the nine-month FY2025 period
FY2026 sales per press release: Rs 4,290 cr, flat versus comparable twelve-month FY2025 period
Healthcare sub-category growth: Management said around 2%-3%
Q4 FY2026 PAT per press release: Rs 153 cr, down 2% YoY
FY2026 purchases of traded goods: Rs 823.96 cr
Feminine Hygiene category growth: Management said 7%-10%, and also described the category as growing in late single digits this year
Q4 FY2026 revenue from operations: Rs 941.32 cr versus Rs 1,261.90 cr in Q3 FY2026 and Rs 991.63 cr in Q4 FY2025
Q4 FY2026 sales per press release: Rs 941 cr, down 5% YoY
Trade receivables at March 31 2026: Rs 242.77 cr versus Rs 304.10 cr at March 31 2025
Q4 FY2026 purchases of traded goods: Rs 193.24 cr
Whisper Period Panties FY2026 volume: More than 10 cr units sold; business tripled in the year
FY2026 cost of raw and packing materials: Rs 738.11 cr
Cash and cash equivalents at March 31 2026: Rs 557.02 cr versus Rs 466.37 cr at March 31 2025
Q4 FY2026 cost of raw and packing materials: Rs 170.68 cr
FY2026 advertising and sales promotion expense: Rs 522.72 cr
Trade payables other than MSME at March 31 2026: Rs 827.91 cr versus Rs 801.88 cr at March 31 2025
Q4 FY2026 advertising and sales promotion expense: Rs 132.54 cr
Net cash generated from operating activities FY2026: Rs 924.08 cr

Financial highlights

AGM: 33rd AGM scheduled on August 14, 2026 through VC/OAVM
Call date: June 12, 2026 at 4:00 p.m. IST
Audit opinion: Tukaram & Co LLP issued unmodified audit reports on standalone and consolidated FY2026 financial results
Final dividend: Rs 10 per equity share of face value Re 1 for FY2026, subject to shareholder approval
Exceptional item: Rs 129.708 mn impairment loss on investment in Patikari Power Private Limited
FY2026 feed sales: 562,060 MT
Q4 FY2026 feed sales: 123,725 MT
FY2026 processing PBT: Rs 178 cr
FY2026 shrimp exports: 16,976 MT versus 14,149 MT in FY2025
Pet-care distribution: 31 distributors in 13 cities
New labour-code impact: Rs 109.043 mn incremental financial impact recorded in FY2026 consolidated employee-benefit expense
Pet-care volume marker: From 53 tons to about 100 tons, with goal of 800 MTs by year-end
Transcript publication: Published on Avanti Feeds corporate-announcements page on June 16, 2026
FY2026 consolidated EPS: Rs 44.48
FY2026 consolidated PBT: Rs 8,818.55 mn after exceptional item
Sealuxe B.V. investment: EUR 400,000 share-capital subscription approved on June 11, 2026
FY2026 feed division PBT: Rs 715 cr
Pet-care Q4 FY2026 sales: Rs 151 lakh versus Rs 136 lakh in Q3 FY2026
Q4 FY2026 processing PBT: Rs 48 cr
FY2026 shrimp feed EBITDA: Rs 7,373.0 mn; 16.8% margin
FY2026 consolidated EBITDA: Rs 9,476.4 mn; 15.6% margin
FY2026 shrimp feed revenue: Rs 43,778.2 mn
FY2027 feed-sales estimate: Around 580,000 MT
Q4 FY2026 consolidated EPS: Rs 9.19
Q4 FY2026 consolidated PBT: Rs 1,839.13 mn after exceptional item
Q4 FY2026 feed division PBT: Rs 139 cr
Potential U.S. tariff refund: Rough estimate of USD 15 mn to USD 20 mn, still being calculated and validated
Q4 FY2026 shrimp feed EBITDA: Rs 1,437.0 mn; 13.8% margin
Audited-results board meeting: May 28, 2026; commenced 12:30 p.m. IST and concluded 5:45 p.m. IST
FY2027 shrimp-export estimate: Around 19,000 MT
Q4 FY2026 consolidated EBITDA: Rs 2,002.5 mn; 13.6% margin
Q4 FY2026 shrimp feed revenue: Rs 10,402.2 mn
FY2026 processing gross income: Rs 1,741 cr
FY2026 shrimp processing EBITDA: Rs 2,103.6 mn; 12.5% margin
India FY2025-26 seafood exports: USD 8.546 bn, described by management as an all-time high
Current fish-meal purchase price: About Rs 230 per kg in the call commentary; management also described May-June price movement from around Rs 100 to Rs 240
FY2026 consolidated total income: Rs 62,788.9 mn
FY2026 shrimp processing revenue: Rs 16,894.6 mn
Estimated CY2026 feed consumption: About 11 lakh to 12 lakh MT
FY2026 feed division gross income: Rs 4,538 cr
Q4 FY2026 processing gross income: Rs 446 cr
Current wheat-flour purchase price: About Rs 30 per kg
Estimated CY2026 shrimp production: About 8 lakh to 9 lakh MT
Q4 FY2026 shrimp processing EBITDA: Rs 565.7 mn; 13.2% margin
Current soybean-meal purchase price: About Rs 72 per kg
Q4 FY2026 consolidated total income: Rs 15,162.0 mn
Q4 FY2026 shrimp processing revenue: Rs 4,275.0 mn
Processing installed capacity marker: About 26,000 MT to 28,000 MT, subject to seasonal raw-material availability
Q4 FY2026 feed division gross income: Rs 1,068 cr
India FY2025-26 frozen shrimp exports: 792,647 MT worth USD 5,624.48 mn
FY2026 consolidated revenue from operations: Rs 60,672.88 mn, up 8.3% YoY
Q4 FY2026 fish-meal average consumption price: Rs 130 per kg versus Rs 117 in Q3 FY2026 and Rs 91 in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 14,677.17 mn, up 6.2% YoY and 6.1% QoQ
FY2026 consolidated PAT after minority interest: Rs 6,568.02 mn; 10.8% net margin
Q4 FY2026 wheat-flour average consumption price: Rs 31 per kg versus Rs 32 in Q3 FY2026 and Rs 36 in Q4 FY2025
Q4 FY2026 soybean-meal average consumption price: Rs 55 per kg versus Rs 44 in Q3 FY2026 and Rs 41 in Q4 FY2025
Q4 FY2026 consolidated PAT after minority interest: Rs 1,388.56 mn; 9.5% net margin

Financial highlights

FY2025 PAT: Rs 788 crore
FY2026 EPS: Rs 25.59 versus Rs 18.90 in FY2025
FY2026 PAT: Rs 1,107 crore, up 41% year on year
Q4 FY2026 EPS: Rs 11.69 versus Rs 8.02 in Q4 FY2025
Q4 FY2026 PAT: Rs 455 crore, up 43% year on year
FY2026 revenue: Rs 8,333 crore, up 23% year on year
Final dividend: Rs 6.70 per share of face value Re 1
JNPT expansion: 318,100 cubic meters liquid storage, 77,236 MT LPG capacity and 35,000 MT annual bottling plant
Target gearing: About 0.6 times
Kandla capacity: About 952,000 cubic meters liquid storage and 48,000 MT LPG capacity
Current NSE ISIN: INE208C01025
Interim dividend: Rs 2.00 per share
Mumbai expansion: 64,000 KL liquid storage at about Rs 125 crore capex, targeted H1 FY2027
FY2026 LPG EBITDA: Rs 1,131 crore, up 68% year on year
Q4 FY2026 revenue: Rs 2,594 crore, up 52% year on year
Current borrowings: Rs 2,070 crore
FY2026 LPG revenue: Rs 7,689 crore, up 26% year on year
Five-year EPS CAGR: 32%
Current investments: Rs 826 crore
FY2026 total assets: Rs 14,490 crore versus Rs 11,233 crore in FY2025
Cash and investments: About Rs 5,939 crore to Rs 6,000 crore at FY2026 year end
FY2026 liquid EBITDA: Rs 472 crore, down 5% year on year
JNPT expansion capex: About Rs 1,675 crore
Pipavav LPG capacity: 48,000 MT cryogenic LPG terminal commissioned in June 2025; total LPG capacity 70,800 MT
FY2026 liquid revenue: Rs 644 crore, broadly stable year on year
FY2026 sourcing sales: 6.07 lakh MT, up 2% year on year
FY2026 total dividend: Rs 8.70 per share
Haldia LPG acquisition: 75% stake in Hindustan Aegis LPG Limited, adding about 25,000 MT LPG storage
Non-current borrowings: Rs 347 crore
Gas-distribution margin: About Rs 7,000 per ton versus roughly Rs 4,000 per ton in the previous year
Mumbai current capacity: 334,000 KL liquid storage and 21,000 MT static LPG capacity
Q4 FY2026 liquid EBITDA: Rs 126 crore
FY2026 normalized EBITDA: Rs 1,599 crore, up 36% year on year
Longer-term growth guide: Conservative 25% CAGR
Pipavav ammonia terminal: 36,000 MT static capacity backed by a 15-year take-or-pay agreement with Hindustan Zinc
Q4 FY2026 LPG throughput: 1.23 million tons
Q4 FY2026 liquid revenue: Rs 184 crore
Cash and cash equivalents: Rs 2,511 crore
Current NSE active symbol: AEGISLOG
Ammonia distribution start: About 200,000 tons, growing 20%-30% year on year
FY2026 distribution volume: 7.54 lakh MT, up 45% year on year
FY2026 operating cash flow: Rs 2,028 crore
FY2028 distribution target: 2 million tons across LPG and ammonia
Itochu corporate guarantee: Rs 80.32 crore, limited to four months, with no current impact on Aegis Logistics
Capex pipeline through 2030: About USD 5 billion
Q4 FY2026 normalized EBITDA: Rs 670 crore, up 54% year on year
Q4 FY2026 LPG and gas EBITDA: Rs 549 crore, up 136% year on year
Q4 FY2026 LPG and gas revenue: Rs 2,410 crore, up 65% year on year
Q4 FY2026 distribution volume: 2.34 lakh MT, up 71% year on year
Vadhavan potential investment: Approximately Rs 20,000 crore, subject to approvals and land allocation
FY2026 LPG terminal throughput: 5.15 million tons, up 14% year on year
Ammonia throughput margin guide: Rs 2,500-Rs 3,000 per ton
Ammonia utilization growth guide: 30%-40% year on year
Mangalore cryogenic LPG terminal: 82,000 MT commissioned in June 2025
Ammonia distribution margin guide: Up to Rs 5,000 per ton
Ammonia first-year utilization guide: About 25%
Itochu stake in Aegis Terminal Pipavav: 10%, with intent to rise to 25% over three years
Expected cumulative capex by March 2027: About USD 1.2 billion
Bank balances other than cash equivalents: Rs 1,683 crore
Pipavav petroleum-products rail-gantry contract: 15-year take-or-pay with committed volumes above 0.5 MMT per year
Legacy queue symbol absent from current NSE EQ list: AEGISCHEM

Financial highlights

DTV ARPU: Rs 122
FY2026 client NPS: 60
Active AI customers: 23
DTV churn at Q4 end: about 0.62%
OIL retail customers: more than 1 million
FY2026 standalone loss: Rs 160.58 crore
FY2026 BFSI vertical mix: 18%
HGS employees March 2026: 17,110
Q4 FY2026 revenue growth: 0.9% QoQ, -6.6% YoY
FY2026 India delivery mix: 42%
Project GANGA target DSPs: 8,000-10,000 entrepreneurs at Nyaya Panchayat level
FY2025 consolidated EBITDA: Rs 811.8 crore
FY2026 consolidated EBITDA: Rs 648.6 crore
FY2026 new client signings: 79 across BPM and Digital services
AI assistants in production: 21
AY2021-22 income-tax demand: Rs 15.49 crore including Rs 6.95 crore interest
CelerityX FY2026 TCV growth: 5x per management
GAAR disputed tax reduction: Rs 281.59 crore
Q4 FY2026 BFSI vertical mix: 17%
Countries present March 2026: 10
Q4 FY2026 India delivery mix: 42%
CM-YUVA loan for selected DSP: up to Rs 5 lakh per selected Digital Service Provider
FY2025 consolidated total PAT: Rs 100.7 crore
FY2026 consolidated basic EPS: about Rs 1.05
FY2026 consolidated total PAT: Rs 4.9 crore
Q4 FY2026 consolidated EBITDA: Rs 197.1 crore
CX services revenue mix FY2026: 55%
FY2026 standalone total income: Rs 2,084.90 crore
OIL broadband cities and towns: more than 350
FY2026 Philippines delivery mix: 13%
FY2026 consolidated tax expense: Rs 70.8 crore
Project GANGA target households: more than 20 lakh homes over 2-3 years
Retail broadband bandwidth cost: 26% of revenue versus 28% earlier
FY2026 consolidated total income: Rs 4,857.0 crore
Q4 FY2026 consolidated basic EPS: negative Rs 1.78
Q4 FY2026 consolidated total PAT: negative Rs 13.6 crore
CX services revenue mix Q4 FY2026: 58%
FY2025 consolidated EBITDA margin: 16.4%
FY2026 Public Sector vertical mix: 8%
FY2026 UK revenue origination mix: 13%
FY2026 consolidated EBITDA growth: -20.1% YoY
FY2026 consolidated EBITDA margin: 13.4%
Project GANGA expected employment: more than 100,000 direct and indirect opportunities
Broadband base plans up to 50 Mbps: 46% versus 54% a year earlier
Broadband customers above 100 Mbps: 15% versus 10.7% a year earlier
FY2026 USA revenue origination mix: 28%
FY2026 consolidated revenue growth: -2.2% YoY
Global delivery centers March 2026: 23
Q4 FY2026 Philippines delivery mix: 14%
Q4 FY2026 consolidated tax expense: Rs 22.9 crore
Broadband 51-100 Mbps package share: 38% versus 31% a year earlier
Q4 FY2026 consolidated total income: Rs 1,254.6 crore
CX/Digital active clients March 2026: 425
Consolidated total assets March 2026: Rs 11,563.65 crore
Consolidated total equity March 2026: Rs 8,436.10 crore
FY2026 India revenue origination mix: 38%
FY2026 final dividend recommendation: Rs 5 per equity share
HGS and NXTDIGITAL pin-code coverage: more than 4,500 pin codes
Q3 FY2026 consolidated EBITDA margin: 11.2%
Q4 FY2025 consolidated EBITDA margin: 21.5%
Q4 FY2026 Public Sector vertical mix: 12%
Q4 FY2026 UK revenue origination mix: 16%
Q4 FY2026 consolidated EBITDA growth: 47.4% QoQ, -29.4% YoY
Q4 FY2026 consolidated EBITDA margin: 15.7%
HGS and NXTDIGITAL franchise partners: more than 15,000
Q4 FY2026 USA revenue origination mix: 26%
Digital Media customer base March 2026: more than 4.8 million
FY2026 Tech Media Telecom vertical mix: 50%
FY2026 consolidated operating expenses: Rs 4,208.4 crore
FY2026 consolidated total other income: Rs 549.7 crore
Q4 FY2026 HRO/payroll client additions: 8
FY2026 standalone basic and diluted EPS: negative Rs 34.52
HGS and NXTDIGITAL fibre infrastructure: more than 2 lakh kilometres
Q4 FY2026 India revenue origination mix: 38%
Q4 FY2026 new digital CX and tech logos: 21
HRO/payroll clients or brands March 2026: 881
Net treasury and cash surplus March 2026: Rs 5,346 crore
Consolidated trade receivables March 2026: Rs 871.81 crore
FY2025 standalone revenue from operations: Rs 1,711.09 crore
FY2026 Consumer Goods Retail vertical mix: 17%
FY2026 standalone revenue from operations: Rs 1,827.12 crore
HGS and NXTDIGITAL city and town coverage: 1,500 cities and towns
Q4 FY2026 Tech Media Telecom vertical mix: 48%
Q4 FY2026 consolidated operating expenses: Rs 1,057.5 crore
Q4 FY2026 consolidated total other income: Rs 170.0 crore
AY2021-22 foreign-exchange loss disallowed: Rs 34.31 crore
CelerityX FY2026 enterprise revenue growth: 2x per management
Consolidated current borrowings March 2026: Rs 1,066.30 crore
Gross treasury and cash surplus March 2026: Rs 6,640 crore
Consolidated current investments March 2026: Rs 4,040.42 crore
FY2025 consolidated revenue from operations: Rs 4,404.2 crore
FY2026 consolidated revenue from operations: Rs 4,307.4 crore
Consolidated total current assets March 2026: Rs 8,009.78 crore
FY2026 consolidated exceptional item expense: Rs 9.3 crore
HGS and NXTDIGITAL homes connected footprint: more than 5 million homes
Q4 FY2026 Consumer Goods Retail vertical mix: 17%
Q4 FY2026 standalone revenue from operations: Rs 450.11 crore
Digital and Media services revenue mix FY2026: 45%
FY2026 consolidated continuing-operations PAT: negative Rs 143.1 crore
Consolidated non-current borrowings March 2026: Rs 227.72 crore
Q3 FY2026 consolidated revenue from operations: Rs 1,075.4 crore
Q4 FY2025 consolidated revenue from operations: Rs 1,161.1 crore
Q4 FY2026 consolidated revenue from operations: Rs 1,084.7 crore
FY2026 consolidated PBT after exceptional items: negative Rs 72.3 crore
FY2026 consolidated discontinued-operations PAT: Rs 148.0 crore
Media and Communications FY2025 segment revenue: Rs 1,254.05 crore
Media and Communications FY2026 segment revenue: Rs 1,242.57 crore
Q4 FY2026 consolidated exceptional item expense: Rs 4.8 crore
Digital and Media services revenue mix Q4 FY2026: 42%
FY2026 consolidated PBT before exceptional items: negative Rs 63.0 crore
FY2026 standalone labour-code exceptional charge: Rs 8.70 crore
Q4 FY2026 consolidated continuing-operations PAT: negative Rs 13.6 crore
Consolidated cash and cash equivalents March 2026: Rs 568.94 crore
Business Process Management FY2025 segment revenue: Rs 3,150.13 crore
Business Process Management FY2026 segment revenue: Rs 3,064.79 crore
Media and Communications Q4 FY2026 segment revenue: Rs 304.05 crore
Q4 FY2026 consolidated PBT after exceptional items: Rs 9.3 crore
Q4 FY2026 consolidated discontinued-operations PAT: Rs 0.0 crore
Q4 FY2026 consolidated PBT before exceptional items: Rs 14.1 crore
Business Process Management Q4 FY2026 segment revenue: Rs 780.62 crore
Consolidated net cash generated from operations FY2026: about Rs 450.01 crore
Consolidated total borrowings per investor presentation: Rs 1,294 crore
FY2026 standalone loss before tax after exceptional items: Rs 133.14 crore
Q4 FY2026 standalone loss before tax after exceptional items: Rs 12.69 crore
Media and Communications FY2025 segment result before interest: negative Rs 38.86 crore
Media and Communications FY2026 segment result before interest: negative Rs 175.46 crore
Business Process Management FY2025 segment result before interest: Rs 327.64 crore
Business Process Management FY2026 segment result before interest: Rs 309.96 crore
Media and Communications Q4 FY2026 segment result before interest: negative about Rs 50.1 crore
Business Process Management Q4 FY2026 segment result before interest: Rs 107.52 crore

Financial highlights

standalone_fy2025_pat_rs_cr: 23.76
standalone_fy2026_pat_rs_cr: 32.09
sdd_events_captured_q4fy2026: 1
sdd_events_required_q4fy2026: 1
consolidated_fy2025_pat_rs_cr: 94.87
consolidated_fy2026_pat_rs_cr: 112.50
standalone_fy2026_basic_eps_rs: 1.09
consolidated_fy2026_basic_eps_rs: 3.81
standalone_q4fy2026_basic_eps_rs: -0.58
consolidated_q4fy2026_basic_eps_rs: -1.81
nse_announcements_apr01_jun27_2026: 11
standalone_assets_march_2026_rs_cr: 7567.00
standalone_equity_march_2026_rs_cr: 5090.79
standalone_fy2026_tax_expense_rs_cr: 6.66
consolidated_assets_march_2025_rs_cr: 29372.34
consolidated_assets_march_2026_rs_cr: 40892.55
standalone_fy2025_total_income_rs_cr: 7085.14
standalone_fy2026_finance_cost_rs_cr: 150.73
standalone_fy2026_total_income_rs_cr: 9291.48
consolidated_fy2026_tax_expense_rs_cr: 51.86
consolidated_fy2025_total_income_rs_cr: 423217.16
consolidated_fy2026_finance_cost_rs_cr: 163.29
consolidated_fy2026_total_income_rs_cr: 778989.14
sebi_order_fy2026_standalone_pat_rs_cr: 32
standalone_fy2026_other_expenses_rs_cr: 3.16
standalone_q4fy2026_total_income_rs_cr: 2515.77
nse_actionable_signals_apr01_jun27_2026: 1
standalone_inventories_march_2026_rs_cr: 583.61
consolidated_fy2026_other_expenses_rs_cr: 357.66
consolidated_q4fy2026_total_income_rs_cr: 237104.84
sebi_order_fy2026_consolidated_pat_rs_cr: 113
consolidated_inventories_march_2026_rs_cr: 17746.48
standalone_fy2025_profit_before_tax_rs_cr: 29.01
standalone_fy2026_profit_before_tax_rs_cr: 38.75
standalone_q4fy2026_loss_before_tax_rs_cr: 21.23
standalone_trade_payables_march_2026_rs_cr: 1458.49
consolidated_fy2025_profit_before_tax_rs_cr: 106.87
consolidated_fy2026_profit_before_tax_rs_cr: 164.36
consolidated_q4fy2026_loss_before_tax_rs_cr: 39.90
consolidated_trade_payables_march_2026_rs_cr: 22177.23
standalone_q4fy2026_net_loss_after_tax_rs_cr: 17.09
standalone_trade_receivables_march_2026_rs_cr: 2651.08
consolidated_q4fy2026_net_loss_after_tax_rs_cr: 53.50
standalone_current_borrowings_march_2026_rs_cr: 1000.11
consolidated_trade_receivables_march_2026_rs_cr: 6442.25
standalone_net_financing_cash_flow_fy2026_rs_cr: 23.86
standalone_net_investing_cash_flow_fy2026_rs_cr: -63.47
standalone_net_operating_cash_flow_fy2026_rs_cr: 163.12
consolidated_current_borrowings_march_2026_rs_cr: 1015.90
promoter_encumbered_or_pledged_shares_march_2026: nil
standalone_fy2026_employee_benefit_expense_rs_cr: 2.48
consolidated_net_financing_cash_flow_fy2026_rs_cr: 195.79
consolidated_net_investing_cash_flow_fy2026_rs_cr: -1088.05
consolidated_net_operating_cash_flow_fy2026_rs_cr: 371.78
consolidated_fy2026_employee_benefit_expense_rs_cr: 227.16
standalone_fy2026_cost_of_materials_consumed_rs_cr: 9158.88
consolidated_fy2026_cost_of_materials_consumed_rs_cr: 778089.57
standalone_cash_and_cash_equivalents_march_2026_rs_cr: 856.68
standalone_fy2026_depreciation_and_amortisation_rs_cr: 0.66
consolidated_cash_and_cash_equivalents_march_2026_rs_cr: 2614.80
consolidated_equity_including_minority_march_2026_rs_cr: 17416.70
consolidated_fy2026_depreciation_and_amortisation_rs_cr: 52.40
standalone_fy2025_net_sales_income_from_operations_rs_cr: 7027.07
standalone_fy2026_net_sales_income_from_operations_rs_cr: 9188.81
consolidated_fy2025_net_sales_income_from_operations_rs_cr: 423099.32
consolidated_fy2026_net_sales_income_from_operations_rs_cr: 778716.04
sebi_order_fy2026_standalone_revenue_from_operations_rs_cr: 9189
standalone_q4fy2025_net_sales_income_from_operations_rs_cr: 1914.86
standalone_q4fy2026_net_sales_income_from_operations_rs_cr: 2441.10
consolidated_bank_balances_other_than_cash_march_2026_rs_cr: 884.21
consolidated_q4fy2025_net_sales_income_from_operations_rs_cr: 109189.68
consolidated_q4fy2026_net_sales_income_from_operations_rs_cr: 236864.21
sebi_order_fy2026_consolidated_revenue_from_operations_rs_cr: 778716
sebi_order_fy2026_pat_from_subsidiaries_and_stepdown_subsidiaries_rs_cr: 81
sebi_order_fy2026_revenue_from_subsidiaries_and_stepdown_subsidiaries_rs_cr: 769527

Financial highlights

Dividend: No dividend recommended because of accumulated losses and FY2026 losses
Borrowings: Annual report says total borrowings were Rs 18,725 crore excluding liability component of RPS; audited results show Rs 2,919.77 crore non-current borrowings and Rs 17,743.27 crore current borrowings
FY2026 EPS: Negative Rs 1.10 versus negative Rs 6.52 in FY2025
Current ratio: 0.42 in FY2026 versus 0.61 in FY2025
FY2026 EBITDA: Rs 624.94 crore versus Rs 578.88 crore in FY2025
Q4 FY2026 EPS: Rs 2.97 versus negative Rs 0.77 in Q3 FY2026 and negative Rs 1.57 in Q4 FY2025
TRAI QoS order: Rs 2,00,000 financial disincentive for alleged QoS parameter non-compliance in broadband wireline service for quarter ending June 2025
Q4 FY2026 EBITDA: Rs 162.74 crore versus Rs 175.62 crore in Q3 FY2026 and Rs 151.82 crore in Q4 FY2025
Net profit margin: Negative 18.56% in FY2026 versus negative 97.50% in FY2025
FY2026 expenditure: Rs 542.82 crore versus Rs 737.26 crore in FY2025
Current liabilities: Rs 18,184.14 crore at March 31, 2026 versus Rs 9,956.90 crore at March 31, 2025
FY2026 total income: Rs 1,167.76 crore versus Rs 1,316.14 crore in FY2025
Shareholders' funds: Negative Rs 19,983 crore at March 31, 2026 versus negative Rs 19,570 crore at March 31, 2025
AGR installment paid: Rs 615.42 crore for AGR dues tabulated in Supreme Court orders plus Rs 37.56 crore for AGR-related dues up to FY2019 not tabulated in the Supreme Court orders
FY2026 loss after tax: Rs 215.30 crore loss versus Rs 1,275.32 crore loss in FY2025
Q4 FY2026 total income: Rs 297.28 crore versus Rs 296.13 crore in Q3 FY2026 and Rs 310.21 crore in Q4 FY2025
Operating profit margin: 40.99% in FY2026 versus 30.80% in FY2025
AGR provision write-back: Rs 666.70 crore provision write-back after DoT shared final AGR outstanding up to FY2019 and installment schedule
FY2026 exceptional items: Net credit of Rs 654.95 crore, including AGR provision write-back partly offset by TRAI/DoT and labour-code items
Cash and cash equivalents: Rs 15.40 crore at March 31, 2026 versus Rs 42.37 crore at March 31, 2025
FY2026 operating cash flow: Net cash generated from operating activities of Rs 667.56 crore versus Rs 505.13 crore in FY2025
Q4 FY2026 profit after tax: Rs 580.93 crore versus Rs 150.43 crore loss in Q3 FY2026 and Rs 306.42 crore loss in Q4 FY2025
Debt service coverage ratio: 0.11 in FY2026 versus 0.06 in FY2025
Q4 FY2026 exceptional items: Net credit of Rs 662.80 crore
FY2026 revenue from operations: Rs 1,160.23 crore versus Rs 1,308.04 crore in FY2025
FY2026 total comprehensive loss: Rs 212.62 crore versus Rs 1,276.78 crore in FY2025
Interest service coverage ratio: 0.90 in FY2026 versus 0.84 in FY2025
Q4 FY2026 revenue from operations: Rs 295.54 crore versus Rs 294.31 crore in Q3 FY2026 and Rs 308.27 crore in Q4 FY2025
FY2026 finance and treasury charges: Rs 1,353.36 crore in annual-report financial highlights; audited-results filing finance costs were Rs 1,360.98 crore
FY2026 depreciation and amortisation: Rs 141.83 crore versus Rs 167.93 crore in FY2025
FY2026 loss before exceptional items and tax: Rs 870.25 crore loss versus Rs 1,275.32 crore loss in FY2025
Q4 FY2026 loss before exceptional items and tax: Rs 81.87 crore loss versus Rs 146.38 crore loss in Q3 FY2026 and Rs 306.42 crore loss in Q4 FY2025

Financial highlights

FY2026 PAT: Rs 199 cr versus a loss of Rs 57 cr in FY2025
QIP proceeds: Rs 1,000 cr gross proceeds, Rs 977.79 cr revised net proceeds, Rs 815.46 cr cumulative utilization and Rs 162.33 cr unutilized as of March 31, 2026
FY2026 EBITDA: Rs 630 cr versus Rs 418 cr in FY2025, up 51%, with 18.7% EBITDA margin
Q4 FY2026 PAT: Rs 164 cr versus a loss of Rs 45 cr in Q4 FY2025
Q4 FY2026 EBITDA: Rs 196 cr versus Rs 79 cr in Q4 FY2025, up 147%, with 20.3% EBITDA margin
FY2026 UK revenue: Rs 1,318 cr, up 13% YoY
FY2026 diluted EPS: Rs 13.10
Q4 FY2026 UK revenue: Rs 349 cr, up 20% YoY
FY2026 Ireland revenue: Rs 209 cr, up 16% YoY
FY2026 biotech revenue: Rs 697 cr, up 27% YoY
FY2026 exceptional items: Rs 85 cr net charge, including US generic-business exit/liquidation, Chapter 7 trustee settlement, Dr. Reddy's settlement gain and New Labour Code impact
Q4 FY2026 Ireland revenue: Rs 52 cr, up 12% YoY
Q4 FY2026 biotech revenue: Rs 252 cr, up 126% YoY
FY2026 Emerging Markets revenue: Rs 958 cr, up 35% YoY
FY2026 consolidated total income: Rs 3,484 cr versus Rs 3,074 cr in FY2025
FY2026 PBT after exceptional items: Rs 238 cr versus a loss of Rs 16 cr in FY2025
Q4 FY2026 Emerging Markets revenue: Rs 320 cr, up 124% YoY
Q4 FY2026 consolidated total income: Rs 1,010 cr versus Rs 758 cr in Q4 FY2025
FY2026 India Branded Business revenue: Rs 523 cr, up 15% YoY
Q4 FY2026 PBT after exceptional items: Rs 189 cr versus a loss of Rs 22 cr in Q4 FY2025
Investor presentation liquidity metric: Rs 662 cr cash and cash equivalents and 0.10 net debt-to-equity excluding promoter debt as of March 31, 2026
FY2026 consolidated operating cash flow: Rs 390 cr inflow versus Rs 22 cr outflow in FY2025
Q4 FY2026 India Branded Business revenue: Rs 112 cr, up 18% YoY
FY2026 consolidated revenue from operations: Rs 3,373 cr versus Rs 3,012 cr in FY2025 in audited-results filing; Q4 press release comparison uses Rs 3,033 cr FY2025 total revenue
FY2026 consolidated cash and cash equivalents: Rs 217 cr at March 31, 2026; bank balances other than cash were Rs 33 cr
Q4 FY2026 consolidated revenue from operations: Rs 965 cr versus Rs 743 cr in Q4 FY2025 and Rs 888 cr in Q3 FY2026; audited-results filing and Q4 press release

Financial highlights

Dividend: Final dividend recommended at Rs 9.00 per equity share, 180% on face value of Rs 5, subject to shareholder approval, with July 31, 2026 as record date
Channel mix: COCO about 65%; franchise close to double digit; e-commerce about 8% to 10%; distribution about 10% to 12%
Store network: Crossed 2,000 exclusive brand outlet network; around 1,300 COCO stores and around 700 franchise stores
E-commerce mix: E-commerce about 12% to 13% of business; B2C about 5% to 6%; bata.com about 14% of B2C and up 81% year-on-year in Q4
Lease liabilities: Rs 10,325.04 million non-current and Rs 3,540.66 million current consolidated lease liabilities at March 31, 2026
Leadership transition: Sanjay S. Rao appointed CEO effective August 24, 2026 and MD and CEO effective October 1, 2026, subject to applicable approvals
Brand/category markers: Hush Puppies contributed roughly 18% to 20% of turnover; below-Rs-1,000 products represented roughly 35% to 40% contribution
Raw-material inflation: Management cited latest blended material inflation of about 5% to 6%
FY2026 consolidated EPS: Basic and diluted EPS of Rs 10.44 versus Rs 25.73 in FY2025
Zero-based merchandising: 550 stores at Q4 end; around 700 stores completed by end-May 2026; target to reach roughly 75% to 80% of network by end of the then-current quarter
Cash and cash equivalents: Rs 92.85 million consolidated at March 31, 2026 versus Rs 2,029.30 million at March 31, 2025
FY2026 inventory movement: Consolidated inventories decreased by Rs 1,070.85 million during FY2026; management said inventory was down 28% over two years and 13% year-on-year
FY2026 operating cash flow: Consolidated cash generated from operations of Rs 6,760.31 million and net cash inflow from operating activities of Rs 5,948.76 million
Q4 FY2026 consolidated EPS: Basic and diluted EPS of Rs 0.17
FY2026 consolidated total income: Rs 35,946.82 million versus Rs 36,748.04 million in FY2025
FY2026 trade receivables movement: Consolidated trade receivables increased by Rs 689.09 million; management said this reflected growth in wholesale, franchise and e-commerce B2B with no material deterioration in credit quality
Q4 FY2026 consolidated total income: Rs 8,473.80 million versus Rs 9,659.94 million in Q3 FY2026 and Rs 8,054.88 million in Q4 FY2025
FY2026 consolidated profit for the period: Rs 1,342.04 million versus Rs 3,306.56 million in FY2025
FY2026 consolidated revenue from operations: Rs 35,154.95 million versus Rs 34,887.86 million in FY2025
Q4 FY2026 consolidated profit for the period: Rs 22.08 million versus Rs 661.02 million in Q3 FY2026 and Rs 459.15 million in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 8,276.26 million versus Rs 9,446.81 million in Q3 FY2026 and Rs 7,882.14 million in Q4 FY2025
FY2026 consolidated PBT after exceptional items: Rs 1,820.39 million after Rs 423.66 million of VRS expense and Rs 66.66 million Labour Code impact
FY2026 consolidated PBT before exceptional items: Rs 2,310.71 million versus Rs 4,263.77 million in FY2025
Q4 FY2026 consolidated PBT after exceptional items: Rs 38.05 million after Rs 280.60 million of VRS exceptional expense
Q4 FY2026 consolidated PBT before exceptional items: Rs 318.65 million versus Rs 967.97 million in Q3 FY2026 and Rs 621.79 million in Q4 FY2025

Financial highlights

Order book: Rs 18,636.99 cr
Credit rating: Infomerics IVR BBB-/Stable for long-term facilities and IVR A3 for short-term facilities
K.R. Puram EMD: Rs 16 cr received from CGST as 2% EMD against indicative value of Rs 800 cr for 21 acres
Liquidated damages: Rs 38.84 cr
Provision for stock: Rs 26.57 cr
Public shareholding: 9.98%, including Special Investment Fund holding of 7.90%
Bank facilities rated: Rs 4,221.39 cr total, including Rs 1,450.00 cr long-term and Rs 2,771.39 cr short-term facilities
Promoter shareholding: 90.02%, including Government of Karnataka holding of 0.03%
Land sale consideration: Rs 914.31 cr for 21 acres of land and building
Profit on sale of assets: Rs 832.19 cr under exceptional items
Consolidated other equity: Rs 942.78 cr at March 31, 2026 versus Rs 663.69 cr at March 31, 2025
Consolidated total assets: Rs 9,346.53 cr at March 31, 2026 versus Rs 10,422.30 cr at March 31, 2025
ASCON Phase IV project value: Rs 8,280.36 cr
Consolidated current borrowings: Rs 764.94 cr at March 31, 2026 versus Rs 1,420.72 cr at March 31, 2025
Corrected standalone FY2026 PAT: Rs 292.79 cr versus Rs 233.15 cr loss in FY2025
Palakkad land under adjudication: 77 acres with carrying value of Rs 60.90 cr
Revival-plan assistance received: Rs 3,084.35 cr
Corrected consolidated FY2026 EPS: Rs 3.04 versus negative Rs 2.24 in FY2025
Corrected consolidated FY2026 PAT: Rs 292.83 cr versus Rs 214.89 cr loss in FY2025
Corrected standalone Q4 FY2026 PAT: Rs 435.91 cr versus Rs 4.84 cr loss in Q4 FY2025
Corrected consolidated Q4 FY2026 EPS: Rs 4.53 versus negative Rs 0.05 in Q4 FY2025
Corrected consolidated Q4 FY2026 PAT: Rs 436.10 cr versus Rs 4.38 cr loss in Q4 FY2025
Expected unbilled-revenue conversion: Rs 2,241.11 cr expected to convert into billed revenue/realization within the next 12 months
Long-outstanding debtors written off: Rs 301.68 cr
Provision for bad and doubtful debts: Rs 14.41 cr
Consolidated cash and cash equivalents: Rs 24.40 cr at March 31, 2026 versus Rs 148.77 cr at March 31, 2025
Consolidated current trade receivables: Rs 2,905.68 cr at March 31, 2026 versus Rs 3,995.37 cr at March 31, 2025
Corrected consolidated FY2026 total income: Rs 2,237.12 cr versus Rs 3,701.62 cr in FY2025
Revival-plan financial assistance approved: Rs 4,156.79 cr
Corrected consolidated FY2026 total expenses: Rs 2,393.48 cr versus Rs 3,969.81 cr in FY2025
Corrected consolidated Q4 FY2026 total income: Rs 640.89 cr versus Rs 1,081.03 cr in Q4 FY2025
Land sale proceeds received by March 31, 2026: Rs 884.20 cr
Corrected consolidated FY2026 exceptional items: Positive Rs 449.15 cr versus positive Rs 35.04 cr in FY2025
Corrected consolidated Q4 FY2026 total expenses: Rs 664.02 cr versus Rs 1,148.29 cr in Q4 FY2025
Corrected consolidated Q4 FY2026 exceptional items: Positive Rs 459.04 cr
Corrected consolidated FY2026 revenue from operations: Rs 2,183.72 cr versus Rs 3,616.42 cr in FY2025
Corrected consolidated FY2026 total comprehensive income: Rs 284.34 cr versus Rs 218.81 cr loss in FY2025
Corrected consolidated Q4 FY2026 revenue from operations: Rs 627.65 cr versus Rs 1,045.70 cr in Q4 FY2025
Corrected consolidated Q4 FY2026 total comprehensive income: Rs 427.61 cr versus Rs 4.38 cr loss in Q4 FY2025
Consolidated bank balances other than cash and cash equivalents: Rs 326.36 cr at March 31, 2026
Corrected consolidated FY2026 loss before exceptional items and tax: Rs 156.36 cr loss versus Rs 268.19 cr loss in FY2025
Corrected consolidated Q4 FY2026 loss before exceptional items and tax: Rs 23.13 cr loss versus Rs 67.26 cr loss in Q4 FY2025

Financial highlights

agm_date: 2026-07-29
net_debt_rs_mn: 86218
fy2026_capex_rs_mn: 20425
fy2026_ebitda_rs_mn: 19836
dividend_record_date: 2026-06-26
fy2026_revenue_rs_mn: 155130
q4fy2026_capex_rs_mn: 7070
dividend_per_share_rs: 3
q4fy2026_ebitda_rs_mn: 6265
fy2026_sales_volume_mt: 649789
q4fy2026_revenue_rs_mn: 40973
fy2026_ebitda_margin_pct: 12.8
q4fy2026_sales_volume_mt: 166879
blended_cost_of_funds_pct: 9
dharwad_bopp_capacity_mtpa: 54000
q4fy2026_ebitda_margin_pct: 15.3
fy2026_normalized_pat_rs_mn: 3362
mexico_wpp_capacity_mn_bags: 80
promoter_encumbrance_fy2026: none disclosed
fy2026_ebitda_growth_yoy_pct: 8.1
fy2026_ebitda_margin_yoy_bps: 70
overall_global_capacity_mtpa: 1351910
fy2026_revenue_growth_yoy_pct: 2.1
q4fy2026_normalized_pat_rs_mn: 2026
fy2026_normalized_ebitda_rs_mn: 19097
q4fy2026_ebitda_growth_qoq_pct: 36.3
q4fy2026_ebitda_growth_yoy_pct: 31.8
q4fy2026_ebitda_margin_qoq_bps: 260
q4fy2026_ebitda_margin_yoy_bps: 300
fy2026_domestic_revenue_mix_pct: 44
fy2026_packaging_volume_mix_pct: 23.4
q4fy2026_revenue_growth_qoq_pct: 12.8
q4fy2026_revenue_growth_yoy_pct: 5.7
dharwad_bopp_project_capex_rs_mn: 7154
egypt_aseptic_project_cost_rs_mn: 11926
fy2026_packaging_sales_volume_mt: 151755
fy2026_reported_net_profit_rs_mn: 3171
income_tax_demand_orders_rs_lakh: 41280.99
mexico_wpp_capex_incurred_usd_mn: 52
q4fy2026_normalized_ebitda_rs_mn: 6109
egypt_aseptic_project_cost_usd_mn: 126
noida_recycling_mlp_capacity_mtpa: 3600
q4fy2026_domestic_revenue_mix_pct: 43
q4fy2026_packaging_volume_mix_pct: 23.3
dharwad_bopp_remaining_capex_rs_mn: 6369
egypt_aseptic_capex_incurred_rs_mn: 9059
fy2026_sales_volume_growth_yoy_pct: 0.4
mf_aif_shareholding_march_2026_pct: 0.28
noida_recycling_rpet_capacity_mtpa: 36000
noida_total_recycling_capacity_mta: 39600
nse_announcements_apr01_jun27_2026: 20
others_shareholding_march_2026_pct: 24.03
q4fy2026_packaging_sales_volume_mt: 38842
q4fy2026_reported_net_profit_rs_mn: 1960
egypt_aseptic_capex_incurred_usd_mn: 95.7
egypt_aseptic_remaining_capex_rs_mn: 2868
fy2026_aseptic_pack_sales_volume_bn: 7.97
fy2026_normalized_ebitda_margin_pct: 12.3
management_cited_depreciation_rs_cr: 787
q4fy2026_egypt_vpet_utilization_pct: 72.3
q4fy2026_panipat_vpet_production_mt: 23994
egypt_aseptic_remaining_capex_usd_mn: 30.3
fy2026_international_revenue_mix_pct: 56
fy2026_normalized_pat_growth_yoy_pct: 5.0
fy2026_packaging_films_production_mt: 492779
management_cited_interest_cost_rs_cr: 777
noida_recycling_project_outlay_rs_mn: 3171
nse_actionable_signals_after_cleanup: 0
promoter_shareholding_march_2026_pct: 44.58
q4fy2026_sales_volume_growth_qoq_pct: 10.3
q4fy2026_sales_volume_growth_yoy_pct: 1.0
fy2026_packaging_films_volume_mix_pct: 76.6
noida_recycling_remaining_capex_rs_mn: 471
q4fy2026_aseptic_pack_sales_volume_bn: 2.08
q4fy2026_normalized_ebitda_margin_pct: 14.9
fii_fpi_fc_shareholding_march_2026_pct: 16.78
fy2026_packaging_films_sales_volume_mt: 498034
fy2026_packaging_films_utilization_pct: 77.5
q4fy2026_international_revenue_mix_pct: 57
q4fy2026_normalized_pat_growth_qoq_pct: 316.9
q4fy2026_normalized_pat_growth_yoy_pct: 105.5
q4fy2026_packaging_films_production_mt: 126076
q4fy2026_packaging_films_volume_mix_pct: 76.7
packaging_films_capacity_march_2026_mtpa: 636160
q4fy2026_egypt_vpet_third_party_sales_mt: 5949
q4fy2026_packaging_films_sales_volume_mt: 128037
q4fy2026_packaging_films_utilization_pct: 79.3
q4fy2026_panipat_adjusted_utilization_pct: 86
aseptic_liquid_pack_capacity_billion_packs: 12
cbo_insurance_fi_shareholding_march_2026_pct: 14.33
fy2026_packaging_sales_volume_growth_yoy_pct: 5.1
q4fy2026_mea_packaging_films_sales_volume_mt: 33899
egypt_aseptic_capacity_billion_packs_per_year: 12
q4fy2026_india_packaging_films_sales_volume_mt: 26888
q4fy2026_packaging_sales_volume_growth_qoq_pct: 7.1
q4fy2026_packaging_sales_volume_growth_yoy_pct: 1.6
dharwad_bopp_capex_incurred_by_march_2026_rs_mn: 785
q4fy2026_europe_packaging_films_sales_volume_mt: 35367
new_labour_codes_exceptional_item_fy2026_rs_lakh: 1905
q4fy2026_americas_packaging_films_sales_volume_mt: 31883
fy2026_packaging_films_sales_volume_growth_yoy_pct: -1.0
new_labour_codes_exceptional_item_q3fy2026_rs_lakh: 1245
new_labour_codes_exceptional_item_q4fy2026_rs_lakh: 660
noida_recycling_capex_incurred_by_march_2026_rs_mn: 2700
q4fy2026_egypt_vpet_third_party_sales_growth_qoq_pct: 121.2
q4fy2026_packaging_films_sales_volume_growth_qoq_pct: 11.4
q4fy2026_packaging_films_sales_volume_growth_yoy_pct: 0.9
fy2027_aseptic_pack_sales_volume_management_marker_bn: 10.5
q4fy2026_mea_packaging_films_sales_volume_growth_qoq_pct: 4.6
q4fy2026_mea_packaging_films_sales_volume_growth_yoy_pct: 1.5
q4fy2026_india_packaging_films_sales_volume_growth_qoq_pct: 6.3
q4fy2026_india_packaging_films_sales_volume_growth_yoy_pct: -6.3
q4fy2026_europe_packaging_films_sales_volume_growth_qoq_pct: 12.9
q4fy2026_americas_packaging_films_sales_volume_growth_qoq_pct: 23.0
q4fy2026_americas_packaging_films_sales_volume_growth_yoy_pct: 18.0

Financial highlights

fy2026_capex: Rs 145 crore
bhilad_capacity: 45 million meters
kolhapur_capacity: 108 million meters
fy2025_sales_volume: 106.4 million meters
fy2026_sales_volume: 94.1 million meters
final_dividend_fy2026: Rs 1.50 per equity share
fy2027_capex_guidance: Rs 250 crore over 12 to 18 months
management_fy2025_pat: Rs 250 crore
management_fy2026_pat: Rs 127 crore
fy2027_volume_guidance: 105 million to 110 million meters
q4_fy2026_sales_volume: 20.5 million meters
management_fy2025_ebitda: Rs 577 crore
management_fy2026_ebitda: Rs 461 crore
management_q4_fy2026_pat: Rs 24 crore
ambika_sharma_second_term: May 27, 2026 to May 26, 2031
fy2026_new_business_revenue: Rs 792 crore
india_home_textile_capacity: 153 million meters
management_q4_fy2026_ebitda: Rs 116 crore
new_business_target_by_2028: about USD 275 million / Rs 2,500 crore
fy2026_core_business_revenue: Rs 3,419 crore
fy2027_total_income_guidance: about Rs 5,500 crore
q4_fy2026_pat_qoq_comparison: Rs 24 crore versus Rs 24 crore in Q3 FY2026
q4_fy2026_pat_yoy_comparison: Rs 24 crore versus Rs 21 crore in Q4 FY2025
fy2027_ebitda_margin_guidance: about 13%
s_and_p_global_esg_score_2025: 78 out of 100
fy2025_total_income_comparison: Rs 4,191 crore in FY2025
fy2027_revenue_growth_guidance: more than 30%
management_net_debt_march_2025: Rs 960 crore
management_net_debt_march_2026: Rs 760 crore
q4_fy2026_new_business_revenue: Rs 270 crore
alte_spinning_capacity_addition: 24,000 spindles
alte_spinning_existing_capacity: 70,000 spindles
alte_spinning_proposed_capacity: 94,000 spindles
fy2025_new_business_revenue_usd: USD 33 million
fy2025_revenue_mix_new_business: 7%
fy2026_new_business_revenue_usd: USD 90 million
fy2026_revenue_mix_new_business: 19%
management_fy2025_ebitda_margin: 13.8%
management_fy2026_ebitda_margin: 11.0%
q4_fy2026_ebitda_qoq_comparison: Rs 116 crore versus Rs 102 crore in Q3 FY2026
q4_fy2026_ebitda_yoy_comparison: Rs 116 crore versus Rs 96 crore in Q4 FY2025
ecommerce_business_revenue_share: 12%
fy2025_revenue_mix_core_business: 93%
fy2026_revenue_mix_core_business: 81%
fy2028_revenue_run_rate_ambition: about Rs 8,000 crore run rate sometime in 2028
final_dividend_face_value_percent: 75%
fy2027_maintenance_and_other_capex: Rs 70 crore
management_q4_fy2026_ebitda_margin: 10.7%
non_us_core_business_revenue_share: about 30%
total_brand_business_revenue_share: 20%
fy2027_incremental_revenue_guidance: about Rs 1,300 crore
gokul_shirgaon_modernization_outlay: about Rs 25 crore
fy2027_new_business_revenue_guidance: about Rs 1,500 crore
management_long_term_debt_march_2026: Rs 425 crore
domestic_india_business_revenue_share: about 2.25%
fy2027_core_business_revenue_guidance: about Rs 4,000 crore
fy2027_effluent_treatment_plant_capex: Rs 95 crore
q4_fy2026_total_income_qoq_comparison: Rs 1,088 crore versus Rs 1,074 crore in Q3 FY2026
q4_fy2026_total_income_yoy_comparison: Rs 1,088 crore versus Rs 1,029 crore in Q4 FY2025
audited_standalone_fy2026_total_income: Rs 3,179.01 crore
management_rounded_fy2026_total_income: Rs 4,211 crore
us_quilt_capacity_after_north_carolina: 1.5 million quilts per annum
audited_consolidated_fy2026_tax_expense: Rs 39.57 crore
us_pillow_capacity_after_north_carolina: 31 million pillows per annum
audited_consolidated_fy2026_finance_cost: Rs 136.04 crore
audited_consolidated_fy2026_other_income: Rs 69.50 crore
audited_consolidated_fy2026_total_income: Rs 4,210.85 crore
us_pillow_capacity_before_north_carolina: 13 million pillows per annum
audited_consolidated_inventory_march_2026: Rs 1,250.87 crore
audited_standalone_q4_fy2026_total_income: Rs 790.39 crore
corrected_spinning_commissioning_timeline: by Q2 FY2028
management_rounded_q4_fy2026_total_income: Rs 1,088 crore
alte_spinning_capacity_addition_investment: about Rs 60 crore
audited_consolidated_fy2026_other_expenses: Rs 1,341.66 crore
audited_consolidated_fy2026_total_expenses: Rs 4,044.60 crore
audited_consolidated_q4_fy2026_tax_expense: Rs 5.96 crore
audited_standalone_fy2026_profit_after_tax: Rs 144.61 crore
management_working_capital_days_march_2025: 132 days
management_working_capital_days_march_2026: 121 days
audited_consolidated_q4_fy2026_finance_cost: Rs 43.60 crore
audited_consolidated_q4_fy2026_other_income: Rs 30.05 crore
audited_consolidated_q4_fy2026_total_income: Rs 1,087.72 crore
audited_standalone_fy2026_eps_basic_diluted: Rs 7.30
audited_standalone_fy2026_profit_before_tax: Rs 190.61 crore
audited_consolidated_fy2026_profit_after_tax: Rs 126.68 crore
audited_consolidated_total_equity_march_2026: Rs 2,355.30 crore
us_utility_bedding_target_utilization_fy2027: 60% to 65%
audited_consolidated_fy2026_eps_basic_diluted: Rs 6.40
audited_consolidated_fy2026_profit_before_tax: Rs 166.25 crore
audited_consolidated_q4_fy2026_other_expenses: Rs 376.18 crore
audited_consolidated_q4_fy2026_total_expenses: Rs 1,057.56 crore
audited_standalone_q4_fy2026_profit_after_tax: Rs 36.79 crore
audited_standalone_q4_fy2026_eps_basic_diluted: Rs 1.86
audited_standalone_q4_fy2026_profit_before_tax: Rs 44.86 crore
s_and_p_global_esg_score_prior_two_year_marker: 45
audited_consolidated_financing_cash_flow_fy2026: negative Rs 348.76 crore
audited_consolidated_investing_cash_flow_fy2026: negative Rs 216.77 crore
audited_consolidated_operating_cash_flow_fy2026: Rs 572.86 crore
audited_consolidated_q4_fy2026_profit_after_tax: Rs 24.20 crore
new_business_annualized_run_rate_from_q4_fy2026: about Rs 1,100 crore
audited_consolidated_q4_fy2026_eps_basic_diluted: Rs 1.23
audited_consolidated_q4_fy2026_profit_before_tax: Rs 30.16 crore
audited_consolidated_trade_receivables_march_2026: Rs 512.96 crore
audited_standalone_fy2026_revenue_from_operations: Rs 3,098.37 crore
fy2027_spinning_expansion_and_modernization_capex: Rs 85 crore
audited_consolidated_current_borrowings_march_2026: Rs 733.68 crore
audited_consolidated_current_investments_march_2026: Rs 190.07 crore
audited_consolidated_fy2026_revenue_from_operations: Rs 4,141.35 crore
audited_consolidated_other_bank_balances_march_2026: Rs 10.22 crore
audited_standalone_q4_fy2026_revenue_from_operations: Rs 757.89 crore
audited_consolidated_fy2026_employee_benefits_expense: Rs 515.90 crore
audited_consolidated_fy2026_cost_of_materials_consumed: Rs 1,716.55 crore
audited_consolidated_non_current_borrowings_march_2026: Rs 339.98 crore
audited_consolidated_q4_fy2026_revenue_from_operations: Rs 1,057.68 crore
audited_consolidated_fy2026_purchases_of_stock_in_trade: Rs 127.38 crore
audited_consolidated_q4_fy2026_employee_benefits_expense: Rs 142.89 crore
audited_consolidated_cash_and_cash_equivalents_march_2026: Rs 113.56 crore
audited_consolidated_fy2026_depreciation_and_amortisation: Rs 159.18 crore
audited_consolidated_q4_fy2026_cost_of_materials_consumed: Rs 416.90 crore
audited_consolidated_q4_fy2026_purchases_of_stock_in_trade: Rs 60.34 crore
audited_consolidated_q4_fy2026_depreciation_and_amortisation: Rs 42.61 crore
s_and_p_global_textiles_apparel_luxury_goods_industry_average: 35

Financial highlights

Book value: About Rs 111 per share
ESOP grant: 9,70,624 stock options to eligible employees
FY2026 ROE: 11.7%
FY2026 net revenue: Rs 2,749 cr, down 2.0% YoY on adjusted basis
Dividend record date: June 12, 2026
IPO filings pipeline: 55 IPOs aggregating about Rs 1,40,000 cr
Q4 FY2026 net revenue: Rs 584 cr, down 12.2% YoY
Affordable Home Loans AUM: About Rs 3,460 cr, up 22% YoY
Margin-trade-finance book: Almost Rs 2,000 cr at FY2026 year-end
Asset Management employees: 217, up 17% YoY
Final dividend recommended: Rs 1.75 per equity share for FY2026
Private Markets recoveries: More than Rs 270 cr in FY2026 versus Rs 250-300 cr annual recovery guide
Wealth Management branches: 72 branches, up 10 YoY
Wealth FY2027 growth target: 20-25% book growth and about Rs 6,000 cr implied inflows per Q&A
FY2026 adjusted operating PAT: Rs 1,133 cr, up 38% YoY
FY2026 total consolidated PAT: Rs 1,202 cr, up 46.3% YoY
Wealth Management franchisees: 874
Wealth recurring share of AUM: 29%
Affordable Home Loans branches: 151
Fees, commission and brokerage: Almost Rs 1,753 cr, up 10% YoY per management opening remarks
Private Markets Q4 net revenue: Rs 154 cr, up 7.1% YoY
Affordable Home Loans customers: More than 33,000
Affordable Home Loans gross NPA: 0.5% at March 31, 2026
Private Markets corporate loans: Rs 2,685 cr at March 2026 per management Q&A
Wealth Management recurring AUM: About Rs 31,000 cr, up 10% YoY
Private Markets capital employed: About Rs 6,600 cr
Private Markets equity portfolio: Rs 971 cr per management Q&A
Q4 FY2026 total consolidated PAT: Rs 165 cr, down 21.1% YoY
FY2026 income-tax refund interest: About Rs 113 cr
Private Markets current loan book: About Rs 4,000 cr at FY2026 after about Rs 10,000 cr in FY2024 and about Rs 5,000 cr in FY2025
Private Markets real estate loans: Rs 1,100 cr at March 2026 per management Q&A
Private Markets FY2026 net revenue: Rs 682 cr, down 22.4% YoY due to planned loan-book reduction
Wealth Management Q4 segment profit: Rs 39 cr
Pre-IPO fund total raise expectation: North of Rs 1,000 cr per management Q&A
Private Markets FY2026 operating PBT: Rs 742 cr, up 3.5x
Wealth Management FY2026 net revenue: Rs 775 cr, up 9% YoY
Affordable Home Loans Q4 total income: Rs 128 cr, up 28.1% YoY
Private Markets March 2027 book target: About Rs 5,000 cr per management Q&A
Private Markets alternatives portfolio: Rs 458 cr per management Q&A
Wealth Management FY2026 operating PAT: Rs 132 cr
FY2026 new Labour Code statutory impact: About Rs 22 cr
Wealth Management sales and RM strength: 1,046 employees, up 30% YoY
Affordable Home Loans net worth plus NCI: Rs 833 cr
JM Financial Home Loans valuation marker: About Rs 3,100 cr based on Bajaj Allianz Life Insurance transaction
Private Markets Q4 segment PAT after NCI: Rs 78 cr
Private Markets distressed credit assets: Rs 3,665 cr per management Q&A
Affordable Home Loans FY2026 total income: Rs 455 cr, up 25.2% YoY
Wealth and Asset Management Q4 net revenue: Rs 210 cr, up 6.0% YoY
Affordable Home Loans collection efficiency: 99.4% at March 31, 2026
Private Markets cash and liquid instruments: About Rs 3,000 cr plus about Rs 500 cr group ICDs per management Q&A
Asset Management mutual-fund management fees: About Rs 44 cr in FY2026, up 65%
Dividend distribution over last four quarters: About Rs 5.95 per share, or about Rs 570 cr
First performing-credit fund committed amount: About Rs 347 cr
Private Markets FY2026 operating PAT after NCI: Rs 543 cr, up almost 3.6x
Wealth and Asset Management FY2026 net revenue: Rs 827 cr, up 10.0% YoY
Affordable Home Loans Q4 operating PAT after NCI: Rs 25 cr, up 80.9% YoY
Consolidated net worth excluding minority interest: Rs 10,605 cr
Asset Management non-liquid mutual-fund average AUM: About Rs 10,500 cr
FY2026 reported PAT after tax and minority interest: Rs 1,202 cr, up 46% YoY
Affordable Home Loans FY2026 operating PAT after NCI: Rs 74 cr, up 45.5% YoY
Asset Management FY2026 loss after minority interest: About Rs 30 cr
Corporate Advisory and Capital Markets FY2026 revenue: About Rs 946 cr, up 20.1% YoY in segment presentation table
Corporate Advisory and Capital Markets Q4 segment PAT: Rs 39 cr
Wealth and Asset Management Q4 operating PAT after NCI: Rs 35 cr, up 17.1% YoY
Corporate Advisory and Capital Markets capital employed: Rs 829 cr, implying about 47% ROE
Asset Management Q4 segment loss after minority interest: About Rs 5 cr
Corporate Advisory and Capital Markets FY2026 net revenue: About Rs 789 cr, up 11% YoY
Corporate Advisory and Capital Markets FY2026 transactions: 41 capital-market transactions aggregating about Rs 95,000 cr
Wealth and Asset Management FY2026 operating PAT after NCI: Rs 102 cr, down 1.3% YoY
Corporate Advisory and Capital Markets FY2026 operating PAT: Rs 347 cr
Private Markets MSME and financial-institutions non-core book: Rs 228 cr, expected to become zero by year-end per management Q&A

Financial highlights

New FY2026 LNG SPAs: Up to 1.36 MTPA or about 4.9 mmscmd with Qatar Energy and Uniper Global Commodities
Dahej regas capacity: 2.25 MTPA firm capacity at Petronet LNG Dahej
Q4 FY2026 CNG volume: 3.60 mmscmd
Scheme effective date: May 1, 2026
FY2025 gas trading PBT: Rs 1,222.09 cr
FY2026 gas trading PBT: Rs 1,334.61 cr
PNGRB HP gas-grid tariff: Revised from Rs 34/MMBTU to Rs 18.10/MMBTU, applicable from May 1, 2024
FY2026 gas trading volume: 10.2 mmscmd including about 5.3 mmscmd of intersegment sales
Q4 FY2026 CGD total volume: 8.88 mmscmd
Morbi late-May 2026 run rate: About 710 units and about 8 mmscmd consumption
Scheme merger appointed date: April 1, 2024 for GSPC, GSPL and GSPC Energy into Gujarat Gas
GSPL 9M FY2026 standalone EPS: Rs 11.33
GSPL 9M FY2026 standalone PAT: Rs 639.22 cr
GSPL 9M FY2026 standalone PBT: Rs 767.20 cr
GSPL Q3 FY2026 standalone EPS: Rs 2.03
GSPL Q3 FY2026 standalone PAT: Rs 114.27 cr
GSPL Q3 FY2026 standalone PBT: Rs 152.98 cr
Gujarat Energy final dividend: Rs 8.90 per equity share of face value Rs 2
Long-term LNG supply portfolio: About 2.96 MTPA or about 10.66 mmscmd equivalent
Scheme demerger appointed date: April 1, 2025 for gas transmission business into GTL
FCCI arbitration bank guarantee: Rs 50.61 cr interest-portion bank guarantee
GSPL 9M FY2026 consolidated EPS: Rs 14.75
GSPL 9M FY2026 consolidated PAT: Rs 1,232.92 cr
GSPL Q3 FY2026 consolidated EPS: Rs 4.55
GSPL Q3 FY2026 consolidated PAT: Rs 379.05 cr
GSPL Q3 FY2026 consolidated PBT: Rs 510.16 cr after share of equity-accounted investees
Q4 FY2026 industrial PNG volume: 4.19 mmscmd
FY2026 gas trading external volume: About 4.9 mmscmd net of intersegment sales
GSPL to Gujarat Energy share ratio: 10 Gujarat Energy shares of Rs 2 each for every 13 GSPL shares of Rs 10 each
Last standalone GSPL results covered: Q3 FY2026 and nine months ended December 31, 2025
GSPL 9M FY2026 standalone total income: Rs 1,222.71 cr
GSPL Q3 FY2026 standalone total income: Rs 315.48 cr
Gujarat Energy FY2026 standalone EBITDA: Rs 3,772 cr before exceptional items
GSPL 9M FY2026 consolidated total income: Rs 12,910.08 cr
GSPL Q3 FY2026 consolidated total income: Rs 4,187.47 cr
FCCI arbitration conditional-stay deposit: Rs 69.34 cr principal deposit
Gujarat Energy Q4 FY2026 standalone EBITDA: Rs 943 cr before exceptional items
Record date for GSPC and GSPL shareholders: May 12, 2026
GSPL 9M FY2026 standalone revenue from operations: Rs 830.16 cr
GSPL Q3 FY2026 standalone revenue from operations: Rs 272.20 cr
GSPL 9M FY2026 consolidated revenue from operations: Rs 12,599.52 cr
GSPL Q3 FY2026 consolidated revenue from operations: Rs 4,091.70 cr
Gujarat Energy shares allotted to GSPL shareholders: 27,06,97,005 equity shares on May 16, 2026
GSPL Q3 FY2026 consolidated profit attributable to owners: Rs 256.75 cr
Gujarat Energy FY2026 standalone PAT from continuing operations: Rs 2,298.55 cr

Financial highlights

Net worth: About Rs 18,517 cr at March 31, 2026
E&P blocks: 16 total fields/blocks, including 6 operated and 10 non-operated
FY2026 EPS: Rs 24.50 on expanded equity base
Morbi units: 83 units in March 2026 to 710 units by late May 2026
CNG stations: 839 at March 2026
E&P reserves: About 6.71 mmboe per management Q&A
Credit rating: AAA Stable / A1+ from CRISIL, CARE and India Ratings
Wind capacity: 123.9 MW across 5 farms
Dividend outgo: About Rs 835 cr
Final dividend: Rs 8.90 per equity share of face value Rs 2, equal to 445%
GSPC LNG stake: About 36.8%
CGD margin guide: About Rs 5 to Rs 6.5 per SCM
CNG vehicle base: About 17.68 lakh at March 2026 versus 15.4 lakh a year earlier
Pipeline network: About 45,250 km
Tax refund watch: About Rs 900 cr, timing subject to income-tax assessment
Districts covered: 44 districts across 6 states and 1 union territory
Domestic PNG base: More than 24.18 lakh customers
FY2026 CNG volume: 3.43 mmscmd
CGD EBITDA per SCM: About Rs 6.16 for FY2026 before amalgamation effects
CGD authorisations: 27
Debt and liquidity: Investor presentation described debt-free balance sheet with cash reserves above Rs 5,000 cr
Power business PLF: About 1% at GPPC and 6.5% at GSEG per management Q&A
Gas trading one-off: About Rs 200 cr related to Petronet LNG/GSPC LNG regas arrangement plus about Rs 50 cr customer-duty refund
Morbi Q4 QoQ growth: 21%
Morbi selling price: About Rs 75 per SCM
Current sourcing mix: APM about 2 mmscmd, New Well Gas about 0.4-0.5 mmscmd, long-term about 3.5 mmscmd, short-term about 3.5 mmscmd
Dahej regas capacity: 2.25 MTPA firm capacity at Petronet LNG Dahej
E&P producing fields: 11 producing fields
FY2026 renewable PLF: 14.94%
Q4 FY2026 CNG volume: 3.60 mmscmd
Tax losses remaining: About Rs 1,900 cr
FY2026 standalone PBT: Rs 3,088.65 cr
FY2027 CGD capex guide: About Rs 1,000 cr
FY2027 E&P capex guide: About Rs 100 cr
Gas trading FY2025 PBT: Rs 1,222.09 cr
Gas trading FY2026 PBT: Rs 1,334.61 cr
Morbi demand potential: Management heard customer indications of about 8.8-8.9 mmscmd
FY2026 CGD total volume: 8.69 mmscmd
Morbi Q4 average volume: 2.02 mmscmd
Non-Morbi selling price: About Rs 68 per SCM
Q4 CNG emissions impact: About 19 lakh kg CO2 per day reduction versus petrol/diesel
Q4 PNG emissions impact: About 60 lakh kg CO2 per day reduction versus coal
Wind turbine generators: 79 WTGs
Commercial PNG customers: More than 16,000 commissioned customers
Commercial unit campaign: New commercial units rose from 152 in March 2026 to 527 by late May 2026
FY2026 renewable revenue: Rs 70.74 cr
FY2026 standalone EBITDA: Rs 3,772 cr before exceptional items
Q4 FY2026 CNG YoY growth: 12%
Q4 FY2026 standalone PBT: Rs 726.07 cr
FY2025 gas trading volume: About 12.6 mmscmd
FY2026 E&P gas production: 27,000 SCMD company share
FY2026 E&P oil production: 326 BOPD company share
FY2026 gas trading volume: 10.2 mmscmd including intersegment sales
Gujarat CNG Q4 YoY growth: 11%
Non-Morbi Q4 QoQ movement: 3.5% decline
FY2026 domestic PNG volume: 0.82 mmscmd
GSPC Mundra LNG investment: About Rs 1,700 cr
Gas trading volume decline: About 19% YoY in FY2026
Q4 FY2026 CGD total volume: 8.88 mmscmd
FY2026 segment result - CGD: Rs 1,398.29 cr
FY2026 segment result - E&P: Negative Rs 31.33 cr
GSPC Mundra LNG utilization: About 17% earlier, then about 35-38% from May-July indications
Q4 FY2026 standalone EBITDA: Rs 943 cr before exceptional items
Trading-segment capex guide: No capex in respect of trading segment
Compressed biogas agreements: 35 agreements
FY2026 CNG station additions: 14 stations, including 7 under FDODO
FY2026 commercial PNG volume: 0.16 mmscmd
FY2026 industrial PNG volume: 4.29 mmscmd
FY2026 segment revenue - CGD: Rs 15,976.00 cr before intersegment elimination
FY2026 segment revenue - E&P: Rs 92.93 cr
LPG-free society conversions: 86 societies/about 13,000 households during March-May 2026; cumulative 2,835 societies/about 4.86 lakh households
Q4 FY2026 domestic PNG volume: 0.91 mmscmd
Tax losses absorbed in FY2025: About Rs 2,800 cr
Tax losses absorbed in FY2026: About Rs 2,500 cr
FY2026 standalone total income: Rs 24,818.89 cr
Long-term LNG supply portfolio: About 2.96 MTPA or 10.66 mmscmd equivalent
Morbi run-rate gas consumption: About 8 mmscmd by late May 2026
Post-scheme shares outstanding: 93.82 cr in investor presentation
Management segment EBITDA - CGD: About Rs 1,900 cr
Management segment EBITDA - E&P: About Rs 29 cr
Q4 FY2026 CNG station additions: 7 stations
Q4 FY2026 commercial PNG volume: 0.17 mmscmd
Q4 FY2026 industrial PNG volume: 4.19 mmscmd
Current run-rate around call date: Total CGD volume close to 14 mmscmd and trading volume close to 5.5 mmscmd
Outside-Gujarat CNG Q4 YoY growth: 18%
Post-scheme indicative market cap: About Rs 21,151 cr as at March 31, 2026 in investor presentation
Q4 FY2026 standalone total income: Rs 6,136.13 cr
LNG cargoes imported till May 2026: More than 480 cargoes
Compressed biogas contracted volume: About 1.6 lakh SCMD
FY2026 segment result - Gas Trading: Rs 1,334.61 cr
Tax losses at merger appointed date: About Rs 7,200 cr
FY2026 CGD infrastructure investment: About Rs 561 cr
FY2026 segment revenue - Gas Trading: Rs 16,100.85 cr before intersegment elimination
FY2026 standalone capex cash outflow: Rs 825.90 cr for PPE/intangibles/investment property/capital advances
Gas trading average five-year volume: About 12 mmscmd
Q4 FY2026 domestic PNG registrations: About 43,000 new customers
FY2026 gas trading intersegment sales: About 5.3 mmscmd
FY2026 gas trading net external volume: About 4.9 mmscmd
Management segment EBITDA - Renewables: About Rs 46 cr
Non-Morbi Q4 average industrial volume: 2.17 mmscmd
Management segment EBITDA - Gas Trading: About Rs 1,300 cr
FY2026 segment result - Power/Renewables: Rs 34.75 cr
PNG commercial customers in presentation: 16,030-plus
PNG domestic connections in presentation: 24.18 lakh-plus
PNG industrial customers in presentation: 4,460-plus
FY2026 segment revenue - Power/Renewables: Rs 70.74 cr
FY2026 standalone revenue from operations: Rs 24,198.00 cr
Gas trading recurring profitability guide: About Rs 1,000-1,100 cr annually after one-offs
FY2026 standalone net cash from operations: About Rs 2,407.44 cr
FY2026 total sales volume in press release: 13.63 mmscmd
Q4 FY2026 standalone revenue from operations: Rs 5,975.63 cr
Q4 FY2026 total sales volume in press release: 13.51 mmscmd
Q4 FY2026 domestic PNG commissioned connections: More than 35,400 connections
FY2026 standalone PAT from continuing operations: Rs 2,298.55 cr
FY2026 gas trading segment volume in press release: 4.94 mmscmd
Q4 FY2026 standalone PAT from continuing operations: Rs 520.58 cr
Q4 FY2026 gas trading segment volume in press release: 4.63 mmscmd

Financial highlights

Dividend: Rs 6 per Re 1 share, subject to shareholder approval
R&D spend: 3.71% of sales
Trophic Wellness: About Rs 125 cr revenue and more than Rs 40 cr profit
FY2026 total API income: Rs 1,395.74 cr vs Rs 1,265.85 cr in FY2025, up 10% YoY
FY2026 API export income: Rs 1,046.85 cr vs Rs 891.49 cr in FY2025, up 18% YoY
FY2026 standalone EBITDA: Rs 1,847.36 cr before forex, other income and exceptional items vs Rs 1,510.92 cr in FY2025, up 22% YoY
FY2026 API domestic income: Rs 348.89 cr vs Rs 374.36 cr in FY2025, down 7% YoY
FY2026 consolidated EBITDA: Rs 1,998.96 cr before forex, other income and exceptional items vs Rs 1,693.05 cr in FY2025, up 18% YoY
Q4 FY2026 total API income: Rs 344.56 cr vs Rs 341.38 cr in Q4 FY2025, up 1% YoY
Q4 FY2026 API export income: Rs 240.23 cr vs Rs 250.75 cr in Q4 FY2025, down 4% YoY
Q4 FY2026 standalone EBITDA: Rs 458.43 cr before forex, other income and exceptional items vs Rs 347.15 cr in Q4 FY2025, up 32% YoY
U.S. business FY2026 revenue: Rs 1,567 cr for Ipca USA plus Unichem USA vs Rs 1,379 cr in FY2025, up 14% YoY
Q4 FY2026 API domestic income: Rs 104.33 cr vs Rs 90.63 cr in Q4 FY2025, up 15% YoY
Q4 FY2026 consolidated EBITDA: Rs 490.21 cr before forex, other income and exceptional items vs Rs 409.74 cr in Q4 FY2025, up 20% YoY
FY2026 standalone EBITDA margin: 25.18% before forex, other income and exceptional items vs 22.66% in FY2025
U.S. business Q4 FY2026 revenue: Rs 428 cr for Ipca USA plus Unichem USA vs Rs 388 cr in Q4 FY2025, up 10% YoY
FY2026 total formulations income: Rs 5,899.82 cr vs Rs 5,374.23 cr in FY2025, up 10% YoY
FY2026 Indian formulations income: Rs 3,817.24 cr vs Rs 3,454.85 cr in FY2025, up 10% YoY
FY2026 consolidated EBITDA margin: 20.72% before forex, other income and exceptional items vs 18.94% in FY2025
FY2026 standalone net total income: Rs 7,431.39 cr vs Rs 6,742.12 cr in FY2025, up 10% YoY
Q4 FY2026 standalone EBITDA margin: 25.27% before forex, other income and exceptional items vs 21.19% in Q4 FY2025
Q4 FY2026 total formulations income: Rs 1,458.63 cr vs Rs 1,287.59 cr in Q4 FY2025, up 13% YoY
FY2026 consolidated net total income: Rs 9,820.78 cr vs Rs 9,032.16 cr in FY2025, up 9% YoY
Q4 FY2026 Indian formulations income: Rs 853.33 cr vs Rs 764.05 cr in Q4 FY2025, up 12% YoY
Q4 FY2026 consolidated EBITDA margin: 20.52% before forex, other income and exceptional items vs 18.24% in Q4 FY2025
FY2026 consolidated exceptional items: Rs 86.43 cr, including European Commission interest settlement, new Labour Code impact and disposal-related line items
Q4 FY2026 standalone net total income: Rs 1,844.23 cr vs Rs 1,659.93 cr in Q4 FY2025, up 11% YoY
Q4 FY2026 consolidated net total income: Rs 2,482.22 cr vs Rs 2,272.51 cr in Q4 FY2025, up 9% YoY
FY2026 export branded formulations income: Rs 663.67 cr vs Rs 582.29 cr in FY2025, up 14% YoY
FY2026 export generic formulations income: Rs 1,149.00 cr vs Rs 982.35 cr in FY2025, up 17% YoY
FY2026 standalone revenue from operations: Rs 7,336.75 cr vs Rs 6,670.88 cr in FY2025, up 10% YoY
Q4 FY2026 consolidated Labour Code impact: Rs 45.82 cr aggregate Labour Code-related exceptional impact
FY2026 consolidated revenue from operations: Rs 9,646.33 cr vs Rs 8,939.59 cr in FY2025, up 8% YoY
Q4 FY2026 export branded formulations income: Rs 190.17 cr vs Rs 166.42 cr in Q4 FY2025, up 14% YoY
Q4 FY2026 export generic formulations income: Rs 341.02 cr vs Rs 246.10 cr in Q4 FY2025, up 39% YoY
Q4 FY2026 standalone revenue from operations: Rs 1,814.35 cr vs Rs 1,638.44 cr in Q4 FY2025, up 11% YoY
FY2026 standalone PAT before exceptional items: Rs 1,162.94 cr vs Rs 928.60 cr in FY2025, up 25% YoY
Q4 FY2026 consolidated revenue from operations: Rs 2,388.48 cr vs Rs 2,246.69 cr in Q4 FY2025, up 6% YoY
FY2026 consolidated PAT after exceptional items: Rs 1,141.12 cr vs Rs 737.25 cr in FY2025, up 55% YoY
FY2026 export institutional formulations income: Rs 269.91 cr vs Rs 354.74 cr in FY2025, down 24% YoY
FY2026 consolidated PAT before exceptional items: Rs 1,277.80 cr vs Rs 991.25 cr in FY2025, up 29% YoY
Q4 FY2026 standalone PAT before exceptional items: Rs 292.71 cr vs Rs 216.49 cr in Q4 FY2025, up 35% YoY
Q4 FY2026 consolidated PAT after exceptional items: Rs 299.07 cr vs Rs 67.82 cr in Q4 FY2025
Q4 FY2026 export institutional formulations income: Rs 74.11 cr vs Rs 111.02 cr in Q4 FY2025, down 33% YoY
Q4 FY2026 consolidated PAT before exceptional items: Rs 355.22 cr vs Rs 270.83 cr in Q4 FY2025, up 31% YoY

Financial highlights

Dividend: Final dividend of Rs 2.5 per share recommended, subject to shareholder approval
FY2026 PAT: Rs 1,362.0 cr, margin 7.8%
Gross debt: Management said the company achieved gross debt-free status by FY2026-end
Cash position: About Rs 1,200 cr at FY2026-end, per management
FY2026 EBITDA: Rs 4,572.4 cr, margin 26.9%
Q4 FY2026 PAT: Rs 301.3 cr, margin 7.6%
R&D intensity: Broadly 7%-8% of sales, with Q4 FY2026 R&D around Rs 225 cr
Q4 FY2026 EBITDA: Rs 762.6 cr, margin 20.2%
Net working capital: Close to 107 days and within the 115-120 day guidance range
Europe FY2026 revenue: Rs 3,100.7 cr, up 8.9% YoY
RYALTRIS FY2026 sales: More than USD 100 million, with about 50% secondary-sales growth
FY2027 normalized capex: Around Rs 900 cr total, per management
FY2027 revenue guidance: Rs 17,000-18,000 cr
Europe Q4 FY2026 revenue: Rs 890.7 cr, up 21.4% YoY
FY2026 exceptional items: Rs 2,266.1 cr on a consolidated basis
IGI future-spend set-aside: USD 70 million per year from AbbVie income, or about USD 17.5 million per quarter
AbbVie/ISB-2001 transaction: USD 700 million upfront payment, up to USD 1.925 billion in development, regulatory and commercial milestones, plus tiered double-digit royalties
FY2026 consolidated revenue: Rs 16,982.5 cr, up 27.5% YoY
Q4 FY2026 exceptional items: Rs 373.4 cr on a consolidated basis
North America FY2026 revenue: Rs 7,139.0 cr, up 136.6% YoY, including deferred out-licensing income recognition for ISB 2001
FY2027 EBITDA margin guidance: 21%-22%
Q4 FY2026 consolidated revenue: Rs 3,770.6 cr, up 15.8% YoY
Emerging Markets FY2026 revenue: Rs 2,940.5 cr, up 4.5% YoY
North America Q4 FY2026 revenue: Rs 924.8 cr, up 29.4% YoY
India FY2026 formulation revenue: Rs 3,723.7 cr, down 17.0% YoY in the MDA table
Emerging Markets Q4 FY2026 revenue: Rs 897.9 cr, up 13.7% YoY
India Q4 FY2026 formulation revenue: Rs 1,020.1 cr, up 8.2% YoY
GCC and consumer care Q4 FY2026 revenue: Rs 126.5 cr, up 9.7% YoY
FY2026 profit before exceptional items and tax: Rs 4,250.8 cr on a consolidated basis
Q4 FY2026 profit before exceptional items and tax: Rs 761.2 cr on a consolidated basis
North America Q4 core growth excluding licensing income: 7.8% YoY

Financial highlights

FY2026 PAT: Rs 8,392.18 cr, up 25.23% YoY
FY2026 PBT: Rs 10,793.25 cr, up 23.13% YoY
FY2026 ROE: 16.4% versus 15.5% in FY2025
Total assets: Rs 1,97,220.93 cr at March 31, 2026, up 5.12% YoY
Q4 FY2026 PAT: Rs 2,254.24 cr versus Rs 2,182.88 cr YoY and Rs 1,518.92 cr QoQ
Q4 FY2026 PBT: Rs 2,960.02 cr versus Rs 2,922.66 cr YoY and Rs 2,116.93 cr QoQ
Final dividend: Rs 13.25 per share, 265% of Rs 5 face value, subject to AGM approval
Solvency ratio: 4.21x versus 3.70x
FY2026 fire GWP: Rs 14,256.05 cr, up 3.91% YoY
FY2026 life GWP: Rs 2,450.48 cr, up 31.27% YoY
FY2026 motor GWP: Rs 7,496.88 cr, up 17.96% YoY
FY2026 health GWP: Rs 9,190.27 cr, down 3.54% YoY
FY2026 combined ratio: 106.02% versus 108.81%
Q4 FY2026 net premium: Rs 9,917.07 cr versus Rs 9,420.91 cr YoY and Rs 10,354.86 cr QoQ
FY2026 agriculture GWP: Rs 3,392.86 cr, up 3.98% YoY
FY2026 incurred claims: Rs 33,627.66 cr versus Rs 31,953.69 cr
Consolidated FY2026 PAT: Rs 9,662.38 cr versus Rs 7,431.84 cr
Consolidated FY2026 PBT: Rs 11,446.70 cr versus Rs 9,104.64 cr
FY2026 investment income: Rs 13,089.34 cr versus Rs 12,772.52 cr
FY2026 underwriting loss: Rs 1,763.00 cr, down 47.40% YoY
Q4 FY2026 combined ratio: 103.43% versus 103.56% YoY and 105.32% QoQ
Q4 FY2026 earned premium: Rs 9,785.06 cr versus Rs 8,680.15 cr YoY and Rs 9,580.28 cr QoQ
Q4 FY2026 incurred claims: Rs 7,902.16 cr versus Rs 7,134.24 cr YoY and Rs 8,425.04 cr QoQ
FY2026 incurred claims ratio: 85.40% versus 88.44%
FY2026 standalone net premium: Rs 40,571.25 cr versus Rs 37,844.21 cr
Q4 FY2026 underwriting result: Profit of Rs 84.31 cr versus losses of Rs 392.26 cr YoY and Rs 551.84 cr QoQ
FY2026 adjusted combined ratio: 84.79% versus 85.79%
FY2026 domestic combined ratio: 101.65% versus 104.20% in FY2025
Q4 FY2026 gross premium income: Rs 11,030.48 cr versus Rs 10,367.08 cr YoY and Rs 10,986.55 cr QoQ
Q4 FY2026 incurred claims ratio: 80.8% versus 82.2% YoY and 87.9% QoQ
FY2026 standalone earned premium: Rs 39,378.35 cr versus Rs 36,130.26 cr
Consolidated FY2026 gross premium: Rs 44,367.88 cr versus Rs 41,955.33 cr
FY2026 international combined ratio: 120.05% versus 121.40% in FY2025
FY2026 domestic gross premium income: Rs 32,979.23 cr, 75% of mix, up 7.56% YoY
Consolidated FY2026 underwriting loss: Rs 1,245.12 cr versus Rs 3,141.40 cr
Net worth excluding fair-value change: Rs 51,301.27 cr versus Rs 43,106.52 cr
Net worth including fair-value change: Rs 84,029.57 cr versus Rs 83,224.33 cr
FY2026 standalone gross premium income: Rs 44,006.74 cr, up 6.93% YoY
FY2026 international gross premium income: Rs 11,027.51 cr, 25% of mix, up 5.11% YoY
Q4 FY2026 transfer to catastrophe reserve: Rs 237.10 cr versus Rs 597.95 cr YoY and Rs 140.38 cr QoQ
Q4 FY2026 investment income net of expenses: Rs 3,059.46 cr versus Rs 3,903.02 cr YoY and Rs 2,924.47 cr QoQ

Financial highlights

FY2026 PAT: Rs 7,421 cr, up 11% YoY from Rs 6,693 cr
FY2026 PBT: Rs 10,155 cr, up 9% YoY
FY2026 capex: Around Rs 3,300 cr, all-time high excluding land acquisition
FY2026 EBITDA: Rs 10,737 cr, up 9% YoY; reported margin 34%
Q4 FY2026 PAT: Rs 2,020 cr, up 35% YoY
Q4 FY2026 PBT: Rs 2,875 cr, up 22% YoY
Bailadila cost: Production cost reduced from about Rs 1,000 per tonne to about Rs 800 per tonne according to management
Deposit 4 ramp: Commercial mining expected in July / Q2 FY2027; 1 mt FY2027 guidance, 2 mt next year, peak rated capacity 7 mt after infrastructure completion
Deposit 13 ramp: Expected start around Q2 subject to clearances and monsoon; 0.5 mt FY2027 guidance, 2 mt next year, long-term 20-21 mt over four to five years
Q4 FY2026 EBITDA: Rs 3,072 cr, up 21% YoY; reported margin 27%
Tokisud coal mine: FY2027 output guidance 0.75-1 mt; peak rated capacity 2.3 mt
FY2026 total income: Rs 33,017 cr, up 31% YoY
May 2026 production: 5.3 mt versus 4.4 mt in May 2025; first two months FY2027 around 10 mt versus about 8.2 mt a year earlier
Vizag blending yard: About Rs 3,000 cr board-sanctioned investment, expected completion in about two to two-and-a-half years
Coal revenue ambition: Rs 5,000-8,000 cr annual topline within three years according to management commentary
FY2026 iron ore sales: 502.39 lakh tonnes, up 13% YoY from 444.04 lakh tonnes
KIOCL pellet job work: Planned 3-3.3 mt in FY2027; 66.5% Fe achieved, 67% Fe DR-grade target; expected DR pellet premium $20-30
Q4 FY2026 other sales: Rs 3,893 cr versus Rs 610 cr in Q4 FY2025
FY2027 capex direction: Management expects a substantial increase, almost double, as expansion projects are on ground
Rohne coking coal mine: Expected to open around late Q3 FY2027; no FY2027 commercial production expected; peak rated capacity 8 mt
FY2027 production target: 60 mt, including about 58.5 mt from existing NMDC assets plus about 1.5 mt from Deposit 4 and Deposit 13
Q4 FY2026 iron ore sales: 152.99 lakh tonnes, up 21% YoY from 126.68 lakh tonnes
FY2026 iron ore production: 531.58 lakh tonnes, up 21% YoY from 440.72 lakh tonnes
Long-term production target: 100 mt by the end of the decade
Q4 FY2026 iron ore production: 162.72 lakh tonnes, up 22% YoY from 133.07 lakh tonnes
FY2026 revenue from operations: Rs 31,554 cr, up 33% YoY from Rs 23,668 cr
Q4 FY2026 iron ore sales value: Rs 7,280 cr, up 15% YoY
FY2026 royalty and other levies: Rs 5,207 cr, up 15% YoY
FY2026 purchase of stock in trade: Rs 3,942 cr versus Rs 197 cr in FY2025, linked to steel trading support
Q4 FY2026 revenue from operations: Rs 11,173 cr, up 61% YoY from Rs 6,953 cr
FY2026 average domestic realization: Rs 4,921 per tonne versus Rs 5,135 per tonne in FY2025, down 4%
Environmental and operating capacity: EC capacity 64.8 mt and CTO around 55.4 mt, with enhancement requests of about 3.32 mt taking CTO to about 58.8 mt
Q4 FY2026 average domestic realization: Rs 4,759 per tonne versus Rs 5,007 per tonne in Q4 FY2025, down 5%
FY2026 additional amount at 150% of royalty: Rs 5,875 cr, up 14% YoY
FY2026 ore transferred for pellets job work: 30.08 lakh tonnes versus 7.04 lakh tonnes in FY2025

Financial highlights

FY2026 standalone EPS: Rs 1.41 versus Rs 0.46 in FY2025
FY2026 consolidated EPS: Rs 2.58 versus Rs 0.58 in FY2025
Standalone other equity: Rs 1,549.13 crore at March 31, 2026 versus Rs 1,306.05 crore at March 31, 2025
Standalone total assets: Rs 2,374.28 crore at March 31, 2026 versus Rs 3,232.31 crore at March 31, 2025
Anglo Coal provision gap: Auditor flagged Rs 82.82 crore not recognized as provision and instead included in contingent liabilities
Consolidated other equity: Rs 1,970.72 crore at March 31, 2026 versus Rs 1,552.19 crore at March 31, 2025
Q4 FY2026 consolidated EPS: Rs 0.84 versus Rs 0.01 in Q4 FY2025
Deferred tax asset adjustment: Rs 163.79 crore adjusted or derecognized during FY2026
FY2026 standalone other income: Rs 177.17 crore versus Rs 260.09 crore in FY2025
FY2026 standalone total income: Rs 180.58 crore versus Rs 262.78 crore in FY2025
NINL escrow exceptional income: Rs 411.76 crore, including Rs 25.75 crore interest net of TDS and bank charges
FY2026 consolidated other income: Rs 177.17 crore versus Rs 260.09 crore in FY2025
FY2026 consolidated total income: Rs 180.58 crore versus Rs 262.78 crore in FY2025
FY2026 standalone profit after tax: Rs 212.07 crore versus Rs 69.53 crore in FY2025
Confiscated gold exceptional income: Rs 13.21 crore booked from Customs receipt pursuant to Supreme Court order
FY2026 standalone exceptional items: Credit of Rs 473.70 crore
FY2026 standalone profit before tax: Rs 463.30 crore versus Rs 97.20 crore in FY2025
FY2026 consolidated profit after tax: Rs 387.38 crore versus Rs 86.63 crore in FY2025
FY2026 consolidated exceptional items: Credit of Rs 473.70 crore
FY2026 consolidated profit before tax: Rs 638.61 crore versus Rs 114.30 crore in FY2025
Q4 FY2026 standalone profit after tax: Rs 31.70 crore versus Rs 0.32 crore in Q4 FY2025
Q4 FY2026 consolidated profit after tax: Rs 126.04 crore versus Rs 2.23 crore in Q4 FY2025
FY2026 standalone revenue from operations: Rs 3.41 crore versus Rs 2.69 crore in FY2025
FY2026 consolidated revenue from operations: Rs 3.41 crore versus Rs 2.69 crore in FY2025
FY2026 standalone total comprehensive income: Rs 243.08 crore versus Rs 101.69 crore in FY2025
FY2026 consolidated total comprehensive income: Rs 418.53 crore versus Rs 118.55 crore in FY2025
FY2026 consolidated share of joint-venture profit: Rs 175.31 crore versus Rs 17.10 crore in FY2025
Trade receivables write-off and provision write-back: Rs 75.49 crore trade receivables written off by Camp Office Chennai with corresponding provisions written back under exceptional items
FY2026 standalone profit before exceptional items and tax: Loss of Rs 10.40 crore versus profit of Rs 116.04 crore in FY2025
FY2026 consolidated profit before exceptional items and tax including JV: Rs 164.90 crore versus Rs 133.14 crore in FY2025

Financial highlights

fy2025_eps_rs: 0.30
fy2026_eps_rs: -0.10
yolobus_routes: 250+
fy2025_pbt_rs_mn: 1429.8
fy2026_pbt_rs_mn: 7.6
fy2025_ebit_rs_mn: 1487.5
fy2026_ebit_rs_mn: 68.7
spree_hotels_keys: 2222
fy2025_ebitda_rs_mn: 1612.2
fy2026_ebitda_rs_mn: 228.6
spree_hotels_nps_ytd: 93
fy2025_goodwill_rs_mn: 496.9
fy2026_goodwill_rs_mn: 496.9
fy2025_dubai_gbr_rs_mn: 7013.7
fy2026_dubai_gbr_rs_cr: 1531
fy2026_dubai_gbr_rs_mn: 15306.9
spree_hotels_properties: 53
fy2025_ebitda_margin_pct: 26.7
fy2026_ebitda_margin_pct: 4.0
q4fy2025_dubai_gbr_rs_cr: 232
q4fy2026_dubai_gbr_rs_cr: 453
fy2025_other_equity_rs_mn: 3659.0
fy2025_total_assets_rs_mn: 11539.3
fy2025_total_equity_rs_mn: 7420.5
fy2026_other_equity_rs_mn: 4376.5
fy2026_total_assets_rs_mn: 12083.6
fy2026_total_equity_rs_mn: 8149.2
fy2025_finance_costs_rs_mn: 57.7
fy2026_finance_costs_rs_mn: 61.1
fy2025_other_expenses_rs_mn: 3392.0
fy2025_trade_payables_rs_mn: 1309.5
fy2026_other_expenses_rs_mn: 4208.0
fy2026_trade_payables_rs_mn: 1082.8
india_etail_gmv_2025_usd_bn: 65-66
fy2026_adjusted_income_rs_cr: 715
nse_slice_actionable_signals: 5
q4fy2026_room_nights_per_day: about 6000
yolobus_annual_occupancy_pct: over 88
fy2025_hotel_room_nights_lakh: 9.4
fy2026_hotel_room_nights_lakh: 17.7
india_etail_expected_cagr_pct: more than 20
preferential_allotment_shares: 347798677
fy2025_direct_taxes_paid_rs_mn: -612.6
fy2025_intangible_assets_rs_mn: 522.9
fy2025_total_tax_expense_rs_mn: 343.3
fy2025_trade_receivables_rs_mn: 2961.9
fy2026_direct_taxes_paid_rs_mn: -22.6
fy2026_exceptional_items_rs_mn: 509.6
fy2026_intangible_assets_rs_mn: 451.7
fy2026_total_tax_expense_rs_mn: 55.8
fy2026_trade_receivables_rs_mn: 2735.7
q4fy2026_adjusted_income_rs_cr: 178
fy2025_current_borrowings_rs_mn: 93.4
fy2026_current_borrowings_rs_mn: 101.2
fy2026_dubai_gbr_yoy_growth_pct: 118.2
q4fy2025_hotel_room_nights_lakh: 2.83
q4fy2026_hotel_room_nights_lakh: 5.52
fy2025_investment_property_rs_mn: 109.9
fy2025_profit_for_the_year_rs_mn: 1086.6
fy2026_investment_property_rs_mn: 166.3
fy2026_profit_for_the_year_rs_mn: -476.0
q4fy2026_revenue_mix_flights_pct: 73.0
fy2025_equity_share_capital_rs_mn: 3544.1
fy2025_net_increase_in_cash_rs_mn: 353.3
fy2025_other_current_assets_rs_mn: 1541.4
fy2025_total_current_assets_rs_mn: 7736.2
fy2026_assets_held_for_sale_rs_mn: 910.3
fy2026_equity_share_capital_rs_mn: 3636.9
fy2026_net_decrease_in_cash_rs_mn: -559.4
fy2026_other_current_assets_rs_mn: 1036.9
fy2026_total_current_assets_rs_mn: 5916.4
q4fy2026_dubai_gbr_yoy_growth_pct: 95.7
yolobus_passengers_served_to_date: more than 2 million
fy2026_gross_booking_revenue_rs_cr: 8376
rights_issue_approved_amount_rs_cr: 500
fy2025_non_current_borrowings_rs_mn: 254.7
fy2025_working_capital_change_rs_mn: 241.3
fy2026_non_current_borrowings_rs_mn: 212.8
fy2026_working_capital_change_rs_mn: -979.2
spree_hotels_average_channel_rating: 4.8
fy2026_revenue_from_operations_rs_cr: 536
fy2026_share_of_associate_loss_rs_mn: -17.4
q4fy2026_gross_booking_revenue_rs_cr: 2138
fy2025_capital_work_in_progress_rs_mn: 32.4
fy2025_property_plant_equipment_rs_mn: 493.5
fy2026_capital_work_in_progress_rs_mn: 158.7
fy2026_property_plant_equipment_rs_mn: 807.5
fy2025_cash_and_cash_equivalents_rs_mn: 1361.5
fy2025_consolidated_other_income_rs_mn: 159.3
fy2025_employee_benefits_expense_rs_mn: 1028.3
fy2025_non_controlling_interests_rs_mn: 217.4
fy2025_total_current_liabilities_rs_mn: 2883.1
fy2026_cash_and_cash_equivalents_rs_mn: 802.2
fy2026_consolidated_other_income_rs_mn: 377.5
fy2026_employee_benefits_expense_rs_mn: 1298.0
fy2026_non_controlling_interests_rs_mn: 135.8
fy2026_total_current_liabilities_rs_mn: 2748.1
india_online_travel_market_2024_usd_bn: 22.8
india_online_travel_market_2027_usd_bn: 36.3
q4fy2025_revenue_from_operations_rs_cr: 139.5
q4fy2026_revenue_from_operations_rs_cr: 152
spree_hotels_five_year_property_target: 200
fy2025_consolidated_total_revenue_rs_mn: 6032.5
fy2025_other_comprehensive_income_rs_mn: 84.4
fy2026_consolidated_total_revenue_rs_mn: 5734.5
fy2026_hotel_room_nights_yoy_growth_pct: 89
fy2026_other_comprehensive_income_rs_mn: 62.0
preferential_allotment_javaphile_shares: 21327529
yolobus_target_electric_buses_by_fy2028: 2000+
q4fy2026_revenue_mix_hotels_holidays_pct: 26.1
fy2025_current_contract_liabilities_rs_mn: 924.8
fy2025_total_equity_and_liabilities_rs_mn: 11539.3
fy2026_current_contract_liabilities_rs_mn: 979.0
fy2026_total_equity_and_liabilities_rs_mn: 12083.6
preferential_allotment_levo_beauty_shares: 26659411
preferential_allotment_ssl_nirvana_shares: 109387377
q4fy2026_hotel_room_nights_yoy_growth_pct: 95.0
fy2025_depreciation_and_amortisation_rs_mn: 124.7
fy2026_depreciation_and_amortisation_rs_mn: 159.8
preferential_allotment_consideration_rs_cr: 319.63
fy2025_cash_generated_from_operations_rs_mn: 1730.8
fy2025_equity_attributable_to_holders_rs_mn: 7203.1
fy2026_cash_generated_from_operations_rs_mn: -928.4
fy2026_equity_attributable_to_holders_rs_mn: 8013.4
nse_slice_announcements_apr01_to_jun27_2026: 19
easy_green_mobility_planned_investment_rs_cr: 200
fy2025_trains_buses_others_transactions_lakh: 13.0
fy2026_trains_buses_others_transactions_lakh: 12.5
q4fy2026_revenue_mix_trains_buses_others_pct: 0.9
easy_green_mobility_investment_timeline_years: 2-3
fy2025_non_current_contract_liabilities_rs_mn: 802.3
fy2026_non_current_contract_liabilities_rs_mn: 808.1
fy2026_tax_benefit_on_exceptional_items_rs_mn: -99.3
india_online_travel_market_2024_2027_cagr_pct: 17
preferential_allotment_divyank_singhal_shares: 190424360
q4fy2025_trains_buses_others_transactions_lakh: 3.6
q4fy2026_trains_buses_others_transactions_lakh: 2.4
spree_hotels_signed_properties_pending_opening: about 31
fy2025_net_cash_from_operating_activities_rs_mn: 1118.2
fy2026_net_cash_from_operating_activities_rs_mn: -951.0
q4fy2026_revenue_from_operations_yoy_growth_pct: 8.9
fy2025_cash_flow_from_financing_activities_rs_mn: 157.8
fy2025_cash_flow_from_investing_activities_rs_mn: -922.7
fy2026_cash_flow_from_financing_activities_rs_mn: -97.0
fy2026_cash_flow_from_investing_activities_rs_mn: 488.7
fy2025_consolidated_revenue_from_operations_rs_mn: 5873.2
fy2026_consolidated_revenue_from_operations_rs_mn: 5357.0
fy2025_operating_profit_before_working_capital_rs_mn: 1489.5
fy2026_operating_profit_before_working_capital_rs_mn: 50.8
preferential_allotment_javaphile_consideration_rs_cr: 19.60
fy2026_investments_accounted_using_equity_method_rs_mn: 1123.8
fy2026_trains_buses_others_transactions_yoy_growth_pct: -4.3
preferential_allotment_levo_beauty_consideration_rs_cr: 24.50
preferential_allotment_ssl_nirvana_consideration_rs_cr: 100.53
q4fy2026_trains_buses_others_transactions_yoy_growth_pct: -31.8
preferential_allotment_divyank_singhal_consideration_rs_cr: 175.00
q4fy2026_hotels_and_packages_segment_revenue_yoy_growth_pct: 148
fy2025_total_comprehensive_income_after_exceptional_items_rs_mn: 1171.0
fy2026_total_comprehensive_income_after_exceptional_items_rs_mn: -413.9

Financial highlights

Dividend: Final dividend recommended at Rs 2.50 per fully paid-up equity share of Re 1 each for FY2026, subject to shareholder approval
FY2026 capex: About Rs 135 crore in management commentary and Rs 13,490 lakh in the investor-presentation cash bridge
Net debt / EBITDA: -0.1x in FY2026 versus 0.4x in FY2025 in the investor presentation
FY2026 adjusted PAT: Rs 180 crore, excluding one-time exceptional impact of goodwill impairment and New Wage Code employee-cost impact
Q4 FY2026 shipments: 117 kilotons versus 136 kilotons in Q3 FY2026 and 124 kilotons in Q4 FY2025
Postal-ballot voting: All May 18, 2026 postal-ballot resolutions were approved and deemed passed on June 21, 2026, including material related-party transaction resolutions with RHI Magnesita GmbH
Q4 FY2026 diluted EPS: Reported diluted loss per share of Rs 25.09 after the goodwill impairment; investor-presentation adjusted EPS was Rs 8.4 excluding impairment impact
Dalmia acquired assets: Management said Dalmia-asset revenue grew 14% to Rs 1,153 crore from Rs 1,013 crore and FY2026 EBITDA margin was 10.8%
FY2026 adjusted EBITDA: Rs 477 crore in the press release; Rs 47,689 lakh and 11.9% margin in the investor presentation; down from 13.7% margin in FY2025
FY2026 shipment volume: 523 kilotons, up 5% YoY in the press release and investor presentation
FY2027 capex indication: Around Rs 150 crore, including about Rs 40-50 crore maintenance capex, plus 4PRO robotics sales capex and structural growth capex
Q4 FY2026 adjusted EBITDA: Rs 113 crore, or Rs 11,306 lakh, with 12.1% adjusted EBITDA margin
FY2026 operating cash flow: Rs 409 crore in the press release; consolidated net cash inflow from operating activities of Rs 40,909.54 lakh in the audited cash-flow statement
FY2026 revenue from operations: Rs 4,020 crore in the press release; Rs 401,994.50 lakh in the consolidated results extract; up 9% YoY in the press release and 9.4% YoY in the investor presentation
Q4 FY2026 revenue from operations: Rs 93,225.90 lakh in the consolidated results extract and Rs 93,226 lakh in the investor presentation; management described it as Rs 932 crore on the call
Intermetal / Ashwath merger turnover: Intermetal Engineers FY2026 turnover of Rs 547.44 lakh and Ashwath Technologies FY2026 turnover of Rs 1,737.68 lakh in the subsidiary merger filing
FY2026 exceptional goodwill impairment: Rs 55,624.03 lakh in the consolidated results and cash-flow statement
Q4 FY2026 adjusted PAT before exceptional items: Rs 39 crore according to management commentary
FY2026 reported net loss after tax and exceptional item: Rs 38,293.78 lakh in the consolidated results extract
Q4 FY2026 reported net loss after tax and exceptional item: Rs 51,810.80 lakh in the consolidated results extract

Financial highlights

FY2026 dividend: Total dividend Rs 12/share, including special dividend Rs 8/share
Renewable power: 98 mn units per annum under long-term captive schemes; 19 mn units per annum ISTS solar at Dahej and Rourkela; 425 mn units per annum ISTS hybrid renewable power contracted for Tata Kalinganagar ASU operation
Lease liabilities: Rs 789.16 mn total current plus non-current at March 31, 2026
Trade receivables: Rs 5,079.94 mn at March 31, 2026 vs Rs 3,848.58 mn at March 31, 2025
FY2025 PED order book: Rs 20,207.21 mn as of March 31, 2025
FY2026 standalone EPS: Rs 64.59 vs Rs 52.51 in FY2025
FY2026 standalone PAT: Rs 5,508.74 mn vs Rs 4,478.13 mn in FY2025
FY2026 standalone PBT: Rs 7,270.10 mn vs Rs 6,064.72 mn in FY2025
FY2025 PED order intake: Rs 7,044.67 mn from third-party and inter-company orders, plus Rs 3,370.88 mn in-house project orders
FY2026 consolidated PAT: Rs 5,489.65 mn vs Rs 4,548.45 mn in FY2025
FY2026 consolidated PBT: Rs 7,334.75 mn vs Rs 6,135.04 mn in FY2025
Capital work-in-progress: Rs 13,427.84 mn at March 31, 2026 vs Rs 9,752.50 mn at March 31, 2025
FY2025 PED EBITDA margin: Management said PED EBITDA margin rose from 13.5% to 22.4%, but cautioned this may not be sustainable at around 20%
Q4 FY2026 standalone PAT: Rs 851.96 mn vs Rs 1,179.02 mn in Q4 FY2025 and Rs 1,915.90 mn in Q3 FY2026
Cash and cash equivalents: Rs 1,104.46 mn at March 31, 2026 vs Rs 1,453.71 mn at March 31, 2025
FY2026 gases segment PBIT: Standalone Rs 6,418.80 mn vs Rs 5,251.81 mn in FY2025
FY2026 total segment PBIT: Standalone Rs 7,606.99 mn vs Rs 6,247.78 mn in FY2025
FY2025 gases EBITDA margin: Management said gases EBITDA margin rose from 33.8% to 35.9%
Q4 FY2026 consolidated PAT: Rs 774.46 mn vs Rs 1,184.12 mn in Q4 FY2025 and Rs 1,933.25 mn in Q3 FY2026
FY2026 gases segment revenue: Standalone Rs 21,231.84 mn vs Rs 20,407.37 mn in FY2025
FY2026 power and fuel expense: Rs 4,174.41 mn vs Rs 5,228.92 mn in FY2025
Property, plant and equipment: Rs 19,859.20 mn at March 31, 2026 vs Rs 18,515.10 mn at March 31, 2025
FY2026 capex/capital-work spending: Purchase of PPE, CWIP and intangibles Rs 7,662.19 mn vs Rs 13,305.24 mn in FY2025
FY2026 project engineering segment PBIT: Standalone Rs 1,188.19 mn vs Rs 995.97 mn in FY2025
FY2026 net cash from operating activities: Rs 7,855.03 mn vs Rs 5,835.95 mn in FY2025
FY2026 standalone revenue from operations: Rs 25,306.40 mn vs Rs 24,853.76 mn in FY2025
FY2026 project engineering segment revenue: Standalone Rs 9,806.14 mn vs Rs 11,052.04 mn in FY2025
Q4 FY2026 standalone revenue from operations: Rs 6,143.33 mn vs Rs 5,918.75 mn in Q4 FY2025 and Rs 7,010.34 mn in Q3 FY2026
FY2026 operating cash flow before working capital: Rs 9,194.42 mn vs Rs 7,911.46 mn in FY2025

Financial highlights

Dividend: Rs 1.25 per equity share of Re 1 each, subject to shareholder approval; record date August 31, 2026
Gross debt: Around Rs 384 cr at the time of the earnings call according to management
ESOP scheme: Postal ballot approved Ion Exchange Employee Stock Option Scheme 2026 and related trust-route share-acquisition/funding resolutions
Bid pipeline: About Rs 9,509.0 cr / Rs 95,090 mn at March 31, 2026
Oman JV stake: ION Exchange holds 51% in Ion Exchange and Co. LLC Oman
Consolidated ROE: 11.2% in FY2026
Consolidated ROCE: 14.3% in FY2026
IEEFL SEBI matter: SEBI repayment direction of Rs 2,202 lakh disclosed in the audited-results notes, with appeal process before SAT
Malawi project JV: USD 18.1 mn water-treatment package awarded by Northern Region Water Board, Malawi
Oman DBOOT contract: OMR 73.46 mn, approximately Rs 1,730 cr, over 20 years
Outstanding UP SWSM: About Rs 295.5 cr / Rs 2,955 mn
FY2027 routine capex: About Rs 30 cr to Rs 40 cr according to management
Working-capital days: 91 days in FY2026 versus 94 days in FY2025
FY2026 Chemicals EBIT: Rs 182.3 cr / Rs 1,823 mn
FY2026 standalone PAT: Rs 138.4 cr / Rs 1,384 mn, down 35.5% YoY
Outstanding Sri Lanka: About Rs 10.0 cr / Rs 100 mn
Engineering order book: About Rs 2,643.3 cr / Rs 26,433 mn at March 31, 2026
FY2026 Engineering EBIT: Rs 90.2 cr / Rs 902 mn
FY2026 consolidated PAT: Rs 143.2 cr / Rs 1,432 mn, down 31.3% YoY
FY2026 Chemicals revenue: Rs 867.7 cr / Rs 8,677 mn consolidated
Oman DBOOT project capex: About USD 40 mn over two years, funded by debt and equity according to management
Q4 FY2026 Chemicals EBIT: Rs 33.4 cr / Rs 334 mn
Q4 FY2026 standalone PAT: Rs 19.6 cr / Rs 196 mn, down 69.7% YoY
FY2026 Engineering revenue: Rs 1,757.8 cr / Rs 17,578 mn consolidated
Q4 FY2026 Engineering EBIT: Rs 21.5 cr / Rs 215 mn
Q4 FY2026 consolidated PAT: Rs 24.3 cr / Rs 243 mn, down 61.6% YoY
Q4 FY2026 Chemicals revenue: Rs 229.7 cr / Rs 2,297 mn consolidated, up around 3% YoY
West Asia engineering impact: About Rs 60 cr of deferred engineering dispatches according to management
FY2026 Consumer Products EBIT: Loss of Rs 11.5 cr / Rs 115 mn
Q4 FY2026 Engineering revenue: Rs 553.9 cr / Rs 5,539 mn consolidated, broadly flat YoY
FY2026 consolidated PAT margin: 4.91%
Consolidated net debt-to-equity: 0.1x in FY2026
Engineering order intake growth: About 40% higher than the previous full financial year according to management
FY2026 consolidated revenue mix: 58% Engineering, 29% Chemicals and 13% Consumer Products
FY2026 standalone EBITDA margin: 6.88%
FY2026 Consumer Products revenue: Rs 379.4 cr / Rs 3,794 mn
Q4 FY2026 Consumer Products EBIT: Loss of Rs 4.6 cr / Rs 46 mn
FY2026 consolidated EBITDA margin: 7.21% versus 10.74% in FY2025
FY2026 consolidated geography mix: 74% domestic and 26% exports
Q4 FY2026 consolidated PAT margin: 2.81%
Engineering projects in order book: About Rs 2,337.8 cr / Rs 23,378 mn, excluding Sri Lanka and UP SWSM
FY2026 standalone operating EBITDA: Rs 184.3 cr / Rs 1,843 mn, down 35.4% YoY
FY2026 standalone operating income: Rs 2,678.9 cr / Rs 26,789 mn, up 5.5% YoY
Q4 FY2026 standalone EBITDA margin: 1.36%
Roha first-year utilization target: About 25% capacity utilization according to management
MANN+HUMMEL technology-transfer fee: 7.5% on revenue generated from manufactured products
Q4 FY2026 Consumer Products revenue: Rs 104.7 cr / Rs 1,047 mn, up 34% YoY
FY2026 consolidated operating EBITDA: Rs 210.2 cr / Rs 2,102 mn, down 28.5% YoY
FY2026 consolidated operating income: Rs 2,914.8 cr / Rs 29,148 mn, up 6.5% YoY
Q4 FY2026 consolidated EBITDA margin: 2.31% versus 10.28% in Q4 FY2025 and 8.07% in Q3 FY2026
Q4 FY2026 standalone operating EBITDA: Rs 11.1 cr / Rs 111 mn, down 86.7% YoY
Q4 FY2026 standalone operating income: Rs 813.9 cr / Rs 8,139 mn, up 3.7% YoY and 21.7% QoQ
Q4 FY2026 consolidated operating EBITDA: Rs 19.9 cr / Rs 199 mn, down 76.8% YoY and 66.4% QoQ
Q4 FY2026 consolidated operating income: Rs 863.3 cr / Rs 8,633 mn, up 3.4% YoY and 17.6% QoQ
FY2026 consolidated PBT before exceptional items: Rs 210.1 cr / Rs 2,101 mn, down 26.2% YoY
Q4 FY2026 consolidated PBT before exceptional items: Rs 32.5 cr / Rs 325 mn, down 61.9% YoY

Financial highlights

Call date: May 29, 2026
Employees: 950-plus
Merchants: More than 10 mn
FY2025 TPV: Rs 3.240 tn / Rs 3,240 bn
FY2026 TPV: Rs 5.038 tn / Rs 5,038 bn, up 55% YoY
Q4 FY2025 TPV: Rs 824 bn
Q4 FY2026 TPV: Rs 1.655 tn / Rs 1,655 bn, up 101% YoY
Domain experts: 300-plus
Geography plan: UAE and Oman operational; Saudi expected fully operational in FY2026; Australia and USA to be operational by FY2027
Current NSE ISIN: INE483S01020
Board result date: May 29, 2026
Rights issue size: Rs 699.99 cr
FY2025 adjusted PAT: Rs 209.5 cr / Rs 2,095 mn
FY2026 PAT guidance: Rs 250-275 cr; actual Rs 332.0 cr
FY2026 adjusted PAT: Rs 332.0 cr / Rs 3,320 mn, up 58% YoY
FY2026 payments NTR: 7 bps, down 40% YoY
Former company name: Infibeam Avenues Limited
OPL FY2025 turnover: Rs 69.00 cr
UAE approval holder: Avenues World FZ LLC, step-down subsidiary
OPL acquisition plan: Up to 7.00% stake for cash consideration not exceeding Rs 65.00 cr
FY2025 adjusted EBITDA: Rs 312.1 cr / Rs 3,121 mn
FY2026 EBITDA guidance: Rs 350-375 cr; actual Rs 387.3 cr
FY2026 adjusted EBITDA: Rs 387.3 cr / Rs 3,873 mn, up 24% YoY
Q4 FY2025 adjusted PAT: Rs 50.3 cr / Rs 503 mn
Q4 FY2026 adjusted PAT: Rs 95.5 cr / Rs 955 mn, up 90% YoY
Q4 FY2026 payments NTR: 6 bps, down 43% YoY
Transcript filing date: June 2, 2026
Annualized TPV run-rate: More than Rs 10 tn
UAE regulatory approval: CBUAE in-principle approval for Retail Payment Services - Category III License
Current NSE active symbol: CCAVENUE
Nueromind FY2026 turnover: Rs 4.80 cr
Q4 FY2025 adjusted EBITDA: Rs 77.9 cr / Rs 779 mn
Q4 FY2026 adjusted EBITDA: Rs 99.4 cr / Rs 994 mn, up 28% YoY
Ratnaafin FY2026 turnover: Rs 286.01 cr
Ratnaafin investment plan: Up to 2.50% stake for cash consideration not exceeding Rs 66.00 cr
Nueromind acquisition plan: Balance 9.90% stake for cash consideration not exceeding Rs 1.25 cr
FY2026 net revenue guidance: Rs 600-630 cr; actual Rs 603.1 cr
International payments goal: Targeting 12-15% international contribution to payments net revenue by FY2028
Rediff stake after transfer: 82.66% / about 82.7%
FY2026 gross revenue guidance: Rs 7,500-8,000 cr; actual Rs 8,115.8 cr
Rights issue oversubscription: 1.40x
India payment gateway position: Top 3 among B2B online payment gateways
Standalone FY2026 total income: Rs 7,627.19 cr / Rs 76,271.9 mn
FY2025 consolidated net revenue: Rs 525.8 cr / Rs 5,258 mn
FY2026 consolidated net revenue: Rs 603.1 cr / Rs 6,031 mn, up 15% YoY
FY2025 consolidated gross revenue: Rs 3,992.6 cr / Rs 39,926 mn
Standalone Q4 FY2026 total income: Rs 2,353.46 cr / Rs 23,534.6 mn
CARE GCP utilization by March 2026: Rs 169.34 cr against maximum Rs 175 cr
Q4 FY2025 consolidated net revenue: Rs 135.1 cr / Rs 1,351 mn
Q4 FY2026 consolidated net revenue: Rs 149.5 cr / Rs 1,495 mn, up 11% YoY
Q4 FY2025 consolidated gross revenue: Rs 1,160.5 cr / Rs 11,605 mn
Standalone investments at March 2026: Rs 1,509.96 cr non-current plus Rs 250.00 cr current
Standalone total assets at March 2026: Rs 5,840.03 cr / Rs 58,400.3 mn
Standalone total equity at March 2026: Rs 4,203.20 cr / Rs 42,032.0 mn
UAE non-bank private payment position: Top 2
CARE unutilized proceeds at March 2026: Rs 367.19 cr
Rediff business transfer consideration: Rs 800.39 cr
FY2025 adjusted PAT margin on net revenue: 40%
FY2026 adjusted PAT margin on net revenue: 55%
Standalone FY2026 revenue from operations: Rs 7,584.68 cr / Rs 75,846.8 mn
CARE issue proceeds utilized by March 2026: Rs 328.78 cr
CARE monitored amount raised by March 2026: Rs 695.98 cr
CARE amount yet to be received at March 2026: Rs 4.01 cr
FY2025 adjusted EBITDA margin on net revenue: 59%
FY2026 adjusted EBITDA margin on net revenue: 64%
Q4 FY2025 adjusted PAT margin on net revenue: 37%
Q4 FY2026 adjusted PAT margin on net revenue: 64%
Standalone FY2026 total comprehensive income: Rs 169.66 cr / Rs 1,696.6 mn
Standalone Q4 FY2026 revenue from operations: Rs 2,339.09 cr / Rs 23,390.9 mn
Q4 FY2025 adjusted EBITDA margin on net revenue: 58%
Q4 FY2026 adjusted EBITDA margin on net revenue: 66%
Standalone cash and cash equivalents at March 2026: Rs 599.06 cr / Rs 5,990.6 mn
Legacy queue symbol absent from current NSE EQ list: INFIBEAM
FY2026 consolidated gross revenue / revenue from operations: Rs 8,115.8 cr / Rs 81,158 mn, up 103% YoY
Standalone FY2026 profit after tax from continuing operations: Rs 93.55 cr / Rs 935.5 mn
Q4 FY2026 consolidated gross revenue / revenue from operations: Rs 2,489.5 cr / Rs 24,895 mn, up 115% YoY
Standalone FY2026 profit before tax from continuing operations: Rs 124.31 cr / Rs 1,243.1 mn
Standalone Q4 FY2026 profit after tax from continuing operations: Rs 26.52 cr / Rs 265.2 mn
Standalone Q4 FY2026 profit before tax from continuing operations: Rs 33.20 cr / Rs 332.0 mn

Financial highlights

ESOP grant: 46,200 options at Rs 250 per option under ESOP 2016 Tranche 10
FY2026 capex: Rs 67 crore
FY2026 volume: 1,004,000 tons
Q4 FY2026 volume: 267,000 tons
Expected FY2027 capex: Rs 131 crore in presentation; management call rounded to Rs 130 crore
FY2025 standalone EPS: Rs 23.7
FY2025 standalone PAT: Rs 90.8 crore
FY2026 free cash flow: Rs 60 crore
FY2026 standalone EPS: Rs 23.4
FY2026 standalone PAT: Rs 89.8 crore
FY2026 standalone PBT: Rs 118.8 crore
E-commerce revenue mix: Around 2.5%, target toward 5%
FY2026 dividend payout: 39.0%
FY2026 standalone EBIT: Rs 120.6 crore
FY2026 standalone ROCE: 19.9%
CRISIL long-term rating: CRISIL AA-/Stable reaffirmed
FY2026 branch additions: About 70 branches, mostly Air and Rail, plus 15 to 20 Surface branches
Q4 FY2026 volume growth: 4% YoY
FY2025 standalone EBITDA: Rs 143.0 crore
FY2026 multimodal growth: Around 20%
FY2026 standalone EBITDA: Rs 146.0 crore
Q3 FY2026 standalone PAT: Rs 22.9 crore
Q4 FY2025 standalone PAT: Rs 20.7 crore
Q4 FY2026 standalone EPS: Rs 5.4
Q4 FY2026 standalone PAT: Rs 20.8 crore
Q4 FY2026 standalone PBT: Rs 27.3 crore
Capex spent FY2023-FY2026: Rs 269 crore in the presentation; management call rounded to Rs 270 crore
FY2026 dividend per share: Rs 9.0
Q4 FY2025 standalone EBIT: Rs 27.8 crore
Q4 FY2026 standalone EBIT: Rs 28.3 crore
Promoter-group shareholding: 26,687,662 shares, 69.46% as of March 31, 2026
Q3 FY2026 standalone EBITDA: Rs 36.7 crore
Q4 FY2025 standalone EBITDA: Rs 33.7 crore
Q4 FY2026 standalone EBITDA: Rs 37.4 crore
CRISIL-rated bank facilities: Rs 100 crore
FY2026 standalone PAT growth: Down 1.0% YoY
FY2026 standalone PAT margin: 7.2%
FY2026 standalone PBT margin: 9.5%
FY2027 branch expansion plan: About 100 branches: 40 Surface and 60 Rail/Air/C2C
FY2026 multimodal revenue mix: 18.5% of revenue
FY2026 standalone EBIT margin: 9.6%
FY2027 volume growth guidance: 10% to 11%
FY2025 standalone total income: Rs 1,221.1 crore
FY2026 standalone other income: Rs 14.3 crore
FY2026 standalone total income: Rs 1,250.4 crore
FY2027 revenue growth guidance: 15% plus
Q4 FY2026 capacity utilization: 83.25% per call, 83.5% in presentation
Standalone payable days FY2026: 33 days
FY2026 standalone EBITDA growth: 1.9% YoY
FY2026 standalone EBITDA margin: 11.7%
FY2026 standalone current ratio: 3.06x
FY2026 standalone income growth: 2.3% YoY
Q4 FY2026 standalone PAT margin: 6.3%
Q4 FY2026 standalone PBT margin: 8.2%
FY2026 cash flow from operations: Rs 112 crore
Q4 FY2026 standalone EBIT margin: 8.5%
Revised FY2023-FY2027 capex plan: Rs 400 crore, revised from Rs 500 crore
Q3 FY2026 standalone total income: Rs 317.1 crore
Q4 FY2025 standalone total income: Rs 313.1 crore
Q4 FY2026 standalone other income: Rs 4.3 crore
Q4 FY2026 standalone total income: Rs 331.1 crore
Standalone receivable days FY2026: 58 days
Q4 FY2026 standalone EBITDA growth: 10.9% YoY and 1.9% QoQ
Q4 FY2026 standalone EBITDA margin: 11.3%
Q4 FY2026 standalone income growth: 6.3% YoY and 4.1% QoQ
Standalone net cash at March 31 2026: Rs 136.4 crore
FY2026 standalone total income growth: 2.4% YoY
Standalone total debt at March 31 2026: Rs 0.0 crore
FY2026 standalone cash-conversion ratio: 76.5%
FY2027 EBITDA margin improvement target: 100 to 150 bps, conditional on fuel and external stability
FY2025 standalone income from operations: Rs 1,208.3 crore
FY2026 standalone income from operations: Rs 1,236.2 crore
Q4 FY2026 standalone total income growth: 5.8% YoY and 4.4% QoQ
Standalone total assets at March 31 2026: Rs 1,000.1 crore
Standalone total equity at March 31 2026: Rs 828.8 crore
Standalone liquid assets at March 31 2026: Rs 136.4 crore
Standalone net working-capital days FY2026: 25 days
Q3 FY2026 standalone income from operations: Rs 314.1 crore
Q4 FY2025 standalone income from operations: Rs 307.5 crore
Q4 FY2026 standalone income from operations: Rs 326.8 crore
Standalone net debt/equity at March 31 2026: -0.16x
Standalone trade receivables at March 31 2026: Rs 238.6 crore
Standalone current investments at March 31 2026: Rs 121.0 crore
Standalone other bank balances at March 31 2026: Rs 3.9 crore
Standalone cash and cash equivalents at March 31 2026: Rs 11.5 crore

Financial highlights

BOT/HAM lane km: 452 lane km in Telangana and Karnataka
BOT/HAM portfolio: Two annuity projects and eight HAM projects
NH-167 HAM bid cost: Rs 1,734 crore; presentation also lists Rs 1,550 crore as newly won project value excluding GST/order-book inclusion basis
HAM bid project cost: Rs 9,618.8 crore across eight HAM projects
Standalone FY2026 PAT: Rs 116.06 crore, down 84% YoY
Standalone FY2026 PBT: Rs 169.65 crore, down 82% YoY
Consolidated FY2026 PAT: Rs 436.86 crore, down 56% YoY
Consolidated FY2026 PBT: Rs 522.81 crore, down 58% YoY
Kaleswaram ECL allowance: Rs 27.92 crore
Presentation filing date: May 29, 2026
Standalone FY2026 EBITDA: Rs 178.15 crore, down 72% YoY
Standalone Q4 FY2026 PAT: Rs 19.23 crore, down 74% YoY and up 9% QoQ
Standalone Q4 FY2026 PBT: Rs 40.27 crore, down 63% YoY and up 81% QoQ
Consolidated total assets: Rs 8,121.55 crore at March 31, 2026
Consolidated total equity: Rs 4,971.78 crore at March 31, 2026
Consolidated FY2026 EBITDA: Rs 711.35 crore, down 56% YoY
Consolidated Q4 FY2026 PAT: Rs 106.11 crore, up 1,298% YoY and 3% QoQ
Consolidated Q4 FY2026 PBT: Rs 130.83 crore, up 126% YoY and 18% QoQ
Malkajgiri flyover EPC LOA: Rs 235.07 crore excluding GST, 24-month construction period
Official transcript status: No official Q4 FY2026 transcript found in checked NSE Apr 1-Jun 27 source pack
Rasoolpura flyover EPC LOA: Rs 50 crore excluding GST, 24-month construction period
Audio-recording filing date: June 1, 2026
Order book at March 31 2026: Rs 8,672.5 crore
Standalone Q4 FY2026 EBITDA: Rs 28.30 crore, down 76% YoY
Mining project in order book: Rs 3,552.4 crore
Standalone trade receivables: Rs 871.48 crore at March 31, 2026
Consolidated Q4 FY2026 EBITDA: Rs 169.13 crore, down 24% YoY and up 1% QoQ
Consolidated trade receivables: Rs 808.36 crore at March 31, 2026
Consolidated current borrowings: Rs 167.82 crore at March 31, 2026
Pipeline projects in order book: Rs 832.4 crore
Standalone FY2026 EBITDA margin: 8.5%
Standalone FY2026 total revenue: Rs 2,096.72 crore, down 38% YoY
Consolidated FY2026 EBITDA margin: 26.4%
Consolidated FY2026 total revenue: Rs 2,698.01 crore, down 43% YoY
Consolidated Q4 FY2026 PAT margin: 15.3%
Hyderabad Growth Corridor EPC LOA: Rs 84 crore excluding GST, nine-month construction period
Irrigation projects in order book: Rs 1,667.7 crore
Other road projects in order book: Rs 651.7 crore
Recommended FY2026 final dividend: Rs 0.25 per equity share of face value Rs 2, subject to shareholder approval
ECR elevated-corridor HAM bid cost: Rs 2,163 crore; presentation also lists Rs 1,680 crore as newly won project value excluding GST/order-book inclusion basis
Standalone Q4 FY2026 EBITDA margin: 5.3%
Standalone Q4 FY2026 total revenue: Rs 535.33 crore, down 37% YoY and 8% QoQ
Consolidated non-current borrowings: Rs 2,269.78 crore at March 31, 2026
Consolidated Q4 FY2026 EBITDA margin: 24.3%
Consolidated Q4 FY2026 total revenue: Rs 695.59 crore, down 29% YoY and 6% QoQ
Standalone cash and cash equivalents: Rs 70.70 crore at March 31, 2026
Top-five road projects in order book: Rs 1,968.3 crore
Consolidated cash and cash equivalents: Rs 186.43 crore at March 31, 2026
Q4 FY2026 revised project-cost provision: Rs 135.52 crore
Standalone FY2026 net operating cash flow: Rs 42.71 crore
Consolidated FY2026 net financing cash flow: Rs 371.23 crore
Consolidated FY2026 net investing cash flow: Negative Rs 139.09 crore
Consolidated FY2026 net operating cash flow: Negative Rs 149.05 crore
Q4 FY2026 client-settlement claims recognized: Rs 162.97 crore
Expanded order book including newly won HAM projects: Rs 11,902.5 crore
New HAM projects not yet included in March order book: Rs 3,230 crore total
Kaleswaram Package 4 receivables/retention/unbilled amount: Rs 1,363.32 crore at March 31, 2026

Financial highlights

Revenue mix: OEM about 78%, non-OEM about 22%.
Part numbers: More than 5,000.
ESOP allotment: 198,500 shares at Rs 50 exercise price.
Export countries: 17.
Aftermarket network: More than 350 distributors, more than 20,000 retailers and more than 25,000 mechanics.
GST show-cause demand: Rs 10.47 cr plus interest and penalty.
Manufacturing locations: 10.
Aftermarket touch points: More than 20,000.
Lakshya RISE ROCE target: 40%.
Final dividend recommended: Rs 1.50 per share of face value Re 1.
ICRA rated bank facilities: Rs 550 cr.
Lakshya RISE revenue target: Rs 5,000 cr.
Audited standalone FY2026 PAT: Rs 249.25 cr.
Audited standalone FY2026 PBT: Rs 335.60 cr.
Audited standalone Q4 FY2026 PAT: Rs 84.76 cr.
Audited standalone Q4 FY2026 PBT: Rs 112.47 cr.
Trailer suspension service network: 29 authorized service centers plus dedicated Pillaipakkam training center.
Audited standalone FY2026 basic EPS: Rs 6.25.
ICRA commercial paper rating amount: Rs 100 cr carved out of working capital.
Lakshya RISE dividend payout target: 50%.
Presentation consolidated FY2026 PAT: Rs 231 cr, up 28% YoY.
Presentation consolidated FY2026 PBT: Rs 320 cr, up 25% YoY.
Audited standalone FY2026 diluted EPS: Rs 6.23.
Audited standalone FY2026 other equity: Rs 1,187.98 cr.
Audited standalone FY2026 total income: Rs 2,576.60 cr.
Audited standalone Q4 FY2026 basic EPS: Rs 2.13.
Lakshya RISE new-market revenue target: 40% from Indian After Market plus exports.
Presentation consolidated FY2026 EBITDA: Rs 394 cr, up 28% YoY.
Presentation consolidated Q4 FY2026 PAT: Rs 87 cr, up 50% QoQ and 74% YoY.
Presentation consolidated Q4 FY2026 PBT: Rs 116 cr, up 40% QoQ and 61% YoY.
Audited standalone Q4 FY2026 diluted EPS: Rs 2.12.
Audited standalone Q4 FY2026 total income: Rs 825.85 cr.
Presentation consolidated FY2026 net sales: Rs 2,612 cr, up 15% YoY.
Presentation consolidated Q4 FY2026 EBITDA: Rs 138 cr, up 31% QoQ and 62% YoY.
Presentation consolidated Q4 FY2026 net sales: Rs 840 cr, up 26% QoQ and 32% YoY.
Presentation consolidated Q4 FY2026 PBT margin: 13.8%.
Audited standalone inventories at March 31 2026: Rs 298.84 cr.
Audited standalone FY2026 investing cash outflow: Rs 268.44 cr.
Audited standalone total assets at March 31 2026: Rs 1,707.09 cr.
Audited standalone total equity at March 31 2026: Rs 1,227.94 cr.
Audited standalone FY2026 revenue from operations: Rs 2,538.53 cr.
Presentation consolidated Q4 FY2026 EBITDA margin: 16.5%.
Presentation consolidated Q4 FY2026 cash accruals: Rs 104 cr.
Audited standalone FY2026 net operating cash inflow: Rs 527.03 cr.
Audited standalone Q4 FY2026 revenue from operations: Rs 816.56 cr.
Audited standalone FY2026 PBT before exceptional item: Rs 346.73 cr.
Audited standalone FY2026 investments in subsidiaries: Rs 45.60 cr.
Audited standalone trade receivables at March 31 2026: Rs 80.84 cr.
Audited standalone Q4 FY2026 PBT before exceptional item: Rs 112.47 cr.
Audited standalone FY2026 new labour codes exceptional item: Rs 11.14 cr.
Audited standalone cash and cash equivalents at March 31 2026: Rs 61.40 cr.
Audited standalone FY2026 PPE and intangible capex including CWIP: Rs 135.74 cr.
Audited standalone FY2026 cash generated from operations before tax: Rs 622.53 cr.
Audited standalone FY2026 EBITDA-style profit before finance costs depreciation amortisation and tax: Rs 411.97 cr.
Audited standalone Q4 FY2026 EBITDA-style profit before finance costs depreciation amortisation and tax: Rs 131.72 cr.

Financial highlights

Revolt market share: About 70% share of India's EV motorcycle market in FY2025-26 per presentation.
Revolt dealer network: 221 dealer stores across 202 cities and 24 states or union territories.
Standalone FY2026 EPS: Negative Rs 1.32.
NeoSky FY2026 training: Close to 1,500 students, including about 1,000 trained on DGCA courses and about 85,000 cumulative training hours.
Consolidated FY2025 EPS: Rs 0.61.
Consolidated FY2026 EPS: Negative Rs 1.20.
Standalone Q4 FY2026 EPS: Negative Rs 0.90.
NeoSky FY2026 new clients: More than 30 new customers.
Revolt PM E-Drive subsidy: Rs 5,000 per motorcycle.
Cocoblu India unique items: About 8.4 million.
Consolidated Q4 FY2026 EPS: Negative Rs 0.80.
NeoSky FY2026 total income: Rs 22.3 cr versus Rs 3.4 cr in FY2025, 6x growth.
Revolt electric kilometres: 72.00 crore plus kilometres in the May 14, 2026 press release; 720,061,295 kilometres in the investor presentation.
Cocoblu India FY2026 orders: 13.7 cr versus 12.7 cr in FY2025, up 8%.
Cocoblu India active vendors: More than 1,500 in Q4 FY2026 versus more than 1,200 in FY2025.
RattanIndia Power FY2026 PLF: 82%.
Cocoblu India lifetime orders: About 45 cr.
Neobrands equity subscription: Rs 350 cr additional equity capital subscribed in FY2026.
Revolt March 2026 sales growth: About 3x month-on-month per April 1, 2026 press release.
Standalone FY2026 total income: Rs 18.16 cr.
Revolt cumulative rider savings: More than Rs 89.28 cr in the May 14 press release; more than Rs 150 cr fuel savings in the investor presentation.
Consolidated FY2025 total income: Rs 6,876.11 cr.
Consolidated FY2026 total income: Rs 7,536.99 cr.
Investment FY2026 segment result: Rs 170.82 cr loss.
NeoSky FY2026 new-client revenue: Rs 17.06 cr from new clients.
Presentation FY2026 total income: Rs 7,537 cr versus Rs 6,876 cr in FY2025, up 10%.
Standalone FY2026 loss after tax: Rs 181.98 cr loss.
Revolt avoided petrol consumption: 93.99 lakh litres in the May 14 press release.
Standalone FY2026 loss before tax: Rs 206.54 cr loss.
Standalone Q4 FY2026 total income: Rs 4.29 cr.
Consolidated FY2026 loss after tax: Rs 166.35 cr loss.
Consolidated FY2026 loss before tax: Rs 162.63 cr loss.
Consolidated Q4 FY2026 total income: Rs 1,697.56 cr.
Investment Q4 FY2026 segment result: Rs 133.58 cr loss.
Standalone Q4 FY2026 loss after tax: Rs 124.76 cr loss.
Consolidated FY2025 profit after tax: Rs 80.72 cr.
RattanIndia Power installed capacity: 1,350 MW.
Standalone Q4 FY2026 loss before tax: Rs 144.11 cr loss.
Consolidated FY2025 profit before tax: Rs 151.91 cr.
Consolidated Q4 FY2026 loss after tax: Rs 110.10 cr loss.
RattanIndia Power FY2026 availability: 88%.
Consolidated Q4 FY2026 loss before tax: Rs 122.63 cr loss.
EV e-motorcycles FY2026 segment income: Rs 135.98 cr.
EV e-motorcycles FY2026 segment result: Rs 29.26 cr loss.
Retail e-commerce FY2026 segment income: Rs 7,368.40 cr.
Retail e-commerce FY2026 segment result: Rs 132.75 cr.
EV e-motorcycles Q4 FY2026 segment income: Rs 33.31 cr.
EV e-motorcycles Q4 FY2026 segment result: Rs 6.23 cr loss.
RattanIndia Power contracted PPA capacity: 1,200 MW with Maharashtra State Electricity Distribution Company Limited.
Standalone FY2026 revenue from operations: Rs 18.06 cr.
Retail e-commerce Q4 FY2026 segment income: Rs 1,649.99 cr.
Retail e-commerce Q4 FY2026 segment result: Rs 40.97 cr.
Consolidated FY2025 revenue from operations: Rs 6,866.35 cr.
Consolidated FY2026 revenue from operations: Rs 7,530.51 cr.
Standalone Q4 FY2026 revenue from operations: Rs 4.23 cr.
Cocoblu India FY2026 revenues in presentation: Rs 7,351 cr versus Rs 6,528 cr in FY2025, up 13%.
Consolidated Q4 FY2026 revenue from operations: Rs 1,696.63 cr.
RattanIndia Power annual coal supply under FSA: 6.10 MMT.
RattanIndia Power FY2026 power exchange revenue: Rs 16.38 cr from 22.19 MUs sold.
Cocoblu India Q4 FY2026 revenues in presentation: Rs 1,644 cr versus Rs 1,461 cr in Q4 FY2025, up 13%.
Consolidated FY2026 share of profit in associate: Rs 1.55 cr.
Consolidated Q4 FY2026 share of profit in associate: Rs 1.55 cr.
Cocoblu India Q4 FY2026 average daily sales run rate: Rs 18.3 cr versus Rs 16.2 cr in Q4 FY2025.
RattanIndia Power unrealized loss in audited results: Rs 172.36 cr in FY2026, including Rs 135.12 cr in Q4 FY2026.
Cocoblu Retail Q4 FY2026 total income in presentation: Rs 1,647 cr versus Rs 1,464 cr in Q4 FY2025, up 13%.
Consolidated FY2026 loss before share of associate and tax: Rs 164.18 cr loss.
Consolidated Q4 FY2026 loss before share of associate and tax: Rs 124.18 cr loss.
Presentation FY2026 EBITDA excluding RattanIndia Power mark-to-market loss: Rs 98 cr.
RattanIndia Power mark-to-market fair-value loss excluded from EBITDA bridge: Rs 172 cr.

Financial highlights

Final dividend: Rs 17.70 per share, equal to 177% of Rs 10 face value.
KOH capacity change: From 120 TPD to 200 TPD.
Standalone FY2026 EPS: Rs 2.84.
Standalone FY2026 PAT: Rs 20.84 cr.
Standalone FY2026 PBT: Rs 43.97 cr.
GACL-NALCO FY2026 loss: Rs 38.69 cr.
Renewable energy share: 35.7% in FY2026 versus 29.7% in FY2025.
Consolidated FY2026 EPS: Negative Rs 0.33.
Consolidated FY2026 PBT: Rs 20.72 cr.
Standalone Q4 FY2026 EPS: Rs 1.08.
Standalone Q4 FY2026 PAT: Rs 7.93 cr.
Standalone Q4 FY2026 PBT: Rs 8.32 cr.
CleanMax renewable project: 75.90 MW wind plus 84.34 MWp solar.
Consolidated Q4 FY2026 EPS: Rs 2.04.
Consolidated Q4 FY2026 PAT: Rs 14.98 cr.
Consolidated FY2026 net loss: Rs 2.41 cr.
MD press-release FY2026 EBITDA: Rs 522 cr, up Rs 69 cr or 15% YoY.
Standalone FY2026 total equity: Rs 5,570.91 cr.
Standalone FY2026 total income: Rs 4,474.70 cr.
Boiler project power generation: About 12 MW.
Consolidated FY2026 total income: Rs 4,474.70 cr.
Food-grade phosphoric acid capex: Rs 560 cr plus or minus 5%.
Standalone Q4 FY2026 total income: Rs 1,143.70 cr.
Biofuel or coal-fired boiler capex: Rs 389 cr aggregate estimated cost.
Cleanmax Sphere Energy contribution: Rs 32.33 cr to maintain 26% shareholding.
Consolidated Q4 FY2026 total income: Rs 1,143.70 cr.
High-purity hydrogen peroxide capex: Rs 67 cr estimated investment.
KOH expected annual revenue increase: Rs 130 cr at current market price.
KOH relocation and enhancement capex: About Rs 80 cr.
Standalone FY2026 current borrowings: Rs 327.57 cr.
MD press-release FY2026 sales revenue: Rs 4,246 cr, up Rs 287 cr or 7% YoY.
Standalone FY2026 operating cash flow: Rs 406.44 cr.
CleanMax expected annual CO2 reduction: About 2,64,204 tons.
Standalone FY2026 non-current borrowings: Rs 240.06 cr.
CleanMax expected annual power generation: About 36.9 crore units.
Standalone FY2026 revenue from operations: Rs 4,358.08 cr.
Consolidated FY2026 revenue from operations: Rs 4,358.08 cr.
Standalone FY2026 cash and cash equivalents: Rs 157.22 cr.
Standalone Q4 FY2026 revenue from operations: Rs 1,125.31 cr.
Consolidated Q4 FY2026 revenue from operations: Rs 1,125.31 cr.
GACL-NALCO accumulated losses at March 31 2026: Rs 633.31 cr.
High-purity hydrogen peroxide project timeline: 18 months from zero date.
Consolidated Q4 FY2026 PBT after JV and associates: Rs 15.37 cr.
Food-grade phosphoric acid expected annual revenue: Up to Rs 350 cr at current market price.
Consolidated FY2026 JV and associates share of loss: Rs 23.25 cr.
Consolidated FY2026 profit before JV and associates: Rs 43.97 cr.
Investment in GACL-NALCO equity reviewed for impairment: Rs 414.00 cr carrying value; no impairment provision recognized.
High-purity hydrogen peroxide expected annual sales revenue: About Rs 42 cr.

Financial highlights

Current ratio: 1.48 as of March 31, 2026.
TTM attrition: 17.0%.
AI specialists: 600 per presentation.
Active clients: 306-plus as of March 31, 2026 per presentation.
People strength: 6,497 as of March 31, 2026.
Repeat business: 92.6% per presentation.
Client additions: 10 in Q4 FY2026 and 51 in FY2026.
FY2026 basic EPS: Rs 14.12.
Debt-equity ratio: 0.88 as of March 31, 2026.
FY2026 current tax: Rs 7,952 lakhs.
FY2026 diluted EPS: Rs 14.11.
FY2027 hiring plan: About 1,050 people.
GBS FY2026 revenue: Rs 7,866 lakhs.
FY2025 other income: Rs 10,138 lakhs.
FY2025 total income: Rs 2,16,222 lakhs.
FY2026 adjusted EPS: Rs 18.51.
FY2026 adjusted PAT: Rs 278.63 cr.
FY2026 deferred tax: Credit of Rs 793 lakhs.
FY2026 other income: Rs 8,497 lakhs.
FY2026 total income: Rs 2,40,008 lakhs.
IMSS FY2026 revenue: Rs 38,909 lakhs.
PDES FY2026 revenue: Rs 1,84,736 lakhs.
Q4 FY2026 basic EPS: Rs 4.06.
Dividend record date: July 17, 2026.
FY2025 finance costs: Rs 9,948 lakhs.
FY2026 dividend paid: Rs 9,391 lakhs.
FY2026 finance costs: Rs 9,736 lakhs.
FY2025 other expenses: Rs 34,108 lakhs.
FY2025 total expenses: Rs 1,89,460 lakhs.
FY2026 other expenses: Rs 35,078 lakhs.
FY2026 total expenses: Rs 2,09,728 lakhs.
GBS Q4 FY2026 revenue: Rs 2,530 lakhs.
Q3 FY2026 utilization: 82.0%.
Q4 FY2025 utilization: 77.4%.
Q4 FY2026 current tax: Rs 1,644 lakhs.
Q4 FY2026 diluted EPS: Rs 4.06.
Q4 FY2026 utilization: 81.4%.
GBS FY2026 revenue mix: 3.3%.
IMSS Q4 FY2026 revenue: Rs 10,256 lakhs.
PDES Q4 FY2026 revenue: Rs 47,622 lakhs.
Q3 FY2026 other income: Rs 1,572 lakhs.
Q3 FY2026 total income: Rs 60,328 lakhs.
Q4 FY2025 other income: Rs 2,595 lakhs.
Q4 FY2025 total income: Rs 57,052 lakhs.
Q4 FY2026 adjusted EPS: Rs 4.74.
Q4 FY2026 adjusted PAT: Rs 71.36 cr.
Q4 FY2026 deferred tax: Rs 287 lakhs.
Q4 FY2026 other income: Rs 1,761 lakhs.
Q4 FY2026 total income: Rs 62,169 lakhs.
Dividend payment timing: On or after August 4, 2026, subject to shareholder approval.
FY2025 consolidated PAT: Rs 18,466 lakhs.
FY2025 consolidated PBT: Rs 25,546 lakhs.
FY2026 consolidated PAT: Rs 21,262 lakhs.
FY2026 consolidated PBT: Rs 28,421 lakhs.
IMSS FY2026 revenue mix: 16.2%.
PDES FY2026 revenue mix: 77.0%.
Q3 FY2026 finance costs: Rs 2,452 lakhs.
Q4 FY2025 finance costs: Rs 2,474 lakhs.
Q4 FY2026 finance costs: Rs 2,261 lakhs.
FY2026 total tax expense: Rs 7,159 lakhs.
Q3 FY2026 other expenses: Rs 8,841 lakhs.
Q3 FY2026 total expenses: Rs 52,705 lakhs.
Q4 FY2025 other expenses: Rs 10,153 lakhs.
Q4 FY2025 total expenses: Rs 50,798 lakhs.
Q4 FY2026 other expenses: Rs 9,604 lakhs.
Q4 FY2026 total expenses: Rs 54,465 lakhs.
GBS FY2026 segment result: Rs 1,099 lakhs.
Q4 FY2026 pipeline growth: 27% per management commentary.
FY2025 financing cash flow: Net cash generated of Rs 49,945 lakhs.
FY2025 investing cash flow: Net cash used of Rs 76,216 lakhs.
FY2025 operating cash flow: Rs 23,642 lakhs.
FY2026 financing cash flow: Net cash used of Rs 14,372 lakhs.
FY2026 investing cash flow: Net cash used of Rs 12,129 lakhs.
FY2026 operating cash flow: Rs 26,141 lakhs.
Final dividend recommended: Rs 3.65 per equity share of face value Rs 2.
IMSS FY2026 segment result: Rs 10,554 lakhs.
PDES FY2026 segment result: Rs 46,876 lakhs.
Q3 FY2026 consolidated PAT: Rs 4,030 lakhs.
Q3 FY2026 consolidated PBT: Rs 5,420 lakhs.
Q4 FY2025 consolidated PAT: Rs 3,400 lakhs.
Q4 FY2025 consolidated PBT: Rs 5,038 lakhs.
Q4 FY2026 consolidated PAT: Rs 6,117 lakhs.
Q4 FY2026 consolidated PBT: Rs 8,048 lakhs.
Aureus acquisition goodwill: Rs 4,783 lakhs.
Debt service coverage ratio: 5.26 for FY2026.
FY2026 total segment result: Rs 58,529 lakhs.
FY2027 operating-margin aim: 17.5% to 18.5%, not formal guidance per management.
Q4 FY2026 total tax expense: Rs 1,931 lakhs.
GBS Q4 FY2026 segment result: Rs 332 lakhs.
Goodwill as of March 31 2026: Rs 77,728 lakhs.
PureSoftware NCLT order date: May 29, 2026.
IMSS Q4 FY2026 segment result: Rs 2,925 lakhs.
PDES Q4 FY2026 segment result: Rs 13,280 lakhs.
Q4 FY2026 total segment result: Rs 16,537 lakhs.
AI productivity training target: 90% of engineers, testers and service-delivery personnel by end FY2027.
Aureus earn-out fair-value gain: Rs 1,591 lakhs in Q4 FY2026 and FY2026.
FY2025 employee benefit expense: Rs 1,36,534 lakhs.
FY2026 EBITDA per press release: Rs 488.35 cr; margin 20.3%.
FY2026 constant-currency growth: 9.2%.
FY2026 employee benefit expense: Rs 1,56,095 lakhs.
FY2027 aspirational growth goal: 15%.
Interest service coverage ratio: 4.26 for FY2026.
Labour Codes exceptional charge: Rs 2,203 lakhs in Q3 FY2026.
Trade receivable turnover ratio: 6.19 for FY2026.
Total assets as of March 31 2025: Rs 3,35,906 lakhs.
Total assets as of March 31 2026: Rs 3,62,511 lakhs.
Total debt to total assets ratio: 0.41 as of March 31, 2026.
Total equity as of March 31 2026: Rs 1,68,949 lakhs.
FY2026 total comprehensive income: Rs 20,219 lakhs.
PureSoftware acquisition goodwill: Rs 56,740 lakhs.
Billion-dollar-corporation clients: 91 per management commentary.
Dedicated AI and GenAI team target: 1,000 people by end FY2027.
GBS FY2026 growth per presentation: 120.8%.
PureSoftware scheme appointed date: April 1, 2026.
Q3 FY2026 employee benefit expense: Rs 39,205 lakhs.
Q4 FY2025 employee benefit expense: Rs 35,916 lakhs.
Q4 FY2026 EBITDA per press release: Rs 121.20 cr; margin 19.5%.
Q4 FY2026 constant-currency growth: 0.5% QoQ and 6.4% YoY.
Q4 FY2026 employee benefit expense: Rs 40,444 lakhs.
Q4 FY2026 operating revenue in USD: $65.0 million, down 1.0% QoQ and up 3.5% YoY.
IMSS FY2026 growth per presentation: 18.5%.
PDES FY2026 growth per presentation: 8.9%.
FY2025 depreciation and amortisation: Rs 8,870 lakhs.
FY2026 contingent consideration paid: Rs 16,489 lakhs.
FY2026 depreciation and amortisation: Rs 8,819 lakhs.
Q4 FY2026 total comprehensive income: Rs 5,304 lakhs.
Aureus acquisition cash consideration: Rs 7,149 lakhs.
Aureus identifiable intangible assets: Rs 4,398 lakhs.
Total liabilities as of March 31 2026: Rs 1,93,562 lakhs.
Trade receivables as of March 31 2026: Rs 39,027 lakhs.
Current borrowings as of March 31 2026: Rs 1,06,974 lakhs.
Current investments as of March 31 2026: Rs 50,352 lakhs.
FY2026 total dividend per press release: Rs 6.40 per equity share.
GenAI-enabled developer and tester base: More than 75% per presentation.
Q3 FY2026 depreciation and amortisation: Rs 2,207 lakhs.
Q4 FY2025 depreciation and amortisation: Rs 2,255 lakhs.
Q4 FY2026 depreciation and amortisation: Rs 2,156 lakhs.
FY2025 exceptional item charge or credit: Charge of Rs 1,216 lakhs.
FY2026 exceptional item charge or credit: Charge of Rs 1,859 lakhs.
FY2027 constant-currency growth guidance: 12.5%.
Net worth under Companies Act definition: Rs 1,70,443 lakhs as of March 31, 2026.
FY2026 operating margin per press release: Rs 401.62 cr; margin 17.4%.
FY2026 operating revenue per presentation: Rs 2,315 cr, up 12.3% YoY.
Non-current borrowings as of March 31 2026: Rs 34,292 lakhs.
FY2025 consolidated revenue from operations: Rs 2,06,084 lakhs.
FY2026 consolidated revenue from operations: Rs 2,31,511 lakhs.
Other intangible assets as of March 31 2026: Rs 19,939 lakhs.
PureSoftware acquisition cash consideration: Rs 64,229 lakhs.
PureSoftware identifiable intangible assets: Rs 15,718 lakhs.
Q3 FY2026 exceptional item charge or credit: Charge of Rs 2,203 lakhs.
Q4 FY2025 exceptional item charge or credit: Charge of Rs 1,216 lakhs.
Q4 FY2026 exceptional item charge or credit: Credit of Rs 344 lakhs.
Q4 FY2026 operating margin per press release: Rs 106.21 cr; margin 17.5%.
Q4 FY2026 operating revenue per presentation: Rs 604 cr, up 2.8% QoQ and 10.9% YoY.
Cash and cash equivalents as of March 31 2026: Rs 11,966 lakhs.
FY2025 profit before exceptional items and tax: Rs 26,762 lakhs.
FY2026 profit before exceptional items and tax: Rs 30,280 lakhs.
Q3 FY2026 consolidated revenue from operations: Rs 58,756 lakhs.
Q4 FY2025 consolidated revenue from operations: Rs 54,457 lakhs.
Q4 FY2026 consolidated revenue from operations: Rs 60,408 lakhs.
Q3 FY2026 profit before exceptional items and tax: Rs 7,623 lakhs.
Q4 FY2025 profit before exceptional items and tax: Rs 6,254 lakhs.
Q4 FY2026 profit before exceptional items and tax: Rs 7,704 lakhs.
Bank balances other than cash and cash equivalents: Rs 79,305 lakhs as of March 31, 2026.
Other current financial assets as of March 31 2026: Rs 16,684 lakhs.
PureSoftware contingent-consideration fair-value loss: Rs 1,247 lakhs in Q4 FY2026 and FY2026.

Financial highlights

FY2026 R&D opex: About Rs 45 cr to Rs 46 cr per management transcript
Country presence: 100-plus countries per investor presentation
FY2026 R&D capex: About Rs 20 cr per management transcript
FY2026 R&D spend: About Rs 65 cr to Rs 66 cr per management transcript
Customer references: 1000-plus references or plants worldwide per investor presentation
Overseas references: 400-plus per investor presentation
R&D scientist count: Almost 100 scientists per management transcript
JMD appointment term: April 30 2026 to April 29 2031 per April 28 filing
Standalone FY2026 PAT: Rs 1,205 mn per investor presentation
Standalone FY2026 PBT: Rs 1,622 mn per investor presentation
Standalone FY2026 tax: Rs 417 mn per investor presentation
Indian patents granted: 24 per investor presentation
Q4 FY2026 order intake: Rs 6,580 mn per investor presentation
Consolidated FY2026 PAT: Rs 238 mn per investor presentation
Consolidated FY2026 PBT: Rs 499 mn per investor presentation
Consolidated FY2026 tax: Rs 261 mn per investor presentation
Consolidated ROE FY2026: 2% per investor presentation
Deferred inquiry basket: More than Rs 300 cr per management transcript
FY2026 HiPurity revenue: Rs 3,326 mn per investor presentation
Q4 FY2026 order backlog: Rs 43,050 mn per investor presentation
Consolidated ROCE FY2026: 7% per investor presentation
FY2026 Bioenergy revenue: Rs 21,423 mn per investor presentation
Manufacturing facilities: Five per investor presentation
Repeat-customer business: More than 40% per investor presentation
Standalone FY2026 EBITDA: Rs 1,746 mn per investor presentation
Standalone Q4 FY2026 PAT: Rs 422 mn per investor presentation
Standalone Q4 FY2026 PBT: Rs 570 mn per investor presentation
Standalone Q4 FY2026 tax: Rs 148 mn per investor presentation
FY2026 export revenue mix: 36% per management transcript
Net debt to equity FY2026: -0.16x per investor presentation
Cash in hand March 31 2026: Rs 6.12 bn per management transcript
Consolidated FY2026 EBITDA: Rs 1,518 mn per investor presentation
Consolidated Q4 FY2026 PAT: Rs 116 mn per investor presentation
Consolidated Q4 FY2026 PBT: Rs 235 mn per investor presentation
Consolidated Q4 FY2026 tax: Rs 119 mn per investor presentation
FY2026 Engineering revenue: Rs 6,936 mn per investor presentation
Final dividend recommended: Rs 3.60 per equity share, 180% of Rs 2 face value
Q4 FY2026 HiPurity revenue: Rs 840 mn per investor presentation
Global ethanol market share: About 10% excluding China per investor presentation
Q4 FY2026 Bioenergy revenue: Rs 6,230 mn per investor presentation
Standalone Q4 FY2026 EBITDA: Rs 344 mn per investor presentation
GenX fixed-overhead run rate: Almost Rs 10 cr per month per management transcript
Standalone FY2026 PAT margin: 4.66% per investor presentation
Consolidated Q4 FY2026 EBITDA: Rs 233 mn per investor presentation
International patents granted: 60 per investor presentation
Q4 FY2026 Engineering revenue: Rs 1,380 mn per investor presentation
Standalone FY2026 diluted EPS: Rs 6.55 per investor presentation
Consolidated FY2026 PAT margin: 0.75% per investor presentation
Q4 FY2026 other-expense offset: About 2% reduction per management transcript
Consolidated FY2026 diluted EPS: Rs 1.30 per investor presentation
Consolidated inventories FY2026: Rs 2,661 mn per investor presentation
Standalone FY2026 EBITDA margin: 6.75% per investor presentation
Standalone Q4 FY2026 PAT margin: 6.09% per investor presentation
Consolidated other equity FY2026: Rs 12,724 mn per investor presentation
Consolidated total assets FY2026: Rs 30,559 mn per investor presentation
Consolidated total equity FY2026: Rs 13,093 mn per investor presentation
Standalone Q4 FY2026 diluted EPS: Rs 2.30 per investor presentation
Consolidated FY2026 EBITDA margin: 4.79% per investor presentation
Consolidated Q4 FY2026 PAT margin: 1.37% per investor presentation
Consolidated share capital FY2026: Rs 368 mn per investor presentation
Q4 FY2026 order intake Export mix: 21% per investor presentation
Consolidated Q4 FY2026 diluted EPS: Rs 0.631 per investor presentation
Consolidated current assets FY2026: Rs 23,676 mn per investor presentation
Consolidated trade payables FY2026: Rs 5,861 mn per investor presentation
Precision fermentation MoU partner: BRIC-NCCS per April 20 press release
Q4 FY2026 additional margin impact: About 1% to 1.5% per management transcript
Q4 FY2026 order backlog Export mix: 34% per investor presentation
Standalone FY2025 operating income: Rs 27,447 mn per investor presentation
Standalone FY2026 operating income: Rs 25,859 mn per investor presentation
Standalone Q4 FY2026 EBITDA margin: 4.97% per investor presentation
Q4 FY2026 order intake Domestic mix: 79% per investor presentation
Q4 FY2026 order intake HiPurity mix: 12% per investor presentation
Consolidated FY2025 operating income: Rs 32,280 mn per investor presentation
Consolidated FY2026 operating income: Rs 31,679 mn per investor presentation
Consolidated Q4 FY2026 EBITDA margin: 2.76% per investor presentation
Investor presentation patent filings: More than 400 patent filings per investor presentation
Q4 FY2026 order backlog Domestic mix: 66% per investor presentation
Q4 FY2026 order backlog HiPurity mix: 5% per investor presentation
Q4 FY2026 order intake Bioenergy mix: 86% per investor presentation
Consolidated lease liabilities FY2026: Rs 1,731 mn total non-current plus current lease-liability lines per investor presentation
Consolidated trade receivables FY2026: Rs 5,587 mn per investor presentation
JMD appointment postal-ballot support: 99.8878% votes in favour per June 18 filing
Q4 FY2026 order backlog Bioenergy mix: 78% per investor presentation
Q4 FY2026 raw-material price increase: About 3% on consolidated basis per management transcript
Standalone Q4 FY2025 operating income: Rs 7,011 mn per investor presentation
Standalone Q4 FY2026 operating income: Rs 6,928 mn per investor presentation
Consolidated non-current assets FY2026: Rs 6,883 mn per investor presentation
JMD remuneration postal-ballot support: 98.7951% votes in favour per June 18 filing
Mangalore facility approvals Q3 FY2026: About nine clients per management transcript
Q4 FY2026 order intake Engineering mix: 2% per investor presentation
Consolidated Q3 FY2026 operating income: Rs 8,415 mn per investor presentation
Consolidated Q4 FY2025 operating income: Rs 8,597 mn per investor presentation
Consolidated Q4 FY2026 operating income: Rs 8,446 mn per investor presentation
Consolidated current investments FY2026: Rs 4,069 mn per investor presentation
Consolidated current liabilities FY2026: Rs 16,189 mn per investor presentation
Consolidated other bank balances FY2026: Rs 614 mn per investor presentation
Indicative future order-inflow ballpark: Rs 800 cr to Rs 900 cr per management Q&A, not formal guidance
Q4 FY2026 order backlog Engineering mix: 16% per investor presentation
Consolidated other current assets FY2026: Rs 9,172 mn per investor presentation
Consolidated working-capital days FY2026: 91 days per investor presentation
Consolidated FY2025 PAT per press release: Rs 2,189.3 mn
Consolidated FY2026 PAT per press release: Rs 238.5 mn
FY2026 consolidated revenue mix Bioenergy: 67% per management transcript and investor presentation
Mangalore facility approvals by call date: About 12 to 13 clients per management transcript
Q4 FY2026 consolidated revenue mix Export: 26% per investor presentation
Consolidated non-current liabilities FY2026: Rs 1,277 mn per investor presentation
FY2026 consolidated revenue mix Engineering: 22% per management transcript and investor presentation
Precision Fermentation Lab patent portfolio: More than 300 national and international patents per April 20 press release
Q4 FY2026 consolidated revenue mix Domestic: 74% per investor presentation
Q4 FY2026 consolidated revenue mix HiPurity: 10% per investor presentation
Consolidated Q3 FY2026 PAT per press release: Rs -123.9 mn
Consolidated Q4 FY2025 PAT per press release: Rs 398.2 mn
Consolidated Q4 FY2026 PAT per press release: Rs 116.1 mn
Q4 FY2026 consolidated revenue mix Bioenergy: 74% per investor presentation
Consolidated FY2025 revenue per press release: Rs 32,280.4 mn
Consolidated FY2026 revenue per press release: Rs 31,678.8 mn
Consolidated cash and cash equivalents FY2026: Rs 1,424 mn per investor presentation
Q4 FY2026 consolidated revenue mix Engineering: 16% per investor presentation
FY2026 consolidated revenue mix PHS or HiPurity: 11% per management transcript and investor presentation
Consolidated Q3 FY2026 revenue per press release: Rs 8,414.9 mn
Consolidated Q4 FY2025 revenue per press release: Rs 8,596.8 mn
Consolidated Q4 FY2026 revenue per press release: Rs 8,445.6 mn
Data-center modular-cooling opportunity ticket size: Rs 50 cr to Rs 150 cr per management transcript
Consolidated Q4 FY2026 order intake per press release: Rs 6,580 mn
Standalone FY2026 profit before exceptional items and tax: Rs 1,860 mn per investor presentation
Consolidated order backlog March 31 2025 per press release: Rs 42,930 mn
Consolidated order backlog March 31 2026 per press release: Rs 43,050 mn
Consolidated FY2026 profit before exceptional items and tax: Rs 763 mn per investor presentation
Standalone Q4 FY2026 profit before exceptional items and tax: Rs 499 mn per investor presentation
Consolidated Q4 FY2026 profit before exceptional items and tax: Rs 155 mn per investor presentation
Consolidated FY2025 PBT before exceptional items per press release: Rs 2,703.9 mn
Consolidated FY2026 PBT before exceptional items per press release: Rs 762.9 mn
Consolidated Q3 FY2026 PBT before exceptional items per press release: Rs 216.1 mn
Consolidated Q4 FY2025 PBT before exceptional items per press release: Rs 582.5 mn
Consolidated Q4 FY2026 PBT before exceptional items per press release: Rs 154.7 mn

Financial highlights

Net debt: Negative Rs 206 crore in FY2026 according to the investor presentation
FY2026 EPS: Rs 7.20 basic and diluted
FY2026 PAT: Rs 179.27 crore, 6.63% margin, up 5.25% YoY
FY2026 PBT: Rs 241.46 crore, 8.94% margin
FY2026 capex: Rs 139 crore net of financial assistance in the investor presentation; management cited about Rs 130 crore on the call
FY2026 EBITDA: Rs 373.98 crore, 13.84% margin
Q4 FY2026 EPS: Rs 2.72 basic and diluted
Q4 FY2026 PAT: Rs 67.67 crore, 9.01% margin, up 20.37% YoY and 154.97% QoQ
Q4 FY2026 PBT: Rs 90.78 crore, 12.09% margin, up 20.46% YoY and 152.73% QoQ
Final dividend: Rs 3.50 per share, 350% of face value, aggregating to Rs 87.13 crore subject to shareholder approval; record date September 18, 2026
Q4 FY2026 EBITDA: Rs 123.98 crore, 16.51% margin, up 10.65% YoY and 78.67% QoQ
FY2026 pairs sold: 17.5 crore pairs versus 17.8 crore pairs in FY2025
Distribution reach: About 70,000-plus retailers/MBOs, 630 active distributors, 420 EBOs and exports to about 37 countries
FY2026 total income: Rs 2,748.36 crore versus Rs 2,816.57 crore in FY2025
Operating cash flow: Cash generated from operations before taxes Rs 414.98 crore and net cash generated from operating activities Rs 348.25 crore
Q4 FY2026 pairs sold: 5.0 crore pairs versus 4.5 crore pairs in Q4 FY2025
FY2027 capex guidance: About Rs 180 crore to Rs 200 crore, including about Rs 30 crore to Rs 35 crore for 100 new EBOs
Manufacturing capacity: 9 manufacturing facilities and about 10.5 lakh pairs per day capacity
Q4 FY2026 total income: Rs 762.76 crore versus Rs 703.24 crore in Q4 FY2025 and Rs 678.99 crore in Q3 FY2026
FY2026 brand revenue mix: 23% Hawai, 36% Flite and 41% Sparx according to the investor presentation
FY2026 average realization: Rs 153 per pair versus Rs 156 in FY2025
FY2026 channel revenue mix: 74% General Trade, 9% New Channel, 12% Retail and 5% Export
Q4 FY2026 average realization: Rs 150 per pair versus Rs 153 in Q4 FY2025 and Rs 164 in Q3 FY2026
Balance sheet at March 31 2026: Net worth Rs 2,206.36 crore, inventories Rs 556.72 crore, trade receivables Rs 298.89 crore, current investments Rs 188.42 crore and cash and cash equivalents Rs 17.69 crore
FY2026 revenue from operations: Rs 2,702.16 crore versus Rs 2,789.61 crore in FY2025, down 3.13%
Q4 FY2026 revenue from operations: Rs 751.10 crore, up 8.05% YoY and 12.44% QoQ
Clean Max renewable SPV investment: Up to Rs 2.50 crore for about 26% equity in a proposed captive solar-power SPV for Haryana manufacturing facilities
FY2026 regional revenue mix for General Trade: 52% North, 24% East, 14% West and 10% South

Financial highlights

Call date: May 29, 2026
Audit opinion: B S R and Co. issued unmodified audit reports on standalone and consolidated annual financial results
Board meeting: May 29, 2026; commenced 11:45 a.m. and concluded 2:05 p.m.
Group net cash: Management said group net cash was about Rs 2,400 cr
NPPA demand notice: Rs 4.92 cr demand including overcharge amount, penalty and interest; company said no material financial, operational or other impact
FY2027 PAT guidepost: Management expects about Rs 700-750 cr PAT including assumed Adcock associate profit
FY2027 R&D guidepost: About 7%-9% of revenue, already budgeted in PAT expectation
FY2027 tax guidepost: About 25% including surcharge under the new tax regime
FY2026 segment result: Pharmaceuticals Rs 1,547.3 cr; agro chemicals negative Rs 19.8 cr
FY2026 total dividend: Rs 5 per equity share of face value Rs 2
FY2026 segment revenue: API Rs 234.7 cr; pharma export formulations Rs 3,234.5 cr; domestic formulations Rs 440.9 cr; crop health sciences Rs 138.2 cr; other operating and non-operating income Rs 327.5 cr
Transcript filing date: June 4, 2026 with NSE/BSE
Consolidated FY2026 EPS: Rs 79.20
Consolidated FY2026 PAT: Rs 1,418.5 cr versus Rs 1,883.4 cr in FY2025
Crop health FY2026 sales: About Rs 140 cr management-cited sales versus about Rs 60 cr in FY2025
FY2027 revenue guidepost: Management expects about Rs 3,400-3,500 cr revenue
Q4 FY2026 segment result: Pharmaceuticals Rs 155.4 cr; agro chemicals negative Rs 0.4 cr
Adcock Ingram acquisition: 35.75% stake completed November 11, 2025 for ZAR 3,873 million, or Rs 1,991.2 cr, plus Rs 87.9 cr transaction costs
Q4 FY2026 segment revenue: API Rs 63.9 cr; pharma export formulations Rs 539.6 cr; domestic formulations Rs 108.7 cr; crop health sciences Rs 22.6 cr; other operating and non-operating income Rs 82.1 cr
Consolidated FY2026 EBITDA: Rs 1,734.1 cr, 39.6% EBITDA margin including other income
Consolidated Q4 FY2026 EPS: Rs 14.96
Consolidated Q4 FY2026 PAT: Rs 269.0 cr versus Rs 406.0 cr in Q4 FY2025
Standalone FY2026 net profit: Rs 1,281.5 cr
Consolidated Q4 FY2026 EBITDA: Rs 205.4 cr, 25.1% EBITDA margin including other income
Standalone FY2026 total income: Rs 3,875.7 cr
Standalone Q4 FY2026 net profit: Rs 209.6 cr
Consolidated FY2026 other income: Rs 297.6 cr
Consolidated FY2026 total income: Rs 4,375.9 cr versus Rs 4,784.0 cr in FY2025
Eribulin reference-product sales: USD 43.7 million estimated annual U.S. sales for Halaven per IQVIA MAT April 2026
Standalone Q4 FY2026 total income: Rs 681.7 cr
Consolidated Q4 FY2026 tax expense: Negative Rs 89.2 cr due to deferred-tax benefit
Consolidated Q4 FY2026 other income: Rs 77.8 cr
Consolidated Q4 FY2026 total income: Rs 816.9 cr versus Rs 1,287.3 cr in Q4 FY2025
Adcock FY2026 associate profit pickup: Rs 46.6 cr net of tax and Rs 4.7 cr share of OCI loss
FY2026 consolidated operating cash flow: Rs 1,768.3 cr net cash generated from operating activities
Brazil FY2026 size and FY2027 expectation: Brazil subsidiary turnover about Rs 257 cr plus about Rs 30 cr direct billing; FY2027 expectation about USD 55-60 million
Canada FY2026 size and growth expectation: Canada revenue about Rs 229 cr; expected to grow 10%-15%
Adcock Q4 FY2026 underlying revenue and PAT: Revenue Rs 1,208.2 cr and PAT Rs 102.5 cr; NATCO's share of profit Rs 35.7 cr
Consolidated FY2026 profit before associate: Rs 1,371.9 cr
Consolidated FY2026 revenue from operations: Rs 4,078.3 cr
Consolidated FY2026 share of associate profit: Rs 46.6 cr
Consolidated Q4 FY2026 profit before associate: Rs 233.3 cr
Consolidated Q4 FY2026 revenue from operations: Rs 739.1 cr
Consolidated Q4 FY2026 share of associate profit: Rs 35.7 cr
Consolidated FY2026 PBT before share of associate: Rs 1,490.8 cr
Consolidated Q4 FY2026 PBT before share of associate: Rs 144.1 cr

Financial highlights

Dividend: Board recommended Rs 1.50 per equity share for FY2026
Call date: May 29, 2026
FY2026 industry ARR: Rs 8,700-8,900
Owned hotel pipeline: 7 properties with 825 keys
Standalone FY2026 PAT: Rs 538 cr versus Rs 751 cr in FY2025
Trident FY2026 RevPAR: Rs 11,716, up 10.2% YoY
FY2026 industry RevPAR: Rs 5,650-5,850
Managed hotel pipeline: 24 properties with 1,893 keys
Q4 FY2026 industry ARR: Rs 10,000-10,200
Consolidated FY2026 EBIT: Rs 1,047 cr versus Rs 1,019 cr in FY2025
Standalone FY2026 EBITDA: Rs 1,064 cr versus Rs 1,005 cr in FY2025
Standalone Q4 FY2026 PAT: Rs 200 cr versus Rs 332 cr in Q4 FY2025
The Oberoi FY2026 RevPAR: Rs 22,004, up 10.4% YoY
Trident Q4 FY2026 RevPAR: Rs 14,350, up 6.8% YoY
FY2026 industry occupancy: 63%-65%
Net capex and investments: Rs 680 cr outflow in FY2026
Q4 FY2026 industry RevPAR: Rs 6,700-7,308
Consolidated FY2026 EBITDA: Rs 1,190 cr versus Rs 1,153 cr in FY2025
Consolidated surplus funds: Rs 1,335 cr at March 31, 2026 versus Rs 1,051 cr at March 31, 2025
Consolidated Q4 FY2026 EBIT: Rs 355 cr versus Rs 356 cr in Q4 FY2025
Standalone Q4 FY2026 EBITDA: Rs 339 cr versus Rs 336 cr in Q4 FY2025
The Oberoi Q4 FY2026 RevPAR: Rs 30,068, up 4.2% YoY
India keys at March 31, 2026: 3,801
Q4 FY2026 industry occupancy: 67%-69%
Consolidated Q4 FY2026 EBITDA: Rs 393 cr versus Rs 389 cr in Q4 FY2025
EIH owned hotels Q4 FY2026 ARR: Rs 28,198 versus Rs 24,548 in Q4 FY2025
Consolidated FY2026 tax expense: Rs 291 cr versus Rs 258 cr in FY2025
Standalone FY2026 total revenue: Rs 2,812 cr versus Rs 2,535 cr in FY2025
Consolidated FY2026 other income: Rs 166 cr versus Rs 136 cr in FY2025
Consolidated FY2026 finance costs: Rs 23 cr versus Rs 21 cr in FY2025
Consolidated FY2026 total revenue: Rs 3,106 cr versus Rs 2,879 cr in FY2025
EIH owned hotels Q4 FY2026 RevPAR: Rs 22,575 versus Rs 21,242 in Q4 FY2025
Consolidated Q4 FY2026 tax expense: Rs 119 cr versus Rs 93 cr in Q4 FY2025
Standalone Q4 FY2026 total revenue: Rs 860 cr versus Rs 757 cr in Q4 FY2025
Consolidated Q4 FY2026 other income: Rs 59 cr versus Rs 38 cr in Q4 FY2025
Consolidated Q4 FY2026 finance costs: Rs 6 cr versus Rs 6 cr in Q4 FY2025
Consolidated Q4 FY2026 total revenue: Rs 954 cr versus Rs 866 cr in Q4 FY2025
EIH owned hotels Q4 FY2026 occupancy: 80% versus 87% in Q4 FY2025
International keys at March 31, 2026: 408
Consolidated FY2026 exceptional items: Rs (132) cr versus Rs (28) cr in FY2025
Consolidated cash flow from operations: Rs 993 cr in FY2026
Consolidated FY2026 profit from operations: Rs 657 cr versus Rs 770 cr in FY2025
Consolidated FY2026 revenue from operations: Rs 2,940 cr versus Rs 2,743 cr in FY2025
Consolidated Q4 FY2026 profit from operations: Rs 249 cr versus Rs 262 cr in Q4 FY2025
Consolidated Q4 FY2026 revenue from operations: Rs 895 cr versus Rs 827 cr in Q4 FY2025
Consolidated Q4 FY2026 total comprehensive income: Rs 292 cr versus Rs 268 cr in Q4 FY2025
All domestic hotels including managed Q4 FY2026 ARR: Rs 26,536 versus Rs 23,648 in Q4 FY2025
All domestic hotels including managed Q4 FY2026 RevPAR: Rs 20,758 versus Rs 19,286 in Q4 FY2025
All domestic hotels including managed Q4 FY2026 occupancy: 78% versus 82% in Q4 FY2025
Consolidated FY2026 share of associates and joint ventures: Rs 57 cr versus Rs 59 cr in FY2025
Consolidated Q4 FY2026 share of associates and joint ventures: Rs 20 cr versus Rs 27 cr in Q4 FY2025
Consolidated FY2026 profit from operations before exceptional items and related tax: Rs 812 cr versus Rs 798 cr in FY2025

Financial highlights

Inventories: Rs 7,107 mn at March 31, 2026 versus Rs 6,085 mn at March 31, 2025
Total equity: About Rs 22,319 mn at March 31, 2026 in the segment capital-employed bridge
Trade receivables: Rs 7,239 mn at March 31, 2026 versus Rs 6,084 mn at March 31, 2025
Current borrowings: Rs 4,048 mn at March 31, 2026 versus Rs 4,837 mn at March 31, 2025
Standalone FY2026 PBT: Rs 4,645 mn versus Rs 4,676 mn in FY2025
Standalone Q4 FY2026 PBT: Rs 1,118 mn versus Rs 1,328 mn in Q4 FY2025
Cash and cash equivalents: Rs 1,635 mn at March 31, 2026 versus Rs 1,203 mn at March 31, 2025
Consolidated FY2026 EBITDA: Rs 5,835 mn with 14.8% EBITDA margin in the official presentation
Gain on sale of properties: Rs 372 mn included in FY2026 other income
Labour Code exceptional item: Rs 150 mn in FY2026
Standalone FY2026 net profit: Rs 3,453 mn versus Rs 3,501 mn in FY2025
Consolidated FY2026 basic EPS: Rs 13.65
Consolidated Q4 FY2026 EBITDA: Rs 1,739 mn with 15.6% EBITDA margin in the official presentation
Final dividend recommendation: Rs 2.70 per share of Re 1 face value, record date July 17, 2026
Standalone FY2026 diluted EPS: Rs 10.92 versus Rs 11.07 in FY2025
Consolidated FY2026 net profit: Rs 4,302 mn versus Rs 3,502 mn in FY2025
Standalone FY2026 total income: Rs 24,287 mn versus Rs 21,505 mn in FY2025
Consolidated FY2026 diluted EPS: Rs 13.61
Standalone Q4 FY2026 net profit: Rs 833 mn versus Rs 897 mn in Q3 FY2026 and Rs 992 mn in Q4 FY2025
Consolidated FY2026 reported PBT: Rs 5,774 mn after Rs 150 mn Labour Code exceptional item
Consolidated FY2026 total income: Rs 40,685 mn versus Rs 35,681 mn in FY2025
Consolidated Q4 FY2026 basic EPS: Rs 4.06
Consolidated Q4 FY2026 net profit: Rs 1,280 mn versus Rs 952 mn in Q3 FY2026 and Rs 1,020 mn in Q4 FY2025
Standalone Q4 FY2026 total income: Rs 6,887 mn versus Rs 6,226 mn in Q3 FY2026 and Rs 5,973 mn in Q4 FY2025
Consolidated Q4 FY2026 diluted EPS: Rs 4.05
Cash plus treasury per presentation: Rs 10,256 mn cash, Rs 4,049 mn debt and Rs 6,207 mn net cash at March 31, 2026
Consolidated Q4 FY2026 total income: Rs 11,348 mn versus Rs 10,279 mn in Q3 FY2026 and Rs 10,096 mn in Q4 FY2025
Air Compressors FY2026 segment result: Rs 5,484 mn versus Rs 4,426 mn in FY2025
Air Compressors FY2026 segment revenue: Rs 36,134 mn versus Rs 32,118 mn in FY2025
Consolidated FY2026 operating cash flow: Rs 4,535 mn versus Rs 3,909 mn in FY2025
Air Compressors Q4 FY2026 segment result: Rs 1,506 mn versus Rs 1,331 mn in Q3 FY2026 and Rs 1,245 mn in Q4 FY2025
Air Compressors Q4 FY2026 segment revenue: Rs 10,092 mn versus Rs 9,195 mn in Q3 FY2026 and Rs 8,999 mn in Q4 FY2025
Standalone FY2026 revenue from operations: Rs 23,429 mn versus Rs 20,809 mn in FY2025
Automotive Equipment FY2026 segment result: Rs 371 mn versus Rs 335 mn in FY2025
Automotive Equipment FY2026 segment revenue: Rs 3,386 mn versus Rs 3,015 mn in FY2025
Consolidated FY2026 revenue from operations: Rs 39,507 mn versus Rs 35,104 mn in FY2025
Standalone Q4 FY2026 revenue from operations: Rs 6,664 mn versus Rs 6,056 mn in Q3 FY2026 and Rs 5,802 mn in Q4 FY2025
Automotive Equipment Q4 FY2026 segment result: Rs 151 mn versus Rs 88 mn in Q3 FY2026 and Rs 147 mn in Q4 FY2025
Automotive Equipment Q4 FY2026 segment revenue: Rs 1,037 mn versus Rs 842 mn in Q3 FY2026 and Rs 938 mn in Q4 FY2025
Consolidated Q4 FY2026 revenue from operations: Rs 11,126 mn versus Rs 10,034 mn in Q3 FY2026 and Rs 9,929 mn in Q4 FY2025
Consolidated FY2026 capex and intangible purchase: Rs 1,544 mn outflow
Total segment assets after inter-segment elimination: Rs 35,455 mn at March 31, 2026
Consolidated FY2026 PBT before exceptional items and tax: Rs 5,857 mn before share of joint venture profit; Rs 5,921 mn in the official presentation before exceptional item
Consolidated Q4 FY2026 PBT before exceptional items and tax: Rs 1,653 mn before share of joint venture loss; Rs 1,638 mn after share of joint venture loss

Financial highlights

Borrowings: No non-current borrowings and Rs 1.01 cr current borrowings at March 31, 2026
Export revenue: Rs 507 cr in FY2026 in the investor-meet presentation
Domestic revenue: Rs 2,566 cr in FY2026 in the investor-meet presentation
FY2026 owner PAT: Rs 415.66 cr
FY2026 EBIT margin: 18.3% of revenue from operations
Current investments: Rs 668.14 cr at March 31, 2026
Q4 FY2026 owner PAT: Rs 118.74 cr
FY2026 dividends paid: Rs 188.22 cr
Five-year capex marker: About Rs 794 cr over the last five years, around 6% of revenue
FY2026 consolidated EPS: Rs 37.54 basic and diluted
FY2026 consolidated PAT: Rs 416.79 cr versus Rs 371.27 cr in FY2025
FY2026 consolidated PBT: Rs 555.36 cr versus Rs 491.96 cr in FY2025
Non-current investments: Rs 315.33 cr at March 31, 2026
FY2026 Abrasives revenue: Rs 1,490.79 cr versus Rs 1,402.51 cr in FY2025
Cash and cash equivalents: Rs 78.66 cr at March 31, 2026
Consolidated total assets: Rs 3,437.86 cr at March 31, 2026
FY2026 capex cash outflow: Rs 118.91 cr toward property, plant, equipment and intangible assets
Q4 FY2026 consolidated EPS: Rs 10.72 basic and diluted
Q4 FY2026 consolidated PAT: Rs 119.34 cr versus Rs 95.58 cr in Q3 FY2026 and Rs 92.84 cr in Q4 FY2025
Q4 FY2026 consolidated PBT: Rs 157.80 cr versus Rs 128.44 cr in Q3 FY2026 and Rs 122.90 cr in Q4 FY2025
FY2026 Other segment result: Rs 16.50 cr
FY2026 recommended dividend: Rs 19 per share of face value Rs 5, subject to shareholder approval
New Labour Codes obligation: Rs 1.0027 cr incremental defined-benefit obligation recognized in FY2026
FY2026 Other segment revenue: Rs 87.89 cr versus Rs 54.08 cr in FY2025
Bank balances other than cash: Rs 411.39 cr at March 31, 2026
Consolidated total liabilities: Rs 887.92 cr at March 31, 2026
FY2026 net operating cash flow: Rs 542.14 cr
FY2026 Abrasives segment result: Rs 192.35 cr
FY2026 Digital Services revenue: Rs 222.52 cr versus Rs 184.10 cr in FY2025
FY2026 business assets turnover: 2.83x
FY2026 consolidated total income: Rs 3,168.11 cr versus Rs 2,891.47 cr in FY2025
FY2026 return on business assets: 45.8% on EBIT excluding investment income
FY2026 Ceramics & Plastics revenue: Rs 1,310.58 cr versus Rs 1,188.71 cr in FY2025
Q4 FY2026 consolidated total income: Rs 863.45 cr versus Rs 771.66 cr in Q3 FY2026 and Rs 732.25 cr in Q4 FY2025
FY2026 as-published investor-meet PBT: Rs 555 cr, up 12.9% YoY
FY2026 Digital Services segment result: Rs 58.06 cr
FY2026 as-published investor-meet EBIT: Rs 564 cr, up 12.5% YoY
FY2026 Ceramics & Plastics segment result: Rs 230.90 cr
FY2026 as-published investor-meet revenue: Rs 3,073 cr, up 9.3% YoY
FY2026 consolidated revenue from operations: Rs 3,073.19 cr versus Rs 2,811.59 cr in FY2025
FY2026 as-published investor-meet net profit: Rs 417 cr, up 12.3% YoY
Q4 FY2026 consolidated revenue from operations: Rs 842.22 cr versus Rs 752.78 cr in Q3 FY2026 and Rs 709.51 cr in Q4 FY2025

Financial highlights

Employees: More than 30,000, with around 90% women
Wind power: 61.92 MW
FY2026 ROCE: 18.4%
Five-year PAT: Rs 841.8 cr in FY2022, Rs 814.1 cr in FY2023, Rs 805.4 cr in FY2024, Rs 815.1 cr in FY2025 and Rs 866.5 cr in FY2026
Rooftop solar: 40 MW
Final dividend: Rs 2.50 per equity share of face value Re 1, subject to AGM approval
Sugar capacity: 20,000 TCD
Ethanol capacity: 470 KLPD
Five-year EBITDA: Rs 1,305.9 cr in FY2022, Rs 1,336.7 cr in FY2023, Rs 1,303.9 cr in FY2024, Rs 1,320.4 cr in FY2025 and Rs 1,401.2 cr in FY2026
Garment capacity: 204 million knitted garments
Knitting capacity: 40,000 MT of fabric
Spinning capacity: 100,000 MT of yarn and 10,500 MT of Vortex Viscose yarn
Co-generation power: 90 MW
FY2026 finance cost: Rs 51.60 cr
Export spread FY2026: Europe 63.1%, North America 15.7%, Australia 14.8%, Asia 4.6% and others 1.8%
FY2025 EBITDA margin: 20.43%
FY2026 EBITDA margin: 20.65%
Q4 FY2026 finance cost: Rs 14.66 cr
FY2025 consolidated PAT: Rs 815.11 cr
FY2026 consolidated PAT: Rs 866.50 cr
FY2026 consolidated PBT: Rs 1,134.00 cr
Five-year EBITDA margin: 26.6% in FY2022, 21.4% in FY2023, 21.3% in FY2024, 20.4% in FY2025 and 20.7% in FY2026
Q3 FY2026 EBITDA margin: 21.9%
Q4 FY2025 EBITDA margin: 19.3%
Q4 FY2026 EBITDA margin: 21.3%
FY2026 sugar sales value: Rs 593 cr
Fabric printing capacity: 15,000 MT
FY2026 sugar sales volume: 154,749 MT
FY2025 consolidated EBITDA: Rs 1,320.42 cr
FY2026 consolidated EBITDA: Rs 1,401.20 cr
FY2026 ethanol sales value: Rs 478 cr
FY2026 garment sales value: Rs 3,179 cr
Fabric processing capacity: 25,000 MT
Q3 FY2026 consolidated PAT: Rs 208.60 cr
Q4 FY2025 consolidated PAT: Rs 204.55 cr
Q4 FY2026 consolidated PAT: Rs 227.17 cr
Q4 FY2026 consolidated PBT: Rs 319.80 cr
FY2026 ethanol sales volume: 760.73 lakh litres
FY2026 garment sales volume: 181.45 million garments
FY2026 sugar segment result: Rs 95.92 cr before finance costs
Aggregate FY2025-26 dividend: 500%
FY2025 basic and diluted EPS: Rs 23.85
FY2026 basic and diluted EPS: Rs 25.35
FY2026 others segment result: Rs 3.79 cr before finance costs
FY2026 sugar segment revenue: Rs 1,172.88 cr
FY2026 others segment revenue: Rs 83.54 cr
FY2026 textile segment result: Rs 951.97 cr before finance costs
Q3 FY2026 consolidated EBITDA: Rs 328.01 cr
Q4 FY2025 consolidated EBITDA: Rs 343.84 cr
Q4 FY2026 consolidated EBITDA: Rs 388.80 cr
FY2026 textile segment revenue: Rs 5,435.32 cr
Q4 FY2026 sugar segment result: Rs 53.86 cr before finance costs
FY2026 consolidated inventories: Rs 1,843.99 cr
Q4 FY2026 basic and diluted EPS: Rs 6.65
Q4 FY2026 others segment result: Rs 0.92 cr before finance costs
Q4 FY2026 sugar segment revenue: Rs 348.02 cr
FY2025 consolidated total income: Rs 6,462.26 cr
FY2026 consolidated total assets: Rs 6,832.84 cr
FY2026 consolidated total equity: Rs 5,697.60 cr
FY2026 consolidated total income: Rs 6,784.29 cr
FY2026 net cash in balance sheet: Rs 835 cr per investor presentation
Q4 FY2026 others segment revenue: Rs 19.12 cr
Q4 FY2026 textile segment result: Rs 239.17 cr before finance costs
Five-year revenue from operations: Rs 4,822.5 cr in FY2022, Rs 6,185.9 cr in FY2023, Rs 6,059.7 cr in FY2024, Rs 6,387.9 cr in FY2025 and Rs 6,650.4 cr in FY2026
Q4 FY2026 textile segment revenue: Rs 1,444.99 cr
FY2026 yarn and fabric sales value: Rs 2,049 cr
FY2026 yarn and fabric sales volume: 79,080 MT
Q4 FY2026 consolidated total income: Rs 1,825.16 cr
FY2026 consolidated total borrowings: Rs 596.1 cr
FY2026 depreciation and amortisation: Rs 215.60 cr
Dividend amount shown in presentation: Rs 170.90 cr
FY2026 consolidated trade receivables: Rs 639.91 cr
FY2026 consolidated capex cash outflow: Rs 314.82 cr for PPE including capital advances
Q4 FY2026 depreciation and amortisation: Rs 54.34 cr
FY2025 consolidated revenue from operations: Rs 6,387.88 cr
FY2026 consolidated revenue from operations: Rs 6,650.37 cr
Q3 FY2026 consolidated revenue from operations: Rs 1,467.42 cr
Q4 FY2025 consolidated revenue from operations: Rs 1,768.98 cr
Q4 FY2026 consolidated revenue from operations: Rs 1,784.65 cr
FY2026 consolidated fixed deposits with banks / NBFCs: Rs 1,303.4 cr
FY2026 consolidated net cash used in financing activities: Rs 90.20 cr
FY2026 consolidated net cash used in investing activities: Rs 1,068.32 cr
FY2026 consolidated net cash generated from operating activities: Rs 1,107.84 cr
FY2026 consolidated operating cash flow before working-capital changes: Rs 1,307.89 cr
FY2026 consolidated cash and cash equivalents plus investments in mutual funds: Rs 127.5 cr

Financial highlights

FY2026 EPS: Loss of Rs 0.61 per share versus EPS of Rs 0.64 in FY2025
FY2026 PAT: Loss of Rs 39.60 cr versus profit of Rs 41.23 cr in FY2025
FY2026 PBT: Loss of Rs 39.91 cr versus profit of Rs 53.74 cr in FY2025
Inventories: Rs 1,237.21 cr at March 2026 versus Rs 945.02 cr at March 2025
Other equity: Rs 703.25 cr at March 2026 versus Rs 773.62 cr at March 2025
Total equity: Rs 1,350.33 cr at March 2026 versus Rs 1,370.70 cr at March 2025
Q4 FY2026 EPS: Rs 0.05 versus Rs 1.09 in Q4 FY2025
Q4 FY2026 PAT: Rs 3.16 cr versus Rs 70.72 cr in Q4 FY2025 and loss of Rs 67.90 cr in Q3 FY2026
Q4 FY2026 PBT: Rs 5.85 cr versus Rs 87.96 cr in Q4 FY2025
Trade receivables: Rs 352.20 cr at March 2026 versus Rs 783.48 cr at March 2025
Current borrowings: Rs 3,951.64 cr at March 2026 versus Rs 3,682.61 cr at March 2025
Labour-code impact: Additional expense of Rs 0.88 cr recognized during FY2026
Subsidy accounting: Dealer-stock subsidy pending sale to ultimate beneficiary at March 31, 2026 recognized on 99% recoverability basis
FY2026 finance cost: Rs 249.73 cr
FY2026 total income: Rs 5,900.08 cr, up from Rs 4,267.36 cr in FY2025
Other bank balances: Rs 1,501.77 cr at March 2026 versus Rs 2,559.03 cr at March 2025
FY2026 other expenses: Rs 900.43 cr
FY2026 total expenses: Rs 5,939.99 cr, up from Rs 4,738.23 cr in FY2025
Q4 FY2026 finance cost: Rs 64.31 cr
Q4 FY2026 total income: Rs 1,517.85 cr, up from Rs 1,113.19 cr in Q4 FY2025
Q4 FY2026 other expenses: Rs 233.61 cr
Q4 FY2026 total expenses: Rs 1,512.00 cr, up from Rs 1,041.59 cr in Q4 FY2025
Cash and cash equivalents: Rs 168.93 cr at March 2026 versus Rs 718.34 cr at March 2025
FY2026 revenue from operations: Rs 5,723.76 cr, up from Rs 4,050.91 cr in FY2025
FY2026 cost of materials consumed: Rs 3,442.43 cr
FY2026 fertilizer segment revenue: Rs 5,711.13 cr versus Rs 4,035.80 cr in FY2025
Q4 FY2026 revenue from operations: Rs 1,483.85 cr, up from Rs 1,053.28 cr in Q4 FY2025
FY2026 interest and dividend income: Rs 164.32 cr versus Rs 200.91 cr in FY2025
FY2026 petrochemical segment revenue: Rs 0.31 cr
Q4 FY2026 cost of materials consumed: Rs 993.30 cr
Q4 FY2026 fertilizer segment revenue: Rs 1,477.06 cr
FY2026 fertilizer segment result before tax and finance cost: Rs 338.60 cr versus Rs 387.24 cr in FY2025
FY2026 petrochemical segment result before tax and finance cost: Loss of Rs 41.76 cr
Q4 FY2026 fertilizer segment result before tax and finance cost: Rs 298.01 cr versus Rs 347.54 cr in Q4 FY2025

Financial highlights

FY2026 sales: Rs 11,950 cr, up 18% YoY from Rs 10,166 cr
FY2026 exports: Rs 1,989 cr, up 12% YoY
Q4 FY2026 sales: Rs 2,963 cr, up 23% YoY and down 1% QoQ
CPCB IV+ pricing: Pricing largely sustained across the range, though lower-cost power products remain price-competitive
Q4 FY2026 exports: Rs 450 cr, down 6% YoY and down 5% QoQ
FY2026 domestic sales: Rs 9,961 cr, up 19% YoY
Data-center order timing: Orders typically arrive 6-12 months before a site is ready, with revenue recognised as gensets are installed
Q4 FY2026 domestic sales: Rs 2,513 cr, up 30% YoY and down 1% QoQ
FY2026 Distribution sales: Rs 3,278 cr, up 22% YoY
High-horsepower lead time: About 3-6 months for the overall high-horsepower portfolio
Overall capacity utilisation: About 70% across combined facilities
Q4 FY2026 Distribution sales: Rs 766 cr, up 21% YoY and down 18% QoQ
Distribution price-led growth: Very low; FY2026 growth mainly from service and solution expansion rather than pricing
FY2026 low-horsepower exports: Rs 807 cr, up 3% YoY
FY2026 high-horsepower exports: Rs 984 cr, up 20% YoY
Non-data-center PowerGen growth: Higher double-digit growth in FY2026, according to management commentary
FY2026 Industrial domestic sales: Rs 1,650 cr, down 1% YoY
Q4 FY2026 low-horsepower exports: Rs 127 cr, down 18% YoY and down 5% QoQ
Q4 FY2026 high-horsepower exports: Rs 217 cr, down 1% YoY and down 7% QoQ
FY2026 PBT after exceptional items: Rs 3,054 cr, up 22% YoY
FY2026 PBT before exceptional items: Rs 3,104 cr, up 24% YoY
Q4 FY2026 Industrial domestic sales: Rs 381 cr, up 1% YoY and down 18% QoQ
Q4 FY2026 PBT after exceptional items: Rs 852 cr, up 25% YoY and up 44% QoQ
FY2026 domestic Power Generation sales: Rs 4,758 cr, up 24% YoY
Q4 FY2026 PBT before exceptional items: Rs 820 cr, up 20% YoY and up 14% QoQ
Cummins India investment over five years: More than Rs 1,000 cr invested in modernisation and line-capability expansion
Q4 FY2026 domestic Power Generation sales: Rs 1,294 cr, up 48% YoY and up 21% QoQ
Data-center share of domestic Power Generation: 30%-35% for FY2026 and about 35% for Q4 FY2026

Financial highlights

Dividend: final dividend Rs 23/share; total FY2026 dividend Rs 27.50/share with 60% payout
Home Decor stores: 74 Beautiful Homes Stores across 20 states
FY2026 standalone PAT: Rs 4,244 cr
Distribution expansion: more than 6,000 retail touchpoints added during FY2026
Q4 FY2026 bath revenue: Rs 95 cr, up 3.7% YoY, with PBT of Rs 4 cr
FY2026 standalone PBDIT: Rs 6,180 cr, up 11.2% YoY
Q4 FY2026 APPPG revenue: Rs 586 cr, up 20.9% YoY
Q4 FY2026 PPGAP revenue: Rs 399 cr, up 15.0% YoY
New product contribution: about 17% of revenues
Q4 FY2026 standalone PAT: Rs 1,161 cr
FY2026 consolidated PBDIT: Rs 6,696 cr, up 11.5% YoY
Q4 FY2026 kitchen revenue: Rs 99 cr, up 16.5% YoY, with PBT loss reduced to Rs 1 cr
Q4 FY2026 standalone PBDIT: Rs 1,670 cr, up 26.0% YoY
FY2026 standalone net sales: Rs 30,680 cr, up 4.3% YoY
FY2026 international revenue: Rs 3,340 cr, up 9% YoY
Q4 FY2026 White Teak revenue: Rs 23 cr, up 16.8% YoY
Q4 FY2026 consolidated PBDIT: Rs 1,787 cr, up 24.4% YoY
FY2026 consolidated net sales: Rs 35,516 cr, up 5.1% YoY
Q4 FY2026 Weatherseal revenue: Rs 20 cr, up 24.9% YoY
FY2026 standalone PBDIT margin: 20.1%, up 130 bps YoY
Q4 FY2026 standalone net sales: Rs 7,894 cr, up 10.3% YoY
Q4 FY2026 international revenue: Rs 888 cr, up 11.0% in INR terms and 8.2% in constant currency
FY2026 consolidated PBDIT margin: 18.9%, up 110 bps YoY
Q4 FY2026 consolidated net sales: Rs 9,228 cr, up 10.8% YoY
Q4 FY2026 standalone PBDIT margin: 21.2%, up 260 bps YoY
Q4 FY2026 standalone gross margin: 45.6%, up 70 bps YoY
Q4 FY2026 international PBT margin: 8.5%, up 370 bps YoY
Q4 FY2026 consolidated PBDIT margin: 19.4%, up 210 bps YoY
Q4 FY2026 consolidated gross margin: 44.7%, up 100 bps YoY
FY2026 India decorative value growth: 4.3%
FY2026 India decorative volume growth: 8.7%
Q4 FY2026 India decorative value growth: 10.2%
Q4 FY2026 India decorative volume growth: 12.4%
FY2026 consolidated PAT before minority interest: Rs 4,395 cr; up 11.8% excluding exceptional items
Q4 FY2026 consolidated PAT before minority interest: Rs 1,185 cr, up 69% YoY; up 34.1% excluding exceptional items
FY2026 India decorative plus industrial value growth: 5.3%
FY2026 India decorative plus industrial volume growth: 9.0%
Q4 FY2026 India decorative plus industrial value growth: 11.0%
Q4 FY2026 India decorative plus industrial volume growth: 12.7%

Financial highlights

BluChip: more than 11 mn registered members
Network: 97 domestic and 45 international destinations at FY2026 end
A321 XLR: India's first A321 XLR inducted; deployed on routes such as Athens and Istanbul
Dividend: no dividend recommended for FY2026
Total cash: around INR 516 bn, including INR 362 bn free cash and INR 154 bn restricted cash
Q4 FY2026 PRASK: INR 4.46, down 4% year-on-year
FY2026 ASK growth: 9.5%
FY2026 RPK growth: 7.5%
FY2026 passengers: more than 123 mn, highest ever
Aircraft ownership: prepaid loans for 17 aircraft; 36 aircraft now unencumbered with more than INR 95 bn book value; 53 aircraft on finance leases with underlying ownership
FY2026 seat growth: around 5%
FY2026 total income: around INR 895 bn, up 6.4% year-on-year
Right-of-use assets: around INR 521 bn
FY2026 closing fleet: 441 aircraft
GIFT City investment: USD 820 mn announced for acquisition of aviation assets; additional prepayment of finance lease obligations aggregating USD 450 mn / INR 43.4 bn
Q4 FY2026 forex loss: INR 48.2 bn after roughly 5% quarter-end rupee depreciation against the US dollar
Pratt and Whitney AOGs: currently in the 40s, expected to trend down to the 30s by end of year
Q4 FY2026 total income: around INR 238 bn, up about 3% year-on-year
FY2026 passengers growth: around 4%
FY2026 reported net loss: INR 23.9 bn
Q4 FY2026 capacity growth: 3%, lower than planned after Middle East disruptions
Q4 FY2026 reported net loss: INR 25.4 bn versus INR 30.7 bn profit in Q4 FY2025
FY2026 aircraft redeliveries: 37 aircraft from original orderbook and 28 damp leases
FY2026 labour-code provision: INR 12.2 bn total, including INR 2.5 bn additional Q4 impact
FY2026 underlying net profit: INR 75 bn excluding forex and exceptional items, versus around INR 89 bn in FY2025
FY2026 EBITDAR excluding forex: INR 231.9 bn, 27.3% margin, versus INR 228.6 bn and 28.3% margin in FY2025
FY2026 gross aircraft additions: 72 aircraft, including 51 from original orderbook and 21 on damp lease basis
Middle East and Europe exposure: around 18% of total capacity and about 160 daily flights affected by route and network disruption
Q4 FY2026 CASK ex fuel ex forex: INR 3.15, up around 7% year-on-year
Q4 FY2026 EBITDAR excluding forex: INR 64.4 bn, 28.7% margin, versus INR 68.6 bn and 31.0% margin in Q4 FY2025
Capitalized operating lease liability: around INR 535 bn
December disruption exceptional impact: INR 5.8 bn reported as exceptional plus estimated INR 15-16 bn from lower capacity and reduced unit revenue
Q4 FY2026 net profit excluding forex and exceptional items: INR 19.2 bn versus INR 29.8 bn in Q4 FY2025
Total debt including capitalized operating lease liability: around INR 777 bn

Financial highlights

AGM: 51st AGM on August 4, 2026 through VC/OAVM
SGAM funding: Debt and internal accruals
Audit opinion: Unmodified opinions on standalone and consolidated FY2026 financial results
Board approval: May 28, 2026; audited standalone and consolidated Q4/FY2026 results approved
Final dividend: Rs 7 per equity share of face value Rs 2, subject to shareholder approval
GrafTech stake: Increased from 6.82% to 9.79%
GrafTech turnover: USD 504.134 million for the year ended December 31, 2025, USD 538.782 million in 2024 and USD 620.500 million in 2023
Standalone net cash: Rs 3,683 cr as of March 2026
Board meeting timing: Commenced at 12:15 p.m. and concluded at 1:50 p.m.
Capacity utilization: Standalone capacity utilization of 104% in Q4 FY2026 versus 87% in Q3 FY2026 and 81% in Q4 FY2025
Dividend record date: July 20, 2026
Consolidated net cash: Rs 3,767 cr as of March 2026
FY2026 standalone EPS: Rs 13.54
Standalone total debt: Rs 254 cr as of March 2026
CFC Finlease ESG score: 71, based on independently prepared public-domain analysis
Consolidated total debt: Rs 367 cr as of March 2026
FY2026 consolidated EPS: Rs 8.97
FY2026 standalone EBITDA: Rs 461 cr versus Rs 656 cr in FY2025
Q4 FY2026 standalone EPS: Negative Rs 3.71
SGAM approved investment: Rs 4,330 cr in phases in Synthetic Graphite Anode Materials and related areas including renewable energy
India steel-demand marker: Estimated to grow 9.2% in 2026 in the presentation
FY2026 consolidated EBITDA: Rs 375 cr versus Rs 692 cr in FY2025
Q4 FY2026 consolidated EPS: Negative Rs 5.31
FY2026 standalone net sales: Rs 2,812 cr, up 16.2% YoY
Q4 FY2026 standalone EBITDA: Negative Rs 65 cr versus positive Rs 104 cr in Q4 FY2025
FY2026 standalone net profit: Rs 264 cr versus Rs 452 cr in FY2025
NSE Sustainability ESG score: 65, revised from 57, based on FY2024-25 public-domain data
FY2026 consolidated net sales: Rs 2,852 cr, up 11.4% YoY
Q4 FY2026 consolidated EBITDA: Negative Rs 100 cr versus positive Rs 96 cr in Q4 FY2025
FY2026 consolidated net profit: Rs 171 cr versus Rs 458 cr in FY2025
GrafTech market capitalization: USD 241.98 million as disclosed in the Graphite India filing
Q4 FY2026 standalone net sales: Rs 816 cr, up 26.5% YoY and 26.9% QoQ
FY2026 standalone EBITDA margin: 16.4% versus 27.1% in FY2025
GrafTech incremental investment: Rs 62.25 cr
Q4 FY2026 standalone net profit: Negative Rs 73 cr versus positive Rs 62 cr in Q4 FY2025
Standalone cash and investments: Rs 3,937 cr as of March 2026
Standalone inventory write-down: Rs 45 cr as of March 31, 2026; Rs 75 cr as of December 31, 2025; Rs 110 cr as of March 31, 2025
Q4 FY2026 consolidated net sales: Rs 816 cr, up 22.5% YoY and 27.1% QoQ
Consolidated cash and investments: Rs 4,134 cr as of March 2026
Consolidated inventory write-down: Rs 47 cr as of March 31, 2026; Rs 77 cr as of December 31, 2025; Rs 113 cr as of March 31, 2025
FY2026 consolidated EBITDA margin: 13.1% versus 27.0% in FY2025
FY2026 consolidated Steel revenue: Rs 257 cr, up 13.2% YoY
GrafTech total investment to date: Rs 230.38 cr
Q4 FY2026 consolidated net profit: Negative Rs 105 cr versus positive Rs 49 cr in Q4 FY2025
FY2026 consolidated Others revenue: Rs 4 cr versus Rs 88 cr in FY2025
Q4 FY2026 standalone EBITDA margin: Negative 8.0%
FY2026 consolidated exceptional item: Net Rs 11 cr charge for New Labour Codes after Rs 27 cr Q3 charge and Rs 16 cr Q4 reversal
Q4 FY2026 consolidated EBITDA margin: Negative 12.3%
Q4 FY2026 consolidated Steel revenue: Rs 76 cr, up 26.7% YoY and 15.2% QoQ
Q1 CY2026 China crude-steel production: 238.4 million metric tonnes, down 6.0% YoY
Q1 CY2026 India crude-steel production: 44.0 million metric tonnes, up 9.7% YoY
Q1 CY2026 global crude-steel production: 449.2 million metric tonnes, down 2.8% YoY
FY2026 consolidated Graphite and Carbon revenue: Rs 2,594 cr, up 15.4% YoY
FY2026 consolidated PBT before exceptional items: Rs 255 cr versus Rs 591 cr in FY2025
Q4 FY2026 consolidated Graphite and Carbon revenue: Rs 758 cr, up 26.3% YoY and 30.7% QoQ
Q4 FY2026 standalone fair-value loss on investments: Rs 212 cr
Q4 FY2026 consolidated fair-value loss on investments: Rs 242 cr
FY2026 consolidated Steel segment profit before tax and interest: Rs 42 cr, up 50.0% YoY
Q4 FY2026 consolidated Steel segment profit before tax and interest: Rs 15 cr versus Rs 8 cr in Q4 FY2025
FY2026 consolidated Graphite and Carbon segment profit before tax and interest: Rs 164 cr, up 12.3% YoY
Q4 FY2026 consolidated Graphite and Carbon segment profit before tax and interest: Rs 94 cr versus Rs 30 cr in Q4 FY2025

Financial highlights

Exports: Exports down 7% YoY in Q4 FY2026 and 1% YoY in FY2026; Africa exports up 30% YoY in Q4 and 26% YoY in FY2026
Dividend: Rs 1.30 per equity share of face value Rs 10 for FY2026, subject to AGM approval; record date July 17, 2026
Inventory: Rs 765.9 cr at March 2026
FY2026 PAT: Rs 543.0 cr, up 7% YoY; net profit margin 16.8%
FY2026 PBT: Rs 727.6 cr, up 7% YoY; PBT margin 22.5%
Herbicides: Revenue up 87% YoY in Q4 FY2026 and 19% YoY in FY2026
Biologicals: Around 8%-10% of revenue per management
FY2026 EBIT: Rs 751.5 cr, up 10% YoY; EBIT margin 23.2%
Credit rating: CRISIL AA/Stable reaffirmed for Rs 200 cr bank facilities
Q4 FY2026 PAT: Rs 111.3 cr, up 12% YoY; net profit margin 16.3%
Q4 FY2026 PBT: Rs 147.6 cr, up 11% YoY; PBT margin 21.6%
Q4 FY2026 EBIT: Rs 149.4 cr, up 11% YoY; EBIT margin 21.9%
Trade payables: Rs 397.1 cr at March 2026 versus Rs 489.4 cr at March 2025
Domestic growth: Domestic revenue up 4% YoY in Q4 FY2026 and 4% YoY in FY2026
Metal phosphides: Revenue up 16% YoY in Q4 FY2026 and 11% YoY in FY2026
Trade receivables: Rs 735.6 cr at March 2026 versus Rs 783.4 cr at March 2025; receivable days improved to 83 from 91
FY2026 collections: About Rs 3,726 cr versus Rs 3,058 cr in FY2025
FY2026 tax expense: Rs 184.6 cr
Specialty products: Around 30% of domestic revenue per management
FY2026 gross profit: Rs 1,360.9 cr, up 6% YoY; gross margin 42.0%, up 107 bps YoY
Net working capital: Rs 649.9 cr; NWC days 103 versus 89 in FY2025
Standalone FY2026 EPS: Rs 10.88 basic and diluted versus Rs 10.06 in FY2025
Q4 FY2026 gross profit: Rs 288.9 cr, up 6% YoY; gross margin 42.3%, up 223 bps YoY
FY2026 exceptional item: Rs 151.86 mn, regulatory-driven and linked to newly notified Labour Codes
FY2026 operating EBITDA: Rs 670.9 cr, up 6% YoY; EBITDA margin 20.7%, up 64 bps YoY
Standalone other equity: Rs 28,850.38 mn as of March 31, 2026
Standalone total assets: Rs 44,341.10 mn as of March 31, 2026
Standalone Q4 FY2026 EPS: Rs 2.22 versus Rs 1.97 in Q4 FY2025
Q4 FY2026 operating EBITDA: Rs 134.2 cr, up 12% YoY; EBITDA margin 19.6%, up 202 bps YoY
Cash and liquid investments: About Rs 2,113 cr as of March 31, 2026 per investor presentation
Standalone FY2026 reported PBT: Rs 7,266.49 mn after exceptional items
Domestic branded formulation mix: 81% of domestic sales in FY2026 versus 79% in FY2025
FY2026 total comprehensive income: Rs 548.6 cr, up 9% YoY
FY2026 PBT before exceptional items: Rs 743.6 cr, up 9% YoY
Standalone FY2026 revenue from operations: Rs 31,857.62 mn, or about Rs 3,185.76 cr
FY2026 consolidated revenue from operations: Rs 3,238.3 cr, up 3% YoY
Standalone Q4 FY2026 revenue from operations: Rs 6,714.91 mn, or about Rs 671.49 cr
Standalone net cash generated from operations: Rs 4,434.01 mn in FY2026
Q4 FY2026 consolidated revenue from operations: Rs 683.7 cr, up 1% YoY and 20% QoQ
Standalone FY2026 PBT before exceptional items: Rs 7,418.35 mn

Financial highlights

FY2026 EPS: Rs 11.47 vs Rs 14.99 in FY2025
Q4 FY2026 EPS: Rs 3.09 vs Rs 7.44 in Q4 FY2025
FY2026 inventories: Rs 4,625.64 cr at March 31, 2026 vs Rs 2,645.11 cr at March 31, 2025
FY2026 other equity: Rs 4,057.69 cr at March 31, 2026 vs Rs 3,825.67 cr at March 31, 2025
FY2026 total equity: Rs 4,240.97 cr at March 31, 2026 vs Rs 4,008.95 cr at March 31, 2025
FY2026 total income: Rs 2,865.56 cr vs Rs 3,695.45 cr in FY2025, down about 22.5%
FY2026 final dividend: Rs 0.40 per share recommended, subject to AGM approval
FY2026 total expenses: Rs 2,297.74 cr vs Rs 2,946.69 cr in FY2025
Q4 FY2026 total income: Rs 599.37 cr vs Rs 1,876.55 cr in Q4 FY2025
FY2026 interim dividend: Rs 4.50 per share paid in February 2026
FY2026 profit after tax: Rs 420.34 cr vs Rs 549.65 cr in FY2025, down about 23.5%
FY2026 profit before tax: Rs 567.82 cr vs Rs 748.76 cr in FY2025, down about 24.2%
FY2026 trade receivables: Rs 422.88 cr at March 31, 2026 vs Rs 826.36 cr at March 31, 2025
Q4 FY2026 total expenses: Rs 445.47 cr vs Rs 1,498.37 cr in Q4 FY2025
FY2026 capex cash outflow: Rs 228.75 cr purchase of property, plant, equipment and intangible assets
Q4 FY2026 profit after tax: Rs 113.18 cr vs Rs 272.77 cr in Q4 FY2025
FY2026 equity share capital: Rs 183.28 cr at March 31, 2026
FY2026 non-moving inventory: Rs 83.27 cr of inventory non-moving for more than five years, backed by Rs 362.34 cr of advances
Q4 FY2026 profit before tax: Rs 153.89 cr vs Rs 378.18 cr in Q4 FY2025
FY2026 Labour Code liability: Rs 7.04 cr additional liability
FY2026 revenue from operations: Rs 2,441.79 cr vs Rs 3,345.05 cr in FY2025, down about 27.0%
FY2026 cash and cash equivalents: Rs 863.31 cr at March 31, 2026 vs Rs 133.86 cr at March 31, 2025
CRISIL medium-term capex estimate: Rs 180-200 cr annual capex over the medium term for Amravati, Ibrahimpatnam and Jhansi
Q4 FY2026 revenue from operations: Rs 480.20 cr vs Rs 1,776.98 cr in Q4 FY2025
FY2026 sales/income from operations: Rs 2,415.36 cr vs Rs 3,323.07 cr in FY2025
CRISIL February 2026 short-term rating: Crisil A1+ reaffirmed on Rs 600 cr short-term bank facilities
Q4 FY2026 sales/income from operations: Rs 488.62 cr vs Rs 1,800.55 cr in Q4 FY2025
CRISIL December 2025 liquidity estimate: Around Rs 4,200 cr cash and equivalents with no debt obligation
FY2026 net cash from operating activities: Rs 604.00 cr vs Rs 167.39 cr in FY2025
Order book disclosed in March 2026 facilities update: Around Rs 26,000 cr current order book
FY2027 additional orders disclosed in March 2026 facilities update: Around Rs 15,000 cr envisaged in FY2027

Financial highlights

Dividend: Final dividend recommended at Rs 10 per share; interim dividend of Rs 43 per share was declared on February 13, 2026
FY2026 R&D: INR 6,173 mn / Rs 617.3 cr, 4.2% of revenue
Chronic share: Close to 22% of branded generic business, per management
FY2026 EBITDA: INR 30,052 mn / Rs 3,005.2 cr, up 19.6% YoY; margin 20.4%
Forex hedging: About 80% of forex exposure hedged, per management
Q4 FY2026 R&D: INR 2,293 mn / Rs 229.3 cr, 6.4% of revenue
ANDA approvals: 167 approvals including 19 tentative approvals, plus 2 NDAs as of FY2026
FY2026 US sales: INR 29,845 mn / Rs 2,984.5 cr, up 20.3% YoY
FY2026 launches: 11 products launched during FY2026
FY2026 sales mix: India 67.8%, US 20.5%, non-US 11.7%
Q4 FY2026 EBITDA: INR 5,174 mn / Rs 517.4 cr, up 32.2% YoY; margin 14.4%
FY2026 India sales: INR 98,514 mn / Rs 9,851.4 cr, up 9.7% YoY
Q4 FY2026 US sales: INR 7,681 mn / Rs 768.1 cr, up 26.2% YoY
FY2026 gross profit: INR 96,195 mn / Rs 9,619.5 cr, up 17.3% YoY; gross margin 65.4%
FY2026 non-US sales: INR 16,964 mn / Rs 1,696.4 cr, up 27.4% YoY
Q4 FY2026 sales mix: India 65.5%, US 21.7%, non-US 12.8%
Q4 FY2026 India sales: INR 23,245 mn / Rs 2,324.5 cr, up 8.8% YoY
Q4 FY2026 gross profit: INR 23,555 mn / Rs 2,355.5 cr, up 26.3% YoY; gross margin 65.4%
Q4 FY2026 non-US sales: INR 4,543 mn / Rs 454.3 cr, up 24.1% YoY
Expected forward tax rate: 27%-29% after moving to the new tax regime from April 2026
FY2026 international sales: INR 46,810 mn / Rs 4,681.0 cr, up 22.5% YoY
FY2026 net profit after NCI: INR 23,018 mn / Rs 2,301.8 cr, up 6.3% YoY
Q4 FY2026 international sales: INR 12,223 mn / Rs 1,222.3 cr, up 25.4% YoY
FY2026 revenue from operations: INR 147,123 mn / Rs 14,712.3 cr, up 13.5% YoY
Q4 FY2026 net profit after NCI: INR 2,365 mn / Rs 236.5 cr, down 22.7% YoY
Q4 FY2026 real-estate impairment: INR 747 mn
Q4 FY2026 revenue from operations: INR 36,033 mn / Rs 3,603.3 cr, up 14.6% YoY and down 3.6% QoQ
FY2026 PBT after exceptional items: INR 28,709 mn / Rs 2,870.9 cr, up 13.6% YoY
Q4 FY2026 PBT before exceptional items: INR 5,578 mn / Rs 557.8 cr, up 40.7% YoY
Q4 FY2026 exceptional labour-code item: INR 602.7 mn incremental gratuity and leave-encashment liability for past service cost

Financial highlights

ESG: Road to School and Road to Livelihood reach about 6.3 lakh students; 77% RE status versus 69% in FY2025; Tamil Nadu plants at 91% RE100
Spares: About Rs 3,800 cr FY2026 revenue disclosed in Q&A
Network: 2,104 touchpoints at FY2026 end: 1,159 MHCV and 945 LCV
Dividend: Second interim dividend of Rs 2.50 per share recommended for FY2026
Net cash: Rs 5,899 cr at FY2026 end, up more than Rs 1,650 cr YoY; press release compares with Rs 4,242 cr at FY2025 end
FY2026 capex: Rs 1,050 cr, with Q4 capex of Rs 203 cr
FY2026 EBITDA: Rs 5,732 cr; EBITDA margin 13.0% versus 12.7% in FY2025
FY2026 revenue: Rs 44,007 cr, up 13.6% YoY
Defense revenue: About Rs 800 cr in standalone books and about Rs 1,200 cr including subsidiaries; revenue including ALDS up 20% YoY
Exports revenue: About Rs 3,200 cr FY2026 revenue disclosed in Q&A
Power Solutions: FY2026 revenue up 16.4% YoY; management also disclosed about Rs 1,400 cr FY2026 revenue
Q4 FY2026 EBITDA: Rs 2,066 cr, up 15.3% YoY; EBITDA margin 14.6%
FY2026 LCV volume: 74,322 units, up 12% YoY and highest-ever annual LCV volume
Q4 FY2026 revenue: Rs 14,161 cr, up 19% YoY
Defense order book: Orders in hand above Rs 1,500 cr with one-to-three-year execution schedules
FY2026 reported PAT: Rs 3,566 cr after Rs 308 cr one-time charge for the new Labour Code
Material cost ratio: 71.4% of revenue in Q4 FY2026, up 80 bps YoY; 71.4% for FY2026, up 10 bps YoY
Domestic aftermarket: Q4 revenue up 11.2% YoY and FY2026 revenue up 9.5%
FY2026 export volume: 18,082 units, up 18.5% YoY from 15,255 units
FY2026 LCV VAHAN share: 12.7%, up 80 bps YoY
Subsidiary investments: Rs 371 cr in Q4 FY2026 and Rs 387 cr for FY2026, primarily toward repayment of loans in offshore books
Hinduja Housing Finance: AUM about Rs 16,000 cr, up 15% YoY; PAT Rs 387 cr, up 4% YoY
Hinduja Leyland Finance: AUM about Rs 59,000 cr, up 24% YoY; PAT Rs 491 cr, up 20% YoY
Q4 FY2026 export volume: 5,322 units, marginally lower YoY due to international logistics issues in March
Switch India order book: About 1,600 units at FY2026 end
FY2026 overall CV volume: 220,437 units, new all-time high versus previous FY2019 peak of 197,366 units
Q4 FY2026 cash generated: Rs 3,280 cr, as disclosed in the official Q4 press release
Q4 FY2026 LCV VAHAN share: 12.8%, up 90 bps YoY
Domestic MHCV industry growth: Q4 FY2026 up 21.5% YoY; FY2026 up 12% YoY
Q4 FY2026 domestic LCV volume: 21,801 units, up 23% YoY
OHM Mobility operational fleet: More than 1,400 e-buses
FY2026 domestic MHCV bus volume: 20,840 units with 34.1% market share and bus leadership
Switch Mobility India deliveries: 1,530 electric buses, up 238% YoY, and 1,600 electric LCVs, up 56% YoY
FY2026 domestic MHCV market share: 30.8%
FY2026 domestic MHCV truck volume: 105,905 units with 30.2% market share
Finance subsidiaries asset quality: Consolidated net NPAs about 1.4%
FY2026 PAT excluding exceptional items: Rs 3,914 cr
Q4 FY2026 PAT excluding exceptional items: Rs 1,405 cr, up 13% YoY
FY2026 operating PBT before exceptional items: Rs 5,163 cr, up 22% YoY
Q4 FY2026 operating PBT before exceptional items: Rs 1,909 cr, up 14% YoY

Financial highlights

Q6 EBITDA: Rs 4.5 bn versus Rs 5.1 bn in the comparable period
Q6 revenue: Rs 46.2 bn, up 14.6% YoY
Order backlog: Rs 450.3 bn, compared with Rs 412 bn twelve months earlier
Q6 new orders: Rs 67.3 bn, up 33% YoY
Q6 EBITDA margin: 9.7%, down from 12.6%
Six-month EBITDA: Rs 8.7 bn, slightly below the comparable period
Six-month revenue: Rs 84.5 bn, up 14.3%
Mobility Q6 orders: Rs 28 bn, up 75%
Copper price impact: Copper rose from about USD 8,800 per tonne to USD 12,800 per tonne, about 45%
EUR/INR cost impact: Average EUR/INR moved from Rs 91 per euro to Rs 107 per euro, about 18% depreciation
Mobility Q6 revenue: Rs 8.3 bn, up 12.7%
Silver price impact: Silver rose from about USD 1,000 per kg to USD 2,700 per kg, about 160%
Q6 profit before tax: Rs 4.6 bn versus Rs 5.3 bn in the comparable period
Six-month new orders: Rs 115.6 bn, up 26.8%
Mobility Q6 EBIT margin: 7.6%, up from 7.2%
Six-month EBITDA margin: 10.3%, down from 12.3%
Mobility Q6 book-to-bill: 3.37
Mobility six-month orders: Rs 34.3 bn, up almost 42%
Products and services mix: About 69-70% of business mix, with projects at about 30-31%
Mobility six-month revenue: Rs 16.5 bn, up 20.4%
Six-month profit before tax: Rs 8.9 bn versus Rs 10.2 bn in the comparable period
Digital Industries Q6 orders: Rs 9.7 bn, up 1.4% YoY
Digital Industries Q6 revenue: Rs 11.5 bn, up 14.35%
Smart Infrastructure Q6 orders: Rs 29.6 bn, up 17.6%
Costs other than material costs: Up only 0.8% from Q2 to Q6
Smart Infrastructure Q6 revenue: Rs 25.8 bn, up 14.5%
Mobility six-month EBITDA margin: 6.4%, down from 8.2%
Data-centre wallet share estimate: Management estimated Siemens portfolio participation at about 10-20% of data-centre capex, with much of total data-centre capex in civil work
Smart Infrastructure localization: About 70-75% localized
Digital Industries Q6 book-to-bill: 0.84
Digital Industries Q6 EBITDA margin: 2.6% versus 5.0% in the comparable period
Digital Industries six-month orders: Rs 20.7 bn, up 17.1%
Smart Infrastructure Q6 book-to-bill: 1.15
Smart Infrastructure six-month orders: Rs 60.6 bn, up 22.9%
Material cost as percentage of revenue: 74% in Q6 versus 69% in Q2
Smart Infrastructure six-month revenue: Up 11.6%
Digital Industries 18-month EBITDA margin: 5.6%, or about 6.8% excluding FX impact according to management
Smart Infrastructure six-month EBITDA margin: 15.1%, down from 16.2%

Financial highlights

Final dividend: Rs 2.40 per equity share, 120% of Rs 2 face value
ARC FY2026 sales: Rs 360 cr according to management
ARC FY2026 orders: Rs 546 cr according to management
ARC HAL SDR order: Rs 250.58 cr including taxes, disclosed April 2, 2026
FY2027 sales plan: Rs 1,300 cr to Rs 1,400 cr according to management, implying 15% to 20% growth
ARC forex provision: Close to USD 2 mn in FY2026 according to management
ARC FY2026 order book: About Rs 625 cr according to management
FY2026 geographic mix: 86.0% India and 14.0% exports
FY2026 standalone EPS: Rs 18.73 versus Rs 15.10 in FY2025
FY2026 standalone PAT: Rs 178 cr versus Rs 143 cr in FY2025, up 23.9% YoY
FY2026 consolidated EPS: Rs 20.32 versus Rs 16.17 in FY2025
FY2026 consolidated PAT: Rs 193 cr versus Rs 154 cr in FY2025, up 25.7% YoY
FY2026 standalone EBITDA: Rs 324 cr versus Rs 266 cr in FY2025, up 21.6% YoY
Q4 FY2026 geographic mix: 83.1% India and 16.9% exports
Q4 FY2026 standalone PAT: Rs 105 cr versus Rs 75 cr in Q4 FY2025, up 40.3% YoY
Q4 FY2026 orders received: Rs 403 cr in press release; management also referenced fresh orders of approximately Rs 530 cr in Q4
FY2026 consolidated EBITDA: Rs 334 cr versus Rs 269 cr in FY2025, up 24.1% YoY
FY2026 customer mix - DRDO: 28.2% of standalone revenue
Q4 FY2026 consolidated PAT: Rs 106 cr versus Rs 73 cr in Q4 FY2025, up 44.2% YoY
Q4 FY2026 standalone EBITDA: Rs 160 cr versus Rs 120 cr in Q4 FY2025, up 33.6% YoY
ARC FY2027 sales expectation: Expected to cross Rs 600 cr according to management
FY2026 standalone PAT margin: 15.4% versus 13.7% in FY2025
ARC FY2027 growth expectation: Minimum 50% growth in both order booking and sales
Astra share of ARC FY2026 PAT: Close to Rs 8 cr after forex provision according to management
Demerger undertaking turnover: Approximately Rs 157 cr in FY2026, 13.58% of Astra Microwave FY2026 turnover
Long-term turnover aspiration: Nearly threefold growth over three to five years / FY2030 to FY2031, subject to order timing and contract finalization
Q4 FY2026 consolidated EBITDA: Rs 162 cr versus Rs 120 cr in Q4 FY2025, up 35.9% YoY
FY2026 consolidated PAT margin: 16.6% versus 14.6% in FY2025
FY2026 customer mix - ISRO/SAC: 6.4% of standalone revenue
FY2026 standalone EBITDA margin: 28.0% versus 25.5% in FY2025
Preferential-warrant issue size: Rs 173.99 cr
Q4 FY2026 standalone PAT margin: 21.6% versus 18.6% in Q4 FY2025
FY2026 consolidated EBITDA margin: 28.7% versus 25.6% in FY2025
FY2026 radar revenue contribution: Nearly 60% of revenue according to management
Q4 FY2026 consolidated PAT margin: 21.7% versus 18.0% in Q4 FY2025
Price-negotiation-completed orders: Around Rs 300 cr expected to be received in the next couple of months according to management
Q4 FY2026 standalone EBITDA margin: 32.8% versus 29.6% in Q4 FY2025
Standalone orders booked in FY2026: Rs 1,335.58 cr
ARC FY2027 EBITDA margin projection: Around 18% to 20% according to management
FY2026 standalone trade receivables: Rs 687 cr at March 31, 2026 versus Rs 783 cr at March 31, 2025
Consolidated orders booked in FY2026: Rs 1,660.22 cr
FY2027 topline-growth target on call: 15% to 20%
Q4 FY2026 consolidated EBITDA margin: 33.3% versus 29.3% in Q4 FY2025
FY2026 consolidated trade receivables: Rs 688 cr at March 31, 2026 versus Rs 786 cr at March 31, 2025
FY2026 operating cash flow improvement: About Rs 370 cr versus negative Rs 99 cr in FY2025 according to management
FY2026 customer mix - IMD / meteorology: 18.0% of standalone revenue
Standalone order book at March 31, 2026: Rs 2,141.21 cr, including Rs 242.29 cr of service orders
FY2027 visible order booking opportunity: Approximately Rs 1,600 cr plus according to management
Consolidated order book at March 31, 2026: Rs 2,609.99 cr, including Rs 230.68 cr of service orders
FY2026 customer mix - BEL and other DPSUs: 22.7% of standalone revenue
FY2026 space and meteorology contribution: Around 16% of revenue according to management
FY2026 standalone revenue from operations: Rs 1,156 cr versus Rs 1,044 cr in FY2025, up 10.7% YoY
FY2026 consolidated revenue from operations: Rs 1,163 cr versus Rs 1,051 cr in FY2025, up 10.6% YoY
FY2026 standalone cash and cash equivalents: Rs 165 cr at March 31, 2026
Preferential-warrant balance to be received: Rs 130.50 cr subject to conversion by warrant holders by December 29, 2026
Preferential-warrant upfront money received: Rs 43.49 cr
Q4 FY2026 standalone revenue from operations: Rs 487 cr versus Rs 405 cr in Q4 FY2025, up 20.4% YoY
FY2026 consolidated cash and cash equivalents: Rs 175 cr at March 31, 2026
FY2027 topline-growth target in press release: 10% to 15%
Q4 FY2026 consolidated revenue from operations: Rs 488 cr versus Rs 408 cr in Q4 FY2025, up 19.7% YoY
FY2026 customer mix - exports via ARC and Aelius: 11.9% of standalone revenue
FY2026 standalone cash generated from operations: Rs 449 cr in investor presentation
FY2026 consolidated cash generated from operations: Rs 460 cr in investor presentation
FY2026 standalone net cash from operating activities: Rs 376 cr in investor presentation
FY2026 consolidated net cash from operating activities: Rs 387 cr in investor presentation
FY2026 standalone bank balances other than cash equivalents: Rs 78 cr at March 31, 2026
FY2026 consolidated bank balances other than cash equivalents: Rs 78 cr at March 31, 2026

Financial highlights

fy2026_eps_rs: -3.96
fy2026_roce_pct: 3.5
q4fy2026_eps_rs: 1.17
fy2026_capex_rs_cr: 149
q4fy2026_pat_rs_cr: 14
fy2025_ebitda_rs_cr: 328
fy2026_ebitda_rs_cr: 220
fy2026_debt_to_equity: 0.56
q3fy2026_ebitda_rs_cr: 83
q4fy2025_ebitda_rs_cr: 123
q4fy2026_ebitda_rs_cr: 105
nse_slice_daily_briefs: 1
fy2025_ebitda_margin_pct: 17.7
fy2026_crop_cdmo_mix_pct: 65
fy2026_ebitda_margin_pct: 12.9
target_annual_dmf_filings: 5-6
fy2026_pharma_cdmo_mix_pct: 52
q3fy2026_ebitda_margin_pct: 16.8
q4fy2025_ebitda_margin_pct: 22.4
q4fy2026_crop_cdmo_mix_pct: 74
q4fy2026_ebitda_margin_pct: 20.3
final_dividend_per_share_rs: 0.40
fy2026_crop_revenue_mix_pct: 40
fy2026_net_debt_to_ebitda_x: 2.9
fy2026_net_debt_to_equity_x: about 0.6
h1fy2026_crop_revenue_rs_cr: 307
h2fy2026_crop_revenue_rs_cr: 385
nse_slice_actionable_signals: 1
q4fy2026_pharma_cdmo_mix_pct: 55
recent_four_year_capex_rs_cr: about 900
fy2026_pharma_revenue_mix_pct: 60
h2fy2026_pharma_revenue_rs_cr: 629
historical_annual_dmf_filings: 2-3
q4fy2026_crop_revenue_mix_pct: 44
fy2026_exceptional_items_rs_cr: 85.1
q4fy2026_exceptional_item_rs_cr: 47
q4fy2026_pharma_revenue_mix_pct: 56
final_dividend_pct_of_face_value: 20
fy2026_crop_own_products_mix_pct: 35
fy2025_consolidated_revenue_rs_cr: 1860
fy2026_consolidated_revenue_rs_cr: 1713
fy2026_pharma_own_products_mix_pct: 48
q4fy2026_crop_own_products_mix_pct: 26
total_fy2026_dividend_per_share_rs: 0.60
animal_health_target_timeline_years: 4-5
fy2026_pbt_before_exceptional_rs_cr: 6.8
q3fy2026_consolidated_revenue_rs_cr: 494
q4fy2025_consolidated_revenue_rs_cr: 552
q4fy2026_consolidated_revenue_rs_cr: 519
q4fy2026_crop_protection_ebit_rs_cr: 39
q4fy2026_pharmaceuticals_ebit_rs_cr: 35
recent_four_year_growth_capex_rs_cr: about 600
fy2025_crop_protection_revenue_rs_cr: 692
fy2025_pharmaceuticals_revenue_rs_cr: 1168
fy2026_crop_protection_revenue_rs_cr: 692
fy2026_pharmaceuticals_revenue_rs_cr: 1021
q4fy2026_crop_revenue_qoq_growth_pct: 45
q4fy2026_crop_revenue_yoy_growth_pct: 13
q4fy2026_pbt_after_exceptional_rs_cr: 8.3
q4fy2026_pharma_own_products_mix_pct: 45
multipurpose_asset_growth_capex_rs_cr: about 300
q4fy2026_pbt_before_exceptional_rs_cr: 55
fy2026_crop_protection_ebit_margin_pct: 8.4
fy2026_pharmaceuticals_ebit_margin_pct: 5.7
q3fy2026_crop_protection_revenue_rs_cr: 157
q3fy2026_pharmaceuticals_revenue_rs_cr: 337
q4fy2025_crop_protection_revenue_rs_cr: 201
q4fy2025_pharmaceuticals_revenue_rs_cr: 351
q4fy2026_crop_protection_revenue_rs_cr: 228
q4fy2026_pharmaceuticals_revenue_rs_cr: 292
pharma_average_capacity_utilization_pct: 80-85
q4fy2026_audited_pat_attributable_rs_cr: 14.4
total_fy2026_dividend_pct_of_face_value: 30
fy2026_exceptional_new_labour_code_rs_cr: 38.0
q4fy2026_crop_protection_ebit_margin_pct: 17.1
q4fy2026_pharmaceuticals_ebit_margin_pct: 12
fy2026_exceptional_panoli_impairment_rs_cr: 47.1
nse_slice_announcements_apr01_to_jun27_2026: 23
fy2026_loss_before_tax_after_exceptional_rs_cr: 78.3
fy2026_loss_attributable_to_equity_holders_rs_cr: 48.8
retooling_balance_for_pharma_animal_health_rs_cr: about 250
fy2026_consolidated_revenue_from_operations_rs_cr: 1712.6
q4fy2026_exceptional_item_panoli_impairment_rs_cr: 47.1
animal_health_prior_long_term_revenue_target_rs_cr: 500+
q4fy2026_consolidated_revenue_from_operations_rs_cr: 519.4
employee_fraud_default_current_previous_period_impact: none per company disclosure
fy2026_crop_protection_ebit_rs_cr_management_commentary: 58
fy2026_pharmaceuticals_ebit_rs_cr_management_commentary: 58
recent_four_year_infra_regulatory_maintenance_capex_rs_cr: about 300
fy2026_crop_protection_segment_result_rs_cr_audited_reconciliation: 51.4
fy2026_pharmaceuticals_segment_result_rs_cr_audited_reconciliation: 32.8

Financial highlights

fy2026_customers: about 2925
fy2026_dpac_volume_kmt: 108
fy2026_countries_served: about 85
fy2026_eps_rs_per_share: 14.32
ptl_tender_offer_shares: 900000000
ecoblue_rpet_capacity_tpa: 49200
q4fy2026_eps_rs_per_share: 7.90
total_resin_capacity_mtpa: 495200
fy2026_standard_volume_kmt: 263
ptl_tender_offer_stake_pct: 100
fy2026_product_mix_bopp_pct: 14
ptl_tender_offer_amount_thb: 13500000000
fy2026_india_revenue_mix_pct: 19
fy2026_product_mix_other_pct: 4
fy2026_europe_revenue_mix_pct: 20
fy2026_normalized_ebitda_rs_cr: 575
agp_holdco_polyplex_corp_shares: 7621390
ecoblue_polyolefin_capacity_tpa: 10500
fy2025_unrealized_fx_gain_rs_cr: 39.59
fy2026_americas_revenue_mix_pct: 31
fy2026_normalized_ebitda_usd_mn: 65
fy2026_product_mix_thin_pet_pct: 53
fy2026_unrealized_fx_loss_rs_cr: 138.49
turkey_coater_investment_usd_mn: 10
fy2026_pat_before_minority_rs_cr: 41
fy2026_product_mix_cpp_blown_pct: 3
fy2026_product_mix_pet_resin_pct: 6
fy2026_product_mix_thick_pet_pct: 4
fy2026_sales_volume_all_films_mt: 370515
q4fy2026_normalized_ebitda_rs_cr: 128
consolidated_ppe_march_2026_rs_cr: 4194.87
fy2026_other_asia_revenue_mix_pct: 25
fy2026_pat_before_minority_usd_mn: 4.6
fy2026_product_mix_downstream_pct: 17
q4fy2025_unrealized_fx_loss_rs_cr: 105.13
q4fy2026_normalized_ebitda_usd_mn: 14
q4fy2026_unrealized_fx_gain_rs_cr: 22.06
agp_holdco_polyplex_corp_stake_pct: 24.28
ecoblue_put_option_valuation_rs_cr: about 377
fy2026_final_dividend_re_per_share: 1
fy2026_sales_volume_growth_yoy_pct: 23
q4fy2026_pat_before_minority_rs_cr: 38
q4fy2026_sales_volume_all_films_mt: 95424
ecoblue_put_option_valuation_thb_mn: 1312
fy2026_sales_revenue_growth_yoy_pct: 3
india_metallizers_investment_usd_mn: 7
q4fy2026_pat_before_minority_usd_mn: 4
fy2026_packaging_application_mix_pct: 65
fy2026_rest_of_world_revenue_mix_pct: 5
ptl_tender_offer_price_thb_per_share: 15
q4fy2026_sales_volume_growth_qoq_pct: 8
q4fy2026_sales_volume_growth_yoy_pct: 6
fy2026_dpac_incremental_ebitda_usd_mn: 87
fy2026_industrial_application_mix_pct: 35
fy2026_standard_product_ebitda_usd_mn: -22
q4fy2026_sales_revenue_growth_qoq_pct: 31
q4fy2026_sales_revenue_growth_yoy_pct: 8
technova_printrite_stake_acquired_pct: 51
india_new_bopet_line_investment_usd_mn: 56
investment_under_implementation_usd_mn: 73
fy2026_sales_revenue_presentation_rs_cr: 7076
fy2026_normalized_ebitda_decline_yoy_pct: 8
fy2026_sales_revenue_presentation_usd_mn: 801
consolidated_inventories_march_2026_rs_cr: 1712.01
q4fy2026_normalized_ebitda_growth_qoq_pct: 11
q4fy2026_sales_revenue_presentation_rs_cr: 1868
consolidated_total_assets_march_2026_rs_cr: 8913.77
consolidated_total_equity_march_2026_rs_cr: 7036.63
q4fy2026_sales_revenue_presentation_usd_mn: 204
technova_printrite_total_investment_rs_lakh: 6209.75
bopet_films_capacity_including_upcoming_mtpa: 365000
capacity_utilization_excluding_new_us_line_pct: 94
fy2026_audited_consolidated_total_income_rs_cr: 7173.43
fy2026_top_10_film_customer_turnover_share_pct: 26
consolidated_trade_receivables_march_2026_rs_cr: 1124.96
consolidated_current_borrowings_march_2026_rs_cr: 758.50
q4fy2026_audited_consolidated_total_income_rs_cr: 1932.58
consolidated_other_bank_balances_march_2026_rs_cr: 501.70
total_base_films_capacity_including_upcoming_mtpa: 491837
fy2026_audited_consolidated_profit_before_tax_rs_cr: 20.39
consolidated_non_current_borrowings_march_2026_rs_cr: 158.59
q4fy2026_audited_consolidated_profit_before_tax_rs_cr: 42.56
consolidated_cash_and_cash_equivalents_march_2026_rs_cr: 323.22
fy2026_audited_consolidated_revenue_from_operations_rs_cr: 7085.86
q4fy2026_audited_consolidated_revenue_from_operations_rs_cr: 1870.72
fy2026_audited_consolidated_profit_for_year_before_minority_rs_cr: 40.93
q4fy2026_audited_consolidated_profit_attributable_to_owners_rs_cr: 24.80
q4fy2026_audited_consolidated_profit_for_period_before_minority_rs_cr: 37.63

Financial highlights

Fluconazole approval: US FDA approval for Fluconazole Tablets USP 50 mg, 100 mg, 150 mg and 200 mg
Standalone FY2026 EPS: Rs 17.62
Cefixime ANDA approval: USFDA approval for Cefixime for Oral Suspension USP, 100 mg/5 mL and 200 mg/5 mL
API Q4 FY2026 sales mix: 7% of consolidated sales
Consolidated FY2025 EPS: Rs 16.39
Consolidated FY2025 PAT: Rs 267 cr in the press release; audited table Rs 26,678.81 lakhs
Consolidated FY2026 EPS: Rs 17.29
Consolidated FY2026 PAT: Rs 281 cr in the press release; audited table Rs 28,142.16 lakhs
FY2026 interim dividend: Rs 5 per equity share of face value Re 1
Standalone Q4 FY2026 EPS: Rs 6.58
Consolidated FY2025 EBITDA: Rs 325 cr
Consolidated FY2026 EBITDA: Rs 346 cr
Consolidated Q4 FY2025 EPS: Rs 2.38
Consolidated Q4 FY2025 PAT: Rs 39 cr in the press release; audited table Rs 3,867.13 lakhs
Consolidated Q4 FY2026 EPS: Rs 6.35
Consolidated Q4 FY2026 PAT: Rs 103 cr in the press release; audited table Rs 10,339.67 lakhs
Postal ballot votes polled: 127,768,004 votes, 78.4767% of voting shares
Postal ballot votes against: 292,160 votes, 0.2287% of valid votes
Standalone FY2026 net profit: Rs 28,692.34 lakhs
Consolidated FY2026 API sales: Rs 121 cr, up 8.5% YoY
Consolidated Q4 FY2025 EBITDA: Rs 54 cr
Consolidated Q4 FY2026 EBITDA: Rs 106 cr
Postal ballot votes in favour: 127,475,844 votes, 99.7713% of valid votes
Consolidated FY2026 EPS growth: 5.5% YoY
Consolidated FY2026 PAT growth: 5.5% YoY
Consolidated FY2026 current tax: Rs 8,643.76 lakhs
Standalone Q4 FY2026 net profit: Rs 10,707.03 lakhs
Consolidated FY2025 other income: Rs 9,066.08 lakhs
Consolidated FY2025 total income: Rs 219,878.12 lakhs
Consolidated FY2026 deferred tax: Rs 673.93 lakhs
Consolidated FY2026 other income: Rs 11,351.83 lakhs
Consolidated FY2026 total income: Rs 228,445.15 lakhs
Consolidated Q4 FY2026 API sales: Rs 42 cr, up 38.6% YoY
Consolidated FY2025 EBITDA margin: 15.4%
Consolidated FY2026 EBITDA growth: 6.6% YoY
Consolidated FY2026 EBITDA margin: 15.9%
Consolidated FY2026 finance costs: Rs 498.57 lakhs
Consolidated Q4 FY2026 EPS growth: 167.4% YoY
Consolidated Q4 FY2026 PAT growth: 167.4% YoY
Consolidated dividend paid FY2026: Rs 8,102.59 lakhs
US business revenue from supplies: Rs 71 cr, up 165.1% YoY
Consolidated FY2025 total expenses: Rs 184,156.36 lakhs
Consolidated FY2026 other expenses: Rs 63,132.39 lakhs
Consolidated FY2026 revenue growth: 3.0% YoY
Consolidated FY2026 total expenses: Rs 188,906.39 lakhs
Consolidated Q4 FY2026 current tax: Rs 3,106.67 lakhs
Overall US business revenue growth: 46.9% YoY
Standalone FY2026 exceptional item: Rs 2,078.91 lakhs
Consolidated Q4 FY2026 deferred tax: Rs 588.69 lakhs
Consolidated Q4 FY2026 other income: Rs 4,989.08 lakhs
Consolidated Q4 FY2026 total income: Rs 63,467.79 lakhs
Consolidated FY2026 exceptional item: Rs 2,078.91 lakhs related to New Labour Codes obligations
Consolidated FY2026 inventory change: Rs 699.27 lakhs
Consolidated Q4 FY2025 EBITDA margin: 11.0%
Consolidated Q4 FY2026 EBITDA growth: 97.0% YoY
Consolidated Q4 FY2026 EBITDA margin: 18.2%
Large Corporate borrowing disclosure: Outstanding borrowing nil as of March 31 2026
Consolidated Q4 FY2026 revenue growth: 18.9% YoY
Domestic formulations FY2026 sales mix: 82% of consolidated sales
Consolidated income tax paid net FY2026: Rs 8,716.18 lakhs
Export formulations Q4 FY2026 sales mix: 15% of consolidated sales
Consolidated inventories at March 31 2026: Rs 35,525.26 lakhs
Domestic formulations Q4 FY2026 sales mix: 78% of consolidated sales
Standalone FY2025 revenue from operations: Rs 207,011.19 lakhs
Standalone FY2026 revenue from operations: Rs 212,632.72 lakhs
Consolidated other equity at March 31 2026: Rs 246,883.10 lakhs
Consolidated total assets at March 31 2026: Rs 291,896.74 lakhs
Consolidated total equity at March 31 2026: Rs 248,511.20 lakhs
Consolidated FY2025 revenue from operations: Rs 2,108 cr in the press release; audited table Rs 210,812.04 lakhs
Consolidated FY2026 revenue from operations: Rs 2,171 cr in the press release; audited table Rs 217,003.32 lakhs
Consolidated current assets at March 31 2026: Rs 113,252.27 lakhs
Consolidated trade payables at March 31 2026: Rs 20,679.08 lakhs including MSME and other creditors
Standalone Q4 FY2025 revenue from operations: Rs 48,200.43 lakhs
Standalone Q4 FY2026 revenue from operations: Rs 56,436.37 lakhs
Consolidated FY2026 employee benefits expense: Rs 48,254.70 lakhs
Consolidated FY2026 export formulations sales: Rs 260 cr, up 23.5% YoY
Standalone FY2026 PBT after exceptional items: Rs 37,836.32 lakhs
Consolidated FY2026 cost of materials consumed: Rs 57,637.29 lakhs
Consolidated FY2026 total comprehensive income: Rs 28,543.72 lakhs
Consolidated Q4 FY2025 revenue from operations: Rs 492 cr in the press release; audited table Rs 49,188.93 lakhs
Consolidated Q4 FY2026 revenue from operations: Rs 585 cr in the press release; audited table Rs 58,478.71 lakhs
IQVIA MAT March 31 2026 secondary-sales growth: 1.7%
Standalone FY2026 PBT before exceptional items: Rs 39,915.23 lakhs
Consolidated FY2025 PBT after exceptional items: Rs 357 cr in the press release; audited table Rs 35,721.76 lakhs
Consolidated FY2026 PBT after exceptional items: Rs 375 cr in the press release; audited table Rs 37,459.85 lakhs
Consolidated FY2026 domestic formulations sales: Rs 1,781 cr, up 0.1% YoY
Consolidated FY2026 purchases of stock-in-trade: Rs 12,759.88 lakhs
Consolidated lease liabilities at March 31 2026: Rs 1,546.50 lakhs total, including Rs 1,059.55 lakhs non-current and Rs 486.95 lakhs current
Consolidated trade receivables at March 31 2026: Rs 15,172.38 lakhs
Consolidated FY2025 PBT before exceptional items: Rs 357 cr in the press release; audited table Rs 35,721.76 lakhs
Consolidated FY2026 PBT after exceptional growth: 4.9% YoY
Consolidated FY2026 PBT before exceptional items: Rs 395 cr in the press release; audited table Rs 39,538.76 lakhs
Consolidated FY2026 export formulations US sales: Rs 94 cr, up 46.9% YoY
Consolidated Q4 FY2026 export formulations sales: Rs 89 cr, up 99.3% YoY
Consolidated current borrowings at March 31 2026: Nil
Consolidated non-current assets at March 31 2026: Rs 178,644.47 lakhs
Consolidated FY2026 PBT before exceptional growth: 10.7% YoY
Consolidated FY2026 depreciation and amortisation: Rs 5,924.29 lakhs
Consolidated Q4 FY2026 total comprehensive income: Rs 10,609.55 lakhs
Consolidated current investments at March 31 2026: Rs 47,272.83 lakhs
Consolidated current liabilities at March 31 2026: Rs 36,407.49 lakhs
Consolidated right-of-use assets at March 31 2026: Rs 4,362.71 lakhs
Standalone Q4 FY2026 PBT before exceptional items: Rs 14,296.46 lakhs
Consolidated Q4 FY2026 PBT after exceptional items: Rs 140 cr in the press release; audited table Rs 14,035.03 lakhs
Consolidated Q4 FY2026 domestic formulations sales: Rs 452 cr, up 8.5% YoY
Consolidated cash generated from operations FY2026: Rs 28,761.37 lakhs
Consolidated Q4 FY2025 PBT before exceptional items: Rs 53 cr in the press release; audited table Rs 5,330.84 lakhs
Consolidated Q4 FY2026 PBT before exceptional items: Rs 140 cr in the press release; audited table Rs 14,035.03 lakhs
Consolidated Q4 FY2026 export formulations US sales: Rs 39 cr, up 283.1% YoY
Consolidated FY2026 export formulations Non-US sales: Rs 166 cr, up 13.3% YoY
Consolidated Q4 FY2026 PBT before exceptional growth: 163.3% YoY
Consolidated cash and cash equivalents at end FY2026: Rs 4,867.81 lakhs
Consolidated non-current borrowings at March 31 2026: Nil
Consolidated non-current investments at March 31 2026: Rs 57,525.26 lakhs
Consolidated non-current liabilities at March 31 2026: Rs 6,978.05 lakhs
Consolidated capital work-in-progress at March 31 2026: Rs 9,610.35 lakhs
Consolidated Q4 FY2026 export formulations Non-US sales: Rs 50 cr, up 44.8% YoY
Consolidated cash and cash equivalents at March 31 2026: Rs 4,867.81 lakhs
Subsidiary total assets before consolidation adjustments: Rs 5,028.21 lakhs at March 31 2026
Consolidated FY2026 other comprehensive income net of tax: Rs 401.56 lakhs
Consolidated net cash used in financing activities FY2026: Rs 9,332.53 lakhs
Consolidated net cash used in investing activities FY2026: Rs 10,993.09 lakhs
Consolidated paid-up equity share capital at March 31 2026: Rs 1,628.10 lakhs
Consolidated property plant and equipment at March 31 2026: Rs 95,237.23 lakhs
Consolidated net change in cash and cash equivalents FY2026: Decrease of Rs 280.43 lakhs
Consolidated Q4 FY2026 other comprehensive income net of tax: Rs 269.88 lakhs
Consolidated acquisition of property plant and equipment FY2026: Rs 18,656.27 lakhs
Consolidated net cash generated from operating activities FY2026: Rs 20,045.19 lakhs
Subsidiary total revenue before consolidation adjustments FY2026: Rs 5,982.91 lakhs
Subsidiary net profit after tax before consolidation adjustments FY2026: Rs 179.03 lakhs

Financial highlights

Net debt: Rs 755 crore at March 31, 2026 versus Rs 934 crore in December 2025
Adjusted ROCE: 10.8% for FY2026
Final dividend: Rs 5 per share of face value Rs 2, subject to shareholder approval
GST demand orders: Rs 65,920, Rs 5,89,258, Rs 4,19,970 and Rs 80,598 across four disclosed periods; company says appealable and no expected operational or financial impact
Net debt to equity: 0.3x
Warrant conversion: 980,000 equity shares allotted at Rs 1,019.75 per share; paid-up equity increased to 79,607,576 shares
Net working capital: 25.9% of sales
RIECO FY2026 EBITDA: Positive Rs 10 crore versus negative Rs 17 crore in FY2025
RIECO FY2026 revenue: Rs 268 crore versus Rs 228 crore in FY2025, up 17.5%
Consolidated inventories: Rs 2,443.6 crore at March 31, 2026
Consolidated total equity: Rs 3,854.0 crore at March 31, 2026
CRISIL commercial-paper rating: CRISIL A1+ reaffirmed on Rs 50 crore commercial paper
Consolidated trade receivables: Rs 1,679.0 crore at March 31, 2026
Consolidated current borrowings: Rs 471.1 crore at March 31, 2026
Q4 FY2026 pigment EBITDA margin: 15.9%, up 2.3 percentage points year on year
FY2027 acquired-group projection: Sales of about EUR 700 million and EBITDA of about EUR 35 million
RIECO Q4 FY2026 revenue and EBITDA: Revenue Rs 102 crore and EBITDA Rs 4 crore
Consolidated non-current borrowings: Rs 1,647.9 crore at March 31, 2026
FY2026 acquired-group business EBITDA: EUR 19 million
FY2026 standalone profit for the year: Rs 290.3 crore
Q4 FY2026 pigment-only revenue growth: 4.6% year on year and about 30% quarter on quarter
Consolidated cash and cash equivalents: Rs 932.9 crore at March 31, 2026
FY2026 consolidated profit for the year: Rs 40.8 crore
Medium-term acquired-group EBITDA target: EUR 90 million to EUR 100 million over three to four years
Q4 FY2026 acquired-group business EBITDA: EUR 11 million versus EUR 9 million to EUR 10 million projection; Rs 118 crore at 6.1% margin
FY2026 standalone revenue from operations: Rs 2,396.7 crore
Incremental inventory optimization target: EUR 15 million to EUR 20 million
Q4 FY2026 acquired-group revenue run rate: About EUR 61 million versus about EUR 47 million in Q3 FY2026
Q4 FY2026 standalone profit for the period: Rs 120.4 crore
FY2026 consolidated revenue from operations: Rs 9,787.2 crore
Q4 FY2026 acquired-group inventory reduction: EUR 29 million versus EUR 20 million projection
Q4 FY2026 consolidated profit for the period: Rs 82.5 crore
Q4 FY2026 standalone revenue from operations: Rs 732.7 crore
FY2026 standalone EPS after exceptional items: Rs 36.9 basic and Rs 36.9 diluted
FY2026 standalone EPS before exceptional items: Rs 39.6 basic and Rs 39.5 diluted
Q4 FY2026 consolidated revenue from operations: Rs 2,789.9 crore
FY2026 consolidated EPS after exceptional items: Rs 2.8 per share
Promoter-group holding after warrant conversion: 9.32% versus 8.19% before allotment
FY2026 consolidated EPS before exceptional items: Rs 6.6 per share
Q4 FY2026 consolidated EPS after exceptional items: Rs 10.0 per share
Q4 FY2026 consolidated EPS before exceptional items: Rs 8.0 per share
Q4 FY2026 pigment-only gross revenue from operations: Rs 2,689 crore
FY2026 standalone profit before exceptional items and tax: Rs 350.5 crore
FY2026 consolidated profit before exceptional items and tax: Rs 186.3 crore
Q4 FY2026 standalone profit before exceptional items and tax: Rs 129.8 crore
Q4 FY2026 consolidated profit before exceptional items and tax: Rs 152.0 crore
FY2026 consolidated net cash generated from operating activities: Rs 344.0 crore

Financial highlights

Dividend: Rs 1.50 per equity share, or 150% of Re 1 face value, recommended for FY2026 subject to shareholder approval
Leverage: Net debt/equity of 0.27 and net debt/annualized adjusted EBITDA of 0.54 at March 31, 2026
Net debt: Rs 4,952 million at March 31, 2026, down Rs 2,528 million from March 31, 2025
FY2026 EPS: Rs 14.73 before adjustment for audit qualification impact
FY2026 PAT: Rs 2,298 million versus Rs 697 million in FY2025
FY2026 ROCE: 24.4%
Debt outlook: Average debt expected around Rs 500 crore to Rs 600 crore in FY2027, with objective of zero debt by end-FY2028
Capex outlook: FY2027 capex expected at Rs 450 crore to Rs 500 crore; FY2028 capex could be Rs 300 crore to Rs 400 crore
FY2026 EBITDA: Rs 8,634 million, with EBITDA margin of 9.4%
Q4 FY2026 PAT: Rs 705 million versus Rs 230 million in Q4 FY2025 and a loss of Rs 113 million in Q3 FY2026
Q4 FY2026 EBITDA: Rs 2,305 million, with EBITDA margin of 9.7%
FY2026 product mix: Body parts 35.2%, ICE powertrain 25.1%, lighting solutions 16.9%, aftermarket 10.0%, e-mobility 6.2%, HMI connectivity 3.9% and overseas 2.7%
FY2026 customer mix: 46% Bajaj and 54% non-Bajaj
FY2026 total income: Rs 89,080.39 million
EV-model revenue mix: About 14% of Q4 FY2026 revenue, up 50% YoY; about 13% of FY2026 revenue, up 39% YoY
KTM AG ECL provision: Rs 30.62 million provision recognized in Q4 FY2025 and FY2025 for KTM AG Group trade receivables
Net new order intake: Rs 32,889 million of annual peak revenue potential in FY2026, with more than 65% related to EV models
FY2026 geographic mix: 89% India and 11% overseas
Other segment revenue: Rs 719.81 million in Q4 FY2026 and Rs 2,417.41 million in FY2026
Outstanding order book: Rs 35,090 million at end-FY2026, with Rs 23,298 million SOP in FY2027, Rs 10,582 million in FY2028 and Rs 1,210 million in FY2029
Automotive segment results: Rs 1,411.07 million in Q4 FY2026 and Rs 4,276.42 million in FY2026
Automotive segment revenue: Rs 22,961.03 million in Q4 FY2026 and Rs 86,487.52 million in FY2026
FY2026 vehicle-segment mix: 76% two-wheelers and three-wheelers and 24% four-wheelers
VTYC disposal consideration: RMB 310.50 million received on May 7, 2025 for transfer of the 50% VTYC shareholding
OPmobility arbitration claim: Some alleged breach claims quantified at US$ 66.41 million plus legal costs; other claims not quantified
Overseas FY2026 order intake: Close to Rs 1,400 crore according to management
FY2026 revenue from operations: Rs 88,904.93 million, up 9.0% YoY
Audit qualification revenue item: Rs 209.89 million FY2026 income and Rs 231.82 million FY2025 income from Chongqing Varroc TYC Auto Lamps Co. Ltd. under the TMA matter
Q4 FY2026 revenue from operations: Rs 23,680.84 million reported in audited consolidated results; investor presentation rounded to Rs 23,681 million, up 12.8% YoY and 3.5% QoQ
GST demand after partial appeal relief: Total demand reduced to Rs 284 million, with further appellate remedies intended
FY2026 PBT before JV and exceptional items: Rs 3,814 million, with margin of 4.3%
Q4 FY2026 PBT before JV and exceptional items: Rs 1,074 million, with margin of 4.5%
FY2026 PBT after exceptional items and JV profit: Rs 3,415 million
Q4 FY2026 PBT after exceptional items and JV profit: Rs 1,088 million
Foreign currency translation reserve reclassification: Rs 611.94 million of cumulative exchange gains reclassified to profit or loss after VTYC disposal

Financial highlights

Ethanol blending: India reached 19.98% ethanol blending in petrol as of January 31, 2026, according to the investor presentation
FY2026 sugar sales: 2.90 LMT versus 2.65 LMT in FY2025
Q4 FY2026 cane cost: Rs 4,087 per MT versus Rs 3,768 per MT in Q4 FY2025
PSRIPL loan payments: USD 49 mn equivalent to Rs 460 cr paid on April 24, 2026 and USD 29 mn equivalent to Rs 272 cr paid on May 15, 2026, according to management
Coromandel share sale: 1,500,000 shares sold at Rs 1,991 per share, aggregating to Rs 298.65 cr and generating gain of Rs 297.64 cr
Q4 FY2026 sugar sales: 97,000 MT including 6,000 MT exports versus 73,000 MT in Q4 FY2025
Jaggery facility capex: About Rs 45 cr planned by management
Q4 FY2026 power tariff: Rs 4.57 per unit versus Rs 4.38 per unit in Q4 FY2025
Q4 FY2026 cane crushing: 17.75 LMT versus 17.62 LMT in Q4 FY2025
Q4 FY2026 power exports: 845 lakh units versus 732 lakh units in Q4 FY2025
FY2026 standalone EBITDA: Rs 399 cr excluding exceptional items of Rs 830 cr; Rs 252 cr excluding exceptional item of Rs 427 cr in FY2025
Q4 FY2026 sugar recovery: 11.19% versus 10.89% in Q4 FY2025
Q4 FY2026 distillery PBIT: Rs 2 cr versus Rs 20 cr in Q4 FY2025
FY2026 consolidated EBITDA: Rs 3,799 cr excluding exceptional item of Rs 478 cr; Rs 2,993 cr excluding exceptional item of Rs 347 cr in FY2025
Q4 FY2026 Farm Inputs PBIT: Rs 365 cr consolidated versus Rs 398 cr in Q4 FY2025
Q4 FY2026 distillery sales: 404 lakh litres versus 389 lakh litres in Q4 FY2025
Q4 FY2026 sugar production: 1.74 LMT versus 1.55 LMT in Q4 FY2025
Q4 FY2026 standalone EBITDA: Rs 244 cr excluding exceptional item of Rs 478 cr; Rs 225 cr excluding exceptional item of Rs 350 cr in Q4 FY2025
Q4 FY2026 sugar realization: Rs 39.28 per kg versus Rs 39.22 per kg in Q4 FY2025
PSRIPL investment impairment: Rs 400.60 cr in FY2026 and Rs 46.16 cr in Q4 FY2026
Q4 FY2026 distillery revenue: Rs 275 cr versus Rs 268 cr in Q4 FY2025
Q4 FY2026 Nutraceuticals PBIT: Rs 3.8 cr standalone; Rs 8 cr consolidated
Q4 FY2026 closing sugar stock: 1.92 LMT valued at Rs 39 per kg versus 1.83 LMT in Q4 FY2025
Q4 FY2026 consolidated EBITDA: Rs 660 cr excluding exceptional item of Rs 478 cr; Rs 626 cr excluding exceptional item of Rs 347 cr in Q4 FY2025
Q4 FY2026 co-generation revenue: Rs 66 cr versus Rs 58 cr in Q4 FY2025
Q4 FY2026 distillery production: 452 lakh litres versus 438 lakh litres in Q4 FY2025
Q4 FY2026 standalone sugar PBIT: Rs 78 cr versus Rs 56 cr in Q4 FY2025
FY2026 average sugar realization: Rs 40.14 per kg versus Rs 38.15 per kg in FY2025
FY2026 standalone loss after tax: Rs 708 cr versus Rs 428 cr loss in FY2025
Q4 FY2026 Nutraceuticals revenue: Rs 13 cr standalone and Rs 50 cr consolidated
Q4 FY2026 distillery realization: Rs 64.25 per litre versus Rs 66.98 per litre in Q4 FY2025
FY2026 consolidated PAT after NCI: Rs 570 cr versus Rs 878 cr in FY2025
Q4 FY2026 standalone sugar revenue: Rs 466 cr versus Rs 408 cr in Q4 FY2025
FY2026 standalone exceptional items: Rs 829.76 cr net exceptional charge
Q4 FY2026 standalone loss after tax: Rs 340 cr versus Rs 232 cr loss in Q4 FY2025
Estimated Coromandel dividend inflow: Rs 32.79 cr from Rs 2 per share final dividend approved by Coromandel after balance-sheet date
Q4 FY2026 consolidated PAT after NCI: Loss of Rs 333 cr versus profit of Rs 286 cr in Q4 FY2025
FY2026 Consumer Products Group result: Loss of Rs 109 cr versus loss of Rs 58 cr in FY2025
FY2026 Consumer Products Group revenue: Rs 607 cr versus Rs 884 cr in FY2025
Q4 FY2026 standalone exceptional items: Rs 477.53 cr net exceptional charge
Property plant and equipment impairment: Rs 137.69 cr in Q4 FY2026 and FY2026 for three CGUs linked to insufficient feedstock availability in Tamil Nadu and Andhra Pradesh
Q4 FY2026 co-generation units generated: 1,499 lakh units versus 1,450 lakh units in Q4 FY2025
Q4 FY2026 Consumer Products Group result: Loss of Rs 33 cr versus loss of Rs 13 cr in Q4 FY2025
FY2026 standalone revenue from operations: Rs 3,120 cr versus Rs 3,168 cr in FY2025
Q4 FY2026 Consumer Products Group revenue: Rs 115 cr versus Rs 195 cr in Q4 FY2025
FY2026 consolidated revenue from operations: Rs 38,534 cr versus Rs 31,609 cr in FY2025
Q4 FY2026 standalone revenue from operations: Rs 846 cr versus Rs 814 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 7,882 cr versus Rs 6,811 cr in Q4 FY2025
PSRIPL financial guarantee and loan commitment provision: Rs 591.32 cr recognized in FY2026

Financial highlights

Dividend: Rs 8.50 per equity share recommended for FY2026, subject to shareholder approval
Treasury: Approximately Rs 190 cr at March 31, 2026 according to management
FY2026 capex: Approximately Rs 270 cr including VOPL investment
FY2027 capex plan: Approximately Rs 200-250 cr; management also discussed Rs 250-300 cr annual organic investment potential over the next 3-5 years
FY2026 standalone PAT: Rs 487.78 cr versus Rs 415.23 cr in FY2025
FY2026 consolidated PAT: Rs 443.74 cr versus Rs 405.25 cr in FY2025
FY2026 standalone EBITDA: Rs 741 cr according to management opening remarks, up 17% from Rs 630 cr in FY2025
Q4 FY2026 standalone PAT: Rs 137.51 cr; management described this as 27% sequential growth
ATBS capacity utilization: Approximately 75%-80% after expansion according to Q&A
ATBS expansion phase cost: Management sized two phases together at roughly Rs 250-300 cr
FY2026 consolidated EBITDA: Rs 707 cr according to management opening remarks, up 13% from Rs 625 cr in FY2025
Q4 FY2026 consolidated PAT: Rs 123.86 cr; management described this as 23% sequential growth
Q4 FY2026 standalone EBITDA: Rs 203 cr according to management opening remarks, up 20% sequentially
FY2026 product-mix commentary: ATBS about one-third to 35% of revenue, antioxidants 15%-20%, IB 10%-12%, IBB 10%-12%, and balance customized and other products
Q4 FY2026 consolidated EBITDA: Rs 191 cr according to management opening remarks, up 15% sequentially
ATBS Phase 1 capacity addition: 10,000 MTPA commercial operations commenced on November 5, 2025
FY2026 standalone total income: Rs 2,280.79 cr versus Rs 2,292.39 cr in FY2025
VOPL FY2027 revenue expectation: About Rs 100-120 cr after process reengineering, with contribution expected from around Q3 FY2027
FY2026 consolidated total income: Rs 2,279.53 cr versus Rs 2,292.48 cr in FY2025
Q4 FY2026 standalone total income: Rs 631.05 cr; management described this as 17% sequential growth in net income including other income
VOPL May 2026 turnover disclosure: Rs 21.94 cr in FY2026, Rs 10.55 cr in FY2025 and Rs 0.09 cr in FY2024
FY2026 standalone profit before tax: Rs 648.54 cr versus Rs 548.23 cr in FY2025
Q4 FY2026 consolidated total income: Rs 624.31 cr; management described this as 16% sequential growth in net income including other income
VOPL May 2026 additional investment: Rs 19.88 cr subscription for 1,98,80,000 shares at Rs 10 each
FY2026 consolidated profit before tax: Rs 594.74 cr versus Rs 536.18 cr in FY2025
VOPL March 2026 additional investment: Rs 22.95 cr subscription for 2,29,50,000 shares at Rs 10 each
Q4 FY2026 standalone profit before tax: Rs 178.69 cr
Q4 FY2026 consolidated profit before tax: Rs 160.20 cr
FY2026 standalone revenue from operations: Rs 2,208.22 cr versus Rs 2,248.10 cr in FY2025
FY2026 consolidated revenue from operations: Rs 2,226.89 cr versus Rs 2,248.17 cr in FY2025
Q4 FY2026 standalone revenue from operations: Rs 610.55 cr; Rs 529.14 cr in Q3 FY2026 and Rs 648.45 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 603.92 cr; Rs 530.78 cr in Q3 FY2026 and Rs 648.46 cr in Q4 FY2025

Financial highlights

Dividend: Final dividend Rs 0.50 per Rs 2 share; FY2026 total dividend Rs 9.00 per share including Rs 5.00 and Rs 3.50 interim dividends
FY2026 EBITDA: Management said Rs 1,666 cr vs Rs 1,550 cr in FY2025, up 7.48%
Ticketing KPIs: Q4 AC tickets 6.85 cr; non-AC tickets 6.54 cr; total tickets 13.39 cr; UPI share 51.7%
Q4 FY2026 EBITDA: Management said Rs 399 cr with 27.33% EBITDA margin
Trade receivables: Standalone trade receivables Rs 1,883.16 cr at March 31, 2026 vs Rs 1,734.23 cr at March 31, 2025
Governance penalty: Rs 5,31,000 each from BSE and NSE including GST for Regulation 17(1) board-composition non-compliance for quarter ended March 31, 2026
FY2026 EBITDA margin: Management said about 31.95%
Channel-partner share: Management said channel partners were around 28%, with details to be shared separately
FY2026 standalone EPS: Rs 17.42 vs Rs 16.43 in FY2025
FY2026 standalone PAT: Rs 1,393.37 cr vs Rs 1,314.66 cr in FY2025
FY2026 standalone PBT: Rs 1,875.08 cr vs Rs 1,756.95 cr in FY2025
Cash and bank balances: Standalone cash and cash equivalents Rs 409.94 cr and bank balances other than cash and cash equivalents Rs 2,431.68 cr at March 31, 2026
Convenience-fee income: Q4 convenience-fee income Rs 247 cr
Election-special revenue: Q4 Rs 2.38 cr; FY2026 Rs 6.77 cr
Internet-ticketing share: Management said IRCTC handles about 89% of reserved railway ticket bookings
Q4 FY2026 standalone EPS: Rs 4.08 vs Rs 4.47 in Q4 FY2025
Q4 FY2026 standalone PAT: Rs 326.57 cr vs Rs 357.95 cr in Q4 FY2025
Q4 FY2026 standalone PBT: Rs 446.90 cr vs Rs 471.93 cr in Q4 FY2025
Rail Neer capacity actions: Ambernath expansion from 2 lakh to 3 lakh bottles/day; Danapur expansion from 1 lakh to 2 lakh bottles/day; greenfield land at Mysore and Prayagraj
FY2026 standalone total income: Rs 5,474.97 cr vs Rs 4,903.45 cr in FY2025
Q4 FY2026 standalone total income: Rs 1,526.45 cr vs Rs 1,329.74 cr in Q4 FY2025
Tourism FY2026 revenue and result: Revenue Rs 890.08 cr; segment result Rs 127.50 cr
Catering FY2026 revenue and result: Revenue Rs 2,398.75 cr; segment result Rs 249.90 cr
Rail Neer FY2026 revenue and result: Revenue Rs 407.51 cr; segment result Rs 55.66 cr
Management dividend payout reference: Management said FY2026 dividend was Rs 720 cr, with Rs 680 cr interim and Rs 40 cr final subject to AGM approval
Tourism Q4 FY2026 revenue and result: Revenue Rs 303.58 cr; segment result Rs 49.38 cr
Catering Q4 FY2026 revenue and result: Revenue Rs 670.88 cr; segment result Rs 42.24 cr
Rail Neer Q4 FY2026 revenue and result: Revenue Rs 100.20 cr; segment result Rs 16.19 cr
FY2026 standalone revenue from operations: Rs 5,214.86 cr vs Rs 4,674.77 cr in FY2025
Internet Ticketing FY2026 revenue and result: Revenue Rs 1,535.51 cr; segment result Rs 1,267.92 cr
Q4 FY2026 standalone revenue from operations: Rs 1,459.72 cr vs Rs 1,268.53 cr in Q4 FY2025
Internet Ticketing Q4 FY2026 revenue and result: Revenue Rs 390.25 cr; segment result Rs 297.97 cr

Financial highlights

FY2026 capex: Rs 9,131 cr, up 18% YoY and described as highest since inception
2030 ambition: Mining 104 MT, thermal more than 10 GW, renewables more than 10 GW, revenue above Rs 37,000 cr, PAT above Rs 5,000 cr and assets above Rs 1.5 lakh cr
FY2026 dividend: Interim dividend Rs 3.60 per share plus proposed final dividend Rs 0.25 per share, total 38.5% of face value
FY2026 group EBITDA: Rs 7,475 cr vs Rs 6,513 cr in FY2025, according to management presentation
FY2026 segment EBITDA: Mines Rs 2,030 cr, thermal Rs 1,393 cr and renewables Rs 492 cr, based on Q&A commentary
FY2026 standalone PAT: Rs 2,525.07 cr vs Rs 1,899.99 cr in FY2025
FY2026 standalone PBT: Rs 3,038.81 cr vs Rs 2,857.83 cr in FY2025
FY2027 revenue bridge: Management discussed revenue projection around Rs 25,300 cr for FY2027 versus about Rs 17,500 cr in FY2026
Consolidated net worth: Rs 21,524.77 cr at March 31, 2026 vs Rs 18,722.97 cr at March 31, 2025
FY2026 consolidated PAT: Rs 3,769.46 cr vs Rs 2,713.61 cr in FY2025
FY2026 capacity addition: 963 MW total additions, comprising 660 MW thermal and 303 MW renewables
Q4 FY2026 standalone PAT: Rs 1,243.46 cr vs Rs 427.92 cr in Q3 FY2026 and Rs 656.23 cr in Q4 FY2025
Q4 FY2026 standalone PBT: Rs 1,255.56 cr vs Rs 572.67 cr in Q3 FY2026 and Rs 1,068.04 cr in Q4 FY2025
Pachwara South coal block: 9 MTPA capacity; production commenced March 2026; management targets peak capacity in the third year versus fourth year in mine plan
FY2026 renewable generation: 2.26 BU, described as highest-ever green power generation
Consolidated debtor turnover: 4.64x for FY2026 vs 3.17x for FY2025
NIRL renewable/BESS pipeline: Presentation cited 2 GW renewable projects and 3,300 MWh BESS across PSPCL, NHPC, GUVNL, SECI, NCRTC, TNGECL and NTPC
Consolidated operating margin: 22.39% for FY2026 vs 19.69% for FY2025; Q4 FY2026 operating margin was 30.35%
FY2027 coal production target: 20 MT from Talabira and 2 MT from Pachwara South, or 22 MT total
Consolidated debt-equity ratio: 1.29x at March 31, 2026 vs 1.20x at March 31, 2025
Consolidated net profit margin: 20.49% for FY2026; Q4 FY2026 net profit margin was 26.04%
FY2026 standalone total income: Rs 12,034.95 cr vs Rs 11,487.16 cr in FY2025
FY2026 Talabira coal production: 19.14 MT coal production and 17.69 MT dispatch from Talabira II and III OCP
FY2026 Talabira e-auction sales: More than 12 MT sold through e-auction vs 7.3 MT in FY2025; sale value Rs 2,517 cr vs Rs 2,429 cr
SECI storage-linked solar award: 600 MW solar with 300 MW / 1,800 MWh energy storage awarded to NIRL
FY2026 consolidated total income: Rs 18,466.89 cr vs Rs 16,889.45 cr in FY2025
Consolidated paid-up debt capital: Rs 27,801.94 cr at March 31, 2026 vs Rs 22,392.11 cr at March 31, 2025
Q4 FY2026 standalone total income: Rs 3,202.27 cr vs Rs 3,248.42 cr in Q3 FY2026 and Rs 3,098.68 cr in Q4 FY2025
Q4 FY2026 consolidated total income: Rs 5,197.22 cr vs Rs 4,807.10 cr in Q3 FY2026 and Rs 3,971.90 cr in Q4 FY2025
FY2026 consolidated profit before tax: Rs 3,875.12 cr vs Rs 3,696.93 cr in FY2025
Consolidated total debt to total assets: 0.43x at March 31, 2026 vs 0.39x at March 31, 2025
Q4 FY2026 consolidated profit before tax: Rs 1,517.59 cr vs Rs 842.60 cr in Q3 FY2026 and Rs 912.08 cr in Q4 FY2025
FY2026 standalone revenue from operations: Rs 10,863.92 cr vs Rs 10,285.78 cr in FY2025
FY2026 consolidated revenue from operations: Rs 17,489.53 cr vs Rs 15,282.96 cr in FY2025
Q4 FY2026 consolidated profit for the period: Rs 1,481.45 cr vs Rs 724.01 cr in Q3 FY2026 and Rs 468.46 cr in Q4 FY2025
Q4 FY2026 standalone revenue from operations: Rs 2,918.33 cr vs Rs 2,885.08 cr in Q3 FY2026 and Rs 2,723.15 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 5,042.46 cr vs Rs 4,443.05 cr in Q3 FY2026 and Rs 3,836.00 cr in Q4 FY2025
FY2026 consolidated profit attributable to owners: Rs 3,522.20 cr vs Rs 2,621.36 cr in FY2025
Q4 FY2026 consolidated profit attributable to owners: Rs 1,393.46 cr vs Rs 668.03 cr in Q3 FY2026 and Rs 481.96 cr in Q4 FY2025
FY2026 standalone EPS after regulatory deferral balances: Rs 18.21 basic and diluted vs Rs 13.70 in FY2025
FY2026 consolidated EPS after regulatory deferral balances: Rs 25.40 basic and diluted vs Rs 18.90 in FY2025
Q4 FY2026 standalone EPS after regulatory deferral balances: Rs 8.97 basic and diluted vs Rs 3.09 in Q3 FY2026 and Rs 4.73 in Q4 FY2025
Q4 FY2026 consolidated EPS after regulatory deferral balances: Rs 10.05 basic and diluted vs Rs 4.80 in Q3 FY2026 and Rs 3.48 in Q4 FY2025

Financial highlights

CQP status: Under commissioning, expected to commence full-scale operations in coming months
Q4 revenue mix: About 92% Lead Acid Battery and the balance New Energy
Current NSE ISIN: INE885A01032
Giga 1 cell line: First 2 GWh line targeted to start production in June 2027
Material cost mix: Lead and alloys about 70% of material cost; plastics about 10%
Q4 ARACT infusion: About Rs 100 crore
FY2027 capex guidance: Rs 1,500 crore to Rs 1,700 crore
Interim dividend paid: Rs 5.40 per equity share
FY2026 lead-acid capex: About Rs 600 crore, or about Rs 500 crore net of insurance proceeds
Q4 telecom pack supply: More than 300 MWh
ESS integration facility: Initial 5 GWh capacity, ultimate 10 GWh capacity at Divitipally
Total FY2025-26 dividend: Rs 10.60 per equity share including interim dividend
Current NSE active symbol: ARE&M
Final dividend recommended: Rs 5.20 per equity share
Press-release Q4 FY2026 PBT: Rs 433 crore
Q4 standalone EBITDA margin: About 11%
Aftermarket Q4 volume growth: About 5%-6%
4-wheeler OEM Q4 volume growth: Above 30%
Q4 export revenue contribution: About 11%
Recycling plant margin benefit: About 0.5 percentage point in the quarter
FY2027 New Energy capex guidance: About Rs 1,100 crore to Rs 1,200 crore
Investor-presentation FY2026 PAT: Rs 8,958 million
Investor-presentation FY2026 PBT: Rs 12,069 million
Tubular battery Q4 volume growth: More than 35%
FY2026 consolidated EBITDA margin: 10.8%
FY2026 export revenue contribution: About 12%
Investor-presentation FY2026 EBITDA: Rs 14,971 million
Investor-presentation Q4 FY2026 PAT: Rs 3,143 million
Investor-presentation Q4 FY2026 PBT: Rs 4,209 million
Lead Acid Battery Q4 revenue growth: About 12% year on year
FY2026 telecom lithium pack milestone: Close to 1 GWh cumulative supply
Investor-presentation Q4 FY2026 EBITDA: Rs 3,855 million
Legacy symbol retired from NSE EQ list: AMARAJABAT
FY2027 Lead Acid Battery capex guidance: About Rs 400 crore
Adjusted Lead Acid Battery EBITDA margin: 12.3% including captive recycling efficiency adjustment
Total ARACT investment after Q4 infusion: About Rs 1,500 crore
FY2026 Lead Acid Battery operating margin: About 12.2%
Investor-presentation FY2026 EBITDA margin: 10.8%
New Energy revenue from packs and chargers: About Rs 280 crore
Adjusted Lead Acid Battery operating margin: 11.6% excluding lithium battery trading revenue
Call-commentary FY2026 consolidated revenue: Rs 13,814 crore
Press-release FY2025 revenue from operations: Rs 12,405 crore
Press-release FY2026 revenue from operations: Rs 13,549 crore
Investor-presentation Q4 FY2026 EBITDA margin: 10.9%
Call-commentary Q4 FY2026 consolidated revenue: About Rs 3,530 crore
Investor-presentation Q4 FY2026 revenue growth: 15.5% year on year and 3.7% quarter on quarter
Press-release Q3 FY2026 revenue from operations: Rs 3,351 crore
Press-release Q4 FY2025 revenue from operations: Rs 2,974 crore
Press-release Q4 FY2026 revenue from operations: Rs 3,460 crore
Investor-presentation FY2026 operational revenue: Rs 1,38,140 million
Investor-presentation Q4 FY2026 operational revenue: Rs 35,357 million
Investor-presentation FY2026 operational revenue growth: 7.5% year on year

Financial highlights

AGM date: August 7, 2026
CMCD LOIs: 6 products with LOIs per management commentary
FY2026 dividend: No dividend recommended
Paste PVC capacity: 107,000 mtpa
CCVL exceptional item: Rs 149.92 crore
CMCD Phase 1 capacity: 5,410 mt, commissioned September 2023
CMCD Phase 2 capacity: 2,000 mt, commissioned December 2024
CMCD Phase 3 capacity: 1,432 mt, project initiated / commercial production started May 2026
Caustic soda capacity: 119,000 mtpa
Consolidated net debt: Rs 1,419 crore at March 31, 2026
CMCD existing capacity: 1,068 mt
CMCD molecule pipeline: 45+ molecules across stages of development
CMCD revenue aspiration: About Rs 1,000 crore, delayed by around 12 months but still targeted for the next financial year per management
Chloromethanes capacity: 35,000 mtpa
FY2026 consolidated EPS: Negative Rs 17.70
Suspension PVC capacity: 331,000 mtpa through CCVL
Consolidated inventories: Rs 602 crore at March 31, 2026 per investor presentation
R32 swing plant capacity: 2 ktpa at Mettur
Standalone FY2026 EBITDA: Rs 108 crore
CMCD commercial molecules: 17 molecules
Consolidated total assets: Rs 6,315.23 crore at March 31, 2026
Consolidated total equity: Rs 1,754.63 crore at March 31, 2026
FY2025 consolidated EBITDA: Rs 219 crore
FY2026 consolidated EBITDA: Rs 198 crore
Hydrogen peroxide capacity: 34,000 mtpa
Q4 FY2026 consolidated EPS: Negative Rs 2.87
India Suspension PVC demand: About 4.3 million tons in FY2025 and about 1% lower in FY2026 per management
R32 planned capacity marker: 14 kt by end of calendar year per management commentary
Standalone Q4 FY2026 EBITDA: Rs 83 crore
CCVL raw-material write-down: Rs 36.15 crore
FY2025 Suspension PVC revenue: Rs 2,259 crore
FY2026 Suspension PVC revenue: Rs 2,186 crore
Q3 FY2026 consolidated EBITDA: Negative Rs 57 crore
Q4 FY2025 consolidated EBITDA: Rs 37 crore
Q4 FY2026 consolidated EBITDA: Rs 194 crore
Suspension PVC Q4 revenue mix: 53% of consolidated revenue
Consolidated trade receivables: Rs 92 crore at March 31, 2026 per investor presentation
CCVL onerous-contract provision: Rs 113.77 crore
Consolidated current borrowings: Rs 847 crore at March 31, 2026 per investor presentation
Q4 FY2025 Suspension PVC revenue: Rs 560 crore
Q4 FY2026 Suspension PVC revenue: Rs 661 crore
FY2025 consolidated EBITDA margin: 5%
FY2026 consolidated EBITDA margin: 5%
Suspension PVC FY2026 revenue mix: 52% of consolidated revenue
FY2025 Specialty Chemicals revenue: Rs 1,464 crore
FY2025 Suspension PVC sales volume: 5,66,556 metric tons
FY2026 Specialty Chemicals revenue: Rs 1,537 crore
FY2026 Suspension PVC sales volume: 5,68,946 metric tons
FY2026 consolidated revenue growth: Down 3% YoY
New Labour Codes standalone impact: Rs 3.49 crore recorded in FY2026
Specialty Chemicals Q4 revenue mix: 38% of consolidated revenue
Standalone FY2026 profit after tax: Loss of Rs 1,003 crore after impairment provision
Standalone Q4 FY2026 EBITDA margin: 13%
Consolidated non-current borrowings: Rs 1,105 crore at March 31, 2026 per investor presentation
FY2025 Value-added Chemicals revenue: Rs 623 crore
FY2025 consolidated profit after tax: Loss of Rs 110.36 crore
FY2026 Value-added Chemicals revenue: Rs 501 crore
FY2026 consolidated exceptional item: Negative Rs 149.92 crore
FY2026 consolidated profit after tax: Loss of Rs 279.87 crore
New Labour Codes consolidated impact: Rs 4.86 crore recorded in FY2026
Q4 FY2025 consolidated EBITDA margin: 3%
Q4 FY2026 consolidated EBITDA margin: 15%
Standalone CCVL impairment provision: Rs 898 crore on investment in CCVL
Value-added Chemicals Q4 revenue mix: 9% of consolidated revenue
Consolidated capital work in progress: Rs 341.39 crore at March 31, 2026
FY2026 cash generated from operations: Rs 294 crore
FY2026 consolidated profit before tax: Loss of Rs 372.41 crore
Q4 FY2025 Specialty Chemicals revenue: Rs 422 crore
Q4 FY2025 Suspension PVC sales volume: 1,48,321 metric tons
Q4 FY2026 Specialty Chemicals revenue: Rs 475 crore
Q4 FY2026 Suspension PVC sales volume: 1,50,259 metric tons
Q4 FY2026 consolidated revenue growth: Up 9% YoY and up 50% QoQ per investor presentation
Standalone Q4 FY2026 profit after tax: Loss of Rs 883 crore after impairment provision
Consolidated cash and cash equivalents: Rs 430 crore at March 31, 2026
Specialty Chemicals FY2026 revenue mix: 36% of consolidated revenue
FY2025 Specialty Chemicals sales volume: 2,99,884 metric tons
FY2026 Specialty Chemicals sales volume: 3,19,708 metric tons
Q4 FY2025 Value-added Chemicals revenue: Rs 169 crore
Q4 FY2025 consolidated profit after tax: Loss of Rs 54.17 crore
Q4 FY2026 Suspension PVC revenue growth: Up 18% YoY
Q4 FY2026 Value-added Chemicals revenue: Rs 120 crore
Q4 FY2026 consolidated exceptional item: Negative Rs 149.92 crore
Q4 FY2026 consolidated profit after tax: Loss of Rs 45.38 crore
Q4 FY2026 consolidated profit before tax: Loss of Rs 61.02 crore
Consolidated property plant and equipment: Rs 4,274.16 crore at March 31, 2026
FY2026 Value-added Chemicals sales volume: 1,14,651 metric tons
FY2026 net cash from operating activities: Rs 294 crore
Standalone FY2026 revenue from operations: Rs 2,170 crore
Q4 FY2025 Specialty Chemicals sales volume: 79,639 metric tons
Q4 FY2026 Specialty Chemicals sales volume: 87,121 metric tons
FY2025 consolidated revenue from operations: Rs 4,346.07 crore
FY2026 consolidated revenue from operations: Rs 4,223.79 crore
Q4 FY2026 Specialty Chemicals volume growth: Up 17% YoY per management commentary
FY2026 net cash used in financing activities: Rs 187 crore
FY2026 net cash used in investing activities: Rs 232 crore
Q4 FY2026 Specialty Chemicals revenue growth: Up 13% YoY
Q4 FY2026 Value-added Chemicals sales volume: 31,043 metric tons
Standalone Q4 FY2026 revenue from operations: Rs 612 crore
Q3 FY2026 consolidated revenue from operations: Rs 835.14 crore
Q4 FY2025 consolidated revenue from operations: Rs 1,150.88 crore
Q4 FY2026 consolidated revenue from operations: Rs 1,255.55 crore
FY2026 net decrease in cash and cash equivalents: Rs 124 crore
Consolidated bank balances other than cash equivalents: Rs 103 crore at March 31, 2026
FY2026 consolidated profit before exceptional items and tax: Loss of Rs 222.49 crore
Q4 FY2026 consolidated profit before exceptional items and tax: Rs 88.90 crore

Financial highlights

SCS FY2026 EBITDA: Rs -237 mn per investor presentation
SCS FY2026 revenue: Rs 4,478 mn per investor presentation
SCS Q4 FY2026 EBITDA: Rs 27 mn per investor presentation
Group debt March 2026: Rs 7,850 mn per investor presentation
SCS Q4 FY2026 revenue: Rs 1,292 mn per investor presentation
Standalone FY2026 PBT: Rs 3,535.13 mn per audited results
Consolidated FY2026 PBT: Rs 2,902.09 mn per audited results
SCS FY2026 EBITDA margin: -5.3% per investor presentation
Standalone Q4 FY2026 PBT: Rs 853.51 mn per audited results
Consolidated Q4 FY2026 PBT: Rs 972.39 mn per audited results
FY2027 group capex guidance: About Rs 200 cr per management transcript
SCS Q4 FY2026 EBITDA margin: 2.1% per investor presentation
Standalone FY2026 basic EPS: Rs 20.01 per audited results
Annual global cable capacity: 400 mn cables per June 1 business update
Annual halogen lamp capacity: 110 mn lamps per June 1 business update
Consolidated FY2026 basic EPS: Rs 13.31 per audited results
DCD FY2026 operational EBITDA: Rs 2,081 mn per investor presentation
FY2027 group revenue guidance: Double-digit growth per management transcript
PLD FY2026 operational EBITDA: Rs 474 mn per investor presentation
SED FY2026 operational EBITDA: Rs 166 mn per investor presentation
DCD FY2026 operational revenue: Rs 12,879 mn per investor presentation
PLD FY2026 operational revenue: Rs 3,778 mn per investor presentation
SED FY2026 operational revenue: Rs 1,576 mn per investor presentation
Standalone FY2026 total income: Rs 19,680.22 mn per audited results
Consolidated FY2026 diluted EPS: Rs 13.30 per audited results
Consolidated FY2026 tax expense: Rs 1,075.36 mn per audited results
Group long-term debt March 2026: Rs 2,238 mn per investor presentation
Consolidated FY2026 total income: Rs 39,406.26 mn per audited results
Consolidated Q4 FY2026 basic EPS: Rs 5.18 per audited results
DCD Q4 FY2026 operational EBITDA: Rs 499 mn per investor presentation
Group short-term debt March 2026: Rs 5,612 mn per investor presentation
SED Q4 FY2026 operational EBITDA: Rs 43 mn per investor presentation
Consolidated FY2026 finance costs: Rs 635.28 mn per audited results
Consolidated equity March 31 2026: Rs 14,369.33 mn per audited balance sheet
DCD Q4 FY2026 operational revenue: Rs 3,282 mn per investor presentation
FY2027 GCM EBITDA margin guidance: 10% to 12% per management transcript
SED Q4 FY2026 operational revenue: Rs 443 mn per investor presentation
Standalone Q4 FY2026 total income: Rs 4,988.72 mn per audited results
Consolidated FY2026 total expenses: Rs 36,426.02 mn per audited results
Consolidated Q4 FY2026 tax expense: Rs 261.26 mn per audited results
Japanese OEM contract annual value: USD 1.2 mn per year per June 1 business update
Consolidated Q4 FY2026 total income: Rs 10,732.47 mn per audited results
Standalone FY2026 exceptional items: Rs 17.11 mn net charge per audited results
Consolidated Q4 FY2026 finance costs: Rs 142.36 mn per audited results
DCD FY2026 operational EBITDA margin: 16.2% per investor presentation
Japanese OEM contract lifetime value: USD 6 mn per June 1 business update
PLD FY2026 operational EBITDA margin: 12.6% per investor presentation
SED FY2026 operational EBITDA margin: 10.6% per investor presentation
Standalone FY2026 operational EBITDA: Rs 3,049 mn per investor presentation
Consolidated FY2026 exceptional items: Rs 78.15 mn charge per audited results
Consolidated Q4 FY2026 total expenses: Rs 9,760.08 mn per audited results
Standalone FY2026 operational revenue: Rs 18,399 mn per investor presentation
Standalone Q4 FY2026 exceptional item: Rs 54.00 mn credit per audited results
Standalone other equity March 31 2026: Rs 15,941.37 mn per audited balance sheet
Standalone total assets March 31 2026: Rs 22,257.29 mn per audited balance sheet
Consolidated inventories March 31 2026: Rs 7,082.72 mn per audited balance sheet
Consolidated other equity March 31 2026: Rs 14,232.16 mn per audited balance sheet
Consolidated total assets March 31 2026: Rs 31,732.02 mn per audited balance sheet
DCD Q4 FY2026 operational EBITDA margin: 15.2% per investor presentation
SED Q4 FY2026 operational EBITDA margin: 9.7% per investor presentation
Standalone FY2026 profit for the period: Rs 2,747.43 mn per audited results
Standalone Q4 FY2026 operational EBITDA: Rs 704 mn per investor presentation
Consolidated Q4 FY2026 exceptional items: Nil per audited results
May 2026 GCM new-contract lifetime value: Estimated USD 75 mn per June 1 business update
Standalone Q4 FY2026 operational revenue: Rs 4,685 mn per investor presentation
Consolidated FY2026 profit for the period: Rs 1,826.73 mn per audited results
Consolidated current assets March 31 2026: Rs 19,349.65 mn per audited balance sheet
European luxury OEM contract annual value: USD 2 mn per year per June 1 business update
Standalone FY2026 revenue from operations: Rs 18,399.25 mn per audited results
FY2027 consolidated EBITDA margin guidance: 12% to 13.5% including SCS per management transcript
May 2026 GCM new-contract annualized value: Approximately USD 12 mn per year per June 1 business update
Standalone Q4 FY2026 profit for the period: Rs 659.93 mn per audited results
Consolidated FY2025 revenue from operations: Rs 32,769.52 mn per audited results
Consolidated FY2026 revenue from operations: Rs 38,248.23 mn per audited results
European luxury OEM contract lifetime value: USD 12 mn per June 1 business update
SCD excluding SCS FY2026 operational EBITDA: Rs 1,711 mn per investor presentation
Standalone FY2026 operational EBITDA margin: 16.6% per investor presentation
Consolidated Q4 FY2026 profit for the period: Rs 711.13 mn per audited results
Consolidated trade receivables March 31 2026: Rs 7,111.57 mn per audited balance sheet
SCD excluding SCS FY2026 operational revenue: Rs 15,537 mn per investor presentation
Standalone Q4 FY2026 revenue from operations: Rs 4,684.72 mn per audited results
Consolidated FY2026 employee benefits expense: Rs 8,883.00 mn per audited results
Consolidated current borrowings March 31 2026: Rs 6,438.63 mn per audited balance sheet
Consolidated non-current assets March 31 2026: Rs 12,382.37 mn per audited balance sheet
Consolidated FY2026 cost of materials consumed: Rs 21,579.19 mn per audited results
Consolidated Q4 FY2025 revenue from operations: Rs 8,769.24 mn per audited results
Consolidated Q4 FY2026 revenue from operations: Rs 10,419.29 mn per audited results
SCD excluding SCS Q4 FY2026 operational EBITDA: Rs 499 mn per investor presentation
Standalone FY2026 PBT before exceptional items: Rs 3,552.24 mn per audited results
SCD excluding SCS Q4 FY2026 operational revenue: Rs 4,411 mn per investor presentation
Consolidated FY2026 PBT before exceptional items: Rs 2,980.24 mn per audited results
Consolidated Q4 FY2026 employee benefits expense: Rs 2,212.38 mn per audited results
Consolidated FY2026 depreciation and amortization: Rs 1,508.78 mn per audited results
Consolidated Q4 FY2026 cost of materials consumed: Rs 5,454.95 mn per audited results
Consolidated non-current borrowings March 31 2026: Rs 1,410.96 mn per audited balance sheet
Standalone Q4 FY2026 PBT before exceptional items: Rs 799.51 mn per audited results
SCD excluding SCS FY2026 operational EBITDA margin: 11.0% per investor presentation
Consolidated Q4 FY2026 PBT before exceptional items: Rs 972.39 mn per audited results
Consolidated Q4 FY2026 depreciation and amortization: Rs 402.52 mn per audited results
Consolidated cash and cash equivalents March 31 2026: Rs 1,000.10 mn per audited balance sheet
Consolidated excluding SCS FY2026 operational EBITDA: Rs 4,432 mn per investor presentation
Standalone FY2026 net cash from operating activities: Rs 1,648.42 mn per audited cash-flow statement
Consolidated excluding SCS FY2026 operational revenue: Rs 33,770 mn per investor presentation
SCD excluding SCS Q4 FY2026 operational EBITDA margin: 11.3% per investor presentation
Consolidated FY2026 net cash from operating activities: Rs 1,710.34 mn per audited cash-flow statement
Group investments in mutual funds and bonds March 2026: Rs 2,354 mn per investor presentation
Consolidated excluding SCS Q4 FY2026 operational EBITDA: Rs 1,161 mn per investor presentation
Consolidated excluding SCS Q4 FY2026 operational revenue: Rs 9,128 mn per investor presentation
North American auto major EV cable contract annual value: USD 5.25 mn per year per June 1 business update
North American auto major EV cable contract lifetime value: USD 37 mn per June 1 business update
Consolidated excluding SCS FY2026 operational EBITDA margin: 13.1% per investor presentation
Consolidated excluding SCS Q4 FY2026 operational EBITDA margin: 12.7% per investor presentation
Consolidated FY2026 purchase of property plant equipment and intangibles: Rs 1,179.97 mn per audited cash-flow statement

Financial highlights

stores_total_march_2026: 1273
fy2026_tmrw_ebitda_rs_cr: -207
net_sqft_added_fy2026_mn: 0.6
fy2026_tmrw_revenue_rs_cr: 872
fy2026_ethnic_ebitda_rs_cr: 242
fy2026_ethnic_revenue_rs_cr: 2227
ownd_store_count_march_2026: 79
q4_fy2026_tmrw_ebitda_rs_cr: -45
gross_store_additions_fy2026: 180
q4_fy2026_tmrw_revenue_rs_cr: 211
tasva_store_count_march_2026: 94
ethnic_store_count_march_2026: 680
fy2026_tmrw_ebitda_margin_pct: -23.8
luxury_store_count_march_2026: 49
q4_fy2026_ethnic_ebitda_rs_cr: 81
bewakoof_fy2026_turnover_rs_cr: 243.12
fy2026_consolidated_ebit_rs_cr: -373
fy2026_pantaloons_ebitda_rs_cr: 739
fy2026_tmrw_revenue_growth_pct: 34
fy2027_expected_cash_use_rs_cr: 600
jaypore_store_count_march_2026: 44
q4_fy2026_ethnic_revenue_rs_cr: 583
tmrw_ncd_funding_tied_up_rs_cr: 500
tmrw_profitability_target_year: 2029
fy2026_ethnic_ebitda_margin_pct: 10.8
fy2026_pantaloons_revenue_rs_cr: 4560
gross_store_additions_q4_fy2026: 70
fy2026_consolidated_ebitda_rs_cr: 967
fy2026_ethnic_revenue_growth_pct: 14
fy2026_pantaloons_ltl_growth_pct: 2
q4_fy2026_tmrw_ebitda_margin_pct: -21.2
pantaloons_store_count_march_2026: 399
q4_fy2026_consolidated_ebit_rs_cr: -38
q4_fy2026_pantaloons_ebitda_rs_cr: 162
q4_fy2026_tmrw_revenue_growth_pct: 45
q4_fy2026_ethnic_ebitda_margin_pct: 13.9
q4_fy2026_pantaloons_revenue_rs_cr: 1048
rights_issue_monitoring_size_rs_cr: 995.12
fy2026_pantaloons_ebitda_margin_pct: 16.2
q4_fy2026_consolidated_ebitda_rs_cr: 311
q4_fy2026_ethnic_revenue_growth_pct: 3
q4_fy2026_pantaloons_ltl_growth_pct: 14
retail_footprint_mn_sqft_march_2026: 7.9
fy2026_pantaloons_revenue_growth_pct: 4
tmrw_cash_after_funding_rs_cr_approx: 800
abfrl_icrpl_stake_after_allotment_pct: 89.29
fy2026_consolidated_ebitda_margin_pct: 11.8
q4_fy2026_consolidated_pat_loss_rs_cr: -164
fy2026_consolidated_total_income_rs_cr: 8486.53
fy2026_luxury_and_others_revenue_rs_cr: 596
icrpl_rights_issue_consideration_rs_cr: 175
q4_fy2026_pantaloons_ebitda_margin_pct: 15.5
standalone_gross_cash_march_2026_rs_cr: 1144
standalone_gross_debt_march_2026_rs_cr: 748
q4_fy2026_pantaloons_revenue_growth_pct: 19
tmrw_bewakoof_stake_after_june_2026_pct: 99.03
consolidated_gross_cash_march_2026_rs_cr: 1545
consolidated_gross_debt_march_2026_rs_cr: 1695
fy2026_consolidated_capex_purchase_rs_cr: 508.82
q4_fy2026_consolidated_ebitda_margin_pct: 15.7
q4_fy2026_consolidated_total_income_rs_cr: 2113.67
q4_fy2026_luxury_and_others_revenue_rs_cr: 157
fy2025_comparable_consolidated_ebitda_rs_cr: 758
fy2026_consolidated_basic_eps_continuing_rs: -6.38
fy2026_consolidated_reported_pat_loss_rs_cr: -830
fy2026_luxury_and_others_revenue_growth_pct: 15
tmrw_store_count_march_2026_including_wrogn: 120
fy2025_comparable_consolidated_revenue_rs_cr: 7355
fy2027_expected_consolidated_capex_rs_cr_low: 250
q4_fy2026_labour_code_exceptional_item_rs_cr: 11.37
fy2025_comparable_consolidated_pat_loss_rs_cr: -882
fy2026_consolidated_pbt_after_wage_code_rs_cr: -928
fy2027_expected_consolidated_capex_rs_cr_high: 300
fy2026_consolidated_pbt_before_wage_code_rs_cr: -888
q4_fy2025_comparable_consolidated_ebitda_rs_cr: 199
q4_fy2026_consolidated_basic_eps_continuing_rs: -1.22
q4_fy2026_luxury_and_others_revenue_growth_pct: 13
q4_fy2026_pantaloons_format_revenue_growth_pct: 17
fy2026_standalone_revenue_from_operations_rs_cr: 5906.03
q4_fy2025_comparable_consolidated_revenue_rs_cr: 1719
q4_fy2026_tmrw_associate_revaluation_gain_rs_cr: 83
fy2026_tmrw_revenue_including_wrogn_rs_cr_approx: 1100
q4_fy2025_comparable_consolidated_pat_loss_rs_cr: -267
q4_fy2026_consolidated_pbt_after_wage_code_rs_cr: -195
fy2025_consolidated_revenue_from_operations_rs_cr: 7354.73
fy2026_consolidated_net_operating_cash_flow_rs_cr: 160.75
fy2026_consolidated_revenue_from_operations_rs_cr: 8176.92
q4_fy2026_consolidated_pbt_before_wage_code_rs_cr: -183
q4_fy2026_standalone_revenue_from_operations_rs_cr: 1379.66
fy2026_consolidated_lease_liability_repayment_rs_cr: 796.47
q3_fy2026_consolidated_revenue_from_operations_rs_cr: 2373.66
q4_fy2026_consolidated_revenue_from_operations_rs_cr: 1990.13
fy2026_consolidated_loss_attributable_to_owners_rs_cr: -775.89
fy2026_consolidated_cash_and_cash_equivalents_end_rs_cr: 66.96
fy2026_consolidated_ebitda_before_revaluation_gain_rs_cr: 903
q4_fy2026_consolidated_loss_attributable_to_owners_rs_cr: -148.4
q4_fy2026_consolidated_ebitda_before_revaluation_gain_rs_cr: 229
fy2026_standalone_loss_after_tax_continuing_operations_rs_cr: -351.49
fy2026_consolidated_ebitda_margin_before_revaluation_gain_pct: 11
fy2026_consolidated_loss_after_tax_continuing_operations_rs_cr: -829.89
q4_fy2026_standalone_loss_after_tax_continuing_operations_rs_cr: -139.13
q4_fy2026_consolidated_ebitda_margin_before_revaluation_gain_pct: 11.5
q4_fy2026_consolidated_loss_after_tax_continuing_operations_rs_cr: -163.81
fy2026_consolidated_pat_loss_without_wage_code_and_revaluation_rs_cr: -854
q4_fy2026_consolidated_pat_loss_without_wage_code_and_revaluation_rs_cr: -235

Financial highlights

Dividend: Final dividend of Rs 2.50 per equity share of Re 1; total FY2026 dividend Rs 5 per share, amounting to Rs 79.64 cr
Net debt: Rs 587 cr at Q4 FY2026, down 11% year on year
ESOP grant: 3,43,569 stock options granted on April 21, 2026, split between 2,40,497 performance-linked options and 1,03,072 tenure-linked ESOPs
FY2026 EPS: Rs 18, up 11% year on year
CDMO funnel: 100 plus opportunities with over Rs 3,400 cr potential, including 20 plus confirmed molecules with about Rs 1,500 cr potential and 10 plus advanced-stage molecules with about Rs 1,100 cr peak revenue
Q4 FY2026 EPS: Rs 5.5, up 17% year on year and up 84% sequentially
FY2027 capex guide: Around Rs 400 cr to Rs 500 cr, including Gajraula MPP
Net debt to EBITDA: 0.99x at Q4 FY2026
FY2026 total EBITDA: Rs 607 cr, up 9% year on year
Net working capital: 59 days at Q4 FY2026
FY2026 total revenue: Rs 4,388 cr, up 5% year on year
Q4 FY2026 PAT margin: 7% versus 7% in Q4 FY2025 and 4% in Q3 FY2026
Q4 FY2026 total EBITDA: Rs 172 cr, up 11% year on year and up 26% sequentially
Q4 FY2026 EBITDA margin: 15% versus 15% in Q4 FY2025 and 13% in Q3 FY2026
Q4 FY2026 total revenue: Rs 1,179 cr, up 12% year on year and up 12% sequentially
Working capital to revenue: 16% at Q4 FY2026 versus 18% in Q4 FY2025
Standalone exceptional item: Rs 12.22 cr one-time New Labour Codes impact in FY2026
Q4 FY2026 capex cash outflow: Rs 69 cr, mainly for Bharuch CDMO commissioning and Gajraula MPP groundbreaking
Consolidated exceptional item: Rs 13.04 cr one-time New Labour Codes impact in FY2026
FY2026 reported EBITDA margin: 13.8% versus 13.3% in FY2025
Specialty Chemicals FY2026 EBITDA: Rs 510 cr, up 21% year on year
FY2026 PAT after exceptional items: Rs 278 cr, up 11% year on year
Specialty Chemicals FY2026 revenue: Rs 1,937 cr, up 7% year on year
Chemical Intermediates FY2026 EBITDA: Rs 73 cr, down 32% year on year
Specialty Chemicals Q4 FY2026 EBITDA: Rs 139 cr, up 8% year on year and up 20% sequentially
Chemical Intermediates FY2026 revenue: Rs 1,662 cr, up 3% year on year
Q4 FY2026 PAT after exceptional items: Rs 86 cr, up 17% year on year and up 84% sequentially
Specialty Chemicals Q4 FY2026 revenue: Rs 516 cr, up 6% year on year and up 13% sequentially
Chemical Intermediates Q4 FY2026 EBITDA: Rs 22 cr, up 111% year on year and up 45% sequentially
Chemical Intermediates Q4 FY2026 revenue: Rs 433 cr, up 15% year on year and up 10% sequentially
Specialty Chemicals FY2026 EBITDA margin: 26% versus 23% in FY2025
Chemical Intermediates FY2026 EBITDA margin: 4% versus 7% in FY2025
Specialty Chemicals Q4 FY2026 EBITDA margin: 27% versus 27% in Q4 FY2025 and 25% in Q3 FY2026
Nutrition and Health Solutions FY2026 EBITDA: Rs 100 cr, down 1% year on year
Nutrition and Health Solutions FY2026 revenue: Rs 790 cr, up 6% year on year
Chemical Intermediates Q4 FY2026 EBITDA margin: 5% versus 3% in Q4 FY2025 and 4% in Q3 FY2026
Nutrition and Health Solutions Q4 FY2026 EBITDA: Rs 32 cr, up 9% year on year and up 42% sequentially
Nutrition and Health Solutions Q4 FY2026 revenue: Rs 230 cr, up 21% year on year and up 15% sequentially
Nutrition and Health Solutions FY2026 EBITDA margin: 13% versus 14% in FY2025
Nutrition and Health Solutions Q4 FY2026 EBITDA margin: 14% versus 16% in Q4 FY2025 and 11% in Q3 FY2026

Financial highlights

Call date: May 26, 2026 at 4:30 p.m. IST
Audit opinion: Price Waterhouse Chartered Accountants LLP and K.S. Rao & Co issued unmodified audit opinions on FY2026 standalone and consolidated financial results
Board meeting: May 25, 2026; commenced 2:00 p.m. IST and concluded 5:30 p.m. IST
Final dividend: Rs 5.20 per equity share of face value Re 1, representing 520%, subject to shareholder approval
Cell capex trend: Original $55 mn to $60 mn per GWh capex assumption already down roughly 20%-25% per management
Interim dividend: Rs 5.40 per equity share declared on November 6, 2025
FY2027 capex guide: Rs 1,500 cr to Rs 1,700 cr total, including about Rs 400 cr in Lead Acid Battery and Rs 1,100 cr to Rs 1,200 cr in New Energy
Q4 FY2026 revenue mix: About 92% Lead Acid Battery and the rest New Energy per management
Total FY2026 dividend: Rs 10.60 per equity share versus Rs 10.50 in FY2025
FY2026 lead-acid capex: Roughly Rs 600 cr across battery and recycling, about Rs 500 cr net of insurance claim
Transcript filing date: June 2, 2026 with NSE/BSE
FY2026 consolidated EPS: Rs 48.95 basic and diluted
FY2026 consolidated PAT: Rs 895.77 cr versus approximately Rs 944.67 cr in FY2025
FY2026 consolidated PBT: Rs 1,206.89 cr
Q4 FY2026 consolidated EPS: Rs 17.17 basic and diluted
Q4 FY2026 consolidated PAT: Rs 314.33 cr versus Rs 161.57 cr in Q4 FY2025
Q4 FY2026 consolidated PBT: Rs 420.91 cr
ARACT cumulative investment: About Rs 1,500 cr after Rs 100 cr additional Q4 FY2026 infusion
Cell-scale economics marker: At 8 GWh to 10 GWh scale, possible 10%-11% cell EBITDA margin and low-double-digit ROCE under management's business case
FY2026 telecom lithium packs: Close to 1 GWh supplied
Standalone margin aspiration: 13%-14% EBITDA margin over time, timing not specified
Lead acid FY2026 segment result: Rs 1,270.46 cr versus Rs 1,233.63 cr in FY2025
Q4 FY2026 telecom lithium packs: More than 300 MWh supplied
Lead acid FY2026 segment revenue: Rs 13,005.29 cr versus Rs 12,345.13 cr in FY2025
New Energy FY2026 segment result: Loss of Rs 135.15 cr
Lead acid FY2026 operating margin: About 12.2%
New Energy FY2026 segment revenue: Rs 808.71 cr versus Rs 501.19 cr in FY2025
FY2026 consolidated revenue growth: About 7.5% YoY per management commentary
Lead acid Q4 FY2026 segment result: Rs 428.61 cr versus Rs 213.19 cr in Q4 FY2025
Lead acid Q4 FY2026 segment revenue: Rs 3,254.72 cr versus Rs 2,902.96 cr in Q4 FY2025
New Energy Q4 FY2026 segment result: Loss of Rs 24.51 cr
Lead acid Q4 FY2026 operating margin: 11.6% after adjusting lithium-pack trading revenue; 12.3% after also adjusting captive recycling efficiency
New Energy Q4 FY2026 segment revenue: Rs 281.03 cr versus Rs 157.11 cr in Q4 FY2025
FY2026 consolidated labour-code impact: Rs 47.63 cr incremental gratuity liability, presented as exceptional item
Q4 FY2026 exceptional insurance income: Rs 181.15 cr for Chittoor property-claim difference
FY2026 EBITDA per investor presentation: Rs 14,971 mn; 10.8% margin
Q4 FY2026 New Energy revenue commentary: About Rs 280 cr from battery packs and chargers
Q4 FY2026 PAT per investor presentation: Rs 3,143 mn, up 94.5% YoY; 8.9% margin
Q4 FY2026 EBITDA per investor presentation: Rs 3,855 mn, up 13.1% YoY; 10.9% margin
FY2026 consolidated revenue from operations: Rs 13,814.00 cr versus Rs 12,846.32 cr in FY2025
FY2026 business-interruption insurance claim: Rs 121.79 cr received in quarter ended September 2025
Q4 FY2026 consolidated revenue from operations: Rs 3,535.75 cr versus Rs 3,060.07 cr in Q4 FY2025
Q4 FY2026 operational revenue per investor presentation: Rs 35,357 mn, up 15.5% YoY and 3.7% QoQ
Q4 FY2026 consolidated profit before exceptional items and tax: Rs 239.76 cr

Financial highlights

FY2026 EPS: Rs 153.35 versus Rs 126.38 in FY2025
FY2026 PAT: Rs 689.2 cr versus Rs 568.0 cr in FY2025
FY2026 PBT: Rs 854.9 cr versus Rs 707.4 cr in FY2025
Inventories: Rs 2,135.5 cr at March 31, 2026 versus Rs 2,361.8 cr at March 31, 2025
Total assets: Rs 5,699.4 cr at March 31, 2026 versus Rs 5,245.9 cr at March 31, 2025
Total equity: Rs 2,965.7 cr at March 31, 2026 versus Rs 2,850.4 cr at March 31, 2025
Q4 FY2026 EPS: Rs 36.07 versus Rs 21.29 in Q3 FY2026 and Rs 31.88 in Q4 FY2025
Q4 FY2026 PAT: Rs 162.1 cr versus Rs 95.7 cr in Q3 FY2026 and Rs 143.3 cr in Q4 FY2025
Q4 FY2026 PBT: Rs 206.4 cr versus Rs 113.0 cr in Q3 FY2026 and Rs 167.9 cr in Q4 FY2025
Trade receivables: Rs 1,115.5 cr at March 31, 2026 versus Rs 952.1 cr at March 31, 2025
FY2026 total income: Rs 5,770.0 cr versus Rs 5,593.1 cr in FY2025
Q4 FY2026 tax expense: Rs 44.3 cr versus Rs 17.3 cr in Q3 FY2026 and Rs 24.6 cr in Q4 FY2025
Q4 FY2026 other income: Rs 46.6 cr versus Rs 15.9 cr in Q3 FY2026 and Rs 37.1 cr in Q4 FY2025
Q4 FY2026 total income: Rs 1,147.4 cr versus Rs 1,122.1 cr in Q3 FY2026 and Rs 1,083.5 cr in Q4 FY2025
Q4 FY2026 total expenses: Rs 941.0 cr versus Rs 1,009.1 cr in Q3 FY2026 and Rs 915.6 cr in Q4 FY2025
Cash and cash equivalents: Rs 1,414.6 cr at March 31, 2026 versus Rs 885.5 cr at March 31, 2025
FY2026 financing cash flow: Negative Rs 623.8 cr, including Rs 562.8 cr dividends paid
FY2026 investing cash flow: Rs 72.5 cr versus Rs 85.6 cr in FY2025
FY2026 operating cash flow: Rs 1,078.5 cr versus Rs 262.0 cr in FY2025
FY2026 working-capital change: Positive Rs 300.6 cr versus negative Rs 365.1 cr in FY2025
FY2026 revenue from operations: Rs 5,675.0 cr versus Rs 5,473.4 cr in FY2025
FY2026 product divestment profit: Rs 22.3 cr
Q4 FY2026 revenue from operations: Rs 1,100.8 cr versus Rs 1,106.2 cr in Q3 FY2026 and Rs 1,046.4 cr in Q4 FY2025
FY2026 final dividend recommendation: Rs 60 per equity share of Rs 10 face value, subject to shareholder approval
FY2026 cash generated from operations: Rs 1,242.0 cr versus Rs 423.8 cr in FY2025
FY2026 inventory write-off/write-down: Rs 26.4 cr
FY2026 inventory movement in cash flow: Rs 199.9 cr release versus Rs 820.8 cr increase in FY2025
Reserves excluding revaluation reserve: Rs 2,920.8 cr at March 31, 2026 versus Rs 2,805.5 cr at March 31, 2025
FY2026 net ECL provision on trade receivables: Rs 33.4 cr
FY2026 trade receivable movement in cash flow: Rs 196.2 cr increase versus Rs 71.7 cr increase in FY2025

Financial highlights

FY2026 EPS: Rs 75.01 versus Rs 46.30 in FY2025
FY2026 PAT: Rs 187.52 cr versus Rs 115.74 cr in FY2025
FY2026 PBT: Rs 252.20 cr versus Rs 156.36 cr in FY2025
Inventories: Rs 1,027.33 cr at March 31, 2026 versus Rs 548.50 cr at March 31, 2025
Total assets: Rs 1,989.10 cr at March 31, 2026 versus Rs 1,518.12 cr at March 31, 2025
Total equity: Rs 872.79 cr at March 31, 2026 versus Rs 770.35 cr at March 31, 2025
Q4 FY2026 EPS: Rs 17.95 versus Rs 13.04 in Q3 FY2026 and Rs 23.30 in Q4 FY2025
Q4 FY2026 PAT: Rs 44.88 cr versus Rs 32.59 cr in Q3 FY2026 and Rs 58.25 cr in Q4 FY2025
Q4 FY2026 PBT: Rs 58.14 cr versus Rs 46.54 cr in Q3 FY2026 and Rs 78.47 cr in Q4 FY2025
Current assets: Rs 1,739.93 cr at March 31, 2026 versus Rs 1,342.35 cr at March 31, 2025
Trade receivables: Rs 213.68 cr at March 31, 2026 versus Rs 184.88 cr at March 31, 2025
Segment disclosure: Single reportable segment: Healthcare
Current liabilities: Rs 981.81 cr at March 31, 2026 versus Rs 703.00 cr at March 31, 2025
FY2026 total income: Rs 2,304.07 cr versus Rs 1,756.92 cr in FY2025
Right-of-use assets: Rs 112.80 cr at March 31, 2026 versus Rs 35.70 cr at March 31, 2025
Assets held for sale: Rs 7.74 cr at March 31, 2026
FY2026 dividend paid: Rs 180.00 cr versus Rs 60.00 cr in FY2025
FY2026 finance costs: Rs 4.49 cr versus Rs 1.46 cr in FY2025
FY2026 other expenses: Rs 235.54 cr versus Rs 156.34 cr in FY2025
Labour Code provision: Rs 27.83 cr provision for past-service cost on gratuity and compensated absences
Q4 FY2026 total income: Rs 584.56 cr versus Rs 616.70 cr in Q3 FY2026 and Rs 496.63 cr in Q4 FY2025
FY2026 Oncology revenue: Rs 1,610.09 cr
FY2026 exceptional items: Rs 5.25 cr expense versus Rs 96.79 cr expense in FY2025
FY2026 income taxes paid: Rs 83.31 cr versus Rs 64.19 cr in FY2025
Cash and cash equivalents: Rs 447.72 cr at March 31, 2026 versus Rs 536.14 cr at March 31, 2025
FY2026 inventory movement: Rs 478.83 cr increase in inventories in the cash-flow statement
FY2026 Rare Disease revenue: Rs 21.46 cr
Q4 FY2026 exceptional items: Rs 1.08 cr expense related to manufacturing-site closure
Recommended FY2026 dividend: Rs 36 per equity share of Rs 2 face value, aggregating to Rs 90.00 cr subject to shareholder approval
FY2026 revenue from operations: Rs 2,275.58 cr versus Rs 1,716.29 cr in FY2025
FY2026 trade payables movement: Rs 326.40 cr increase in trade payables in the cash-flow statement
FY2026 employee-benefit expense: Rs 264.38 cr versus Rs 257.44 cr in FY2025
FY2026 Biopharmaceuticals revenue: Rs 524.32 cr across CVRM, R&I and V&I
FY2026 trade receivables movement: Rs 45.81 cr increase in trade receivables in the cash-flow statement
Q4 FY2026 revenue from operations: Rs 578.61 cr versus Rs 611.57 cr in Q3 FY2026 and Rs 480.48 cr in Q4 FY2025
FY2026 purchases of stock-in-trade: Rs 1,859.42 cr versus Rs 1,008.82 cr in FY2025
FY2026 PBT before exceptional items: Rs 257.45 cr versus Rs 253.15 cr in FY2025
Trade payables to non-MSME creditors: Rs 780.66 cr at March 31, 2026 versus Rs 453.77 cr at March 31, 2025
FY2026 cash generated from operations: Rs 68.17 cr versus Rs 129.58 cr in FY2025
FY2026 expected credit loss allowance: Rs 17.09 cr versus Rs 0.66 cr in FY2025
Q4 FY2026 PBT before exceptional items: Rs 59.22 cr versus Rs 45.06 cr in Q3 FY2026 and Rs 84.15 cr in Q4 FY2025
FY2026 operating profit before working capital: Rs 285.55 cr versus Rs 232.77 cr in FY2025
FY2026 selling, marketing and distribution expense: Rs 116.00 cr versus Rs 84.87 cr in FY2025

Financial highlights

FY2026 capex: Rs 1,085.20 cr achieved according to management; official standalone cash flow shows Rs 1,084.67 cr payment for property, plant and equipment
FY2026 throughput: 5.58 million TEUs, up 9.6% YoY; EXIM up 8% and domestic up 14.6%
FY2026 market share: EXIM 53.9%, domestic 55.9% and overall 54.5% according to management
FY2027 capex budget: Rs 945 cr approved by the board, with possible mid-year review
FY2026 EBITDA margin: 24.33% versus 24.98% in FY2025 according to management
Tank-container fleet: About 500 tank containers at the time of the call, adding about 200 per month; 2,000 more approved after 1,000 earlier
FY2026 final dividend: Rs 1.00 per share final dividend, subject to shareholder approval
FY2026 standalone PAT: Rs 1,221.81 cr versus Rs 1,271.98 cr in FY2025
FY2026 total dividend: Rs 8.60 per share including three interim dividends and final dividend
Paid-up share capital: Rs 380.81 cr after 1:4 bonus-share allotment; 76,16,17,935 shares of Rs 5 each
Domestic empty running: Q4 domestic empty-running cost Rs 76.76 cr, up 11.3% YoY; FY2026 domestic empty-running cost Rs 280.35 cr, down 3.8% YoY
FY2026 consolidated EPS: Rs 16.36 basic and diluted on the post-bonus share base
FY2026 land license fee: Rs 395.24 cr booked under Indian Railways land-management master circular based on company assessment
FY2026 operating margin: 30.89% versus 29.99% in FY2025
Q4 FY2026 standalone PAT: Rs 258.23 cr versus Rs 329.12 cr in Q3 FY2026 and Rs 302.14 cr in Q4 FY2025
Q4 FY2026 handling volume: 1,428,102 TEUs total, including 1,068,283 EXIM and 359,819 domestic
FY2026 operating cash flow: Standalone net cash from operating activities Rs 1,468.01 cr
FY2026 rail freight margin: 27.16% versus 25.65% in FY2025
Q4 FY2026 consolidated EPS: Rs 3.46 basic and diluted on face value Rs 5
FY2026 EXIM handling volume: 4.21 million TEUs, an all-time high according to management
Q4 FY2026 originating volume: 678,338 TEUs total, including 549,273 EXIM and 129,065 domestic
Rake and container additions: 43 high-speed rakes commissioned in FY2026, taking the total to 423; 4,729 containers procured, taking owned container fleet to 57,746
FY2026 cash and cash equivalents: Standalone cash and cash equivalents Rs 610.20 cr at March 31, 2026
FY2026 consolidated EXIM revenue: Rs 6,026.04 cr versus Rs 5,734.02 cr in FY2025
FY2026 consolidated total income: Rs 9,443.18 cr versus Rs 9,333.93 cr in FY2025
Q4 FY2026 consolidated EXIM revenue: Rs 1,502.27 cr versus Rs 1,491.01 cr in Q4 FY2025
Q4 FY2026 consolidated total income: Rs 2,352.13 cr versus Rs 2,399.97 cr in Q3 FY2026 and Rs 2,416.34 cr in Q4 FY2025
FY2026 consolidated domestic revenue: Rs 3,052.93 cr versus Rs 3,153.00 cr in FY2025
FY2026 consolidated profit before tax: Rs 1,620.90 cr before share of joint ventures
JNPT rail coefficient and CONCOR share: 15.12% rail coefficient and 60% CONCOR share for FY2026
FY2026 consolidated EXIM segment result: Rs 1,436.34 cr versus Rs 1,315.32 cr in FY2025
Q4 FY2026 consolidated domestic revenue: Rs 761.03 cr versus Rs 796.82 cr in Q4 FY2025
Mundra rail coefficient and CONCOR share: 24.6% rail coefficient and 35.4% CONCOR share for FY2026
Q4 FY2026 consolidated profit before tax: Rs 341.71 cr before share of joint ventures
FY2026 consolidated profit for the period: Rs 1,245.74 cr versus Rs 1,293.10 cr in FY2025
FY2026 standalone revenue from operations: Rs 9,059.45 cr versus Rs 8,863.37 cr in FY2025
Pipavav rail coefficient and CONCOR share: 57.5% rail coefficient and 48.3% CONCOR share for FY2026
Q4 FY2026 consolidated EXIM segment result: Rs 351.26 cr versus Rs 298.45 cr in Q4 FY2025
FY2026 consolidated domestic segment result: Rs 152.85 cr versus Rs 251.30 cr in FY2025
FY2026 consolidated revenue from operations: Rs 9,078.97 cr versus Rs 8,887.02 cr in FY2025
Q4 FY2026 consolidated profit for the period: Rs 263.50 cr after Rs 4.21 cr share of profit from joint ventures
Q4 FY2026 standalone revenue from operations: Rs 2,256.84 cr versus Rs 2,301.72 cr in Q3 FY2026 and Rs 2,281.37 cr in Q4 FY2025
Q4 FY2026 consolidated domestic segment result: Rs 3.35 cr versus Rs 41.82 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 2,263.30 cr versus Rs 2,307.51 cr in Q3 FY2026 and Rs 2,287.83 cr in Q4 FY2025
FY2026 consolidated profit attributable to owners: Rs 1,241.80 cr
Q4 FY2026 consolidated profit attributable to owners: Rs 262.65 cr

Financial highlights

R-32 capacity: More than 10,000 tons achieved; target ramp to 20,000 tons
Final dividend: Rs 3 per Re 1 share, subject to shareholder approval
Segment assets: Chemicals Rs 9,090 cr and EV Products Rs 2,793 cr at March 31, 2026
FY2027 capex plan: Rs 3,150 cr total, including Rs 2,300 cr for GFCL EV and Rs 850 cr for GFL
Segment liabilities: Chemicals Rs 2,777 cr and EV Products Rs 1,193 cr at March 31, 2026
FY2026 finance costs: Rs 138 cr vs Rs 147 cr in FY2025
GFL FY2027 capex split: Rs 150 cr refrigerant gas and related infrastructure; Rs 222 cr high-purity electronic specialty chemicals; Rs 250 cr new fluoropolymer capacities; Rs 230 cr backward integration and maintenance
FY2026 consolidated PAT: Rs 574 cr vs Rs 546 cr in FY2025
GFCL EV target economics: About 2x asset turnover and above 25% EBITDA margin at maturity
Fluoropolymers Q4 revenue: Rs 848 cr, up 19% YoY and 14% QoQ
Q4 FY2026 consolidated PAT: Rs 112 cr vs Rs 162 cr in Q4 FY2025, down 32% YoY
FY2026 chemical segment PAT: Rs 677 cr
March 2026 GFCL EV fundraise: About USD 80 Mn raised from a global marquee investor in addition to about USD 50 Mn from IFC
GFCL EV cumulative capex plan: About Rs 6,000 cr by FY2028
Q4 FY2026 consolidated EBITDA: Rs 308 cr vs Rs 306 cr in Q4 FY2025, up 1% YoY
FY2026 EV products segment PAT: Negative Rs 103 cr
Q4 FY2026 chemical-segment PAT: Rs 169 cr vs Rs 161 cr in Q4 FY2025, up 5% YoY
Q4 FY2026 consolidated revenue: Rs 1,369 cr vs Rs 1,225 cr in Q4 FY2025, up 12% YoY
GFCL EV funds raised or tied up: About Rs 3,730 cr, including Rs 1,000 cr from Indian investors, Rs 430 cr from IFC, about Rs 1,200 cr from Middle Eastern sovereign funds and Rs 1,100 cr parent funding
Q4 FY2026 battery-materials PAT: Negative Rs 57 cr vs Rs 1 cr in Q4 FY2025
New labour code exceptional item: Rs 3 cr consolidated Q4 FY2026 and Rs 20 cr consolidated FY2026
Q4 FY2026 chemical-segment EBITDA: Rs 353 cr vs Rs 312 cr in Q4 FY2025, up 13% YoY
Q4 FY2026 battery-materials EBITDA: Negative Rs 45 cr vs negative Rs 6 cr in Q4 FY2025
Q4 FY2026 chemical-segment revenue: Rs 1,358 cr vs Rs 1,225 cr in Q4 FY2025, up 11% YoY
Q4 FY2026 battery-materials revenue: Rs 11 cr
FY2026 consolidated capex cash spend: Rs 1,206 cr purchase of PPE including CWIP, capital creditors and capital advances
Q4 FY2026 consolidated EBITDA margin: 22% vs 25% in Q4 FY2025
FY2026 consolidated operating cash flow: Rs 961 cr vs Rs 545 cr in FY2025
Q4 FY2026 chemical-segment EBITDA margin: 26%, up 52 bps YoY
FY2026 consolidated revenue from operations: Rs 4,996 cr vs Rs 4,737 cr in FY2025
FY2026 consolidated PBT after exceptional items: Rs 807 cr vs Rs 713 cr in FY2025
FY2026 consolidated PBT before exceptional items: Rs 827 cr vs Rs 713 cr in FY2025
FY2026 chemical segment PBT before exceptional item: Rs 947 cr
FY2026 EV products segment PBT before exceptional item: Negative Rs 120 cr

Financial highlights

UK PAT: Negative GBP 0.7 Mn in Q4 FY2026 and negative GBP 1.9 Mn in FY2026 after acquisition-loan interest, intangible amortization and deferred-tax effects
Net debt: Rs 22,397 Mn, with net debt-to-equity ratio of 0.49
CIHL EBITDA: Negative USD 5.1 Mn in Q4 FY2026 and negative USD 8.0 Mn in FY2026
Final dividend: Rs 4.50 per share, with July 17, 2026 record date, subject to shareholder approval
Expansion target: 7,600-plus bed capacity
Total borrowings: Rs 48,661 Mn at March 31, 2026
UK FY2026 revenue: Rs 12,992 Mn from November 6, 2025 acquisition date
Current investments: Rs 4,143 Mn at March 31, 2026
FY2026 adjusted PAT: Rs 9,374 Mn after one-time acquisition cost and new labor code adjustment
India FY2026 revenue: Rs 47,974 Mn, up 10.3% YoY
UK Q4 FY2026 revenue: Rs 8,090 Mn
Cash and bank balance: Rs 21,292 Mn at March 31, 2026
Cayman FY2026 revenue: Rs 18,893 Mn, up 59.7% YoY
Foreign currency debt: USD 117 Mn and GBP 150 Mn
Operational footprint: 55 healthcare facilities, 5,945 operational beds, 6,244 capacity beds and about 20,750 staff
FY2026 adjusted EBITDA: Rs 17,928 Mn after adjusting for Rs 760 Mn one-time acquisition cost
FY2026 consolidated PAT: Rs 8,105 Mn, margin 10.3%
India Q4 FY2026 revenue: Rs 12,505 Mn, up 12.8% YoY
Cayman Q4 FY2026 revenue: Rs 5,618 Mn, up 47.9% YoY
Q4 FY2026 consolidated PAT: Rs 2,280 Mn, margin 8.8%
Q4 FY2026 consolidated EBITDA: Rs 5,392 Mn, margin 20.8%
Cayman hospital FY2026 revenue: USD 178.7 Mn, up 27.0% YoY
NHIC and NHIL Q4 FY2026 EBITDA: Negative Rs 181 Mn
Cayman insurance FY2026 revenue: USD 41.8 Mn, up 1,073% YoY
Cayman hospital Q4 FY2026 revenue: USD 49.6 Mn, up 12.6% YoY and 10.6% QoQ
Debt-securities enabling approval: Board to seek shareholder approval for secured or unsecured debt securities including NCDs up to Rs 1,500 cr in a financial year
Cayman insurance Q4 FY2026 revenue: USD 14.3 Mn, up 588% YoY and 11.0% QoQ
FY2026 consolidated operating revenue: Rs 78,960 Mn, up 44.0% YoY
Q4 FY2026 consolidated operating revenue: Rs 25,938 Mn, up 75.8% YoY and 20.6% QoQ
UK FY2026 EBITDA after new-centre losses: GBP 10.7 Mn, margin 9.8%
FY2027 planned greenfield/inorganic capex: Rs 4,600 Mn
UK Q4 FY2026 EBITDA after new-centre losses: GBP 7.1 Mn, margin 10.5%
FY2026 consolidated EBITDA before adjustment: Rs 17,169 Mn, margin 21.7%
FY2027 planned replacement/maintenance capex: Rs 2,700 Mn
India hospital Q4 FY2026 EBITDA including NHIC, NHIL, ATHMA and MEDHA: Rs 2,911 Mn, margin 23.3%
India hospital FY2026 EBITDA excluding Jammu, NHIC, NHIL, ATHMA and MEDHA: Rs 10,949 Mn, margin 23.1%
India hospital Q4 FY2026 EBITDA excluding Jammu, NHIC, NHIL, ATHMA and MEDHA: Rs 3,106 Mn, margin 25.1%

Financial highlights

Dividend: Rs 16 per share recommended for FY2026; record date September 5, 2026; payable on or before October 14, 2026 if approved
Order book: Rs 868 cr as at April 1, 2026
Cash position: Management said net cash was about Rs 4,300 cr
US duty exposure: 3.16% Countervailing Duty and 6.91% Anti-Dumping Duty cash-deposit rates effective June 12, 2025 on certain high chrome iron grinding media imported from India
Installed capacity: 436,000 TPA
Labour-code impact: Rs 4.34 cr incremental gratuity liability recognized in FY2026
FY2026 EBITDA margin: 39.46% of income from operations vs 34.81% in FY2025
FY2026 capex incurred: Rs 104 cr
FY2026 standalone PAT: Rs 1,276.997 cr vs Rs 1,021.51 cr in FY2025
Realization commentary: Q4 realization about Rs 178/kg; management indicated Rs 165/kg as the more normal full-year realization reference
FY2026 consolidated PBT: Rs 1,591.77 cr vs Rs 1,368.43 cr in FY2025
Q4 FY2026 EBITDA margin: 39.70% of income from operations vs 34.53% in Q4 FY2025
Q4 FY2026 standalone PAT: Rs 330.76 cr vs Rs 350.79 cr in Q4 FY2025
Welcast exceptional item: Rs 3.28 cr closure compensation provision in consolidated results
FY2026 consolidated EBITDA: Rs 1,744.26 cr vs Rs 1,492.60 cr in FY2025
Q4 FY2026 consolidated PBT: Rs 468.45 cr vs Rs 363.12 cr in Q4 FY2025
FY2026 consolidated net CFF: Rs -659.86 cr vs Rs -742.71 cr in FY2025
FY2026 consolidated net CFI: Rs -124.21 cr vs Rs -194.11 cr in FY2025
FY2026 consolidated net CFO: Rs 591.50 cr vs Rs 1,162.31 cr in FY2025
Q4 FY2026 consolidated EBITDA: Rs 502.67 cr vs Rs 399.52 cr in Q4 FY2025
Consolidated trade receivables: Rs 1,168.61 cr at March 31, 2026 vs Rs 826.38 cr at March 31, 2025
FY2026 consolidated production: 255,820 MT vs 248,200 MT in FY2025
FY2026 consolidated sales volume: 258,002 MT vs 255,443 MT in FY2025
FY2026 consolidated total income: Rs 4,893.91 cr vs Rs 4,619.07 cr in FY2025
FY2026 other non-operating income: Rs 474.05 cr, including Rs 169.98 cr foreign-exchange gain
Q4 FY2026 consolidated production: 59,519 MT vs 61,078 MT in Q4 FY2025
Q4 FY2026 consolidated sales volume: 70,138 MT vs 68,741 MT in Q4 FY2025
Q4 FY2026 consolidated total income: Rs 1,398.33 cr vs Rs 1,249.24 cr in Q4 FY2025
Q4 FY2026 other non-operating income: Rs 132.06 cr, including Rs 64.47 cr foreign-exchange gain
FY2026 mining and others sales volume: Mining 159,813 MT vs 166,053 MT in FY2025; Others 98,189 MT vs 89,390 MT in FY2025
Consolidated cash and cash equivalents: Rs 215.06 cr at March 31, 2026 vs Rs 397.11 cr at March 31, 2025; excludes large investment balances included in management's net-cash framing
Q4 FY2026 mining and others sales volume: Mining 44,601 MT; Others 25,537 MT
FY2026 standalone revenue from operations: Rs 3,762.86 cr vs Rs 3,486.45 cr in FY2025
FY2026 consolidated revenue from operations: Rs 4,419.86 cr vs Rs 4,287.44 cr in FY2025
Q4 FY2026 standalone revenue from operations: Rs 990.95 cr vs Rs 860.61 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 1,266.26 cr vs Rs 1,157.04 cr in Q4 FY2025
FY2026 consolidated PAT after minority interest: Rs 1,270.16 cr vs Rs 1,060.74 cr in FY2025
Q4 FY2026 consolidated PAT after minority interest: Rs 393.27 cr vs Rs 285.22 cr in Q4 FY2025

Financial highlights

Order inflow: Standalone order inflow Rs 4,644 cr in Q4 FY2026 and Rs 5,875 cr in FY2026; joint ventures secured Rs 1,201 cr of works
KRCL receivable: Rs 1,116.26 cr total receivable at March 31, 2026, including Rs 889.95 cr of interest on delayed payment
MoR recoverable: Management said about Rs 3,400 cr was recoverable from Ministry of Railways at year-end and received in April 2026
BharatNet project: Rs 13,236 cr project covering 8,206 km of OFC infrastructure; 15.01% physical progress per management
FY2026 final dividend: Board recommended Rs 0.71 per equity share, in addition to Rs 1 per share interim dividend paid during FY2026
FY2026 standalone EPS: Rs 3.84 basic and diluted vs Rs 5.70 in FY2025
FY2026 standalone PAT: Rs 800.48 cr vs Rs 1,188.62 cr in FY2025
FY2026 standalone PBT: Rs 1,102.27 cr vs Rs 1,550.17 cr in FY2025
FY2026 consolidated EPS: Rs 4.20 basic and diluted vs Rs 6.13 in FY2025
FY2026 consolidated PAT: Rs 870.66 cr vs Rs 1,277.79 cr in FY2025
FY2026 consolidated PBT: Rs 1,181.24 cr vs Rs 1,646.37 cr in FY2025
Margin adjustment items: Management cited about Rs 54 cr onerous-contract adjustment, municipal taxes on the new building and about Rs 35 cr SPV reconciliation adjustment
Q4 FY2026 standalone EPS: Rs 1.02 basic and diluted vs Rs 1.79 in Q4 FY2025
Q4 FY2026 standalone PAT: Rs 212.27 cr vs Rs 264.23 cr in Q3 FY2026 and Rs 373.34 cr in Q4 FY2025
Q4 FY2026 standalone PBT: Rs 281.13 cr vs Rs 352.14 cr in Q3 FY2026 and Rs 457.19 cr in Q4 FY2025
Q4 FY2026 consolidated EPS: Rs 0.90 basic and diluted vs Rs 2.18 in Q4 FY2025
Q4 FY2026 consolidated PAT: Rs 181.66 cr vs Rs 324.14 cr in Q3 FY2026 and Rs 455.39 cr in Q4 FY2025
Q4 FY2026 consolidated PBT: Rs 250.34 cr vs Rs 415.12 cr in Q3 FY2026 and Rs 542.55 cr in Q4 FY2025
Order book at March 31, 2026: Rs 99,262 cr total order book; railways Rs 57,000 cr, signalling Rs 14,900 cr, ports/roads/highways Rs 10,400 cr, metros Rs 9,900 cr, power/transmission about Rs 4,000 cr, hydro/irrigation about Rs 2,000 cr
Rishikesh-Karnaprayag project: Rs 37,000 cr, 125 km project; 74% overall progress and around 96% tunnel excavation; target completion December 2029
FY2026 standalone total income: Rs 20,818.75 cr vs Rs 20,888.24 cr in FY2025
JV and subsidiary contribution: Q4 FY2026 consolidated revenue contribution Rs 399.86 cr and PAT contribution Rs 64.23 cr; dividend income Rs 43.45 cr in Q4 and Rs 47.88 cr for FY2026
FY2026 consolidated total income: Rs 21,187.35 cr vs Rs 20,923.38 cr in FY2025
Q4 FY2026 standalone total income: Rs 6,815.85 cr vs Rs 4,738.49 cr in Q3 FY2026 and Rs 6,538.52 cr in Q4 FY2025
Q4 FY2026 consolidated total income: Rs 6,780.89 cr vs Rs 4,936.14 cr in Q3 FY2026 and Rs 6,614.49 cr in Q4 FY2025
Standalone EBITDA margin commentary: Management said standalone EBITDA margin reduced from 10.36% in Q3 FY2026 to 5.83% in Q4 FY2026
Standalone cash and cash equivalents: Rs 447.76 cr at March 31, 2026 vs Rs 3,044.80 cr at March 31, 2025
Vande Bharat sleeper trainset project: Rs 14,400 cr project with 35-year maintenance arrangement through Kinet Railway Solutions; first prototype targeted December 2026
June 2026 South East Central Railway LOA: NSE filing shows Letter of Acceptance for Bilaspur Division S&T/electronic-interlocking work valued at Rs 221.33 cr, to be executed over 730 days
Standalone net cash flow from operations: Negative Rs 1,922.64 cr in FY2026 vs positive Rs 1,919.90 cr in FY2025
FY2026 standalone revenue from operations: Rs 20,012.26 cr vs Rs 19,869.35 cr in FY2025
FY2026 consolidated revenue from operations: Rs 20,412.12 cr vs Rs 19,923.25 cr in FY2025
Q4 FY2026 standalone revenue from operations: Rs 6,648.40 cr vs Rs 4,503.97 cr in Q3 FY2026 and Rs 6,345.11 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 6,695.91 cr vs Rs 4,684.46 cr in Q3 FY2026 and Rs 6,427.11 cr in Q4 FY2025
Q4 FY2026 consolidated PAT attributable to equity holders: Rs 187.07 cr vs Rs 322.83 cr in Q3 FY2026 and Rs 455.42 cr in Q4 FY2025

Financial highlights

ROE: 15.7% according to the Q4 investor presentation
ROCE: 19.4% according to management
Order book: About Rs 17,200 cr / Rs 172 bn-plus at FY2026 close; annual investor presentation showed Rs 17,235 cr
O&M revenue: Rs 6.8 bn in FY2026 versus Rs 6.0 bn in FY2025 according to the annual investor presentation
Credit rating: IND AA-/Stable long-term rating and IND A1+ short-term rating reaffirmed
Final dividend: Rs 5 per equity share of Rs 2 face value, or 250%, subject to shareholder approval
FY2026 revenue mix: 83% EPC and 17% O&M; 80% municipal and 20% industrial; roughly 50% India and 50% overseas according to management
Revenue visibility: More than 4x revenue according to management
FY2026 order intake: More than Rs 75 bn / about Rs 7,500 cr
FY2026 standalone PAT: Rs 3,344 mn
Kuwait Doha SWRO order: Mega international order above USD 150 mn; 60 MIGD / about 272 MLD SWRO DBO with 36-month EPC phase and five years of O&M
Bengaluru East GST order: Total demand of Rs 6.47 cr, including basic tax Rs 5.71 cr, interest Rs 0.18 cr and penalty Rs 0.57 cr; company plans appeal
FY2026 order-backlog mix: About 62% EPC and 38% O&M; 85% municipal and 15% industrial; about 60% India and 40% rest of world according to the annual investor presentation
FY2026 order-book growth: 26% YoY according to the annual investor presentation
FY2026 standalone EBITDA: Rs 4,709 mn versus Rs 4,029 mn in FY2025, up 16.9% YoY
Net working-capital days: Around 100 days according to management
Nimble Vision investment: About Rs 3.00 cr for 955 equity shares and approximately 10.02% initial shareholding
Q4 FY2026 standalone PAT: Rs 1,226 mn
FY2026 free cash retained: Rs 1,130 mn according to the annual investor presentation
Ghaziabad Bio-CNG project: Commercial operations expected within one year; estimated carbon-emission reduction of about 250,000 metric tons over project life
FY2026 consolidated EBITDA: Rs 5,241 mn versus Rs 4,302 mn in FY2025, up 21.8% YoY
Q4 FY2026 standalone EBITDA: Rs 1,653 mn versus Rs 1,390 mn in Q4 FY2025, up 18.9% YoY
Delhi Jal Board Mitraon order: Medium domestic order in Rs 100 cr to Rs 250 cr range; 17 MGD WWTP to be completed within 21 months followed by 15 years of O&M
Q4 FY2026 consolidated EBITDA: Rs 1,771 mn versus Rs 1,408 mn in Q4 FY2025, up 25.8% YoY
Ajman Sewage Biorefinery order: Large international order in USD 30 mn to USD 75 mn range; 60 MLD sewage treatment plant to be completed within 24 months
FY2026 consolidated PAT margin: 9.4%
FY2026 standalone total income: Rs 34,014 mn versus Rs 29,107 mn in FY2025, up 16.9% YoY
FY2026 standalone EBITDA margin: 14.3% versus 14.0% in FY2025
Uttar Pradesh GST rectification: Earlier Rs 43.74 lakh demand reduced to Rs 1.98 lakh, to be discharged by the company
FY2026 consolidated total income: Rs 40,385 mn versus Rs 33,386 mn in FY2025, up 21.0% YoY
FY2026 consolidated EBITDA margin: 13.3% versus 13.1% in FY2025
Q4 FY2026 standalone total income: Rs 12,197 mn versus Rs 10,497 mn in Q4 FY2025, up 16.2% YoY
Q4 FY2026 standalone EBITDA margin: 14.2% versus 13.4% in Q4 FY2025
Q4 FY2026 consolidated total income: Rs 14,462 mn versus Rs 11,676 mn in Q4 FY2025, up 23.9% YoY
Q4 FY2026 consolidated EBITDA margin: 12.5% versus 12.2% in Q4 FY2025
FY2026 consolidated net cash position: Rs 8,337 mn including HAM projects according to the press release
FY2026 consolidated trade receivables: Rs 25,236 mn at March 31, 2026 versus Rs 20,129 mn at March 31, 2025
FY2026 net cash excluding HAM projects: Rs 9,500 mn according to the press release and Q4 presentation
FY2026 standalone revenue from operations: Rs 32,844 mn versus Rs 28,738 mn in FY2025, up 14.3% YoY
FY2026 consolidated cash and bank balances: Rs 10,592 mn at March 31, 2026
FY2026 consolidated free cash flow to firm: Rs 2,964 mn according to the Q4 investor presentation
FY2026 consolidated revenue from operations: Rs 39,442 mn versus Rs 32,940 mn in FY2025, up 19.7% YoY
FY2026 consolidated segment revenue - India: Rs 18,643 mn
FY2026 consolidated free cash flow to equity: Rs 1,316 mn according to the Q4 investor presentation
Q4 FY2026 standalone revenue from operations: Rs 11,669 mn versus Rs 10,385 mn in Q4 FY2025, up 12.4% YoY
FY2026 consolidated cash and cash equivalents: Rs 7,851 mn at March 31, 2026
FY2026 consolidated PAT attributable to owners: Rs 3,705 mn versus Rs 2,953 mn in FY2025, up 25.5% YoY
Q4 FY2026 consolidated revenue from operations: Rs 14,144 mn versus Rs 11,562 mn in Q4 FY2025, up 22.3% YoY
Q4 FY2026 consolidated segment revenue - India: Rs 6,218 mn
Q4 FY2026 consolidated PAT attributable to owners: Rs 1,283 mn
FY2026 consolidated segment revenue - Rest of world: Rs 20,913 mn
Q4 FY2026 consolidated segment revenue - Rest of world: Rs 7,924 mn
FY2026 consolidated bank balances other than cash equivalents: Rs 2,741 mn at March 31, 2026
FY2026 standalone net cash generated from operating activities: Rs 2,033 mn
FY2026 consolidated net cash generated from operating activities: Rs 2,067 mn

Financial highlights

filters_per_annum: more than 600
fy2026_payable_days: 79
fy2026_inventory_days: 98
fy2026_receivable_days: 61
fy2025_order_book_rs_cr: 575.1
omeras_order_book_rs_cr: 78
current_order_book_rs_cr: 681.6
fy2026_audited_pbt_rs_cr: 70.95
thaletec_ebit_margin_pct: about 11-11.5
q4fy2026_audited_pbt_rs_cr: 25.25
fy2025_total_debt_to_equity: 0.63x
fy2026_basic_diluted_eps_rs: 7.20
fy2026_total_debt_to_equity: 0.51x
omeras_fy2026_pat_loss_rs_cr: 15.6
fy2026_consolidated_pat_rs_cr: 56.6
q4fy2026_basic_diluted_eps_rs: 2.65
fy2026_exceptional_items_rs_cr: 6.69
thaletec_fy2026_revenue_eur_mn: 34
filtration_drying_installations: more than 4500
fy2026_heat_transfer_ebit_rs_cr: 28.18
fy2026_net_working_capital_days: 80
glass_lined_equipment_per_annum: more than 2500
india_operations_export_mix_pct: 5-7
omeras_fy2026_ebitda_loss_rs_cr: 15.3
q4fy2026_consolidated_pat_rs_cr: 20.1
fy2026_consolidated_ebitda_rs_cr: 148.5
fy2026_audited_total_income_rs_cr: 1361.76
fy2026_dividend_pct_of_face_value: 55
heat_transfer_expected_growth_pct: 15-20 annually for next couple of years
omerase_aug13_mar31_revenue_rs_cr: 89.5
q4fy2026_heat_transfer_ebit_rs_cr: 7.34
fy2026_consolidated_pat_margin_pct: 4.2
fy2026_final_dividend_rs_per_share: 1.10
fy2026_heat_transfer_revenue_rs_cr: 200.3
glass_lined_india_market_share_pct: about 25
q4fy2026_consolidated_ebitda_rs_cr: 43.9
fy2026_working_capital_inflow_rs_cr: 19.6
q4fy2026_audited_total_income_rs_cr: 392.80
fy2026_audited_profit_for_year_rs_cr: 56.57
q4fy2026_consolidated_pat_margin_pct: 5.1
q4fy2026_heat_transfer_revenue_rs_cr: 50.0
fy2026_consolidated_ebitda_margin_pct: 11.0
fy2026_consolidated_pat_growth_yoy_pct: -8.4
fy2026_glass_lined_products_ebit_rs_cr: 28.61
heat_transfer_capacity_utilization_pct: about 70-75
q4fy2026_consolidated_ebitda_margin_pct: 11.2
filtration_drying_india_market_share_pct: more than 50
omeras_fy2026_ebit_loss_in_segment_rs_cr: 17.4
q4fy2026_audited_profit_for_period_rs_cr: 20.14
q4fy2026_consolidated_pat_growth_qoq_pct: 338.0
q4fy2026_consolidated_pat_growth_yoy_pct: -36.3
q4fy2026_glass_lined_products_ebit_rs_cr: 14.70
consolidated_inventories_march_2026_rs_cr: 355.80
fy2026_consolidated_ebitda_growth_yoy_pct: 5.4
fy2026_filtration_drying_other_ebit_rs_cr: 57.00
fy2026_glass_lined_products_revenue_rs_cr: 676.4
q4fy2026_other_standalone_revenue_mix_pct: 18
cash_and_cash_equivalents_march_2026_rs_cr: 34.4
consolidated_total_assets_march_2026_rs_cr: 1381.80
consolidated_total_equity_march_2026_rs_cr: 618.25
fy2026_consolidated_revenue_growth_yoy_pct: 31.7
fy2026_labour_code_past_service_cost_rs_cr: 2.07
fy2026_profit_attributable_to_owners_rs_cr: 49.42
glass_lined_india_capacity_utilization_pct: about 75
fy2026_cash_generated_from_operations_rs_cr: 177.6
fy2026_heat_transfer_revenue_growth_yoy_pct: 64.6
q4fy2026_consolidated_ebitda_growth_qoq_pct: 78.7
q4fy2026_consolidated_ebitda_growth_yoy_pct: -19.0
q4fy2026_filtration_drying_other_ebit_rs_cr: 14.33
q4fy2026_glass_lined_products_revenue_rs_cr: 219.5
fy2026_audited_revenue_from_operations_rs_cr: 1352.98
fy2026_filtration_drying_other_revenue_rs_cr: 474.3
omeras_ebitda_breakeven_annual_revenue_rs_cr: 200-225
q4fy2026_consolidated_revenue_growth_qoq_pct: 19.9
q4fy2026_consolidated_revenue_growth_yoy_pct: 17.4
q4fy2026_profit_attributable_to_owners_rs_cr: 18.19
q4fy2026_heat_transfer_revenue_growth_yoy_pct: -7.4
q4fy2026_api_pharma_standalone_revenue_mix_pct: 37
q4fy2026_audited_revenue_from_operations_rs_cr: 391.69
q4fy2026_filtration_drying_other_revenue_rs_cr: 122.0
consolidated_trade_receivables_march_2026_rs_cr: 269.92
fy2026_net_cash_from_operating_activities_rs_cr: 161.2
omeras_ebitda_breakeven_quarterly_revenue_rs_cr: 45-50
consolidated_current_borrowings_march_2026_rs_cr: 212.63
fy2026_cash_flow_from_financing_activities_rs_cr: -84.9
fy2026_cash_flow_from_investing_activities_rs_cr: -85.9
thaletec_products_share_of_glass_lined_india_pct: about 20
fy2026_audited_pbt_before_exceptional_items_rs_cr: 77.63
fy2026_consolidated_revenue_from_operations_rs_cr: 1353.0
fy2026_business_acquisition_transaction_cost_rs_cr: 4.62
fy2026_glass_lined_products_revenue_growth_yoy_pct: 16.2
q4fy2026_audited_pbt_before_exceptional_items_rs_cr: 25.68
q4fy2026_consolidated_revenue_from_operations_rs_cr: 391.7
consolidated_non_current_borrowings_march_2026_rs_cr: 100.60
fy2026_operating_profit_before_working_capital_rs_cr: 158.1
q4fy2026_glass_lined_products_revenue_growth_qoq_pct: 29.2
q4fy2026_glass_lined_products_revenue_growth_yoy_pct: 30.8
fy2026_filtration_drying_other_revenue_growth_yoy_pct: 50.9
q4fy2026_filtration_drying_other_revenue_growth_yoy_pct: 11.9
q4fy2026_speciality_chemicals_standalone_revenue_mix_pct: 26
q4fy2026_agrochemicals_pesticides_standalone_revenue_mix_pct: 19

Financial highlights

Depots: 55 across all 28 states.
ESOP grant: 44,400 options at Rs 10 exercise price.
Active dealers: 19,352 per investor presentation.
Tinting machines: 12,217 per investor presentation.
Q4 emulsions growth: 10.5% value growth and 11.2% volume growth.
Manufacturing plants: 6 per investor presentation.
Q4 FY2026 standalone PAT: Rs 57.3 cr, up 0.8% year on year.
Q4 FY2026 consolidated PAT: Rs 59.2 cr, up 3.1% year on year.
Apple Chemie FY2026 revenue: Rs 75.1 cr, up 17.8% year on year.
FY2026 dividend recommended: Rs 5 per share.
Jodhpur water-based capacity: 90,000 KLPA with trial production expected in June 2026.
Apple Chemie Q4 FY2026 revenue: Rs 27.5 cr, up 34.7% year on year.
FY2026 standalone gross margin: 46.9% versus 46.5% in FY2025.
FY2026 standalone EBITDA margin: 18.5%.
Q4 FY2026 standalone PAT margin: 14.4%.
Q4 primers and distemper growth: 14.9% value growth and 9.6% volume growth.
Apple Chemie gross margin marker: Around 40%, plus or minus about 1 percentage point depending on mix.
Q4 putty and cement paint growth: 12.6% value growth and 9.5% volume growth.
FY2026 consolidated EBITDA margin: 18.1%.
Q4 FY2026 consolidated PAT margin: 13.9%.
Q4 FY2026 standalone gross margin: 48.6% versus 47.4% in Q4 FY2025.
Q4 FY2026 standalone EBITDA margin: 23.0%.
Q4 enamels and wood coatings growth: 7.2% value growth and 5.4% volume growth.
Q4 FY2026 consolidated EBITDA margin: 22.5%.
FY2026 standalone operating cash flow: Rs 211.37 cr inflow.
FY2026 consolidated financing cash flow: Rs 31.54 cr outflow.
FY2026 consolidated investing cash flow: Rs 196.03 cr outflow.
FY2026 consolidated operating cash flow: Rs 222.58 cr inflow.
FY2026 standalone revenue from operations: Rs 1,330.1 cr, up 4.1% year on year.
Consolidated total assets at March 31 2026: Rs 1,628.95 cr.
Consolidated total equity at March 31 2026: Rs 1,153.97 cr.
FY2026 consolidated revenue from operations: Rs 1,405.0 cr, up 4.8% year on year.
Q4 FY2026 standalone revenue from operations: Rs 397.9 cr, up 8.4% year on year.
Q4 FY2026 consolidated revenue from operations: Rs 425.3 cr, up 9.7% year on year.
Consolidated trade receivables at March 31 2026: Rs 285.51 cr.
FY2026 standalone EBITDA excluding other income: Rs 246.7 cr, up 6.5% year on year.
FY2026 standalone PAT excluding exceptional item: Rs 149.8 cr, up 4.0% year on year.
FY2026 standalone PAT including exceptional item: Rs 145.4 cr.
Consolidated current investments at March 31 2026: Rs 299.83 cr.
FY2026 consolidated EBITDA excluding other income: Rs 254.8 cr, up 9.1% year on year.
FY2026 consolidated PAT excluding exceptional item: Rs 152.2 cr, up 7.1% year on year.
FY2026 consolidated PAT including exceptional item: Rs 147.6 cr.
Q4 FY2026 standalone EBITDA excluding other income: Rs 91.7 cr, up 6.8% year on year.
Q4 FY2026 consolidated EBITDA excluding other income: Rs 95.6 cr, up 9.3% year on year.
Consolidated capital work-in-progress at March 31 2026: Rs 220.19 cr.
Consolidated cash and cash equivalents at March 31 2026: Rs 32.12 cr.
FY2026 standalone PAT margin excluding exceptional item: 11.2%.
FY2026 consolidated PAT margin excluding exceptional item: 10.7%.

Financial highlights

ESG rating: Overall ESG rating of 52 assigned on May 4, 2026 by ESG Risk Assessments & Insights Limited
FY2026 AS volume: Production 5.53 lakh MT; sales 5.76 lakh MT
FY2026 APS volume: Production 7.18 lakh MT; sales 7.16 lakh MT
FY2026 DAP volume: Production 1.47 lakh MT; sales 1.46 lakh MT
Equity share count: 39,84,77,530 equity shares; investor presentation rounded to 39.84 cr shares
FY2026 Urea volume: Production 3.33 lakh MT; sales 3.25 lakh MT
FY2026 nylon volume: Production 0.37 lakh MT; sales 0.35 lakh MT
Final dividend FY2026: Rs 5 per share, 250% of Rs 2 face value
Highest ever Q4 sales: Rs 2,622 cr standalone operating revenue in Q4 FY2026 per management and presentation
Standalone FY2026 EPS: Rs 16.35 versus Rs 14.38 in FY2025
Standalone FY2026 PAT: Rs 651.52 cr versus Rs 573.18 cr in FY2025
Standalone FY2026 PBT: Rs 838.12 cr versus Rs 740.18 cr in FY2025
FY2026 melamine volume: Production 0.38 lakh MT; sales 0.39 lakh MT
Consolidated FY2026 EPS: Rs 16.88 versus Rs 14.83 in FY2025
Consolidated FY2026 PAT: Rs 673.00 cr versus Rs 591.16 cr in FY2025
FY2026 MEK Oxime volume: Production 0.04 lakh MT; sales 0.04 lakh MT
Operating EBITDA FY2026: Rs 781 cr, up 24% YoY per media release and call transcript
Sikka PA and SA project: 198 KTPA phosphoric acid and 594 KTPA sulphuric acid listed as FY2028/FY2029 ongoing project
FY2026 capex capitalized: Rs 675 cr per media release
FY2026 traded urea sales: 3.20 lakh MT
Standalone Q4 FY2026 EPS: Rs 0.86 versus Rs 1.46 in Q4 FY2025
Standalone Q4 FY2026 PAT: Rs 34.24 cr versus Rs 58.40 cr in Q4 FY2025
Standalone Q4 FY2026 PBT: Rs 48.20 cr versus Rs 77.27 cr in Q4 FY2025
FY2026 caprolactam volume: Production 0.79 lakh MT; sales 0.55 lakh MT
Consolidated Q4 FY2026 EPS: Rs 1.30 versus Rs 1.80 in Q4 FY2025
Consolidated Q4 FY2026 PAT: Rs 52.14 cr versus Rs 71.76 cr in Q4 FY2025
Sikka C-Train modification: 1200 MTPD APS production capacity; expected completion July/August 2026 per Q&A
Capro-Benzene spread FY2026: USD 535 per MT average versus USD 578 per MT in FY2025
Fertilizer sales volume FY2026: 22.31 lakh MT versus 19.88 lakh MT in FY2025
Standalone FY2026 total income: Rs 11,100.31 cr
Consolidated FY2026 total income: Rs 11,221.87 cr
FII/FPI holding at March 31 2026: 12.35%
Promoter holding at March 31 2026: 37.84% for GSIL
Standalone Q4 FY2026 total income: Rs 2,656.94 cr
Capro-Benzene spread Q&A reference: Above USD 800 per MT at call date versus around USD 670 per MT in Q4, per management
FY2026 traded P&K fertilizer sales: 1.43 lakh MT
Consolidated Q4 FY2026 total income: Rs 2,668.12 cr
Manufactured fertilizer sales FY2026: 17.68 lakh MT versus 16.61 lakh MT in FY2025
DII and others holding at March 31 2026: 7.31%
Standalone inventories at March 31 2026: Rs 1,769.61 cr
Standalone total assets at March 31 2026: Rs 14,182.77 cr
Consolidated inventories at March 31 2026: Rs 1,878.77 cr
Manufactured fertilizer production FY2026: 17.56 lakh MT in investor presentation; management rounded to 17.59 lakh MT in call transcript
Standalone FY2026 revenue from operations: Rs 10,827.25 cr, up 15% YoY from Rs 9,428.71 cr
Consolidated total assets at March 31 2026: Rs 14,389.55 cr
Consolidated FY2026 revenue from operations: Rs 10,945.50 cr versus Rs 9,533.96 cr in FY2025
Standalone fertilizer FY2026 segment result: Rs 435.61 cr versus Rs 429.71 cr in FY2025
600 MTPD SA-V Project commissioned in FY2026: Rs 233 cr
Standalone Q4 FY2026 revenue from operations: Rs 2,621.59 cr versus Rs 1,906.71 cr in Q4 FY2025
Standalone fertilizer FY2026 segment revenue: Rs 8,423.04 cr versus Rs 7,226.61 cr in FY2025
Urea Revamping Project commissioned in FY2026: Rs 364 cr
Consolidated Q4 FY2026 revenue from operations: Rs 2,632.67 cr versus Rs 1,922.19 cr in Q4 FY2025
Standalone fertilizer Q4 FY2026 segment result: Negative Rs 45.72 cr versus negative Rs 39.74 cr in Q4 FY2025
Standalone fertilizer Q4 FY2026 segment revenue: Rs 1,984.82 cr versus Rs 1,383.62 cr in Q4 FY2025
Standalone FY2026 cash generated from operations: Rs 276.05 cr
Consolidated FY2026 PBT after share of associates: Rs 861.29 cr versus Rs 756.27 cr in FY2025
Consolidated FY2026 cash generated from operations: Rs 266.61 cr
Consolidated Q4 FY2026 PBT after share of associates: Rs 65.29 cr versus Rs 88.67 cr in Q4 FY2025
Standalone FY2026 net cash from operating activities: Rs 145.62 cr
Standalone Industrial Products FY2026 segment result: Rs 200.06 cr versus Rs 56.01 cr in FY2025
Standalone Industrial Products FY2026 segment revenue: Rs 2,404.21 cr versus Rs 2,202.10 cr in FY2025
Standalone cash and cash equivalents at March 31 2026: Rs 160.75 cr
Consolidated FY2026 net cash from operating activities: Rs 136.14 cr
Consolidated cash and cash equivalents at March 31 2026: Rs 191.77 cr
Standalone Industrial Products Q4 FY2026 segment result: Rs 112.85 cr versus Rs 97.43 cr in Q4 FY2025
Standalone Industrial Products Q4 FY2026 segment revenue: Rs 636.77 cr versus Rs 523.09 cr in Q4 FY2025
Standalone government subsidies receivable at March 31 2026: Rs 1,490.95 cr
15 MW Solar Power Project at Charanka commissioned in FY2026: Rs 77 cr
Indian public and non-institutional holding at March 31 2026: 42.50%
Consolidated government subsidies receivable at March 31 2026: Rs 1,452.88 cr

Financial highlights

Cash: Reported cash about Rs 4,200 cr; own cash excluding advances/project cash about Rs 950 cr
Order book: Rs 24,984 cr at March 31, 2026
Bid pipeline: 107 bids submitted for about Rs 48,000 cr, many under evaluation
FY2026 dividend: Rs 1.20 per share interim dividend paid plus Rs 0.70 per share final dividend recommended
Order book by sector: Railways Rs 19,459 cr; highways Rs 3,919 cr; others Rs 1,606 cr
Routine capex marker: About Rs 50-60 cr for routine capex and machinery
Standalone FY2026 EPS: Rs 6.58 per share versus Rs 7.84 in FY2025
Standalone FY2026 PAT: Rs 618.5 cr, down 16.2% YoY
Consolidated FY2026 EPS: Rs 6.33 per share versus Rs 7.73 in FY2025
Consolidated FY2026 PAT: Rs 591.9 cr, down 18.7% YoY
Consolidated FY2026 PBT: Rs 766.5 cr, down 18.4% YoY
Order book by geography: Domestic Rs 22,956 cr; international Rs 2,028 cr
Consolidated debt marker: About Rs 5,700 cr, related to PPP project financing and not standalone IRCON debt
Order book by award mode: Competitive Rs 13,459 cr; nomination Rs 11,525 cr
Standalone FY2026 EBITDA: Rs 852.6 cr, down 11.5% YoY
Standalone Q4 FY2026 PAT: Rs 192.0 cr, up 110.6% QoQ and down 12.0% YoY
Consolidated FY2026 EBITDA: Rs 1,279.3 cr, up 0.3% YoY
Consolidated Q4 FY2026 PAT: Rs 191.5 cr, up 91.8% QoQ and down 9.6% YoY
Standalone Q4 FY2026 EBITDA: Rs 259.9 cr, up 80.6% QoQ and down 3.6% YoY
Working-capital demand loan: Rs 103 cr at March 31, 2026, project-specific; almost 50% repaid by call date
FY2027 SPV investment marker: About Rs 400 cr in SPV projects per CMD; finance commentary frames Rs 400-500 cr for PPP projects and Rs 700-800 cr total equity/quasi-equity need
Consolidated Q4 FY2026 EBITDA: Rs 389.2 cr, up 44.5% QoQ and 8.9% YoY
FY2026 railway orders secured: About Rs 5,000 cr
Standalone FY2026 core EBITDA: Rs 352.8 cr, down 26.4% YoY
Standalone FY2026 total income: Rs 8,978.6 cr, down 15.9% YoY
Consolidated FY2026 core EBITDA: Rs 848.4 cr, down 6.2% YoY
Consolidated FY2026 total revenue: Rs 9,502.0 cr, down 14.6% YoY
Consolidated Q4 FY2026 total income: Rs 3,291.2 cr, up 49.2% QoQ and down 6.4% YoY
Standalone FY2026 operating revenue: Rs 8,478.9 cr, down 16.8% YoY
Standalone FY2026 core EBITDA margin: 4.2%, down 54 bps YoY
Consolidated FY2026 operating revenue: Rs 9,071.1 cr, down 15.7% YoY
Consolidated FY2026 core EBITDA margin: 9.4%, up 94 bps YoY
Standalone Q4 FY2026 operating revenue: Rs 2,997.8 cr, up 52.5% QoQ and down 7.6% YoY
Standalone Q4 FY2026 core EBITDA margin: 4.4%, up 154 bps QoQ and 12 bps YoY
Consolidated Q4 FY2026 operating revenue: Rs 3,189.0 cr, up 50.5% QoQ and down 6.5% YoY
Consolidated Q4 FY2026 core EBITDA margin: 9.0%, up 41 bps QoQ and 155 bps YoY
Government of India shareholding disclosure: 61,29,28,392 equity shares held by Government of India through Ministry of Railways at March 31, 2026, with no encumbrance during FY2026

Financial highlights

Dividend: Rs 3.5 per share recommended for FY2026
FY2026 capex: Rs 296 cr
FY2026 standalone PAT: Rs 336.0 cr
FY2027 capex guidance: Rs 200-225 cr
Labour-code provision: Rs 6.8 cr provision for past service gratuity and compensated absences recognized as extraordinary expense
Consolidated total debt: Rs 341.6 cr at March 31, 2026
FY2026 consolidated PAT: Rs 320.7 cr, 16.1% margin
Q4 FY2026 standalone PAT: Rs 80.6 cr
Q4 FY2026 consolidated PAT: Rs 65.0 cr, 11.8% margin
FY2026 standalone gross profit: Rs 1,132.0 cr, 68.1% gross margin
FY2026 consolidated diluted EPS: Rs 31.8
FY2026 consolidated gross profit: Rs 1,278.4 cr, 68.2% gross margin
Medyneo Brazil acquisition outlay: About USD 40,000 according to Q&A commentary
Q4 FY2026 standalone gross profit: Rs 295.2 cr, 66.6% gross margin
FY2026 standalone operating EBITDA: Rs 446.1 cr, 26.8% margin
FY2027 standalone revenue guidance: Rs 1,900-1,950 cr
PendraCare and Citieffe Q4 revenue: About Rs 65 cr, with about Rs 43-44 cr from Citieffe and balance from PendraCare
Q4 FY2026 consolidated gross profit: Rs 356.3 cr, 66.7% gross margin
FY2026 consolidated domestic revenue: Rs 581.7 cr, up 19.6% YoY
FY2026 consolidated operating EBITDA: Rs 457.7 cr, 24.4% margin
FY2027 consolidated revenue guidance: Rs 2,300-2,400 cr
Standalone cash and cash equivalents: Rs 796.8 cr at March 31, 2026
One-time acquisition-related expenses: Rs 9.7 cr excluded from FY2026 consolidated operating EBITDA
Q4 FY2026 standalone operating EBITDA: Rs 121.1 cr, 27.3% margin
Consolidated cash and cash equivalents: Rs 842.2 cr at March 31, 2026
Q4 FY2026 consolidated operating EBITDA: Rs 112.1 cr, 21.0% margin
FY2027 standalone EBITDA margin guidance: 25%-27%
FY2026 consolidated international revenue: Rs 1,280.2 cr, up 9.3% YoY
FY2026 standalone revenue from operations: Rs 1,662.5 cr
FY2027 consolidated EBITDA margin guidance: 23%-25%
FY2026 consolidated revenue from operations: Rs 1,875.3 cr, up 12.3% YoY
Q4 FY2026 standalone revenue from operations: Rs 443.0 cr, up 5.2% YoY
Q4 FY2026 consolidated revenue from operations: Rs 534.5 cr, up 21.3% YoY

Financial highlights

Call date: May 25, 2026 at 3:30 p.m. IST
ESG rating: NSRAL ESG score 60, Adequate, for FY2025; environment 45, social 63 and governance 76
Audit opinion: S R Batliboi and Co. issued unmodified audit reports on standalone and consolidated annual financial results
Board meeting: May 22, 2026; commenced 2:30 p.m. and concluded 3:53 p.m.
Final dividend: Re 1 per equity share of face value Re 1 for FY2026
Interest cover: 4.15x at FY2026 end
MDF utilization: Management said current utilization was about 80%-85% on rated capacity, with product mix allowing 85%-90% on rated capacity
Total forex loss: Rs 57.28 cr in FY2026 and Rs 24.19 cr in Q4 FY2026 across EBITDA and finance cost
MDF FY2026 volume: Plain MDF 353,056 CBM and prelam MDF 77,657 CBM; total 430,713 CBM, up 22.9%
Plywood expansion: Hoshiarpur 48,000 CBM in H2 FY2027 plus Kandla, Chennai and Guwahati brownfield additions of about 20% of current capacity
Laminates capacity: 87.70 lakh sheets with 84% utilization; Badvel laminate capacity 11,200 CBM with 47% utilization
Century Ports capex: Presentation capex table showed Rs 262.0 cr total Century Ports capex through FY2026
Odisha plywood plan: Phase 1 60,000 CBM by Q1 FY2030 for about Rs 230 cr; Phase 2 60,000 CBM by Q1 FY2031 for about Rs 140 cr
Total debt to EBITDA: 2.47x at FY2026 end
CACL resin production: Century Adhesives and Chemicals Ltd. Naidupetta resin unit started commercial production on May 28, 2026
Cash conversion cycle: 81.19 days in FY2026 versus 83.74 days in FY2025
Plywood FY2026 volume: Plywood 485,403 CBM, decoply 8,195 CBM and commercial veneer 13,510 CBM
Consolidated net worth: Rs 2,630.04 cr at FY2026 end
Transcript filing date: May 27, 2026 with NSE/BSE
Consolidated FY2026 PAT: Rs 268.33 cr versus Rs 186.09 cr in FY2025
Consolidated total debt: Rs 1,531.26 cr at FY2026 end
Plywood current capacity: 406,000 CBM as of March 31, 2026 per management, and 406,800 CBM per year per Odisha disclosure
Consolidated FY2026 EBITDA: Rs 660.64 cr, 12.2% of total income
Consolidated Q4 FY2026 PAT: Rs 79.41 cr versus Rs 65.04 cr in Q3 FY2026 and Rs 53.16 cr in Q4 FY2025
MDF FY2026 net sales value: Rs 1,271.75 cr, up 25.0%
Odisha particle-board plan: 240,000 CBM by Q1 FY2032 for about Rs 500 cr, with possible partial change to MDF depending on business priorities
Cash, bank and liquid funds: Rs 59.01 cr at FY2026 end
MDF FY2026 growth and margin: Total income grew 25.6%; EBITDA margin excluding forex losses improved to 12.7% from 10.1%
Particle-board FY2026 volume: Plain particle board 52,174 CBM and prelam particle board 55,326 CBM; total 107,500 CBM, up 53.4%
Standalone FY2026 net profit: Rs 276.82 cr
Consolidated Q4 FY2026 EBITDA: Rs 182.11 cr, 12.2% of total income
Plywood FY2026 net sales value: Rs 2,895.34 cr total, up 16.5% versus FY2025
MDF Q4 FY2026 growth and margin: Total income grew 9.4% QoQ and 31.5% YoY; EBITDA margin excluding forex losses was 11.3%
Standalone Q4 FY2026 net profit: Rs 77.47 cr
Consolidated FY2026 total income: Rs 5,407.42 cr in the statutory results
MDF capacity and debottlenecking: Current capacity about 530,000-540,000 CBM per year; brownfield expansion to add 60,000-70,000 CBM and take capacity to about 600,000 CBM per year
Plywood FY2026 growth and margin: Total income grew 15.6%; EBITDA margin excluding forex losses was 15.2%
CFS FY2026 total income and EBITDA: Rs 159.07 cr total income and Rs 25.93 cr EBITDA excluding forex
Laminates FY2026 growth and margin: Total income grew 13.9%; EBITDA margin excluding forex losses improved to 8.5% from 5.2%
Consolidated Q4 FY2026 total income: Rs 1,496.95 cr in the statutory results
Plywood Q4 FY2026 growth and margin: Total income grew 11.4% QoQ and 17.9% YoY; EBITDA margin excluding forex losses was 16.1%
Consolidated FY2026 profit before tax: Rs 357.38 cr versus Rs 277.29 cr in FY2025
Laminates Q4 FY2026 growth and margin: Total income grew 8.4% QoQ and 16.4% YoY in the presentation; EBITDA margin excluding forex losses was 10.3%
Others FY2026 total income and EBITDA: Rs 94.56 cr total income and Rs 15.02 cr EBITDA excluding forex
Particle-board FY2026 net sales value: Rs 196.26 cr, up 37.5%
Particle-board FY2026 growth and margin: Total income grew 38.2%; EBITDA margin excluding forex losses was 1.2%
Consolidated Q4 FY2026 profit before tax: Rs 103.58 cr versus Rs 84.77 cr in Q3 FY2026 and Rs 81.66 cr in Q4 FY2025
Standalone FY2026 revenue from operations: Rs 4,645.97 cr
Particle-board Q4 FY2026 growth and margin: Total income grew 3.9% QoQ and 108.3% YoY; EBITDA margin excluding forex losses was 7.2%
Consolidated FY2026 revenue from operations: Rs 5,397.18 cr versus Rs 4,527.80 cr in FY2025
Standalone Q4 FY2026 revenue from operations: Rs 1,277.39 cr
Consolidated Q4 FY2026 revenue from operations: Rs 1,492.21 cr versus Rs 1,350.08 cr in Q3 FY2026 and Rs 1,198.33 cr in Q4 FY2025
Consolidated FY2026 EBITDA excluding forex and extraordinary items: Rs 701.69 cr, 13.0% of total income
Consolidated Q4 FY2026 EBITDA excluding forex and extraordinary items: Rs 203.78 cr, 13.7% of total income

Financial highlights

Mahan Coal Mine: Executed mining lease for 981.75 hectares at Singrauli, Madhya Pradesh
FY2026 incentive: About Rs 230 cr
FY2026 grey volume: 210.4 lakh tonnes vs 180.0 lakh tonnes in FY2025
Q4 FY2026 fuel mix: Around 50% petcoke, 12% alternate fuels and balance Indian coal on heat-value basis
Q4 FY2026 Kcal cost: Rs 1.48
Q4 FY2026 trade mix: 68% vs 60% in Q3 FY2026
FY2026 paint revenue: Rs 380 cr
Green power capacity: 290.7 MW, including 119.3 MW WHRS and 171.4 MW captive solar and wind
Grey cement capacity: 32.26 MTPA including 0.42 MTPA in subsidiary
Q4 FY2026 rail share: 8%
FY2026 standalone EPS: Rs 133.7 vs Rs 110.1 in FY2025
FY2026 standalone PAT: Rs 1,033 cr vs Rs 851 cr in FY2025, up 21%
FY2027 capex guidance: Rs 3,500-4,000 cr
FY2028 capex guidance: Rs 1,500-2,000 cr for commitments as of the call date
FY2026 consolidated EPS: Rs 128.44 vs Rs 111.44 in FY2025
FY2026 consolidated PAT: Rs 987.99 cr vs Rs 872.17 cr in FY2025
FY2026 paint EBITDA loss: More than Rs 40 cr
FY2026 standalone EBITDA: Rs 2,318 cr vs Rs 1,968 cr in FY2025
Q4 FY2026 standalone EPS: Rs 44.5
Q4 FY2026 standalone PAT: Rs 345 cr vs Rs 181 cr in Q3 FY2026 and Rs 412 cr in Q4 FY2025
Consolidated total equity: Rs 7,090.31 cr at March 31, 2026
FY2026 consolidated EBITDA: Rs 2,374 cr vs Rs 2,027 cr in FY2025
Net cash at March 31, 2026: Rs 1,765 cr, as stated by management on the call
Net debt at March 31, 2026: Rs 3,370 cr, as stated by management on the call
Q4 FY2026 consolidated EPS: Rs 43.08 vs Rs 46.64 in Q4 FY2025
Q4 FY2026 consolidated PAT: Rs 330.88 cr vs Rs 361.33 cr in Q4 FY2025
Q4 FY2026 grey realization: Rs 4,841 per tonne vs Rs 4,724 per tonne in Q3 FY2026
Q4 FY2026 premium products: 18% of trade sales
FY2026 standalone net sales: Rs 12,568 cr, up 16% YoY
FY2027 expected cost saving: About Rs 50 per tonne from green power and AFR initiatives
Q4 FY2026 incentive accrual: About Rs 29 cr
Q4 FY2026 standalone EBITDA: Rs 670 cr vs Rs 536 cr in Q3 FY2026 and Rs 736 cr in Q4 FY2025
FY2027 incentive expectation: About Rs 250-260 cr
Gross debt at March 31, 2026: Rs 5,136 cr, as stated by management on the call
Q4 FY2026 blended cement mix: 65% of grey cement mix
FY2026 consolidated net sales: Rs 13,391 cr, up 17% YoY
FY2027 paint revenue guidance: Rs 500-550 cr with full-year EBITDA breakeven or positive EBITDA
Q4 FY2026 consolidated EBITDA: Rs 683 cr vs Rs 558 cr in Q3 FY2026 and Rs 765 cr in Q4 FY2025
Itauri-Jharkua Limestone Block: LOI for 349.709 hectares in Panna district, Madhya Pradesh
J.K. Cement Saifco acquisition: 60% equity interest acquired on June 6, 2025 for Rs 149.79 cr
Q4 FY2026 standalone net sales: Rs 3,614 cr, up 15% QoQ and 11% YoY
Consolidated current borrowings: Rs 1,411.84 cr at March 31, 2026
FY2026 standalone EBITDA margin: 18.5% vs 18.2% in FY2025
Consolidated operating cash flow: Rs 1,872.99 cr in FY2026
FY2026 standalone grey net sales: Rs 10,125 cr, up 18% YoY
Q4 FY2026 consolidated net sales: Rs 3,826 cr, up 14% QoQ and 11% YoY
Q4 FY2026 standalone grey volume: 61.5 lakh tonnes vs 53.5 lakh tonnes in Q3 FY2026 and 54.6 lakh tonnes in Q4 FY2025
Coal-based captive power capacity: 50.0 MW
FY2026 consolidated EBITDA margin: 17.7% vs 17.6% in FY2025
FY2026 standalone white net sales: Rs 2,125 cr, up 6% YoY
Nathdwara wall-putty project cost: About Rs 195 cr with Rs 100 cr spent up to March 2026
Punjab grinding-unit project cost: About Rs 610 cr with Rs 83 cr spent up to March 2026
Q4 FY2026 clinker-to-cement ratio: 67%
Bikaner grinding-unit project cost: About Rs 565 cr with Rs 89 cr spent up to March 2026
FY2026 consolidated grey net sales: Rs 10,175 cr, up 18% YoY
Q4 FY2026 standalone EBITDA margin: 18.5% vs 17.1% in Q3 FY2026 and 22.5% in Q4 FY2025
Consolidated non-current borrowings: Rs 4,661.79 cr at March 31, 2026
FY2026 consolidated white net sales: Rs 3,216 cr, up 11% YoY
Q4 FY2026 standalone grey net sales: Rs 2,965 cr, up 18% QoQ and 11% YoY
Net debt to EBITDA at March 31, 2026: 1.45x, as stated by management on the call
Net debt to equity at March 31, 2026: 0.48x, as stated by management on the call
Q4 FY2026 consolidated EBITDA margin: 17.8% vs 16.5% in Q3 FY2026 and 22.1% in Q4 FY2025
Q4 FY2026 standalone white net sales: Rs 572 cr, up 7% QoQ and 8% YoY
White cement and wall putty capacity: 3.05 MTPA including 0.60 MTPA in subsidiary
Q4 FY2026 consolidated grey net sales: Rs 2,980 cr, up 18% QoQ and 11% YoY
Q4 FY2026 standalone EBITDA per tonne: Rs 1,012 vs Rs 927 in Q3 FY2026 and Rs 1,251 in Q4 FY2025
Dommarnandyala Block-3 Limestone Block: LOI for 1,188 hectares in YSR Kadapa district, Andhra Pradesh
Jaisalmer integrated-unit project cost: About Rs 3,630 cr with Rs 742 cr spent up to March 2026
Q4 FY2026 consolidated white net sales: Rs 846 cr, down 1% QoQ and up 7% YoY
Incentive outstanding at March 31, 2026: Close to Rs 300 cr
Standalone Labour Code exceptional item: Rs 46.00 cr in FY2026
Consolidated Labour Code exceptional item: Rs 47.80 cr in FY2026
FY2026 standalone revenue from operations: Rs 12,945.34 cr vs Rs 11,187.20 cr in FY2025
FY2026 white cement and wall putty volume: 24.0 lakh tonnes vs 22.2 lakh tonnes in FY2025
Q4 FY2026 grey cement capacity utilization: 82% cement and 93% clinker
FY2026 consolidated revenue from operations: Rs 13,722.30 cr vs Rs 11,879.15 cr in FY2025
Q4 FY2026 standalone revenue from operations: Rs 3,683.93 cr vs Rs 3,378.32 cr in Q4 FY2025
Q4 FY2026 white cement and wall putty volume: 6.5 lakh tonnes vs 6.5 lakh tonnes in Q3 FY2026 and 6.0 lakh tonnes in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 3,887.50 cr vs Rs 3,581.18 cr in Q4 FY2025
FY2026 purchase of property, plant, equipment and intangible assets: Rs 2,266.45 cr consolidated

Financial highlights

FY2026 AUM: Rs 59,908 cr as of March 31, 2026 vs Rs 51,476 cr as of March 31, 2025, up 16.4%
FY2026 ROA: 3.03% vs 2.85% in FY2025
FY2026 ROE: 17.49% vs 16.30% in FY2025
FY2026 net NPA: 1.27% vs 1.38% at March 31, 2025
FY2026 gross NPA: 2.14% vs 2.17% at March 31, 2025
FY2026 final dividend: Rs 24 per share, or 240% of face value
FY2026 standalone PAT: Rs 1,834 cr vs Rs 1,543 cr in FY2025, up 19%
FY2026 total dividend: Rs 40 per share, or 400% of face value, as highlighted in the performance deck
FY2026 capital adequacy: 19.1% including Tier I of 17.2% vs 20.4% including Tier I of 17.4% at March 31, 2025
FY2026 consolidated PAT: Rs 2,059 cr vs Rs 1,879 cr in FY2025, up 10%, after Rs 76 cr exceptional Labour Code impact
FY2026 exceptional item: Rs 75 cr for incremental impact of the new Labour Codes
Q4 FY2026 standalone PAT: Rs 608 cr, up 11% YoY
FY2026 Royal Sundaram PAT: Rs 107 cr vs Rs 133 cr in FY2025
FY2026 net stage 3 assets: 0.69% at March 31, 2026 vs 0.75% at March 31, 2025
FY2026 net interest income: Rs 3,376 cr vs Rs 2,793 cr in FY2025, up 21%
FY2026 LSCV industry growth: 14.9% YoY, according to the FY2026 performance deck
FY2026 asset-management AUM: Rs 77,457 cr vs Rs 71,826 cr at March 31, 2025
FY2026 cost-to-income ratio: 28.71% vs 30.80% in FY2025
FY2026 gross stage 3 assets: 1.44% with 53% provision cover vs 1.44% with 49% provision cover at March 31, 2025
FY2026 profit from operations: Rs 2,151 cr vs Rs 1,825 cr in FY2025, up 18%
Q4 FY2026 net interest income: Rs 901 cr, up 20% YoY
FY2026 asset-management profit: Rs 174 cr vs Rs 154 cr in FY2025
FY2026 tractor industry growth: 29.3% YoY, according to the FY2026 performance deck
FY2026 standalone disbursements: Rs 32,321 cr vs Rs 28,405 cr in FY2025, up 14%
FY2026 MHICV TIV industry growth: 14.5% YoY, according to the FY2026 performance deck
FY2026 Sundaram Home Finance AUM: Rs 19,909 cr vs Rs 17,428 cr in FY2025, based on the performance deck
FY2026 Sundaram Home Finance PAT: Rs 282 cr vs Rs 245 cr in FY2025
Q4 FY2026 profit from operations: Rs 622 cr, up 14% YoY
Q4 FY2026 standalone disbursements: Rs 8,051 cr vs Rs 6,873 cr in Q4 FY2025, up 17%
FY2026 Sundaram Home Finance net NPA: 0.59% vs 0.77% at March 31, 2025
FY2026 passenger-car industry growth: Approximately 11% YoY, according to the FY2026 performance deck
FY2026 Sundaram Home Finance gross NPA: 1.21% vs 1.33% at March 31, 2025
FY2026 Sundaram Home Finance net stage 3: 0.51% vs 0.53% at March 31, 2025
FY2026 Sundaram Home Finance disbursements: Rs 6,805 cr vs Rs 6,517 cr in FY2025, up 4%
FY2026 Sundaram Home Finance gross stage 3: 1.11% vs 1.02% at March 31, 2025
FY2026 Royal Sundaram gross written premium: Rs 4,638 cr vs Rs 4,065 cr in FY2025, up 14%
FY2026 ROA and ROE including Labour Code impact: 2.94% ROA and 17.00% ROE
FY2026 consolidated AUM across lending and general insurance: Rs 89,541 cr vs Rs 78,145 cr at March 31, 2025, up 15%
FY2026 construction-equipment/backhoe-loader industry growth: Backhoe loaders declined 7% YoY, according to the FY2026 performance deck

Financial highlights

Net cash: Rs 2,384 cr at March 2026 versus Rs 1,943 cr at March 2025
Net worth: Rs 9,464 cr at March 2026 versus Rs 6,106 cr at March 2025
Borrowings: Rs 264 cr at March 2026 versus Rs 283 cr at March 2025
FY2026 PAT: Rs 3,163 cr in the investor presentation, including Rs 742 cr deferred tax asset recognition
FY2026 PBT: Rs 2,422 cr versus Rs 1,447 cr in FY2025, up 67% YoY
Order book: About 5.9 GW at March 2026; presentation mix based on 5,892 MW including post-March orders
Inventories: Rs 4,512 cr at March 2026 versus Rs 3,234 cr at March 2025
FY2026 EBITDA: Rs 3,022 cr versus Rs 1,857 cr in FY2025, up 63% YoY; EBITDA margin 18.1%
Q4 FY2026 PAT: Rs 1,114 cr, including deferred-tax-asset related tax credit; management said roughly Rs 281 cr should be adjusted for Q4 PAT
Q4 FY2026 PBT: Rs 833 cr versus Rs 551 cr in Q4 FY2025, up 51% YoY
Sunsure order: 195 MW repeat order; 65 S144 WTGs of 3.0 MW each in Karnataka
Q4 FY2026 EBITDA: Rs 964 cr versus Rs 693 cr in Q4 FY2025, up 39% YoY; EBITDA margin 17.6%
S144 order intake: Close to 9 GW cumulative orders
Trade receivables: Rs 6,487 cr at March 2026 versus Rs 3,866 cr at March 2025
FY2026 net revenue: Rs 16,679 cr versus Rs 10,851 cr in FY2025, up 54% YoY
WTG FY2026 revenue: Rs 14,040 cr, up about 65-66% YoY
FY2026 contribution: Rs 5,378 cr; contribution margin 32.2%
FY2026 net deliveries: 2,456 MW versus 1,550 MW in FY2025, up 58% YoY
Q4 FY2026 net revenue: Rs 5,468 cr versus Rs 3,774 cr in Q4 FY2025, up 45% YoY
DevCo capital deployed: About Rs 300-350 cr as of the Q4 FY2026 call
Q4 FY2026 contribution: Rs 1,623 cr; contribution margin 29.7%
SE Forge FY2026 EBITDA: Rs 119 cr, up 61% YoY; 19.9% EBITDA margin
EPC share of order book: 28% at year end versus about 20% in Q2 FY2026; management target 50% by FY2028
OMS India FY2026 EBITDA: Rs 839 cr; 40.5% EBITDA margin
SE Forge FY2026 revenue: Rs 597 cr, up 22% YoY
OMS India FY2026 revenue: Rs 2,073 cr
Q4 FY2026 net deliveries: 830 MW versus 573 MW in Q4 FY2025
Cash and cash equivalents: Rs 2,648 cr at March 2026 versus Rs 2,227 cr at March 2025
Suzlon 2.0 FY2031 ambition: 10 GW annual RE sales, 15 GW order book, 70 GW AUM, about 40% India wind market share and 3 GW export order intake
FY2027-FY2030 capex guidepost: About Rs 600 cr plus or minus Rs 50 cr per year
WTG FY2026 contribution margin: 24.5%
Unrecognized deferred tax assets: Rough estimate of Rs 3,000-3,500 cr

Financial highlights

CGD target: About 500 CNG stations and 1.4 million PNG domestic connections by 2030-2035
Renewables: 188 MW existing solar and wind assets and about 2 GW renewable pipeline via JVs
CGD footprint: 81 CNG stations and 73.3K PNG connections in FY2026
Mozambique LNG: Two 6.5 MMTPA trains, total 13 MMTPA, expected end-2028 or early-2029 after force majeure lifted in November 2025
NRL FY2026 GRM: $13.43/bbl excluding excise duty benefit
NRL FY2026 PAT: Rs 3,065 cr, up 90% YoY
FY2026 dividend: Rs 11.5/share, 115% on face value of Rs 10/share
NRL debt tie-up: About Rs 28,000 cr, with about Rs 18,000 cr drawn and peak debt expected around Rs 28,000 cr
Operated blocks: 63 operated blocks across about 93,061 sq km
FY2026 workovers: 307 well workovers, highest ever
NRL FY2026 capex: Rs 8,317 cr, including Rs 6,855 cr for refinery expansion
Offshore acreage: About 51,000 sq km across shallow, deep and ultra-deep offshore blocks
NRL product sales: 3,200 TMT in FY2026, highest ever
CBG capex approval: Rs 3,750 cr approved for 25 greenfield CBG plants
NRL FY2026 revenue: Rs 26,658 cr, up 5% YoY
NRL green hydrogen: 2.4 KTPA plant by year-end at about Rs 138 cr capex; 10 KTPA BOO arrangement at discovered Rs 279/kg
2G bioethanol plant: 49 KTPA bamboo-based plant inaugurated September 14, 2025
Domestic 2P reserves: 231 MMTOE total 2P reserves in FY2026, with 31-year domestic 2P reserve life
FY2026 wells drilled: 74 wells, including 22 exploratory wells and 52 development wells
NRL crude processing: 3,113 TMT in FY2026, highest ever
NRL distillate yield: 87.25% in FY2026, highest ever
Standalone capex mix: More than 60% directed toward exploratory/development drilling and reserve/production accretion; 25% toward capital projects and production facilities; 13% toward strategic investments
FY2026 gas production: About 3.15 BCM according to management commentary
FY2026 oil production: About 3.45 MMT according to management commentary; presentation chart shows 3.45/3.46 MMT range
FY2026 standalone EPS: Rs 27.39/share
FY2026 standalone PAT: Rs 4,455 cr
Market capitalization: About Rs 82,000 cr as of May 20, 2026, up about 32% from April 1, 2025
New energy commitment: More than Rs 20,000 cr planned till 2040 across renewables, CBG, green hydrogen and biofuels
FY2026 standalone ROCE: 10.1%
NRL expansion capacity: 3 MMTPA to 9 MMTPA
FY2026 consolidated PAT: Rs 7,551 cr, up 7% YoY
FY2026 standalone capex: Rs 13,025 cr
International portfolio: Six assets across five countries with $3.4 billion committed investment
FY2026 consolidated ROCE: 9.0%
FY2026 standalone EBITDA: Rs 8,753 cr
NRL capacity utilization: 103.75% in FY2026
Domestic 2P reserve split: About 69 MMT 2P crude oil reserves and 121 MMTOE 2P natural gas reserves in domestic portfolio
FY2026 consolidated EBITDA: Rs 13,498 cr, up 5% YoY
FY2026 standalone net worth: Rs 42,128 cr
NRL expansion and PPU capex: About Rs 46,000 cr combined capex, including about Rs 7,200 cr for polypropylene unit
Duliajan feeder line to IGGL: 3.5 MMSCMD capacity, expected completion by FY2028
FY2026 crude oil realization: $69.04/bbl versus $78.09/bbl in FY2025
NRL operational availability: 99.13% in FY2026
FY2026 consolidated net worth: Rs 53,716 cr
FY2026 standalone debt-equity: 0.27x
Stratigraphic well initiative: Rs 3,200 cr Government corpus for four wells to be undertaken by Oil India and ONGC
FY2026 standalone total income: Rs 24,039 cr
Highest daily crude production: 10,566 MT/day, or 81,354 barrels/day, highest in the last decade
NRL FY2026 excise duty benefit: About Rs 3,000 cr according to management Q&A
Deep-water well cost indication: About Rs 1,200 cr per well; four-plus-four well model discussed
FY2026 consolidated debt-equity: 0.56x
Mozambique committed investment: About $1.8 billion already committed, with additional cost escalation impact up to about $300 million
Duliajan-Numaligarh gas pipeline: Expanded from 1.2 MMSCMD to 2.5 MMSCMD; mechanical completion achieved
FY2026 consolidated total income: Rs 38,981 cr, up 3% YoY
Paradip-Numaligarh crude pipeline: 9 MMTPA pipeline, 92% physical completion and 99% RoU opened at April 30, 2026; mechanical completion expected by October 2026
FY2026 standalone operating margin: 17.3%
Russian assets cumulative dividend: About $997 million through FY2026 from Taas and Vankor
Shallow-water well cost indication: About Rs 800 cr per well
FY2026 standalone net profit margin: 20.9%
FY2026 consolidated operating margin: 20.9%
FY2026 standalone net debt to EBITDA: 1.5x
Numaligarh-Siliguri product pipeline: Expanded from 1.72 MMTPA to 5.5 MMTPA; mechanical completion October 12, 2025; Rs 750 cr actual project cost versus Rs 860 cr approved outlay
Domestic 2P reserve replacement ratio: Above 1; presentation gives 1.02x for FY2026
FY2026 consolidated net profit margin: 20.4%
FY2026 combined oil and gas production: 6.64 MMTOE
FY2026 consolidated net debt to EBITDA: 2.6x
Dividend distribution over last five years: Rs 9,028 cr
Total acreage including non-operated blocks: About 1,06,481 sq km
Additional gas offtake with new well gas premium: Incremental 1.5 MMSCMD offtake to NRL allocated 20% new-well-gas premium
FY2026 production loss from blockade/disruptions: About 0.33 MMTOE, including 0.10 MMTOE crude and 0.23 MMTOE gas equivalent
FY2026 consolidated contribution to exchequer over last five years: Rs 50,687 cr, including Rs 31,168 cr to central exchequer and Rs 19,519 cr to state exchequer

Financial highlights

Current NSE ISIN: INE292B01021
Board result date: May 23, 2026
Standalone FY2026 PAT: Rs 796.79 crore versus Rs 267.50 crore in FY2025
Standalone inventories: Rs 550.74 crore at March 31, 2026 versus Rs 520.59 crore at March 31, 2025
Standalone total assets: Rs 2,877.59 crore at March 31, 2026 versus Rs 1,937.42 crore at March 31, 2025
Consolidated diluted EPS: Rs 2.32 in Q4 FY2026 and Rs 29.39 in FY2026
Consolidated inventories: Rs 562.08 crore at March 31, 2026 versus Rs 533.57 crore at March 31, 2025
Standalone Q4 FY2026 PAT: Rs 57.17 crore versus Rs 51.27 crore in Q4 FY2025
Current NSE active symbol: HBLENGINE
Standalone trade receivables: Rs 656.56 crore at March 31, 2026 versus Rs 386.03 crore at March 31, 2025
Standalone current borrowings: Rs 35.72 crore at March 31, 2026 versus Rs 45.44 crore at March 31, 2025
Consolidated exceptional items: Rs 31.25 crore, including Rs 26.49 crore unrecoverable costs for high-performance batteries for torpedoes
Consolidated trade receivables: Rs 663.79 crore at March 31, 2026
Standalone FY2026 total income: Rs 3,310.19 crore versus Rs 1,972.92 crore in FY2025
Consolidated current borrowings: Rs 39.95 crore at March 31, 2026 versus Rs 48.85 crore at March 31, 2025
Patiala Loco Works KAVACH order: Rs 83.81 crore inclusive of 18% GST; completion on or before April 15, 2027
Consolidated shareholders' funds: Rs 2,214.24 crore at March 31, 2026 versus Rs 1,482.75 crore at March 31, 2025
Consolidated FY2026 PAT after tax: Rs 798.10 crore versus Rs 262.57 crore in FY2025
Recommended FY2026 final dividend: Re 1 per share
Shareholder information note date: May 24, 2026
Standalone Q4 FY2026 total income: Rs 609.59 crore versus Rs 467.21 crore in Q4 FY2025
Consolidated Q4 FY2026 PAT after tax: Rs 52.03 crore versus Rs 52.32 crore in Q4 FY2025
Standalone cash and cash equivalents: Rs 515.12 crore at March 31, 2026 versus Rs 112.96 crore at March 31, 2025
Consolidated New Labour Codes expense: Rs 25.49 crore recognized under other expenses
Standalone FY2026 Electronics revenue: Rs 1,626.25 crore
Standalone FY2026 operating cash flow: Rs 712.87 crore versus Rs 235.00 crore in FY2025
Consolidated cash and cash equivalents: Rs 528.21 crore at March 31, 2026 versus Rs 116.95 crore at March 31, 2025
Consolidated FY2026 Electronics revenue: Rs 1,626.25 crore versus Rs 282.15 crore in FY2025
Consolidated FY2026 operating cash flow: Rs 738.44 crore versus Rs 246.72 crore in FY2025
Interim dividend declared February 7 2026: Rs 2 per share
Chittaranjan Locomotive Works KAVACH order: Rs 1,714 crore excluding 18% GST; completion within 12 months
Standalone FY2026 Electronics segment result: Rs 818.49 crore
Standalone FY2026 PBT after exceptional items: Rs 1,067.99 crore versus Rs 361.66 crore in FY2025
Consolidated FY2026 Electronics segment result: Rs 818.49 crore versus Rs 25.96 crore in FY2025
Standalone FY2026 Industrial Batteries revenue: Rs 1,375.57 crore
Standalone FY2026 sales/income from operations: Rs 3,251.80 crore versus Rs 1,946.13 crore in FY2025
Consolidated FY2026 PBT after exceptional items: Rs 1,075.41 crore versus Rs 359.94 crore in FY2025
Consolidated FY2026 Industrial Batteries revenue: Rs 1,416.22 crore versus Rs 1,412.84 crore in FY2025
Consolidated FY2026 sales/income from operations: Rs 3,302.83 crore versus Rs 1,967.20 crore in FY2025
Standalone Q4 FY2026 PBT after exceptional items: Rs 68.35 crore versus Rs 70.57 crore in Q4 FY2025
Consolidated Q4 FY2026 Electronics segment result: Rs 25.92 crore versus negative Rs 10.85 crore in Q4 FY2025
Standalone Q4 FY2026 sales/income from operations: Rs 597.31 crore versus Rs 459.76 crore in Q4 FY2025
Consolidated Q4 FY2026 PBT after exceptional items: Rs 67.45 crore versus Rs 70.63 crore in Q4 FY2025
Consolidated Q4 FY2026 sales/income from operations: Rs 604.12 crore versus Rs 475.58 crore in Q4 FY2025
Legacy queue symbol absent from current NSE EQ list: HBLPOWER
Standalone FY2026 Industrial Batteries segment result: Rs 333.26 crore
Consolidated FY2026 Industrial Batteries segment result: Rs 341.16 crore versus Rs 323.10 crore in FY2025
Standalone FY2026 Defence and Aviation Batteries revenue: Rs 211.58 crore
Consolidated FY2026 Defence and Aviation Batteries revenue: Rs 211.58 crore versus Rs 227.22 crore in FY2025
Consolidated Q4 FY2026 Industrial Batteries segment result: Rs 60.82 crore versus Rs 88.63 crore in Q4 FY2025
Standalone FY2026 Defence and Aviation Batteries segment result: Rs 57.61 crore
Consolidated FY2026 Defence and Aviation Batteries segment result: Rs 57.61 crore versus Rs 84.92 crore in FY2025
Consolidated FY2026 net profit after associates/minority interest: Rs 814.89 crore versus Rs 276.92 crore in FY2025
Consolidated Q4 FY2026 Defence and Aviation Batteries segment result: Rs 17.85 crore versus Rs 12.67 crore in Q4 FY2025
Consolidated Q4 FY2026 net profit after associates/minority interest: Rs 63.75 crore versus Rs 44.95 crore in Q4 FY2025

Financial highlights

ROE: 14.9% excluding MAT credit
ROCE: 23.5% excluding MAT credit
Net cash: Rs 295.7 crore at March 31, 2026
Call date: May 22, 2026
Retention: Approximately 38%
FY2026 EBITDA: Rs 399.5 crore, up 25.9% YoY
Meals donated: More than 112 million since inception; about 56,000 meals every school day
ICRA ESG score: 74, categorized as Strong
FY2026 dividend: Rs 6.00 per share including Rs 1.50 final dividend and Rs 4.50 interim dividends
FY2026 basic EPS: Rs 15.97
Q4 FY2026 EBITDA: Rs 95.9 crore in press release; Rs 96.3 crore in transcript, up 36.0% YoY
Digital mix target: 50% toward the end of FY2027 per management
Lab-grown diamonds: 11% of retail revenue at around USD 250 average selling price
TV household reach: Approximately 127 million households globally in Q4 FY2026
Digital revenue mix: 45% in Q4 FY2026 and 44% in FY2026
FY2026 reported PAT: Rs 266.13 crore including MAT credit
Labour Codes impact: Rs 1.71 crore incremental gratuity provision
Q4 FY2026 basic EPS: Rs 5.47
FY2026 EBITDA margin: 10.8%, up 140 bps YoY
Unique customer base: 681,000 / 6.8 lakh trailing-12-month customers
FY2026 free cash flow: Rs 272 crore
RSU grant May 20 2026: 348,748 RSUs convertible into 348,748 equity shares at Rs 2 exercise price
ESOP grant May 20 2026: 907,502 ESOPs convertible into 907,502 equity shares at Rs 2 exercise price
FY2026 dividend payout: About Rs 100 crore and around 37% of free cash flow
Germany FY2026 revenue: Euro 26.8 million in investor presentation
Q4 FY2026 gross margin: 63.9%, up 178 bps YoY and 92 bps QoQ
Q4 FY2026 reported PAT: Rs 91.14 crore including MAT credit
Transcript filing date: May 28, 2026
Q4 FY2026 EBITDA margin: 10.3%
FY2026 profit before tax: Rs 281.85 crore
Local-currency Q4 growth: U.S. +1%, U.K. -1%, Germany +7%; total +3% YoY in U.S. dollar terms per transcript
U.S. import tariffs paid: USD 4.59 million / Rs 43.39 crore treated as contingent assets after refund claims
Consolidated total assets: Rs 2,547.25 crore at March 31, 2026
Consolidated total equity: Rs 1,647.93 crore at March 31, 2026
MAT credit asset assessed: Rs 66.91 crore
FY2026 U.K. segment EBITDA: Rs 77 crore, up 28% YoY
FY2026 U.S. segment EBITDA: Rs 194 crore, up 9% YoY
FY2026 operating cash flow: Rs 305 crore per management; audited consolidated cash flow shows Rs 310.22 crore net cash generated from operating activities
Final dividend record date: June 26, 2026
Q4 FY2026 exceptional item: Net gain of Rs 0.18 crore / Rs 17.53 lakh
Average pieces per customer: 23 pieces on a trailing-12-month basis
Encase Packaging impairment: Rs 4.50 crore expected credit loss on secured loan
FY2026 U.K. segment revenue: Rs 1,032 crore, up 11% YoY
FY2026 U.S. segment revenue: Rs 2,058 crore, up 8% YoY
In-house brand contribution: About 53% of gross B2C sales in Q4 FY2026 and about 50% for FY2026
Lifestyle product sales mix: Approximately 35% of total sales; medium-term target 50%
Q4 FY2026 profit before tax: Rs 63.91 crore
FY2026 Europe segment EBITDA: Rs 7 crore versus negative Rs 11 crore in FY2025
FY2026 Europe segment revenue: Rs 404 crore, up 7% YoY
Ideal World Q4 FY2026 revenue: GBP 5.8 million
Q4 FY2026 U.K. segment EBITDA: Rs 11 crore, up 116% YoY
Q4 FY2026 U.S. segment EBITDA: Rs 51 crore, up 13% YoY
Consolidated total liabilities: Rs 899.32 crore at March 31, 2026
Germany Q4 FY2026 gross margin: Approximately 69.3%
Q4 FY2026 U.K. segment revenue: Rs 252 crore, up 13% YoY in presentation segment table
Q4 FY2026 U.S. segment revenue: Rs 526 crore, up 8% YoY in presentation segment table
Consolidated current borrowings: Rs 112.23 crore at March 31, 2026
FY2026 PAT excluding MAT credit: Rs 219.4 crore, up 43.4% YoY
Germany Q4 FY2026 EBITDA margin: 3.0%
Mindful Souls Q4 FY2026 revenue: Approximately USD 4 million
Q4 FY2026 Europe segment EBITDA: Rs 5 crore, up 130% YoY
FY2026 consolidated total income: Rs 3,733.06 crore
May 29 2026 ESOP trust allotment: 193,033 shares; paid-up capital became Rs 33,45,21,362 / 16,72,60,681 shares
Q4 FY2026 Europe segment revenue: Rs 106 crore, up 13% YoY in presentation segment table
June 16 2026 ESOP trust allotment: 91,491 shares; paid-up capital became Rs 33,47,04,344 / 16,73,52,172 shares
Mindful Souls goodwill impairment: Rs 25.02 crore
Q4 FY2026 PAT excluding MAT credit: Rs 44.4 crore, up 30.4% YoY
Germany Q4 FY2026 digital sales mix: Approximately 28%
Q4 FY2026 consolidated total income: Rs 947.25 crore
Exceptional Shop LC ERC grant income: USD 2.76 million grant plus USD 0.58 million interest, total Rs 29.69 crore
Credit ratings listed in presentation: Long-term ICRA A+/Stable Outlook and CARE A+/Stable; short-term ICRA A1+ and CARE A1
Consolidated cash and cash equivalents: Rs 333.54 crore at March 31, 2026
Incremental MAT credit deferred tax asset: Rs 46.71 crore
FY2026 consolidated revenue from operations: Rs 3,691.79 crore, up 9.2% YoY
FY2026 manufacturing/sourcing/service EBITDA: Rs 121 crore, up 33% YoY
FY2026 manufacturing/sourcing/service revenue: Rs 198 crore, up 19% YoY
FY2026 profit before exceptional items and tax: Rs 281.68 crore
Q4 FY2026 consolidated revenue from operations: Rs 934.71 crore in audited results; press release rounded to Rs 934.7 crore, up 10.0% YoY
Q4 FY2026 manufacturing/sourcing/service EBITDA: Rs 29 crore, up 58% YoY
Q4 FY2026 manufacturing/sourcing/service revenue: Rs 50 crore, up 16% YoY
Q4 FY2026 profit before exceptional items and tax: Rs 63.74 crore

Financial highlights

FY2026 PAT: Rs 107 cr.
FY2026 RoCE: 11.5%.
FY2026 EBITDA: Rs 438 cr.
Q4 FY2026 PAT: Rs 40 cr.
FY2026 EBO count: 8 exclusive brand outlets.
FY2026 MBO count: 215 multi-brand outlets.
FY2026 bill cuts: 2.974 million.
Q4 FY2026 EBITDA: Rs 129 cr.
FY2026 PAT margin: 1.5% per investor presentation.
FY2026 POPL stores: 14.
FY2026 retail area: 1.94 million square feet.
FY2026 store count: 223 retail stores.
Mature-store count: 83 stores older than four years.
FY2026 gross profit: Rs 1,037 cr.
FY2026 owned stores: 20.
NCR store footprint: 34 MBOs and 1 EBO across 5 cities.
Q4 FY2026 bill cuts: 785,000.
FY2026 EBITDA margin: 6.1%.
FY2026 leased stores: 189.
Q4 FY2026 PAT growth: Up 49% year on year.
Q4 FY2026 PAT margin: 2.1% per investor presentation.
FY2026 Delhi NCR SSSG: 22.8%.
FY2026 city footprint: 95 cities.
FY2026 revenue growth: Up 7% year on year.
FY2026 bill-cut growth: Up 10.4%.
FY2026 state footprint: 6 states.
Kerala store footprint: 1 MBO across 1 city.
Non-mature-store count: 140 stores younger than four years.
Q4 FY2026 gross profit: Rs 282 cr.
Q4 FY2026 EBITDA growth: Up 20% year on year.
Q4 FY2026 EBITDA margin: 6.7%.
New Labour Code reversal: Rs 4.09 cr recognized in the current quarter after compensation restructuring.
Q4 FY2026 Delhi NCR SSSG: 18.6%.
Q4 FY2026 revenue growth: Up 15% year on year.
FY2026 average store size: About 10,000 square feet.
FY2026 central warehouses: 14 total: 6 in Telangana, 4 in Andhra Pradesh and 4 in NCR.
FY2026 net store openings: 23.
Q4 FY2026 bill-cut growth: Up 19.5%.
Telangana store footprint: 111 MBOs and 7 EBOs across 40 cities.
FY2026 Andhra Pradesh SSSG: 4.4%.
FY2026 average ticket size: Rs 23,125.
FY2026 gross-profit growth: Up 4% year on year.
FY2026 gross-profit margin: 14.4%.
Mature-store FY2026 EBITDA: Rs 345 cr.
FY2026 Delhi NCR MBO revenue: Rs 585 cr, up 29% year on year.
FY2026 product mix - mobiles: 44%.
Godown fire inventory damage: Rs 8.17 cr inventory value damaged in the May 29, 2025 incident.
Non-mature-store average age: 1.9 years.
Q4 FY2026 net store openings: 4.
IQ retail-store transfer gain: Rs 7.67 cr recognized as an exceptional item.
Q4 FY2026 Andhra Pradesh SSSG: 16.2%.
Q4 FY2026 average ticket size: Rs 23,287.
Q4 FY2026 gross-profit growth: Up 15% year on year.
Q4 FY2026 gross-profit margin: 14.8%.
Andhra Pradesh store footprint: 69 MBOs across 49 cities.
April 2 2026 Kavali store area: 5,400 square feet.
FY2026 revenue from operations: Rs 7,183 cr.
FY2026 same-store sales growth: 5.3%.
Non-mature-store FY2026 EBITDA: Rs 66 cr.
Total equity at March 31, 2026: Rs 1,626 cr per investor presentation.
FY2026 Telangana-Hyderabad SSSG: 4.1%.
May 12 2026 Pallakol store area: 5,200 square feet.
New Labour Code one-time impact: Rs 4.26 cr recognized in December 2025.
Q4 FY2026 Delhi NCR MBO revenue: Rs 148 cr, up 31% year on year.
Q4 FY2026 North cluster revenue: Rs 151 cr, up 31% year on year.
Q4 FY2026 South cluster revenue: Rs 1,677 cr, up 15% year on year.
Q4 FY2026 pre-Ind-AS 116 EBITDA: Rs 91 cr per call transcript.
Q4 FY2026 product mix - mobiles: 45%.
FY2026 Telangana up-country SSSG: 2.7%.
Godown fire insurance settlement: Rs 7.53 cr full and final settlement recognized in the previous quarter.
June 11 2026 Guntakal store area: 7,500 square feet.
June 8 2026 Huzurabad store area: 8,300 square feet.
FY2026 Andhra Pradesh MBO revenue: Rs 1,128 cr, up 9% year on year.
Mature-store FY2026 EBITDA margin: 7.3%.
Q4 FY2026 revenue from operations: Rs 1,913 cr.
Q4 FY2026 same-store sales growth: 12.1% per investor presentation and press release; 12.2% per call transcript.
Q4 FY2026 Telangana-Hyderabad SSSG: 10.2%.
FY2026 top-five brand concentration: 62.0% of sales.
June 22 2026 Kagaz Nagar store area: 7,680 square feet.
Q4 FY2026 Telangana up-country SSSG: 12.7%.
Q4 FY2026 Andhra Pradesh MBO revenue: Rs 330 cr, up 26% year on year.
FY2026 product mix - large appliances: 43%.
Non-mature-store FY2026 EBITDA margin: 3.1%.
FY2026 Telangana-Hyderabad MBO revenue: Rs 4,065 cr, up 5% year on year.
IQ retail-store transfer consideration: Rs 8.00 cr.
Q4 FY2026 pre-Ind-AS 116 EBITDA margin: 4.7% per call transcript.
FY2026 Telangana up-country MBO revenue: Rs 1,014 cr, up 7% year on year.
Mature-store FY2026 retail product sales: Rs 4,744 cr.
Q4 FY2026 product mix - large appliances: 42%.
Q4 FY2026 Telangana-Hyderabad MBO revenue: Rs 1,058 cr, up 12% year on year.
Q4 FY2026 Telangana up-country MBO revenue: Rs 278 cr, up 20% year on year.
Cash and cash equivalents at March 31, 2026: Rs 50 cr per investor presentation.
Non-mature-store FY2026 retail product sales: Rs 2,134 cr.
FY2026 North cluster store-level EBITDA margin: 0.3% on a pre-Ind-AS 116 basis, excluding corporate and warehouse expenses.
FY2026 South cluster store-level EBITDA margin: 6.5% on a pre-Ind-AS 116 basis, excluding corporate and warehouse expenses.
FY2026 pre-Ind-AS 116 cash flow from operations: Rs 299 cr.
FY2026 post-Ind-AS 116 cash flow from operations: Rs 444 cr.
FY2026 product mix - small appliances, IT and others: 13%.
Q4 FY2026 product mix - small appliances, IT and others: 13%.

Financial highlights

Final dividend: Rs 0.30 per equity share of face value Rs 2, equal to 15% of face value.
QIP issue size: Rs 259.12 cr.
IPO net proceeds: Rs 484.38 cr.
FY2026 revenue mix: 75% Essentials and 25% Specialties per investor presentation.
IPO gross proceeds: Rs 500.00 cr.
Essentials FY2026 revenue: Rs 2,026.8 cr, broadly flat year on year.
Presentation FY2026 EBITDA: Rs 171.4 cr, down 39% year on year.
Specialties FY2026 revenue: Rs 779.1 cr, down 18% year on year.
FY2026 exports/domestic mix: 32% exports and 68% domestic revenue.
Essentials Q4 FY2026 revenue: Rs 522.0 cr, up 7% year on year.
QIP revised Dahej allocation: Rs 172.92 cr.
Lote fluorination ramp marker: 40-45% of peak revenues achieved in FY2026 with a good FY2027 opening order book.
Presentation Q4 FY2026 EBITDA: Rs 53.6 cr, down 9% year on year.
Specialties Q4 FY2026 revenue: Rs 213.2 cr, down 3% year on year.
Presentation FY2026 PAT margin: 2.8%, down 100 bps year on year.
Corrected standalone FY2026 PAT: Rs 79.26 cr.
Corrected standalone FY2026 PBT: Rs 92.58 cr.
Ethyl acetate spread commentary: Management said ETAC spreads moved from below USD 100 to about USD 130 in Jan-Feb, about USD 220 in March, about USD 250 in April and about USD 150-160 at the time of the call.
IPO utilization at March 31 2026: Rs 500.00 cr utilized, with no unutilized amount.
Presentation FY2026 gross margin: 32.9%, down 190 bps year on year.
Corrected consolidated FY2026 PAT: Rs 79.36 cr.
Corrected consolidated FY2026 PBT: Rs 87.97 cr.
Presentation FY2026 EBITDA margin: 6.0%, down 330 bps year on year.
Presentation Q4 FY2026 PAT margin: 2.9%, down 10 bps year on year.
Corrected standalone Q4 FY2026 PAT: Rs 22.52 cr.
Corrected standalone Q4 FY2026 PBT: Rs 32.39 cr.
Presentation FY2026 revenue growth: Down 5% year on year on the headline adjusted chart.
Presentation Q4 FY2026 gross margin: 33.6%, down 100 bps year on year.
Corrected consolidated Q4 FY2026 PAT: Rs 21.55 cr.
Corrected consolidated Q4 FY2026 PBT: Rs 32.07 cr.
Presentation Q4 FY2026 EBITDA margin: 7.3%, down 100 bps year on year.
Presentation Q4 FY2026 revenue growth: 4% year on year, mainly driven by higher price realizations.
Top 10 customer revenue concentration: 20% in FY2026 versus 23% in FY2025, 27% in FY2024 and 34% in FY2023.
QIP total utilization at March 31 2026: Rs 248.33 cr utilized, Rs 10.79 cr unutilized.
FY2026 adjusted EBITDA contribution mix: 68% Essentials and 32% Specialties.
Presentation one-time Labour Code impact: Rs 3.8 cr expense.
Consolidated inventories at March 31 2026: Rs 378.0 cr per investor presentation.
Consolidated total assets at March 31 2026: Rs 3,445.8 cr per investor presentation.
Q4 FY2026 adjusted EBITDA contribution mix: 63% Essentials and 37% Specialties.
Consolidated trade payables at March 31 2026: Rs 697.2 cr per investor presentation.
Consolidated trade receivables at March 31 2026: Rs 537.9 cr per investor presentation.
QIP revised Mahape innovation-centre allocation: Rs 25.04 cr.
Consolidated current borrowings at March 31 2026: Rs 210.7 cr per investor presentation.
Consolidated shareholders' funds at March 31 2026: Rs 1,985.9 cr per investor presentation.
Corrected consolidated FY2026 financing cash flow: Rs 247.22 cr.
Corrected consolidated FY2026 investing cash flow: Negative Rs 403.61 cr.
Corrected consolidated FY2026 operating cash flow: Rs 174.90 cr.
Corrected standalone FY2026 revenue from operations: Rs 2,808.53 cr.
Presentation adjusted FY2026 revenue from operations: Rs 2,805.9 cr, excluding Rs 40.7 cr one-time favorable wheeling/transmission settlement.
Corrected consolidated FY2026 revenue from operations: Rs 2,846.67 cr.
Presentation one-time favorable litigation settlement: Rs 40.7 cr wheeling and transmission charges gain included in FY2026 results and excluded from adjusted revenue in the presentation.
Corrected standalone Q4 FY2026 revenue from operations: Rs 723.33 cr.
Consolidated cash and cash equivalents at March 31 2026: Rs 60.1 cr per investor presentation.
Corrected consolidated Q4 FY2026 revenue from operations: Rs 735.31 cr.
Presentation Q4 FY2026 adjusted EBITDA margin sequential improvement: Up 520 bps versus Q3 FY2026.

Financial highlights

FY2026 Elica growth: Revenue 12%; PBT 15%
FY2026 standalone EPS: Rs 19.09
FY2026 standalone PAT: Rs 242.23 cr
Q4 FY2026 Elica growth: Revenue more than 30%; PBT about 48%-50%
FY2026 consolidated EPS: Rs 23.15
FY2026 consolidated PAT: Rs 295.30 cr
FY2026 standalone EBITDA: Rs 396 cr, down 16.7% YoY, 5.3% EBITDA margin
Q4 FY2026 standalone PAT: Rs 66.62 cr
Consolidated total equity: Rs 4,160.64 cr at March 31, 2026
FY2026 consolidated EBITDA: Rs 481 cr, down 12.6% YoY, 6.0% EBITDA margin
Q4 FY2026 consolidated EPS: Rs 6.32
Q4 FY2026 consolidated PAT: Rs 80.50 cr
Q4 FY2026 standalone EBITDA: Rs 100 cr, down 40.9% YoY, 4.9% EBITDA margin
Q4 FY2026 consolidated EBITDA: Rs 121 cr, down 33.7% YoY, 5.6% EBITDA margin
FY2026 consolidated total income: Rs 8,233.39 cr
FY2026 final dividend recommended: Rs 5 per share
FY2026 standalone exceptional item: Net loss of Rs 23.50 cr
Q4 FY2026 consolidated total income: Rs 2,233.84 cr
FY2026 consolidated exceptional item: Net loss of Rs 28.93 cr, reflecting Wage Code provision partly offset by insurance claim
Consolidated cash and cash equivalents: Rs 614.97 cr at March 31, 2026
Q4 FY2026 air-conditioner volume growth: More than 50%; more than 1 lakh units in March 2026
FY2026 standalone revenue from operations: Rs 7,473.80 cr, up 0.7% YoY
FY2026 consolidated net operating cash flow: Rs 297.94 cr
FY2026 consolidated revenue from operations: Rs 8,034.20 cr versus Rs 7,919.37 cr in FY2025
Q4 FY2026 standalone revenue from operations: Rs 2,030.05 cr, up 7.4% YoY
FY2026 standalone PBT before exceptional items: Rs 348.36 cr; presentation rounded to Rs 348 cr, down 16.6% YoY
Q4 FY2026 consolidated revenue from operations: Rs 2,180.77 cr versus Rs 2,004.67 cr in Q4 FY2025
FY2026 consolidated PBT before exceptional items: Rs 425.56 cr; presentation rounded to Rs 426 cr, down 11.9% YoY
Q4 FY2026 standalone PBT before exceptional items: Rs 90.81 cr; presentation rounded to Rs 91 cr, down 36.4% YoY
Q4 FY2026 consolidated PBT before exceptional items: Rs 109.83 cr; presentation rounded to Rs 110 cr, down 29.0% YoY
FY2026 consolidated PAT attributable to equity holders: Rs 293.75 cr
Consolidated bank balances other than cash and cash equivalents: Rs 1,937.78 cr at March 31, 2026

Financial highlights

Exports: 54% of FY2026 income
Dividend: Rs 0.50 per share first interim dividend for FY2027; record date May 23, 2026
Return ratios: Standalone ROE 7.9% and ROCE 10.7% in FY2026
TEXPROCIL award: Gold Trophy for Highest Global Exports at TEXPROCIL Export Awards 2023-24
Standalone net debt: Rs 987.3 cr at March 31, 2026, with net debt/EBITDA 1.05x and net debt/equity 0.21x
FY2026 revenue split: 53% Bed & Bath Linen; 31% Yarn; 16% Paper
Standalone net worth: Rs 4,757.1 cr at March 31, 2026
Consolidated net debt: Rs 975 cr per press release, with net debt/EBITDA 1.02x and net debt/equity 0.22x
Standalone FY2026 EPS: Rs 0.74 versus Rs 0.73 in FY2025
Standalone FY2026 PBT: Rs 518.4 cr, up 10.37% YoY
Standalone gross debt: Rs 1,767.8 cr at March 31, 2026
Q4 FY2026 Textile EBIT: Rs 178.1 cr, up 18.72% YoY
Working-capital ratios: Inventory days 65 and debtor days 13 in FY2026
Consolidated FY2026 EPS: Rs 0.74 versus Rs 0.73 in FY2025
Consolidated FY2026 PBT: Rs 520 cr, up 9.56% YoY
NCD enabling resolution: Up to Rs 500 cr non-convertible debentures by public or private offering in one or more tranches, subject to shareholder approval
Standalone FY2026 EBITDA: Rs 944.5 cr, down 1.73% YoY
Standalone Q4 FY2026 PBT: Rs 147.0 cr, up 146.93% QoQ and down 13.55% YoY
Q4 FY2026 Textile revenue: Rs 1,333.1 cr, down 16.21% YoY
Consolidated FY2026 EBITDA: Rs 951 cr, down 2.03% YoY
Consolidated Q4 FY2026 EPS: Rs 0.20 versus Rs 0.09 in Q3 FY2026 and Rs 0.25 in Q4 FY2025
Consolidated Q4 FY2026 PBT: Rs 146 cr, up 136.99% QoQ and down 14.72% YoY
Standalone Q4 FY2026 EBITDA: Rs 247.6 cr, up 59.02% QoQ and down 5.34% YoY
Standalone FY2026 net profit: Rs 376.1 cr, up 2.52% YoY
Consolidated Q4 FY2026 EBITDA: Rs 248 cr, up 55.97% QoQ and down 5.94% YoY
Q4 FY2026 Textile EBIT margin: 13.36%, up 393 bps YoY
Consolidated FY2026 net profit: Rs 377 cr, up 1.72% YoY
Standalone FY2026 total income: Rs 6,758.1 cr, down 3.80% YoY
Consolidated FY2026 cash profit: Rs 694 cr, down 5.77% YoY
Standalone FY2026 EBITDA margin: 13.98%, up 30 bps YoY
Standalone Q4 FY2026 net profit: Rs 102.0 cr, up 141.46% QoQ and down 22.60% YoY
Consolidated FY2026 total income: Rs 6,775 cr, down 3.86% YoY
Consolidated FY2026 EBITDA margin: 14.04%, up 26 bps YoY
Consolidated Q4 FY2026 PBT margin: 8.87%, up 500 bps QoQ and down 24 bps YoY
Consolidated Q4 FY2026 net profit: Rs 102 cr, up 130.51% QoQ and down 23.56% YoY
Q4 FY2026 Paper and Chemical EBIT: Rs 56.2 cr, down 6.01% YoY
Standalone Q4 FY2026 total income: Rs 1,648.5 cr, up 3.93% QoQ and down 12.20% YoY
Consolidated Q4 FY2026 cash profit: Rs 172 cr, up 47.87% QoQ and down 23.06% YoY
Q4 FY2026 consolidated revenue mix: 50% Bed & Bath Linen; 32% Yarn; 18% Paper
Standalone Q4 FY2026 EBITDA margin: 15.02%, up 520 bps QoQ and 109 bps YoY
Consolidated Q4 FY2026 total income: Rs 1,650 cr, up 3.46% QoQ and down 12.38% YoY
Consolidated Q4 FY2026 EBITDA margin: 15.05%, up 507 bps QoQ and 103 bps YoY
Q4 FY2026 Paper and Chemical revenue: Rs 296.8 cr, up 10.60% YoY
Standalone cash and cash equivalents: Rs 780.5 cr at March 31, 2026
Q4 FY2026 Paper and Chemical EBIT margin: 18.93%, down 335 bps YoY

Financial highlights

AGM: 82nd AGM on August 12, 2026 at 3:00 p.m. through VC/OAVM
ROCE: 16.3% in FY2026 versus 18.5% in FY2025
RONOA: 19.7% in FY2026
FY2026 EPS: Rs 97.1 from continuing and discontinued operations
Inventories: Rs 2,708.91 cr as of March 31, 2026
FY2026 capex: About Rs 200 cr, including about Rs 150 cr on Celasto expansion
Meeting date: May 22, 2026 at 4:00 p.m.
Total assets: Rs 8,435.64 cr as of March 31, 2026
Total equity: Rs 3,957.46 cr as of March 31, 2026
Audit opinion: Unmodified opinions on standalone and consolidated FY2026 financial results
Board meeting: May 19, 2026; audited standalone and consolidated Q4/FY2026 financial results approved
Final dividend: Rs 25 per equity share of face value Rs 10, subject to shareholder approval
Inventory days: 82 days in FY2026 versus 72 in FY2025
Merchandise mix: About 58% of business, per management
Receivable days: 65 days in FY2026; overdue receivables around 8%
Trade receivables: Rs 2,734.46 cr as of March 31, 2026
Operating expenses: 13.7% of revenue in FY2026
FY2026 total profit: Rs 420.10 cr in audited consolidated results
Net working capital: About Rs 600 cr higher than March 2025, driven by higher receivables and lower payables
Operating cash flow: Negative Rs 110 cr in FY2026 versus positive Rs 373 cr in FY2025, per presentation
Dividend record date: July 30, 2026
Free cash flow marker: Around negative Rs 300 cr after about Rs 200 cr of capital investment, per management
Q4 FY2026 total profit: Rs 68.88 cr in audited consolidated results, including discontinued operations
Dividend payment timing: On or after August 17, 2026 if approved at AGM
Maintenance capex marker: About Rs 82-100 cr annually depending on the year
Merchandise gross margin: About 5%-10% at aggregate level, per management
Cash and cash equivalents: Rs 868.90 cr as of March 31, 2026
MCD production line revenue: About Rs 15 cr in FY2025, equal to 0.1% of company revenue
EBIT before exceptional items: 4.0% in FY2026
Trade payables excluding MSME: Rs 3,613.89 cr as of March 31, 2026
Celasto remaining capex marker: About Rs 150-170 cr to bring additional capacity to production
Coatings business FY2026 sales: Rs 595 cr, about 4% of consolidated sales
Owned manufactured products mix: About 42% of business, per management
Assets classified as held for sale: Rs 490.13 cr as of March 31, 2026
Coatings divestiture consideration: Rs 230.16 cr, subject to closing adjustments
FY2026 segment revenue - Chemicals: Rs 1,847 cr, 12% of segment revenue
FY2026 segment revenue - Materials: Rs 4,625 cr, 30% of segment revenue
Agricultural Solutions market share: Around 7% in India, per management
FY2026 continuing-operations profit: Rs 416.23 cr in audited consolidated results
FY2026 discontinued-operations profit: Rs 3.87 cr in audited consolidated results
Mangalore dispersions capacity expansion: About 15% increase in country dispersions capacity; startup targeted by end-2027
Owned manufactured products gross margin: About 25%-30% at aggregate level, per management
FY2026 continuing-operations total income: Rs 15,009.8 cr in audited consolidated results
FY2026 segment revenue - Nutrition and Care: Rs 3,501 cr, 23% of segment revenue
Audited consolidated net operating cash flow: Negative Rs 110.09 cr
FY2026 segment revenue - Industrial Solutions: Rs 2,946 cr, 19% of segment revenue
FY2026 segment revenue - Surface Technologies: Rs 595 cr, 4% of segment revenue, discontinued operations
Agricultural Solutions new-product contribution: 12 products launched in last four years contribute about 25% of Ag top line
FY2026 segment revenue - Agricultural Solutions: Rs 1,944 cr, 12% of segment revenue
Agricultural Solutions demerger share entitlement: 1:1; demerger to be completed during FY2026-27 per presentation
FY2026 continuing-operations revenue from operations: Rs 14,944.0 cr in audited consolidated results
Q4 FY2026 continuing-operations revenue from operations: Rs 3,443.87 cr in audited consolidated results
FY2026 continuing-operations PBT before exceptional items: Rs 561.26 cr in audited consolidated results
Q4 FY2026 continuing-operations PBT before exceptional items: Rs 83.44 cr in audited consolidated results
FY2026 consolidated revenue including discontinued operations: Rs 15,539 cr, up 2% YoY
Audited consolidated operating cash flow before working capital: Rs 690.02 cr
Q4 FY2026 consolidated revenue including discontinued operations: Rs 3,606 cr, up 10% YoY
FY2026 consolidated PBT before exceptional items including discontinued operations: Rs 564 cr, down 9% YoY
Q4 FY2026 consolidated PBT before exceptional items including discontinued operations: Rs 90 cr, up more than 100% YoY

Financial highlights

Dividend: Rs 5 per equity share proposed by the board
FY2026 RoCE: 12% in the presentation
FY2026 capex: Rs 1,668 cr
Webinar date: May 22, 2026
FY2026 EBITDA: Rs 1,326 cr, up 8% YoY
FY2026 revenue: Rs 8,280 cr, up 14% YoY
FY2026 net debt: Rs 1,952 cr at year-end in the presentation
Line 3 pipeline: 10-plus products under tech transfer, about 80% complex biologics
Q4 FY2026 EBITDA: Rs 363 cr, up 2% YoY
API FY2026 EBITDA: Rs 83 cr
Net debt / EBITDA: 1.3x at March 2026 versus 1.1x at March 2025
Q4 FY2026 revenue: Rs 2,290 cr, up 19% YoY
API FY2026 revenue: Rs 564 cr
FY2027 capex guide: Similar to FY2026
FY2026 total income: Rs 8,346 cr, up 14% YoY
FY2026 EBITDA margin: 15.9%, down 99 bps YoY
PET pharmacies capex: USD 22 mn done, USD 50 mn pending
Spokane Line 4 capex: Almost USD 200 mn done, USD 34 mn remaining
FY2026 normalized PAT: Rs 442 cr, up 7% YoY
Montreal Line 5 capex: USD 27 mn done, USD 87 mn pending
Radiopharmacy network: 45 radiopharmacies; PET manufacturing expansion from 3 to 9 sites by FY2028
Spokane FY2026 EBITDA: Rs 463 cr, up 59% YoY; 27% margin
Generics FY2026 EBITDA: Rs 83 cr, up 250% YoY; 11% margin
Q4 FY2026 total income: Rs 2,314 cr, up 19% YoY
Spokane FY2026 revenue: Rs 1,714 cr, up 48% YoY
Drug Discovery FTE plan: 1,000 FTEs in FY2025 to 2,000 in FY2028 and 4,000 in FY2030
Generics FY2026 revenue: Rs 774 cr, up 13% YoY
Q4 FY2026 EBITDA margin: 15.7%, down 272 bps YoY
PET expansion investment: USD 50 mn, expected 1.0x asset turnover and 20%+ RoCE
Q4 FY2026 normalized PAT: Rs 129 cr, down 7% YoY
Generics Q4 FY2026 EBITDA: Rs 32 cr; 15% margin
MIBG potential peak sales: USD 70 mn to USD 100 mn in the presentation
Generics Q4 FY2026 revenue: Rs 214 cr, up 36% YoY
Line 3 peak revenue marker: USD 80 mn to USD 90 mn, expected one-and-a-half to two years earlier than earlier projected
New PET/SPECT pipeline TAM: USD 535 mn incremental TAM and USD 140 mn potential peak annual sales
Vision 2030 revenue target: Rs 13,500 cr
Radiopharmacy FY2026 EBITDA: Rs 36 cr, up 20% YoY
Vision 2030 net debt target: Zero net debt
Drug Discovery FY2026 EBITDA: Rs 151 cr, up 11% YoY
Line 3 FY2027 revenue marker: USD 60 mn to USD 80 mn, predominantly technology-transfer revenue
Radiopharmacy FY2026 revenue: Rs 2,512 cr, up 9% YoY
Drug Discovery FY2026 revenue: Rs 654 cr, up 15% YoY
Ruby-Fill install-base growth: 35% in FY2026 versus 21% in FY2025
US product launches in FY2026: 4 new products
Drug Discovery expansion capex: USD 150 mn with expected RoCE above 20%
Radiopharmacy Q4 FY2026 EBITDA: Rs 11 cr, up 86% YoY
ANDA approvals since April 2024: 11 approvals
Radiopharmacy Q4 FY2026 revenue: Rs 671 cr, up 12% YoY
Vision 2030 EBITDA margin target: 23%-25%
Radiopharmaceuticals FY2026 EBITDA: Rs 480 cr, down 5% YoY; 41% margin
Allergy Immunotherapy FY2026 EBITDA: Rs 278 cr, up 13% YoY; 35% margin
Radiopharmaceuticals FY2026 revenue: Rs 1,178 cr, up 10% YoY
Allergy Immunotherapy FY2026 revenue: Rs 785 cr, up 12% YoY
Radiopharmaceuticals Q4 FY2026 EBITDA: Rs 106 cr, down 22% YoY; 33% margin
Allergy Immunotherapy Q4 FY2026 EBITDA: Rs 90 cr, up 2% YoY; 41% margin
CDMO Sterile Injectables FY2026 EBITDA: Rs 314 cr, up 8% YoY
Radiopharmaceuticals Q4 FY2026 revenue: Rs 319 cr, up 8% YoY
Allergy Immunotherapy Q4 FY2026 revenue: Rs 218 cr, up 13% YoY
CDMO Sterile Injectables FY2026 revenue: Rs 1,755 cr, up 38% YoY

Financial highlights

Net debt: Rs 3,664 cr at March 31, 2026 versus Rs 4,481 cr at March 31, 2025
Cost of debt: 7.29% in FY2026 versus 7.90% in FY2025
FY2026 capex: Rs 997 cr including maintenance capex
FY2026 dividend: Rs 2.50 per equity share of face value Re 1 each
Consolidated PPE: Rs 12,382.63 cr at March 31, 2026
FY2026 sale volume: 18.81 million tonnes including construction chemicals versus 18.50 million tonnes in FY2025
Net debt reduction: Rs 817 cr in FY2026
Net debt to EBITDA: 2.47x in FY2026 versus 3.51x in FY2025
Standalone net worth: Rs 8,142.37 cr at March 31, 2026
FY2027 capex guidance: Rs 800 cr
Standalone FY2026 EPS: Rs 29.33 basic and diluted versus Rs 17.65 in FY2025
Standalone FY2026 PAT: Rs 693.62 cr versus Rs 417.39 cr in FY2025
Standalone FY2026 PBT: Rs 879.23 cr versus Rs 465.74 cr in FY2025
Consolidated net worth: Rs 8,093.88 cr at March 31, 2026
Consolidated FY2026 EPS: Rs 29.56 basic and diluted versus Rs 11.53 in FY2025
Consolidated FY2026 PAT: Rs 698.79 cr versus Rs 269.57 cr in FY2025
Consolidated borrowings: Rs 2,803.89 cr non-current borrowings and Rs 1,193.47 cr current borrowings at March 31, 2026
Standalone Q4 FY2026 EPS: Rs 6.19 basic and diluted
Standalone Q4 FY2026 PAT: Rs 146.39 cr versus Rs 386.91 cr in Q3 FY2026 and Rs 30.99 cr in Q4 FY2025
Standalone Q4 FY2026 PBT: Rs 176.89 cr versus Rs 485.63 cr in Q3 FY2026 and Rs 49.26 cr in Q4 FY2025
Consolidated Q4 FY2026 EPS: Rs 6.38 basic and diluted
Consolidated Q4 FY2026 PAT: Rs 150.72 cr versus Rs 385.63 cr in Q3 FY2026 and Rs 25.65 cr in Q4 FY2025
Standalone FY2026 total income: Rs 9,055.92 cr versus Rs 8,539.10 cr in FY2025
FY2026 EBITDA per press release: Rs 1,482 cr versus Rs 1,276 cr in FY2025, up 16%
FY2026 blended EBITDA per tonne: Rs 788 versus Rs 690 in FY2025
Consolidated FY2026 total income: Rs 9,070.22 cr versus Rs 8,559.57 cr in FY2025
Standalone Q4 FY2026 total income: Rs 2,618.32 cr versus Rs 2,119.10 cr in Q3 FY2026 and Rs 2,404.90 cr in Q4 FY2025
FY2026 cement capacity utilisation: 74% versus 77% in FY2025 after a 2 MTPA capacity increase during February 2026
Consolidated Q4 FY2026 total income: Rs 2,622.08 cr versus Rs 2,122.86 cr in Q3 FY2026 and Rs 2,409.72 cr in Q4 FY2025
Standalone FY2026 exceptional items: Rs 553.22 cr
FY2026 net revenue per press release: Rs 9,056 cr versus Rs 8,539 cr in FY2025, up 6%
Consolidated FY2026 exceptional items: Rs 553.17 cr
Consolidated capital work-in-progress: Rs 921.78 cr at March 31, 2026
Consolidated cash and cash equivalents: Rs 188.32 cr at March 31, 2026
Standalone Q4 FY2026 exceptional items: Rs 74.17 cr
Consolidated Q4 FY2026 exceptional items: Rs 74.17 cr
Standalone FY2026 revenue from operations: Rs 9,012.57 cr versus Rs 8,495.10 cr in FY2025
Consolidated FY2026 revenue from operations: Rs 9,028.76 cr versus Rs 8,518.40 cr in FY2025
Standalone Q4 FY2026 revenue from operations: Rs 2,606.14 cr versus Rs 2,101.46 cr in Q3 FY2026 and Rs 2,391.95 cr in Q4 FY2025
Consolidated Q4 FY2026 revenue from operations: Rs 2,610.32 cr versus Rs 2,105.68 cr in Q3 FY2026 and Rs 2,397.27 cr in Q4 FY2025
Standalone FY2026 PBT before exceptional items: Rs 326.01 cr versus Rs 125.91 cr in FY2025
Consolidated FY2026 PBT before exceptional items: Rs 317.93 cr versus Rs 119.90 cr in FY2025
Standalone Q4 FY2026 PBT before exceptional items: Rs 102.72 cr versus Rs 6.58 cr in Q3 FY2026 and Rs 38.43 cr in Q4 FY2025
Consolidated Q4 FY2026 PBT before exceptional items: Rs 99.16 cr versus Rs 4.07 cr in Q3 FY2026 and Rs 35.32 cr in Q4 FY2025

Financial highlights

FY2026 EPS: Rs 463.66 basic and diluted
FY2026 PAT: Rs 522.32 cr, up 9.7% YoY
Inventories: Rs 822.96 cr at March 31, 2026
Total assets: Rs 3,137.25 cr at March 31, 2026
Total equity: Rs 1,768.15 cr at March 31, 2026
Employee base: Approximately 1,273 employees according to the May 2026 investor presentation
FY2026 EBITDA: Rs 1,035 cr, up 23.2% YoY
Q4 FY2026 EPS: Rs 191.16 basic and diluted
Q4 FY2026 PAT: Rs 215.34 cr versus Rs 71.37 cr in Q4 FY2025
Q4 FY2026 EBITDA: Rs 269 cr, up 12.2% YoY
Trade receivables: Rs 838.60 cr at March 31, 2026
Dividend record date: July 17, 2026
FY2025 VSV tax expense: Rs 98.91 cr
APA-related tax expense: Rs 139.47 cr plus Rs 31.49 cr related interest in FY2026
FY2026 Consumer revenue: Rs 537.24 cr, 11% mix, up 15.6% YoY
Cash and cash equivalents: Rs 812.14 cr at March 31, 2026
FY2026 capex cash outflow: Rs 58.33 cr for property, plant, equipment, intangibles and capital work-in-progress
FY2026 Health Care revenue: Rs 1,016.58 cr, 20% mix, up 17.5% YoY
Final and special dividend: Rs 506 per equity share of face value Rs 10, comprising Rs 160 final dividend and Rs 346 special dividend
Q4 FY2026 Consumer revenue: Rs 135.61 cr, up about 15.7% YoY
Labour Code exceptional item: Rs (40.24) cr in Q4 FY2026 and Rs 34.33 cr in FY2026
R&D and technical capability: 173 patents filed and 5,150 customer technical center visitors in FY2025-26 according to the investor presentation
Q4 FY2026 Health Care revenue: Rs 283.53 cr, up about 21.3% YoY
FY2026 Consumer segment result: Rs 94.11 cr versus Rs 82.33 cr in FY2025
FY2026 revenue from operations: Rs 5,089.76 cr, up 14.5% YoY
Manufacturing and R&D footprint: 3 manufacturing facilities, 1 R&D center and 2 customer technical centers
FY2026 PAT excluding APA and VSV: Rs 662 cr according to the May 2026 investor presentation
FY2026 Health Care segment result: Rs 209.82 cr versus Rs 174.67 cr in FY2025
Q4 FY2026 revenue from operations: Rs 1,399.24 cr, up 16.8% YoY and 13.9% QoQ
FY2026 PBT after exceptional items: Rs 894.03 cr, up 15.6% YoY
FY2026 PBT before exceptional items: Rs 928.36 cr in audited results; investor presentation rounded or adjusted to Rs 960 cr
FY2026 Safety and Industrial revenue: Rs 1,640.04 cr, 32% mix, up 16.0% YoY
Q4 FY2026 PBT after exceptional items: Rs 289.17 cr, up 28.4% YoY
Q4 FY2026 PBT before exceptional items: Rs 248.93 cr, up 10.5% YoY
Q4 FY2026 Safety and Industrial revenue: Rs 455.83 cr, up about 19.5% YoY
Cash generated from operations before tax: Rs 803.50 cr in FY2026 versus Rs 562.19 cr in FY2025
FY2026 Safety and Industrial segment result: Rs 257.57 cr versus Rs 146.72 cr in FY2025
Net cash generated from operating activities: Rs 513.72 cr in FY2026 versus Rs 355.11 cr in FY2025
FY2026 Transportation and Electronics revenue: Rs 1,845.54 cr, 36% mix, up 10.1% YoY
Q4 FY2026 Transportation and Electronics revenue: Rs 518.33 cr, up about 12.6% YoY
FY2026 Transportation and Electronics segment result: Rs 347.79 cr versus Rs 300.92 cr in FY2025
FY2026 total income from operations and other income: Rs 5,138.50 cr versus Rs 4,515.82 cr in FY2025
Q4 FY2026 total income from operations and other income: Rs 1,411.23 cr versus Rs 1,211.74 cr in Q4 FY2025

Financial highlights

Net worth: Rs 9,405.86 cr at March 31, 2026
DJSI score: 78 in 2025
FY2026 EPS: Rs 61.2
Order book: Around Rs 25,350 cr, described by management as about USD 2.5 bn
Debtor days: 35 days in Q4 FY2026 and 38 days in FY2026
FY2026 ROCE: 22.3%
FY2026 capex: Rs 2,532 cr
Total assets: Rs 20,434.00 cr at March 31, 2026
Current ratio: 1.33x at March 31, 2026
FY2026 EBITDA: Rs 2,371 cr, up 28% YoY
Q4 FY2026 EPS: Rs 14.0
Final dividend: Rs 5 per equity share of face value Rs 5, subject to shareholder approval
Inventory days: 151 days in Q4 FY2026 and 158 days in FY2026
ROCE guardrail: More than 20%
US market share: More than 33-35% per management Q&A
Q4 FY2026 EBITDA: Rs 539 cr, up 7% YoY
Debt equity ratio: 0.23x at March 31, 2026
Current borrowings: Rs 564.81 cr at March 31, 2026
Order book tonnage: Roughly 1.2-1.3 million tonnes per management Q&A
Current investments: Rs 817.69 cr at March 31, 2026
FY2026 EBITDA margin: About 14% in investor presentation
Order book geography: About two-thirds US and one-third India per management Q&A
Anjar facility update: Spiral facility enhanced into hybrid Spiral/LSAW facility with fungibility
FY2026 free cash flow: Rs 672 cr
Net debt / cash trend: Net debt of Rs 1,138 cr in FY2023, net debt of Rs 387 cr in FY2024, net cash of Rs 1,049 cr in FY2025 and net cash of Rs 1,627 cr in FY2026
DI pipes FY2026 volume: 342 KMT, up 26% YoY
FY2027 EBITDA guidance: Rs 2,850 cr
Non-current borrowings: Rs 1,597.73 cr at March 31, 2026
S&P Global CSA ranking: 5th globally and 2nd in India among steel companies
FY2026 consolidated PBT: Rs 2,146.51 cr
FY2027 revenue guidance: Rs 20,000 cr
New Labour Codes impact: Rs 25.20 cr under employee benefits
TMT rebar FY2026 volume: 185 KMT, down 12% YoY
FY2025 exceptional gains: Rs 377.79 cr EPIC stake-sale gain and Rs 476.50 cr Nauyaan Shipyard stake-sale gain
FY2026 income taxes paid: Rs 297.46 cr
FY2026 net cash position: Rs 1,627 cr
FY2026 net profit margin: 9.66%
Net working capital days: Negative 5 days in FY2026 versus 30 days in FY2025
Cash and cash equivalents: Rs 1,512.59 cr at March 31, 2026
DI pipes Q4 FY2026 volume: 105 KMT, up 38% YoY
WSSL FY2026 EBITDA growth: Up 52% YoY
FY2026 operating cash flow: Rs 3,204 cr
Q4 FY2026 consolidated PBT: Rs 504.01 cr
TMT rebar Q4 FY2026 volume: 60 KMT, up 17% YoY
Net debt / EBITDA guardrail: Less than 1x
Q4 FY2026 net profit margin: 8.61%
Clean Max Dhyuthi stake sale: 48,599 equity shares, or 26%, proposed to be sold to Welspun Living Ltd. for Rs 760 lakh
FY2027 implied EBITDA growth: About 20% over FY2026 actual EBITDA
Bank balances other than cash: Rs 1,459.34 cr at March 31, 2026
FY2027 implied revenue growth: About 19% over FY2026 actual revenue
FY2026 consolidated net profit: Rs 1,620.49 cr
FY2026 operating EBITDA margin: 15.63%
Great Place To Work Trust Index: 91 in 2025 versus 89 in 2024
FY2026 consolidated total income: Rs 16,905.39 cr
Q4 FY2026 consolidated net profit: Rs 371.46 cr
Q4 FY2026 operating EBITDA margin: 14.57%
Additional Bhopal coating capacity: 3 million square metres per annum
FY2025 Sintex Logistics write-down: Rs 10.82 cr
FY2026 debt service coverage ratio: 5.03x
Stainless steel bars FY2026 volume: 27.2 KMT, up 44% YoY
Q4 FY2026 consolidated total income: Rs 4,348.17 cr
Stainless steel pipes FY2026 volume: 5.2 KMT, up 9% YoY
FY2026 PAT without exceptional items: Rs 1,613 cr, up 42% YoY
FY2026 profit attributable to owners: Rs 1,613.05 cr
Steel products FY2026 segment result: Rs 2,026.50 cr
Q4 FY2026 debt service coverage ratio: 2.15x
Stainless steel bars Q4 FY2026 volume: 6.6 KMT, up 28% YoY
Steel products FY2026 segment revenue: Rs 16,134.11 cr
FY2026 interest service coverage ratio: 21.61x
Line pipes India and USA FY2026 volume: 954 KMT, up 12% YoY
Others / plastic FY2026 segment result: Negative Rs 101.55 cr
Stainless steel pipes Q4 FY2026 volume: 1.1 KMT, down 17% YoY
Others / plastic FY2026 segment revenue: Rs 636.03 cr
Q4 FY2026 PAT without exceptional items: Rs 370 cr, up 28% YoY
Q4 FY2026 profit attributable to owners: Rs 370.36 cr
Steel products Q4 FY2026 segment result: Rs 447.54 cr
Steel products Q4 FY2026 segment revenue: Rs 4,136.08 cr
FY2026 net cash from financing activities: Rs 875.09 cr
FY2026 net cash from operating activities: Rs 3,204.28 cr after income taxes paid
Line pipes India and USA Q4 FY2026 volume: 255 KMT, up 4% YoY
Others / plastic Q4 FY2026 segment result: Negative Rs 34.44 cr
Q4 FY2026 interest service coverage ratio: 21.11x
Others / plastic Q4 FY2026 segment revenue: Rs 176.48 cr
FY2026 consolidated revenue from operations: Rs 16,770.14 cr
FY2026 net cash used in investing activities: Rs 3,722.80 cr
Q4 FY2026 consolidated revenue from operations: Rs 4,312.56 cr
FY2026 cash generated from operations before tax: Rs 3,501.74 cr
FY2026 share of profit from associates and joint ventures: Rs 342.34 cr
Q4 FY2026 share of profit from associates and joint ventures: Rs 106.58 cr
FY2026 consolidated PBT before exceptional items, share of associates/JVs and tax: Rs 1,804.17 cr
Q4 FY2026 consolidated PBT before exceptional items, share of associates/JVs and tax: Rs 397.43 cr

Financial highlights

Net debt: Rs 109,082 mn as at March 31, 2026
FY2026 sales: Rs 300,245 mn / about Rs 30,024.5 cr, up 76% YoY
FY2026 launches: 31.84 mn sq ft, GDV Rs 273,504 mn, with Rs 173,442 mn sales from new launches
Q4 FY2026 sales: Rs 76,973 mn / about Rs 7,697.3 cr, up 11% YoY
FY2026 sales mix: Bengaluru 34%, NCR 33%, Mumbai 20%, other markets 13%
Office portfolio: FY2026 leasing 4.47 mn sq ft; Q4 leasing 0.40 mn sq ft; operational occupancy 92%
Retail portfolio: FY2026 turnover Rs 25,671 mn; Q4 turnover Rs 6,520 mn, up 15% YoY; occupancy 99%
Debt-equity ratio: 0.65x as at March 31, 2026
FY2026 deliveries: 18.22 mn sq ft delivered
FY2026 collections: Rs 185,146 mn / about Rs 18,514.6 cr, up 53% YoY
Q4 FY2026 launches: 8.00 mn sq ft with estimated GDV of Rs 77,314 mn
FY2026 sales volume: 22.28 mn sq ft, up 77% YoY; 11,692 units sold
Average cost of debt: 9.33%
Residential pipeline: Rs 920,817 mn per investor presentation
Unrecognised revenue: Rs 659,353 mn per investor presentation
Q4 FY2026 collections: Rs 52,314 mn / about Rs 5,231.4 cr, up 66% YoY
Q4 FY2026 completions: 5.51 mn sq ft
Retail FY2026 segment: Revenue Rs 2,953 mn; EBITDA excluding other income Rs 1,625 mn; EBITDA margin 55%; PAT Rs 914 mn
Q4 FY2026 sales volume: 5.34 mn sq ft, up 19% YoY; 3,094 units sold
Consolidated FY2026 PBT: Rs 17,136 mn vs Rs 7,558 mn in FY2025
Consolidated borrowings: Non-current Rs 56,311 mn and current Rs 93,550 mn at March 31, 2026
Services FY2026 segment: Revenue Rs 8,741 mn; EBITDA excluding other income Rs 989 mn; EBITDA margin 11%; PAT Rs 604 mn
Consolidated inventories: Rs 402,519 mn at March 31, 2026
Upcoming launch pipeline: 58.12 mn sq ft with GDV Rs 578,288 mn
Commercial FY2026 segment: Revenue Rs 6,243 mn; EBITDA excluding other income Rs 5,183 mn; EBITDA margin 83%; PAT Rs 1,223 mn
Consolidated Q4 FY2026 PBT: Rs 4,127 mn vs Rs 871 mn in Q4 FY2025
FY2026 average realization: Rs 14,470 per sq ft, up 3% YoY; plotted development Rs 8,321 per sq ft, up 16% YoY
Residential FY2026 segment: Revenue Rs 92,053 mn; EBITDA excluding other income Rs 19,092 mn; EBITDA margin 21%; PAT Rs 9,301 mn
Q4 FY2026 average realization: Rs 16,569 per sq ft, up 7% YoY; plotted Rs 8,005 per sq ft, up 15% YoY
Consolidated FY2026 net profit: Rs 13,054 mn vs Rs 6,169 mn in FY2025
Consolidated trade receivables: Rs 20,422 mn at March 31, 2026
Consolidated FY2026 total income: Rs 131,955 mn vs Rs 77,355 mn in FY2025
Presentation operating cash flow: FY2026 net cash flow from operating activities Rs 71,164 mn
Consolidated Q4 FY2026 net profit: Rs 2,918 mn vs Rs 431 mn in Q4 FY2025
Consolidated Q4 FY2026 total income: Rs 41,435 mn vs Rs 15,893 mn in Q4 FY2025
FY2026 business-development additions: 427 acres with tentative GDV Rs 514,200 mn
Hospitality FY2026 management comment: Revenue about Rs 1,050 cr; EBITDA about Rs 440 cr
Consolidated cash and cash equivalents: Rs 15,560 mn at March 31, 2026
FY2026 EBITDA per investor presentation: Rs 42,192 mn, up 43.27% YoY; EBITDA margin 31.97%
Q4 FY2026 EBITDA per investor presentation: Rs 11,152 mn, up 85.25% YoY; EBITDA margin 26.91%
Consolidated FY2026 revenue from operations: Rs 126,854 mn vs Rs 73,494 mn in FY2025
Audited consolidated net cash from operations: Rs 32,232 mn in FY2026 vs Rs 1,307 mn in FY2025
Consolidated FY2026 total comprehensive income: Rs 13,119 mn
Consolidated Q4 FY2026 revenue from operations: Rs 40,738 mn vs Rs 15,284 mn in Q4 FY2025
Consolidated Q4 FY2026 total comprehensive income: Rs 2,972 mn

Financial highlights

Talent Pulse: About Rs 30-35 cr revenue last year, expected by management to grow faster than Naukri overall
Final dividend: Rs 3.60 per share of face value Rs 2, subject to shareholder approval
AI-Rex adoption: More than 1,000 clients onboarded and about 30,000 job mandates
SIHL investment: About Rs 30 cr through 14,01,214 CCDs at Rs 214.10 each, with SIHL remaining wholly owned
99acres Q4 revenue: Rs 144 cr, up 36% YoY, helped by a Rs 20.5 cr warranty provision reversal
Shiksha Q4 revenue: Rs 44 cr, up 11% YoY
99acres Q4 billings: Rs 163 cr, up about 2% YoY
Shiksha Q4 billings: Rs 45 cr, down 13% YoY
Aisle FY2026 billings: Rs 39 cr, up 30% YoY
FY2026 total dividend: Rs 8.40 per share, up 40% YoY
99acres FY2026 revenue: Rs 488 cr, up 19% YoY
Deferred sales revenue: Rs 1,498 cr at March 31, 2026
Jeevansathi Q4 revenue: Rs 36 cr, up 19% YoY
NaukriGulf Q4 billings: Rs 41 cr, up 9% YoY, with about 42% operating PBT margin
Shiksha FY2026 revenue: Rs 170 cr, up 13% YoY
99acres FY2026 billings: Rs 497 cr, up 10% YoY
Jeevansathi Q4 billings: Rs 39 cr, up 21% YoY
Shiksha FY2026 billings: Rs 164 cr, up 1% YoY
Standalone cash balance: Rs 4,963 cr at March 31, 2026, including wholly owned subsidiaries
FY2026 standalone billings: Rs 3,178 cr, up 10% YoY
Jeevansathi FY2026 revenue: Rs 138 cr, up 26% YoY
NaukriGulf FY2026 billings: Rs 126 cr, up 16% YoY, with Rs 41 cr operating profit and 35% margin
99acres Q4 operating profit: Rs 3 cr
Jeevansathi FY2026 billings: Rs 142 cr, up 28% YoY
Shiksha Q4 operating profit: Rs 6 cr
99acres FY2026 operating loss: Rs 59 cr
Jeevansathi Q4 operating loss: Rs 3 cr
Q4 FY2026 standalone billings: Rs 1,057 cr, up 7.4% YoY
FY2026 consolidated net profit: Rs 1,762.8 cr
99acres Q4 cash from operations: Rs 22 cr
Recruitment Q4 operating profit: Rs 340 cr with about 58% operating margin
Shiksha FY2026 operating profit: Rs 13 cr
Shiksha Q4 cash from operations: Rs 11 cr
Jeevansathi FY2026 operating loss: Rs 4 cr
Q4 FY2026 consolidated net profit: Rs 755.7 cr
Recruitment Q4 standalone revenue: Rs 581 cr, up 14% YoY
FY2026 standalone operating margin: About 37%
FY2026 standalone operating profit: Rs 1,138 cr, up 17% YoY
Jeevansathi plus Aisle Q4 billings: Rs 49 cr, up 23% YoY, with Rs 7 cr combined operating losses
Recruitment Q4 standalone billings: Rs 811 cr, up 10% YoY
Jeevansathi Q4 cash from operations: Rs 4 cr
Recruitment FY2026 operating profit: Rs 1,277 cr with about 57% margin
Recruitment Q4 cash from operations: Rs 619 cr, up 16% YoY
Shiksha FY2026 cash from operations: Rs 22 cr
Naukri Jobseeker Services Q4 billings: Rs 53 cr, up 33% YoY, with about 60% operating profit margin
Q4 FY2026 standalone operating margin: 40.1%, up 639 bps YoY
Q4 FY2026 standalone operating profit: Rs 323 cr, up 39.4% YoY
Recruitment FY2026 standalone revenue: Rs 2,256 cr, up 14% YoY
Jeevansathi plus Aisle FY2026 billings: Rs 182 cr, up 29% YoY, with combined operating losses reduced about 50% to Rs 15 cr
Recruitment FY2026 standalone billings: Rs 2,374 cr, up 10% YoY
Jeevansathi FY2026 cash from operations: Rs 15 cr
Recruitment FY2026 cash from operations: Rs 1,513 cr, up 13% YoY
99acres FY2026 cash loss from operations: Rs 5 cr
FY2026 standalone revenue from operations: Rs 3,052 cr, up 15% YoY
Naukri Jobseeker Services FY2026 billings: Rs 176 cr, up 19% YoY, with Rs 98 cr operating profit and 57% margin
Q4 FY2026 cash from operations before tax: Rs 621 cr, up about 16% YoY
FY2026 consolidated revenue from operations: Rs 3,284.7 cr
Q4 FY2026 standalone revenue from operations: Rs 805 cr, up 17.2% YoY
Q4 FY2026 consolidated revenue from operations: Rs 869.0 cr
FY2026 standalone cash from operations before tax: Rs 1,469 cr, up about 12% YoY
Q4 FY2026 standalone EPS before exceptional items: Rs 4.59, up 20% YoY
FY2026 standalone net profit after exceptional items: Rs 5,535.7 cr
Recruitment Q4 revenue including Zwayam and DoSelect: Rs 608 cr, up 12% YoY
Recruitment Q4 billings including Zwayam and DoSelect: Rs 838 cr, up 9% YoY
Q4 FY2026 standalone net profit after exceptional items: Rs 309.1 cr
Recruitment FY2026 revenue including acquired businesses: Rs 2,343 cr, up 13% YoY
Recruitment FY2026 billings including acquired businesses: Rs 2,461 cr, up 9% YoY

Financial highlights

FY2026 EBITDA: Rs 6,856 cr, with 20.4% EBITDA margin
FY2026 revenue: Rs 33,653 cr versus Rs 31,724 cr in FY2025, up 6.1%
FY2026 R&D spend: Rs 1,590 cr, about 5% of revenue
FY2026 net capex: About $341 million
Q4 FY2026 EBITDA: Rs 1,801 cr, up 0.5% YoY; EBITDA margin 20.3%
US ANDA activity: Nine approvals and 12 launches in Q4 FY2026
Q4 FY2026 revenue: Rs 8,853 cr, up 5.6% YoY and up 2.4% QoQ
FY2026 API revenue: Rs 4,047 cr, about 12% of revenue
FY2026 ARV revenue: Rs 1,384 cr, up 33%; $157 million
Q4 FY2026 R&D spend: Rs 400 cr, 4.5% of sales
Q4 FY2026 net capex: $82 million
Average finance cost: 5% for Q4 FY2026
Q4 FY2026 net profit: Rs 921 cr, up 2.0% YoY
Q4 FY2026 API revenue: Rs 1,208 cr, up 25% QoQ and about 14% of revenue
Q4 FY2026 ARV revenue: Rs 328 cr, up 6% YoY; $36 million
US revenue aspiration: Management is aiming to touch $2 billion revenue over the near term, with Lannett contributing about $300 million if approved and closed
Biologics CMO capacity: About 120,000 litres mammalian cell-culture capacity across disclosed product schedules
Biosimilars investment: About $450 million cumulative investment including capex and opex from July 2018 to Q4 FY2026
FY2026 Europe milestone: Europe formulations achieved EUR 1 billion annual revenue
Europe margin commentary: Europe EBITDA just above 20%, with management expecting northward movement
Q4 FY2026 free cash flow: $35 million before dividend and buyback, after about $32 million Khandelwal Labs non-oncology acquisition payment
FY2026 gross contribution: Rs 20,165 cr; about 60% margin, around 100 bps improvement
Pen-G annualized production: Expected to exceed 10,000 metric tons with capacity utilization above 80% at consistent yields
Biologics CMO revenue timing: Unit 1 revenue from 2028; Unit 2 revenue from 2031, both calendar-year references
FY2027 EBITDA margin outlook: Management expects EBITDA margins to sustain and progressively improve to north of 21%
Q4 FY2026 gross contribution: Rs 5,424 cr; gross margin 61.3%, up 153 bps QoQ
FY2026 growth markets revenue: Rs 3,499 cr, up 10%; $397 million versus $376 million in FY2025
Biosimilar gross-margin target: 65-70% in the US on average, potentially shifting toward 70-75% as product mix matures
Net cash including investments: About $317 million at March 31, 2026 versus $276 million at December 31, 2025
Pen-G and 6-APA external sales: More than Rs 100 cr sold to outside customers in Q4 FY2026
Q4 FY2026 formulations revenue: Rs 7,646 cr, up 5% YoY and about 86% of revenue
Biosimilar approvals and filings: Four European approvals, two Health Canada approvals and three more product filings according to management
Q4 FY2026 growth markets revenue: Rs 980 cr, up 25% YoY and 13% QoQ
Q4 FY2026 US formulations revenue: $387 million, down 18% YoY in constant currency due to high gRevlimid base in Q4 FY2025
Q4 FY2026 ex-gRevlimid YoY growth: 15.3%, or 7% in USD terms
FY2026 ex-gRevlimid revenue growth: 9.5%
Pen-G and 6-APA FY2026 EBITDA loss: More than Rs 200 cr for FY2026, but positive EBITDA contribution in Q4 FY2026
Biologics CMO greenfield investment: About $175 million for the CMO greenfield facility
Q4 FY2026 Europe formulations revenue: Rs 2,795 cr, up 30% YoY; EUR 261 million versus EUR 236 million in Q4 FY2025
FY2026 global specialty and injectable revenue: $513 million; ex-gRevlimid growth 12%
Q4 FY2026 global specialty and injectable revenue: $122 million; ex-gRevlimid sales grew 13% YoY

Financial highlights

Net debt: Rs 1,908 cr at March 2026, versus Rs 2,166 cr at December 2025; net debt-to-EBITDA below 1x
Final dividend: Rs 2 per share recommended by the board, subject to shareholder approval
Q4 FY2026 ALOS: Temporarily higher by 9% YoY
Digital revenue: Rs 838 cr, about 31% of gross revenue; website traffic above 90 lakh sessions, up 39% YoY
Future projects: 100 beds at Max Nagpur expected in FY2028; 400 beds at Zirakpur/Mohali expected in FY2028; 260 beds at Max Dwarka and 200 beds at Max Vaishali expected about 24 months after approvals; 400 beds at Max Patparganj expected in FY2029
Q4 FY2026 ARPOB: Rs 77,900, versus Rs 77,100 in Q4 FY2025
FY2026 Network PAT: Rs 1,631 cr, up 22% YoY versus Rs 1,336 cr in FY2025
Gurgaon greenfield: 500-bed Sector 56 facility targeted for commissioning by end-FY2027; management expects phase-one operationalization of about 200 beds
Lucknow greenfield: About Rs 1,400 cr investment approved for a 712-bed Shaheed Path facility expected to commission in FY2030
Max Lucknow expansion: Current capacity 426 beds, expected to increase to 570 beds over the next two quarters
Q4 FY2026 Network PAT: Rs 387 cr, versus Rs 376 cr in Q4 FY2025 and Rs 344 cr in Q3 FY2026
Operational bed capacity: 4,966 beds at March 2026, reflecting addition of 412 beds over the previous 12 months
Q4 FY2026 Max Lab revenue: Rs 52 cr, up 14% YoY and 11% QoQ
Q4 FY2026 Max@Home revenue: Rs 73 cr, up 30% YoY and 8% QoQ
FY2026 expansion deployment: Rs 1,627 cr toward ongoing expansion projects and newer-unit upgrades; Rs 131 cr toward Vaishali land; Rs 146 cr dividend distributed
Q4 FY2026 average occupancy: 75%, same as Q4 FY2025 and versus 74% in Q3 FY2026
Q4 FY2026 occupied bed days: Up 8% YoY and 4% QoQ
FY2026 Network gross revenue: Rs 10,538 cr, up 16% YoY
Kalinga Hospital acquisition: 58.28% controlling stake acquired for about Rs 297.97 cr; 250-bed hospital in Bhubaneswar
International patient revenue: Rs 227 cr, up 12% YoY, about 9% of hospital revenue
FY2026 Network operating EBITDA: Rs 2,638 cr, up 14% YoY, with margin of 26.2%
Q4 FY2026 Network gross revenue: Rs 2,664 cr, up 10% YoY and 2% QoQ
FY2026 annualized EBITDA per bed: Rs 72 lakh
FY2026 free cash from operations: Rs 1,541 cr after interest, tax, working-capital changes and routine capex
Q4 FY2026 Network operating EBITDA: Rs 682 cr, up 8% YoY and 5% QoQ
Oncology share of inpatient revenue: 21% in Q4 FY2026, down from 26% in Q4 FY2025 and 24% in Q3 FY2026
Q4 FY2026 annualized EBITDA per bed: Rs 73.4 lakh, versus Rs 73.9 lakh in Q4 FY2025 and Rs 71.3 lakh in Q3 FY2026
Q4 FY2026 free cash from operations: Rs 581 cr, with Rs 328 cr deployed toward expansion projects and upgrades
Q4 FY2026 Network operating EBITDA margin: 26.8%, versus 27.2% in Q4 FY2025 and 26.1% in Q3 FY2026
Q4 FY2026 gross revenue excluding oncology: Up 15% YoY and 5% QoQ

Financial highlights

Net worth: Rs 66,365 cr as on March 31, 2026
FY2026 capex: Rs 9,594 cr
LNG portfolio: 16.56 MMTPA upstream LNG portfolio
Final dividend: Re 0.50 per equity share recommended for FY2026
LHC production: 813 TMT in FY2026
Capital employed: Rs 98,667 cr as on March 31, 2026
LPG transmission: 4,600 TMT in FY2026
Pipeline network: 18,000-plus km, about 65% market share; about 1,500 km under construction
Petrochemical sales: 785 TMT in FY2026
Gas marketing volume: 104.21 MMSCMD in FY2026
FY2026 standalone PAT: Rs 6,968 cr versus Rs 11,312 cr in FY2025
FY2026 standalone PBT: Rs 8,964 cr versus Rs 14,825 cr in FY2025
Total FY2026 dividend: Rs 5.50 per share, 51.90% payout according to the presentation
FY2026 consolidated PAT: Rs 7,582 cr versus Rs 12,450 cr in FY2025
FY2026 consolidated PBT: Rs 9,725 cr versus Rs 16,096 cr in FY2025
FY2026 standalone EBITDA: Rs 13,119 cr versus Rs 19,168 cr in FY2025
Q4 FY2026 standalone PAT: Rs 1,262 cr according to the official press release
Q4 FY2026 standalone PBT: Rs 1,577 cr according to the official press release
FY2027 capital allocation: Rs 11,600 cr
FY2026 consolidated EBITDA: Rs 14,524 cr versus Rs 20,643 cr in FY2025
Long-term loan outstanding: Rs 14,259 cr as on March 31, 2026
Q4 FY2026 consolidated PBT: Rs 1,966 cr according to the official press release
Q4 FY2026 standalone EBITDA: Rs 2,175 cr according to the official press release
Total financial indebtedness: Rs 17,414 cr as on March 31, 2026 according to the audited results filing
Q4 FY2026 consolidated EBITDA: Rs 2,703 cr according to the official press release
Natural gas transmission volume: 122.18 MMSCMD in FY2026
FY2026 standalone gross turnover: Rs 1,38,328 cr versus Rs 1,36,960 cr in FY2025
FY2027 petrochemicals allocation: Rs 1,486 cr
FY2027 pipeline capex allocation: Rs 2,401 cr
FY2026 consolidated gross turnover: Rs 1,41,716 cr versus Rs 1,41,949 cr in FY2025
FY2027 operational capex allocation: Rs 3,530 cr
FY2027 net zero and renewables allocation: Rs 1,950 cr
Q4 FY2026 standalone revenue from operations: Rs 34,797 cr according to the official press release
Q4 FY2026 consolidated revenue from operations: Rs 35,705 cr according to the official press release
Q4 FY2026 consolidated PAT excluding minority interest: Rs 1,485 cr according to the official press release

Financial highlights

Dividend: Final dividend recommended at Rs 82/share for FY2026
FY2026 VECV PAT: Rs 1,471 cr
FY2026 VECV EBITDA: Rs 2,562.6 cr
Q4 FY2026 VECV PAT: Rs 595.8 cr
FY2026 VECV exports: 6,933 units, up 33.9%
FY2026 VECV volumes: 103,404 units, up 14.7% YoY
Q4 FY2026 VECV EBITDA: Rs 921.5 cr
FY2026 VECV LMD trucks: 46,195 units, market share 34.9%
Q4 FY2026 VECV revenue: Rs 8,280.6 cr
Q4 FY2026 VECV volumes: 33,976 vehicles, up 18.4% YoY
FY2026 VECV bus volumes: 18,651 units
FY2026 consolidated EML PAT: Rs 5,515.2 cr / Rs 5,515 cr, up 17% YoY
Royal Enfield Brazil growth: about 71% during FY2026, described as the largest and fastest-growing international market after India
FY2026 VECV spare-parts sales: Rs 3,045.5 cr, up 13.9%
Q4 FY2026 Royal Enfield sales: 313,811 motorcycles, highest Q4 sales, up 12% YoY
Andhra Pradesh greenfield land: Government of Andhra Pradesh approved 215.7 acres at Tada for proposed expansion
FY2026 consolidated EML EBITDA: Rs 5,785 cr, up 23% YoY
Q4 FY2026 consolidated EML PAT: Rs 1,520 cr, up 12% YoY
Royal Enfield allied businesses: Global genuine motorcycle accessories revenue up 32%; spare-parts business up 18%; apparel up 21%
Q4 FY2026 consolidated EML EBITDA: Rs 1,514 cr, up 20% YoY
Andhra Pradesh proposed investment: Up to Rs 2,500 cr, subject to Board finalisation and approval, funded through internal accruals
Volvo Financial Services India AUM: Rs 1,806 cr at the time of the call
FY2026 Royal Enfield domestic sales: 1,107,343 units, up 23% YoY
FY2026 VECV revenue from operations: Rs 27,076.6 cr, up 15% YoY
FY2026 VECV Eicher heavy-duty trucks: 25,155 units, up 14.1%, market share 9.1%
Cheyyar brownfield capacity expansion: Rs 958 cr investment; annual production capacity to rise from 14.6 lakh units to 20 lakh units by the end of FY2027-28
FY2026 Royal Enfield motorcycle sales: 1,227,977 units, up 22% YoY
Q4 FY2026 consolidated EML EBITDA margin: 24.9%
Volvo finance JV proposed EML investment: Up to Rs 750 cr for a 50% stake
Royal Enfield mid-size India market share: 87% in FY2026 per SIAM, as shown in the investor presentation
FY2026 Royal Enfield international volumes: 120,634 units, up 20% YoY
FY2026 consolidated EML revenue from operations: Rs 23,407.6 cr / Rs 23,408 cr, up 24% YoY
Q4 FY2026 consolidated EML revenue from operations: Rs 6,080 cr, up 16% YoY
Royal Enfield April 2026 domestic sales indication: about 1.04 lakh motorcycles, up 57% YoY, according to management commentary

Financial highlights

Dividend: Rs 5/share recommended for FY2026
FY2026 capex: Rs 31,619 cr, up 47% YoY
FY2026 copper EBITDA: Rs 2,809 cr
Novelis cost savings: more than USD 125 mn delivered in FY2026; run-rate now about USD 200 mn
FY2027 hedge position: 29% of aluminium commodity hedged at USD 3,013/t and 14% currency hedged at Rs 90.13/USD
Q4 FY2026 copper EBITDA: Rs 907 cr, up 48% YoY
Peak net debt indication: Rs 80,000-90,000 cr over the next two years
Q4 FY2026 copper revenue: Rs 22,156 cr, up 52% YoY
Q4 FY2026 Novelis revenue: USD 4.8 bn, up 4% YoY
FY2026 consolidated EBITDA: Rs 38,097 cr, all-time high
Q4 FY2026 copper CCR sales: 91 KT, up 11% YoY
FY2026 consolidated revenue: Rs 2,74,944 cr, up 15% YoY
Q4 FY2026 Hindalco India PAT: Rs 3,549 cr, up 11% YoY
Q4 FY2026 copper metal sales: 128 KT, down 5% YoY
Q4 FY2026 consolidated EBITDA: Rs 11,197 cr, up 9% YoY
Q4 FY2026 consolidated revenue: Rs 78,133 cr, up 20% YoY
Consolidated net debt to EBITDA: 1.83x as of 31 March 2026
FY2026 aluminium upstream EBITDA: Rs 18,884 cr, up 16% YoY
FY2026 cash flow from operations: Rs 21,858 cr, up 11% YoY
FY2026 consolidated reported PAT: Rs 13,391 cr, impacted by Oswego disruption due to fires
Q4 FY2026 Novelis adjusted EBITDA: USD 459 mn
FY2026 aluminium downstream EBITDA: Rs 978 cr, up 55% YoY
Q1 FY2027 cost inflation indication: about 5% cost increase versus Q4, led by furnace oil, CP coke and pitch
Q4 FY2026 aluminium upstream EBITDA: Rs 5,448 cr, up 13% YoY
Q4 FY2026 consolidated reported PAT: Rs 2,597 cr, impacted by Oswego disruption due to fires
Q4 FY2026 aluminium upstream revenue: Rs 11,418 cr, up 11% YoY
FY2026 Hindalco India business EBITDA: Rs 22,671 cr, up 14% YoY
Q4 FY2026 aluminium downstream EBITDA: Rs 255 cr, up 16% YoY
Q4 FY2026 aluminium downstream revenue: Rs 4,867 cr, up 35% YoY
Q4 FY2026 aluminium upstream shipments: 339 KT, up 2% YoY
Q4 FY2026 Hindalco India business EBITDA: Rs 6,610 cr, up 17% YoY
Q4 FY2026 aluminium downstream shipments: 124 KT, up 18% YoY
Q4 FY2026 aluminium upstream EBITDA margin: 48%
FY2026 consolidated business segment EBITDA: Rs 37,217 cr, up 6% YoY
Q4 FY2026 Novelis adjusted EBITDA per tonne: USD 544/t, up 10% YoY
Q4 FY2026 aluminium upstream EBITDA per tonne: USD 1,756/t, up 4% YoY
Q4 FY2026 consolidated business segment EBITDA: Rs 10,812 cr, up 11% YoY
FY2026 consolidated PAT before exceptional items: Rs 18,733 cr, up 10% YoY
Q4 FY2026 consolidated PAT before exceptional items: Rs 5,796 cr, up 10% YoY

Financial highlights

Call date: May 21, 2026
FY2026 presales: Rs 4,631 cr, up 128% YoY
KIADB land area: Approximately 78 acres at Kadugodi Industrial Area, Bengaluru
Total portfolio: More than 40 projects and more than 38 mn sq ft saleable plus leasable portfolio
Current NSE ISIN: INE069I01010
FY2026 area sold: 3.581 mn sq ft, up 62% YoY
Shareholder debt: Approximately Rs 1,121 cr
Board result date: May 20, 2026
Q4 FY2026 presales: Rs 2,632 cr, up 89% QoQ
Debt-cost objective: Toward 10% over 12-18 months
FY2026 launched GDV: About Rs 16,300 cr across six launches
Q4 FY2026 area sold: 1.783 mn sq ft, up 50% QoQ
Commercial portfolio: About 12 mn sq ft
Current cost of debt: Around 14.8%
Former company names: Equinox India Developments Limited; Indiabulls Real Estate Limited
Fully paid land bank: 3,251 acres
Gross debt-to-equity: 0.4x
NCLAT CIRP order date: May 4, 2026
Owned-project surplus: Rs 30,238 cr
Q4 FY2026 collections: Rs 577 cr, up 39% QoQ
Residential portfolio: About 26 mn sq ft
FY2026 collections YoY: Down 10% versus FY2025 Rs 1,852 cr
Net institutional debt: About Rs 3,000 cr
Transcript filing date: May 29, 2026
FY2025 consolidated PAT: Profit of Rs 194 cr
FY2026 consolidated PAT: Loss of Rs 872 cr
FY2026 consolidated PBT: Negative Rs 897 cr
Owned-project GDV total: Rs 51,774 cr
CARE unutilized proceeds: None at March 31, 2026
Gross institutional debt: About Rs 4,100 cr
CARE total realised funds: Rs 3,510.66 cr
Current NSE active symbol: EMBDL
Embassy Eden FY2026 sales: Rs 954 cr
FY2026 construction spend: Rs 1,182 cr
FY2027 collections target: About Rs 3,000 cr
Lucknow MoU proposed area: About 2.5 mn to 3.0 mn sq ft of commercial development
FY2025 consolidated EBITDA: Positive Rs 531 cr
FY2026 consolidated EBITDA: Negative Rs 300 cr
FY2026 project collections: Rs 1,673 cr
FY2028 onwards planned GDV: 20.3 mn sq ft / Rs 23,470 cr
Q4 FY2026 consolidated PAT: Loss of Rs 323 cr
Q4 FY2026 consolidated PBT: Negative Rs 345 cr
Embassy Citadel Q4 presales: Rs 797 cr
Investor-update total assets: Rs 21,538 cr
Q4 FY2026 construction spend: Rs 314 cr
Embassy Citadel estimated GDV: Over / about Rs 8,800 cr
Q4 FY2026 consolidated EBITDA: Negative Rs 196 cr
Senior management appointment: Chirag Boonlia appointed Chief Technology Officer effective May 20, 2026
NCLT admission order set aside: December 9, 2025 order set aside by NCLAT
Total project GDV including DM: Rs 57,874 cr
FY2026 net financing cash flows: Rs 629 cr
FY2026 net operating cash flows: Rs 53 cr
FY2027 Juhu DM project pipeline: 0.3 mn sq ft / Rs 3,050 cr GDV
Lucknow MoU proposed investment: About Rs 1,500 cr
Normal trading restoration date: May 6, 2026
Embassy Verde Phase 2 absorption: 87% within the quarter
FY2025 consolidated total income: Rs 2,547 cr
FY2026 consolidated total income: Rs 1,905 cr
Investor-update gross borrowings: Rs 5,218 cr
Net institutional debt-to-equity: 0.3x
CARE lapsed-warrant unpaid amount: Rs 397.48 cr not received and adjusted against issue objects
DM project surplus / fee estimate: Rs 610 cr
Embassy Citadel Leighton contract: Over Rs 850 cr construction contract
Embassy Verde Phase 2 Q4 presales: Rs 588 cr
FY2027 DM-project presales target: Rs 2,000 cr
FY2027 Embassy Hub Plot A pipeline: 1.2 mn sq ft / Rs 2,100 cr GDV; Embassy economic interest 91%
Total project surplus including DM: Rs 30,848 cr
Q4 FY2026 consolidated total income: Rs 407 cr
FY2027 owned-project launch pipeline: 8.7 mn sq ft / Rs 13,300 cr GDV
FY2027 owned-project presales target: Rs 6,000 cr
FY2027 Embassy Springs plots pipeline: 0.2 mn sq ft / Rs 200 cr GDV
OC-received portfolio FY2026 presales: Rs 573 cr
OC-received portfolio cumulative sold: 98%
Bengaluru Rs 10 cr-plus category share: More than 65% of FY2026 sales in about Rs 2,000 cr category market
CARE monitored preferential issue size: Rs 3,908.14 cr after reduced warrant issuance
FY2027 109 Commercial Gurgaon pipeline: 0.5 mn sq ft / Rs 800 cr GDV
FY2027 Whitefield JDA project pipeline: 1.7 mn sq ft / Rs 2,000 cr GDV; Embassy economic interest 68.5%
Embassy Citadel absorption at Q4 launch: About 8% of inventory
FY2027 Embassy One North Tower pipeline: 0.4 mn sq ft / Rs 1,400 cr GDV
FY2027 Sky Terraces DM project pipeline: 1.5 mn sq ft / Rs 3,050 cr GDV
FY2026 closing cash and cash equivalents: Rs 1,165 cr
FY2026 construction spend to collections: About 71%
FY2026 opening cash and cash equivalents: Rs 501 cr
FY2027 Embassy Serenity Alibaug pipeline: 0.3 mn sq ft / Rs 450 cr GDV
Investor-update total equity / net worth: Rs 9,964 cr
OC-received portfolio FY2026 collections: Rs 645 cr
FY2025 consolidated revenue from operations: Rs 2,180 cr
FY2026 consolidated revenue from operations: Rs 1,732 cr
FY2026 presales achievement versus guidance: About 93% of Rs 5,000 cr guidance
FY2027 Embassy Springs front parcel pipeline: 1.7 mn sq ft / Rs 1,900 cr GDV
FY2027 launch pipeline including DM projects: 10.5 mn sq ft / Rs 19,400 cr GDV
Embassy Citadel project size in press release: About 1.6 mn sq ft and 316 residences
FY2027 Embassy Knowledge Park Villas pipeline: 1.1 mn sq ft / Rs 2,500 cr GDV
Sepset / Mega Mall Jodhpur sale consideration: Rs 100 cr cash
Cash and cash equivalents used for debt bridge: About Rs 1,100 cr
Embassy Citadel plus Verde Phase 2 Q4 presales: Rs 1,385 cr
FY2027 collection growth implied by management: About 75% YoY
Q4 FY2026 consolidated revenue from operations: Rs 343 cr
FY2027 total presales target including DM projects: Rs 8,000 cr
Legacy queue symbol absent from current NSE EQ list: IBREALEST
FY2026 total collections including land monetisation: Rs 1,721 cr
FY2027 Embassy Knowledge Park Apartments South pipeline: 1.5 mn sq ft / Rs 1,950 cr GDV

Financial highlights

Finance costs: Nil in standalone and consolidated FY2026 results
Current NSE ISIN: INE269B01029
Dividend record date: July 17, 2026
LMW China order book: Rs 120 crore
FY2026 final dividend: Rs 35 per share
GST/e-way-bill period: June 2026
LMW Global order book: Rs 44 crore
Standalone FY2026 EPS: Rs 144.08
GST/e-way-bill penalty: Rs 22,42,792
LMW Global FY2026 loss: Rs 32 crore
Consolidated FY2026 EPS: Rs 122.37
LMW China FY2026 result: Breakeven per management commentary
Current NSE active symbol: LMW
LMW China FY2026 turnover: Rs 130 crore
Machine-tool customer mix: About 50%-52% automotive and 48% non-automotive
LMW Global FY2026 turnover: Rs 184 crore
LMW Holding FY2025 turnover: Rs 2.03 crore
LMW Holding FY2026 turnover: Rs 18.19 crore
LMW Holding shares acquired: 1,10,175 shares of AED 1000 each
Textile Machinery sales mix: 66% domestic, 8% exports, 26% spares
Textile Machinery order book: Rs 3,300 crore, with active orders around Rs 2,300 crore
Consolidated FY2026 total income: Rs 3,353.36 crore
Consolidated current investments: Rs 338.16 crore at March 31, 2026
LMW Holding additional investment: Not exceeding USD 30 million
Standalone FY2026 profit before tax: Rs 207.88 crore
Advanced Technology Centre order book: Around Rs 360 crore, to execute over about 18 months
Consolidated FY2026 profit before tax: Rs 181.81 crore
Consolidated cash and cash equivalents: Rs 394.71 crore at March 31, 2026
LMW Holding ownership after investment: 100%
Legacy symbol retired from NSE EQ list: LAXMIMACH
Machine-tool imported material content: About 50%
Standalone FY2026 net profit after tax: Rs 153.92 crore
Machine Tool and Foundry FY2026 revenue: Rs 1,204.94 crore
Consolidated FY2026 net profit after tax: Rs 130.73 crore
Advanced Technology Centre FY2026 revenue: Rs 206.82 crore
Standalone FY2026 revenue from operations: Rs 3,081.84 crore
Consolidated bank balances other than cash: Rs 869.76 crore at March 31, 2026
Machine Tool and Foundry Q4 FY2026 revenue: Rs 351.85 crore
Consolidated FY2026 revenue from operations: Rs 3,207.42 crore
Consolidated Q4 FY2026 net profit after tax: Rs 63.69 crore
Standalone Textile Machinery FY2026 revenue: Rs 1,801.17 crore
Advanced Technology Centre Q4 FY2026 revenue: Rs 56.53 crore
Standalone Q4 FY2026 revenue from operations: Rs 853.69 crore
Consolidated Q4 FY2026 revenue from operations: Rs 933.16 crore
Machine Tool and Foundry FY2026 segment result: Rs 97.20 crore profit
Standalone Textile Machinery Q4 FY2026 revenue: Rs 485.27 crore
Advanced Technology Centre export concentration: Almost 90% concentrated toward exports
Advanced Technology Centre FY2026 segment result: Rs 28.74 crore profit
Advanced Technology Centre composite utilization: Around 50%
Machine Tool and Foundry Q4 FY2026 segment result: Rs 41.11 crore profit
Standalone Textile Machinery FY2026 segment result: Rs 9.75 crore profit
Advanced Technology Centre Q4 FY2026 segment result: Rs 11.18 crore profit
Advanced Technology Centre infrastructure capex reference: About Rs 150 crore over five years for infrastructure, excluding machinery
Standalone FY2026 profit before exceptional items and tax: Rs 221.06 crore
Consolidated FY2026 profit before exceptional items and tax: Rs 194.99 crore

Financial highlights

AGM date: August 4, 2026 at 12:00 noon by VC/OAVM
Final dividend: Rs 1 per equity share of face value Rs 2, subject to shareholder approval
India FY2026 PAT: Rs 59 crore in press release, up 40% YoY
Net debt to equity: 0.1x per management commentary
FY2026 order intake: Rs 3,714 crore, up 20% YoY
India FY2026 EBITDA: Rs 135 crore in press release, up 22% YoY
India Q4 FY2026 PAT: Rs 16 crore in press release, up 8% YoY
FY2026 dividend paid: Rs 8.69 crore
India FY2026 revenue: Rs 1,034 crore in press release, up 12% YoY
Consolidated goodwill: Rs 229.64 crore at March 31, 2026
Total FY2026 dividend: Rs 2 per equity share including interim dividend
India Q4 FY2026 EBITDA: Rs 26 crore in press release, down 24% YoY
Q4 FY2026 adjusted PAT: Rs 21.8 crore after PPA, excluding exceptional items
Q4 FY2026 order intake: Rs 871 crore, up 32% YoY
India Q4 FY2026 revenue: Rs 289 crore in press release, up 15% YoY
Consolidated inventories: Rs 636.89 crore at March 31, 2026
FY2026 direct taxes paid: Rs 68.68 crore
FY2026 exceptional items: Rs 65.31 crore in audited results
FY2026 finance cost paid: Rs 87.36 crore
Consolidated total assets: Rs 4,023.55 crore at March 31, 2026
Consolidated total equity: Rs 1,232.99 crore at March 31, 2026
India FY2026 order intake: Rs 967 crore, flat YoY
FY2026 adjusted PAT margin: 2.8%
FY2026 consolidated EBITDA: Rs 403 crore in investor presentation / press release, up 11% YoY
FY2026 reported PAT margin: 1.5%
FY2026 GMM Inox acquisition: 51% stake in GMM Inox sp. z o.o. with capital contribution of Rs 25.30 crore approx.
FY2026 acquisition goodwill: Rs 88.09 crore from updated provisional purchase-price-allocation values
FY2026 consolidated revenue: Rs 3,524 crore in investor presentation / press release, up 10% YoY
Net debt to adjusted EBITDA: 0.4x, down from 0.5x, per management commentary
Q4 FY2026 exceptional items: Rs 9 crore in investor presentation; Rs 8.99 crore in audited results
International FY2026 revenue: Rs 2,583 crore in investor presentation, gross of inter-company eliminations
FY2026 adjusted PAT after PPA: Rs 99.0 crore excluding exceptional items
Intended group debt repayment: Around USD 20 million, timing not confirmed by March 2027
Q4 FY2026 consolidated EBITDA: Rs 75 crore in investor presentation / press release, down 10% YoY and 28% QoQ
Consolidated lease liabilities: Rs 206.34 crore at March 31, 2026, including Rs 161.20 crore non-current and Rs 45.14 crore current
Consolidated trade receivables: Rs 465.33 crore at March 31, 2026
FY2026 net financing cash flow: Negative Rs 43.94 crore
FY2026 net investing cash flow: Negative Rs 154.29 crore
FY2026 net operating cash flow: Rs 388.80 crore
Q4 FY2026 consolidated revenue: Rs 944 crore in investor presentation / press release, up 17% YoY and 7% QoQ
Consolidated current borrowings: Rs 290.46 crore at March 31, 2026
FY2026 free cash flow to EBITDA: Slightly above 90% per management commentary
FY2026 long-term debt repayment: Rs 59.63 crore in audited cash flow; about Rs 60 crore cited by management
Opening backlog at April 1 2026: Rs 2,194 crore, up 34% YoY
FY2026 consolidated EBITDA margin: 11.4%
International FY2026 adjusted PAT: Rs 29.1 crore excluding Waghausel site workforce reduction measures
Q4 FY2026 consolidated PAT margin: 1.6%
India Labour Code exceptional item: Rs 12.69 crore gross in audited results
Consolidated non-current borrowings: Rs 544.60 crore at March 31, 2026
FY2026 payment of lease liabilities: Rs 55.14 crore
Q4 FY2026 consolidated depreciation: Rs 42 crore
Q4 FY2026 consolidated finance cost: Rs 16 crore in investor presentation; Rs 16.41 crore in audited results
Q4 FY2026 consolidated other income: Rs 18 crore in investor presentation; Rs 18.31 crore in audited results
Audited India segment FY2026 revenue: Rs 976.42 crore
Consolidated other intangible assets: Rs 622.74 crore at March 31, 2026
International Q4 FY2026 adjusted PAT: Rs 11.1 crore
Q4 FY2026 consolidated EBITDA margin: 8.0%
FY2026 cash generated from operations: Rs 457.48 crore
Consolidated cash and cash equivalents: Rs 635.38 crore at March 31, 2026
FY2026 SEMCO acquisition consideration: Rs 162 crore approx. for 100% stake in SEMCO Tecnologia em Processos Ltda., Brazil
FY2026 management-cited free cash flow: Rs 367 crore
Q4 FY2026 Hyderabad facility sale gain: Rs 27.23 crore under other income
Audited India segment Q4 FY2026 revenue: Rs 278.94 crore
Audited overseas segment FY2026 revenue: Rs 2,547.52 crore
German restructuring annualized savings: Rs 45 crore per management commentary
Non-traditional industry order-intake mix: Nearly 50% of FY2026 order intake per management commentary
Audited overseas segment Q4 FY2026 revenue: Rs 664.61 crore
FY2026 consolidated revenue from operations: Rs 3,623.94 crore in audited results
FY2026 net increase in cash and equivalents: Rs 190.57 crore
FY2026 reported EPS after exceptional items: Rs 12.86
International FY2026 reported PAT after PPA: Negative Rs 8.6 crore
FY2026 adjusted EPS before exceptional items: Rs 23.35
FY2026 payment toward acquisition of business: Rs 108.31 crore net
FY2026 profit before exceptional items and tax: Rs 167.28 crore in audited results
International Q4 FY2026 reported PAT after PPA: Rs 4.6 crore
Q4 FY2026 consolidated revenue from operations: Rs 943.55 crore in audited results
Q4 FY2026 reported EPS after exceptional items: Rs 3.82
Consolidated assets classified as held for sale: Rs 0.13 crore at March 31, 2026, down from Rs 46.47 crore
FY2026 consolidated PAT after exceptional items: Rs 52 crore in investor presentation / press release; Rs 51.82 crore in audited results
Q4 FY2026 adjusted EPS before exceptional items: Rs 5.25
Q4 FY2026 profit before exceptional items and tax: Rs 35 crore in investor presentation; Rs 34.83 crore in audited results
Q4 FY2026 consolidated PAT after exceptional items: Rs 15 crore in investor presentation / press release; Rs 15.34 crore in audited results
Q4 FY2026 profit before tax after exceptional items: Rs 26 crore in investor presentation; Rs 25.84 crore in audited results
Waghausel FY2026 workforce reduction exceptional item: Rs 52.62 crore gross in audited results
Consolidated bank balances other than cash equivalents: Rs 52.26 crore at March 31, 2026
FY2026 proceeds from sale of PPE / assets held for sale: Rs 55.84 crore
Waghausel Q4 FY2026 workforce reduction exceptional item: Rs 8.99 crore gross in audited results
Audited India segment FY2026 result before tax and interest: Rs 113.21 crore
Audited India segment Q4 FY2026 result before tax and interest: Rs 26.61 crore
Audited overseas segment FY2026 result before tax and interest: Rs 111.56 crore
Audited overseas segment Q4 FY2026 result before tax and interest: Rs 15.64 crore

Financial highlights

FY2026 ROCE: 9.4%
FY2025 inventories: Rs 827.76 cr
FY2026 debt-equity: 0.32x
FY2026 debtor days: 140 days
FY2026 inventories: Rs 993.67 cr
FY2025 total assets: Rs 2,563.71 cr
FY2025 total equity: Rs 1,714.79 cr
FY2026 total assets: Rs 3,088.86 cr
FY2026 total equity: Rs 1,820.76 cr
FY2026 creditor days: 67 days
FY2026 interest cover: 5x
FY2026 inventory cycle: 124 days
FY2025 consolidated EPS: Rs 54.97
FY2025 consolidated PBT: Rs 220.66 cr
FY2026 consolidated EPS: Rs 34.52
FY2026 consolidated PBT: Rs 137.51 cr
FY2025 trade receivables: Rs 904.81 cr
FY2026 trade receivables: Rs 1,125.87 cr
FY2025 current borrowings: Rs 284.55 cr
FY2026 Vertical A revenue: Rs 1,365.22 cr
FY2026 Vertical B revenue: Rs 1,235.65 cr
FY2026 Vertical C revenue: Rs 327.87 cr
FY2026 current borrowings: Rs 578.28 cr
FY2025 consolidated EBITDA: Rs 266 cr
FY2026 consolidated EBITDA: Rs 205 cr
FY2026 financing cash flow: Rs 244.92 cr generated
FY2026 investing cash flow: Rs 34.38 cr used
FY2026 operating cash flow: Rs 148.51 cr used
Q4 FY2026 consolidated EPS: Rs 14.59
Q4 FY2026 consolidated PBT: Rs 56.66 cr
Recommended final dividend: Rs 2 per equity share
FY2026 working capital days: 197 days
Q4 FY2026 Vertical A revenue: Rs 398.65 cr
Q4 FY2026 Vertical B revenue: Rs 356.65 cr
Q4 FY2026 Vertical C revenue: Rs 117.71 cr
Q4 FY2025 consolidated EBITDA: Rs 78 cr
Q4 FY2026 consolidated EBITDA: Rs 75 cr
FY2025 consolidated net profit: Rs 164.54 cr
FY2026 consolidated net profit: Rs 106.07 cr
FY2026 consolidated tax expense: Rs 31.44 cr
FY2025 cash and cash equivalents: Rs 29.02 cr
FY2026 Vertical A segment result: Rs 64.18 cr
FY2026 Vertical B segment result: Rs 74.51 cr
FY2026 Vertical C segment result: Rs 17.80 cr
FY2026 cash and cash equivalents: Rs 91.05 cr
FY2026 consolidated total income: Rs 2,960.82 cr
FY2025 consolidated EBITDA margin: 10%
FY2026 consolidated EBITDA margin: 7%
Q4 FY2025 consolidated net profit: Rs 48.00 cr
Q4 FY2026 consolidated net profit: Rs 47.26 cr
FY2026 consolidated revenue growth: 13% year on year
FY2026 consolidated total expenses: Rs 2,817.20 cr
Q4 FY2026 consolidated tax expense: Rs 9.40 cr
Q4 FY2026 consolidated other income: Rs 11.29 cr
Q4 FY2026 consolidated total income: Rs 884.30 cr
Q4 FY2025 consolidated EBITDA margin: 10%
Q4 FY2026 consolidated EBITDA margin: 9%
FY2026 consolidated exceptional items: Rs 6.11 cr
Q4 FY2026 consolidated revenue growth: 7% year on year
Q4 FY2026 consolidated total expenses: Rs 827.64 cr
FY2026 profit attributable to shareholders: Rs 103.80 cr
FY2025 consolidated revenue from operations: Rs 2,583.06 cr
FY2026 consolidated revenue from operations: Rs 2,928.74 cr
Q4 FY2026 profit attributable to shareholders: Rs 43.88 cr
Q4 FY2025 consolidated revenue from operations: Rs 817.81 cr
Q4 FY2026 consolidated revenue from operations: Rs 873.01 cr

Financial highlights

Ind-Ra NCD rating: IND AA/Stable affirmed on Rs 1,200 crore NCDs
Exceptional income: Rs 45.10 crore in FY2026, mainly development-right certificate recognition/fair valuation
GTG dispute refund: Rs 218.46 crore refunded to LSTK contractor in March 2026 with about Rs 31.62 crore interest in FY2026 finance cost; company challenged the Bombay High Court order
FY2026 standalone PAT: Rs 429.81 crore
Interim dividend paid: Rs 1.00 per equity share paid in March 2026
Consolidated net worth: Rs 5,121.20 crore at March 31, 2026 vs Rs 4,745.33 crore at March 31, 2025
Freight subsidy income: About Rs 98.17 crore recognized in Q4 FY2026, of which Rs 77.28 crore pertained to earlier periods up to FY2025
Gas-pooling receivable: Rs 80.57 crore cumulative up to March 2026
ICRA monitored ratings: ICRA AA(Stable) for NCDs, cash-credit and term-loan facilities; ICRA AA(Stable)/A1+ for non-fund facilities; ICRA A1+ for commercial paper
FY2026 consolidated EPS: Rs 7.75 vs Rs 4.39 in FY2025
FY2026 consolidated PAT: Rs 427.45 crore vs Rs 242.45 crore in FY2025
FY2026 consolidated PBT: Rs 609.40 crore vs Rs 328.32 crore in FY2025
Consolidated inventories: Rs 1,597.37 crore at March 31, 2026 vs Rs 1,585.59 crore at March 31, 2025
Q4 FY2026 standalone PAT: Rs 188.63 crore
Consolidated total assets: Rs 16,700.88 crore at March 31, 2026 vs Rs 11,266.63 crore at March 31, 2025
Final dividend recommended: Rs 1.34 per equity share of face value Rs 10, subject to shareholder approval
Outstanding long-term debt: Rs 1,955.07 crore at March 31, 2026 vs Rs 1,546.66 crore at March 31, 2025
Q4 FY2026 consolidated PAT: Rs 186.72 crore vs Rs 72.46 crore in Q4 FY2025 and Rs 80.95 crore in Q3 FY2026
Q4 FY2026 consolidated PBT: Rs 275.84 crore vs Rs 100.33 crore in Q4 FY2025 and Rs 117.83 crore in Q3 FY2026
FY2026 trading segment result: Rs 239.52 crore vs Rs 92.03 crore in FY2025
Consolidated trade receivables: Rs 4,690.29 crore at March 31, 2026 vs Rs 3,100.67 crore at March 31, 2025
FY2026 trading segment revenue: Rs 5,925.70 crore vs Rs 4,675.13 crore in FY2025
FY2026 consolidated total income: Rs 18,690.90 crore vs Rs 17,098.46 crore in FY2025
FY2026 fertilizer segment result: Rs 308.19 crore vs Rs 101.67 crore in FY2025
GAIL gas-pooling demand disputed: Rs 52.18 crore demand against Rs 71.39 crore receivable; total FY2023 disputed amount Rs 123.57 crore
Q4 FY2026 trading segment result: Rs 60.81 crore
FY2026 fertilizer segment revenue: Rs 10,912.08 crore vs Rs 10,590.49 crore in FY2025
Phosphoric-acid capacity addition: 300 MTPD at Thal Unit, about Rs 865.25 crore investment, expected within 24 months from Letter of Intent, debt/equity funded
Q4 FY2026 trading segment revenue: Rs 2,059.41 crore
Q4 FY2026 consolidated total income: Rs 5,648.83 crore vs Rs 3,779.58 crore in Q4 FY2025
Q4 FY2026 fertilizer segment result: Rs 142.88 crore
Q4 FY2026 fertilizer segment revenue: Rs 3,021.73 crore
Consolidated cash and cash equivalents: Rs 123.89 crore at March 31, 2026 vs Rs 987.03 crore at March 31, 2025
FY2026 industrial-chemicals segment result: Rs 314.75 crore vs Rs 359.40 crore in FY2025
FY2026 consolidated revenue from operations: Rs 18,480.17 crore vs Rs 16,933.64 crore in FY2025
FY2026 industrial-chemicals segment revenue: Rs 1,627.21 crore vs Rs 1,656.36 crore in FY2025
Total gas-pooling exposure noted by auditors: About Rs 204.14 crore
Q4 FY2026 industrial-chemicals segment result: Rs 114.72 crore
Q4 FY2026 consolidated revenue from operations: Rs 5,580.57 crore vs Rs 3,729.67 crore in Q4 FY2025 and Rs 4,236.44 crore in Q3 FY2026
Q4 FY2026 industrial-chemicals segment revenue: Rs 495.80 crore
FY2026 consolidated PBT before exceptional items: Rs 564.30 crore vs Rs 323.95 crore in FY2025
Estimated subsidy income above notified NBS rates: Rs 928.40 crore for FY2026 current period, including Rs 362.61 crore in Q4 FY2026; Rs 630.46 crore outstanding at March 31, 2026
Q4 FY2026 consolidated PBT before exceptional items: Rs 230.74 crore vs Rs 95.96 crore in Q4 FY2025

Financial highlights

Dividend: Board recommended Rs 6.50 per equity share, or 130%, for FY2026 subject to shareholder approval
GST orders: June 2026 Durg appeal set aside FY2020 demands of Rs 879.15 lakh tax, Rs 659.35 lakh interest and Rs 87.91 lakh penalty; May 2026 Chhattisgarh order raised Rs 179.19 lakh tax, Rs 33.46 lakh interest and Rs 179.19 lakh penalty; April 2026 Rajasthan order upheld Rs 11.52 lakh plus equivalent penalty after dropping Rs 252.32 lakh of demand
Current capacity: About 18.0 million tonnes per annum total cement capacity; management said FY2026 utilization was 73% because the 1.35 mtpa addition came around September 2025
NECEM acquisition: NECEM Cement became a 77.96% subsidiary effective March 27, 2026, with Rs 18.83 crore goodwill recognized; management discussed about Rs 19 crore consideration and settlement of past liabilities around Rs 12.5 crore
Captive solar SPVs: DynoSpark investment up to Rs 16 crore for 25 MW AC / 36.25 MW DC plus 20 MWh BESS at Udaipur; Elevate Solar investment up to Rs 8 crore for 17.14 MW AC / 24 MW DC at Durg
Dug railway siding: Rs 325 crore project, with Rs 225 crore debt funding and balance from internal accruals; first phase completed
Durg project spend: Management said about Rs 500 crore had been spent by FY2026 end including railway siding
Standalone leverage: Net debt to EBITDA of 1.12x and net debt to equity of 0.32x as of March 31, 2026 in the presentation
2030 capacity target: 30 million tonnes cement capacity by 2030, according to management and the press release
FY2026 standalone EPS: Rs 34.66 in the presentation, up 52% YoY
FY2026 standalone PAT: Rs 430 crore in the presentation and Rs 430.34 crore in the press release; presentation showed 52% YoY growth
Q4 FY2026 sales volume: 38.96 lakh tonnes in the operational and financial performance presentation; up 8% YoY and 19% QoQ
FY2026 standalone PBIDT: Rs 1,128 crore in the presentation and Rs 1,127.90 crore in the press release; presentation showed 23% YoY growth
Standalone debt profile: Gross debt Rs 2,491 crore, cash Rs 1,225 crore and net debt Rs 1,266 crore as of March 31, 2026 in the presentation
Q4 FY2026 standalone EPS: Rs 11.13 in the operational and financial performance presentation
Q4 FY2026 standalone PAT: Rs 138 crore in the presentation and Rs 138.22 crore in the press release; presentation showed 138% QoQ growth and 19% YoY decline
Q4 FY2026 standalone PBIDT: Rs 324 crore in the presentation and Rs 324.42 crore in the press release; presentation showed 38% QoQ growth and 12% YoY decline
FY2026 standalone net sales: Rs 6,763 crore in the presentation and Rs 6,762.63 crore in the press release; presentation showed 9% YoY growth
FY2027-FY2029 capex outlook: Management indicated Rs 1,500-1,700 crore FY2027 capex, close to Rs 2,000 crore FY2028 capex and Rs 1,000-1,500 crore FY2029 capex
Q4 FY2026 sales realization: Rs 4,495 per tonne of cement in the presentation; down 8% YoY and up 1% QoQ
FY2026 standalone sales volume: 133.46 lakh tonnes in the press release versus 121.29 lakh tonnes in FY2025
Q4 FY2026 capacity utilization: 81% on total annual cement capacity of 18.0 million tonnes; presentation showed 84% in Q4 FY2025 and 67% in Q3 FY2026
Q4 FY2026 standalone net sales: Rs 1,902 crore in the presentation and Rs 1,901.53 crore in the press release; flat YoY and up 20% QoQ in the presentation
Q4 FY2026 trade and premium mix: Trade sales were 58% and premium products were 24% of trade sales in the presentation
Dug and split grinding expansion: Additional 2.3 mtpa clinker line, 4.6 mtpa grinding at Dug and 3.4 mtpa split grinding at Prayagraj, Madhubani and Patratu; project cost about Rs 3,000 crore and expected completion by March 2028
Q4 FY2026 cost and operating markers: Fuel cost was Rs 1.54 per Kcal, lead distance 380 km, power consumption 70 kWh per tonne, blended cement 62%, renewable energy 46%, CC ratio 1.44 and power cost Rs 5.79 per unit
Assam limestone / Trivikram accounting: Rs 325 crore investment derecognized, Rs 195 crore unpaid liability written back and Rs 130 crore claims recoverable recognized in standalone results; Rs 325 crore mining rights derecognized in consolidated results
Q4 FY2026 EBITDA excluding other income: Rs 286 crore and Rs 734 per tonne in the presentation; EBITDA per tonne was down 25% YoY and up 17% QoQ

Financial highlights

Dividend: Final dividend recommended at Rs 40 per equity share for FY2026, subject to shareholder approval
BAPA tax effect: Incremental prior-year tax expense of INR 614.8 million, including INR 72.8 million of interest disclosed as an exceptional item
Promoter holding: SKF Vertevo AB held 25,992,059 shares, or 52.58%, after FY2026 group transfer / renaming steps
FY2026 sales bridge: Price / mix positive 0.6% and volume positive 12.2%
Net working capital: 24.3% of sales; down 3.7 percentage points YoY and up 4.6 percentage points QoQ
Q4 FY2026 sales mix: OEM 66%, distribution 20%, exports 8% and SKF Industrial 6%
FY2026 net sales KPI: INR 20,304 million, up 12.8% YoY; excludes other operating income
FY2026 net-sales split: OEM INR 13,393 million; distribution INR 4,692 million; SKF Industrial INR 737 million; exports INR 1,482 million
Q4 FY2026 net sales KPI: INR 5,550 million, up 3% QoQ and about 14.8% YoY; excludes other operating income
Demerger exceptional costs: INR 334.4 million across IT cost, professional services and estimated transfer premium payable to statutory authorities
FY2026 operating cash flow: INR 4,058 million with 85% cash conversion ratio
FY2026 standalone reported PBT: INR 2,350.0 million versus INR 3,551.5 million in FY2025
Secondary adjustment tax impact: INR 88.8 million included within incremental tax expense
SKF India Industrial share allotment: 49,437,963 equity shares of face value Rs 10 each allotted in a 1:1 ratio to SKF India shareholders as of October 15, 2025
FY2026 PBT before exceptional items KPI: INR 2,621 million, 12.3% margin, down 694 bps YoY
Q4 FY2026 price / mix and volume bridge: Price / mix negative 0.4% QoQ and positive 3.1% YoY; volume positive 3.4% QoQ and positive 11.8% YoY
FY2026 standalone revenue from operations: INR 21,295.9 million, up 15.4% YoY in the press release
Q4 FY2026 PBT before exceptional items KPI: INR 534 million, 9.0% margin
Q4 FY2026 standalone revenue from operations: INR 5,945.4 million, up 20.7% YoY in the press release
Q4 FY2026 standalone PBT after exceptional items: INR 461.0 million versus INR 1,107.4 million in Q4 FY2025
Q4 FY2026 standalone PBT before exceptional items and tax: INR 533.8 million versus INR 1,107.4 million in Q4 FY2025

Financial highlights

Inventory: 30 warehouse inventory days; 112 days for first-year stores; 36 days for stores older than 12 months
FY2026 PAT: Rs 2,196.06 million versus Rs 1,502.33 million in FY2025
FY2026 EBITDA: Rs 6,786.9 million, 9.8% margin
Q4 FY2026 PAT: Rs 639.73 million versus Rs 513.20 million in Q4 FY2025
Working capital: 53 days net working capital in Q4 FY2026
Q4 FY2026 EBITDA: Rs 1,897.7 million, 10.2% margin
FY2026 gross margin: Rs 18,078.6 million, 26.2% of revenue
Omni-channel revenue: Rs 927 million in Q4 FY2026
Online delivery hubs: 711 hubs in Q4 FY2026
FY2026 retail revenue: Rs 67,601.06 million
Cash and bank deposits: Rs 5,942.1 million at March 31, 2026
Q4 FY2026 gross margin: Rs 4,934.4 million, 26.5% of revenue
FY2026 operating EBITDA: Rs 3,658.4 million, up 31.8% YoY, with 5.3% margin
Stores at March 31 2026: 5,330 stores, more than 2.8 million square feet, average store size 528 square feet
Q4 FY2026 retail revenue: Rs 18,289.76 million
Private-label revenue mix: 22.0% of Q4 FY2026 revenue, with pharma at 11.4% and non-pharma at 10.6%
FY2026 net store additions: 618 net stores, after 792 gross additions
Q4 FY2026 operating EBITDA: Rs 1,076.3 million, up 34.0% YoY and 11.2% QoQ, with 5.8% margin
Stores older than 12 months: 17.8% YoY revenue growth, 13.1% store-level EBITDA margin and 80.0% store-level operating ROCE in Q4 FY2026
Q4 FY2026 net store additions: 218 net stores, after 295 openings and 77 closures
FY2026 revenue from operations: Rs 68,924.66 million versus Rs 61,360.53 million in FY2025
FY2026 pharmacy operating EBITDA: Rs 3,476.2 million, 5.1% margin
Q4 FY2026 revenue from operations: Rs 18,643.85 million versus Rs 15,096.09 million in Q4 FY2025
FY2026 diagnostic operating EBITDA: Rs 196.0 million, 15.0% margin
FY2026 diagnostic-services revenue: Rs 1,309.87 million
Q4 FY2026 pharmacy operating EBITDA: Rs 1,021.8 million, 5.6% margin
Corrected FY2026 operating cash flow: Management corrected FY2026 operating cash flow to Rs 4,956 million and OCF-to-operating-EBITDA to 135.5%
Q4 FY2026 diagnostic operating EBITDA: Rs 53.1 million, 15.3% margin
Q4 FY2026 diagnostic-services revenue: Rs 347.80 million
Paid-up share capital after ESOP allotment: 120,137,061 equity shares of Rs 2 each

Financial highlights

AGM: 24th AGM scheduled for August 18, 2026
Products: More than 600 products
End users: More than 5,400
U.S. land: Approximately 159.92 acres in Jonesville, Union County, South Carolina
Borrowings: Rs 44.95 cr total non-current plus current borrowings at March 31, 2026
FY2026 EPS: Rs 136.03
Warehouses: USA and Europe
Inventories: Rs 402.49 cr at March 31, 2026
Distributors: More than 330
Total equity: Rs 2,664.52 cr at March 31, 2026
Audit opinion: Unmodified opinions on standalone and consolidated FY2026 financial results
Earnings call: May 21, 2026 at 3:30 p.m. IST
OFM net worth: RM 34.245075 mn, equivalent to Rs 79.65 cr as of January 31, 2026
Q4 FY2026 EPS: Rs 38.32
Board approval: May 19, 2026; audited standalone and consolidated Q4/FY2026 results approved
Final dividend: Rs 11 per equity share of face value Rs 5, subject to shareholder approval
Countries served: More than 110
Direct customers: More than 950
Call participants: Mukesh Shah, Chairman and Whole-Time Director; Sonali Bhadani, Chief Financial Officer
FY2026 PAT margin: 17.6%
Trade receivables: Rs 351.13 cr at March 31, 2026
OFM proposed stake: Up to 80% of Oleofine Organics Sdn. Bhd.
Exports revenue mix: Around 55% of revenue in Q4 FY2026 and FY2026
FY2026 gross profit: Rs 949.2 cr
Board meeting timing: Commenced at 12:00 noon and concluded at 4:40 p.m.
Dividend record date: July 31, 2026
Domestic revenue mix: Around 45% of revenue in Q4 FY2026 and FY2026
OFM acquisition cost: Up to RM 34.210542 mn, about Rs 82.86 cr plus applicable transaction costs
Q4 FY2026 PAT margin: 18.8%
Labour Code provision: Rs 7.11 cr incremental gratuity provision for the quarter and nine months ended December 31, 2025
OFM completion timing: Expected within three months, subject to definitive agreements
Tax assessment demand: Rs 56.06 lakh under Section 271(1)(c) for assessment year 2016-17; appeal filed; company says no material impact
Q4 FY2026 gross profit: Rs 252.1 cr
SEZ investment to date: About Rs 192.5 cr total investment in Fine Organic Industries (SEZ) Private Limited after Rs 65 cr additional preference shares
FY2026 consolidated PAT: Rs 417.07 cr, up 1.6% YoY
FY2026 exceptional item: Rs 6.98 cr business-interruption insurance settlement income related to the January 18, 2024 adjacent-plant fire incident
U.S. construction timing: 18-24 months after construction starts, with management aiming for 18 months
Cash and cash equivalents: Rs 188.33 cr at March 31, 2026
FY2026 consolidated EBITDA: Rs 483.0 cr versus Rs 512.9 cr in FY2025
FY2026 gross profit margin: 40.1%
FY2026 operating cash flow: Rs 429.60 cr net cash flow from operating activities
Q4 FY2026 consolidated PAT: Rs 117.49 cr, up 21.0% YoY
Thailand JV equity infusion: THB 22.50 mn, equivalent to Rs 6.17 cr, in Q3 FY2026
Q4 FY2026 consolidated EBITDA: Rs 129.8 cr, up 8.6% YoY and 37.6% QoQ
Q4 FY2026 gross profit margin: 40.3%
UAE subsidiary equity infusion: AED 200,000, equivalent to Rs 49.48 lakh, in Q4 FY2026
FY2026 PPE and capital advances: Rs 142.01 cr purchase of property, plant and equipment, intangibles including CWIP and capital advances
FY2026 consolidated total income: Rs 2,482.47 cr
SEZ commercial-production timing: Management expects commercial production sometime in FY2028, with Q&A indicating the second half of FY2028 is possible
SEZ first-phase capex indication: Approximately Rs 700-750 cr, including some base infrastructure for phase two
FY2026 consolidated EBITDA margin: 20.4%
U.S. subsidiary equity investment: USD 1.12 mn, about Rs 9.6 cr, into Fine Organics Americas LLC
FY2026 PBT before exceptional items: Rs 535.95 cr
Q4 FY2026 consolidated total income: Rs 659.92 cr
Q4 FY2026 consolidated EBITDA margin: 20.8%
OFM FY ended January 31, 2026 revenue: RM 23.287742 mn, equivalent to Rs 54.17 cr
Q4 FY2026 PBT before exceptional items: Rs 142.79 cr
FY2026 consolidated revenue from operations: Rs 2,365.80 cr, up 4.3% YoY per release
Q4 FY2026 consolidated revenue from operations: Rs 625.32 cr, up 3.1% YoY and 12.7% QoQ per release

Financial highlights

Net cash: Rs 883 cr as of March 31, 2026 in the performance update
Call date: May 21, 2026
Channel mix: Organised and new-age channels 32% of domestic business in FY2026; D2C brands about 9%; wholesale dependency 27% of domestic sales
IncNut stake: 59.69% acquired on June 1, 2026 and increased to 60.00% on June 11, 2026
Talc revenue: Management cited roughly Rs 300 cr FY2026 talc revenue, down about Rs 100 cr from the prior year
Audit opinion: S.R. Batliboi & Co. LLP issued unmodified audit opinions on standalone and consolidated audited financial results
Board meeting: May 21, 2026; commenced 12:00 noon and concluded 1:30 p.m.
Price increase: Management cited around 3% weighted average price increase over the preceding 1.5-2 months
IncNut turnover: Rs 175.1 cr in FY2025, Rs 196.5 cr in FY2024 and Rs 231.9 cr in FY2023
FY2026 dividends: Rs 10 per share, Rs 436.5 cr total payout; 51% of adjusted PAT and 56% of reported PAT
Trade receivables: Rs 343.3 cr at March 31, 2026 versus Rs 451.3 cr at March 31, 2025
Brand growth - FY2026: Navratna & Dermicool -15%; Pain Management +7%; BoroPlus +2%; Healthcare +5%; Kesh King -2%; Male Grooming -5%; 7 Oils in One +13%; The Man Company & Brillare +20%
Transcript filing date: May 25, 2026 with BSE and NSE
Axiom EBITDA commentary: Management said Axiom does about Rs 40-45 cr EBITDA
Consolidated FY2026 A&P: Rs 739.2 cr, up 6.5% YoY; 19.6% of revenue
Consolidated FY2026 PBT: Rs 846.1 cr versus Rs 893.9 cr in FY2025, down 5.3%
Brand growth - Q4 FY2026: Navratna & Dermicool -21%; Pain Management +11%; BoroPlus -8%; Healthcare +7%; Kesh King +14%; Male Grooming -4%; 7 Oils in One +34%; The Man Company & Brillare +34%
FY2026 domestic net sales: Down 1%; domestic ex-summer up 5%; summer portfolio down 16%
Axiom corporate guarantees: Rs 7.10 cr for Axiom Ayurveda, Rs 151.52 cr for Axiom Foods & Beverages and Rs 17.62 cr for Axiom Packwell
Consolidated FY2026 EBITDA: Rs 963.6 cr versus Rs 1,025.1 cr in FY2025, down 6.0%; margin 25.5% versus 26.9%
Consolidated Q4 FY2026 A&P: Rs 212.0 cr, up 12.2% YoY; 22.9% of revenue
Consolidated Q4 FY2026 PAT: Rs 143.2 cr versus Rs 162.2 cr in Q4 FY2025, down 11.7%
Consolidated Q4 FY2026 PBT: Rs 164.1 cr versus Rs 193.7 cr in Q4 FY2025, down 15.3%
Quick commerce and GT Marts: Quick commerce grew 70% and GT Marts grew 25% in Q4 FY2026
Q4 FY2026 domestic net sales: Down 3%; domestic ex-summer up 11%; summer portfolio down 22%
Audited standalone FY2026 PAT: Rs 841.62 cr
Axiom expected FY2026 topline: Around Rs 180 cr in the Axiom acquisition press release
Consolidated FY2026 net sales: Rs 3,745.3 cr versus Rs 3,765.1 cr in FY2025, down 0.5%
Consolidated Q4 FY2026 EBITDA: Rs 186.7 cr versus Rs 219.4 cr in Q4 FY2025, down 14.9%; margin 20.2% versus 22.8%
FY2026 international business: Up 3%
Audited standalone diluted EPS: Rs 3.81 in Q4 FY2026 and Rs 19.28 in FY2026
Audited consolidated FY2026 PAT: Rs 775.26 cr in the SEBI results
Axiom acquisition consideration: Aggregate consideration not exceeding Rs 200 cr for remaining about 73.5% stake
Audited consolidated diluted EPS: Rs 3.28 in Q4 FY2026 and Rs 17.76 in FY2026
Audited standalone Q4 FY2026 PAT: Rs 166.39 cr
Consolidated FY2026 gross margin: 69.9%, up 130 bps YoY
Consolidated Q4 FY2026 net sales: Rs 918.0 cr versus Rs 954.0 cr in Q4 FY2025, down 3.8%
IncNut acquisition consideration: Up to Rs 321 cr for 60% fully diluted stake
Q4 FY2026 international business: Down 5%; January-February 2026 international business up 16%
New Labour Codes exceptional item: Rs 10.15 cr exceptional item in FY2026 consolidated and standalone audited results
Audited consolidated Q4 FY2026 PAT: Rs 143.17 cr in the SEBI results
Consolidated Q4 FY2026 gross margin: 68.4%, up 250 bps YoY
Consolidated FY2026 PAT - presentation: Rs 775.3 cr versus Rs 802.7 cr in FY2025, down 3.4%
Audited standalone FY2026 revenue from operations: Rs 3,048.26 cr
Audited consolidated FY2026 revenue from operations: Rs 3,779.51 cr in the SEBI results
Audited standalone Q4 FY2026 revenue from operations: Rs 729.61 cr
Audited consolidated Q4 FY2026 revenue from operations: Rs 925.10 cr in the SEBI results
Consolidated FY2026 revenue from operations - presentation: Rs 3,779.5 cr versus Rs 3,809.2 cr in FY2025, down 0.8%
Consolidated Q4 FY2026 revenue from operations - presentation: Rs 925.1 cr versus Rs 963.0 cr in Q4 FY2025, down 3.9%

Financial highlights

Standalone FY2026 EPS: Rs 35.36 versus Rs 41.98 in FY2025
Consolidated FY2026 EPS: Rs 36.56 versus Rs 43.22 in FY2025
Consolidated FY2026 PAT: Rs 1,440.63 cr
FY2026 interim dividends: Four interim dividends totalling Rs 12.50 per share, equal to 250% of face value
Standalone FY2026 EBITDA: Rs 2,156.46 cr according to the earnings release
Standalone Q4 FY2026 EPS: Rs 5.55 versus Rs 8.03 in Q3 FY2026 and Rs 9.19 in Q4 FY2025
Standalone Q4 FY2026 PAT: Rs 218.64 cr versus Rs 316.44 cr in Q3 FY2026 and Rs 362.18 cr in Q4 FY2025
Consolidated total assets: Rs 13,841.11 cr at March 31, 2026
Consolidated total equity: Rs 12,659.86 cr at March 31, 2026
Consolidated FY2026 EBITDA: Rs 2,214.21 cr, described by the earnings release as up 3.82%
Consolidated Q4 FY2026 EPS: Rs 5.90 versus Rs 8.23 in Q3 FY2026 and Rs 9.42 in Q4 FY2025
Consolidated Q4 FY2026 PAT: Rs 232.34 cr versus Rs 324.33 cr in Q3 FY2026 and Rs 371.09 cr in Q4 FY2025
Domestic subscription revenue: Rs 1,891.68 cr in FY2026, up 9.69% from Rs 1,724.62 cr in FY2025
Consolidated trade receivables: Rs 1,433.46 cr at March 31, 2026
Standalone FY2026 total income: Rs 4,637.70 cr versus Rs 4,543.96 cr in FY2025
FY2026 cricket-franchise income: Rs 662.12 cr with corresponding costs of Rs 422.56 cr
Consolidated Q4 FY2026 owner PAT: Rs 232.02 cr
Consolidated current investments: Rs 6,260.07 cr at March 31, 2026
Standalone Q4 FY2026 total income: Rs 941.67 cr versus Rs 958.39 cr in Q3 FY2026 and Rs 1,135.86 cr in Q4 FY2025
Q4 FY2026 cricket-franchise income: Rs 79.96 cr with corresponding costs of Rs 73.44 cr
Consolidated Q4 FY2026 total income: Rs 982.21 cr versus Rs 999.27 cr in Q3 FY2026 and Rs 1,182.06 cr in Q4 FY2025
Standalone Q4 FY2026 total expenses: Rs 564.40 cr versus Rs 528.73 cr in Q3 FY2026 and Rs 597.23 cr in Q4 FY2025
Consolidated Q4 FY2026 total expenses: Rs 593.01 cr versus Rs 558.65 cr in Q3 FY2026 and Rs 634.92 cr in Q4 FY2025
Consolidated cash and cash equivalents: Rs 243.04 cr at March 31, 2026
Standalone Q4 FY2026 exceptional items: Negative Rs 70.98 cr
Consolidated FY2026 operating cash flow: Rs 1,801.64 cr versus Rs 1,664.51 cr in FY2025
Consolidated Q4 FY2026 exceptional items: Negative Rs 67.89 cr
Standalone FY2026 revenue from operations: Rs 4,102.13 cr versus Rs 3,878.86 cr in FY2025
Consolidated FY2026 revenue from operations: Rs 4,334.82 cr, described by the earnings release as up 7.96%
Consolidated radio joint-venture impairment: Rs 67.89 cr recognised in Q4/FY2026
Standalone Q4 FY2026 revenue from operations: Rs 848.48 cr versus Rs 827.87 cr in Q3 FY2026 and Rs 909.01 cr in Q4 FY2025
Consolidated New Labour Code exceptional item: Rs 5.09 cr recognised during Q3 FY2026
Standalone FY2026 PAT after exceptional items: Rs 1,393.52 cr versus Rs 1,654.46 cr in FY2025
Consolidated Q4 FY2026 revenue from operations: Rs 882.51 cr versus Rs 862.16 cr in Q3 FY2026 and Rs 941.81 cr in Q4 FY2025
Standalone Q4 FY2026 PBT after exceptional items: Rs 306.29 cr versus Rs 425.43 cr in Q3 FY2026 and Rs 465.11 cr in Q4 FY2025
Standalone Q4 FY2026 PBT before exceptional items: Rs 377.27 cr versus Rs 429.66 cr in Q3 FY2026 and Rs 538.63 cr in Q4 FY2025
Consolidated Q4 FY2026 PBT before exceptional items and tax: Rs 390.41 cr versus Rs 441.15 cr in Q3 FY2026 and Rs 532.78 cr in Q4 FY2025

Financial highlights

Portfolio: 28 highway projects: 18 BOT, 6 TOT and 4 HAM projects
Asset base: About Rs 94,000 cr after expanding from Rs 80,000 cr
Order book: About Rs 45,000 cr, including EPC order book of Rs 2,100 cr
BOT pipeline: About 1,400 km and Rs 34,500 cr capital outlay for FY2027 based on NHAI website, per management
FY2026 EBITDA: Rs 4,188 cr versus Rs 4,024 cr in FY2025, up 4% YoY
Q4 FY2026 EBITDA: Rs 1,133 cr versus Rs 1,066 cr in Q4 FY2025, up 6% YoY
FASTag penetration: About 97% through roughly 1,000 FASTag-compliant lanes at 86 toll plazas
Net debt to equity: 0.5:1 in presentation, described as one of the lowest in the sector
Road AUM objective: Rs 800 bn to about Rs 1,400 bn over three years
FY2026 finance cost: Rs 1,755.1 cr in the presentation summary
FY2026 total income: Rs 7,854 cr versus Rs 8,032 cr in FY2025, down 2% YoY
Operational lane km: About 17,500 lane km across 13 states
Q4 FY2026 finance cost: Rs 405.8 cr in the presentation summary; down from Rs 457.7 cr in Q4 FY2025
Q4 FY2026 total income: Rs 1,977 cr versus Rs 2,218 cr in Q4 FY2025, down 11% YoY
Presentation order book: Rs 449 bn total, split as EPC Rs 21 bn and O&M Rs 428 bn
Public InvIT AUM target: About Rs 40,000 cr AUM in two to three years, after moving from about Rs 8,000 cr EV to Rs 18,000 cr EV
Awarded TOT market share: 44% through 6 TOT assets
Projects added in FY2026: About Rs 14,000 cr
Group FY2026 toll revenue: Rs 8,323 cr versus Rs 7,400 cr in FY2025, up 12% YoY
Assets monetized in FY2026: About Rs 8,400 cr
FY2030 financial objective: Net debt 0.6x to 0.0x, cash ROE 8% to 14% plus, PAT CAGR 25%
Golden Quadrilateral share: About 16% of India's Golden Quadrilateral connectivity
Mumbai-Pune Q4 toll growth: 6% YoY
North-South corridor share: About 12% of North-South highway connectivity
FY2026 net profit after tax: Rs 850.36 cr after exceptional items in the audited consolidated statement
Gandeva-to-Ena HAM transfer: Rs 513 cr equity contribution and Rs 700 cr debt reduction
FY2026 dividend distribution: About Rs 180 cr per management commentary
FY2026 BOT/TOT segment revenue: Rs 2,691.86 cr versus Rs 2,483.88 cr in FY2025
FY2026 revenue from operations: Rs 7,648.15 cr in the audited consolidated statement
Q4 FY2026 net profit after tax: Rs 296.26 cr in the audited consolidated statement
Ahmedabad-Vadodara Q4 toll growth: 23% YoY
Equity capital unlocked in FY2026: About Rs 4,900 cr
FY2026 InvIT distributions to IRB: Almost Rs 300 cr from both InvITs, according to management
Q4 FY2026 BOT/TOT segment revenue: Rs 711.82 cr versus Rs 641.15 cr in Q4 FY2025
Q4 FY2026 revenue from operations: Rs 1,927.00 cr in the audited consolidated statement
FY2026 PAT before exceptional items: Rs 893 cr versus Rs 677 cr in FY2025, up 32% YoY
FY2026 construction segment revenue: Rs 3,622.37 cr versus Rs 4,560.68 cr in FY2025
Q4 FY2026 Public InvIT distribution: About Rs 205 cr; IRB effective 17% share nearly Rs 34 cr
Q4 FY2026 Private InvIT distribution: About Rs 199 cr; IRB 51% share about Rs 101 cr
Q4 FY2026 PAT before exceptional items: Rs 296 cr versus Rs 215 cr in Q4 FY2025, up 38% YoY
Q4 FY2026 construction segment revenue: Rs 811.98 cr versus Rs 1,197.53 cr in Q4 FY2025
Share of India's aggregate toll revenue: 10% of Rs 82,900 cr FY2026 aggregate toll revenue
Remaining Private InvIT migration potential: Five assets with roughly Rs 30,000 cr to Rs 35,000 cr enterprise value over two to three years
Three BOT assets transferred to Public InvIT: Enterprise value Rs 8,436 cr; unlocked capital Rs 4,905 cr
FY2026 InvITs and related assets segment revenue: Rs 1,318.32 cr versus Rs 760.39 cr in FY2025
Two-asset Private InvIT to Public InvIT transfer: Solapur-Yedeshi and Chittorgarh-Gulabpura, about Rs 4,500 cr enterprise value
Q4 FY2026 InvITs and related assets segment revenue: Rs 400.56 cr versus Rs 306.60 cr in Q4 FY2025
Q4 FY2026 Private InvIT average daily toll collection: Rs 11.79 cr versus Rs 9.10 cr in Q4 FY2025, up about 30%
Q4 FY2026 combined Private InvIT and IRB average daily toll collection: Rs 19.80 cr versus Rs 16.31 cr in Q4 FY2025, up 21%

Financial highlights

Credit rating: CARE AA; Stable / CARE A1+ for Rs 56 cr long-term/short-term bank facilities
New warehouse: About 3 lakh sq ft commissioned during Q4 FY2026
Final dividend: Rs 3 per equity share recommended for FY2025-26
FY2026 store network: 1,032 stores across 221 cities and 31 states/union territories
FY2026 standalone PAT: Rs 400 cr, up 14.6% YoY, margin 14.3%
FY2026 loyalty members: More than 19 mn
FY2026 consolidated PAT: Rs 416 cr, up 17.3% YoY, margin 14.5%
New Labour Code expense: Rs 3.39 cr actuarial provision impact in FY2026
Consolidated inventories: Rs 856 cr at March 31, 2026 versus Rs 637 cr at March 31, 2025
FY2026 standalone EBITDA: Rs 854 cr, up 14.1% YoY, margin 30.5%
Net core working capital: Rs 678 cr and 86 days at March 31, 2026 versus Rs 502 cr and 73 days at March 31, 2025
Q4 FY2026 standalone PAT: Rs 115 cr, up 17.6% YoY, margin 15.1%
FY2026 e-commerce revenue: Rs 361 cr, 12.9% of standalone revenue, up 39% YoY
FY2026 standalone revenue: Rs 2,797 cr, up 14.2% YoY from Rs 2,450 cr
FY2026 consolidated EBITDA: Rs 869 cr, up 14.5% YoY, margin 30.3%
FY2026 net store additions: 124 net additions from 147 openings and 23 closures
Q4 FY2026 consolidated PAT: Rs 118 cr, up 23.5% YoY, margin 15.2%
Consolidated trade payables: Rs 278 cr at March 31, 2026 versus Rs 226 cr at March 31, 2025
FY2026 consolidated revenue: Rs 2,864 cr, up 14.2% YoY from Rs 2,507 cr
In-house brand contribution: 73% of revenue at Metro, Mochi and Walkway MBOs
Q4 FY2026 standalone EBITDA: Rs 234 cr, up 20.2% YoY, margin 31.0%
Q4 FY2026 standalone revenue: Rs 757 cr, up 19.8% YoY from Rs 632 cr
FY2026 consolidated net capex: Rs 138 cr versus Rs 86 cr in FY2025
Q4 FY2026 consolidated EBITDA: Rs 238 cr, up 20.5% YoY, margin 30.8%
Q4 FY2026 net store additions: 42 net additions from 47 openings and 5 closures
Consolidated trade receivables: Rs 100 cr at March 31, 2026 versus Rs 91 cr at March 31, 2025
Q4 FY2026 consolidated revenue: Rs 773 cr, up 20.3% YoY from Rs 643 cr
Consolidated current investments: Rs 656 cr at March 31, 2026 versus Rs 529 cr at March 31, 2025
Q4 FY2026 standalone gross profit: Rs 439 cr, gross margin 57.9%
Q4 FY2026 consolidated gross profit: Rs 447 cr, gross margin 57.8%
Consolidated cash and cash equivalents: Rs 33 cr at March 31, 2026 versus Rs 95 cr at March 31, 2025
FY2026 consolidated operating cash flow: Rs 474 cr versus Rs 698 cr in FY2025
Warehouse lease-liability reversal gain: Rs 7 cr under other income
Q4 FY2026 e-commerce and omni-channel growth: Up 53% YoY, 12.2% of revenue versus 9.5% in Q4 FY2025

Financial highlights

Dividend: Fourth interim dividend of Rs 150 per share; FY2026 interim dividends declared were Rs 150, Rs 125, Rs 125 and Rs 150 per share
FY2026 EPS: Rs 684.81 basic and diluted vs Rs 653.71 in FY2025
FY2026 PAT: Rs 763.82 cr vs Rs 729.14 cr in FY2025; up 4.8% YoY
Inventories: Rs 1,055.66 cr at March 31, 2026 vs Rs 858.87 cr at March 31, 2025
Ecommerce mix: Management said ecommerce contributed about 15% of topline and gained a couple of percentage points versus last year
FY2026 EBITDA: Rs 1,152.9 cr; up 8.5% YoY; EBITDA margin 22.0%
Q4 FY2026 EPS: Rs 160.24 basic and diluted
Q4 FY2026 PAT: Rs 178.73 cr vs Rs 164.01 cr in Q4 FY2025; up about 9.0% YoY
Q4 FY2026 PBT: Rs 237.80 cr vs Rs 218.68 cr in Q4 FY2025
Inventory days: 73 days at Q4 FY2026 end vs 64 days at the beginning of the year
Exceptional item: Rs 35.00 cr in FY2026 related to New Labour Codes
Q4 FY2026 EBITDA: Rs 260.5 cr; up 10.7% YoY; EBITDA margin 20.8%
Trade receivables: Rs 201.10 cr at March 31, 2026 vs Rs 191.61 cr at March 31, 2025
FY2026 capex proxy: Purchase of property, plant and equipment including capital work-in-progress, intangible assets and capital advances was Rs 107.87 cr
FY2026 sales volume: 228.4 million pieces; up 3.9% YoY
FY2026 total income: Rs 5,310.67 cr vs Rs 4,996.54 cr in FY2025
FY2026 dividends paid: Rs 669.29 cr, including amount transferred to Investor Education and Protection Fund
FY2026 total expenses: Rs 4,250.33 cr vs Rs 4,017.96 cr in FY2025
Distribution footprint: Around 116,600-plus multi-brand outlets, 1,615 exclusive brand stores and 893 large-format stores
Q4 FY2026 sales volume: 54.5 million pieces; up 10.8% YoY
Q4 FY2026 total income: Rs 1,269.77 cr vs Rs 1,118.20 cr in Q4 FY2025
Net working capital days: 56 days at Q4 FY2026 end vs 54 days at the beginning of the year
Q4 FY2026 total expenses: Rs 1,031.96 cr vs Rs 899.53 cr in Q4 FY2025
Cash and cash equivalents: Rs 267.26 cr at March 31, 2026 vs Rs 238.29 cr at March 31, 2025
FY2026 operating cash flow: Cash generated from operations Rs 1,062.88 cr; net CFO after taxes Rs 794.40 cr
FY2026 revenue from operations: Rs 5,246.78 cr vs Rs 4,934.91 cr in FY2025; up 6.3% YoY
FY2026 PBT after exceptional item: Rs 1,025.34 cr vs Rs 978.58 cr in FY2025
Q4 FY2026 revenue from operations: Rs 1,252.59 cr vs Rs 1,098.07 cr in Q4 FY2025; up 14.1% YoY
FY2026 PBT before exceptional item: Rs 1,060.34 cr vs Rs 978.58 cr in FY2025
Company website FY2026 return metrics: Return on net worth 53%; return on capital employed 73%

Financial highlights

ROCE: 21.2% in FY2026 versus 11.3% in FY2025
Inventory: Rs 1,642.16 cr at March 31, 2026 versus Rs 1,417.54 cr at March 31, 2025
PAT trend: Rs 21 cr in FY2023, Rs 40 cr in FY2024, Rs 72 cr in FY2025 and Rs 204 cr in FY2026
FY2026 PAT: Rs 204 cr, up 183% YoY; 2.0% PAT margin
EBITDA trend: Rs 256 cr in FY2023, Rs 346 cr in FY2024, Rs 474 cr in FY2025 and Rs 752 cr in FY2026
FY2026 EBITDA: Rs 752 cr, up 59% YoY; 7.5% EBITDA margin
Q4 FY2026 PAT: Rs 79 cr, up 313% YoY; 3.0% PAT margin
Revenue trend: Rs 5,144 cr in FY2023, Rs 6,386 cr in FY2024, Rs 7,950 cr in FY2025 and Rs 10,022 cr in FY2026
Store network: 313 stores across 99 cities and more than 3.1 lakh sq ft at March 31, 2026
Store additions: 76 stores added in FY2026; Q4 included 26 new openings and 11 Kiehl's integrations
Q4 FY2026 EBITDA: Rs 223 cr, up 67% YoY; 8.4% EBITDA margin
FY2026 Beauty GMV: Rs 14,954 cr, up 27% YoY
FY2026 Beauty NSV: Rs 8,504 cr, up 27% YoY
Trade receivables: Rs 289.38 cr at March 31, 2026 versus Rs 246.61 cr at March 31, 2025
FY2026 Fashion GMV: Rs 4,954 cr, up 30% YoY
FY2026 Fashion NSV: Rs 1,447 cr, up 29% YoY
FY2026 gross profit: Rs 4,516 cr, up 30% YoY; 45.1% gross margin
Dot & Key FY2026 GMV: Rs 1,790 cr, 13x over three years
FY2026 Beauty EBITDA: Rs 819 cr; 9.6% of NSV
Q4 FY2026 Beauty GMV: Rs 3,892 cr, up 27% YoY
Q4 FY2026 Beauty NSV: Rs 2,269 cr, up 29% YoY
FY2026 Fashion EBITDA: Negative Rs 37 cr; negative 2.6% of NSV
Kay Beauty FY2026 GMV: Rs 380 cr, 3x over three years
Q4 FY2026 Fashion GMV: Rs 1,334 cr, up 29% YoY
Q4 FY2026 Fashion NSV: Rs 397 cr, up 42% YoY
Superstore FY2026 GMV: Rs 1,187 cr, up 26% YoY
Cash and bank balances: Cash and cash equivalents Rs 177.20 cr plus bank balances other than cash and cash equivalents Rs 142.83 cr at March 31, 2026
Q4 FY2026 gross profit: Rs 1,203 cr, up 32% YoY; 45.4% gross margin
Consolidated borrowings: Non-current borrowings Rs 18.33 cr and current borrowings Rs 728.88 cr at March 31, 2026
FY2026 consolidated GMV: Rs 19,963 cr, up 28% YoY
Q4 FY2026 Beauty EBITDA: Rs 233 cr; 10.3% of NSV
Earth Rhythm acquisition: Remaining stake acquisition not exceeding Rs 9.4 cr for not more than 24.2%; ERPL FY2026 turnover Rs 23.75 cr
Q4 FY2026 Fashion EBITDA: Rs 1 cr; 0.3% of NSV
House of Nykaa FY2026 GMV: Rs 3,176 cr, up 49% YoY
FY2026 operating cash flow: Rs 644.30 cr net cash generated from operating activities versus Rs 466.63 cr in FY2025
Nykaa Cosmetics FY2026 GMV: More than Rs 400 cr
Q4 FY2026 consolidated GMV: Rs 5,241 cr, up 28% YoY
FY2026 revenue from operations: Rs 10,022 cr, up 26% YoY
Superstore onboarded retailers: 493,000 in FY2026, up 38% YoY
House of Nykaa Beauty FY2026 GMV: Rs 2,788 cr, up 65% YoY
Q4 FY2026 revenue from operations: Rs 2,648 cr, up 28% YoY

Financial highlights

FY2026 PAT: Rs 2,770 cr, up 37.6% YoY
JV ownership: 50:50 joint venture between Bosch and TSF Group companies represented by Brakes India and Wheels India
FY2026 EBITDA: Rs 2,650 cr, up 14.7% YoY
Q4 FY2026 PAT: Rs 568 cr, up 2.7% YoY
Final dividend: Rs 270 per equity share recommended for FY2026
JV target timing: Operations targeted to commence by end of 2026 according to the investor presentation
Q4 FY2026 EBITDA: Rs 782 cr, up 20.8% YoY
FY2026 HCV production: 476,000 units, up 16% YoY
FY2026 LCV production: 712,000 units, up 11% YoY
Q4 FY2026 HCV production: 155,000 units, up 26% YoY and 29% QoQ
Q4 FY2026 LCV production: 208,000 units, up 16% YoY and 19% QoQ
FY2026 tractor production: 1.242 million units, up 22% YoY
Q4 FY2026 tractor production: 335,000 units, up 31% YoY and 16% QoQ
FY2026 Consumer Goods revenue: Rs 1,836 cr versus Rs 1,725 cr in FY2025, up 6.4% YoY
FY2026 Power Solutions growth: Up 17.6% YoY according to the investor presentation
FY2027 HCV production outlook: 0.48 million units versus FY2026 actual 0.48 million units
FY2027 LCV production outlook: 0.72-0.73 million units versus FY2026 actual 0.71 million units
FY2026 revenue from operations: Rs 20,035 cr, up 10.8% YoY
FY2026 passenger-car production: 5.611 million units, up 10% YoY
FY2026 three-wheeler production: 1.282 million units, up 25% YoY
Q4 FY2026 Consumer Goods revenue: Rs 618 cr versus Rs 540 cr in Q4 FY2025, up 14.3% YoY
Q4 FY2026 Power Solutions growth: Up 27.4% YoY according to the investor presentation
FY2026 Mobility Solutions revenue: Rs 17,068 cr versus Rs 14,597 cr in FY2025, up 16.9% YoY
Q4 FY2026 revenue from operations: Rs 5,566 cr, up 13.3% YoY
FY2026 Mobility Aftermarket growth: Up 3.7% YoY
Q4 FY2026 passenger-car production: 1.588 million units, up 12% YoY and 12% QoQ
Q4 FY2026 three-wheeler production: 340,000 units, up 32% YoY and 1% QoQ
Q4 FY2026 Mobility Solutions revenue: Rs 4,728 cr versus Rs 3,834 cr in Q4 FY2025, up 23.3% YoY
FY2026 auto industry total production: About 26.856 million vehicles, up 11% YoY according to the presentation
FY2026 two-wheeler powersports growth: Up 69.1% YoY
FY2027 passenger-car production outlook: 5.78-5.90 million units versus FY2026 actual 5.61 million units
FY2027 three-wheeler production outlook: 1.29-1.31 million units versus FY2026 actual 1.28 million units
FY2027 total vehicle production outlook: 27.92-28.27 million units versus FY2026 actual 26.86 million units
Q4 FY2026 auto industry total production: About 7.081 million vehicles, up 20% YoY and 4% QoQ according to the presentation
Q4 FY2026 two-wheeler powersports growth: Up 63.4% YoY

Financial highlights

AHLL Q4 EBITDA: Rs 75 cr, up 58% YoY, margin of 15.3%
AHLL FY2026 PAT: Loss of Rs 10 cr versus loss of Rs 27 cr in FY2025
AHLL Q4 revenue: Rs 489 cr, up 24% YoY
Pharmacy stores: 7,289 stores after 176 net new stores opened in Q4 FY2026
AHLL FY2026 EBITDA: Rs 213 cr, up 38% YoY, margin of 11.4%
Apollo 24/7 Q4 GMV: Rs 528 cr, up 20% YoY
FY2026 diluted EPS: Rs 134.95
AHLL FY2026 revenue: Rs 1,865 cr, up 20% YoY
New units Q4 EBITDA: Loss of Rs 41 cr according to management commentary
Q4 FY2026 diluted EPS: Rs 36.76
Q4 hospital occupancy: 68% overall, versus 67% in Q4 FY2025
Apollo 24/7 FY2026 GMV: Rs 2,037 cr
Average length of stay: 3.19 days in Q4 FY2026 versus 3.3 days in Q4 FY2025
New hospital additions: 185 beds operationalized in FY2026 out of 855 potential beds across Apollo Athenaa NCR, Pune, Financial District Hyderabad and Narendrapur Kolkata; remaining 670 beds planned over the next 12 months
FY2026 consolidated PAT: Rs 1,942 cr, up 34% YoY
Operating hospital beds: 8,131 operating beds across the owned network as of March 31, 2026, excluding AHLL and managed beds
Apollo HealthCo Q4 EBITDA: Rs 156 cr versus Rs 36 cr in Q4 FY2025, margin of 5.5%
Online business cash loss: Rs 16 cr in Q4 FY2026 versus Rs 80 cr in Q4 FY2025
Apollo 24/7 order run rate: About 69,000 orders per day across pharma, diagnostics and consultations in Q4, excluding IP/OP referrals, versus 63,000 per day a year earlier
Apollo HealthCo FY2026 PAT: Rs 324 cr versus Rs 47 cr in FY2025
Apollo HealthCo Q4 revenue: Rs 2,848 cr, up 20% YoY
FY2026 consolidated EBITDA: Rs 3,769 cr, up 25% YoY
Q4 FY2026 consolidated PAT: Rs 529 cr, up 36% YoY
Average revenue per patient: Rs 1,87,208 in Q4 FY2026, up 9% YoY
Cloudnine transaction value: AHLL mother-and-child/fertility business valued at Rs 1,550 cr through cash plus 9.9% equity stake in the combined platform
Digital platform Q4 revenue: Rs 330 cr versus Rs 292 cr in Q4 FY2025
FY2026 consolidated revenue: Rs 25,229 cr, up 16% YoY
Apollo HealthCo FY2026 EBITDA: Rs 488 cr versus Rs 168 cr in FY2025, margin of 4.5%
Healthcare Services Q4 EBITDA: Rs 781 cr, up 14% YoY, with margin of 23.9%
Q4 FY2026 consolidated EBITDA: Rs 1,011 cr, up 31% YoY
Apollo HealthCo FY2026 revenue: Rs 10,808 cr, up 19% YoY
Healthcare Services FY2026 PAT: Rs 1,628 cr, up 14% YoY
Healthcare Services Q4 revenue: Rs 3,268 cr, up 16% YoY
Q4 FY2026 consolidated revenue: Rs 6,605 cr, up 18% YoY
Cradle/Fertility FY2026 revenue: Rs 450 cr, with IGAAP EBITDA of Rs 45 cr according to management commentary
Healthcare Services FY2026 ROCE: 25.4%
Healthcare Services FY2026 EBITDA: Rs 3,069 cr, up 14% YoY, with margin of 24.4%
Healthcare Services FY2026 revenue: Rs 12,555 cr, up 13% YoY
Established hospitals Q4 EBITDA margin: 25.5% according to management commentary
Offline pharmacy distribution Q4 revenue: Rs 2,518 cr versus Rs 2,084 cr in Q4 FY2025

Financial highlights

FY2026 PAT: Rs 2,246 million, up 1,334.0% YoY
API R&D team: About 250 scientists per management
Q4 FY2026 PAT: Rs 664 million versus Rs -322 million in Q4 FY2025
FY2026 revenue: Rs 34,203 million, up 13.8% YoY
FY2025 net debt: Rs 4,511 million in investor presentation snapshot
Current NSE ISIN: INE807F01027
FY2026 ESOP cost: Rs 362 million
Q4 FY2026 revenue: Rs 9,200 million, up 19.1% YoY
FY2026 API revenue: Rs 14,906 million, up 8% YoY
Q4 FY2026 net debt: Rs 1,661 million in investor presentation snapshot
FY2026 gross margin: 54.3%
Q4 FY2026 ESOP cost: Rs 53 million
FY2026 EBITDA margin: 20.5% versus 14.6% in FY2025
Existing depreciation: About 6% of revenue per management
Minority share of PAT: About 20% of PAT from minority interests per management discussion
Q4 FY2026 API revenue: Rs 3,836 million, up 5% YoY and 5% QoQ
FY2026 adjusted EBITDA: Rs 7,025 million, up 59.6% YoY
Q4 FY2026 gross margin: 55.1%
BioForLife CY2023 sales: EUR 7.1 million
BioForLife CY2024 sales: EUR 8.3 million
BioForLife CY2025 sales: EUR 9.0 million
Q4 FY2026 EBITDA margin: 21.7% versus 15.8% in Q4 FY2025
CDMO business inside API: About Rs 200 crore, roughly 15% of API topline per management
Spain subsidiary revenue: About Rs 550 crore in FY2026 per management
BioForLife customer reach: More than 80% of veterinary clinics in Italy
Current NSE active symbol: VIYASH
FY2026 gross margin value: Rs 18,576 million
FY2026 operating expenses: Rs 6,378 million, up 6.6% YoY
Q4 FY2026 adjusted EBITDA: Rs 2,001 million, up 63.8% to 63.9% YoY
BioForLife closing payment: EUR 15.0 million
FY2026 formulations revenue: Rs 18,657 million, up 18% YoY
Initial synergy expectation: About Rs 50 crore, later Rs 60 crore
BioForLife acquisition stake: 100% shareholding
Implied annual growth marker: About 15% annual growth per management response
Q4 FY2026 gross margin value: Rs 5,071 million
Q4 FY2026 operating expenses: Rs 1,689 million, up 7.0% YoY
BioForLife closing expectation: Q2 FY2027
Q4 FY2026 formulations revenue: Rs 4,991 million, up 28% YoY and 4% QoQ
FY2026 USA formulations revenue: Rs 4,266 million, up 9% YoY
FY2026 employee benefit expense: Rs 5,293 million
Net debt to LTM adjusted EBITDA: 0.2x versus 1.0x in FY2025
Internal EBITDA target discussed: Rs 1,000 crore
BioForLife deferred consideration: EUR 1.975 million
FY2026 India formulations revenue: Rs 1,405 million, up 22% YoY
FY2026 EBITDA management shorthand: About Rs 700 crore
FY2026 Europe formulations revenue: Rs 6,682 million, up 19% YoY
Q4 FY2026 USA formulations revenue: Rs 1,154 million, up 38% YoY and 17% QoQ
Q4 FY2026 employee benefit expense: Rs 1,445 million
US formulations subsidiary revenue: About Rs 400 crore to Rs 425 crore annually per management
BioForLife transaction consideration: EUR 16.975 million
Potential incremental synergy marker: At least Rs 125 crore to Rs 150 crore over 12 to 18 months per management commentary
Q4 FY2026 India formulations revenue: Rs 379 million, up 44% YoY and down 5% QoQ
BioForLife rupee consideration marker: About Rs 188 crore in press release
Q4 FY2026 Europe formulations revenue: Rs 1,733 million, up 27% YoY and down 3% QoQ
Legacy symbol retired from NSE EQ list: SEQUENT
Investor Day patents and filings marker: 60 patents filed since FY2023 and 57 regulatory filings
Investor Day API and formulation breadth: More than 200 APIs and about 15,000 formulation SKUs
FY2026 emerging markets formulations revenue: Rs 6,305 million, up 23% YoY
Q4 FY2026 emerging markets formulations revenue: Rs 1,725 million, up 21% YoY and 6% QoQ

Financial highlights

AI use cases: 37 identified
Q4 FY2026 LCR: 139%
Dividend policy: At least 25% of PAT, with management target around 40%
Capital adequacy: 20.3% in press release / 20.25% CRAR in audited-results filing
Current NSE ISIN: INE148I01020
FY2026 net worth: Rs 18,991 crore
Gearing guardrail: Capped at 3.5x to 4.0x
Liquidity guardrail: Higher of six months repayments in cash or 10% to 15% of borrowings
FY2027 projected AUM: Rs 70,700 crore
FY2027 projected NIM: 3.5%
FY2027 projected PAT: Rs 1,400 crore
FY2027 projected ROA: 1.8%
FY2027 projected ROE: 6.8%
FY2028 projected AUM: Rs 1,03,000 crore
FY2028 projected NIM: 5.8%
FY2028 projected PAT: Rs 3,200 crore
FY2029 projected AUM: Rs 1,42,000 crore
FY2029 projected NIM: 7.2%
FY2029 projected PAT: Rs 4,500 crore
FY2030 projected AUM: Rs 1,94,000 crore
FY2030 projected NIM: 8.1%
FY2030 projected PAT: Rs 5,600 crore
FY2030 projected ROA: 4.4%
FY2030 projected ROE: 18.7%
Target portfolio mix: 60% secured retail, 20% unsecured/semi-secured and 20% commercial/wholesale
GNPA at March 31 2026: 0.0%
IHC current ownership: 28.5%
NNPA at March 31 2026: 0.0%
Preferential warrants: 86,892,966 Tranche I warrants and 219,797,569 Tranche II warrants at Rs 139 per warrant
USD bond tender offer: Up to USD 45 million of USD 450 million 7.5% senior secured social bonds due 2030
Q4 FY2026 finance costs: Rs 1,678.56 crore
Asset-light model target: About 30% of total disbursals
Balance warrant proceeds: Rs 3,197.25 crore still to be received
Domestic rating upgrades: CRISIL AA+/Stable, CARE AA+/Stable and ICRA AA+/Stable within about 50 days of IHC investment
FY2026 consolidated loss: Rs 7,144.56 crore
FY2026 exceptional items: Rs 6,499.17 crore
S&P international rating: BB-/Stable
Agent productivity target: About 30% improvement
Current NSE active symbol: SAMMAANCAP
FY2027 projected branches: About 270
FY2030 projected branches: About 1,600
Preferential equity issue: 330,000,111 equity shares at Rs 139 per share, aggregating Rs 4,587 crore
FY2027 projected employees: About 8,000
FY2027 projected loan book: Rs 53,000 crore
FY2028 projected loan book: Rs 73,500 crore
FY2029 projected loan book: Rs 97,500 crore
FY2030 projected employees: About 20,000
FY2030 projected loan book: Rs 1,30,500 crore
IHC first tranche received: Rs 5,652.75 crore during quarter ended March 31 2026
ESOP allotment June 17 2026: 26,87,663 equity shares
FY2027 projected disbursals: Rs 30,100 crore
FY2028 projected disbursals: Rs 50,500 crore
FY2029 projected disbursals: Rs 72,500 crore
FY2030 projected disbursals: Rs 92,000 crore
Historical sold-down amount: About Rs 1.05 lakh crore / USD 11 billion across 24 bank and NBFI relationships
Q4 FY2026 consolidated loss: Rs 8,101.41 crore
Q4 FY2026 exceptional items: Rs 6,499.17 crore
Secured mortgage TAT target: From about five to seven days to about two to three days
Opening AUM at March 31 2026: Rs 53,160 crore
Standalone debt-equity ratio: 2.41
Total financial indebtedness: Rs 47,903.66 crore
Q1 FY2027 disbursement marker: At least 50% to 60% more than Q4 FY2026 per management
FY2027 projected cost of funds: 9.3%
FY2028 projected cost of funds: 8.9%
FY2029 projected cost of funds: 8.0%
FY2030 projected cost of funds: 7.8%
IHC total committed investment: Rs 8,850 crore / about USD 1 billion
Domestic bond yield improvement: About 100 bps after IHC announcement per management
FY2027 projected cost-to-income: 49.0%
FY2030 projected cost-to-income: 26.2%
Moody's corporate family rating: B1 with Positive outlook
Board debt-raising authorization: Up to Rs 10,000 crore or equivalent in USD/other currencies
FY2026 consolidated total income: Rs 8,190.23 crore
FY2026 consolidated total expenses: Rs 10,475.48 crore
Q4 FY2026 consolidated total income: Rs 1,361.32 crore
International bond yield improvement: About 250 bps after IHC announcement per management
Legacy symbol retired from NSE EQ list: IBULHSGFIN
Historical disbursals behind opening AUM: About Rs 3.60 lakh crore
FY2026 consolidated revenue from operations: Rs 8,166.16 crore
Monitoring account balance at March 31 2026: Rs 5,652.75 crore
FY2026 loss before exceptional items and tax: Rs 2,285.25 crore
Q4 FY2026 impairment on financial instruments: Rs 2,958.08 crore
Q4 FY2026 consolidated revenue from operations: Rs 1,357.66 crore
IHC expected ownership after warrant conversion: 43.5%
Q4 FY2026 loss before exceptional items and tax: Rs 3,597.45 crore
Historical borrowings serviced from September 2018: About Rs 1.3 lakh crore net servicing against about Rs 1.35 lakh crore borrowings at September 2018

Financial highlights

Staffing DSO: 6 days
Buyback price: Rs 1,600 per share
FY2025 EBITDA: Rs 138.3 crore
FY2026 EBITDA: Rs 158.0 crore
Funding exposure: 14%
Q3 FY2026 EBITDA: Rs 42.5 crore
Q4 FY2025 EBITDA: Rs 47.7 crore
Q4 FY2026 EBITDA: Rs 46.0 crore
Buyback record date: July 3, 2026
FY2025 EBITDA margin: 1.24%
FY2026 EBITDA growth: 14% YoY
FY2026 EBITDA margin: 1.34%
FY2026 revenue growth: 6% YoY
Buyback maximum shares: 14,87,500 equity shares
Q4 FY2026 EBITDA growth: 8% QoQ
Q4 FY2026 EBITDA margin: 1.5%
Buyback aggregate amount: up to Rs 238 crore
Outstanding TDS receivable: about Rs 149 crore
GST Order-in-Appeal penalty: approximately Rs 32.29 crore, no tax demand raised
Net free cash per management: about Rs 600 crore
FY2026 General Staffing EBITDA: Rs 117.5 crore
FY2026 General Staffing revenue: Rs 10,880 crore
FY2026 Other HR Services EBITDA: Rs 10.5 crore
General Staffing PAPM Q1 FY2026: Rs 669
General Staffing PAPM Q4 FY2026: Rs 689
FY2026 Other HR Services revenue: Rs 242 crore
NEEM EPFO order financial impact: not quantified; no immediate or ascertainable financial impact as disclosed
Q3 FY2026 consolidated headcount: 335,165
Q4 FY2025 consolidated headcount: 346,070
Q4 FY2026 consolidated headcount: 340,600
TEAMLEASE NSE announcement slice: 24 filings, 8 actionable market signals, 7 daily briefs after classifier hardening
FY2026 consolidated total revenue: Rs 11,859 crore
Q4 FY2026 General Staffing EBITDA: Rs 30.3 crore
FY2026 Specialised Staffing EBITDA: Rs 49.8 crore
Q4 FY2026 General Staffing revenue: Rs 2,671 crore
Q4 FY2026 Other HR Services EBITDA: Rs 12.7 crore
FY2025 PAT before exceptional items: Rs 110.5 crore
FY2025 PBT before exceptional items: Rs 114.5 crore
FY2026 EPS before exceptional items: Rs 83.3
FY2026 PAT before exceptional items: Rs 147.1 crore
FY2026 PBT before exceptional items: Rs 155.9 crore
FY2026 Specialised Staffing revenue: Rs 669 crore
Q4 FY2026 Other HR Services revenue: Rs 77 crore
EPFO trust show-cause notice quantum: Rs 184.58 crore including interest, disputed by the company
Q4 FY2026 General Staffing headcount: 286,500
Q4 FY2026 consolidated total revenue: Rs 2,949 crore
FY2025 consolidated operating revenue: Rs 11,156 crore
FY2026 consolidated operating revenue: Rs 11,791 crore
Q4 FY2026 Specialised Staffing EBITDA: Rs 13.0 crore
Q3 FY2026 PAT before exceptional items: Rs 48.2 crore
Q3 FY2026 PBT before exceptional items: Rs 49.1 crore
Q4 FY2025 PAT before exceptional items: Rs 37.9 crore
Q4 FY2025 PBT before exceptional items: Rs 39.8 crore
Q4 FY2026 PAT before exceptional items: Rs 46.0 crore
Q4 FY2026 PBT before exceptional items: Rs 51.6 crore
Q4 FY2026 Specialised Staffing revenue: Rs 177 crore
FY2025 consolidated operating cash flow: Rs 104.4 crore
FY2026 consolidated operating cash flow: Rs 301.8 crore
Income-tax refund received in Q4 FY2026: Rs 143.1 crore including Rs 13.1 crore interest
Q3 FY2026 consolidated operating revenue: Rs 2,990 crore
Q4 FY2025 consolidated operating revenue: Rs 2,858 crore
Q4 FY2026 Specialised Staffing headcount: 7,500
Q4 FY2026 consolidated operating revenue: Rs 2,925 crore
Q4 FY2026 Degree Apprenticeship headcount: 46,600
Buyback percentage of equity share capital: 8.87%
FY2026 total operating EBITDA in presentation segment view: Rs 177.8 crore
Q4 FY2026 total operating EBITDA in presentation segment view: Rs 56.0 crore

Financial highlights

employees: 2184
channel_partners: 1500+
fy2026_pbt_rs_cr: 102
fy2026_ebit_rs_cr: 112
q4fy2026_pbt_rs_cr: 76
fy2026_ebitda_rs_cr: 232
q4fy2026_ebit_rs_cr: 80
gst_order_penalty_rs: 1010484
fy2026_pat_margin_pct: 3
gst_order_interest_rs: 1091322
q4fy2026_ebitda_rs_cr: 110
fy2026_ebit_margin_pct: 4
gst_order_amount_rs_cr: 0.31
receivable_days_fy2025: 61
receivable_days_fy2026: 51
gst_order_tax_demand_rs: 1010484
q4fy2026_pat_margin_pct: 7
aquel_retail_touchpoints: 200+
fy2026_ebitda_margin_pct: 9
manufacturing_facilities: 9
q4fy2026_ebit_margin_pct: 9
fy2026_depreciation_rs_cr: 131
fy2026_finance_cost_rs_cr: 10
fy2026_gross_profit_rs_cr: 704
fy2026_pat_growth_yoy_pct: 70
inventory_days_march_2026: 70
q4fy2026_ebitda_margin_pct: 13
final_dividend_per_share_rs: 1
fy2026_other_expenses_rs_cr: 288
q4fy2026_depreciation_rs_cr: 34
q4fy2026_finance_cost_rs_cr: 4
q4fy2026_gross_profit_rs_cr: 245
q4fy2026_pat_growth_yoy_pct: 133
working_capital_days_fy2025: 98
working_capital_days_fy2026: 45
fy2026_ebitda_growth_yoy_pct: 43
fy2026_volume_growth_yoy_pct: 8
inventories_march_2025_rs_cr: 609
inventories_march_2026_rs_cr: 495
q4fy2026_bathware_loss_rs_cr: 5
final_dividend_pct_face_value: 10
fy2026_revenue_growth_yoy_pct: 3
gst_order_aggregate_amount_rs: 3112290
q4fy2026_other_expenses_rs_cr: 84
total_equity_march_2026_rs_cr: 1645
total_installed_capacity_mtpa: 435222
fy2026_employee_expenses_rs_cr: 184
fy2026_gross_profit_margin_pct: 27
q4fy2026_ebitda_growth_qoq_pct: 293
q4fy2026_ebitda_growth_yoy_pct: 100
q4fy2026_volume_growth_qoq_pct: 46
q4fy2026_volume_growth_yoy_pct: 23
fy2026_finished_goods_volume_mt: 191238
q4fy2026_bathware_revenue_rs_cr: 16
q4fy2026_revenue_growth_qoq_pct: 48
q4fy2026_revenue_growth_yoy_pct: 18
q4fy2026_employee_expenses_rs_cr: 51
q4fy2026_gross_profit_margin_pct: 29
q4fy2026_finished_goods_volume_mt: 62167
total_borrowings_march_2026_rs_cr: 140
fy2026_raw_material_consumed_rs_cr: 1894
nse_announcements_apr01_jun27_2026: 19
total_liabilities_march_2026_rs_cr: 779
trade_receivables_march_2025_rs_cr: 423
trade_receivables_march_2026_rs_cr: 363
current_borrowings_march_2026_rs_cr: 78
current_investments_march_2025_rs_cr: 27
current_investments_march_2026_rs_cr: 148
fy2026_revenue_from_operations_rs_cr: 2598
nse_actionable_signals_after_dry_run: 2
q4fy2026_raw_material_consumed_rs_cr: 605
fy2026_cash_flow_from_financing_rs_cr: -153
fy2026_cash_flow_from_investing_rs_cr: -325
q4fy2026_revenue_from_operations_rs_cr: 850
non_current_borrowings_march_2026_rs_cr: 62
fy2026_pat_after_exceptional_items_rs_cr: 73
fy2026_cash_and_cash_equivalents_end_rs_cr: 128
management_fy2027_volume_growth_marker_pct: 12-15
q4fy2026_pat_after_exceptional_items_rs_cr: 56
fy2026_cash_generated_from_operations_rs_cr: 530
fy2026_bihar_plant_interest_subvention_rs_mn: 64.44
management_fy2027_operating_margin_marker_pct: 11-13
fy2026_excess_scheme_provision_writeback_rs_mn: 51.50
fy2026_net_cash_from_operating_activities_rs_cr: 526
aquel_identified_assets_acquisition_marker_rs_cr: 55
management_target_receivable_days_reduction_fy2027: 10-15 days
fy2026_labour_code_exceptional_item_net_of_tax_rs_cr: 2.05
fy2026_labour_code_exceptional_item_net_of_tax_rs_mn: 20.48

Financial highlights

FY2026 PAT: Loss of Rs 91 crore
FY2026 PBT: Loss of Rs 89 crore
PSOP grant: 11,725 Performance Stock Options granted under PSOP Plan 2023
FY2026 EBIT: Rs 72 crore, down 67.0% YoY
87th AGM date: August 6, 2026
Q4 FY2026 PAT: Loss of Rs 68 crore
Q4 FY2026 PBT: Loss of Rs 52 crore
ESOP allotment: 2,056 equity shares allotted on exercise of options
Q4 FY2026 EBIT: Rs 20 crore, down 70.6% YoY
FY2026 PAT margin: Negative 2.0%
FY2026 staff cost: Rs 391 crore
Earnings-call date: May 20, 2026
FY2026 EBIT margin: 1.6%
FY2026 finance cost: Rs 56 crore, down 19.5% YoY
FY2026 gross margin: Rs 1,365 crore, down 8.6% YoY
Results filing date: May 15, 2026
Dividend record date: July 17, 2026
Q4 FY2026 PAT margin: Negative 5.4%
Q4 FY2026 staff cost: Rs 94 crore
FY2026 other expenses: Rs 823 crore
Q4 FY2026 EBIT margin: 1.6%
Q4 FY2026 finance cost: Rs 13 crore, including about Rs 8 crore vendor-financing interest and about Rs 4 crore lease-liability interest
Q4 FY2026 gross margin: Rs 364 crore, down 7.6% YoY
Standalone inventories: Rs 533.52 crore at March 31, 2026 versus Rs 717.36 crore at March 31, 2025
Transcript filing date: May 26, 2026
Q4 FY2026 other expenses: Rs 226 crore
Telangana dropped demand: Rs 22.89 lakh demand including Rs 2.08 lakh penalty dropped in company favour
Consolidated total assets: Rs 4,260.14 crore at March 31, 2026
Consolidated total equity: Rs 1,594.18 crore at March 31, 2026
Madhya Pradesh GST demand: Rs 5.75 crore including Rs 1.88 crore penalty
Consolidated trade credits: Rs 1,508.22 crore at March 31, 2026
FY2026 operating cash flow: Rs 619 crore
Moulds and dies impairment: Rs 29.31 crore in FY2026
Labour Code exceptional item: Rs 28.72 crore in FY2026
Standalone trade receivables: Rs 1,141.49 crore at March 31, 2026 versus Rs 1,286.39 crore at March 31, 2025
Bihar GST appeal-order demand: Rs 1.16 crore including Rs 39.68 lakh penalty
FY2026 Consumer Products EBIT: Negative Rs 49 crore
Q4 FY2026 operating cash flow: About Rs 397 crore in presentation / around Rs 400 crore in transcript
Closing cash and bank balances: Rs 222 crore in presentation cash-flow bridge
Consolidated total liabilities: Rs 2,665.96 crore at March 31, 2026
FY2026 Lighting Solutions EBIT: Rs 95 crore
FY2026 net financing cash flow: Negative Rs 137 crore
FY2026 net investing cash flow: Negative Rs 380 crore
FY2026 revenue from operations: Rs 4,462 crore, down 7.6% YoY
Share of associate and JV loss: Rs 3.21 crore in Q4 FY2026 and Rs 13.60 crore in FY2026
Standalone current investments: Rs 261.96 crore at March 31, 2026
FY2026 working-capital movement: Rs 421 crore positive movement in the presentation cash-flow bridge
CRISIL withdrawn facility rating: CRISIL A1+ withdrawn on Rs 600 crore of bank-wise loan facilities at company request
FY2026 Consumer Products revenue: Rs 3,343 crore, down 12.2% YoY
Q4 FY2026 Consumer Products EBIT: Negative Rs 7 crore
FY2026 Lighting Solutions revenue: Rs 1,120 crore, up 9.5% YoY
Investor-presentation filing date: May 18, 2026
Karnataka GST appeal-order demand: Rs 18.90 lakh including Rs 0.86 lakh penalty
Q4 FY2026 Lighting Solutions EBIT: Rs 27 crore
Q4 FY2026 revenue from operations: Rs 1,240 crore, down 2.1% YoY and up from Rs 1,051 crore in Q3 FY2026
Rajasthan GST appeal-order demand: Rs 3.45 crore including Rs 31.53 lakh penalty
Recommended FY2026 final dividend: Rs 3 per equity share of face value Rs 2
Telangana dismissed appeal demand: Rs 16.42 lakh including Rs 1.49 lakh penalty
Q4 FY2026 Consumer Products revenue: Rs 926 crore, down 6.9% YoY
West Bengal GST appeal-order demand: Rs 2.69 crore including Rs 0.14 crore penalty
FY2026 Consumer Products EBIT margin: Negative 1.5%
FY2026 depreciation and amortisation: Rs 142 crore
Morphy Richards brand/IP acquisition: Rs 167.99 crore consideration under definitive agreements executed March 16, 2026
Q4 FY2026 Lighting Solutions revenue: Rs 314 crore, up 15.6% YoY
Standalone cash and cash equivalents: Rs 222.31 crore at March 31, 2026
Aurangabad/Nirlep goodwill impairment: Rs 26.44 crore in FY2026
FY2026 Lighting Solutions EBIT margin: 8.5%
FY2026 consolidated exceptional items: Rs 91.15 crore
Telangana reduced appeal-order demand: Rs 3.61 lakh including Rs 0.33 lakh penalty, reduced from Rs 83.78 lakh
Uttar Pradesh GST appeal-order demand: Rs 10.95 crore including Rs 0.99 crore penalty
CRISIL reaffirmed bank loan facilities: Rs 1,400 crore at CRISIL AA-/Stable and CRISIL A1+
Q4 FY2026 Consumer Products EBIT margin: Negative 0.7%
Q4 FY2026 depreciation and amortisation: Rs 33 crore
Chhattisgarh reduced appeal-order demand: Rs 92.89 lakh including Rs 4.28 lakh penalty, reduced from Rs 1.34 crore
Dividend payout cash outflow if approved: Approximately Rs 34.62 crore
Enabling fund raise / borrowing approval: Up to Rs 500 crore through securities including NCDs and/or commercial papers
Q4 FY2026 Lighting Solutions EBIT margin: 8.7%
Q4 FY2026 consolidated exceptional items: Rs 55.58 crore
FY2026 net increase in cash and bank balances: Rs 102 crore
Cash, cash equivalents and surplus investments: About Rs 934 crore at FY2026 year-end
Consolidated trade payables to other than MSMEs: Rs 421.21 crore at March 31, 2026
FY2026 profit before exceptional items and taxes: Rs 16 crore
FY2026 exceptional items and joint-venture losses: Negative Rs 105 crore in the presentation
Q4 FY2026 profit before exceptional items and taxes: Rs 7 crore
Q4 FY2026 exceptional items and joint-venture losses: Negative Rs 59 crore in the presentation
Standalone bank balances other than cash equivalents: Rs 35.38 crore at March 31, 2026

Financial highlights

FY2026 EPS: Negative Rs 0.39
FY2026 goodwill: Rs 28,194.15 lakh
FY2026 inventory: Rs 13,055.84 lakh
Bopkhel land size: 3,54,600 square metres
FY2026 other equity: Rs 14,871.17 lakh
FY2026 other income: Rs 405.65 lakh
FY2026 total assets: Rs 1,16,284.53 lakh
FY2026 total equity: Rs 43,371.17 lakh
FY2026 total income: Rs 504.90 lakh
FY2026 cash decrease: Rs 2,500.39 lakh
FY2026 finance costs: Rs 800.56 lakh
Pune land fair value: Rs 2,03,889 lakh
Bopkhel H1 bid amount: Rs 640.50 cr
FY2026 loss after tax: Rs 1,122.01 lakh
FY2026 other expenses: Rs 1,004.30 lakh
FY2026 total expenses: Rs 1,862.41 lakh
FY2026 loss before tax: Rs 1,357.52 lakh
Q4 FY2026 other income: Rs 63.53 lakh
Q4 FY2026 total income: Rs 89.05 lakh
Q4 FY2026 finance costs: Rs 233.78 lakh
FY2026 trade receivables: Rs 15.52 lakh
HyperVault FY2025-26 PAT: Negative Rs 400.54 lakh
Q4 FY2026 loss after tax: Rs 172.38 lakh
Q4 FY2026 other expenses: Rs 250.22 lakh
Q4 FY2026 total expenses: Rs 496.94 lakh
Bopkhel RFP reserve price: Rs 600 cr
FY2026 current borrowings: Rs 500.00 lakh
Q4 FY2026 loss before tax: Rs 407.89 lakh
Chattarpur land fair value: Rs 73,081 lakh
FY2026 deferred tax assets: Rs 1,479.76 lakh
FY2026 financing cash flow: Rs 6,489.17 lakh generated
FY2026 investing cash flow: Rs 6,153.61 lakh generated
FY2026 operating cash flow: Rs 15,143.17 lakh used
FY2026 equity share capital: Rs 28,500.00 lakh
FY2026 non-current borrowings: Rs 8,236.66 lakh
FY2026 other financial assets: Rs 3,008.30 lakh
FY2025 revenue from operations: Rs 90.64 lakh
FY2026 revenue from operations: Rs 99.24 lakh
HyperVault FY2025-26 net worth: Rs 27,672.99 lakh
Greater Kailash land fair value: Rs 7,30,003 lakh
FY2026 cash and cash equivalents: Rs 2,503.55 lakh
Halisahar Kolkata land fair value: Rs 9,268 lakh
Q4 FY2025 revenue from operations: Rs 23.86 lakh
Q4 FY2026 revenue from operations: Rs 25.51 lakh
FY2026 other financial liabilities: Rs 64,041.59 lakh
FY2026 total equity and liabilities: Rs 1,16,284.53 lakh
Padianallur Chennai land fair value: Rs 42,555 lakh
Investment-property disclosed fair value: Rs 10,58,886 lakh
FY2026 investment property carrying value: Rs 66,561.67 lakh
Bopkhel premium recognized as inventory cost: Rs 130.56 cr
Outstanding stamp-duty liability not reassessed: Rs 63,980.21 lakh
Stamp-duty provision computed on FY2016-17 circle rates: Rs 65,100 lakh

Financial highlights

FY2025 PAT: Rs 147.59 cr per consolidated financial results.
FY2026 PAT: Rs 134.02 cr per consolidated financial results.
FY2025 EBITDA: Rs 179.90 cr per results press release and investor presentation.
FY2026 EBITDA: Rs 175.50 cr per results press release and investor presentation.
Q3 FY2026 PAT: Rs 18.80 cr per results press release.
Q4 FY2026 PAT: Rs 50.93 cr per consolidated financial results.
FY2026 basic EPS: Rs 24.56.
Q3 FY2026 EBITDA: Rs 26.80 cr per results press release and investor presentation.
Q4 FY2026 EBITDA: Rs 64.70 cr per results press release and investor presentation.
FY2025 PAT margin: 29.0% of total income per results press release.
FY2026 PAT margin: 25.5% of total income per results press release.
FY2026 diluted EPS: Rs 24.46.
FY2025 other income: Rs 52.44 cr.
FY2025 total income: Rs 515.69 cr.
FY2026 finance cost: Rs 1.78 cr.
FY2026 other income: Rs 52.40 cr.
FY2026 total income: Rs 526.50 cr.
Q4 FY2026 basic EPS: Rs 9.28.
FY2025 EBITDA margin: 39.0% of revenue from operations.
FY2026 EBITDA margin: 37.0% of revenue from operations.
FY2026 dividend paid: Negative Rs 19.05 cr.
Q3 FY2026 PAT margin: 18.0% of total income per results press release.
Q4 FY2026 PAT margin: 31.3% of total income per results press release.
FY2026 other expenses: Rs 72.06 cr.
FY2026 total expenses: Rs 330.79 cr.
Q4 FY2026 diluted EPS: Rs 9.24.
Q3 FY2026 other income: Rs 10.53 cr.
Q3 FY2026 total income: Rs 104.21 cr.
Q4 FY2025 other income: Rs 23.24 cr.
Q4 FY2025 total income: Rs 166.79 cr.
Q4 FY2026 finance cost: Rs 0.15 cr.
Q4 FY2026 other income: Rs 17.75 cr.
Q4 FY2026 total income: Rs 162.79 cr.
Q3 FY2026 EBITDA margin: 28.6% of revenue from operations.
Q4 FY2026 EBITDA margin: 44.6% of revenue from operations.
FY2026 profit before tax: Rs 188.97 cr.
FY2026 total tax expense: Rs 54.95 cr.
Q4 FY2026 other expenses: Rs 19.73 cr.
Q4 FY2026 total expenses: Rs 88.34 cr.
FY2026 financing cash flow: Negative Rs 52.80 cr.
FY2026 investing cash flow: Negative Rs 47.68 cr.
FY2026 operating cash flow: Rs 93.31 cr.
Recommended final dividend: Rs 3.50 per equity share of Rs 2 face value, equal to 175% of face value.
Q4 FY2026 profit before tax: Rs 73.22 cr.
Q4 FY2026 total tax expense: Rs 22.29 cr.
FY2025 revenue from operations: Rs 463.25 cr.
FY2026 revenue from operations: Rs 474.10 cr.
FY2026 sale of devices revenue: Rs 54.68 cr.
FY2026 employee-benefits expense: Rs 90.79 cr.
FY2026 cost of materials consumed: Rs 32.95 cr.
FY2026 employee costs capitalized: Rs 16.50 cr.
FY2026 purchase of stock-in-trade: Rs 28.28 cr.
FY2026 total comprehensive income: Rs 136.12 cr.
Open order book at March 31, 2025: Rs 1,500 cr.
Open order book at March 31, 2026: Rs 1,754 cr.
Q3 FY2026 revenue from operations: Rs 93.68 cr.
Q4 FY2025 revenue from operations: Rs 143.55 cr.
Q4 FY2026 revenue from operations: Rs 145.04 cr.
Q4 FY2026 sale of devices revenue: Rs 17.85 cr.
Q4 FY2026 employee-benefits expense: Rs 21.77 cr.
FY2026 depreciation and amortisation: Rs 30.42 cr.
FY2026 map data and services revenue: Rs 419.42 cr.
FY2026 profit attributable to owners: Rs 134.16 cr.
Q4 FY2026 cost of materials consumed: Rs 13.09 cr.
Q4 FY2026 employee costs capitalized: Rs 5.73 cr.
Q4 FY2026 purchase of stock-in-trade: Rs 8.85 cr.
Q4 FY2026 total comprehensive income: Rs 51.91 cr.
Q4 FY2026 depreciation and amortisation: Rs 7.91 cr.
Q4 FY2026 map data and services revenue: Rs 127.19 cr.
Q4 FY2026 profit attributable to owners: Rs 50.77 cr.
Investment in Prashant Advanced Survey LLP: Rs 2.00 cr for a 20% associate interest effective February 25, 2026.
Consolidated total assets at March 31, 2026: Rs 1,036.04 cr.
Consolidated total equity at March 31, 2026: Rs 905.23 cr.
Consolidated current assets at March 31, 2026: Rs 566.71 cr.
FY2026 communication and cloud-hosting expense: Rs 22.70 cr.
Equity attributable to owners at March 31, 2026: Rs 904.95 cr.
FY2026 marketing and business-promotion expense: Rs 6.76 cr.
Consolidated trade receivables at March 31, 2026: Rs 176.41 cr.
FY2026 share of associate and joint-venture loss: Rs 6.74 cr.
Consolidated non-current assets at March 31, 2026: Rs 469.33 cr.
Q4 FY2026 communication and cloud-hosting expense: Rs 6.26 cr.
Consolidated current investments at March 31, 2026: Rs 248.66 cr.
Q4 FY2026 marketing and business-promotion expense: Rs 2.12 cr.
Q4 FY2026 share of associate and joint-venture loss: Rs 1.23 cr.
Consolidated non-current investments at March 31, 2026: Rs 268.28 cr.
Consolidated cash and cash equivalents at March 31, 2026: Rs 61.10 cr.
FY2026 profit before share of associate and joint venture and tax: Rs 195.71 cr.
FY2026 technical-services outsourcing and project-software expense: Rs 75.41 cr.
FY2026 purchase of property, plant, equipment and intangible assets: Negative Rs 42.40 cr.
Q4 FY2026 profit before share of associate and joint venture and tax: Rs 74.45 cr.
Q4 FY2026 technical-services outsourcing and project-software expense: Rs 19.36 cr.
Cash and cash equivalents including financial investments at March 31, 2026: Rs 685.00 cr per results press release and investor presentation.

Financial highlights

FY2025 standalone PAT: Rs 706 cr.
FY2026 standalone PAT: Rs 344 cr.
FY2025 consolidated PAT: Rs 815 cr.
FY2026 consolidated PAT: Rs 832 cr.
FY2027 revenue guidance: Around INR 6,000 cr standalone top line, implying about 30% growth over FY2026.
FY2025 standalone EBITDA: Rs 1,049 cr.
FY2026 standalone EBITDA: Rs 583 cr.
FY2028 revenue guidepost: Around INR 7,500 cr standalone top line, implying about 25% growth from FY2027.
Q4 FY2025 standalone PAT: Rs 121 cr.
Q4 FY2026 standalone PAT: Rs 100 cr.
FY2025 standalone revenue: Rs 5,513 cr, including Rs 56 cr MSRDC bonus and Rs 379 cr arbitration claim received through two SPVs.
FY2026 standalone revenue: Rs 4,633 cr.
NHPC solar/BESS EPC value: About Rs 2,000 cr, not included in orderbook.
SECL mining project value: Rs 2,957 cr exclusive of GST.
FY2025 consolidated EBITDA: Rs 2,066 cr.
FY2026 consolidated EBITDA: Rs 1,137 cr.
Q4 FY2025 consolidated PAT: Rs 75 cr.
Q4 FY2026 consolidated PAT: Rs 108 cr.
FY2025 consolidated revenue: Rs 6,769 cr.
FY2026 consolidated revenue: Rs 5,368 cr.
FY2026 road segment revenue: Rs 4,070 cr, 76% of consolidated segment revenue.
HAM debtor at March 31 2026: INR 372 cr per management Q&A.
Q4 FY2025 standalone EBITDA: Rs 176 cr.
Q4 FY2026 standalone EBITDA: Rs 175 cr.
FY2026 standalone PAT margin: 7.4%.
FY2026 water segment revenue: Rs 584 cr, 11% of consolidated segment revenue.
FY2027 EBITDA margin posture: Around 12%.
Q4 FY2025 standalone revenue: Rs 1,415 cr.
Q4 FY2026 standalone revenue: Rs 1,458 cr.
FY2026 standalone tax expense: Rs 127 cr.
Q4 FY2025 consolidated EBITDA: Rs 362 cr.
Q4 FY2026 consolidated EBITDA: Rs 277 cr.
Total debtor at March 31 2026: INR 1,660 cr per management Q&A.
Water debtor at March 31 2026: INR 868 cr per management Q&A.
FY2026 consolidated PAT margin: 15.5%.
FY2026 standalone depreciation: Rs 95 cr.
FY2026 standalone finance cost: Rs 95 cr.
FY2026 standalone other income: Rs 74 cr.
FY2027 order-inflow aspiration: Around INR 15,000 cr.
Q4 FY2025 consolidated revenue: Rs 1,704 cr.
Q4 FY2026 consolidated revenue: Rs 1,617 cr per press release and presentation.
Q4 FY2026 road segment revenue: Rs 1,256 cr, 78% of consolidated segment revenue.
Submitted bids pending opening: 15 EPC bids and one HAM bid aggregating around INR 14,000 cr.
FY2025 standalone EBITDA margin: 19.0%.
FY2026 consolidated tax expense: Rs 235 cr.
FY2026 standalone EBITDA margin: 12.6%.
Q4 FY2026 standalone PAT margin: 6.9%.
Q4 FY2026 water segment revenue: Rs 210 cr, 13% of consolidated segment revenue.
FY2026 consolidated depreciation: Rs 122 cr.
FY2026 consolidated finance cost: Rs 582 cr.
FY2026 consolidated other income: Rs 141 cr.
FY2027 further order expectation: INR 9,000 cr to INR 10,000 cr.
Q4 FY2026 standalone tax expense: Rs 38 cr.
Remaining HAM equity requirement: INR 542 cr over the next two years.
Retention money at March 31 2026: INR 264 cr per management Q&A.
FY2026 consolidated EBITDA margin: 21.2%.
Q4 FY2026 consolidated PAT margin: 6.7%.
Q4 FY2026 standalone depreciation: Rs 29 cr.
Q4 FY2026 standalone finance cost: Rs 30 cr.
Q4 FY2026 standalone other income: Rs 22 cr.
Unbilled revenue at March 31 2026: INR 475 cr per management Q&A.
Combined diversification portfolio: About Rs 4,957 cr across solar energy and mining segments.
FY2026 standalone exceptional item: Rs 5 cr, including gain on sale of PNC Bareilly Nainital Highways equity shares and about Rs 1 cr Labour Codes impact.
Q4 FY2025 standalone EBITDA margin: 12.4%.
Q4 FY2026 consolidated tax expense: Rs 47 cr.
Q4 FY2026 standalone EBITDA margin: 12.0%.
FY2026 toll/annuity segment revenue: Rs 714 cr, 13% of consolidated segment revenue.
Q4 FY2026 consolidated depreciation: Rs 35 cr.
Q4 FY2026 consolidated finance cost: Rs 137 cr.
Q4 FY2026 consolidated other income: Rs 41 cr.
FY2026 consolidated exceptional item: Rs 492 cr.
Q4 FY2026 consolidated EBITDA margin: 17.1%.
CIDCO NAINA project balance orderbook: Rs 2,040 cr and disclosed as under sub judice.
FY2026 consolidated monetisation gain: Rs 337 cr net of tax from monetisation of 12 HAM assets.
Mobilization advance at March 31 2026: INR 155 cr per management Q&A.
Standalone net worth at March 31 2026: INR 5,811 cr per management remarks.
FY2027 HAM equity infusion expectation: Around INR 350 cr.
FY2027 orders already won by call date: INR 3,957 cr in highways, or around INR 6,000 cr including renewable energy.
March 31 2026 remaining contract value: Rs 18,094 cr per investor presentation.
Q4 FY2026 toll/annuity segment revenue: Rs 151 cr, 9% of consolidated segment revenue.
Standalone total debt at March 31 2026: Rs 741 cr.
Consolidated net worth at March 31 2026: INR 6,813 cr per management remarks.
Q4 FY2026 consolidated exceptional item: Rs 8 cr.
Standalone debtor days at March 31 2026: 134 days.
Standalone net surplus at March 31 2026: INR 327 cr per management remarks.
Consolidated total debt at March 31 2026: Rs 5,151 cr.
Q4 FY2026 consolidated monetisation gain: Rs 19 cr net of tax from monetisation of one HAM asset.
FY2026 standalone net operating cash flow: Negative Rs 179 cr.
Consolidated total assets at March 31 2025: Rs 18,059 cr.
Consolidated total assets at March 31 2026: Rs 13,858 cr.
FY2026 consolidated net financing cash flow: Negative Rs 4,796 cr.
FY2026 consolidated net investing cash flow: Negative Rs 67 cr.
FY2026 consolidated net operating cash flow: Rs 4,593 cr.
Western Bhopal Bypass EPC cost in orderbook: Rs 1,091 cr awaiting appointed date.
Consolidated current assets at March 31 2026: Rs 6,284 cr.
FY2026 standalone PBT after exceptional item: Rs 471 cr.
FY2026 standalone total comprehensive income: Rs 352 cr.
FY2026 standalone PBT before exceptional item: Rs 466 cr.
FY2027 solar/BESS equity infusion expectation: Around INR 120 cr.
Post-March 2026 project wins not in orderbook: Rs 3,957 cr.
Consolidated HAM project loan at March 31 2026: Rs 4,895 cr.
FY2026 consolidated PBT after exceptional item: Rs 1,067 cr.
FY2026 consolidated total comprehensive income: Rs 839 cr.
Standalone net debt to equity at March 31 2026: 0.13x per management remarks.
Consolidated trade receivables at March 31 2026: Rs 1,509 cr current trade receivables plus Rs 5,346 cr non-current trade receivables.
FY2026 consolidated PBT before exceptional item: Rs 574 cr.
Q4 FY2026 standalone PBT after exceptional item: Rs 138 cr.
Standalone equipment term loan at March 31 2026: Rs 256 cr.
Consolidated current borrowings at March 31 2026: Rs 417 cr.
Consolidated net debt to equity at March 31 2026: 0.76x per management remarks.
Consolidated non-current assets at March 31 2026: Rs 7,574 cr.
Q4 FY2026 standalone PBT before exceptional item: Rs 138 cr.
Standalone unsecured loan / ICD at March 31 2026: Rs 485 cr.
Standalone working capital loan at March 31 2026: Nil.
Q4 FY2026 consolidated PBT after exceptional item: Rs 155 cr.
Q4 FY2026 consolidated total comprehensive income: Rs 109 cr.
Consolidated gross debt to equity at March 31 2026: 0.8x per presentation.
Q4 FY2026 consolidated PBT before exceptional item: Rs 146 cr.
Consolidated non-current borrowings at March 31 2026: Rs 4,734 cr.
Standalone net working capital days at March 31 2026: 134 days.
FY2026 consolidated closing cash and cash equivalents: Rs 871 cr.
Consolidated cash and cash equivalents at March 31 2026: Rs 871 cr.
March 31 2026 aggregate contract value in orderbook table: Rs 28,769 cr.
Consolidated bank balances other than cash at March 31 2026: Rs 1,367 cr.
Consolidated equity attributable to owners at March 31 2026: Rs 6,813 cr.
Standalone cash and bank balance including current investments: INR 1,068 cr at March 31, 2026.
Consolidated cash and bank balance including current investments: INR 2,856 cr at March 31, 2026.
FY2026 standalone operating cash flow before working capital changes: Rs 614 cr.
FY2026 consolidated operating cash flow before working capital changes: Rs 1,157 cr.

Financial highlights

SKUs: Around 20,000
Buyback price: INR 680 per equity share
Patents filed: 101
Waste recycled: 65% of waste produced
Patents granted: 29
Buyback record date: May 20, 2026
Buyback tender period: May 26, 2026 to June 2, 2026
Final dividend FY2026: Re 1 per share on 9,92,65,845 shares before buyback extinguishment
ICRA long-term rating: ICRA AA+ Stable reaffirmed
Renewable power share: 65% of power from renewable sources
Standalone FY2026 EPS: Rs 21.28
Standalone FY2026 PAT: Rs 21,126.53 lakhs
Buyback maximum amount: INR 110 cr
ICRA short-term rating: ICRA A1+ reaffirmed
Buyback approved shares: Up to 16,17,500 equity shares
GHG emissions reduction: 24%
Interim dividend FY2026: Rs 8 per share
Waste sold to recyclers: 35%
Post-buyback paid-up shares: 9,76,48,345 equity shares
Water consumption reduction: 25%
Consolidated FY2025 basic EPS: Rs 23.32 audited and adjusted
Consolidated FY2026 basic EPS: Rs 20.01 audited; Rs 21.06 adjusted in press release
Promoter holding after buyback: 5,29,70,480 shares; 54.25%
Consolidated FY2026 current tax: Rs 7,148.72 lakhs
Promoter holding before buyback: 5,29,70,480 shares; 53.36%
Consolidated FY2025 total income: Rs 157,817.94 lakhs
Consolidated FY2026 deferred tax: Credit of Rs 51.63 lakhs
Consolidated FY2026 other income: Rs 4,768.88 lakhs
Consolidated FY2026 total income: Rs 157,647.51 lakhs
Consolidated Q4 FY2025 basic EPS: Rs 7.16 audited and adjusted
Consolidated Q4 FY2026 basic EPS: Rs 5.77 audited; Rs 6.82 adjusted in press release
Consolidated FY2026 finance costs: Rs 1,355.93 lakhs
Consolidated dividend paid FY2026: Rs 9,381.66 lakhs
Fossil-fuel consumption reduction: 25%
Shares extinguished after buyback: 16,17,500 equity shares
Consolidated FY2025 total expenses: Rs 126,972.23 lakhs
Consolidated FY2026 other expenses: Rs 40,595.70 lakhs
Consolidated FY2026 total expenses: Rs 129,318.47 lakhs
ICRA working-capital rating amount: Rs 400 cr
Standalone FY2026 exceptional item: Rs 1,390.00 lakhs
Consolidated Q4 FY2026 other income: Rs 780.94 lakhs
Consolidated Q4 FY2026 total income: Rs 43,422.41 lakhs
Consolidated FY2026 exceptional item: Rs 1,390.00 lakhs related to new Labour Codes
Consolidated Q4 FY2026 finance costs: Rs 312.19 lakhs
Consolidated Q4 FY2026 other expenses: Rs 10,826.92 lakhs
Consolidated Q4 FY2026 total expenses: Rs 34,238.44 lakhs
Consolidated direct taxes paid FY2026: Rs 7,820.23 lakhs
Cage nets supplied globally since 2010: More than 30,000
Consolidated goodwill at March 31 2026: Rs 7,064.41 lakhs
Consolidated FY2026 inter-segment revenue: Rs 2,519.65 lakhs deduction
Consolidated inventories at March 31 2026: Rs 39,859.74 lakhs
Post-buyback paid-up equity share capital: INR 97,64,83,450
Standalone FY2026 revenue from operations: Rs 141,898.37 lakhs
Buyback standalone free-reserve percentage: 9.46% of paid-up equity share capital and free reserves at March 31 2025
Consolidated other equity at March 31 2026: Rs 125,515.82 lakhs
Consolidated total assets at March 31 2026: Rs 187,874.64 lakhs
Consolidated total equity at March 31 2026: Rs 135,442.40 lakhs
Standalone FY2026 synthetic cordage revenue: Rs 110,545.17 lakhs
Buyback consolidated free-reserve percentage: 9.35% of paid-up equity share capital and free reserves at March 31 2025
Consolidated Q4 FY2026 inter-segment revenue: Rs 404.36 lakhs deduction
Consolidated current assets at March 31 2026: Rs 119,165.25 lakhs
Consolidated trade payables at March 31 2026: Rs 26,741.04 lakhs including MSME and other creditors
Standalone Q4 FY2026 revenue from operations: Rs 37,147.81 lakhs
Consolidated FY2025 synthetic cordage revenue: Rs 127,391.03 lakhs
Consolidated FY2026 employee benefits expense: Rs 23,676.44 lakhs
Consolidated FY2026 synthetic cordage revenue: Rs 121,525.43 lakhs
Consolidated FY2025 net sales in press release: Rs 1,540.1 cr
Consolidated FY2026 cost of materials consumed: Rs 41,019.63 lakhs
Consolidated FY2026 net sales in press release: Rs 1,528.8 cr
Standalone FY2026 PBT before exceptional items: Rs 29,381.33 lakhs
Consolidated FY2026 PBT after exceptional items: Rs 26,939.04 lakhs
Consolidated FY2025 PBT before exceptional items: Rs 30,845.71 lakhs
Consolidated FY2026 PBT before exceptional items: Rs 28,329.04 lakhs
Consolidated Q4 FY2025 synthetic cordage revenue: Rs 37,039.28 lakhs
Consolidated Q4 FY2026 employee benefits expense: Rs 5,740.90 lakhs
Consolidated Q4 FY2026 synthetic cordage revenue: Rs 34,965.44 lakhs
Consolidated current borrowings at March 31 2026: Rs 2,117.22 lakhs
Consolidated non-current assets at March 31 2026: Rs 68,709.39 lakhs
Consolidated unallocable assets at March 31 2026: Rs 76,239.65 lakhs
Consolidated FY2026 adjusted PAT in press release: Rs 209.1 cr excluding exceptional items
Consolidated FY2026 depreciation and amortisation: Rs 3,444.69 lakhs
Consolidated Q4 FY2025 net sales in press release: Rs 432.5 cr
Consolidated Q4 FY2026 cost of materials consumed: Rs 10,339.90 lakhs
Consolidated Q4 FY2026 net sales in press release: Rs 426.4 cr
Consolidated current investments at March 31 2026: Rs 28,066.74 lakhs
Consolidated current liabilities at March 31 2026: Rs 43,528.12 lakhs
Consolidated other bank balances at March 31 2026: Rs 4,106.49 lakhs
Garware Youth Development Centre jobs or own work: 127 beneficiaries
Standalone Q4 FY2026 PBT before exceptional items: Rs 8,824.90 lakhs
Consolidated FY2026 processing and testing charges: Rs 14,854.20 lakhs
Consolidated Q4 FY2026 PBT after exceptional items: Rs 7,793.97 lakhs
Consolidated cash generated from operations FY2026: Rs 24,026.96 lakhs
Consolidated total segment assets at March 31 2026: Rs 187,874.64 lakhs
Consolidated FY2025 revenue from operations audited: Rs 154,011.29 lakhs
Consolidated FY2026 revenue from operations audited: Rs 152,878.63 lakhs
Consolidated Q4 FY2025 PBT before exceptional items: Rs 9,678.48 lakhs
Consolidated Q4 FY2026 PBT before exceptional items: Rs 9,183.97 lakhs
Consolidated purchase of PPE and intangibles FY2026: Rs 5,637.87 lakhs
Consolidated short-term borrowings repayment FY2026: Rs 4,228.64 lakhs
Consolidated FY2026 synthetic cordage segment result: Rs 24,972.06 lakhs
Consolidated Q4 FY2026 adjusted PAT in press release: Rs 67.7 cr excluding exceptional items
Consolidated Q4 FY2026 depreciation and amortisation: Rs 909.16 lakhs
Consolidated non-current borrowings at March 31 2026: Rs 1,912.51 lakhs
Consolidated total capital employed at March 31 2026: Rs 135,442.40 lakhs
Consolidated Q4 FY2026 processing and testing charges: Rs 3,541.94 lakhs
Consolidated non-current liabilities at March 31 2026: Rs 8,904.12 lakhs
Consolidated Q3 FY2026 revenue from operations audited: Rs 38,724.71 lakhs
Consolidated Q4 FY2025 revenue from operations audited: Rs 43,255.12 lakhs
Consolidated Q4 FY2026 revenue from operations audited: Rs 42,641.47 lakhs
Consolidated net cash from financing activities FY2026: Rs 15,225.13 lakhs outflow
Consolidated net cash from investing activities FY2026: Rs 6,365.79 lakhs inflow
Consolidated net cash from operating activities FY2026: Rs 16,206.73 lakhs
Consolidated synthetic cordage assets at March 31 2026: Rs 95,960.49 lakhs
Consolidated Q4 FY2026 synthetic cordage segment result: Rs 8,775.76 lakhs
Consolidated cash and cash equivalents at March 31 2026: Rs 9,865.76 lakhs
Consolidated interest and financial charges paid FY2026: Rs 1,337.01 lakhs
Consolidated trade receivables current at March 31 2026: Rs 27,668.24 lakhs
Consolidated cash and cash equivalents at year-end FY2026: Rs 9,865.76 lakhs
Consolidated paid-up equity share capital at March 31 2026: Rs 9,926.58 lakhs before June buyback extinguishment
Consolidated property plant and equipment at March 31 2026: Rs 34,268.10 lakhs
Consolidated non-current other investments at March 31 2026: Rs 21,021.10 lakhs
Consolidated FY2025 profit after tax and share of associates: Rs 23,154.09 lakhs
Consolidated FY2026 profit after tax and share of associates: Rs 19,867.39 lakhs
Consolidated net increase in cash and cash equivalents FY2026: Rs 7,347.39 lakhs
Garware Youth Development Centre skilling-course beneficiaries: 283
Consolidated Q4 FY2025 profit after tax and share of associates: Rs 7,108.16 lakhs
Consolidated Q4 FY2026 profit after tax and share of associates: Rs 5,725.54 lakhs
Consolidated synthetic cordage capital employed at March 31 2026: Rs 62,845.60 lakhs
Garware Youth Development Centre foundation-course beneficiaries: 333 completed
Consolidated operating profit before working-capital changes FY2026: Rs 26,804.15 lakhs
Standalone FY2026 fibre and industrial products and projects revenue: Rs 33,872.85 lakhs
Consolidated FY2025 fibre and industrial products and projects revenue: Rs 29,980.49 lakhs
Consolidated FY2026 fibre and industrial products and projects revenue: Rs 33,872.85 lakhs
Consolidated Q4 FY2025 fibre and industrial products and projects revenue: Rs 7,284.95 lakhs
Consolidated Q4 FY2026 fibre and industrial products and projects revenue: Rs 8,080.39 lakhs
Consolidated FY2026 fibre and industrial products and projects segment result: Rs 6,772.86 lakhs
Consolidated fibre and industrial products and projects assets at March 31 2026: Rs 15,674.50 lakhs
Consolidated Q4 FY2026 fibre and industrial products and projects segment result: Rs 1,639.10 lakhs
Consolidated amount paid for acquisition of controlling stake in subsidiaries FY2026: Rs 10,884.03 lakhs
Consolidated fibre and industrial products and projects capital employed at March 31 2026: Rs 7,226.56 lakhs

Financial highlights

Order book: Rs 9,416 crore at March 31, 2026, described by the company as all-time high
Final dividend: Rs 2.75 per share recommended for FY2026; presentation cited 95.4% dividend payout for the year
Export order book: More than Rs 1,700 crore, described by management as all-time high
FY2026 export income: About Rs 300 crore after nearly two years of export-income gap
FY2026 standalone PAT: Rs 400.66 crore versus Rs 380.22 crore in FY2025
Promoter shareholding: 34,70,09,546 shares, or 72.20% of paid-up share capital, held by the Hon'ble President of India through Ministry of Railways as of March 31, 2026
FY2026 consolidated PAT: Rs 454 crore, up 7.3% YoY, with 18.0% PAT margin
Q4 FY2026 standalone PAT: Rs 136.28 crore versus Rs 134.41 crore in Q4 FY2025
Q4 FY2026 order additions: More than 120 orders worth over Rs 958 crore, including extensions
FY2026 consolidated EBITDA: Rs 568 crore, up 7.7% YoY, with 23.5% EBITDA margin
Q4 FY2026 consolidated PAT: Rs 139 crore with 17.4% PAT margin
Q4 FY2026 consolidated EBITDA: Rs 172 crore with 22.4% EBITDA margin
FY2026 standalone total income: Rs 2,425.88 crore versus Rs 2,222.06 crore in FY2025
FY2026 consolidated total revenue: Rs 2,525 crore versus Rs 2,302 crore in FY2025
Q4 FY2026 NALCO order enhancement: Contract value enhanced from Rs 79.73 crore to Rs 118.89 crore excluding GST, including RITES fees
Q4 FY2026 standalone total income: Rs 785.81 crore versus Rs 609.57 crore in Q4 FY2025
Q4 FY2026 consolidated total revenue: Rs 799 crore, up 27.7% YoY from Rs 626 crore in Q4 FY2025
FY2026 consolidated operating revenue: Rs 2,415 crore versus Rs 2,196 crore in FY2025
Standalone FY2026 export-sale revenue: Rs 316.25 crore
Q4 FY2026 consolidated operating revenue: Rs 768 crore, up 27.6% YoY from Rs 602 crore in Q4 FY2025
Standalone Q4 FY2026 export-sale revenue: Rs 190.48 crore
FY2026 standalone revenue from operations: Rs 2,275.74 crore versus Rs 2,074.21 crore in FY2025
Standalone FY2026 leasing-domestic revenue: Rs 172.07 crore
FY2026 consolidated revenue from operations: Rs 2,415.08 crore versus Rs 2,196.35 crore in FY2025
Consolidated FY2026 power-generation revenue: Rs 14.62 crore
Q4 FY2026 standalone revenue from operations: Rs 737.08 crore versus Rs 573.53 crore in Q4 FY2025
Standalone FY2026 consultancy-abroad revenue: Rs 67.21 crore
Standalone Q4 FY2026 leasing-domestic revenue: Rs 43.59 crore
Q4 FY2026 consolidated revenue from operations: Rs 768.26 crore versus Rs 602.29 crore in Q4 FY2025
Standalone FY2026 domestic consultancy revenue: Rs 1,117.81 crore
Standalone Q4 FY2026 consultancy-abroad revenue: Rs 19.23 crore
Consolidated FY2026 domestic consultancy revenue: Rs 1,242.01 crore
Standalone Q4 FY2026 domestic consultancy revenue: Rs 315.16 crore
Consolidated Q4 FY2026 domestic consultancy revenue: Rs 343.12 crore
Standalone FY2026 turnkey construction-projects revenue: Rs 602.40 crore
Standalone Q4 FY2026 turnkey construction-projects revenue: Rs 168.62 crore

Financial highlights

Inventories: Rs 436.82 cr at March 31, 2026 versus Rs 334.83 cr at March 31, 2025
Total assets: Rs 7,365.51 cr at March 31, 2026 versus Rs 7,036.41 cr at March 31, 2025
Total equity: Rs 3,895.66 cr at March 31, 2026 versus Rs 3,271.76 cr at March 31, 2025
Current ratio: 0.74x in the audited financial results
Closing net debt: Rs 2,255 cr, about 2.0x EBITDA per management commentary
Debtors turnover: 4.58x for FY2026
Interim dividend: Rs 7.21 per equity share for FY2026-27, record date May 29, 2026 and payment on or before June 19, 2026
DBF EBITDA margin: 37% in Q4 FY2026 and FY2026
DBF FY2026 EBITDA: Rs 1,026 cr, up 12% YoY per management commentary
Debt-equity ratio: 0.61x in the audited financial results
Trade receivables: Rs 680.34 cr at March 31, 2026 versus Rs 458.64 cr at March 31, 2025
Core FY2026 EBITDA: Rs 1,146 cr with 37.5% core EBITDA margin per management commentary
Current borrowings: Rs 1,353.85 cr at March 31, 2026 versus Rs 684.15 cr at March 31, 2025
DBF FY2026 revenue: Rs 2,778 cr, up 11% YoY per management commentary
FY2026 diluted EPS: Rs 45.26
Inventory turnover: 2.06x for FY2026
DBF Q4 FY2026 EBITDA: Rs 246 cr, up 10% YoY per management commentary
Other current assets: Rs 293.56 cr at March 31, 2026 versus Rs 195.96 cr at March 31, 2025
Rated NCD maturities: Two Rs 625 cr NCD tranches with stated maturity dates of December 7, 2026 and June 7, 2027 in the Ind-Ra filing
DBF Q4 FY2026 revenue: Rs 671 cr, up 12% YoY per management commentary
Q4 FY2026 diluted EPS: Rs 20.57
NCD interest servicing: June 8, 2026 intimation recorded interest servicing for NCD ISINs INE406M08029 and INE406M08011
Non-current borrowings: Rs 955.83 cr at March 31, 2026 versus Rs 1,737.51 cr at March 31, 2025
FY2026 operating margin: 27.11%
FY2026 net profit margin: 20.69%
Cash and cash equivalents: Rs 54.74 cr at March 31, 2026 versus Rs 199.74 cr at March 31, 2025
Q4 FY2026 operating margin: 27.26%
Total debt to total assets: 0.32x in the audited financial results
Board-composition penalties: BSE and NSE each levied Rs 4,24,800 for Regulation 17(1) non-compliance for the quarter ended March 31, 2026; company said compliance was restored from March 14, 2026
Debt service coverage ratio: 2.91x for FY2026
International FY2026 EBITDA: Rs 110 cr with 32% margin
Q4 FY2026 net profit margin: 36.89%
International FY2026 revenue: Rs 348 cr versus Rs 375 cr target
Labour Code exceptional item: Rs 17.24 cr
Swiss Parenteral acquisition: Remaining minority acquisition completed on January 16, 2026, making Swiss Parenteral a wholly owned subsidiary
Consolidated FY2026 net profit: Rs 647.51 cr versus Rs 374.67 cr in FY2025
International Q4 FY2026 EBITDA: Rs 28 cr with 32.4% margin
PAT from continuing operations: Rs 132 cr in Q4 FY2026 and Rs 498 cr in FY2026, with FY2026 up 34% YoY per management commentary
Eris Lifesciences credit rating: India Ratings affirmed issuer rating at IND AA/Stable, NCDs at IND AA/Stable and bank facilities at IND AA/Stable/IND A1+
Eris Therapeutics credit rating: India Ratings assigned or affirmed bank loan facilities at IND AA/Stable/IND A1+
Interest service coverage ratio: 4.40x for FY2026
International Q4 FY2026 revenue: Rs 86 cr versus Rs 115 cr plan
One-off deferred-tax adjustment: About Rs 150 cr benefit to reported PAT per management commentary
Consolidated FY2026 total income: Rs 3,137.17 cr versus Rs 2,912.00 cr in FY2025
Consolidated Q4 FY2026 net profit: Rs 279.10 cr versus Rs 102.35 cr in Q4 FY2025
Consolidated FY2026 total expenses: Rs 2,481.48 cr versus Rs 2,425.62 cr in FY2025
Consolidated Q4 FY2026 total income: Rs 758.79 cr versus Rs 713.25 cr in Q4 FY2025
FY2026 profit attributable to owners: Rs 619.52 cr
Consolidated FY2026 profit before tax: Rs 638.54 cr versus Rs 486.38 cr in FY2025
Consolidated Q4 FY2026 total expenses: Rs 598.18 cr versus Rs 575.77 cr in Q4 FY2025
FY2026 capex and intangibles purchase: Rs 296.86 cr outflow
Q4 FY2026 profit attributable to owners: Rs 281.61 cr
Consolidated Q4 FY2026 profit before tax: Rs 159.41 cr versus Rs 136.28 cr in Q4 FY2025
Consolidated FY2026 revenue from operations: Rs 3,129.42 cr versus Rs 2,893.64 cr in FY2025
Consolidated Q4 FY2026 revenue from operations: Rs 756.56 cr versus Rs 705.30 cr in Q4 FY2025
FY2026 net cash generated from operating activities: Rs 537.99 cr versus Rs 1,065.01 cr in FY2025
FY2026 operating profit before working-capital changes: Rs 1,120.40 cr

Financial highlights

Own-app MAU: 17.1 mn in Q4 FY2026, up 25% YoY
Own-app MTU: 5.5 mn in Q4 FY2026, up 18% YoY
FY2026 Turkey PAT: Rs 2,036 mn, up 62.4% YoY, PAT margin 8.3%
Q4 FY2026 Turkey PAT: Rs 576 mn, up 150.0% YoY, PAT margin 7.5%
FY2026 Turkey revenue: Rs 24,560 mn, up 28.8% YoY
FY2026 Sri Lanka revenue: Rs 1,285 mn, up 64.3% YoY
FY2026 standalone EBITDA: Rs 13,730 mn, up 15.1% YoY, margin 20.0% versus 19.7%
Q4 FY2026 Turkey revenue: Rs 7,644 mn, up 59.2% YoY
FY2026 Bangladesh revenue: Rs 799 mn, up 27.4% YoY
FY2026 group system sales: Rs 109,838 mn, up 17.9% YoY
Q4 FY2026 Sri Lanka revenue: Rs 367 mn, up 61.4% YoY
Q4 FY2026 standalone EBITDA: Rs 3,444 mn, up 11.5% YoY, margin 20.5% versus 19.6%
FY2026 India store additions: 289 net stores after Dunkin reclassification
Q4 FY2026 Bangladesh revenue: Rs 209 mn, up 29.4% YoY
Q4 FY2026 Domino's India ADS: Rs 80,069
Q4 FY2026 group system sales: Rs 27,643 mn
Q4 FY2026 group store network: 3,636 stores after Dunkin reclassification; April business update had shown 3,663 including Dunkin
Q4 FY2026 Popeyes India stores: 78 stores after 5 net additions in Q4
Q4 FY2026 India store additions: 61 net stores across all brands, including 59 Domino's India stores and 5 Popeyes stores, partly offset by Hong's Kitchen closures
FY2026 Domino's India LFL growth: 6.5%, after 7.5% in FY2025
FY2026 group net store additions: 351 stores after Dunkin reclassification
Q4 FY2026 COFFY Turkey LFL growth: 18.4% before inflation adjustment and negative 9.7% after inflation adjustment
Q4 FY2026 standalone gross margin: 75.5%, up 98 bps YoY
Q4 FY2026 Domino's India LFL growth: 0.2% YoY
Q4 FY2026 group net store additions: 69 stores after Dunkin reclassification
FY2026 consolidated operating EBITDA: Rs 18,878 mn, up 19.1% YoY, margin 19.8% versus 19.6%
Q4 FY2026 Domino's Turkey LFL growth: 42.8% before inflation adjustment and 9.0% after IAS 29 inflation adjustment
Q4 FY2026 Domino's India delivery mix: 76.1%
Q4 FY2026 Domino's India order growth: 10.4% YoY
Q4 FY2026 Domino's India revenue growth: Up 5.0% YoY
Q4 FY2026 consolidated operating EBITDA: Rs 4,849 mn, up 23.7% YoY, margin 19.4% versus 18.7%
Standalone FY2026 free cash flow to firm: Rs 1,027 mn
FY2026 standalone revenue from operations: Rs 68,562 mn, up 13.0% YoY from Rs 60,674 mn
Consolidated FY2026 free cash flow to firm: Rs 2,472 mn
FY2026 consolidated revenue from operations: Rs 95,125 mn, up 17.4% YoY from Rs 81,045 mn
Standalone FY2026 cash flow from operations: Rs 9,166 mn
FY2026 Popeyes India same-store sales growth: About 28%
Q4 FY2026 standalone revenue from operations: Rs 16,797 mn, up 6.4% YoY from Rs 15,790 mn
Consolidated FY2026 cash flow from operations: Rs 12,521 mn
Q4 FY2026 consolidated revenue from operations: Rs 24,995 mn, up 19.3% YoY from Rs 20,950 mn
Q4 FY2026 Domino's India delivery revenue growth: 10.3% YoY
FY2026 standalone PAT from continuing operations before exceptional items: Rs 2,762 mn, up 18.4% YoY, margin 4.0% versus 3.8%
FY2026 consolidated PAT from continuing operations before exceptional items: Rs 4,113 mn, up 63.8% YoY, margin 4.3% versus 3.1%
Q4 FY2026 standalone PAT from continuing operations before exceptional items: Rs 537 mn, down 2.8% YoY, margin 3.2% versus 3.5%
Q4 FY2026 consolidated PAT from continuing operations before exceptional items: Rs 936 mn, up 67.3% YoY, margin 3.7% versus 2.7%

Financial highlights

Dividend: Final dividend Rs 2.50 per share recommended, in addition to Rs 1.50 interim dividend
SKU count: Increased from 6,939 to 8,103 in FY2026
Brand spend: Rs 16 cr spent in Q4 FY2026 on Bondtite brand association event
FY2026 capex: Rs 328.4 cr standalone and Rs 372.9 cr consolidated
CPVC resin capacity: 40,000 MT Phase I under construction; potential scale-up to 100,000 MT in Phase II
FY2027 capex guidance: Management guided about Rs 300 cr
FY2026 plumbing EBITDA: Rs 916.6 cr vs Rs 792.4 cr in FY2025; up 15.7% YoY; margin 19.6%
Standalone inventories: Rs 962.8 cr at March 31, 2026 vs Rs 887.0 cr at March 31, 2025
FY2026 consolidated EPS: Rs 19.97 basic and diluted vs Rs 19.50 in FY2025
FY2026 consolidated PBT: Rs 753.2 cr vs Rs 702.5 cr in FY2025; up 7.2% YoY
FY2026 plumbing revenue: Rs 4,678.7 cr vs Rs 4,196.3 cr in FY2025; up 11.5% YoY
Bond IT UK Q4 commentary: 22.9% growth and 6.5% positive EBITDA, per management
Kanpur phase-one capacity: 19,037 MT installed after operations commenced in October 2025
Paint FY2026 sales growth: 23%; management said Q4 growth was 31%
Q4 FY2026 plumbing EBITDA: Rs 351.9 cr vs Rs 250.4 cr in Q4 FY2025; up 40.5% YoY; margin 22.9%
FY2026 consolidated EBITDA: Rs 1,109.2 cr vs Rs 987.2 cr in FY2025; up 12.4% YoY
Q4 FY2026 consolidated EPS: Rs 7.93 basic and diluted vs Rs 6.67 in Q4 FY2025
Q4 FY2026 consolidated PBT: Rs 302.7 cr vs Rs 236.4 cr in Q4 FY2025; up 28.0% YoY
Q4 FY2026 plumbing revenue: Rs 1,534.2 cr vs Rs 1,226.6 cr in Q4 FY2025; up 25.1% YoY
Pipes and fittings capacity: Increased from 381,957 MT to 417,645 MT during FY2026
Bathware FY2026 sales growth: 27.3%
FY2026 plumbing sales volume: 263,026 MT vs 227,090 MT in FY2025; up 15.8% YoY
Standalone FY2026 net profit: Rs 611.0 cr vs Rs 566.3 cr in FY2025
Standalone trade receivables: Rs 334.6 cr at March 31, 2026 vs Rs 315.8 cr at March 31, 2025
Q4 FY2026 consolidated EBITDA: Rs 400.2 cr vs Rs 310.8 cr in Q4 FY2025; up 28.8% YoY
FY2026 consolidated cash profit: Rs 826.3 cr vs Rs 762.3 cr in FY2025; up 8.4% YoY
Q4 FY2026 plumbing sales volume: 84,041 MT vs 67,692 MT in Q4 FY2025; up 24.2% YoY
Standalone Q4 FY2026 net profit: Rs 237.7 cr vs Rs 190.0 cr in Q4 FY2025
FY2026 consolidated EBITDA margin: 16.9%, broadly flat vs FY2025
FY2026 consolidated PAT before OCI: Rs 534.7 cr vs Rs 518.9 cr in FY2025; up 3.0% YoY
FY2026 paints and adhesives EBITDA: Rs 192.6 cr vs Rs 194.8 cr in FY2025; down 1.1% YoY; margin 10.2%
Q4 FY2026 consolidated cash profit: Rs 287.0 cr vs Rs 242.9 cr in Q4 FY2025; up 18.2% YoY
Consolidated cash and bank balances: Rs 943.3 cr at March 31, 2026
FY2026 paints and adhesives revenue: Rs 1,889.9 cr vs Rs 1,636.1 cr in FY2025; up 15.5% YoY
Q4 FY2026 consolidated EBITDA margin: 19.2% vs 18.5% in Q4 FY2025
Standalone cash and cash equivalents: Rs 870.9 cr at March 31, 2026 vs Rs 581.1 cr at March 31, 2025
Q4 FY2026 consolidated PAT before OCI: Rs 213.0 cr vs Rs 178.1 cr in Q4 FY2025; up 19.6% YoY
Q4 FY2026 paints and adhesives EBITDA: Rs 48.3 cr vs Rs 60.4 cr in Q4 FY2025; down 20.0% YoY; margin 8.7%
Q4 FY2026 paints and adhesives revenue: Rs 554.3 cr vs Rs 454.8 cr in Q4 FY2025; up 21.9% YoY
Standalone FY2026 revenue from operations: Rs 5,907.6 cr vs Rs 5,295.9 cr in FY2025
FY2026 consolidated revenue from operations: Rs 6,568.6 cr vs Rs 5,832.4 cr in FY2025; up 12.6% YoY
Standalone Q4 FY2026 revenue from operations: Rs 1,902.8 cr vs Rs 1,542.3 cr in Q4 FY2025
Adhesive India FY2026 sales growth and margin: Sales up 15.1%; EBITDA margin 15.1%
Q4 FY2026 consolidated revenue from operations: Rs 2,088.5 cr vs Rs 1,681.4 cr in Q4 FY2025; up 24.2% YoY
Adhesive overseas FY2026 sales growth and margin: Sales up 12.6%; EBITDA margin 3.9%
Standalone FY2026 cash generated from operations: Rs 1,084.3 cr after working-capital changes

Financial highlights

ROCE: 18.8%, computed excluding cash, bank and investments
FY2026 EPS: Rs 87.06 basic and diluted vs Rs 109.44 basic in FY2025
Order book: Management said order book continues around USD 1.0-1.2 billion
Inventories: Rs 1,216.7 cr at March 31, 2026 vs Rs 983.9 cr at March 31, 2025
FY2026 capex: Rs 1,150.8 cr vs Rs 928.0 cr in FY2025
Inventory DIO: 66 days at Q4 FY2026 end
Q4 FY2026 EPS: Rs 13.20 basic and diluted vs Rs 21.79 basic in Q4 FY2025
Final dividend: Rs 10 per share recommended; total FY2026 dividend Rs 16 per share including Rs 6 interim dividend
Contract assets: Rs 709.1 cr at March 31, 2026 vs Rs 426.8 cr at March 31, 2025
Debt-equity ratio: 0.02 as of March 31, 2026
Exceptional items: Rs 126.0 cr contingent-consideration writeback partly offset by Rs 22.9 cr New Labour Codes provisioning
FY2026 pharma PBT: Loss of Rs 274.4 cr before inter-segment adjustment and exceptional items; presentation PBT loss narrowed to Rs 78.5 cr post eliminations/exceptionals
New product share: New products contributed about 18% of Agchem Exports revenue
Trade receivables: Rs 1,610.8 cr at March 31, 2026 vs Rs 1,405.8 cr at March 31, 2025
Global biologicals: Global biologicals ex-India annualized revenue about USD 12 mn; margin upward of 60%; expected to grow in double digits
FY2026 gross margin: 58%; up about 507 bps YoY
FY2026 new products: 5 molecules commercialized in Agchem Exports and 4 products launched in Domestic Agri Brands
FY2026 EBITDA margin: 25% vs 27% in FY2025; down about 197 bps
FY2026 dividends paid: Rs 227.8 cr
FY2026 domestic trend: Domestic revenue declined about 7% YoY with volume down about 1%
FY2027 capex guidance: About Rs 700-800 cr across manufacturing, new launches, R&D, pharma and agrochemicals
Trade receivables DSO: 126 days at Q4 FY2026 end
Trade working capital: 139 days at Q4 FY2026 end
Q4 FY2026 gross margin: 58%; up about 277 bps YoY
Q4 FY2026 EBITDA margin: 22% vs 26% in Q4 FY2025; down about 402 bps
Q4 FY2026 pharma revenue: Rs 104.8 cr vs Rs 85.0 cr in Q4 FY2025; up 23% YoY
Surplus cash net of debt: Rs 3,426.5 cr
Cash and cash equivalents: Rs 283.3 cr at March 31, 2026 vs Rs 592.3 cr at March 31, 2025
Cash, bank and investments: Rs 3,509.4 cr at March 31, 2026
FY2026 agchem export trend: Agchem exports declined 19% YoY with volume down about 14%
FY2026 consolidated EBITDA: Rs 1,705.3 cr vs Rs 2,183.3 cr in FY2025; down 22% YoY
FY2026 financing cash flow: Net cash outflow from financing activities Rs 171.0 cr
FY2026 investing cash flow: Net cash used in investing activities Rs 613.5 cr
FY2026 operating cash flow: Operating profit before working-capital changes Rs 1,783.5 cr
Q4 FY2026 domestic revenue: Rs 306.7 cr vs Rs 338.3 cr in Q4 FY2025
Electronic chemicals target: About USD 100 mn over the next 4-5 years, per management commentary
FY2026 agchem segment revenue: Rs 6,416.8 cr vs Rs 7,765.0 cr in FY2025
FY2026 pharma segment revenue: Rs 300.5 cr vs Rs 215.1 cr in FY2025; up 40% YoY
Q4 FY2026 consolidated EBITDA: Rs 337.3 cr vs Rs 456.9 cr in Q4 FY2025; down 26% YoY
FY2026 consolidated net profit: Rs 1,320.8 cr vs Rs 1,660.2 cr in FY2025; down 20% YoY
Q4 FY2026 agchem export revenue: Rs 1,258.5 cr vs Rs 1,448.8 cr in Q4 FY2025
Q4 FY2026 consolidated net profit: Rs 200.2 cr vs Rs 330.5 cr in Q4 FY2025; down 39% YoY
FY2026 consolidated revenue from operations: Rs 6,713.7 cr vs Rs 7,977.8 cr in FY2025; down 16% YoY
Q4 FY2026 consolidated revenue from operations: Rs 1,565.2 cr vs Rs 1,787.1 cr in Q4 FY2025; down 12% YoY
FY2026 consolidated PBT after exceptional items: Rs 1,696.1 cr vs Rs 2,142.0 cr in FY2025
FY2026 consolidated PBT before exceptional items: Rs 1,593.0 cr vs Rs 2,142.0 cr in FY2025
Q4 FY2026 consolidated PBT before exceptional items: Rs 302.5 cr vs Rs 432.2 cr in Q4 FY2025

Financial highlights

FY2026 GRM: USD 11.74 per barrel before Special Additional Excise Duty and Road & Infrastructure Cess impact, versus USD 6.82 in FY2025
FY2026 total sales: 55.72 MMT versus 53.63 MMT in FY2025
FY2027 capex target: Rs 25,000 cr, including about Rs 11,000 cr for refinery and petrochemicals, Rs 10,000 cr for marketing and logistics, Rs 2,250 cr for BPRL equity infusion and Rs 1,700 cr for CGD expansion
Standalone net worth: Rs 95,233 cr according to management commentary
FY2026 capex incurred: Rs 20,400 cr according to management
FY2026 domestic sales: 54.18 MMT versus 52.40 MMT in FY2025
Standalone FY2026 EPS: Rs 54.54 versus Rs 31.07 in FY2025
Standalone FY2026 PAT: Rs 23,303.22 cr versus Rs 13,275.26 cr in FY2025
Standalone FY2026 PBT: Rs 31,104.00 cr versus Rs 17,664.33 cr in FY2025
Consolidated FY2026 EPS: Rs 60.49 versus Rs 31.21 in FY2025
Consolidated FY2026 PAT: Rs 25,843.45 cr versus Rs 13,336.55 cr in FY2025
Consolidated FY2026 PBT: Rs 34,791.24 cr versus Rs 18,182.30 cr in FY2025
FY2026 distillate yield: 84.54% versus 84.33% in FY2025
Standalone Q4 FY2026 EPS: Rs 7.47 versus Rs 7.52 in Q4 FY2025
Standalone Q4 FY2026 PAT: Rs 3,191.49 cr versus Rs 3,214.06 cr in Q4 FY2025
Standalone Q4 FY2026 PBT: Rs 4,257.96 cr versus Rs 4,262.51 cr in Q4 FY2025
Consolidated Q4 FY2026 PAT: Rs 5,624.54 cr versus Rs 4,391.83 cr in Q4 FY2025
Consolidated Q4 FY2026 PBT: Rs 7,837.77 cr versus Rs 5,896.76 cr in Q4 FY2025
FY2026 refinery throughput: 41.15 MMT versus 40.51 MMT in FY2025
Standalone gross borrowings: Rs 10,480 cr as of March 2026, with debt-equity at 0.11x
Consolidated gross borrowings: Rs 43,482 cr according to management commentary, with group debt-equity at 0.43x and 0.25x net of current investments
FY2026 forex fluctuation loss: Rs 1,644 cr versus Rs 358 cr loss in FY2025
Q4 FY2026 refinery throughput: 10.40 MMT versus 10.58 MMT in Q4 FY2025
Standalone exceptional expense: Rs 4,349.13 cr in Q4 and FY2026, mainly related to upstream impairment according to the earnings call
FY2026 marketing inventory gain: Rs 842 cr versus Rs 905 cr loss in FY2025
Q4 FY2026 forex fluctuation loss: Rs 936 cr versus Rs 45 cr loss in Q4 FY2025
Q4 FY2026 marketing inventory gain: Rs 1,275 cr versus Rs 523 cr in Q4 FY2025
Standalone FY2026 revenue from operations: Rs 5,22,668.25 cr versus Rs 5,00,371.25 cr in FY2025
Consolidated FY2026 revenue from operations: Rs 5,22,820.41 cr versus Rs 5,00,517.48 cr in FY2025
Standalone Q4 FY2026 revenue from operations: Rs 1,34,896.40 cr versus Rs 1,26,864.93 cr in Q4 FY2025
Standalone current investments and oil bonds: About Rs 18,465 cr according to management, leaving BPCL net surplus on a standalone basis
Consolidated Q4 FY2026 revenue from operations: Rs 1,34,947.90 cr versus Rs 1,26,916.18 cr in Q4 FY2025
Standalone FY2026 profit before exceptional items and tax: Rs 35,453.13 cr versus Rs 19,438.26 cr in FY2025
Standalone Q4 FY2026 profit before exceptional items and tax: Rs 8,607.09 cr versus Rs 6,036.44 cr in Q4 FY2025

Financial highlights

Dividend: INR 10 per equity share, marking the 63rd consecutive year of uninterrupted dividend payments
Birla Pivot reach: 5,000-plus pin codes, 400-plus cities and 5,000-plus retail touchpoints; Q4 revenue more than doubled year-on-year
Lyocell expansion: Phase 1 Harihar capacity of 55,000 TPA within total proposed 110,000 TPA expansion progressing
Chemicals capacity: chloralkali installed capacity 1.5 million MTPA, expanding from 1,505 KTPA to 1,530 KTPA
UltraTech capacity: crossed 200 MTPA total grey capacity in April 2026; target 240-plus MTPA by March 2028
Birla Opus capacity: 1,332 million litres per annum, about 24% of industry capacity
AB Capital investment: Grasim Board approved INR 2,880 cr investment to maintain 52.3% fully diluted stake in AB Capital's INR 4,000 cr preferential equity raise
Birla Opus distribution: 11,500 towns, 50,000-plus dealers, 146 depots, nearly 37,000 active tinting machines and 1,200-plus exclusive branded franchise stores across 700-plus towns
Birla Opus market share: about 90 bps quarter-on-quarter expansion in Q4 FY2026; about 370 bps expansion over FY2025; crossed 10% revenue market share in March 2026 based on company-commissioned retail study
Caustic soda sales volume: highest ever at 321,000 tons in Q4 and 1,232 KT for FY2026
FY2026 standalone revenue: INR 41,039 cr; 27% CAGR over FY2021-FY2026
Cellulosic fibres Q4 EBITDA: INR 588 cr, about 2x year-on-year
FY2026 consolidated revenue: INR 1,75,431 cr, above USD 18 bn; 18% CAGR over FY2021-FY2026
Cellulosic fibres Q4 revenue: INR 4,614 cr, up 14% year-on-year
Institutional paints channel: 43% quarter-on-quarter and 212% year-on-year growth, with over 10,000 sites billed in Q4 FY2026 and a 45,000-site pipeline across 650-plus towns
Cellulosic fibres FY2026 EBITDA: INR 1,751 cr versus INR 1,524 cr in FY2025, up 15%
Birla Opus FY2026 revenue growth: 100% versus FY2025
Cellulosic fibres FY2026 revenue: INR 17,104 cr versus INR 15,897 cr in FY2025, up 8%
UltraTech operating EBITDA per ton: INR 1,253; cumulative FY2025-FY2026 efficiency gains of INR 185 per ton
Birla Opus Q4 FY2026 revenue growth: 52% year-on-year on a like-for-like basis; 71% excluding CWIP on a like-for-like basis
Decorative paints industry estimate: about INR 15,500 cr revenue in Q4 FY2026 excluding industrial and non-decorative revenue
UltraTech dividend cash inflow to Grasim: nearly INR 4,000 cr before taxes

Financial highlights

Dividend: Rs 2 per equity share of face value Re 1 recommended for FY2026, subject to shareholder approval
FIFA rights: Rights to broadcast, stream and distribute 39 FIFA competitions in India from 2026 to 2034
Inventories: Rs 65,123 million at March 31, 2026 versus Rs 67,748 million at March 31, 2025
ZEE5 EBITDA: Adjusted EBITDA breakeven in FY2026; positive adjusted EBITDA excluding the movie-rights amortisation estimate change
Capital raise: Minimum Rs 2,300 crore approved on June 10, 2026, with fund-raising options still to be deliberated
Jiostar claim: Damages claim of about Rs 28.75 crore, subject to increase during adjudication
Trade receivables: Rs 17,243 million at March 31, 2026
Zee Music Company: About 176 million YouTube subscribers and 217 billion video views in FY2026
FY2026 other costs: Rs 6,257 million
ZEE5 FY2026 revenue: Rs 14,888 million, up 53% year on year
FY2026 operating cost: Rs 48,594 million
FY2026 personnel cost: Rs 8,424 million
Q4 FY2026 other costs: Rs 1,642 million
FY2026 adjusted EBITDA: Rs 7,547 million, with adjusted EBITDA margin of 9.3%
FY2026 reported EBITDA: Rs 3,463 million, with reported EBITDA margin of 4.3%
ZEE5 Q4 FY2026 revenue: Rs 4,700 million, up 71% year on year
Phantom FY2025 turnover: Rs 1,022 million
Q4 FY2026 ZEE5 releases: 45 shows and movies, including 11 originals
ZBullet FY2026 turnover: Rs 34 million
FY2026 operating revenue: Rs 80,989 million versus Rs 82,941 million in FY2025
Q4 FY2026 operating cost: Rs 15,048 million
Q4 FY2026 personnel cost: Rs 1,920 million
Q4 FY2026 adjusted EBITDA: Rs 1,398 million, with adjusted EBITDA margin of 6.9%
Q4 FY2026 reported EBITDA: Negative Rs 2,686 million after the movie-rights charge and weaker ad revenue
All-India TV network share: 17.4% in FY2026, up 60 bps year on year; Q4 FY2026 share also 17.4%, up 80 bps year on year
Cash and other investments: Rs 27,595 million at March 31, 2026 versus Rs 24,063 million at March 31, 2025
FY2026 advertising revenue: Rs 32,243 million versus Rs 35,911 million in FY2025
CORE live-events investment: Rs 200 million investment in CORE Private Limited per earnings release
FY2026 subscription revenue: Rs 40,796 million versus Rs 39,261 million in FY2025
Q4 FY2026 operating revenue: Rs 20,248 million versus Rs 22,801 million in Q3 FY2026 and Rs 21,841 million in Q4 FY2025
ZBullet investment approval: Up to Rs 100 crore in OCDs approved on May 19, 2026
Q4 FY2026 advertising revenue: Rs 8,080 million
Q4 FY2026 subscription revenue: Rs 10,247 million
Q4 FY2026 profit for the period: Loss of Rs 1,037 million
FY2026 shows and movies released: 127 shows and movies, including 34 originals
Linear weekly reach and impressions: Weekly reach of 741 million and weekly impressions of 28.4 billion in FY2026
FY2026 advertising and publicity cost: Rs 14,251 million
Content inventory advances and deposits: Rs 67.6 billion at March 2026 per management, down Rs 2.8 billion year on year
FY2026 other sales and services revenue: Rs 7,950 million versus Rs 7,769 million in FY2025
Q4 FY2026 advertising and publicity cost: Rs 4,324 million
Q4 FY2026 other sales and services revenue: Rs 1,921 million
Phantom Digital Effects investment approval: Up to Rs 116 crore in CCDs approved on April 17, 2026
Movie-rights amortisation and impairment charge: Rs 4,084 million in Q4 FY2026
FY2026 profit after tax from continuing operations: Rs 2,713 million versus Rs 6,923 million in FY2025

Financial highlights

Borrowings: Rs 675.14 cr non-current borrowings and Rs 656.81 cr current borrowings at March 31, 2026
FY2026 EPS: Rs 15.99 basic and diluted
FY2026 PAT: Rs 356.20 cr versus Rs 278.81 cr in FY2025, up 27.76%
FY2026 PBT: Rs 470.46 cr versus Rs 377.30 cr in FY2025
Inventories: Rs 591.47 cr at March 31, 2026 versus Rs 996.31 cr at March 31, 2025
Total assets: Rs 4,442.51 cr at March 31, 2026
Total equity: Rs 1,944.52 cr at March 31, 2026
Credit rating: CRISIL AA / Stable on Rs 2,120 cr bank-loan facilities, upgraded from AA- / Positive
FY2026 EBITDA: Rs 1,190.34 cr versus Rs 1,029.67 cr in FY2025, up 15.60%
Q4 FY2026 EPS: Rs 2.28 basic and diluted
Q4 FY2026 PAT: Rs 50.89 cr versus Rs 60.58 cr in Q3 FY2026 and Rs 43.01 cr in Q4 FY2025
Q4 FY2026 PBT: Rs 59.77 cr versus Rs 78.92 cr in Q3 FY2026 and Rs 58.55 cr in Q4 FY2025
Debt-to-equity: 0.68 in FY2025-26 versus 1.44 in FY2023-24 according to Chairman commentary in the FY2026 press release
Q4 FY2026 EBITDA: Rs 237.87 cr according to the FY2026 press release
Trade receivables: Rs 4.77 cr at March 31, 2026 versus Rs 8.16 cr at March 31, 2025
FY2026 total income: Rs 9,972.94 cr versus Rs 8,719.32 cr in FY2025
FY2026 finance costs: Rs 146.30 cr versus Rs 181.89 cr in FY2025
Q4 FY2026 total income: Rs 2,580.21 cr versus Rs 2,366.68 cr in Q3 FY2026 and Rs 2,251.37 cr in Q4 FY2025
Capital work-in-progress: Rs 58.62 cr at March 31, 2026
FY2026 borrowings repayment: Rs 537.46 cr repayment of non-current borrowings and Rs 413.96 cr net repayment of current borrowings
FY2027 first interim dividend: Rs 10 per share, aggregating Rs 222.75 cr, record date May 26, 2026
Property, plant and equipment: Rs 2,882.10 cr at March 31, 2026
FY2026 net operating cash flow: Rs 1,556.54 cr versus Rs 1,450.20 cr in FY2025
FY2026 revenue from operations: Rs 9,959.22 cr versus Rs 8,699.76 cr in FY2025, up 14.48%
Q4 FY2026 revenue from operations: Rs 2,577.63 cr versus Rs 2,363.72 cr in Q3 FY2026 and Rs 2,202.85 cr in Q4 FY2025
FY2026 capex and intangible outflow: Rs 438.56 cr versus Rs 657.69 cr in FY2025
FY2026 depreciation and amortisation: Rs 573.58 cr versus Rs 470.48 cr in FY2025
FY2026 cash generated from operations: Rs 1,684.35 cr versus Rs 1,562.05 cr in FY2025
FY2026 operating cash flow before working capital: Rs 1,181.03 cr versus Rs 1,019.14 cr in FY2025

Financial highlights

Closing order book: Rs 2,053.9 cr at March 31, 2026, up 8% year on year
Segment disclosure: Single reportable segment: Power Generating Equipment and Solutions
FY2026 export sales: Rs 1,258.1 cr, up 30% year on year and 58% of FY2026 revenue
FY2026 dividend paid: Rs 135.1 cr versus Rs 104.9 cr in FY2025
FY2026 standalone PAT: Rs 336.7 cr versus Rs 374.4 cr in FY2025
FY2026 product revenue: Rs 1,581.6 cr, up 16% year on year
Q4 FY2026 export sales: Rs 408.5 cr, up 46% year on year and 60% of Q4 revenue
FY2026 consolidated EPS: Rs 11.00 versus Rs 11.28 in FY2025
FY2026 consolidated PAT: Rs 349.4 cr versus Rs 358.6 cr in FY2025
Q4 FY2026 order booking: Rs 747.1 cr, up 19% year on year
Consolidated inventories: Rs 244.3 cr at March 31, 2026 versus Rs 194.8 cr at March 31, 2025
Q4 FY2026 domestic sales: Rs 271.1 cr, up 5% year on year
Q4 FY2026 standalone PAT: Rs 78.9 cr versus Rs 95.2 cr in Q3 FY2026 and Rs 93.7 cr in Q4 FY2025
Closing export order book: Rs 1,054.0 cr, 51% of closing order book
Consolidated total assets: Rs 2,496.8 cr at March 31, 2026 versus Rs 2,019.0 cr at March 31, 2025
Consolidated total equity: Rs 1,446.0 cr at March 31, 2026 versus Rs 1,219.5 cr at March 31, 2025
Q4 FY2026 product revenue: Rs 512.2 cr, up 30% year on year and 75% of Q4 revenue
FY2026 aftermarket revenue: Rs 599.5 cr, down 7% year on year
FY2026 consolidated EBITDA: Rs 526.8 cr, 24.2% margin, versus Rs 517.7 cr and 25.8% margin in FY2025
FY2026 total order booking: Rs 2,325.6 cr versus Rs 2,362.7 cr in FY2025
Q4 FY2026 consolidated EPS: Rs 3.21 versus Rs 2.89 in Q3 FY2026 and Rs 2.99 in Q4 FY2025
Q4 FY2026 consolidated PAT: Rs 101.9 cr versus Rs 91.7 cr in Q3 FY2026 and Rs 94.6 cr in Q4 FY2025
Consolidated current assets: Rs 1,990.1 cr at March 31, 2026 versus Rs 1,658.2 cr at March 31, 2025
Consolidated trade payables: Rs 558.1 cr at March 31, 2026, including Rs 112.6 cr MSME and Rs 445.5 cr non-MSME payables
Q4 FY2026 aftermarket revenue: Rs 167.4 cr, up 16% year on year and 25% of Q4 revenue
Q4 FY2026 consolidated EBITDA: Rs 144.4 cr, 21.2% margin, versus Rs 140.3 cr and 26.1% margin in Q4 FY2025
Closing aftermarket order book: Rs 539.4 cr, up 107% year on year and 26% of closing order book
Consolidated trade receivables: Rs 639.1 cr at March 31, 2026 versus Rs 363.2 cr at March 31, 2025
Q4 FY2026 export order booking: Rs 515.5 cr, up 174% year on year and 69% of Q4 order booking
Consolidated current investments: Rs 302.7 cr at March 31, 2026 versus Rs 345.2 cr at March 31, 2025
Consolidated current liabilities: Rs 1,005.8 cr at March 31, 2026 versus Rs 746.5 cr at March 31, 2025
FY2026 adjusted consolidated PAT: Rs 361.1 cr excluding Rs 15.7 cr New Labour Code exceptional item versus Rs 358.6 cr in FY2025
FY2026 aftermarket order booking: Rs 878.2 cr, up 41% year on year and 38% of FY2026 order booking
New Labour Code exceptional item: Rs 15.7 cr one-time employee-benefit obligation impact recognized in FY2026
FY2026 consolidated capex cash flow: Rs 71.6 cr purchase of property, plant and equipment
Q4 FY2026 aftermarket order booking: Rs 375.2 cr, up 121% year on year and 50% of Q4 order booking
Q4 FY2026 consolidated total income: Rs 696.0 cr versus Rs 643.5 cr in Q3 FY2026 and Rs 557.9 cr in Q4 FY2025
Consolidated cash and cash equivalents: Rs 100.7 cr at March 31, 2026 versus Rs 98.2 cr at March 31, 2025
FY2026 consolidated cash from operations: Rs 111.0 cr net operating cash inflow versus Rs 186.8 cr in FY2025
FY2026 standalone revenue from operations: Rs 2,009.7 cr versus Rs 1,795.2 cr in FY2025
Consolidated bank balances other than cash: Rs 177.1 cr at March 31, 2026 versus Rs 228.3 cr at March 31, 2025
FY2026 consolidated revenue from operations: Rs 2,181.1 cr versus Rs 2,005.8 cr in FY2025
FY2026 consolidated working-capital movement: Rs 313.4 cr trade receivable increase and Rs 50.7 cr inventory increase, partly offset by Rs 269.3 cr trade payable increase
Q4 FY2026 standalone revenue from operations: Rs 602.5 cr versus Rs 584.0 cr in Q3 FY2026 and Rs 490.4 cr in Q4 FY2025
Q4 FY2026 consolidated revenue from operations: Rs 679.6 cr versus Rs 624.0 cr in Q3 FY2026 and Rs 538.0 cr in Q4 FY2025
FY2026 consolidated PBT after exceptional items: Rs 473.1 cr versus Rs 488.6 cr in FY2025
FY2026 consolidated PBT before exceptional items: Rs 488.8 cr versus Rs 488.6 cr in FY2025
Q4 FY2026 consolidated PBT before exceptional items: Rs 134.4 cr versus Rs 142.6 cr in Q3 FY2026 and Rs 132.1 cr in Q4 FY2025

Financial highlights

Final dividend: Rs. 1.50 per share, 75% of Rs. 2 face value, subject to shareholder approval
FY2026 CNG volume: 2,532.28 million SCM, up 4% YoY
FY2026 gross sales: Rs. 17,785.36 cr, up 8% YoY
FY2027 capex outlook: Approximately Rs. 1,980 cr planned
Q4 FY2026 CNG volume: 636.70 million SCM, up 5% YoY
FY2026 standalone PAT: Rs. 1,364.10 cr versus Rs. 1,467.59 cr in FY2025
FY2027 volume outlook: Company efforts to reach approximately 10.60 MMSCMD
FY2026 CNG gross sales: Rs. 13,533.20 cr, up 8% YoY
FY2026 PNG gross sales: Rs. 4,248.50 cr, up 10% YoY
FY2026 consolidated EPS: Rs. 11.07 versus Rs. 12.27 in FY2025
FY2026 total PNG volume: 894.27 million SCM, up 5% YoY
FY2026 standalone EBITDA: Rs. 1,850.04 cr, down 6% YoY
Standalone Q4 FY2026 PAT: Rs. 277.08 cr versus Rs. 349.23 cr in Q4 FY2025
FY2026 total sales volume: 3,427.21 million SCM, up 4% YoY; 9.39 MMSCMD versus 8.99 MMSCMD
Q4 FY2026 CNG gross sales: Rs. 3,403.66 cr, up 4% YoY
Q4 FY2026 PNG gross sales: Rs. 1,167.09 cr, up 12% YoY
Consolidated Q4 FY2026 EPS: Rs. 2.43 versus Rs. 3.25 in Q4 FY2025
FY2026 domestic PNG volume: 279.25 million SCM, up 9% YoY
FY2026 operating cash flow: Rs. 1,935.58 cr consolidated net cash flow generated from operating activities
Q4 FY2026 total PNG volume: 235.63 million SCM, up 6% YoY
Standalone Q4 FY2026 EBITDA: Rs. 422.94 cr, down 14% YoY
Q4 FY2026 total sales volume: 872.46 million SCM, up 6% YoY; 9.69 MMSCMD versus 9.18 MMSCMD
FY2026 capex cash flow marker: Rs. 1,347.33 cr payment for PPE, intangibles, capital work-in-progress and capital advances
Q4 FY2026 domestic PNG volume: 77.52 million SCM, up 13% YoY
FY2026 consolidated parent PAT: Rs. 1,549.62 cr versus Rs. 1,717.76 cr in FY2025
FY2026 standalone EBITDA margin: 11% of net revenue from operations versus 13% in FY2025
FY2026 consolidated total income: Rs. 18,219.97 cr versus Rs. 16,800.85 cr in FY2025
Consolidated Q4 FY2026 parent PAT: Rs. 340.54 cr versus Rs. 455.14 cr in Q4 FY2025
FY2026 net revenue from operations: Rs. 16,166.99 cr, up 8% YoY
Standalone Q4 FY2026 EBITDA margin: 10% of net revenue from operations versus 13% in Q4 FY2025
Consolidated Q4 FY2026 total income: Rs. 4,684.78 cr versus Rs. 4,431.11 cr in Q4 FY2025
Q4 FY2026 net revenue from operations: Rs. 4,162.62 cr, up 5% YoY
FY2026 consolidated profit for the period: Rs. 1,543.51 cr versus Rs. 1,713.01 cr in FY2025
FY2026 standalone revenue from operations: Rs. 17,845.71 cr versus Rs. 16,451.27 cr in FY2025
FY2026 consolidated revenue from operations: Rs. 17,846.31 cr versus Rs. 16,451.55 cr in FY2025
FY2026 industrial and commercial PNG volume: 432.61 million SCM, up 5% YoY
Consolidated Q4 FY2026 profit for the period: Rs. 338.75 cr versus Rs. 453.21 cr in Q4 FY2025
Standalone Q4 FY2026 revenue from operations: Rs. 4,584.51 cr versus Rs. 4,337.30 cr in Q4 FY2025
Consolidated Q4 FY2026 associate profit share: Rs. 66.03 cr versus Rs. 108.10 cr in Q4 FY2025
Consolidated Q4 FY2026 revenue from operations: Rs. 4,584.58 cr versus Rs. 4,337.57 cr in Q4 FY2025
Q4 FY2026 industrial and commercial PNG volume: 113.20 million SCM, up 4% YoY
Consolidated Q4 FY2026 PBT before associate share: Rs. 380.57 cr versus Rs. 461.60 cr in Q4 FY2025

Financial highlights

Dividend: Rs 2.50 per equity share of Rs 10 recommended for FY2026
Bharuch revenue: About Rs 80 cr in FY2026, including about Rs 60 cr in Q4 FY2026
GGB acquisition: 100% equity acquired for Rs 128.8 cr; GGB FY2026 turnover Rs 58.71 cr
Civil suit claim: Artech damages claim of approximately Rs 107.86 cr
Sunstream investment: Rs 0.7 cr for 26.1% equity to secure renewable electricity
FY2026 standalone EPS: Rs 52.96
FY2026 standalone PAT: Rs 398.33 cr
FY2026 standalone PBT: Rs 530.39 cr
FY2026 consolidated PAT: Rs 414.89 cr
FY2026 consolidated PBT: Rs 552.63 cr
Q4 FY2026 standalone EPS: Rs 20.58
Q4 FY2026 standalone PAT: Rs 154.79 cr
Q4 FY2026 standalone PBT: Rs 207.38 cr; management-cited PBT margin 19.3%
Jamshedpur rail expansion: Roughly Rs 120 cr-plus capex; first bearing targeted around November/December 2026
Bharuch utilization target: Management expected utilization above 70% around July/August 2026, subject to PPAP and customer approvals
Q4 FY2026 consolidated PAT: Rs 158.31 cr
Q4 FY2026 consolidated PBT: Rs 212.03 cr
FY2026 standalone total income: Rs 3,447.32 cr
FY2026 management segment split: Rail Rs 781 cr; mobile/CV/tractors Rs 681 cr; distribution Rs 582 cr; process Rs 651 cr; intercompany exports Rs 707 cr
GGB Q4 FY2026 management figure: Revenue Rs 16.6 cr and PBT Rs 4.6 cr, implying about 30-32% PBT
March 2026 standalone inventories: Rs 778.34 cr
Q4 FY2026 standalone total income: Rs 1,075.77 cr
March 2026 standalone total assets: Rs 3,751.42 cr
Q4 FY2026 management segment split: Rail Rs 278 cr; mobile/CV/tractors Rs 205 cr; distribution Rs 162 cr; process Rs 200 cr; intercompany exports Rs 222.5 cr
FY2026 standalone operating cash flow: Rs 437.43 cr
March 2026 standalone trade receivables: Rs 797.72 cr
FY2026 standalone revenue from operations: Rs 3,419.32 cr
FY2026 consolidated revenue from operations: Rs 3,478.03 cr
Q4 FY2026 standalone revenue from operations: Rs 1,073.14 cr, up 14.2% YoY
Q4 FY2026 consolidated revenue from operations: Rs 1,089.83 cr
FY2026 standalone PPE/CWIP/capital-advance cash outflow: Rs 297.07 cr
March 2026 standalone total equity attributable to owners: Rs 2,973.50 cr

Financial highlights

Buyback: Up to Rs 11,000 mn at Rs 1,150 per equity share
Dividend: 100% dividend recommended for FY2026
Net debt: Rs 43,050 mn as at March 31, 2026
FY2026 R&D: Rs 22,732 mn, 8.4% of revenue
FY2026 EBITDA: Rs 84,751 mn, up 20.1% YoY, margin 31.2%
Q4 FY2026 R&D: Rs 6,982 mn, 9.2% of revenue
Q4 FY2026 EBITDA: Rs 25,544 mn, up 20.2% YoY, margin 33.7%
Net debt to EBITDA: 0.50x as at March 31, 2026
Net debt to equity: 0.16x as at March 31, 2026
FY2026 adjusted PBT: Rs 71,377 mn, up 14.3% YoY
FY2026 gross margin: 73.1%
FY2026 organic capex: Rs 17,145 mn
FY2026 MedTech revenue: Rs 7,823 mn
Q4 FY2026 adjusted PBT: Rs 20,572 mn, up 8.8% YoY
Q4 FY2026 gross margin: 74.0%
FY2027 capex indication: Around Rs 1,500 cr according to management Q&A
Q4 FY2026 organic capex: Rs 3,577 mn
Q4 FY2026 MedTech revenue: Rs 3,275 mn, 4% of consolidated revenue
FY2026 adjusted net profit: Rs 54,564 mn, up 15.0% YoY
FY2026 reported net profit: Rs 50,400 mn, up 11.4% YoY
India chronic portfolio share: 46.3% of India formulations as per IQVIA MAT March 2026, up 620 bps over three years
Q4 FY2026 adjusted net profit: Rs 15,929 mn, up 14.6% YoY
Q4 FY2026 reported net profit: Rs 12,725 mn, up 8.7% YoY
FY2026 Pharma Business revenue: Rs 220,240 mn, up 10.7% YoY
FY2026 revenue from operations: Rs 271,484 mn, up 16.8% YoY
FY2026 Consumer Wellness revenue: Rs 39,134 mn, up 46.0% YoY
US generics Q4 pipeline activity: 3 ANDA filings, 9 approvals and 6 launches
Consumer Wellness domestic growth: 1.7% YoY in Q4; skin and haircare up 39.7%, food and nutrition up 9.4%, seasonal brands down 9.8%
FY2026 India Formulations revenue: Rs 65,740 mn, up 10.9% YoY
Q4 FY2026 Pharma Business revenue: Rs 56,436 mn, up 4.9% YoY
Q4 FY2026 revenue from operations: Rs 75,870 mn, up 16.2% YoY and 10.5% QoQ
Assertio acquisition consideration: USD 166 mn
Q4 FY2026 Consumer Wellness revenue: Rs 14,633 mn, up 61.1% YoY
Q4 FY2026 India Formulations revenue: Rs 17,528 mn, up 14.0% YoY
US generics FY2026 pipeline activity: 30 ANDA filings and 26 approvals according to the presentation
FY2026 North America Formulations revenue: Rs 116,820 mn, up 5.7% YoY; USD 1,323 mn
Quarterly depreciation run-rate indication: Around Rs 550 cr, including capitalized Mirabegron settlement licensing fees through September 2027
Q4 FY2026 North America Formulations revenue: Rs 29,523 mn, down 5.7% YoY and up 5.3% QoQ; USD 323 mn in constant currency
FY2026 International Markets Formulations revenue: Rs 30,700 mn, up 39.9% YoY
Consumer Wellness international like-for-like growth: 31.4% including Comfort Click
Q4 FY2026 International Markets Formulations revenue: Rs 8,041 mn, up 45.0% YoY

Financial highlights

LPG loss: Rs 2,405 cr in Q4 FY2026 and Rs 9,211 cr in FY2026 before recognising subsidy receipts
FY2026 PAT: Rs 36,802 cr versus Rs 12,962 cr in FY2025
FY2026 capex: Rs 32,405 cr provisional capex incurred
Q4 FY2026 PAT: Rs 11,378 cr versus Rs 12,126 cr in Q3 FY2026
FY2026 gas sales: 7,276 TMT, including CGD sales of 188 TMT
FY2026 lube sales: 905 TMT, about 16% growth
FY2027 capex target: Rs 32,700 cr
LPG buffer position: Rs 23,102 cr as of 31 March 2026
Q4 FY2026 gas sales: 1,814 TMT, including CGD sales of 54 TMT
Gross debt to equity: 0.54 as of 31 March 2026
FY2026 standalone PBT: Rs 48,784 cr
FY2026 interest income: Rs 1,688 cr
Paradip PX-PTA complex: Approved cost Rs 13,805 cr; 93.5% physical progress; expected Aug 2026
FY2026 ethanol blending: 19.97% on all-India basis up to March 2026
Q4 FY2026 standalone PBT: Rs 15,322 cr
FY2026 total sales volume: 105.117 MMT, highest-ever, about 5% growth
Q4 FY2026 interest income: Rs 342 cr
Barauni refinery expansion: 6 MMTPA to 9 MMTPA; approved cost Rs 18,113 cr; 90.5% physical progress; expected Aug 2026
FY2026 EBITDA contribution: Rs 73,718 cr
FY2026 petrochemical sales: 3.396 MMT, highest-ever
FY2026 pipeline throughput: 105.6 MMT, highest-ever, capacity utilisation 73.7%
FY2026 refining throughput: 75.5 MMT, highest-ever, capacity utilisation 107.4%
Gujarat refinery expansion: 13.7 MMTPA to 18 MMTPA; approved cost Rs 18,936 cr; 87.8% physical progress; expected Nov 2026
Panipat refinery expansion: 15 MMTPA to 25 MMTPA; approved cost Rs 38,231 cr; 92.8% physical progress; expected Dec 2026 with progressive start from Jun 2026
FY2026 interest expenditure: Rs 7,969 cr
Project SPRINT FY2027 target: Rs 2,500 cr savings target
Q4 FY2026 total sales volume: 27.343 MMT versus 27.184 MMT in Q3 FY2026
Mundra-Panipat crude pipeline: Approved cost Rs 9,028 cr; 90.8% physical progress; expected Jun 2026
Project SPRINT FY2026 savings: About Rs 2,200 cr from repairs and maintenance, energy efficiency, supply-chain optimisation and margin-side initiatives
Q4 FY2026 EBITDA contribution: Rs 22,345 cr
Q4 FY2026 petrochemical sales: 0.901 MMT versus 0.893 MMT in Q3 FY2026
Q4 FY2026 pipeline throughput: 27.7 MMT, capacity utilisation 78.3%
Q4 FY2026 refining throughput: 19.7 MMT, capacity utilisation 113.9%
Borrowings as of 31 March 2026: Rs 1,10,668 cr, down Rs 5,280 cr during Q4 and Rs 23,798 cr during FY2026
FY2026 revenue from operations: Rs 8,86,224 cr versus Rs 8,45,513 cr in FY2025
Q4 FY2026 interest expenditure: Rs 1,849 cr
LPG under-recovery per cylinder: Rs 100 in Q4 FY2026, Rs 171 in April 2026 and Rs 670 in May 2026
FY2027 renewable capex indication: about Rs 5,000 cr within the FY2027 capex plan, according to Q&A commentary
Q4 FY2026 revenue from operations: Rs 2,32,855 cr versus Rs 2,17,725 cr in Q4 FY2025 and Rs 2,31,769 cr in Q3 FY2026
FY2026 retail outlets commissioned: 2,597 outlets, taking total retail outlets to 42,818
Panipat polybutadiene rubber plant: Approved cost Rs 2,949 cr; 84.3% physical progress; expected Jun 2026
FY2026 domestic petroleum sales growth: about 4.8%, supported by positive market-share increase
FY2026 national-highway retail outlets: Record 909 retail outlets commissioned in D1 / national-highway markets
FY2026 crude liability exchange fluctuation: Loss of Rs 2,407 cr
Net debt to equity after financial investments: 0.32 as of 31 March 2026
Q4 FY2026 crude liability exchange fluctuation: Loss of Rs 1,375 cr
FY2026 other-than-crude liability exchange fluctuation: Loss of Rs 4,876 cr
FY2026 refinery operations high-sulphur crude utilisation: 56.2%
Q4 FY2026 other-than-crude liability exchange fluctuation: Loss of Rs 2,950 cr
Q4 FY2026 refinery operations high-sulphur crude utilisation: 61.3%

Financial highlights

IVI order: About Rs 600 crore estimated annual peak value, SOP in Q3 FY2029
FY2026 ROE: 19.1%
FY2026 ROCE: 19.2%
FY2026 capex: Rs 1,572 crore
Final dividend: Rs 1.75 per share
Current NSE ISIN: INE405E01023
Q4 FY2026 EBITDA: Rs 603 crore, up 14% YoY
Net debt-to-equity: 0.30x at March 31 2026
Sunroof order book: More than Rs 350 crore potential after additional Rs 85 crore annual peak order
FY2027 growth capex: About Rs 1,100 crore
4W EV powertrain SOP: Q2 FY2028
FY2027 planned capex: About Rs 1,750 crore
Total FY2026 dividend: Rs 2.65 per share / about Rs 153 crore
FY2026 casting revenue: Rs 3,694 crore
FY2026 expansion capex: Rs 861 crore
FY2027 sustaining capex: About Rs 650 crore
Q4 FY2026 4W EV revenue: Rs 46 crore
Q4 FY2026 EBITDA margin: 11.3%
2-wheeler lighting order: About Rs 450 crore annual peak value, SOP in H2 FY2028
FY2026 normalized EBITDA: Rs 2,182 crore, up 16% YoY
Silver-box display order: About Rs 200 crore annual peak value, production expected Q4 FY2027
Current NSE active symbol: UNOMINDA
EBITDA margin expectation: Around 11% plus or minus 50 bps
International revenue mix: About 10% of Q4 FY2026 revenue
Net debt at March 31 2025: Rs 2,091 crore
Net debt at March 31 2026: Rs 2,179 crore
Q4 FY2026 casting revenue: Rs 982 crore
Seating export order wins: About Rs 390 crore annual peak value from three Europe and North America customers
FY2026 CSN land acquisition: Rs 149 crore
Minda Onkyo remaining stake: 19% remaining stake at revised Rs 0.68 per share; post-acquisition holding to become 99%
Q4 FY2026 acoustics revenue: Rs 225 crore
Enabling fund raise approval: Up to Rs 2,500 crore
4W EV powertrain project cost: About Rs 550 crore
EV Systems further investment: Up to Rs 20 crore
FY2026 green mobility revenue: Rs 1,405 crore, up 7% YoY
FY2026 other products revenue: Rs 3,801 crore, up 26% YoY
Q4 FY2026 aftermarket revenue: Rs 340 crore
FY2026 alternate fuels revenue: Rs 592 crore, up 18% YoY
FY2026 seating systems revenue: Rs 1,416 crore, up 23% YoY
FY2026 2-wheeler switch exports: More than Rs 280 crore
FY2026 2W/3W EV systems revenue: Rs 501 crore, up 31% YoY
FY2026 lighting systems revenue: Rs 4,402 crore
FY2026 normalized EBITDA margin: 11.1%
Q4 FY2026 OEM spare-parts sales: Rs 232 crore
Q4 FY2026 blow moulding revenue: Rs 118 crore
FY2026 cash flow from operations: Rs 1,722 crore
FY2026 switching systems revenue: Rs 4,871 crore
Q4 FY2026 green mobility revenue: Rs 423 crore, up 25% YoY
Q4 FY2026 other products revenue: Rs 1,053 crore
FRIWO/UMEVS acquisition cash flow: About Rs 200 crore
Q4 FY2026 alternate fuels revenue: Rs 186 crore
Q4 FY2026 seating systems revenue: Rs 381 crore
4W EV powertrain proposed capacity: 1.85 lakh units per year on two-shift basis
Auto Innovations equity investment: About Rs 310 crore over two years
Q4 FY2026 2-wheeler switch exports: Rs 86 crore
Q4 FY2026 2W/3W EV systems revenue: Rs 147 crore
Q4 FY2026 lighting systems revenue: Rs 1,154 crore
Q4 FY2026 sensors and ADAS revenue: Rs 205 crore
Q4 FY2026 non-EV controller revenue: Rs 86 crore
Q4 FY2026 switching systems revenue: Rs 1,343 crore
FY2026 2-wheeler alloy wheel revenue: Rs 1,058 crore
FY2026 4-wheeler alloy wheel revenue: Rs 1,964 crore
FY2026 aluminium die casting revenue: Rs 673 crore
Q4 FY2026 PAT attributable to owners: Rs 326 crore, up 22% YoY
FY2026 normalized consolidated revenue: Rs 19,589 crore, up 17% YoY
Legacy symbol retired from NSE EQ list: MINDAIND
Q4 FY2026 2-wheeler alloy wheel revenue: Rs 259 crore
Q4 FY2026 4-wheeler alloy wheel revenue: Rs 535 crore
Q4 FY2026 aluminium die casting revenue: Rs 188 crore
Aluminium pass-through in casting growth: Roughly 4% to 5% in Q4 FY2026
Q4 FY2026 EV-specific controller revenue: Rs 44 crore
FY2026 normalized PAT attributable to owners: Rs 1,166 crore, up 24% YoY
FY2026 share of profit from associates and JVs: Rs 249 crore
Q4 FY2026 consolidated revenue from operations: Rs 5,336 crore, up 18% YoY
FY2026 group revenue including JVs and associates: Rs 25,203 crore, unaudited
Q4 FY2026 share of profit from associates and JVs: Rs 64 crore
Q4 FY2026 group revenue including JVs and associates: Rs 6,829 crore, unaudited

Financial highlights

Employees: More than 2,200
FY2026 EPS: Rs 21.36
FY2026 RoE: 12.6% in investor presentation chart
FY2026 RoCE: 11.5% in investor presentation chart
API molecules: More than 50
Planned capex: Around Rs 300-400 crore over the next two to three years / three to four years, mostly brownfield/quasi-greenfield and formulation-led
Q4 FY2026 EPS: Rs 6.05
Completed capex: About Rs 600 crore at Sayakha and Tarapur per investor presentation
FY2026 net debt: About Rs 566 crore in investor presentation chart
Consolidated PPE: Rs 1,068.3 crore at March 31, 2026
Countries served: More than 100
FY2026 R&D spend: Rs 66 crore
FY2026 production: 53,139 MT
Finished products: More than 80
FY2026 API revenue: Rs 1,979.4 crore, up 2% YoY
FY2026 API sales mix: 77.2%
FY2026 net production: 39,931 MT
Q4 FY2026 API revenue: Rs 551.0 crore, flat YoY and up 21% QoQ
API installed capacity: 48,204 MTPA
FY2026 consolidated PAT: Rs 194.9 crore, up 16% YoY
FY2026 consolidated PBT: Rs 210.9 crore
Q4 FY2026 API sales mix: 76.5%
Consolidated inventories: Rs 490.8 crore at March 31, 2026
Manufacturing facilities: 14 facilities
Consolidated total assets: Rs 2,808.1 crore at March 31, 2026
Consolidated total equity: Rs 1,549.2 crore at March 31, 2026
FY2026 installed capacity: 82,512 MT in investor presentation manufacturing-footprint table
FY2026 net debt to equity: About 0.37x in investor presentation chart
FY2026 captive consumption: 13,208 MT
FY2026 consolidated EBITDA: Rs 311.6 crore, up 3% YoY
FY2026 export contribution: 38%, up from 35% in FY2025
Q4 FY2026 consolidated PAT: Rs 55.3 crore, down 12% YoY and up 36% QoQ
Q4 FY2026 consolidated PBT: Rs 70.4 crore
FY2026 Formulation sales mix: 12.9%
Q4 FY2026 standalone revenue: Rs 631.7 crore versus Rs 623.0 crore in Q4 FY2025
FY2026 working-capital change: Negative Rs 64.2 crore
Q4 FY2026 consolidated EBITDA: Rs 96.6 crore, up 1% YoY and 72% QoQ
Sayakha Q3 FY2026 utilization: Around 29%
Sayakha Q4 FY2026 utilization: A little above 40%
Consolidated trade receivables: Rs 829.9 crore at March 31, 2026
FY2026 consolidated PAT margin: 7.6%
FY2026 net financing cash flow: Negative Rs 77.4 crore
FY2026 net investing cash flow: Negative Rs 173.4 crore
FY2026 net operating cash flow: Rs 253.5 crore
Formulation installed capacity: 3 billion tablets and 300 million capsules
Consolidated current borrowings: Rs 318.0 crore at March 31, 2026
FY2026 standalone volume growth: 7% in investor presentation five-year bridge
Q4 FY2026 Formulation sales mix: 12.8%
Q4 FY2026 standalone export mix: 37% of standalone revenue
FY2026 consolidated depreciation: Rs 67.0 crore
FY2026 consolidated finance cost: Rs 33.7 crore
FY2026 consolidated gross margin: 37.0%, up 90 bps YoY
FY2026 consolidated gross profit: Rs 949.0 crore, up 10% YoY
Completed capex revenue potential: More than Rs 1,200 crore revenue plus Rs 300 crore captive consumption per investor presentation
FY2026 consolidated EBITDA margin: 12.1%
FY2026 consolidated total revenue: Rs 2,567.7 crore, up 7% YoY
Q4 FY2026 consolidated PAT margin: 7.7%
Q4 FY2026 standalone domestic mix: 63% of standalone revenue
FY2026 Specialty Chemicals revenue: Rs 178.3 crore, up 37% YoY
Q4 FY2026 standalone export growth: Down 7% YoY
Consolidated cash and bank balances: Rs 8.8 crore at March 31, 2026
Consolidated non-current borrowings: Rs 256.9 crore at March 31, 2026
FY2026 Formulations segment revenue: Rs 331.2 crore, up 33% YoY
Q4 FY2026 consolidated depreciation: Rs 18.0 crore
Q4 FY2026 consolidated finance cost: Rs 8.2 crore
Q4 FY2026 consolidated gross margin: 37.6%, up 190 bps YoY and 170 bps QoQ
Q4 FY2026 consolidated gross profit: Rs 270.7 crore, up 12% YoY
Sayakha one-year utilization marker: Expected to operate above 70%
FY2026 Specialty Chemicals sales mix: 7.0%
FY2026 regulated-market contribution: 73%, up from 66% in FY2025
Q4 FY2026 consolidated EBITDA margin: 13.4%
Q4 FY2026 consolidated total revenue: Rs 721.1 crore, up 6% YoY and 20% QoQ
Q4 FY2026 standalone domestic growth: 7% YoY
Consolidated capital work in progress: Rs 213.8 crore at March 31, 2026
FY2026 cash generated from operations: Rs 249.4 crore
Q4 FY2026 Specialty Chemicals revenue: Rs 56.8 crore, up 46% YoY and 11% QoQ
Q4 FY2026 antibiotic share within API: 37.8%
Q4 FY2026 Formulations segment revenue: Rs 92.0 crore, up 42% YoY and 20% QoQ
Q4 FY2026 anti-fungal share within API: 10.0%
FY2026 Intermediates and Others revenue: Rs 76.4 crore, up 10% YoY
FY2026 new-project EBITDA loss estimate: Roughly Rs 18-20 crore
Q4 FY2026 Specialty Chemicals sales mix: 7.9%
Q4 FY2026 anti-diabetic share within API: 15.0%
Sayakha methylamines March 2026 run-rate: Nearly 1,000 tonnes per month
FY2026 Intermediates and Others sales mix: 3.0%
FY2026 standalone pricing growth/degrowth: Negative 3% in investor presentation five-year bridge
Q4 FY2026 anti-protozoal share within API: 19.6%
Q4 FY2026 standalone revenue contribution: 88% of consolidated revenue
Q4 FY2026 Intermediates and Others revenue: Rs 20.5 crore, up 3% YoY and 3% QoQ
Management-cited FY2026 formulation revenue: Rs 330.5 crore, up 16% YoY versus Rs 284.9 crore
Management-cited consolidated long-term debt: Around Rs 328 crore on the call
Q4 FY2026 Intermediates and Others sales mix: 2.8%
Q4 FY2026 anti-inflammatory share within API: 11.9%
Management-cited consolidated short-term debt: Around Rs 248 crore on the call
FY2026 net change in cash and cash equivalents: Rs 2.7 crore
Management-cited Q4 FY2026 formulation revenue: Rs 91.3 crore, up 41% YoY
Sayakha June-quarter FY2027 utilization marker: Expected to cross around 55%-60%
FY2026 consolidated net revenue from operations: Rs 2,565.3 crore
Q4 FY2026 consolidated net revenue from operations: Rs 720.3 crore
FY2026 operating profit before working-capital changes: Rs 313.7 crore
Specialty chemicals and intermediates installed capacity: 34,308 MTPA

Financial highlights

Final dividend: Rs 5 per share of face value Rs 2.
Standalone ROCE: 149%.
CTPL FY2026 loss: About Rs 33 cr.
Standalone FY2026 EPS: Negative Rs 24.20.
Standalone FY2026 PAT: Negative Rs 166 cr.
Total FY2026 dividend: Rs 9 per share.
CT Australia FY2026 PAT: Rs 11 cr loss including US profit and interest outflow.
GSK China FY2026 EBITDA: Rs 8 cr.
GSK China FY2026 topline: Rs 96 cr.
Standalone FY2026 EBITDA: Rs 115 cr, down 60% year on year.
US business FY2026 sales: About Rs 45 cr.
Treasury at March 31 2026: Rs 287 cr.
Consolidated FY2026 EBITDA: Rs 128 cr, down 60% year on year.
IMPCO Mexico FY2026 EBITDA: Rs 21 cr.
Bonaire USA FY2024 turnover: US$4,543,533.
Bonaire USA FY2025 turnover: US$2,851,951.
Bonaire USA FY2026 turnover: US$5,117,991.
CT Australia FY2026 topline: Rs 182 cr.
GST UP order revised demand: Rs 28,162 against original demand of Rs 2.65 cr.
IMPCO Mexico FY2026 topline: Rs 182 cr.
Standalone Q4 FY2026 EBITDA: Rs 34 cr versus Rs 99 cr in Q4 FY2025.
GSK China remaining net loan: Rs 4 cr, down from peak above Rs 60 cr.
Total FY2026 dividend payout: About Rs 62 cr.
Australia March 2026 infusion: AUD 25 mn, about Rs 165 cr.
Consolidated Q4 FY2026 EBITDA: Rs 52 cr versus Rs 103 cr in Q4 FY2025.
GST UP order interest dropped: Rs 2.65 cr.
Standalone FY2026 total income: Rs 823 cr.
VAT UP order revised liability: Rs 12,563 against earlier liability of Rs 13.70 cr.
Standalone FY2026 EBITDA margin: 15.0%, down from 24.2% in FY2025.
Standalone FY2026 dividend paid: Rs 82 cr.
CHPL acquisition-loan prepayment: AUD 20 mn, about Rs 132 cr.
Standalone core capital employed: Rs 78 cr.
Consolidated FY2026 EBITDA margin: 11.3%, down from 20.1% in FY2025.
Standalone CHPL equity impairment: Rs 298 cr.
CTPL IPR acquisition consideration: AUD 3.3 mn, about Rs 23 cr in May filing and about Rs 22 cr in completion filing.
Standalone FY2026 exceptional item: Rs 291 cr.
Standalone Q4 FY2026 EBITDA margin: 17.0% versus 26.9% in Q4 FY2025.
Standalone equity at March 31 2026: Rs 520 cr.
US business potential sales marker: At least Rs 140 cr per management commentary.
Consolidated Q4 FY2026 gross margin: 46.4%.
Consolidated Q4 FY2026 EBITDA margin: 15.5% versus 21.2% in Q4 FY2025.
Bonaire USA acquisition consideration: AUD 4.3 mn, about Rs 30 cr.
Standalone FY2026 operating cash flow: Rs 16 cr.
GSK China CY2026 loan repayment to date: Rs 26 cr.
Standalone FY2026 investing cash inflow: Rs 65 cr.
CTPL cumulative loss over last two years: About Rs 60 cr.
Standalone total assets at March 31 2026: Rs 688 cr.
Standalone FY2026 revenue from operations: Rs 765 cr, down from Rs 1,182 cr in FY2025.
Consolidated ROCE before exceptional items: 34% based on PBIT before exception over monthly average capital employed.
Consolidated FY2026 revenue from operations: Rs 1,131 cr, down 28% year on year.
Consolidated core-business capital employed: Rs 384 cr.
Standalone corporate funds at March 31 2026: Rs 268 cr.
Standalone Q4 FY2026 revenue from operations: Rs 199 cr versus Rs 368 cr in Q4 FY2025.
Standalone FY2026 PBT after exceptional items: Negative Rs 127 cr.
Consolidated Q4 FY2026 revenue from operations: Rs 338 cr versus Rs 488 cr in Q4 FY2025.
Standalone FY2026 PBT before exceptional items: Rs 164 cr, down from Rs 329 cr in FY2025.
Consolidated FY2026 PAT after exceptional items: Negative Rs 141 cr.
Consolidated goodwill and intangible impairment: Rs 280 cr.
Standalone Beyond India Summer Products revenue: Rs 192 cr, representing 25% of standalone revenue.
Standalone FY2026 India revenue from operations: Rs 684 cr.
Standalone prior exceptional provision reversal: Rs 8.50 cr.
Consolidated FY2026 PBT before exceptional items: Rs 149 cr, down from Rs 326 cr in FY2025.
Standalone Australia reset net exceptional impact: Rs 289.50 cr.
Standalone FY2026 Corporate Funds segment revenue: Rs 34 cr.
Standalone Q4 FY2026 PBT before exceptional items: Rs 41 cr versus Rs 109 cr in Q4 FY2025.
CTPL working-capital reduction from March infusion: AUD 5 mn, about Rs 33 cr.
Consolidated fixed-asset and working-capital reset: Rs 9 cr.
Completed Bonaire USA plus IPR aggregate remittance: AUD 7.6 mn, about Rs 52 cr.
Consolidated Australia reset net exceptional impact: About Rs 259 cr.
Consolidated Q4 FY2026 PBT before exceptional items: Rs 52 cr versus Rs 110 cr in Q4 FY2025.
CTPL working-capital borrowings after March infusion: About AUD 13 mn, about Rs 90 cr.
Beyond India Summer Products FY2026 consolidated sales: Rs 558 cr, representing 49% of consolidated revenue.
Standalone FY2026 Rest of World revenue from operations: Rs 81 cr.
Consolidated deferred-tax and other-liability write-back: Rs 30 cr.
Annual interest-burden reduction from Australia repayment: About Rs 12 cr.
CTPL working-capital borrowings after completion proceeds: About AUD 5.5 mn, about Rs 37 cr.
Standalone FY2026 cash generated from operations before tax: Rs 58 cr.
Standalone FY2026 operating profit before working-capital changes: Rs 128 cr.
Standalone FY2026 Air Cooling and Other Appliances segment revenue: Rs 777 cr.

Financial highlights

CSR FY2026: Rs 24.98 cr across 876 villages, 10 states and 1 Union Territory, with over 12.5 lakh direct beneficiaries
Final dividend FY2026: Rs 4.00 per share, 40% of face value, amounting to Rs 72.53 cr
Standalone FY2026 EPS: Rs 13.29 versus Rs 20.40 in FY2025
Standalone FY2026 PBT: Rs 320.41 cr versus Rs 464.67 cr in FY2025
Consolidated FY2026 EPS: Rs 14.66 versus Rs 22.55 in FY2025
Consolidated FY2026 PBT: Rs 364.48 cr versus Rs 516.96 cr in FY2025
Standalone FY2026 EBITDA: Rs 828.76 cr versus Rs 914.42 cr in FY2025
Standalone Q4 FY2026 EPS: Rs 4.55 versus Rs 4.08 in Q4 FY2025
Standalone Q4 FY2026 PBT: Rs 108.18 cr versus Rs 95.94 cr in Q4 FY2025
Consolidated FY2026 EBITDA: Rs 984.11 cr versus Rs 1,026.31 cr in FY2025
Consolidated Q4 FY2026 EPS: Rs 5.07 versus Rs 3.74 in Q4 FY2025
Consolidated Q4 FY2026 PBT: Rs 116.80 cr versus Rs 92.55 cr in Q4 FY2025
Social farm forestry FY2026: 11.93 cr saplings covering 90,238 acres
Standalone Q4 FY2026 EBITDA: Rs 232.30 cr versus Rs 215.97 cr in Q4 FY2025
BPPL incremental acquisition: 40,08,899 equity shares, 15.40% of BPPL paid-up share capital
Standalone FY2026 net profit: Rs 241.02 cr versus Rs 369.89 cr in FY2025
BPPL post-acquisition holding: 87.36%
Consolidated Q4 FY2026 EBITDA: Rs 279.07 cr versus Rs 229.11 cr in Q4 FY2025
Standalone FY2026 total income: Rs 6,685.68 cr versus Rs 6,702.53 cr in FY2025
Standalone Q4 FY2026 net profit: Rs 82.56 cr versus Rs 73.98 cr in Q4 FY2025
Consolidated FY2026 total income: Rs 7,136.09 cr versus Rs 6,759.53 cr in FY2025
Standalone Q4 FY2026 total income: Rs 1,812.96 cr versus Rs 1,669.67 cr in Q4 FY2025
Consolidated FY2026 Others revenue: Rs 192.17 cr versus Rs 53.97 cr in FY2025
Highest ever paper and board sales: 8.19 lakh MT in FY2026 per management press release
Consolidated Q4 FY2026 total income: Rs 1,968.50 cr versus Rs 1,688.65 cr in Q4 FY2025
Standalone FY2026 exceptional items: Rs 13.60 cr
Consolidated FY2026 exceptional items: Rs 17.36 cr
Consolidated Q4 FY2026 Others revenue: Rs 81.99 cr
Standalone Q4 FY2026 exceptional items: Rs 0.64 cr
Standalone inventories at March 31 2026: Rs 1,154.51 cr
Consolidated Q4 FY2026 exceptional items: Rs 3.00 cr
Standalone total assets at March 31 2026: Rs 8,820.35 cr
Consolidated inventories at March 31 2026: Rs 1,348.47 cr
Consolidated total assets at March 31 2026: Rs 10,538.25 cr
Consolidated FY2026 EBITDA in press release: Rs 984.11 cr
Consolidated FY2026 net profit for the period: Rs 271.87 cr versus Rs 406.68 cr in FY2025
Consolidated FY2026 turnover in press release: Rs 7,568.93 cr, up 7%
Standalone FY2026 net revenue from operations: Rs 6,631.70 cr versus Rs 6,609.44 cr in FY2025
Consolidated Q4 FY2026 EBITDA in press release: Rs 279.07 cr
Standalone current borrowings at March 31 2026: Rs 901.56 cr
Consolidated FY2026 Paper and Packaging revenue: Rs 6,890.28 cr versus Rs 6,619.48 cr in FY2025
Consolidated FY2026 net revenue from operations: Rs 7,076.03 cr versus Rs 6,662.49 cr in FY2025
Standalone FY2026 gross revenue from operations: Rs 7,124.60 cr versus Rs 7,011.65 cr in FY2025
Consolidated Q4 FY2026 net profit for the period: Rs 90.19 cr versus Rs 66.14 cr in Q4 FY2025
Consolidated Q4 FY2026 turnover in press release: Rs 2,111.54 cr
Consolidated current borrowings at March 31 2026: Rs 1,003.81 cr
Standalone Q4 FY2026 net revenue from operations: Rs 1,807.00 cr versus Rs 1,652.49 cr in Q4 FY2025
Consolidated FY2026 gross revenue from operations: Rs 7,568.93 cr versus Rs 7,064.62 cr in FY2025
Consolidated Q4 FY2026 Paper and Packaging revenue: Rs 1,885.56 cr
Consolidated Q4 FY2026 net revenue from operations: Rs 1,965.95 cr versus Rs 1,677.05 cr in Q4 FY2025
Standalone Q4 FY2026 gross revenue from operations: Rs 1,952.59 cr versus Rs 1,768.29 cr in Q4 FY2025
Standalone non-current borrowings at March 31 2026: Rs 1,199.50 cr
Consolidated Q4 FY2026 gross revenue from operations: Rs 2,111.54 cr versus Rs 1,792.76 cr in Q4 FY2025
Consolidated non-current borrowings at March 31 2026: Rs 1,432.44 cr
Standalone FY2026 net cash from operating activities: Rs 518.23 cr
Consolidated FY2026 net profit attributable to owners: Rs 265.84 cr versus Rs 408.79 cr in FY2025
New Labour Codes standalone FY2026 exceptional impact: Rs 13.60 cr
Consolidated FY2026 net cash from operating activities: Rs 772.81 cr
Consolidated FY2026 Others PBIT before exceptional items: Rs 27.95 cr versus Rs 5.06 cr in FY2025
Consolidated Q4 FY2026 net profit attributable to owners: Rs 91.98 cr versus Rs 67.75 cr in Q4 FY2025
Standalone FY2026 profit before exceptional items and tax: Rs 334.01 cr versus Rs 464.67 cr in FY2025
Standalone FY2026 purchase of property plant and equipment: Rs 452.24 cr
Consolidated FY2026 profit before exceptional items and tax: Rs 381.84 cr versus Rs 516.96 cr in FY2025
Consolidated Q4 FY2026 Others PBIT before exceptional items: Rs 20.00 cr
Standalone Q4 FY2026 profit before exceptional items and tax: Rs 108.82 cr versus Rs 95.94 cr in Q4 FY2025
Consolidated Q4 FY2026 profit before exceptional items and tax: Rs 119.80 cr versus Rs 92.55 cr in Q4 FY2025
Consolidated FY2026 PAT attributable to owners in press release: Rs 265.84 cr
New Labour Codes consolidated assessed retiral-obligation impact: Rs 16.30 cr per note; consolidated exceptional-items table shows Rs 17.36 cr
Consolidated Q4 FY2026 PAT attributable to owners in press release: Rs 91.98 cr
Consolidated FY2026 Paper and Packaging PBIT before exceptional items: Rs 519.17 cr versus Rs 592.59 cr in FY2025
Consolidated FY2026 purchase of property plant equipment and intangibles: Rs 503.28 cr
Consolidated Q4 FY2026 Paper and Packaging PBIT before exceptional items: Rs 156.78 cr

Financial highlights

New logos added: 4
FY2025 basic EPS: Rs 8.45
FY2026 basic EPS: Rs 9.59
FY2025 PAT margin: 18.9%
FY2025 PBT margin: 24.9% to 25.0%
FY2026 PAT margin: 17.8%
FY2026 PBT margin: 23.0%
T&M-type work mix: About 80%
FY2025 diluted EPS: Rs 8.41
FY2026 diluted EPS: Rs 9.56
FY2026 gross margin: 50.8%
Q3 FY2026 basic EPS: Rs 2.43
Q4 FY2025 basic EPS: Rs 2.59
Q4 FY2026 basic EPS: Rs 2.55
Q3 FY2026 PAT margin: 17.2%
Q3 FY2026 PBT margin: 22.6%
Q4 FY2025 PAT margin: 20.2%
Q4 FY2025 PBT margin: 24.6%
Q4 FY2026 PAT margin: 18.1%
Q4 FY2026 PBT margin: 23.2%
FY2024 revenue in USD: USD 77.7 mn
FY2025 revenue in USD: USD 100.3 mn
FY2026 PBT growth YoY: 14.2%
FY2026 revenue in USD: USD 119.8 mn
FY2026 standalone PBT: Rs 1,711.79 mn
Q3 FY2026 diluted EPS: Rs 2.42
Q4 FY2025 diluted EPS: Rs 2.58
Q4 FY2026 diluted EPS: Rs 2.55
Q4 FY2026 utilization: Almost 89%
FY2025 reported EBITDA: Rs 1,957 mn
FY2026 reported EBITDA: Rs 2,363 mn
FY2025 consolidated PBT: Rs 2,287.40 mn
FY2026 consolidated PBT: Rs 2,611.64 mn
FY2027 planning USD/INR: About Rs 92
FY2026 revenue milestone: Crossed Rs 1,000 cr
FY2026 standalone profit: Rs 1,294.50 mn
Q3 FY2026 revenue in USD: USD 31.3 mn
Q4 FY2025 revenue in USD: USD 26.8 mn
Q4 FY2026 PBT growth QoQ: 5.9%
Q4 FY2026 PBT growth YoY: 13.6%
Q4 FY2026 revenue in USD: USD 31.4 mn
Q4 FY2026 standalone PBT: Rs 451.08 mn
Healtheon SAFE investment: USD 3 mn
Q3 FY2026 reported EBITDA: Rs 621 mn
Q4 FY2025 reported EBITDA: Rs 549 mn
Q4 FY2026 reported EBITDA: Rs 675 mn
BFSI FY2026 revenue growth: More than 80%
Expected Databricks growth: About 60% plus
FY2027 BFSI growth posture: At least about 40%
Postal ballot e-voting end: July 19, 2026 at 5:00 p.m. IST
Q3 FY2026 consolidated PBT: Rs 667.81 mn
Q4 FY2025 consolidated PBT: Rs 622.58 mn
Q4 FY2026 consolidated PBT: Rs 707.15 mn
Decision Point seller claim: INR 2,203.30 mn
FY2026 basic EPS growth YoY: 13.4%
Prior utilization reference: About 85%
Q4 FY2026 standalone profit: Rs 349.56 mn
FY2026 consolidated goodwill: Rs 2,448.82 mn
FY2027 planned EBITDA margin: 21% to 22%
Healtheon incorporation date: March 20, 2026
Postal ballot e-voting start: June 20, 2026 at 9:00 a.m. IST
Claude certification sign-ups: More than 200 people
FY2024 adjusted EBITDA margin: 21.2%
FY2025 adjusted EBITDA margin: 23.7%
FY2025 reported EBITDA margin: 23.1%
FY2026 USD revenue growth YoY: 19.4%
FY2026 adjusted EBITDA margin: 23.0%
FY2026 diluted EPS growth YoY: 13.7%
FY2026 reported EBITDA margin: 22.3%
Postal ballot result deadline: On or before July 21, 2026
FY2026 reported PAT growth YoY: 16.5%
FY2026 standalone total income: Rs 4,708.59 mn
FY2027 consumer growth posture: 18% to 22%
FY2027 targeted organic growth: 18% to 20%
FY2026 consolidated current tax: Rs 711.78 mn
FY2025 consolidated other income: Rs 689.39 mn
FY2025 consolidated total assets: Rs 17,886.34 mn
FY2025 consolidated total income: Rs 9,167.82 mn
FY2026 consolidated deferred tax: Rs -121.38 mn
FY2026 consolidated other income: Rs 758.11 mn
FY2026 consolidated total assets: Rs 20,943.87 mn
FY2026 consolidated total equity: Rs 17,838.94 mn
FY2026 consolidated total income: Rs 11,360.03 mn
Q3 FY2026 adjusted EBITDA margin: 23.0%
Q3 FY2026 reported EBITDA margin: 22.4%
Q4 FY2025 adjusted EBITDA margin: 24.5%
Q4 FY2025 reported EBITDA margin: 23.7%
Q4 FY2026 USD revenue growth QoQ: 0.5%
Q4 FY2026 USD revenue growth YoY: 17.0%
Q4 FY2026 adjusted EBITDA margin: 24.1%
Q4 FY2026 reported EBITDA margin: 23.4%
AI-led project gross margin range: 55% to 58%
FY2026 adjusted EBITDA growth YoY: 21.2%
FY2026 consolidated cash increase: Rs 850.35 mn
FY2026 reported EBITDA growth YoY: 20.7%
FY2026 top 5 client concentration: 56%
Fixed-bid and fixed-type work mix: 18% to 20%
Largest-client deal conversations: USD 3 mn-plus, USD 1 mn and USD 1.5 mn opportunities
Q4 FY2026 reported PAT growth QoQ: 8.5%
Q4 FY2026 reported PAT growth YoY: 7.4%
Q4 FY2026 standalone total income: Rs 1,198.59 mn
FY2025 transaction-related expense: Rs 55 mn
FY2026 consolidated current assets: Rs 9,949.85 mn
FY2026 top 10 client concentration: 69%
FY2026 top 20 client concentration: 84%
FY2026 transaction-related expense: Rs 76 mn
Q4 FY2026 consolidated current tax: Rs 192.17 mn
FY2024 consolidated adjusted EBITDA: Rs 1,360 mn
FY2025 Databricks ecosystem revenue: About USD 12 mn
FY2025 consolidated adjusted EBITDA: Rs 2,012 mn
FY2025 consolidated profit for year: Rs 1,734.97 mn
FY2026 Databricks ecosystem revenue: About USD 17.5 mn
FY2026 consolidated adjusted EBITDA: Rs 2,438 mn
FY2026 consolidated income tax paid: Rs 736.22 mn
FY2026 consolidated profit for year: Rs 2,021.24 mn
FY2026 consolidated purchase of PPE: Rs 224.87 mn
Q3 FY2026 consolidated other income: Rs 176.10 mn
Q3 FY2026 consolidated total income: Rs 2,956.19 mn
Q4 FY2025 consolidated other income: Rs 211.18 mn
Q4 FY2025 consolidated total income: Rs 2,532.95 mn
Q4 FY2026 consolidated deferred tax: Rs -35.64 mn
Q4 FY2026 consolidated other income: Rs 161.76 mn
Q4 FY2026 consolidated total income: Rs 3,047.94 mn
Q3 FY2026 top 5 client concentration: 61%
Q4 FY2026 adjusted EBITDA growth QoQ: 8.5%
Q4 FY2026 adjusted EBITDA growth YoY: 22.3%
Q4 FY2026 reported EBITDA growth QoQ: 8.7%
Q4 FY2026 reported EBITDA growth YoY: 23.0%
Call-time USD/INR cited by management: About Rs 95 to Rs 96 or higher
FY2026 cash from business combination: Rs 200.25 mn
FY2026 consolidated intangible assets: Rs 953.43 mn
FY2026 consolidated trade receivables: Rs 2,311.80 mn
FY2026 standalone operating cash flow: Rs 520.93 mn
Largest-client revenue-loss reference: Closer to USD 7 mn
Managed-services construct within T&M: About 65% to 68%
Q3 FY2026 top 10 client concentration: 74%
Q3 FY2026 top 20 client concentration: 86%
Q3 FY2026 transaction-related expense: Rs 19 mn
Q4 FY2025 transaction-related expense: Rs 19 mn
Q4 FY2026 transaction-related expense: Rs 20 mn
Rest-of-world Q4 FY2026 revenue share: About 15%
FY2026 consolidated revenue growth YoY: 25.0%
FY2026 non-controlling interest profit: Rs 40.02 mn
Q3 FY2026 consolidated adjusted EBITDA: Rs 640 mn
Q4 FY2025 consolidated adjusted EBITDA: Rs 568 mn
Q4 FY2026 consolidated adjusted EBITDA: Rs 695 mn
FY2025 consolidated operating cash flow: Rs 1,304.74 mn
FY2026 consolidated current investments: Rs 3,176.67 mn
FY2026 consolidated current liabilities: Rs 2,454.63 mn
FY2026 consolidated operating cash flow: Rs 1,645.32 mn
FY2026 consolidated sale of investments: Rs 10,834.12 mn
Q4 FY2026 adjusted EBITDA forex benefit: About 1.1 percentage points
US revenue share eight quarters earlier: About 94%
Work involving AI in some shape or form: Almost half
Decision Point initial acquisition stake: 70%
FY2026 net profit attributable to owners: Rs 1,981.22 mn
FY2026 revenue with visible AI component: 28%
Q3 FY2026 consolidated profit for period: Rs 507.71 mn
Q4 FY2025 consolidated profit for period: Rs 512.57 mn
Q4 FY2026 consolidated profit for period: Rs 550.62 mn
Revenue growth since FY2022 listing year: 2.20x in USD terms
Decision Point prior redemption liability: INR 676.85 mn
FY2025 standalone revenue from operations: Rs 3,471.25 mn
FY2026 standalone revenue from operations: Rs 3,975.43 mn
FY2027 technology vertical growth posture: 5% to 8%
Healtheon immediate shareholding acquired: Nil
Q4 FY2026 consolidated revenue growth QoQ: 3.8%
Q4 FY2026 consolidated revenue growth YoY: 24.3%
Q4 FY2026 non-controlling interest profit: Rs 23.10 mn
FY2026 consolidated non-current borrowings: Rs 0.19 mn
Largest-client current-year revenue target: At least 95% of prior-year revenue
FY2025 consolidated revenue from operations: Rs 8,478.43 mn
FY2026 consolidated lease liabilities total: Rs 332.22 mn
FY2026 consolidated non-current investments: Rs 5,992.82 mn
FY2026 consolidated non-current liabilities: Rs 650.30 mn
FY2026 consolidated purchase of investments: Rs 11,172.02 mn
FY2026 consolidated revenue from operations: Rs 10,601.92 mn
Healtheon immediate voting control acquired: None
Q4 FY2026 net profit attributable to owners: Rs 527.52 mn
Revenue from clients served over five years: 72% of current revenue
Technology vertical Q4 FY2026 revenue share: About 55%
Decision Point remaining stake not completed: 20%
Q3 FY2026 standalone revenue from operations: Rs 1,050.50 mn
Q4 FY2025 standalone revenue from operations: Rs 978.68 mn
Q4 FY2026 standalone revenue from operations: Rs 1,004.70 mn
Claude certification final-stage participants: Almost 40 people
FY2026 consolidated cash and cash equivalents: Rs 1,585.14 mn
Decision Point additional FY2026 consideration: INR 11.09 mn
FY2026 consolidated total comprehensive income: Rs 2,424.10 mn
FY2027 high-visibility growth at start of year: 12% to 13%
Q3 FY2026 consolidated revenue from operations: Rs 2,780.09 mn
Q4 FY2025 consolidated revenue from operations: Rs 2,321.77 mn
Q4 FY2026 consolidated revenue from operations: Rs 2,886.18 mn
Decision Point additional FY2026 stake acquired: 10%
Decision Point initial acquisition consideration: INR 3,315 mn
FY2026 consolidated bank balance other than cash: Rs 1,752.64 mn
ESG rating from ESG Risk Assessments and Insights: 76
Q4 FY2026 consolidated total comprehensive income: Rs 758.51 mn
FY2026 consolidated cash generated from operations: Rs 2,381.54 mn
Rest-of-world revenue share eight quarters earlier: About 6%
Typical effective tax rate highlighted by management: About 25%
Q4 FY2026 effective tax rate highlighted by management: About 22%
FY2026 consolidated equity attributable to shareholders: Rs 17,552.02 mn
ESG rating from NSE Sustainability Ratings and Analytics: 70
Healtheon SAFE investment INR equivalent in audited note: INR 279.98 mn
Technology vertical revenue share eight quarters earlier: About 70%
FY2026 consolidated payment for acquisition of subsidiary: Rs 11.09 mn
Financial Services FY2026 revenue growth per presentation: 84%
Q4 FY2025 forex gain in other income highlighted by management: About Rs 4.5 cr
Decision Point management-estimated maximum redemption liability: INR 703.46 mn

Financial highlights

rd_day_headcount_context: from more than 400 in FY2024 to about 250 expected next year
rd_day_lab_centers_context: from 4 lab centers to 2 lab centers
rd_day_prior_annual_spend_base: about USD 50 million
derived_full_warrant_issue_size: about Rs 600.19 crore
preferential_warrant_issue_price: Rs 155.80 per warrant
rd_day_fixed_cost_savings_target: about USD 10 million annually
audited_consolidated_ppe_march_2026: Rs 85.18 crore
rd_day_operational_spend_projection: USD 29 million versus USD 31 million last year
rd_day_promoter_backed_debt_context: more than USD 45 million cumulatively as of Q2 FY2026
audited_consolidated_fy2026_tax_credit: Rs 0.19 crore
audited_standalone_fy2026_total_income: Rs 1,890.00 crore
warrant_upfront_consideration_received: Rs 149.99645 crore
audited_consolidated_fy2026_other_income: Rs 10.95 crore
audited_consolidated_fy2026_total_income: Rs 1,890.12 crore
audited_standalone_fy2026_total_expenses: Rs 325.51 crore
audited_consolidated_fy2026_finance_costs: Rs 34.13 crore
audited_consolidated_q4_fy2026_tax_credit: Rs 0.38 crore
audited_standalone_q4_fy2026_total_income: Rs 1,855.02 crore
priority_review_voucher_income_recognized: Rs 1,840.02 crore
audited_consolidated_fy2025_loss_after_tax: Rs 342.51 crore
audited_consolidated_fy2026_other_expenses: Rs 46.64 crore
audited_consolidated_fy2026_total_expenses: Rs 324.75 crore
audited_standalone_fy2026_profit_after_tax: Rs 1,552.13 crore
audited_standalone_total_assets_march_2026: Rs 2,167.98 crore
audited_standalone_total_equity_march_2025: Rs -220.62 crore
audited_standalone_total_equity_march_2026: Rs 1,333.58 crore
priority_review_voucher_sale_consideration: USD 195 million
audited_consolidated_q4_fy2026_other_income: Rs 1.80 crore
audited_consolidated_q4_fy2026_total_income: Rs 1,855.02 crore
audited_standalone_fy2026_profit_before_tax: Rs 1,552.13 crore
audited_standalone_q4_fy2026_total_expenses: Rs 94.32 crore
audited_consolidated_fy2026_profit_after_tax: Rs 1,553.20 crore
audited_consolidated_q4_fy2026_finance_costs: Rs 11.64 crore
audited_consolidated_total_assets_march_2026: Rs 2,170.86 crore
audited_consolidated_total_equity_march_2025: Rs -216.95 crore
audited_consolidated_total_equity_march_2026: Rs 1,338.82 crore
audited_consolidated_fy2026_profit_before_tax: Rs 1,553.01 crore
audited_consolidated_q4_fy2026_other_expenses: Rs 16.70 crore
audited_consolidated_q4_fy2026_total_expenses: Rs 94.06 crore
audited_standalone_fy2026_financing_cash_flow: Rs 261.53 crore
audited_standalone_fy2026_investing_cash_flow: Rs -23.51 crore
audited_standalone_fy2026_operating_cash_flow: Rs -238.89 crore
audited_standalone_q4_fy2026_profit_after_tax: Rs 1,760.70 crore
audited_standalone_q4_fy2026_profit_before_tax: Rs 1,760.70 crore
audited_consolidated_fy2026_financing_cash_flow: Rs 261.39 crore
audited_consolidated_fy2026_investing_cash_flow: Rs -23.50 crore
audited_consolidated_fy2026_operating_cash_flow: Rs -238.77 crore
audited_consolidated_q4_fy2026_profit_after_tax: Rs 1,761.34 crore
audited_standalone_fy2026_eps_basic_and_diluted: Rs 47.83
audited_consolidated_fy2026_professional_charges: Rs 69.48 crore
audited_consolidated_q4_fy2026_profit_before_tax: Rs 1,760.96 crore
audited_standalone_current_borrowings_march_2026: Rs 556.14 crore
audited_standalone_fy2026_revenue_from_contracts: Rs 39.15 crore
audited_consolidated_fy2025_eps_basic_and_diluted: Rs -10.55
audited_consolidated_fy2026_eps_basic_and_diluted: Rs 47.86
audited_standalone_fy2026_revenue_from_operations: Rs 1,879.17 crore
audited_consolidated_current_borrowings_march_2026: Rs 556.14 crore
audited_consolidated_fy2026_revenue_from_contracts: Rs 39.15 crore
audited_standalone_q4_fy2026_eps_basic_and_diluted: Rs 54.26
preferential_warrants_allotted_to_shanghvi_finance: 3,85,10,000 warrants
audited_consolidated_fy2025_revenue_from_operations: Rs 71.77 crore
audited_consolidated_fy2026_repayment_of_borrowings: Rs 1,817.85 crore
audited_consolidated_fy2026_revenue_from_operations: Rs 1,879.17 crore
audited_consolidated_q4_fy2026_professional_charges: Rs 29.30 crore
audited_standalone_q4_fy2026_revenue_from_contracts: Rs 13.20 crore
audited_consolidated_current_other_assets_march_2026: Rs 1,845.91 crore
audited_consolidated_fy2026_proceeds_from_borrowings: Rs 2,115.81 crore
audited_consolidated_q4_fy2026_eps_basic_and_diluted: Rs 54.27
audited_standalone_q4_fy2026_revenue_from_operations: Rs 1,853.22 crore
audited_consolidated_fy2026_employee_benefits_expense: Rs 118.03 crore
audited_consolidated_fy2026_finance_cost_cash_outflow: Rs 34.22 crore
audited_consolidated_q4_fy2026_revenue_from_contracts: Rs 13.20 crore
audited_standalone_fy2026_other_operating_revenue_prv: Rs 1,840.02 crore
audited_consolidated_fy2026_cost_of_materials_consumed: Rs 23.60 crore
audited_consolidated_fy2026_total_comprehensive_income: Rs 1,555.77 crore
audited_consolidated_non_current_borrowings_march_2026: nil
audited_consolidated_q4_fy2026_revenue_from_operations: Rs 1,853.22 crore
audited_consolidated_fy2026_other_operating_revenue_prv: Rs 1,840.02 crore
audited_standalone_cash_and_cash_equivalents_march_2026: Rs 0.32 crore
audited_consolidated_q4_fy2026_employee_benefits_expense: Rs 26.02 crore
audited_standalone_q4_fy2026_other_operating_revenue_prv: Rs 1,840.02 crore
audited_consolidated_cash_and_cash_equivalents_march_2026: Rs 1.16 crore
audited_consolidated_fy2026_depreciation_and_amortisation: Rs 10.21 crore
audited_consolidated_q4_fy2026_cost_of_materials_consumed: Rs 5.16 crore
audited_consolidated_q4_fy2026_total_comprehensive_income: Rs 1,762.69 crore
audited_consolidated_q4_fy2026_other_operating_revenue_prv: Rs 1,840.02 crore
audited_consolidated_q4_fy2026_depreciation_and_amortisation: Rs 2.40 crore
audited_consolidated_fy2026_new_labour_codes_exceptional_expense: Rs 12.36 crore
audited_consolidated_fy2026_profit_before_exceptional_item_and_tax: Rs 1,565.37 crore
audited_consolidated_intangible_assets_under_development_march_2026: Rs 71.21 crore
audited_consolidated_fy2026_clinical_trial_and_product_development_expense: Rs 22.66 crore
audited_consolidated_q4_fy2026_clinical_trial_and_product_development_expense: Rs 2.84 crore

Financial highlights

DME plant: 100,000 TPA commercial production commenced May 20, 2026
NMM project: 5,000 TPA, expected during FY2027
Consolidated debt: Rs 133 crore per management commentary, mainly for expansion activities
Standalone leverage: Management said the standalone company remains zero debt
FY2027 margin marker: Management indicated EBITDA sustainability of 22% to 23% of total sales, subject to raw-material conditions
BSCL phased expansion: About Rs 750 crore for HCN, NaCN, EDTA, EDTA-2Na and other products
FY2026 final dividend: Rs 11 per share of face value Rs 2; record date July 3, 2026; AGM July 10, 2026
FY2026 standalone EPS: Rs 51.09 basic and diluted
FY2026 standalone PAT: Rs 165.53 crore
FY2026 standalone PBT: Rs 227.40 crore
Consolidated net worth: Rs 2,152 crore at March 2026 per management commentary
FY2026 consolidated EPS: Rs 51.60 basic and diluted
FY2026 consolidated PAT: Rs 169.16 crore
FY2026 consolidated PBT: Rs 232.49 crore
Q4 FY2026 amines volume: 7,746 MT
Consolidated inventories: Rs 247.12 crore at March 31, 2026
Q4 FY2026 standalone EPS: Rs 19.09 basic and diluted
Q4 FY2026 standalone PAT: Rs 61.87 crore
Q4 FY2026 standalone PBT: Rs 82.04 crore
Current-year capex marker: Management indicated about Rs 275 crore to Rs 290 crore consolidated capex
ACN improved-process plant: Expected during Q2 FY2027
Q4 FY2026 consolidated EPS: Rs 19.99 basic and diluted
Q4 FY2026 consolidated PAT: Rs 64.77 crore
Q4 FY2026 consolidated PBT: Rs 85.86 crore
FY2027 volume-growth marker: Management indicated 20% to 30% / minimum 25% to 30% volume growth by FY2027-end from current value
FY2026 hotel division revenue: Rs 35.70 crore
Consolidated trade receivables: Rs 345.86 crore at March 31, 2026
Consolidated current borrowings: Rs 68.08 crore at March 31, 2026
Consolidated other bank balances: Rs 197.43 crore at March 31, 2026
FY2026 consolidated total income: Rs 1,453.79 crore
Q4 FY2026 hotel division revenue: Rs 8.38 crore
Consolidated non-current borrowings: Rs 64.83 crore at March 31, 2026
Q4 FY2026 amines derivatives volume: 8,935 MT
Q4 FY2026 consolidated sales volume: 27,341 MT versus 25,871 MT in Q4 FY2025
Q4 FY2026 consolidated total income: Rs 402.52 crore
Q4 FY2026 specialty chemicals volume: 10,660 MT
FY2026 standalone investing cash flow: Negative Rs 128.68 crore
FY2026 standalone operating cash flow: Rs 199.55 crore
Consolidated cash and cash equivalents: Rs 73.93 crore at March 31, 2026
FY2026 consolidated investing cash flow: Negative Rs 343.57 crore
FY2026 consolidated operating cash flow: Rs 184.04 crore
FY2026 hotel division PBT after interest: Rs 9.18 crore
FY2026 standalone revenue from operations: Rs 1,291.54 crore
FY2026 consolidated revenue from operations: Rs 1,424.98 crore
Q4 FY2026 hotel division PBT after interest: Rs 1.60 crore
Management-stated FY2026 consolidated EBITDA: Rs 294 crore, 20% margin
Q4 FY2026 standalone revenue from operations: Rs 361.77 crore
Q4 FY2026 consolidated revenue from operations: Rs 394.79 crore
Management-stated Q4 FY2026 consolidated EBITDA: Rs 102 crore, 25% margin
FY2026 amines and specialty chemicals segment revenue: Rs 1,415.69 crore
Q4 FY2026 amines and specialty chemicals segment revenue: Rs 393.53 crore
FY2026 amines and specialty chemicals segment PBT after interest: Rs 220.08 crore
Q4 FY2026 amines and specialty chemicals segment PBT after interest: Rs 83.67 crore

Financial highlights

Net worth: Rs 5,806 cr in the Q4 FY2026 investor presentation
FY2026 EPS: Basic EPS from continuing operations Rs 28.30
FY2026 PAT: Rs 648.04 cr, 10.5% margin
FY2026 EBITDA: Rs 973 cr, 15.8% margin, up 32% YoY
Q4 FY2026 PAT: Rs 155 cr, 10.1% margin
Rice inventory: Rs 2,667 cr and 427,000 tons as of March 31, 2026
Inventory value: Rs 3,714 cr as of March 31, 2026 versus Rs 3,885 cr as of March 31, 2025
Paddy inventory: Rs 879 cr and 230,000 tons as of March 31, 2026
Q4 FY2026 EBITDA: Rs 237 cr, 15.5% margin
Retail footprint: 3.4 lakh retail outlets and 1.2 crore urban Indian households
Edible oil revenue: Rs 12 cr in FY2026
Dhuri ED attachment: ED attachment to the extent of Rs 1,532 lakh remains until PMLA appellate adjudication; Rs 1,113 lakh deposit refund received March 6, 2026
FY2026 gross margin: 28.3%
FY2026 total income: Rs 6,168 cr, up 9% YoY
FY2026 export revenue: Rs 1,555 cr, up about 6% YoY
Q4 FY2026 gross margin: 29.6% versus 31.5% in Q4 FY2025
Q4 FY2026 gross profit: Rs 453 cr
Q4 FY2026 total income: Rs 1,534 cr, up 6% YoY and 2% QoQ
Dividend recommendation: Rs 4.50 per share, 450% of Rs 1 face value, aggregating about Rs 103 cr
Q4 FY2026 export revenue: Rs 279 cr versus Rs 450 cr in Q4 FY2025, down 33% YoY
FY2026 export rice volume: About 160,000 metric tons
Rice-equivalent inventory: About 530,000 tons as of March 31, 2026
FY2026 domestic rice volume: About 560,000 metric tons
Q4 FY2026 export realization: About Rs 1,38,500-1,39,000 per metric ton
FY2026 branded basmati revenue: Up 9% YoY
FY2026 revenue from operations: Rs 6,098 cr, up 9% YoY
E-commerce packaged basmati share: 40.1% at March 2026 end
Q4 FY2026 revenue from operations: Rs 1,526 cr, up 6% YoY and 3% QoQ
FY2026 branded non-basmati revenue: Rs 271 cr versus Rs 197 cr in FY2025, up 38% YoY
Modern trade packaged basmati share: 38.7% in FY2026
General trade packaged basmati share: 36.9% in FY2026
Q4 FY2026 branded non-basmati revenue: Rs 78 cr versus Rs 54 cr in Q4 FY2025, up 44% YoY
FY2026 domestic revenue excluding power: Rs 4,444 cr, up 10% YoY
Q4 FY2026 domestic revenue excluding power: Rs 1,230 cr, up 22% YoY
Q4 FY2026 domestic basmati branded realization: About Rs 79,000-80,000 per metric ton
Net bank borrowings including treasury investments: Negative Rs 789 cr as of March 31, 2026 versus negative Rs 405 cr a year earlier
Cash and bank balance plus investments excluding equity shares: Rs 919 cr in the Q4 FY2026 investor presentation

Financial highlights

ROCE: 15.8% in FY2026 versus 14.9% in FY2025
US portfolio: 223 ANDAs filed and 208 ANDAs approved, representing 150 products, as of March 2026
FY2026 EBITDA: Rs 9,253 mn, up 15.3% year on year
FY2026 revenue: Rs 48,587 mn, up 6.4% year on year
Final dividend: Rs 5 per equity share of Rs 10 face value for FY2026, subject to shareholder approval
Net finance cost: Rs 1,381 mn in FY2026 versus Rs 1,957 mn in FY2025
Q4 FY2026 EBITDA: Rs 2,397 mn, up 10.0% year on year and up 1.6% sequentially
Q4 FY2026 revenue: Rs 13,235 mn, up 11.2% year on year and up 10.8% sequentially
Reported net debt: Rs 14,365 mn at March 2026, including Rs 1,115 mn adverse currency impact
US FY2026 revenue: USD 284 mn, up 2% year on year
Net debt to EBITDA: 1.55x in FY2026 versus 1.9x in FY2025
US product actions: Six launches and nine discontinuations in FY2026
FY2026 gross margin: Rs 29,000 mn, or 59.7%, up 310 bps year on year
FY2026 reported EPS: Rs 60.3, up 37.0% year on year
FY2026 reported PAT: Rs 5,745 mn, up 40.3% year on year
Operating cash flow: Rs 703 cr in FY2026, with 76% EBITDA-to-operating-cash conversion
Ex-US FY2026 revenue: USD 254 mn, up 21% year on year
FY2026 EBITDA margin: 19.0%, up 140 bps year on year
US Q4 FY2026 revenue: USD 70 mn; INR revenue Rs 6,467 mn
FY2026 operational EPS: Rs 56.2, up 50.1% year on year
FY2026 operational PAT: Rs 5,181 mn, up 50.3% year on year
Q4 FY2026 gross margin: Rs 7,872 mn, or 59.5%, up 140 bps year on year and down 170 bps sequentially
Q4 FY2026 reported EPS: Rs 13.8, up 54.3% year on year and down 37.2% sequentially
Q4 FY2026 reported PAT: Rs 1,293 mn, up 51.0% year on year and down 37.9% sequentially
Q4 FY2026 EBITDA margin: 18.1%, down 20 bps year on year and down 170 bps sequentially
Q4 FY2026 operational EPS: Rs 14.7, up 20.0% year on year
Q4 FY2026 operational PAT: Rs 1,357 mn, up 20.0% year on year and up 5.9% sequentially
OneSource retained interest: About Rs 337 cr, not adjusted from net debt
Growth Markets FY2026 revenue: USD 68 mn, up 22% year on year
Growth capex and growth initiatives: Rs 418 cr in FY2026, including Rs 236 cr tangible capex and Rs 182 cr intangible investments
Constant-currency net debt reduction: Rs 197 cr reduction in FY2026
Other Regulated Markets FY2026 revenue: USD 186 mn, up 21% year on year

Financial highlights

Credit ratings: CRISIL AA+/Stable and A1+; India Ratings IND AA+/Stable and IND A1+
FY2026 sugar PBIT: Rs 514.66 crore, 9.35% margin
PLA project capacity: 80,000 TPA, optimized from 75,000 TPA
Q4 FY2026 sugar PBIT: Rs 231.29 crore, 14.31% margin
FY2026 distillery PBIT: Rs 203.27 crore, 11.8% margin
Preferential allotment: 93,16,771 equity shares at Rs 483 per share, aggregating Rs 450,00,00,393
FY2026 PLA segment PBIT: Loss of Rs 16.72 crore
FY2026 consolidated PBT: Rs 560.15 crore
FY2026 distillery sales: 26.56 crore bulk litres, with Rs 60.15 per bulk litre blended realization
PLA project gross capex: About Rs 3,080 crore
FY2026 total sugar sales: 100.56 lakh quintals versus 94.22 lakh quintals in FY2025
PLA proposed funding mix: Rs 1,650 crore debt and Rs 1,430 crore equity or internal accruals
FY2026 distillery revenue: Rs 1,720.97 crore versus Rs 1,430.01 crore in FY2025
Q4 FY2026 distillery PBIT: Rs 53.68 crore, 10.7% margin
Lactogypsum project outlay: Rs 160 crore
Q4 FY2026 consolidated PBT: Rs 236.17 crore
Q4 FY2026 total sugar sales: 21.42 lakh quintals versus 19.95 lakh quintals in Q4 FY2025
FY2026 sugar segment revenue: Rs 5,507.23 crore versus Rs 4,897.41 crore in FY2025
Q4 FY2026 distillery revenue: Rs 501.18 crore versus Rs 530.05 crore in Q4 FY2025
SS 2025-26 sugarcane crushed: 104.30 lakh MT, versus 99.16 lakh MT in SS 2024-25
FY2026 consolidated basic EPS: Rs 18.74 versus Rs 21.65 in FY2025
PLA project revenue potential: About Rs 2,000 crore at full capacity
SS 2025-26 net sugar produced: 9.68 lakh MT
PLA project purchases committed: About Rs 2,894 crore
Q4 FY2026 sugar segment revenue: Rs 1,616.01 crore versus Rs 1,447.32 crore in Q4 FY2025
FY2026 average sugar realization: Rs 40.73 per kg versus Rs 39.06 per kg in FY2025
PLA capex spent to April 30 2026: About Rs 1,718 crore
Q4 FY2026 consolidated basic EPS: Rs 7.90 versus Rs 11.35 in Q4 FY2025
Sugar inventory at March 31 2026: 66.56 lakh quintals including WIP, valued at Rs 36.70 per kg
Q4 FY2026 standalone EBITDA margin: 17.76% versus 24.29% in Q4 FY2025
Q4 FY2026 average sugar realization: Rs 40.83 per kg versus Rs 40.47 per kg in Q4 FY2025
SS 2025-26 gross recovery in C-terms: 11.24% versus 11.28% in SS 2024-25
Long-term borrowings at March 31 2026: Rs 97.50 crore for existing business and Rs 903.00 crore for PLA
Existing-business debt repaid in FY2026: Rs 89 crore
FY2026 consolidated revenue from operations: Rs 6,271.15 crore versus Rs 5,415.38 crore in FY2025, up 15.80%
FY2026 standalone operating cash generation: Rs 599.47 crore
FY2026 standalone net cash used in investing: Rs 946.66 crore
Paid-up equity share capital after allotment: 21,12,67,207 equity shares on a fully diluted basis
SS 2025-26 net sugar recovery after diversion: 9.28% versus 9.32% in SS 2024-25
FY2026 consolidated total comprehensive income: Rs 380.35 crore versus Rs 438.84 crore in FY2025, down 13.33%
Long-term debt for PLA capex availed in FY2026: Rs 508 crore
Q4 FY2026 consolidated revenue from operations: Rs 1,603.99 crore versus Rs 1,503.68 crore in Q4 FY2025, up 6.67%
FY2026 consolidated EBITDA excluding other income: Rs 741.28 crore versus Rs 704.24 crore in FY2025, up 5.26%
FY2026 ethanol production indicated by management: About 27 crore litres
Q4 FY2026 consolidated total comprehensive income: Rs 157.23 crore versus Rs 225.43 crore in Q4 FY2025, down 30.25%
Lactogypsum project capacity and revenue potential: About 63 lakh pieces to 76 lakh boards per annum and about Rs 150 crore annual revenue potential indicated on the PLA update call
Q4 FY2026 consolidated EBITDA excluding other income: Rs 284.79 crore versus Rs 365.24 crore in Q4 FY2025, down 22.03%
Existing ethanol nameplate potential indicated by management: About 34 crore to 35 crore litres, route-mix dependent on price